data_1yjr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yjr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.455 -0.184 0 N-CA-C 109.128 -0.693 . . . . 3.36 109.128 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 tp -144.69 142.32 29.98 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.156 -1.054 . . . . 3.66 108.156 168.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -101.14 132.88 46.39 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.975 0.91 . . . . 2.47 109.487 166.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -132.6 162.18 31.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.934 1.294 . . . . 3.09 107.644 166.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 t -117.7 133.09 65.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 126.166 1.786 . . . . 2.59 107.108 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.48 99.36 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 C-N-CA 124.086 0.954 . . . . 2.41 110.891 -168.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.4 mtt85 -68.84 150.64 47.58 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.924 -1.139 . . . . 6.08 107.924 171.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.72 -5.14 39.95 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.215 0.912 . . . . 1.05 113.67 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 69.7 mtm -74.17 69.2 1.51 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.831 1.315 . . . . 2.1 112.543 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 t -65.82 126.35 28.2 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.214 0.531 . . . . 3.55 111.817 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 t 52.02 82.42 0.07 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.811 2.044 . . . . 4.13 114.391 156.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 50.77 -101.83 0.1 Allowed 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.614 1.166 . . . . 2.26 110.229 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 9.85 -71.65 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 129.99 3.316 . . . . 2.83 115.781 172.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.7 m -36.78 -46.49 0.61 Allowed 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 125.589 1.555 . . . . 1.87 112.516 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.1 t -36.42 -68.12 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.027 1.331 . . . . 2.22 111.579 168.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -29.0 65.78 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.896 -0.503 . . . . 1.48 110.072 -175.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -38.29 77.37 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.531 0.733 . . . . 4.41 109.59 177.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.7 mt -74.41 -68.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 106.422 -1.696 . . . . 1.64 106.422 172.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -48.0 -56.34 7.9 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.311 1.444 . . . . 3.08 111.369 -166.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 t -60.99 -42.3 98.15 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.586 0.708 . . . . 2.0 109.992 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.3 t -65.95 -49.45 67.88 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.224 -0.658 . . . . 1.59 109.224 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.41 -39.44 83.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.023 -1.048 . . . . 3.31 111.301 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.2 p -58.34 -11.24 2.59 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.934 1.087 . . . . 1.74 113.934 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -68.7 -34.95 76.52 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.505 1.048 . . . . 4.53 111.592 170.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -62.71 122.06 14.94 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.784 0.434 . . . . 2.51 110.509 -167.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -76.56 65.9 2.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.209 1.004 . . . . 7.11 110.824 -172.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.78 9.31 0.02 OUTLIER Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.953 1.739 . . . . 1.52 112.504 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -103.19 132.98 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.778 1.631 . . . . 2.6 106.765 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -90.17 -56.87 3.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.51 1.124 . . . . 3.76 108.777 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -148.64 136.58 20.82 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.101 0.56 . . . . 4.12 111.549 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.0 m -106.51 161.78 14.3 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.933 0.893 . . . . 2.13 109.035 172.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.1 m -150.84 96.95 2.41 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.089 0.555 . . . . 2.14 109.675 162.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.58 86.2 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 C-N-CA 126.147 1.779 . . . . 3.54 109.341 176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.86 129.41 34.84 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 121.323 -0.861 . . . . 2.11 110.946 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -77.83 -45.63 23.82 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.516 -0.766 . . . . 3.04 111.063 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.58 -45.88 90.56 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.299 0.571 . . . . 2.31 110.352 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -10.5 59.66 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.463 1.105 . . . . 3.11 111.513 176.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 51.72 31.04 7.46 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.203 1.801 . . . . 3.83 111.802 -171.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -117.21 133.83 55.51 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.641 0.777 . . . . 2.74 109.632 -165.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.94 114.39 28.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.648 -1.242 . . . . 1.87 107.648 161.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.3 142.3 27.86 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.94 -1.133 . . . . 1.33 107.94 159.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 mp -127.93 127.64 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 106.581 -1.637 . . . . 2.14 106.581 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -98.51 80.85 2.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.364 1.466 . . . . 4.08 108.376 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -116.95 165.46 13.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.591 1.556 . . . . 3.7 110.883 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -81.13 115.77 58.3 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 122.589 0.356 . . . . 3.44 110.511 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.88 -13.06 21.79 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.79 2.327 . . . . 1.68 113.92 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -81.93 -45.97 14.69 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 119.316 0.962 . . . . 4.39 108.956 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pt -81.92 -89.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.08 0.4 . . . . 2.33 112.08 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 tt -57.38 -47.02 85.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.806 1.242 . . . . 1.97 111.09 -173.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.42 164.29 28.02 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 121.512 0.507 . . . . 1.3 112.681 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.22 -37.57 31.16 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.058 3.172 . . . . 1.15 112.215 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -60.08 -50.17 74.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.442 0.697 . . . . 8.67 110.902 -168.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -50.21 -56.3 11.65 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.978 0.911 . . . . 2.43 110.037 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.9 mt -53.6 -60.6 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.496 1.118 . . . . 1.65 109.745 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.4 mt -50.69 -43.54 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 118.641 0.655 . . . . 2.8 111.208 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -76.37 -30.94 57.77 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.363 -0.836 . . . . 3.99 112.272 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.6 m -61.67 -49.76 75.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.401 -0.962 . . . . 1.66 108.401 171.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -59.58 -49.03 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.716 1.206 . . . . 2.51 109.814 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -48.84 -61.16 2.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.307 1.443 . . . . 3.53 109.252 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.0 t -59.5 -31.76 69.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.202 1.001 . . . . 1.66 112.646 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.2 mt -67.06 -14.34 62.8 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.63 -0.7 . . . . 3.13 111.526 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.23 49.4 1.14 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.451 -1.06 . . . . 0.85 110.451 168.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -141.37 169.25 17.96 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.355 1.062 . . . . 3.44 108.519 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -108.03 85.56 2.67 Favored Pre-proline 0 CA--C 1.529 0.139 0 CA-C-O 117.361 -1.304 . . . . 3.76 112.943 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 75.52 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.847 2.365 . . . . 1.46 112.133 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.1 m -66.91 143.16 57.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.646 -0.872 . . . . 2.56 108.646 166.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.4 mt . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 121.867 0.841 . . . . 4.23 109.266 171.942 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.5 t . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 108.595 -0.891 . . . . 3.21 108.595 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -90.18 99.07 12.16 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.905 -1.517 . . . . 4.24 106.905 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.2 142.63 50.63 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.026 -0.361 . . . . 2.58 110.026 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 131.83 55.76 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.133 -1.432 . . . . 2.48 107.133 166.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 t -70.02 133.76 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 105.343 -2.095 . . . . 2.39 105.343 165.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.94 114.69 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.413 1.085 . . . . 2.31 108.093 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -74.05 155.27 38.7 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.429 -0.952 . . . . 6.33 108.429 171.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.6 -20.86 10.86 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.191 -0.783 . . . . 1.02 114.115 164.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -73.63 73.5 1.49 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.537 1.669 . . . . 2.42 109.921 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 t -59.58 -34.72 73.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.869 0.868 . . . . 3.38 111.805 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.1 m -144.83 -167.01 2.55 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.284 -1.006 . . . . 5.08 108.284 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.36 -174.05 0.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.622 0.769 . . . . 2.78 111.057 173.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m 72.52 -58.53 0.59 Allowed 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 125.108 1.363 . . . . 2.22 110.5 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.6 m -40.4 -46.71 2.44 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.714 1.206 . . . . 1.82 110.491 168.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.4 t -38.11 -69.61 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.272 1.029 . . . . 1.74 111.3 169.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -26.51 62.46 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.58 -0.7 . . . . 1.63 111.236 -175.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -50.81 -40.44 55.47 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 108.881 -0.785 . . . . 3.86 108.881 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.6 mt -81.25 -69.14 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 108.065 -1.087 . . . . 1.89 108.065 172.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -46.52 -55.94 6.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.661 1.584 . . . . 3.27 111.928 -169.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 t -62.02 -38.62 89.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.711 0.804 . . . . 1.99 109.973 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.5 t -72.97 -27.55 61.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.992 0.517 . . . . 1.32 110.878 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.89 -44.51 55.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.709 0.804 . . . . 3.13 110.218 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.6 p -65.17 80.55 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.242 0.617 . . . . 2.04 110.373 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 165.91 -26.18 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.773 2.829 . . . . 4.49 111.415 -174.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -66.44 76.25 0.1 Allowed 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.484 1.038 . . . . 2.5 110.378 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -42.17 97.74 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.417 1.887 . . . . 6.33 110.948 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.39 -40.93 0.91 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.386 -1.486 . . . . 1.67 109.386 -165.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.47 154.93 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.941 -0.762 . . . . 4.4 108.941 156.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.05 -23.89 10.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.906 0.883 . . . . 3.58 110.812 165.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -159.44 155.02 25.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.696 0.68 . . . . 3.25 109.3 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.3 t -136.48 147.84 47.36 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.197 1.399 . . . . 2.63 108.014 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.5 m -146.05 131.55 18.74 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.62 -0.881 . . . . 2.41 108.62 151.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.3 m -111.69 163.73 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 123.234 0.614 . . . . 2.67 109.994 173.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.13 137.15 11.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.774 -0.579 . . . . 1.76 111.297 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 pp -72.98 -41.25 64.55 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.948 1.299 . . . . 2.35 111.262 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.45 -27.56 69.2 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.105 0.562 . . . . 1.9 111.376 -171.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 t -114.97 6.64 15.36 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.925 1.29 . . . . 3.14 110.579 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.3 m120 51.2 45.53 27.74 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.741 1.616 . . . . 3.16 111.609 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -141.74 162.13 36.23 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 113.504 0.927 . . . . 3.08 113.504 -174.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.45 120.72 34.75 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.491 1.916 . . . . 1.72 106.889 167.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.21 135.38 39.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.587 -1.264 . . . . 1.56 107.587 161.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -119.27 135.84 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 104.236 -2.505 . . . . 2.11 104.236 168.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -97.46 112.13 24.1 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.141 -1.8 . . . . 4.4 106.141 165.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -150.48 160.79 43.52 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 122.989 0.516 . . . . 3.76 110.029 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -87.61 112.6 49.65 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 108.455 -0.943 . . . . 4.42 108.455 169.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.86 -18.45 36.53 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.078 1.852 . . . . 1.66 112.595 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -69.82 -38.93 76.73 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.683 1.129 . . . . 3.88 110.913 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -83.2 -56.16 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 112.381 0.512 . . . . 2.67 112.381 -172.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 tt -98.13 -51.16 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.268 0.627 . . . . 2.56 110.694 -172.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.73 163.7 37.04 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 115.846 -0.615 . . . . 1.06 113.153 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.84 -37.23 28.21 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 124.161 3.24 . . . . 1.19 112.527 -175.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -52.73 -49.17 65.95 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.902 0.481 . . . . 6.1 112.019 -174.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -48.73 -60.5 2.68 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.925 0.89 . . . . 3.03 110.082 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.4 mt -56.19 -54.31 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.01 1.324 . . . . 1.99 110.35 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.7 mt -54.44 -58.29 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.609 0.764 . . . . 2.35 110.173 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -62.77 -34.73 77.85 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.384 0.611 . . . . 5.73 110.636 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 83.5 m -62.36 -51.71 66.51 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.349 -0.844 . . . . 1.8 109.717 173.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.8 -37.77 80.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 121.299 -0.876 . . . . 2.95 111.649 -175.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -47.79 -50.97 24.23 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.866 0.866 . . . . 2.56 108.767 167.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.8 t -65.26 -45.58 83.99 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.287 0.477 . . . . 1.82 112.287 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.47 -32.03 69.87 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.37 -0.831 . . . . 2.87 110.769 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.23 45.9 0.56 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.196 -0.762 . . . . 1.07 111.196 161.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -136.16 161.14 36.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.035 -1.469 . . . . 3.65 107.035 174.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -106.38 85.66 1.82 Allowed Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 118.045 -0.979 . . . . 4.32 113.139 -165.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.61 134.12 31.88 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.533 2.155 . . . . 1.67 112.889 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.8 t -143.46 172.68 12.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.787 1.635 . . . . 3.24 106.897 162.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 CA--C 1.534 0.334 0 C-N-CA 122.953 0.501 . . . . 6.03 111.416 -177.58 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 121.616 0.722 . . . . 3.17 110.888 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.98 146.56 51.01 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.466 -1.309 . . . . 3.86 107.466 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -125.85 150.17 48.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.459 -0.941 . . . . 2.21 108.459 159.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.91 118.2 15.62 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.189 -1.412 . . . . 2.71 107.189 172.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.26 122.57 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 106.528 -1.656 . . . . 2.33 106.528 165.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.35 137.43 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.903 0.881 . . . . 3.88 109.576 -172.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -120.7 168.51 11.33 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.684 0.794 . . . . 7.44 110.688 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.56 -19.47 11.46 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 125.101 1.334 . . . . 0.96 112.396 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.3 mtm -60.41 113.35 2.36 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.838 0.819 . . . . 2.55 111.272 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.9 p -77.14 -42.34 38.28 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.771 0.828 . . . . 4.92 111.414 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.4 t -162.64 171.76 16.4 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.579 0.752 . . . . 4.16 109.103 -165.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.07 -35.7 2.24 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.916 1.686 . . . . 2.96 112.661 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -47.98 -53.37 16.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.172 0.589 . . . . 2.38 110.882 171.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.7 m -62.47 -43.99 97.48 Favored 'General case' 0 CA--C 1.522 -0.104 0 O-C-N 121.627 -0.67 . . . . 1.94 110.118 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.6 t -49.2 -59.83 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 109.256 -0.646 . . . . 1.93 109.256 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -26.62 66.33 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.702 -0.399 . . . . 1.94 111.341 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -60.26 -51.58 68.95 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.587 -0.894 . . . . 3.54 108.587 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.5 mt -62.86 -57.15 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.753 -1.573 . . . . 1.91 106.753 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -52.79 -53.63 45.53 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 123.993 0.808 . . . . 3.27 110.073 -173.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.6 t -58.94 -53.2 61.03 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.498 -0.556 . . . . 1.92 109.498 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.9 t -63.98 -20.01 65.58 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 118.571 -0.728 . . . . 0.99 112.609 -176.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.41 -47.74 10.36 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.29 -0.862 . . . . 3.1 111.251 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.3 p -50.88 -26.85 6.35 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.158 0.89 . . . . 1.88 113.025 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -25.11 66.44 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.752 1.39 . . . . 4.06 114.752 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.496 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 28.7 m-70 -67.77 129.14 39.0 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 120.199 1.363 . . . . 2.57 110.594 -174.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.73 71.63 1.45 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.555 -0.715 . . . . 7.93 109.595 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.42 -40.13 0.07 OUTLIER Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.612 -0.549 . . . . 1.62 113.254 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.93 158.01 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.078 0.939 . . . . 4.46 109.594 170.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 pp -107.94 -25.74 11.04 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.708 0.803 . . . . 4.07 110.206 164.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -158.44 149.21 20.41 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 118.773 0.715 . . . . 4.02 109.289 171.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.7 t -117.97 137.6 52.74 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 105.315 -2.106 . . . . 3.14 105.315 163.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.97 103.8 6.5 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.186 -1.413 . . . . 1.78 107.186 173.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.1 p -103.68 151.11 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 118.436 0.562 . . . . 3.42 112.13 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.92 136.24 16.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.11 0.481 . . . . 1.76 110.73 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.05 -31.92 56.52 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.107 0.963 . . . . 2.9 111.335 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.94 -52.86 62.64 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.211 0.604 . . . . 2.19 109.915 175.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.98 -30.41 68.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.845 0.858 . . . . 2.91 109.446 173.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.256 0.0 OUTLIER 52.72 56.29 7.82 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.023 -1.473 . . . . 4.32 107.023 -164.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -140.85 143.61 34.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.613 -1.176 . . . . 2.2 109.086 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.73 129.16 55.64 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.421 -1.326 . . . . 1.71 107.421 155.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.67 145.81 24.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.616 -1.253 . . . . 1.3 107.616 154.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -129.21 117.88 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 106.61 -1.626 . . . . 2.0 106.61 170.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -88.21 125.99 34.92 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.575 -1.639 . . . . 2.9 106.575 167.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -170.45 151.97 3.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.396 0.678 . . . . 3.41 110.331 -167.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -77.64 118.78 74.27 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.499 -1.297 . . . . 3.56 107.499 168.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.11 -18.61 23.68 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.441 2.094 . . . . 1.23 112.37 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -74.62 -51.27 14.94 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.6 0.636 . . . . 4.28 109.364 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 pt -69.72 -54.96 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 112.566 0.58 . . . . 2.32 112.566 -168.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 tt -98.96 -48.83 11.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 123.662 0.785 . . . . 2.34 110.913 -169.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.33 157.77 26.87 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.226 0.917 . . . . 0.88 111.85 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.02 -25.23 32.22 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 124.026 3.15 . . . . 0.75 113.34 -172.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -55.15 -51.62 65.89 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.316 0.507 . . . . 6.82 111.226 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -42.6 -61.92 1.11 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.192 1.397 . . . . 3.36 109.9 176.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mt -51.44 -63.46 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 124.785 1.234 . . . . 2.13 110.685 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.5 mt -49.93 -43.76 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.573 0.624 . . . . 2.21 111.228 -175.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -75.92 -31.53 59.18 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.064 0.546 . . . . 3.24 111.391 -176.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.496 ' HG1' ' CE1' ' A' ' 29' ' ' HIS . 7.7 m -62.6 -53.23 57.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.808 -0.812 . . . . 2.46 108.808 169.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.7 mm -55.93 -47.9 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.135 0.574 . . . . 2.82 110.2 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -49.13 -66.56 0.38 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.102 1.361 . . . . 2.65 109.753 170.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 t -51.95 -42.88 63.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.445 1.498 . . . . 2.13 112.598 -174.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.03 -14.58 55.34 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.782 -0.627 . . . . 2.8 112.658 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.01 47.4 1.35 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.75 -0.94 . . . . 0.71 110.75 172.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -135.74 168.63 18.94 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.049 0.939 . . . . 3.46 108.805 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -117.38 88.75 29.39 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-O 117.962 -1.018 . . . . 4.4 110.38 -173.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.04 108.93 0.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.181 2.588 . . . . 1.12 111.853 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.1 t -72.41 -165.85 0.22 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.8 0.81 . . . . 3.31 109.128 156.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.237 0.406 0 C-N-CA 124.422 1.089 . . . . 5.41 110.71 -174.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.125 0 N-CA-C 111.666 0.247 . . . . 3.5 111.666 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.5 tp -138.9 141.68 38.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.36 -0.978 . . . . 2.99 108.36 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -108.02 123.31 48.48 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.052 -1.462 . . . . 2.38 107.052 174.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.5 mt -106.87 122.17 45.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.108 -1.812 . . . . 3.41 106.108 172.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.87 118.56 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 106.082 -1.821 . . . . 2.09 106.082 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.9 m -117.4 115.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 123.573 0.749 . . . . 2.16 109.097 -169.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -83.88 175.0 9.92 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.561 -0.903 . . . . 7.71 108.561 168.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.6 -32.52 7.44 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.452 0.548 . . . . 1.16 112.737 172.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -61.4 138.74 58.27 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.684 1.242 . . . . 2.41 110.336 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -155.49 28.89 0.39 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.001 0.52 . . . . 3.09 111.066 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.2 t -167.87 141.58 3.4 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 107.79 -1.189 . . . . 4.51 107.79 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -38.38 -48.91 1.4 Allowed 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.001 1.32 . . . . 2.18 112.069 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.6 m -42.68 -40.97 2.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.601 1.16 . . . . 2.29 111.827 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.2 m -47.6 -39.61 17.23 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.739 0.816 . . . . 2.25 111.364 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.6 t -53.17 -61.9 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 123.295 0.638 . . . . 2.11 109.943 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -28.83 69.07 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.494 -0.558 . . . . 1.6 109.494 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -59.51 -52.79 64.05 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.958 -1.127 . . . . 3.82 107.958 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.94 -51.23 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.115 -1.068 . . . . 1.97 108.115 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -47.82 -61.97 1.69 Allowed 'General case' 0 C--N 1.341 0.229 0 O-C-N 123.901 0.75 . . . . 4.72 109.16 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -62.76 -43.32 99.1 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.974 0.91 . . . . 2.27 109.97 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.6 t -58.49 -30.02 66.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 118.798 -0.62 . . . . 1.51 111.489 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 mt -85.46 -48.48 8.94 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.253 0.835 . . . . 3.43 113.253 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.4 p -71.6 66.31 0.5 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.541 1.536 . . . . 1.94 110.742 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.99 -33.91 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.618 2.367 . . . . 4.68 110.832 -171.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -53.87 -29.69 42.6 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.733 1.012 . . . . 3.06 113.733 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? 60.4 67.75 0.82 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.739 -1.208 . . . . 7.25 107.739 -173.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.54 -51.22 0.07 OUTLIER Glycine 0 CA--C 1.52 0.373 0 N-CA-C 107.171 -2.372 . . . . 1.81 107.171 -171.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -42.04 132.01 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 123.486 0.715 . . . . 2.91 109.158 147.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.8 tp -95.4 -46.15 6.82 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.8 2.04 . . . . 3.62 107.9 160.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -154.79 138.16 15.83 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 122.908 0.483 . . . . 3.76 110.306 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -111.15 147.64 34.46 Favored 'General case' 0 CA--C 1.523 -0.084 0 N-CA-C 108.005 -1.109 . . . . 2.09 108.005 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.74 104.43 2.87 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.589 -0.893 . . . . 2.05 108.589 171.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.05 157.43 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 122.873 0.469 . . . . 2.96 111.477 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.62 136.66 17.37 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.611 0.765 . . . . 1.95 109.53 170.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.72 -38.17 64.89 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.622 -0.717 . . . . 2.77 110.722 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.05 -46.5 82.39 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.27 0.628 . . . . 2.13 110.89 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -74.74 -11.42 60.16 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.283 1.033 . . . . 2.89 110.871 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 49.78 41.91 22.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.394 1.878 . . . . 3.65 110.84 -172.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -137.61 147.68 45.19 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.291 -0.413 . . . . 2.16 111.26 -164.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.92 112.26 18.55 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.098 1.759 . . . . 1.92 107.422 164.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.78 143.05 27.16 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.198 -1.038 . . . . 1.27 108.198 166.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.5 mp -127.03 124.08 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 107.259 -1.386 . . . . 1.94 107.259 174.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -97.15 120.65 37.9 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.477 -1.675 . . . . 3.09 106.477 158.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -153.48 157.15 39.43 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.89 1.276 . . . . 3.39 107.773 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -85.51 118.44 70.69 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 107.55 -1.278 . . . . 3.19 107.55 170.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.69 -31.41 40.19 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.714 1.609 . . . . 1.47 111.611 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -86.65 29.11 0.81 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.321 0.964 . . . . 3.64 111.378 -166.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 pt -142.77 -53.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 124.846 1.258 . . . . 2.32 110.384 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.4 tt -98.85 -45.55 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.764 0.826 . . . . 2.06 111.015 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.36 158.98 7.38 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.039 0.828 . . . . 0.97 111.251 -172.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.86 -23.78 40.93 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.804 2.336 . . . . 1.18 111.5 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -56.74 -55.13 38.13 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.571 1.148 . . . . 7.14 111.338 -175.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -52.59 -52.13 56.66 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 122.472 1.129 . . . . 2.62 109.824 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.7 mt -56.99 -57.87 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.049 1.339 . . . . 2.14 110.259 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.9 mt -51.12 -51.54 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 109.964 -0.384 . . . . 2.45 109.964 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -63.17 -34.73 78.26 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.73 0.696 . . . . 3.33 112.393 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.9 m -59.92 -56.83 16.92 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.608 -0.886 . . . . 1.73 108.608 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mm -62.11 -46.34 96.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 119.667 -0.206 . . . . 2.71 110.962 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -42.02 -57.76 2.33 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.461 1.504 . . . . 3.44 109.574 166.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 t -65.41 -9.03 21.76 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.353 1.242 . . . . 1.76 114.353 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.1 mt -83.44 -10.01 58.65 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 120.553 1.524 . . . . 3.15 111.128 170.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.34 40.56 28.16 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.056 -1.218 . . . . 1.21 110.056 -170.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -126.67 151.29 48.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.262 -1.755 . . . . 2.92 106.262 161.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -110.64 84.86 4.35 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 113.59 0.959 . . . . 5.54 113.59 -158.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.61 85.67 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.402 2.735 . . . . 1.2 113.756 -173.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.1 t -70.52 156.54 39.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.624 0.77 . . . . 3.66 109.878 161.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 109.549 -0.537 . . . . 5.87 109.549 161.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.7 t . . . . . 0 C--O 1.232 0.139 0 N-CA-C 108.122 -1.066 . . . . 3.34 108.122 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.2 tt -140.71 137.15 33.26 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.561 -0.903 . . . . 3.36 108.561 166.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -103.54 132.04 50.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.059 1.344 . . . . 2.26 109.416 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.08 131.81 42.75 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.67 0.788 . . . . 3.08 109.435 173.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.41 132.97 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.183 -2.155 . . . . 2.28 105.183 165.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.34 129.15 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.298 -1.001 . . . . 2.7 108.298 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -101.38 -176.85 3.27 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.213 -0.662 . . . . 5.11 109.213 170.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.98 -29.01 11.33 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.636 1.112 . . . . 1.5 110.698 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 73.2 mtm -57.71 120.71 8.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.964 -0.754 . . . . 2.11 108.964 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 t -155.84 43.92 0.43 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.831 0.824 . . . . 3.77 110.393 -170.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -164.08 -89.02 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.37 -0.831 . . . . 3.27 110.064 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -175.57 -62.3 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 125.428 1.491 . . . . 2.49 107.299 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 t -41.46 -46.16 3.37 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.706 1.202 . . . . 3.22 110.304 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.4 m -25.46 -48.4 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.63 1.972 . . . . 1.96 114.099 169.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.6 t -51.44 -64.2 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.26 0.624 . . . . 1.78 110.347 174.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -27.83 66.43 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.101 -0.999 . . . . 1.57 110.706 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.93 -44.01 70.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.126 1.37 . . . . 4.11 108.373 176.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.1 mt -72.69 -67.49 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 106.288 -1.745 . . . . 1.6 106.288 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -48.91 -56.17 9.6 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.612 1.165 . . . . 3.55 111.563 -166.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 m -68.95 -20.17 64.19 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.753 1.221 . . . . 3.54 111.792 -174.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.5 t -87.08 -48.89 7.7 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.027 -1.101 . . . . 1.54 108.027 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.27 -35.7 76.14 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.035 -1.041 . . . . 3.28 111.718 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 p -57.69 -18.94 23.63 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.483 0.92 . . . . 1.94 113.483 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.9 mtmt -63.02 -34.21 77.08 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.571 1.078 . . . . 4.71 110.28 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -72.41 107.75 5.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.895 -1.15 . . . . 2.41 107.895 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -52.52 -26.12 12.22 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.006 1.113 . . . . 5.56 114.006 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.09 -21.23 69.71 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 118.198 0.454 . . . . 1.7 113.05 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.76 124.31 14.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 118.965 1.382 . . . . 4.01 108.689 171.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.5 tp -84.45 -45.31 12.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.732 -1.21 . . . . 4.2 107.732 162.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -163.62 114.44 1.36 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 119.152 -0.451 . . . . 4.5 111.042 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.7 m -77.92 161.9 27.21 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.713 -0.847 . . . . 2.15 108.713 166.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -166.18 94.5 0.55 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.399 -0.963 . . . . 3.69 108.399 170.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 p -104.87 147.99 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 123.428 0.691 . . . . 3.38 112.075 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.9 135.02 30.87 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.635 0.774 . . . . 1.76 109.904 174.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.93 -39.87 63.5 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.31 -0.859 . . . . 2.35 110.728 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.36 -46.33 80.07 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.134 0.574 . . . . 1.85 110.349 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.19 -15.49 60.56 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.131 0.972 . . . . 2.69 111.086 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.39 36.32 26.85 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.676 0.79 . . . . 3.52 109.155 -172.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -135.69 135.6 40.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 122.411 0.284 . . . . 2.45 110.575 -168.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.06 124.69 49.96 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.594 -1.262 . . . . 1.73 107.594 160.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.79 147.51 25.99 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.674 -1.232 . . . . 1.72 107.674 155.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.4 mp -130.17 139.15 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 107.139 -1.43 . . . . 2.43 107.139 166.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -97.18 123.73 41.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.79 -1.559 . . . . 3.96 106.79 161.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -168.58 171.43 8.86 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.835 -1.172 . . . . 3.87 107.835 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.74 110.16 30.05 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-N 119.015 0.825 . . . . 3.89 109.364 175.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.28 51.32 3.16 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.694 2.263 . . . . 2.58 110.365 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -145.44 -60.5 0.34 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.922 1.689 . . . . 4.39 107.598 -159.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 pt -94.57 -60.37 2.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 C-N-CA 123.893 0.877 . . . . 2.89 111.469 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.7 tt -72.28 -52.71 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.246 -1.02 . . . . 3.15 108.246 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.8 160.69 24.28 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.287 -0.869 . . . . 0.88 112.02 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -57.37 -39.69 87.53 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.755 2.97 . . . . 0.98 110.909 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -59.44 -53.9 52.8 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.251 0.463 . . . . 7.68 112.251 -171.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -52.67 -46.74 67.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.897 0.856 . . . . 2.55 109.75 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.96 -66.45 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.827 -1.079 . . . . 2.14 110.025 172.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.353 2.7 pp -61.62 -28.88 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 121.075 1.762 . . . . 4.79 114.366 -174.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.49 -51.77 66.13 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 118.819 0.736 . . . . 4.33 109.139 173.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.0 m -57.39 -52.34 65.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.567 -0.531 . . . . 1.6 109.567 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mm -56.35 -49.6 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.516 1.126 . . . . 2.63 110.181 -175.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -48.4 -62.84 1.29 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.39 1.076 . . . . 3.91 109.675 170.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -62.47 -23.89 67.16 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.79 -0.641 . . . . 1.96 112.286 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -82.7 -5.16 58.73 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.951 1.7 . . . . 3.52 110.966 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.38 48.36 1.56 Allowed Glycine 0 CA--C 1.525 0.696 0 C-N-CA 125.103 1.335 . . . . 1.09 111.803 167.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -141.61 162.54 35.23 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.794 0.838 . . . . 3.22 109.902 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -109.66 93.2 13.68 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-O 117.95 -1.024 . . . . 4.41 109.578 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.78 136.78 6.28 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 121.553 1.502 . . . . 1.49 112.826 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.3 m -135.79 117.5 15.01 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 126.02 1.728 . . . . 2.52 107.751 170.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 CA--C 1.531 0.215 0 C-N-CA 122.438 0.295 . . . . 4.02 110.482 175.255 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 107.191 -1.411 . . . . 3.06 107.191 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.22 127.27 44.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.678 -1.601 . . . . 3.78 106.678 174.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.37 117.69 35.08 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.72 -1.215 . . . . 2.18 107.72 170.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.12 141.82 42.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.298 -1.371 . . . . 3.12 107.298 172.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.85 135.79 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 106.357 -1.72 . . . . 2.2 106.357 167.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.26 108.74 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 C-N-CA 125.853 1.661 . . . . 2.27 108.869 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -67.48 158.48 31.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.688 -0.856 . . . . 6.48 108.688 160.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.02 -23.58 7.69 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.03 0.824 . . . . 1.21 113.111 163.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -70.44 85.59 0.61 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.819 1.309 . . . . 2.16 112.6 -175.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.3 t -76.79 100.41 5.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.02 0.914 . . . . 3.11 110.845 175.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.4 t 68.62 -76.33 0.06 Allowed 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 115.21 1.559 . . . . 4.15 115.21 164.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.41 170.34 15.99 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 123.864 0.865 . . . . 3.33 108.709 -171.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m 69.7 -58.48 0.52 Allowed 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 124.978 1.311 . . . . 2.47 111.034 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.8 m -44.21 -47.16 9.21 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 124.924 1.289 . . . . 1.82 111.512 -177.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.6 t -42.99 -64.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.45 0.7 . . . . 2.0 110.197 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -25.9 61.11 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.861 -0.524 . . . . 1.75 111.395 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -51.53 -41.61 61.16 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.767 0.827 . . . . 4.1 108.824 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.6 mt -80.23 -65.91 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.682 -1.229 . . . . 1.68 107.682 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.0 -56.62 7.23 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.013 1.325 . . . . 3.29 111.311 -169.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 t -65.23 -45.12 85.9 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.897 0.879 . . . . 2.05 110.12 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 t -62.16 -29.6 70.47 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 119.161 -0.447 . . . . 1.26 111.388 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.39 -55.22 5.04 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.957 -0.544 . . . . 3.73 111.311 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.9 p -68.83 66.08 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.962 1.305 . . . . 2.06 111.956 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.87 -42.33 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.77 1.628 . . . . 5.24 110.779 -170.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -72.99 150.32 42.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.04 -0.726 . . . . 5.02 109.04 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -60.69 160.07 9.86 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.919 -0.401 . . . . 6.17 109.919 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.2 -5.09 81.66 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.028 -0.873 . . . . 1.8 113.111 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.18 146.43 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 106.712 -1.588 . . . . 2.87 106.712 176.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.9 tp -104.53 -48.74 3.73 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.681 1.192 . . . . 3.8 110.603 172.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -164.95 162.4 20.58 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.007 0.923 . . . . 3.72 108.761 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.0 m -138.15 161.34 37.06 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 119.332 0.969 . . . . 1.85 108.538 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.6 t -155.0 133.62 12.01 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.774 -0.824 . . . . 3.09 108.774 150.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 m -115.94 155.81 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.369 0.668 . . . . 2.69 111.036 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.39 137.69 16.6 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.101 0.561 . . . . 2.1 110.88 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -79.24 -34.83 42.36 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 124.559 1.144 . . . . 2.62 112.521 -174.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.82 -41.34 91.05 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 109.596 -0.52 . . . . 2.05 109.596 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.3 t -92.9 -6.36 48.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.533 -0.746 . . . . 3.21 111.297 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.269 0.0 OUTLIER 39.32 60.69 1.48 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 126.576 1.951 . . . . 4.03 109.791 -172.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -131.38 147.13 52.54 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.201 1.4 . . . . 3.18 108.866 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.93 120.71 38.09 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.938 -1.504 . . . . 1.77 106.938 159.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.01 138.18 31.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.043 -1.466 . . . . 1.95 107.043 161.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.63 130.3 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.619 -1.252 . . . . 2.22 107.619 169.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -101.06 139.26 37.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.085 -1.82 . . . . 3.27 106.085 161.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -175.18 177.38 1.91 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.371 1.468 . . . . 3.84 108.777 -160.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -112.85 81.33 4.4 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 125.241 1.416 . . . . 4.09 107.544 -170.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.74 -43.53 55.05 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.421 2.747 . . . . 1.51 113.902 -167.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.33 -23.72 65.94 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.239 0.829 . . . . 3.74 113.239 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.8 pt -100.75 -58.17 4.05 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 118.888 0.767 . . . . 2.29 112.629 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.7 tt -89.32 -45.35 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 121.356 0.598 . . . . 2.13 110.425 -171.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.68 151.47 13.87 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.859 0.742 . . . . 1.14 111.815 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -66.42 -31.42 42.63 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.389 2.726 . . . . 1.63 111.866 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -56.55 -43.17 79.65 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.91 -0.494 . . . . 7.15 111.452 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -53.99 -53.01 58.81 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 121.225 0.536 . . . . 2.71 109.732 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.3 mt -57.58 -49.15 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 124.276 1.03 . . . . 1.89 110.25 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.4 mt -54.85 -56.74 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 110.151 -0.314 . . . . 2.46 110.151 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -60.88 -36.96 80.53 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.742 0.701 . . . . 3.47 112.027 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.7 m -59.21 -51.16 71.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.479 -0.763 . . . . 2.06 109.095 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.7 mt -65.25 -43.03 95.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 121.508 -0.745 . . . . 3.31 111.753 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -49.48 -49.76 44.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.425 1.09 . . . . 3.05 108.356 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 t -64.96 -44.31 89.8 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.57 0.748 . . . . 2.04 111.419 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.6 mt -63.47 -30.41 71.54 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.5 -0.75 . . . . 3.09 110.651 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.07 53.45 0.2 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.44 -0.664 . . . . 1.24 111.44 156.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -137.47 175.28 9.74 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.709 -0.849 . . . . 3.43 108.709 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -106.65 77.15 0.46 Allowed Pre-proline 0 N--CA 1.47 0.547 0 CA-C-O 117.734 -1.127 . . . . 4.35 111.76 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.68 71.79 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.662 2.908 . . . . 1.27 112.37 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.7 m -74.38 117.84 16.65 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.357 1.063 . . . . 2.82 108.49 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tt . . . . . 0 N--CA 1.451 -0.393 0 C-N-CA 124.086 0.954 . . . . 4.09 109.466 -179.941 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.347 1.2 m . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 122.796 1.284 . . . . 4.12 113.161 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -74.07 99.28 3.3 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.557 -1.275 . . . . 3.85 107.557 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -78.22 117.94 19.97 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.848 0.356 . . . . 2.59 110.046 169.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 pp -108.21 133.99 51.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.544 -1.28 . . . . 3.0 107.544 160.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.1 t -85.63 136.67 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 105.563 -2.014 . . . . 2.6 105.563 169.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -156.38 112.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 108.499 -0.926 . . . . 3.73 108.499 -163.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -96.89 178.71 5.2 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.326 -0.99 . . . . 5.49 108.326 174.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.08 -36.99 4.04 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.375 -1.09 . . . . 1.02 110.375 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.6 ptp -57.08 123.11 14.08 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.811 -0.811 . . . . 3.42 108.811 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.0 t -149.07 21.54 0.97 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.368 0.507 . . . . 2.87 112.368 -167.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.5 t -162.98 142.74 9.0 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 106.097 -1.816 . . . . 4.73 106.097 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.58 -49.27 5.46 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.755 1.222 . . . . 2.3 111.817 -173.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -37.2 -47.45 0.79 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.082 1.753 . . . . 2.37 112.45 174.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.7 m -52.62 -43.62 65.5 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 124.102 0.961 . . . . 2.38 110.864 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.9 t -54.62 -61.49 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.479 -0.934 . . . . 2.09 108.479 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -24.66 67.02 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.241 -0.89 . . . . 1.8 109.792 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -65.25 -52.73 52.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.977 0.808 . . . . 5.6 108.96 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.7 mt -58.79 -54.49 32.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.834 -1.173 . . . . 1.73 107.834 -172.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -38.35 -69.34 0.12 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.369 1.468 . . . . 3.16 111.588 165.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -53.21 -50.35 64.89 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.642 1.177 . . . . 2.15 110.71 -171.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -33.13 73.56 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.154 1.382 . . . . 1.27 110.469 -177.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.8 mt -77.25 -47.54 19.86 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.828 0.451 . . . . 3.1 111.155 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.4 p -66.99 74.57 0.11 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.578 1.151 . . . . 1.78 110.079 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 163.13 -9.63 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.501 2.72 . . . . 4.49 113.284 -171.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -69.67 -101.45 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 121.76 2.073 . . . . 3.07 110.01 170.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -167.8 158.85 11.19 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.059 -2.2 . . . . 7.08 105.059 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.11 -58.44 2.3 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.688 -0.565 . . . . 1.99 111.688 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -38.74 99.92 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 126.905 2.082 . . . . 3.26 111.258 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.4 mt -82.46 -44.64 15.76 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.497 1.919 . . . . 3.79 108.694 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -145.36 150.12 36.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.218 1.007 . . . . 3.5 109.926 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -131.24 154.48 48.41 Favored 'General case' 0 C--O 1.231 0.082 0 N-CA-C 107.01 -1.478 . . . . 1.97 107.01 169.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.7 m -152.41 141.93 21.72 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.044 -0.725 . . . . 2.58 109.044 150.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 m -119.59 168.19 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.365 0.666 . . . . 2.69 111.355 170.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.01 139.66 13.78 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.631 0.772 . . . . 1.97 109.853 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.32 -36.05 22.84 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.994 0.918 . . . . 2.66 112.236 -172.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.29 -39.04 81.7 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.67 -0.493 . . . . 2.14 109.67 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 t -97.17 -4.63 38.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.151 -0.928 . . . . 3.36 111.394 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.38 61.3 2.06 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.221 1.808 . . . . 4.01 109.13 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -135.27 145.36 47.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.736 -1.12 . . . . 2.33 108.614 -171.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.84 123.44 35.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.14 -1.43 . . . . 1.8 107.14 164.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -103.92 130.69 51.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.098 -1.075 . . . . 1.82 108.098 169.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.85 124.35 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.746 -0.835 . . . . 2.0 108.746 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -97.48 82.16 3.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.743 0.817 . . . . 2.94 108.869 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -122.77 151.18 41.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.749 1.22 . . . . 3.54 109.956 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.77 114.06 22.01 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 109.511 -0.552 . . . . 3.25 109.511 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.95 -25.85 59.32 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.046 1.831 . . . . 1.19 113.225 -176.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -54.5 -30.36 53.1 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.839 1.256 . . . . 4.11 113.453 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 pt -105.57 -92.74 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.366 0.666 . . . . 2.15 111.854 -172.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 tt -49.7 -52.37 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.982 1.313 . . . . 2.35 112.291 -174.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.44 162.1 35.5 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.992 0.806 . . . . 0.87 111.831 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.2 -36.78 27.31 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.795 2.997 . . . . 0.96 112.776 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -56.64 -45.69 81.44 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.689 0.625 . . . . 7.22 112.689 -173.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -54.42 -57.48 11.14 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 122.15 0.976 . . . . 3.01 109.538 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.4 mt -49.7 -62.46 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.329 1.452 . . . . 1.91 109.725 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.6 mt -52.81 -52.77 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 122.755 0.422 . . . . 2.26 110.201 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -68.7 -30.66 69.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.119 0.418 . . . . 4.11 111.746 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.9 m -65.69 -52.18 53.51 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.567 -0.708 . . . . 2.13 109.313 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 mm -65.31 -33.64 65.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 121.742 -0.599 . . . . 2.91 111.174 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -54.32 -58.64 6.63 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.787 1.235 . . . . 3.0 108.712 166.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.8 t -60.04 -26.5 66.17 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.083 0.953 . . . . 2.03 113.57 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.81 -20.47 61.63 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.382 0.992 . . . . 3.86 111.9 172.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.87 38.75 5.4 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.222 -1.151 . . . . 1.2 110.222 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -126.32 163.2 23.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.082 -1.821 . . . . 3.72 106.082 171.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.14 83.58 8.21 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 119.375 0.989 . . . . 3.9 112.96 -172.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.89 147.51 24.3 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.374 2.049 . . . . 1.56 112.224 -175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.3 m -154.37 144.29 21.79 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.157 1.383 . . . . 2.69 108.311 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--N 1.333 -0.114 0 C-N-CA 122.862 0.465 . . . . 4.65 111.052 -177.48 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 108.84 -0.8 . . . . 3.4 108.84 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.8 tp -129.86 138.31 50.9 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.407 -1.331 . . . . 2.9 107.407 164.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -110.9 137.69 48.22 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.784 1.234 . . . . 2.46 109.535 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.04 128.15 20.79 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.848 -0.797 . . . . 2.5 108.848 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.0 t -65.35 145.15 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 107.619 -1.252 . . . . 2.24 107.619 167.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.42 98.16 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 125.767 1.627 . . . . 2.48 107.68 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -63.57 162.94 12.0 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.972 -0.751 . . . . 4.9 108.972 160.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.47 -0.32 46.46 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.866 1.222 . . . . 1.42 113.014 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.2 mtm -73.64 75.76 1.52 Allowed 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.336 -1.096 . . . . 2.22 112.097 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.9 p -67.54 81.58 0.17 Allowed 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 121.686 -0.634 . . . . 5.59 109.892 168.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 t 72.75 176.28 0.27 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.04 1.736 . . . . 3.87 112.253 165.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.7 -36.11 4.71 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 126.363 1.865 . . . . 2.64 112.667 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -41.22 -60.63 1.19 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.673 1.189 . . . . 3.41 110.845 168.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.4 m -68.19 -31.54 71.14 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.532 -0.73 . . . . 1.85 111.675 -176.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.0 t -57.04 -56.26 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.887 -0.783 . . . . 2.15 108.887 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -30.49 71.07 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.709 -0.619 . . . . 1.65 110.626 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -50.58 72.42 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.333 -0.988 . . . . 4.64 108.333 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.5 mt -62.52 -65.18 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 107.207 -1.405 . . . . 2.24 107.207 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -46.53 -57.12 5.03 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.855 0.862 . . . . 3.64 110.151 -174.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -56.79 -49.56 74.96 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.354 -0.839 . . . . 2.21 109.283 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.7 t -65.67 -29.38 69.92 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 118.993 -0.527 . . . . 1.23 111.811 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.63 -44.25 67.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.76 0.709 . . . . 3.78 111.648 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.8 p -54.56 -21.54 10.55 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.649 0.981 . . . . 2.13 113.649 -172.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.12 -4.49 58.83 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 115.064 1.505 . . . . 5.39 115.064 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -67.11 122.94 18.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.869 1.213 . . . . 2.63 110.162 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -71.0 73.43 0.61 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.679 1.192 . . . . 8.13 111.176 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.39 -2.42 0.8 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.887 1.232 . . . . 1.27 112.62 -177.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.94 150.14 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 125.075 1.35 . . . . 2.99 108.282 170.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.1 tp -111.4 -48.12 3.12 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.278 1.831 . . . . 4.16 110.055 172.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -157.34 155.14 30.12 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.357 1.063 . . . . 4.15 108.32 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.43 163.95 28.54 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.169 -1.048 . . . . 3.33 108.169 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -162.56 103.14 1.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.82 -1.178 . . . . 2.63 107.82 170.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.7 147.21 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 C-N-CA 124.997 1.319 . . . . 3.02 110.641 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.97 137.14 16.46 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.764 0.792 . . . . 2.15 111.601 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 pp -77.7 -23.22 49.56 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.29 -0.868 . . . . 2.45 111.967 -176.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.14 -41.15 97.98 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.245 -0.65 . . . . 2.2 109.245 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -86.34 -31.21 21.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.565 -0.743 . . . . 3.18 109.909 172.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 77.68 44.3 0.09 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.63 1.972 . . . . 4.04 107.75 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -140.17 146.76 39.18 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.944 -0.391 . . . . 2.54 109.944 -167.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.98 127.1 55.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.136 1.375 . . . . 1.76 107.359 162.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.19 141.74 32.62 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.914 -1.143 . . . . 1.29 107.914 155.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.73 136.47 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 107.572 -1.27 . . . . 2.36 107.572 170.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -100.61 125.37 47.0 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.421 -1.696 . . . . 3.21 106.421 160.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -166.57 142.04 4.47 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 128.126 2.571 . . . . 3.12 107.267 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -71.61 125.54 91.71 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 118.833 -1.147 . . . . 3.83 108.93 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -82.67 -9.78 10.96 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.745 2.296 . . . . 1.3 113.275 -173.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.92 -44.08 11.31 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.255 0.934 . . . . 4.18 109.191 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 pt -67.41 -54.66 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 112.716 0.635 . . . . 2.66 112.716 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.5 tt -105.14 -58.08 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.84 0.856 . . . . 2.8 111.653 -173.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.04 161.6 27.55 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.579 0.609 . . . . 0.77 113.905 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.78 -36.48 6.24 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.048 3.165 . . . . 0.78 112.983 -171.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.5 ttm105 -55.39 -47.11 76.35 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.768 0.427 . . . . 5.8 111.186 -173.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -47.36 -61.4 1.93 Allowed 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.477 1.511 . . . . 2.79 110.312 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.5 mt -51.09 -63.34 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.127 0.971 . . . . 1.81 109.791 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.7 mt -51.86 -52.66 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.235 0.471 . . . . 2.13 110.689 -173.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -64.18 -34.38 77.95 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.99 0.814 . . . . 3.58 112.272 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.4 m -61.01 -53.13 61.01 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.355 -0.841 . . . . 1.88 109.888 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.2 mm -61.56 -38.44 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 O-C-N 121.667 -0.645 . . . . 2.72 110.693 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -55.76 -59.7 4.49 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.954 1.301 . . . . 2.77 108.803 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.5 t -52.37 -40.49 62.08 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.587 1.155 . . . . 1.8 111.739 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.7 mt -70.32 5.38 1.76 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.466 0.913 . . . . 3.01 113.466 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.19 45.98 5.45 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 119.069 0.849 . . . . 0.93 111.249 169.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -135.74 174.69 10.33 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.046 0.938 . . . . 3.13 109.782 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -113.59 68.34 1.4 Allowed Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.892 0.701 . . . . 3.61 112.892 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.76 85.09 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.194 3.263 . . . . 1.1 112.503 -174.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.2 m -101.3 125.54 47.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.726 1.611 . . . . 2.92 108.177 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 109.154 -0.684 . . . . 4.68 109.154 175.239 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 107.059 -1.459 . . . . 3.29 107.059 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tt -153.08 82.3 1.2 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 103.618 -2.734 . . . . 4.04 103.618 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.0 152.81 42.19 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.882 -0.727 . . . . 3.4 110.438 -169.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.39 133.92 50.33 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.125 -1.435 . . . . 2.57 107.125 168.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.61 136.14 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.441 -2.059 . . . . 2.01 105.441 153.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 m -134.92 134.97 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.573 -1.269 . . . . 2.48 107.573 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -117.2 173.73 6.51 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.737 -0.838 . . . . 6.51 108.737 170.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.24 -22.93 37.21 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 110.916 -0.874 . . . . 1.23 110.916 -172.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.2 mtm -60.1 151.81 25.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.554 0.677 . . . . 2.21 109.583 170.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -158.45 -58.27 0.07 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.472 -0.566 . . . . 2.89 109.472 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.3 t -73.38 140.45 46.63 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.206 -0.664 . . . . 4.61 109.206 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.35 -43.94 5.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.022 0.929 . . . . 2.01 111.728 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 m -41.21 -47.32 3.31 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.422 1.089 . . . . 2.27 111.811 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.7 m -45.44 -49.1 13.63 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 118.992 0.815 . . . . 1.79 110.671 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.8 t -52.32 -59.49 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.646 0.778 . . . . 2.38 109.694 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.21 -36.57 71.03 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.418 1.087 . . . . 2.37 109.37 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -61.47 -49.78 75.4 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.375 -0.602 . . . . 5.35 109.375 -174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.9 mt -63.33 -53.27 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.167 -1.049 . . . . 2.17 108.167 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -48.04 -59.98 2.96 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.089 0.956 . . . . 3.15 110.016 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.1 m -66.31 -43.25 86.78 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.027 0.931 . . . . 3.3 109.99 -173.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.5 t -57.23 -38.31 73.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.862 -0.59 . . . . 1.37 110.222 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 mt -75.53 -51.09 13.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.385 -0.817 . . . . 3.56 112.48 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.9 p -68.18 73.28 0.2 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.466 0.706 . . . . 2.1 110.277 -172.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.405 ' HZ3' ' CD2' ' A' ' 29' ' ' HIS . 1.8 pptp? 177.84 -33.93 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.633 2.773 . . . . 4.35 111.638 -171.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.405 ' CD2' ' HZ3' ' A' ' 28' ' ' LYS . 10.2 m-70 -44.41 -76.95 0.02 OUTLIER 'General case' 0 C--N 1.348 0.515 0 N-CA-C 113.904 1.076 . . . . 3.59 113.904 -171.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 ptt85 171.01 134.05 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 104.924 -2.25 . . . . 12.22 104.924 -172.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.76 -59.66 2.98 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 118.774 0.716 . . . . 2.57 113.216 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -33.89 116.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 127.432 2.293 . . . . 2.92 111.605 177.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 72.2 mt -89.03 -46.32 8.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.357 1.063 . . . . 4.17 110.52 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -154.45 152.13 29.78 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.947 0.899 . . . . 3.73 108.946 -173.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.1 m -125.7 160.75 28.93 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.761 -1.2 . . . . 1.88 107.761 168.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.1 t -146.64 120.42 9.25 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.108 -1.071 . . . . 2.54 108.108 155.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 t -102.69 150.87 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 124.519 1.127 . . . . 3.51 108.584 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.16 135.11 20.15 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.598 -0.689 . . . . 1.76 110.465 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -73.35 -49.85 25.13 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.29 -0.868 . . . . 2.83 111.148 -172.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.98 -48.42 80.03 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.586 0.707 . . . . 2.0 110.376 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.64 -16.54 62.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.35 1.06 . . . . 2.58 111.1 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 50.76 42.07 27.09 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.886 1.274 . . . . 3.59 108.117 -171.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -129.32 144.8 51.37 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 122.565 0.346 . . . . 2.32 110.957 -166.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.72 110.49 17.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.094 1.758 . . . . 1.87 107.393 161.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.92 142.7 27.42 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 107.471 -1.307 . . . . 1.66 107.471 166.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.58 128.56 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 108.169 -1.048 . . . . 2.34 108.169 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -93.85 74.72 4.22 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 126.43 1.892 . . . . 3.08 108.926 171.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -119.32 179.43 4.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.437 1.495 . . . . 3.8 113.434 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.18 88.3 31.94 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 130.774 3.63 . . . . 4.07 108.097 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -61.16 -22.23 74.04 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.963 2.442 . . . . 1.58 112.892 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -57.52 -30.74 65.4 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 118.911 -0.566 . . . . 3.03 112.051 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.9 pt -114.15 -54.43 4.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 N-CA-C 113.976 1.102 . . . . 2.23 113.976 -173.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.6 tt -74.02 -63.35 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.496 -0.927 . . . . 2.85 108.496 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.2 147.91 23.38 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.128 -0.942 . . . . 1.13 111.553 173.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -54.11 -43.74 55.65 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.985 3.124 . . . . 1.03 111.753 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -56.61 -51.85 67.08 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.048 0.539 . . . . 6.47 112.35 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -47.32 -55.38 8.9 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.087 1.355 . . . . 2.61 109.391 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.1 mt -56.42 -65.11 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 114.687 -1.142 . . . . 2.17 110.406 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.2 mt -48.37 -52.86 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.259 1.024 . . . . 2.15 109.81 -173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -68.92 -30.41 68.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 111.839 0.311 . . . . 3.87 111.839 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.8 m -67.32 -51.42 52.73 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.613 -0.835 . . . . 2.25 109.905 173.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.2 mm -64.17 -33.67 63.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.748 -0.595 . . . . 3.06 111.092 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -55.11 -60.32 3.54 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.918 1.287 . . . . 2.81 108.607 167.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -52.66 -38.54 60.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.862 1.265 . . . . 1.82 112.759 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -55.22 -22.84 19.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.925 0.713 . . . . 3.99 112.925 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.39 46.66 1.4 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.121 -1.192 . . . . 0.99 110.121 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -132.63 168.49 18.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.333 -1.358 . . . . 2.9 107.333 172.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -112.47 88.14 10.57 Favored Pre-proline 0 N--CA 1.454 -0.231 0 CA-C-O 118.515 -0.755 . . . . 3.88 109.324 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.45 151.65 22.85 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.578 2.185 . . . . 1.58 111.944 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.5 m -157.75 145.97 19.0 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.662 1.585 . . . . 3.18 107.386 170.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 109.038 -0.727 . . . . 4.55 109.038 179.315 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 108.533 -0.914 . . . . 3.68 108.533 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 tt -134.59 115.5 13.93 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.453 -1.314 . . . . 3.38 107.453 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.407 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 51.1 mt-10 -89.74 84.85 6.31 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.071 1.348 . . . . 2.67 108.89 174.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.61 132.04 34.24 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.961 -1.126 . . . . 2.64 107.961 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -74.17 149.57 7.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 106.038 -1.838 . . . . 2.09 106.038 164.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -152.69 54.58 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 127.082 2.153 . . . . 2.21 107.696 -169.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -56.84 157.33 5.67 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.779 -0.646 . . . . 6.5 109.338 171.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.48 -37.99 3.55 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 107.851 -2.099 . . . . 1.24 107.851 -162.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 40.5 mtp -53.03 143.63 16.96 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.331 -0.988 . . . . 2.59 108.331 157.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.9 t -168.08 -56.24 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.422 -0.955 . . . . 4.85 108.422 -174.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.8 t -86.9 171.39 10.85 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.466 -0.938 . . . . 3.05 108.466 172.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.81 -166.07 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.467 -0.568 . . . . 2.81 109.467 160.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.5 m 71.79 -60.23 0.53 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.433 1.093 . . . . 2.79 109.728 -171.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 77.7 m -36.98 -53.04 0.97 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 126.123 1.769 . . . . 1.48 109.875 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.6 t -36.08 -66.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.899 1.28 . . . . 1.84 111.336 173.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -26.02 56.26 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.124 -0.36 . . . . 1.31 111.073 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -51.78 -41.64 61.8 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 124.157 0.983 . . . . 4.07 108.786 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 mt -77.7 -70.3 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 107.234 -1.395 . . . . 2.23 107.234 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -47.17 -55.92 7.6 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.746 1.218 . . . . 3.29 112.165 -166.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.8 t -58.15 -49.22 77.76 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.097 -0.705 . . . . 2.11 109.097 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.8 t -62.62 -50.16 72.33 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 122.029 -0.42 . . . . 1.07 110.11 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.02 -36.79 80.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.575 -1.328 . . . . 3.41 111.547 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.1 p -57.67 -17.21 13.59 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.55 0.945 . . . . 1.87 113.55 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -62.25 -33.89 75.47 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.267 0.939 . . . . 4.56 111.641 171.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.504 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 45.5 m-70 -73.34 76.09 1.37 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.127 0.571 . . . . 2.71 110.868 -173.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 mtm105 -42.39 99.87 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.062 1.345 . . . . 6.42 110.668 169.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.39 -44.66 0.86 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.413 -1.875 . . . . 1.74 108.413 -168.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.93 144.83 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 106.303 -1.74 . . . . 2.74 106.303 142.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -105.02 -57.88 1.97 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.969 1.308 . . . . 4.45 107.526 163.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -136.77 144.8 43.95 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.81 0.844 . . . . 2.99 110.886 -172.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.8 m -114.82 158.12 22.34 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 124.488 1.115 . . . . 2.87 108.013 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.0 t -150.97 76.23 1.23 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.697 -0.853 . . . . 3.61 108.697 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.1 t -81.35 136.19 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 125.292 1.437 . . . . 3.53 109.742 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.14 130.23 22.03 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.747 0.819 . . . . 1.93 111.357 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.53 -51.39 36.06 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 124.197 0.999 . . . . 2.62 111.308 -171.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.65 -44.86 90.23 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.537 0.684 . . . . 2.0 110.344 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -13.53 62.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.577 0.751 . . . . 2.62 110.922 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 52.95 33.45 14.65 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.762 1.225 . . . . 3.56 109.561 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.407 ' NZ ' ' OE1' ' A' ' 7' ' ' GLU . 13.0 ttmt -128.83 150.71 50.21 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.673 -0.491 . . . . 2.42 109.673 -164.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.84 123.24 36.86 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.372 -0.973 . . . . 2.08 108.372 153.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 129.65 34.65 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 104.459 -2.423 . . . . 1.59 104.459 159.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.8 mt -114.15 133.97 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 107.425 -1.324 . . . . 3.36 107.425 168.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -118.64 99.13 6.6 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.677 2.791 . . . . 5.28 105.297 -170.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -151.71 157.23 41.77 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 126.633 1.973 . . . . 3.37 109.425 -157.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -82.29 123.09 79.54 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 119.365 0.984 . . . . 3.85 108.553 171.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.08 -2.96 12.42 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.625 2.216 . . . . 1.44 113.61 -173.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -100.23 -51.01 3.77 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.174 0.897 . . . . 3.11 109.196 -176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 pt -69.19 -54.52 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.777 0.323 . . . . 2.28 111.701 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.5 tt -91.06 -49.81 13.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 124.199 1.0 . . . . 2.09 109.739 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.65 154.58 5.75 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 111.667 -0.573 . . . . 0.97 111.667 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.76 -25.35 28.68 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.655 2.237 . . . . 0.87 112.862 -172.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -55.19 -48.91 73.15 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.395 0.543 . . . . 7.22 111.121 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -54.48 -58.53 7.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 122.475 1.131 . . . . 2.78 109.709 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.2 mt -48.82 -56.57 2.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 125.855 1.662 . . . . 2.13 111.711 175.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.7 -50.86 64.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.863 -0.421 . . . . 2.48 109.863 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.08 -39.83 83.38 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.145 0.578 . . . . 6.38 110.921 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.504 ' HG1' ' CE1' ' A' ' 29' ' ' HIS . 36.5 m -58.52 -56.82 17.21 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.542 -0.724 . . . . 2.48 109.57 173.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.9 mt -63.64 -41.12 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 119.031 0.832 . . . . 3.38 111.413 -172.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -45.73 -58.35 3.54 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.256 1.023 . . . . 3.51 108.858 168.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t -61.54 -30.19 70.48 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.87 0.692 . . . . 2.16 112.87 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.92 -34.67 69.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.369 0.986 . . . . 2.85 110.717 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.37 51.34 0.29 Allowed Glycine 0 C--N 1.334 0.445 0 O-C-N 123.863 0.727 . . . . 1.11 112.068 160.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -140.67 170.66 15.36 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 106.345 -1.724 . . . . 3.22 106.345 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.67 86.19 0.42 Allowed Pre-proline 0 N--CA 1.466 0.367 0 CA-C-O 117.167 -1.397 . . . . 4.48 114.248 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.69 76.4 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.504 2.803 . . . . 1.57 112.244 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 p -90.62 128.43 36.61 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.288 1.435 . . . . 2.52 108.669 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 107.87 -1.159 . . . . 4.48 107.87 169.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 107.118 -1.438 . . . . 3.72 107.118 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.1 tt -138.03 97.29 3.37 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.06 -1.83 . . . . 3.6 106.06 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -83.2 135.5 34.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.487 -0.324 . . . . 2.41 110.354 -174.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.46 139.04 54.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.532 -0.914 . . . . 3.28 108.532 175.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.16 116.4 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 106.461 -1.681 . . . . 1.92 106.461 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 m -104.38 83.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 106.395 -1.705 . . . . 2.38 106.395 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -65.3 136.52 56.67 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.999 -0.741 . . . . 6.24 108.999 -169.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.76 -2.09 10.09 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.463 -0.632 . . . . 1.66 113.701 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 73.9 mtm -68.64 79.25 0.28 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.981 1.391 . . . . 2.28 111.038 174.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 t -50.39 -52.9 33.42 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.532 1.133 . . . . 3.75 112.661 -172.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -170.04 -103.16 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.346 0.658 . . . . 6.72 109.557 176.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.67 168.98 18.75 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.595 0.634 . . . . 3.05 110.625 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.0 m 69.53 -62.63 0.41 Allowed 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 126.067 1.747 . . . . 2.08 110.004 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.9 m -37.36 -51.42 1.09 Allowed 'General case' 0 N--CA 1.458 -0.044 0 C-N-CA 127.068 2.147 . . . . 2.28 111.492 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.9 t -45.56 -70.77 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.232 1.013 . . . . 2.01 110.156 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -23.76 67.29 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.873 -0.517 . . . . 1.32 111.171 -175.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -59.03 -52.19 66.82 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.718 -1.216 . . . . 3.89 107.718 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.3 mt -75.34 -56.42 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 108.583 -0.895 . . . . 2.16 108.583 -174.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -38.0 -65.87 0.3 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.186 1.394 . . . . 3.49 112.02 170.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.2 t -62.72 -38.58 91.02 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.928 0.491 . . . . 2.42 110.373 -174.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.6 t -65.62 -24.94 67.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 118.973 -0.537 . . . . 1.34 111.702 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.8 mt -86.75 -44.87 11.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.05 0.94 . . . . 3.4 112.277 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.4 p -72.01 61.63 0.43 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.179 0.992 . . . . 2.06 111.183 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.34 -26.67 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.714 1.606 . . . . 4.57 113.132 -165.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -67.99 -128.72 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 119.621 1.1 . . . . 2.6 110.169 172.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -144.97 163.17 34.99 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 129.503 3.121 . . . . 7.0 104.757 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.41 -61.39 2.75 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.192 -0.763 . . . . 2.24 111.192 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -51.52 111.59 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 117.842 0.821 . . . . 3.54 109.102 172.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 pp -107.71 -23.54 12.06 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.602 1.561 . . . . 3.49 110.962 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -145.32 158.97 43.71 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.842 -0.799 . . . . 3.83 108.842 167.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.7 t -153.48 145.97 24.08 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.003 -1.11 . . . . 2.05 108.003 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 p -150.51 132.52 15.22 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.387 -0.968 . . . . 3.41 108.387 169.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.38 125.13 67.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.247 0.619 . . . . 3.18 111.395 170.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.97 128.04 44.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.279 0.632 . . . . 2.47 110.397 172.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -72.95 -52.55 14.13 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.91 -1.041 . . . . 3.09 111.436 -165.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.44 87.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 121.614 0.721 . . . . 3.09 109.72 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -77.17 -6.36 52.66 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.71 -0.677 . . . . 3.01 110.573 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 56.55 31.53 19.22 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 125.235 1.414 . . . . 3.03 110.146 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -108.66 125.64 52.1 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 121.841 -0.537 . . . . 3.24 109.919 -164.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.5 121.98 37.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.454 1.102 . . . . 2.22 108.558 167.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.72 114.21 28.23 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 103.615 -2.735 . . . . 1.72 103.615 168.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.8 mp -111.37 132.5 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 106.392 -1.707 . . . . 2.01 106.392 173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -101.23 98.76 9.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.44 -1.689 . . . . 4.2 106.44 169.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -140.53 155.27 46.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.816 0.846 . . . . 3.7 112.006 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.73 111.01 19.62 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 108.429 -0.952 . . . . 3.09 108.429 166.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.97 -21.8 36.66 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.944 2.429 . . . . 1.31 112.72 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -46.61 -54.62 9.11 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.132 1.373 . . . . 3.49 109.773 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pt -90.36 -71.13 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 124.92 1.288 . . . . 2.55 112.38 -166.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.2 tt -67.01 -62.93 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.912 -0.773 . . . . 2.98 108.912 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.47 159.44 23.5 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 115.701 -0.681 . . . . 1.16 112.205 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -54.83 -40.16 86.44 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 124.08 3.187 . . . . 1.4 111.337 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -35.51 -65.04 0.26 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.582 1.953 . . . . 10.95 113.516 175.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -60.47 -54.01 50.61 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.024 0.93 . . . . 3.03 108.546 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 88.7 mt -49.33 -57.62 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.282 0.633 . . . . 2.22 109.542 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.5 mt -54.81 -52.87 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.76 -0.587 . . . . 2.65 110.835 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -58.72 -45.01 90.54 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.095 0.95 . . . . 4.02 110.55 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 54.2 m -69.31 -50.59 45.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.956 -0.757 . . . . 1.91 108.956 -174.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.61 -33.7 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 118.798 -0.62 . . . . 3.1 110.919 -177.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -53.01 -58.12 8.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.886 -0.783 . . . . 4.09 108.886 165.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.4 t -58.84 -27.5 65.18 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.247 0.832 . . . . 2.24 113.247 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 25.0 mt -69.35 -10.1 56.41 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.511 1.05 . . . . 2.84 112.808 174.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.45 50.43 2.19 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 124.466 1.031 . . . . 1.03 111.256 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -142.07 171.71 13.68 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 124.739 1.216 . . . . 3.56 107.877 172.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -110.74 84.55 4.23 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.68 -0.676 . . . . 4.48 110.992 -175.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.3 128.08 15.91 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.047 2.498 . . . . 1.9 112.52 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.2 p -138.54 129.63 26.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.627 1.571 . . . . 2.69 107.736 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 CA--C 1.53 0.196 0 N-CA-C 109.245 -0.65 . . . . 4.36 109.245 177.19 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.1 t . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 108.956 -0.757 . . . . 2.97 108.956 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.82 111.97 21.96 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.73 -1.211 . . . . 3.16 107.73 -170.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -85.21 123.48 30.76 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 123.622 0.576 . . . . 2.42 109.612 169.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.21 124.91 44.07 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.584 -2.006 . . . . 2.91 105.584 167.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -82.93 111.32 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 105.698 -1.964 . . . . 2.39 105.698 171.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 m -96.9 77.38 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 125.062 1.345 . . . . 2.41 109.079 -163.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -67.14 107.21 2.24 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.284 1.034 . . . . 7.76 108.892 -166.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.1 -40.76 0.27 Allowed Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.151 -0.805 . . . . 1.59 113.543 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -62.77 162.88 10.17 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 119.182 1.491 . . . . 2.3 111.169 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.9 t -163.98 -56.86 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.245 -1.02 . . . . 3.89 108.245 -175.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.5 m -81.82 172.74 12.99 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.389 0.676 . . . . 4.09 109.818 176.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.88 -172.27 0.17 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.059 -0.519 . . . . 3.14 109.76 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.8 m 71.55 -61.89 0.47 Allowed 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 124.68 1.192 . . . . 2.16 110.286 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.2 m -34.62 -51.74 0.49 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.903 1.681 . . . . 1.78 112.081 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.0 t -48.42 -59.66 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.817 0.847 . . . . 2.24 111.197 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -32.03 73.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.718 -0.613 . . . . 2.12 109.41 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -60.46 -45.75 92.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.553 -0.906 . . . . 4.64 108.553 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.95 -62.16 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.817 -1.549 . . . . 1.92 106.817 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -47.59 -62.09 1.61 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.375 1.083 . . . . 3.96 110.812 -175.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.6 m -63.8 -44.43 93.34 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.835 -1.075 . . . . 3.24 109.34 -168.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.7 t -59.31 -51.63 69.12 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.234 -0.654 . . . . 1.39 109.234 175.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.99 -36.61 77.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.043 -1.036 . . . . 3.43 112.277 -175.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 78.1 p -55.51 -19.56 10.14 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.509 1.05 . . . . 1.98 113.755 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -61.16 -30.94 70.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.573 1.079 . . . . 4.5 111.491 175.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -77.9 63.33 2.9 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 124.495 1.118 . . . . 2.67 110.932 -164.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -28.45 -25.85 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 120.261 3.43 . . . . 7.73 120.261 -164.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.09 -16.3 68.51 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-N 120.64 1.563 . . . . 1.8 111.823 169.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.04 125.87 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 127.435 2.294 . . . . 2.76 108.467 171.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.4 mt -91.45 -48.06 7.09 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.699 1.199 . . . . 4.06 109.274 174.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -154.04 138.45 16.74 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 118.495 -0.764 . . . . 3.26 110.137 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.95 164.56 15.9 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 119.444 1.02 . . . . 2.81 108.664 167.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.0 m -157.44 112.86 2.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.432 -1.321 . . . . 2.46 107.432 162.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.61 154.09 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 O-C-N 123.518 0.511 . . . . 3.16 110.697 166.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.81 137.3 19.93 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 124.008 0.923 . . . . 2.21 110.629 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -74.72 -41.92 59.29 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 122.943 0.497 . . . . 2.45 111.762 -172.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.54 -34.7 74.51 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 122.744 0.418 . . . . 2.49 110.99 -173.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 t -100.86 -7.28 23.7 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.063 0.945 . . . . 3.7 110.791 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 53.19 22.9 2.83 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.282 1.833 . . . . 4.58 112.475 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -94.04 133.97 36.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.09 -1.448 . . . . 2.7 107.09 -172.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.17 112.99 23.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.777 -1.564 . . . . 1.73 106.777 160.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.29 138.46 36.35 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.322 -1.362 . . . . 1.26 107.322 165.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.62 131.14 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 109.132 -0.692 . . . . 2.14 109.132 170.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -103.81 88.51 3.07 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 127.365 2.266 . . . . 4.21 108.061 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -115.79 162.25 17.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.486 1.514 . . . . 3.68 110.282 171.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.04 106.89 4.49 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.187 0.595 . . . . 3.18 109.575 171.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -64.97 -22.53 62.57 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.046 1.831 . . . . 1.47 111.981 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -41.1 -44.49 2.49 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.376 1.87 . . . . 5.6 111.6 170.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.6 pt -113.94 -62.85 2.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 113.34 0.867 . . . . 2.11 113.34 -165.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 tt -88.73 -48.03 14.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.482 0.658 . . . . 2.8 110.4 -165.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.3 159.94 35.04 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 115.474 -0.785 . . . . 0.9 112.676 169.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.02 -42.14 25.18 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.477 3.452 . . . . 0.88 112.263 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -53.0 -51.23 62.3 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.41 0.684 . . . . 6.53 111.48 -172.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -47.97 -57.22 6.03 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.722 0.773 . . . . 2.79 110.435 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.4 mt -61.67 -48.62 87.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 124.821 1.248 . . . . 2.29 111.043 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.2 mt -52.85 -58.56 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.541 -0.541 . . . . 2.26 109.541 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -61.55 -31.74 71.78 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.077 0.551 . . . . 3.6 111.966 -176.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.2 m -58.99 -53.14 61.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.457 -0.777 . . . . 1.78 109.518 173.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.6 mt -73.38 -36.02 47.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 O-C-N 121.617 -0.677 . . . . 3.01 110.647 -173.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -48.39 -50.4 30.91 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.337 1.055 . . . . 3.31 108.924 166.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.4 t -66.27 -42.55 88.28 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.336 0.654 . . . . 1.57 112.001 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -59.37 -40.5 86.68 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.606 0.639 . . . . 2.83 109.897 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.46 46.96 0.47 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.346 -0.702 . . . . 1.14 111.346 164.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -140.91 141.31 34.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.805 -1.924 . . . . 3.96 105.805 168.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -94.27 106.23 21.97 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 118.186 -0.911 . . . . 5.59 112.25 -158.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.75 80.68 1.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.277 2.651 . . . . 1.45 110.838 -174.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.1 m -67.15 111.42 3.9 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.859 -1.163 . . . . 2.58 107.859 168.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 107.921 -1.14 . . . . 4.51 107.921 166.516 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 106.396 -1.705 . . . . 3.66 106.396 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.1 tt -84.33 115.21 22.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.672 -0.862 . . . . 3.52 108.672 -172.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -90.18 133.37 34.94 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.292 0.496 . . . . 2.69 111.227 172.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 pp -129.07 130.57 46.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.109 -1.441 . . . . 2.92 107.109 166.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.15 134.48 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.426 -2.065 . . . . 2.46 105.426 170.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.24 82.04 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.668 -1.604 . . . . 2.8 106.668 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -72.37 146.36 47.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.002 -1.481 . . . . 7.3 107.002 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.14 -36.44 4.4 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.87 -0.892 . . . . 1.22 110.87 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.6 ttp -57.72 133.34 55.27 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.286 -1.005 . . . . 3.14 108.286 167.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -153.48 -57.62 0.12 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.536 1.134 . . . . 3.12 110.264 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.2 t -67.46 140.13 57.08 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.314 -0.866 . . . . 4.64 110.342 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.69 -50.3 2.3 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.215 1.006 . . . . 2.51 112.155 175.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -43.72 -43.45 5.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.448 1.099 . . . . 2.09 111.768 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.2 m -46.48 -41.6 14.25 Favored 'General case' 0 C--N 1.338 0.104 0 C-N-CA 124.566 1.147 . . . . 1.83 111.116 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.5 t -54.16 -62.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.157 -0.683 . . . . 2.14 109.157 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -30.31 68.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.507 -0.746 . . . . 1.78 110.061 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.61 -51.41 67.23 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 107.435 -1.32 . . . . 3.92 107.435 177.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -68.84 -54.18 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.712 1.205 . . . . 2.09 108.584 -176.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -50.79 -61.11 2.41 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 108.724 -0.843 . . . . 4.58 108.724 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -60.17 -47.96 83.76 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.808 0.813 . . . . 2.53 109.715 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.4 t -66.96 -22.51 65.92 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 118.415 -0.802 . . . . 1.46 112.087 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.8 mt -82.3 -63.32 1.4 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 118.274 -0.87 . . . . 3.35 111.107 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.2 p -54.11 -28.37 39.15 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.286 0.948 . . . . 2.63 113.109 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -30.72 65.57 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.369 0.878 . . . . 4.83 113.369 173.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -70.9 72.49 0.56 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.694 -0.854 . . . . 2.84 108.694 164.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -13.23 -50.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 129.193 2.997 . . . . 6.46 116.713 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -43.22 -50.62 6.42 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.975 -0.903 . . . . 1.65 113.251 174.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.53 100.94 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.327 -1.36 . . . . 3.88 107.327 170.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.99 -34.65 32.86 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.699 0.4 . . . . 3.8 111.526 -176.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -148.17 120.35 8.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.628 1.171 . . . . 3.35 109.072 -175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 t -99.47 168.43 9.98 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.239 0.927 . . . . 2.53 108.807 170.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.3 m -145.97 66.2 1.21 Allowed 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 120.892 -1.13 . . . . 2.19 108.846 160.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.7 p -58.06 138.47 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.312 -0.858 . . . . 3.12 111.624 161.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.71 137.69 16.33 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.697 1.199 . . . . 2.5 110.31 175.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.12 -34.33 61.67 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.479 0.712 . . . . 2.73 111.365 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.58 -31.35 71.4 Favored 'General case' 0 C--O 1.226 -0.155 0 O-C-N 121.838 -0.539 . . . . 3.02 110.77 -173.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -111.69 5.73 19.41 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.512 1.125 . . . . 3.88 110.998 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.23 44.29 6.44 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 127.889 2.475 . . . . 3.94 112.068 176.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -142.06 169.6 17.29 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 122.23 -0.294 . . . . 3.54 110.808 -175.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.4 132.45 39.4 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 124.416 1.073 . . . . 2.53 108.988 160.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.43 135.46 34.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.538 -1.282 . . . . 1.49 107.538 158.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.68 120.6 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 105.516 -2.031 . . . . 2.8 105.516 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -90.83 99.9 12.85 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.513 -0.921 . . . . 4.22 108.513 166.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.8 159.26 42.49 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.202 0.601 . . . . 3.17 112.284 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -81.98 120.14 76.76 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 106.08 -1.822 . . . . 3.51 106.08 162.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -63.56 -40.43 30.49 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.525 1.484 . . . . 1.29 111.381 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -85.63 30.96 0.61 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.693 1.197 . . . . 3.72 112.067 -160.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.3 pt -134.98 -50.23 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.762 1.225 . . . . 2.4 109.96 172.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 tt -96.79 -41.68 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.921 1.288 . . . . 2.11 111.494 -174.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.68 148.26 5.56 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 111.33 -0.708 . . . . 1.14 111.33 -175.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.11 -36.46 58.4 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.208 2.606 . . . . 0.81 111.554 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -50.65 -50.38 54.64 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.829 0.852 . . . . 7.29 112.256 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -52.28 -56.06 17.25 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 121.765 0.793 . . . . 2.62 109.537 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.0 mt -57.41 -53.54 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.463 1.105 . . . . 2.26 111.56 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.7 mt -57.53 -54.29 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 122.02 -0.425 . . . . 2.47 109.98 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -64.93 -33.04 75.07 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.535 -0.728 . . . . 3.98 111.769 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.3 m -56.81 -52.04 66.59 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 121.565 -0.71 . . . . 1.6 109.091 171.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.7 mt -64.32 -42.08 94.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 119.608 1.094 . . . . 3.48 111.079 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -49.56 -51.73 34.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.159 0.984 . . . . 3.4 109.039 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -64.51 -43.86 92.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.609 0.764 . . . . 1.83 111.387 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.19 -34.6 72.33 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.891 1.676 . . . . 3.68 111.262 -175.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.36 39.46 0.23 Allowed Glycine 0 C--N 1.333 0.416 0 O-C-N 124.685 1.241 . . . . 0.97 111.857 152.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -142.74 174.62 10.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.78 -0.822 . . . . 3.02 108.78 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -108.93 92.07 10.1 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.955 1.302 . . . . 3.96 109.848 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.99 65.85 7.74 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.685 2.924 . . . . 1.78 111.124 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.7 m -74.98 119.9 19.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.575 0.702 . . . . 2.93 110.256 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 C--N 1.33 -0.254 0 N-CA-C 109.177 -0.675 . . . . 5.39 109.177 177.947 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 106.835 -1.543 . . . . 3.52 106.835 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 tt -150.47 147.29 27.34 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.772 -1.196 . . . . 3.17 107.772 170.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -103.3 150.45 23.74 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.981 1.312 . . . . 2.74 109.431 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.95 138.15 25.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.601 -0.888 . . . . 3.59 108.601 164.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -77.79 143.29 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.256 -1.387 . . . . 1.95 107.256 170.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.28 103.74 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.529 1.532 . . . . 2.52 107.618 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -73.89 166.49 23.25 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.251 -1.018 . . . . 6.51 108.251 165.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.6 -11.34 59.51 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.663 0.649 . . . . 1.02 112.612 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.7 mtm -73.83 65.5 1.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.523 1.161 . . . . 2.3 110.423 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 t -91.18 12.72 19.18 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.352 1.061 . . . . 3.11 112.849 -166.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.4 t -165.52 173.86 10.53 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.428 -0.953 . . . . 3.62 108.428 -173.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.21 -176.01 0.06 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.398 0.545 . . . . 3.17 110.435 164.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.0 p 68.77 -54.37 0.55 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.804 2.042 . . . . 2.98 111.388 -171.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.4 m -24.98 -54.11 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.492 2.717 . . . . 2.42 113.105 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.1 t -43.18 -70.85 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.444 1.098 . . . . 2.06 110.614 172.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -26.74 64.86 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.315 -0.866 . . . . 1.48 111.069 -176.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -51.51 -41.62 61.12 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.158 0.983 . . . . 4.26 109.195 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.9 -65.0 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.454 -1.313 . . . . 2.07 107.454 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -47.85 -56.0 8.48 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.026 1.33 . . . . 3.37 111.645 -169.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 t -62.39 -50.6 70.91 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.676 0.75 . . . . 1.91 109.22 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 t -60.79 -24.43 65.79 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 118.686 -0.673 . . . . 1.07 111.923 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.96 -46.57 14.92 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 117.947 -1.025 . . . . 3.17 111.494 172.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.9 p -51.58 -32.02 26.98 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.612 1.096 . . . . 1.93 112.336 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -47.44 -45.26 25.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.014 1.325 . . . . 5.86 113.475 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -67.69 136.26 54.04 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 119.412 1.005 . . . . 2.44 108.402 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -63.66 -53.06 57.25 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.75 -0.593 . . . . 9.18 112.513 -168.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.05 47.07 3.28 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 117.881 0.309 . . . . 1.71 113.261 -169.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.83 112.85 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.49 -1.3 . . . . 2.78 107.49 177.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 tp -73.53 -48.73 30.88 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.882 0.873 . . . . 4.51 109.025 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -156.94 120.25 4.14 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.843 -0.536 . . . . 4.04 110.825 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.37 157.86 15.83 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.542 -1.281 . . . . 2.58 107.542 168.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.9 t -163.35 113.35 1.34 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.859 -0.793 . . . . 1.94 108.859 168.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.93 145.48 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 112.544 0.572 . . . . 3.47 112.544 175.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.57 133.1 44.66 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.869 0.868 . . . . 1.7 110.3 174.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.61 -43.83 65.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.067 -0.97 . . . . 2.48 110.555 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.93 -50.81 71.44 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.316 0.579 . . . . 1.98 110.547 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -65.54 -14.09 60.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.745 0.818 . . . . 2.68 110.967 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 55.02 30.36 14.06 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.264 1.426 . . . . 3.57 109.15 -171.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -132.45 131.12 41.4 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.319 0.509 . . . . 2.43 111.365 -164.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.52 132.63 44.72 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.996 -1.112 . . . . 1.71 107.996 160.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.21 144.88 32.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.535 -1.283 . . . . 1.3 107.535 156.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 55.5 mt -135.72 126.31 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 107.929 -1.137 . . . . 3.13 107.929 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -93.86 72.96 4.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.366 1.466 . . . . 2.88 108.418 172.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -101.58 170.74 7.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.702 0.801 . . . . 3.59 113.147 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -95.33 97.48 2.76 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.365 1.466 . . . . 3.97 108.861 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.86 -33.04 85.45 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.931 2.421 . . . . 1.06 113.636 -166.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.1 mp0 -63.74 -30.21 71.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.244 0.617 . . . . 4.01 112.05 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.0 pt -107.09 -56.14 5.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 112.864 0.691 . . . . 2.15 112.864 -168.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 tt -87.07 -52.03 12.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.46 -0.941 . . . . 2.72 108.46 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.42 167.51 28.8 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 115.482 -0.781 . . . . 0.96 113.099 173.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.72 -38.53 70.6 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.273 3.316 . . . . 0.95 111.838 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -58.76 -60.15 4.29 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.973 0.509 . . . . 6.6 112.061 -172.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -49.85 -52.47 32.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 122.44 1.114 . . . . 2.75 110.173 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 95.0 mt -48.63 -69.72 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 114.08 -1.418 . . . . 1.87 109.894 171.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.8 mt -51.34 -40.92 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.714 0.688 . . . . 2.12 111.535 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 52.8 m170 -63.15 -47.47 82.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.547 0.689 . . . . 4.93 109.456 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.2 m -66.27 -44.73 82.76 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.606 -0.516 . . . . 1.95 109.606 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.4 mm -57.01 -47.59 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.994 0.918 . . . . 2.61 110.081 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -53.09 -58.85 5.6 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.181 -0.674 . . . . 3.62 109.181 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -55.38 -38.68 69.17 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.057 0.943 . . . . 1.66 112.279 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.8 mt -63.62 -14.49 52.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.611 0.764 . . . . 2.99 112.584 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.66 48.24 1.12 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.482 1.039 . . . . 0.77 110.964 168.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -141.74 171.2 14.39 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.399 1.08 . . . . 3.49 108.809 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -109.96 79.89 1.62 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 118.534 -0.746 . . . . 3.89 112.923 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.76 123.73 11.41 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.141 1.894 . . . . 1.25 111.511 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.9 t -148.68 152.69 37.11 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.726 0.81 . . . . 3.32 109.235 172.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 N--CA 1.466 0.352 0 O-C-N 121.346 -0.846 . . . . 4.2 111.601 -165.337 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 107.802 -1.184 . . . . 4.01 107.802 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.63 89.8 3.19 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.43 -2.433 . . . . 3.49 104.43 166.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -70.06 145.94 51.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.506 -0.553 . . . . 2.24 109.506 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.78 139.31 21.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.807 -0.812 . . . . 3.15 108.807 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.7 t -94.44 129.64 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.645 -1.243 . . . . 2.36 107.645 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.6 m -132.26 74.7 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 C-N-CA 125.215 1.406 . . . . 2.21 109.953 -160.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -66.83 153.3 43.75 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.777 -0.823 . . . . 5.72 108.777 175.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.14 -29.56 7.61 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 109.632 -1.387 . . . . 1.16 109.632 -163.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.4 mtp -56.26 144.66 29.31 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.831 -0.805 . . . . 2.65 109.375 166.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 t -166.09 -58.92 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.005 0.522 . . . . 3.02 109.719 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.8 t -77.2 147.23 36.54 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.977 -0.749 . . . . 4.57 108.977 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.29 -43.34 10.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.409 0.684 . . . . 1.89 111.796 174.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.7 p -48.34 -41.27 28.01 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.374 0.67 . . . . 2.8 111.561 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 99.3 m -50.24 -29.04 8.65 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.774 0.83 . . . . 1.91 112.544 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t -55.85 -69.5 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.56 0.618 . . . . 2.09 109.421 169.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -27.98 67.59 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.895 -1.128 . . . . 2.3 111.436 -172.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.63 -33.64 16.01 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.924 1.29 . . . . 4.62 110.375 172.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 98.8 mt -91.07 -60.2 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.123 -1.436 . . . . 1.55 107.123 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -54.44 -64.17 0.92 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.618 1.167 . . . . 3.26 111.267 -170.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.6 m -59.55 -35.27 73.9 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.303 0.641 . . . . 2.95 111.504 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -62.62 -40.49 97.12 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.305 -0.247 . . . . 1.49 110.383 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.4 mt -72.02 -62.33 1.47 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 119.306 -0.378 . . . . 3.28 111.092 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.2 p -66.91 69.83 0.08 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.495 1.918 . . . . 2.33 111.03 -168.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.64 -40.84 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.071 2.148 . . . . 4.77 110.561 -172.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -74.26 150.73 40.1 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.119 0.872 . . . . 5.29 110.371 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -54.14 148.8 10.47 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.045 0.45 . . . . 7.7 110.215 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.22 -31.51 5.37 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.491 -0.616 . . . . 1.77 112.473 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.19 148.58 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 118.005 0.903 . . . . 2.96 108.679 171.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 36.0 mt -114.5 -51.29 2.76 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.821 1.249 . . . . 4.1 109.604 167.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -150.35 161.36 42.62 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.895 0.878 . . . . 3.76 109.881 -175.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.8 m -143.29 168.35 19.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.16 -1.052 . . . . 2.02 108.16 170.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.0 m -148.01 132.21 17.39 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.487 -1.301 . . . . 2.12 107.487 148.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.0 p -104.57 142.25 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 118.433 0.561 . . . . 3.31 110.048 164.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.62 132.26 48.14 Favored 'General case' 0 C--N 1.339 0.15 0 O-C-N 121.864 -0.522 . . . . 1.84 111.407 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.39 -58.96 6.28 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.236 1.014 . . . . 3.87 110.501 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.28 -39.41 69.81 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.59 0.756 . . . . 2.24 112.664 -169.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.6 m -95.63 -8.39 34.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.338 0.655 . . . . 3.46 110.499 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 54.65 23.16 4.5 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.562 1.945 . . . . 4.57 112.577 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -98.96 145.12 27.37 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 119.035 -0.507 . . . . 3.01 110.494 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.16 138.69 40.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.121 -1.437 . . . . 1.67 107.121 154.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -107.82 150.82 26.54 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 106.632 -1.618 . . . . 1.61 106.632 154.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 mp -126.29 122.04 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.172 -1.788 . . . . 2.11 106.172 173.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -94.36 82.43 4.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.356 1.863 . . . . 4.76 106.591 169.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -118.76 164.32 15.56 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.967 2.107 . . . . 3.26 109.775 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -86.89 117.76 69.11 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 107.856 -1.164 . . . . 3.26 107.856 167.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.2 -29.73 38.78 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.162 1.908 . . . . 1.31 112.918 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -86.66 29.23 0.8 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.664 1.12 . . . . 3.55 111.285 -166.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.7 pt -144.47 -50.48 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 123.95 0.9 . . . . 1.98 112.236 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.254 17.6 tt -95.56 -85.26 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.572 -0.899 . . . . 2.42 108.572 174.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.28 166.52 11.71 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.811 0.719 . . . . 1.24 112.955 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.59 -47.43 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.356 3.37 . . . . 0.87 111.305 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.435 ' HE ' ' CG ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -46.43 -48.25 18.88 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.118 0.967 . . . . 9.72 111.392 176.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.435 ' CG ' ' HE ' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -53.48 -56.91 13.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.876 1.271 . . . . 4.62 108.884 179.49 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.7 mt -57.56 -56.07 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.845 0.858 . . . . 1.98 109.965 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.6 mt -50.56 -51.54 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.426 -0.583 . . . . 2.34 109.426 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -36.65 84.47 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.48 0.712 . . . . 5.62 111.056 -178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.9 m -64.58 -53.66 44.26 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.34 -0.85 . . . . 1.78 109.35 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.1 mm -68.78 -33.14 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 121.335 -0.853 . . . . 2.71 111.158 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -49.63 -62.07 1.76 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.12 0.968 . . . . 3.33 109.162 162.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -54.88 -38.7 67.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.763 0.825 . . . . 1.57 112.865 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.24 -14.71 27.92 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.954 -1.091 . . . . 3.31 112.88 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.02 47.01 2.31 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.317 0.961 . . . . 0.69 111.051 175.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -136.02 172.05 13.58 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.194 0.997 . . . . 3.56 108.387 171.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -111.89 84.8 5.8 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 113.098 0.777 . . . . 4.27 113.098 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.03 80.42 0.52 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.633 2.889 . . . . 1.05 114.013 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.9 p -77.13 119.68 21.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.553 -0.749 . . . . 3.04 109.654 169.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 108.687 -0.857 . . . . 3.75 108.687 178.412 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 107.691 -1.225 . . . . 3.27 107.691 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.32 111.68 4.96 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.818 -1.549 . . . . 3.28 106.818 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -92.29 141.38 28.62 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 123.28 0.632 . . . . 2.81 110.047 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.9 137.0 23.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.209 -0.663 . . . . 2.75 109.209 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.02 121.89 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 105.751 -1.944 . . . . 2.09 105.751 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -116.02 100.57 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.722 -1.214 . . . . 2.53 107.722 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -73.45 166.2 23.66 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.233 -1.025 . . . . 6.77 108.233 175.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.78 -10.76 57.5 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.511 -0.605 . . . . 1.02 112.618 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 75.8 mtm -68.05 73.02 0.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.555 1.177 . . . . 1.93 111.686 174.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -71.71 -30.12 65.31 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.533 1.133 . . . . 2.87 112.604 -171.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 82.5 m -143.46 158.92 43.26 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.225 -0.657 . . . . 3.72 109.225 -176.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.23 -45.15 8.34 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.97 1.308 . . . . 1.88 112.205 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 m -43.35 -42.46 4.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.431 1.092 . . . . 2.1 112.163 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.2 m -54.66 -40.05 68.65 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.683 -0.635 . . . . 1.87 111.608 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 t -58.34 -57.9 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.436 -0.95 . . . . 1.94 108.436 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -31.07 72.13 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.48 -0.563 . . . . 1.35 109.48 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -60.16 -51.31 70.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.946 -1.131 . . . . 4.77 107.946 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.7 mt -62.86 -54.83 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.855 -1.165 . . . . 1.96 107.855 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -51.99 -56.83 11.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 123.714 0.634 . . . . 3.09 109.53 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.7 t -59.8 -46.25 89.8 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.244 0.618 . . . . 2.47 110.079 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.3 t -65.13 -29.61 70.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.363 0.665 . . . . 1.06 111.422 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mt -79.87 -45.49 18.55 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.535 -0.745 . . . . 3.49 111.098 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.0 p -65.42 75.84 0.06 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.751 0.82 . . . . 2.09 110.747 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.94 -32.66 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 129.197 2.999 . . . . 4.36 110.301 -175.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -59.68 -23.45 63.11 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.914 0.779 . . . . 2.46 111.527 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 78.57 -42.26 0.32 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.424 1.49 . . . . 9.03 113.383 162.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.15 -20.5 58.29 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 111.735 -0.546 . . . . 1.57 111.735 168.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.72 130.86 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.584 0.753 . . . . 4.34 110.746 176.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.9 mt -74.66 -42.26 58.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.217 1.007 . . . . 3.92 108.748 169.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -161.58 165.28 28.66 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.952 -0.388 . . . . 4.03 109.952 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 p -141.25 59.29 1.52 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 126.481 1.912 . . . . 3.11 110.894 -176.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.32 95.72 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.827 -0.546 . . . . 1.78 111.682 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.32 149.11 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 126.265 1.826 . . . . 3.21 112.83 173.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.98 131.08 10.23 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.06 1.344 . . . . 1.99 112.086 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -65.89 -53.05 44.53 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 115.285 -0.87 . . . . 2.74 111.45 -170.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.0 -45.63 88.14 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.563 0.697 . . . . 2.85 109.435 -168.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.4 t -80.6 1.64 28.95 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.86 -0.59 . . . . 3.9 111.3 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 57.24 31.44 20.08 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.451 1.1 . . . . 3.51 109.828 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -107.1 138.79 42.61 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.453 -0.943 . . . . 2.98 108.453 -167.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.12 141.23 48.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.868 -1.901 . . . . 1.72 105.868 141.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -117.84 158.38 24.92 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 118.211 -1.395 . . . . 2.16 108.04 149.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 mp -119.46 128.93 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 106.32 -1.733 . . . . 2.11 106.32 168.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -95.34 132.32 40.49 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.396 -2.076 . . . . 3.54 105.396 163.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -165.07 167.77 17.97 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.044 0.838 . . . . 3.8 111.514 -168.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -87.71 119.09 70.49 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 107.015 -1.476 . . . . 3.49 107.015 156.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.15 -39.31 18.67 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.043 1.829 . . . . 1.34 111.065 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -89.14 39.17 0.92 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.206 1.002 . . . . 3.94 110.528 -160.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.7 pt -142.24 -49.9 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 126.052 1.741 . . . . 2.3 109.898 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 tt -95.68 -43.13 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.676 1.19 . . . . 2.37 111.373 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.36 150.64 4.93 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 123.911 0.767 . . . . 1.11 111.493 -174.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.66 -29.35 60.37 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.109 2.539 . . . . 0.96 111.775 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -55.92 -52.49 63.94 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.44 0.696 . . . . 6.85 111.458 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -50.28 -54.8 18.72 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 122.226 1.012 . . . . 2.52 109.869 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mt -54.26 -61.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.843 1.257 . . . . 1.77 110.144 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.5 mt -53.59 -47.43 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.42 0.555 . . . . 2.42 110.791 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -62.65 -42.89 99.86 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.298 0.639 . . . . 3.49 109.72 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.9 m -60.83 -54.0 50.46 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.209 -0.663 . . . . 1.77 109.209 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.2 mm -62.74 -37.58 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 119.215 -0.422 . . . . 2.63 111.037 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -52.99 -64.92 0.66 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.206 -0.664 . . . . 3.61 109.206 169.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.6 t -59.86 -24.79 64.51 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.438 0.695 . . . . 1.86 112.791 -176.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.1 tp -72.72 -5.15 35.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.078 1.351 . . . . 3.5 111.548 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.68 47.59 1.62 Allowed Glycine 0 C--N 1.337 0.628 0 C-N-CA 125.229 1.395 . . . . 0.86 110.825 168.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -144.16 172.34 13.04 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 123.949 0.9 . . . . 2.96 109.53 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -114.94 77.92 5.13 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.664 -0.684 . . . . 4.3 111.311 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.36 93.66 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.598 2.198 . . . . 1.06 112.41 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.3 t -97.04 139.65 32.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.895 0.855 . . . . 3.22 109.896 171.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 107.562 -1.273 . . . . 4.66 107.562 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 108.989 -0.745 . . . . 3.23 108.989 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.1 tp -133.65 141.74 47.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.507 -2.035 . . . . 3.78 105.507 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -129.83 139.47 51.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.278 -1.378 . . . . 2.48 107.278 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.84 148.5 35.59 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.073 -1.084 . . . . 4.28 108.073 176.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.39 133.25 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.893 -1.521 . . . . 1.94 106.893 175.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.09 87.97 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.75 0.82 . . . . 2.64 109.224 -168.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 77.0 mmt-85 -62.77 150.87 40.28 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.544 -0.909 . . . . 6.4 108.544 171.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.26 -4.5 48.26 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.862 -0.966 . . . . 1.19 113.954 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.8 mtp -75.1 49.61 0.45 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.871 1.835 . . . . 2.27 112.249 -176.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 t -82.79 37.22 0.52 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.695 -1.253 . . . . 3.12 113.407 -164.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.3 t -173.41 142.4 0.98 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.615 0.766 . . . . 4.04 108.959 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.38 -50.26 3.81 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.468 1.107 . . . . 2.55 112.456 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 m -46.36 -34.34 4.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.93 1.292 . . . . 1.94 112.866 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.0 m -48.23 -34.98 11.09 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 123.571 0.748 . . . . 2.17 111.029 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.4 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 93.9 t -49.07 -72.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 118.18 0.446 . . . . 2.19 110.115 173.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -27.9 68.47 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.693 -0.629 . . . . 1.72 111.178 -175.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -49.56 -42.84 45.3 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.213 0.605 . . . . 4.31 110.088 173.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.3 mt -83.06 -61.71 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.099 -1.075 . . . . 2.08 108.099 175.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -51.88 -61.31 2.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.39 1.476 . . . . 3.35 111.231 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 t -62.05 -45.49 93.33 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.855 0.862 . . . . 2.25 109.181 -173.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -59.95 -37.16 78.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.777 -0.647 . . . . 1.03 111.302 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mt -75.34 -37.41 60.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.235 -0.888 . . . . 3.37 112.521 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.5 p -64.35 77.6 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.749 0.704 . . . . 1.8 111.218 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 168.32 -31.35 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.762 2.825 . . . . 4.16 111.152 -174.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -52.72 120.75 6.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.881 0.764 . . . . 2.69 110.108 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -70.97 80.26 0.65 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.836 0.855 . . . . 5.7 111.307 -166.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.86 -16.87 1.07 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.933 1.254 . . . . 1.25 110.743 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.5 148.95 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 107.659 -1.238 . . . . 2.74 107.659 163.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 pp -122.11 -29.94 4.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.841 0.856 . . . . 3.6 112.346 167.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -159.64 154.7 24.94 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 119.547 1.067 . . . . 3.63 109.143 174.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -132.94 157.91 43.96 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.314 -0.995 . . . . 1.9 108.314 174.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.6 t -159.67 128.58 5.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.477 -0.934 . . . . 2.43 108.477 159.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.4 ' CG2' ' HA ' ' A' ' 19' ' ' VAL . 1.1 m -121.12 159.93 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 123.203 0.601 . . . . 2.89 110.249 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.22 134.32 17.03 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.118 0.485 . . . . 1.98 110.458 174.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.92 -33.92 68.67 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.152 -0.931 . . . . 2.33 110.462 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.98 80.44 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.547 0.739 . . . . 1.96 111.659 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.6 m -96.56 2.38 52.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.72 0.808 . . . . 3.31 109.974 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 46.67 44.71 14.01 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.453 2.301 . . . . 4.04 112.113 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -133.66 157.79 44.88 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 112.01 0.374 . . . . 3.13 112.01 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.66 135.94 53.37 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.422 -1.325 . . . . 1.86 107.422 162.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.59 149.77 27.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 123.832 0.707 . . . . 1.37 109.783 159.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.65 139.31 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 C-N-CA 127.481 2.312 . . . . 1.95 106.172 175.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -113.45 135.14 54.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.62 -1.993 . . . . 3.15 105.62 161.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -170.97 175.08 4.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.228 1.011 . . . . 3.37 110.569 -164.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -98.09 96.26 3.38 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 125.457 1.503 . . . . 3.3 108.063 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -60.35 -29.75 89.51 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.128 1.885 . . . . 1.11 112.12 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -54.79 -43.93 73.28 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.872 0.869 . . . . 3.96 111.792 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.4 pt -94.77 -86.79 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.877 0.471 . . . . 2.04 112.027 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.7 tt -59.24 -45.83 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.971 0.908 . . . . 2.59 111.381 -171.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.95 161.8 31.26 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 115.329 -0.851 . . . . 0.83 112.342 172.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.27 -35.65 23.61 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.644 2.896 . . . . 0.74 111.865 -174.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -55.23 -49.35 72.22 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.918 0.487 . . . . 6.42 111.742 -174.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.28 -53.75 20.3 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.742 0.782 . . . . 2.78 109.75 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.55 -50.11 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.627 1.171 . . . . 2.09 110.555 -174.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.2 mt -55.18 -52.31 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 109.767 -0.457 . . . . 2.25 109.767 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -62.27 -36.35 81.81 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.376 -0.828 . . . . 3.18 112.22 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 66.6 m -57.21 -50.44 72.85 Favored 'General case' 0 C--O 1.225 -0.21 0 O-C-N 121.262 -0.899 . . . . 2.02 108.937 174.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.5 mt -65.73 -42.85 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.693 -0.63 . . . . 3.23 111.315 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -48.31 -46.1 35.81 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.424 1.09 . . . . 2.7 109.104 171.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.0 t -69.83 -44.07 70.68 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.741 0.817 . . . . 2.27 111.695 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.9 mt -59.38 -28.33 66.79 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.467 -0.77 . . . . 3.01 110.653 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.21 47.65 0.69 Allowed Glycine 0 C--O 1.228 -0.219 0 N-CA-C 110.117 -1.193 . . . . 1.05 110.117 157.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -134.62 171.55 14.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.529 -1.656 . . . . 3.05 106.529 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -108.93 82.01 1.69 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.06 -0.971 . . . . 4.22 111.313 -170.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.74 75.55 1.61 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.515 2.81 . . . . 1.12 112.823 -174.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m -73.51 116.92 14.66 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.959 -0.756 . . . . 2.96 108.959 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.2 tp . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.557 -1.275 . . . . 4.17 107.557 176.179 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 109.535 -0.543 . . . . 3.27 109.535 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 tt -152.05 136.0 16.44 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.681 -1.97 . . . . 3.87 105.681 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -114.13 130.01 56.6 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.251 1.021 . . . . 2.56 108.452 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.9 131.76 56.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.11 -1.441 . . . . 2.56 107.11 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 t -73.87 103.99 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 105.233 -2.136 . . . . 2.2 105.233 167.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 p -99.57 124.47 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 109.42 -0.585 . . . . 3.79 109.42 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -82.5 104.85 13.09 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.369 -1.715 . . . . 6.16 106.369 164.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.29 -54.32 0.03 OUTLIER Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.76 -0.257 . . . . 3.12 112.93 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -76.68 73.4 3.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.863 -0.787 . . . . 2.75 110.396 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 t -56.51 -39.06 72.66 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.907 0.483 . . . . 3.19 110.222 171.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 65.2 m -143.31 -168.01 2.7 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.743 1.617 . . . . 3.82 107.202 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.39 -168.15 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.537 0.735 . . . . 2.72 111.115 170.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.8 m 69.57 -66.86 0.25 Allowed 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.74 1.216 . . . . 2.18 109.693 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.5 m -40.85 -48.89 3.16 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.887 1.275 . . . . 1.69 110.671 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.0 t -43.26 -67.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.931 1.292 . . . . 1.97 110.968 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -24.54 67.74 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.836 -0.62 . . . . 1.43 109.643 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -65.27 -51.31 61.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.431 -0.951 . . . . 4.66 108.431 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.4 mt -65.12 -53.76 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 107.667 -1.235 . . . . 1.75 107.667 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -45.28 -51.71 10.55 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.455 0.702 . . . . 3.55 112.569 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 53.2 m -63.43 -52.88 59.66 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.684 -0.635 . . . . 2.58 110.167 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.0 t -54.45 -37.32 65.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.388 1.075 . . . . 1.22 111.506 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.07 -44.89 15.98 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.404 1.082 . . . . 2.88 110.954 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.7 p -58.24 -37.67 75.37 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.72 1.146 . . . . 1.96 110.834 176.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -51.25 -29.75 15.47 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.24 1.416 . . . . 5.74 113.057 169.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -78.8 99.45 6.7 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.76 -1.213 . . . . 2.72 110.3 175.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.71 107.83 0.17 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.864 -1.162 . . . . 7.8 107.864 157.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.75 -36.07 1.87 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.672 -1.371 . . . . 1.83 109.672 -170.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.68 142.49 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.697 -1.223 . . . . 3.29 107.697 168.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.0 tp -98.58 -47.4 5.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.639 1.576 . . . . 4.16 108.721 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -154.98 128.69 8.62 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.249 0.62 . . . . 4.62 109.913 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.0 t -108.05 150.44 27.16 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 108.347 -0.983 . . . . 2.12 108.347 171.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.9 t -156.55 129.52 7.88 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.148 -1.426 . . . . 2.47 107.148 162.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.0 m -122.85 144.71 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.89 0.768 . . . . 2.78 110.759 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.26 132.25 35.53 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.727 0.811 . . . . 1.96 111.28 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 pp -68.62 -51.71 39.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.661 1.185 . . . . 2.63 110.994 -174.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.32 -51.32 65.06 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.404 0.621 . . . . 2.25 110.178 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.04 -14.71 61.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.672 1.189 . . . . 2.6 111.738 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 55.52 33.79 21.78 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.198 1.399 . . . . 3.77 108.367 -172.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -126.48 140.72 52.25 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 118.801 0.728 . . . . 2.25 111.264 -162.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.32 120.25 39.0 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.127 -1.064 . . . . 1.8 108.127 161.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -95.27 132.0 40.73 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 126.684 1.994 . . . . 4.37 106.466 173.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.5 mt -130.47 130.32 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.799 -1.186 . . . . 2.73 107.799 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -104.66 131.99 51.44 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 105.967 -1.864 . . . . 3.95 105.967 159.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -162.78 160.8 25.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.601 1.16 . . . . 3.55 109.283 -169.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -82.2 104.5 3.36 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 107.432 -1.321 . . . . 3.65 107.432 172.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -61.78 -45.02 18.43 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.447 2.098 . . . . 1.45 111.923 -166.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -53.32 -40.9 65.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.308 1.443 . . . . 4.41 112.938 -174.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 pt -88.56 -47.51 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 113.838 1.051 . . . . 2.08 113.838 -168.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.2 tt -83.99 -56.71 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 118.142 0.428 . . . . 2.74 111.191 -178.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.41 135.01 8.3 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.002 0.811 . . . . 1.33 112.444 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.65 -45.18 14.66 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.703 2.935 . . . . 0.99 111.059 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -53.55 -52.4 59.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.51 -0.552 . . . . 8.18 109.51 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.94 -46.39 85.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.916 1.686 . . . . 5.32 109.928 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 mt -52.31 -58.86 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 122.696 0.399 . . . . 2.14 110.732 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 mt -50.49 -43.87 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 118.091 0.405 . . . . 2.54 111.184 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -63.4 -36.35 83.43 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.495 -0.753 . . . . 3.12 111.483 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.6 m -62.25 -50.33 72.16 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.282 -0.886 . . . . 1.89 109.273 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.9 mm -59.71 -45.01 94.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.881 -0.512 . . . . 2.28 111.321 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -52.11 -53.74 38.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.115 1.366 . . . . 2.71 109.528 172.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -56.56 -39.42 73.43 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.357 1.063 . . . . 1.69 112.124 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.76 -17.27 34.06 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.573 0.583 . . . . 3.43 112.573 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.45 29.26 11.29 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.344 0.973 . . . . 1.46 110.724 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -120.31 158.68 26.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.645 1.178 . . . . 3.06 108.684 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -105.65 104.11 46.87 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-O 118.029 -0.986 . . . . 4.69 110.271 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -84.54 83.74 1.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.934 3.089 . . . . 1.06 111.552 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 m -72.54 103.67 3.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.877 -0.786 . . . . 2.84 108.877 173.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--N 1.327 -0.402 0 N-CA-C 108.237 -1.023 . . . . 4.63 108.237 174.084 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 CA--C 1.531 0.244 0 N-CA-C 109.211 -0.663 . . . . 3.11 109.211 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -74.91 111.57 10.25 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.029 -1.1 . . . . 3.69 108.029 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -92.56 122.79 35.33 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.272 -1.381 . . . . 2.94 107.272 169.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -118.66 151.0 38.77 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 108.099 -1.074 . . . . 2.53 108.099 170.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 t -103.78 119.0 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.34 -0.985 . . . . 2.34 108.34 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.56 119.98 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 126.937 2.095 . . . . 2.51 109.406 174.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -82.38 161.63 22.45 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.674 -1.232 . . . . 6.88 107.674 154.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.91 -28.17 5.47 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.185 0.898 . . . . 1.08 112.569 172.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -65.53 113.62 4.3 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.438 1.119 . . . . 2.21 109.845 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 t -67.31 -54.8 17.52 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.567 -0.531 . . . . 3.75 109.567 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 t -177.34 -90.03 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.658 1.183 . . . . 5.46 109.914 170.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.02 160.23 32.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.651 0.38 . . . . 3.23 109.989 -176.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.5 m 68.02 -60.66 0.4 Allowed 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.424 1.49 . . . . 2.04 110.983 -173.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.6 m -39.64 -41.91 1.12 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 126.438 1.895 . . . . 1.67 113.04 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.7 t -51.16 -69.57 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.709 0.29 . . . . 1.86 110.337 173.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.19 -30.73 71.66 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.302 -0.874 . . . . 2.31 110.872 -175.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.28 -40.83 17.62 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.771 1.228 . . . . 4.37 109.49 174.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.9 mt -85.32 -60.44 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 107.352 -1.351 . . . . 1.81 107.352 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -51.36 -62.28 1.72 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.242 1.417 . . . . 3.47 111.52 -170.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -61.93 -43.11 99.53 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.809 0.844 . . . . 3.35 110.144 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.9 t -62.28 -35.2 78.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.079 -0.509 . . . . 1.67 110.858 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.9 mt -70.43 -46.99 62.81 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.32 -0.847 . . . . 3.32 111.041 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.5 p -63.89 77.45 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.257 0.481 . . . . 1.78 110.779 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? 170.72 -24.58 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.654 3.182 . . . . 4.18 111.437 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -70.91 59.24 0.22 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.94 1.245 . . . . 2.83 111.683 172.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 41.04 -73.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 129.454 3.101 . . . . 6.4 115.766 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.43 97.14 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.918 0.771 . . . . 1.94 111.526 -175.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 tp -66.65 97.66 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 117.635 0.717 . . . . 3.17 110.877 -175.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 pp -86.5 -32.77 20.58 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.605 1.162 . . . . 4.22 111.721 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -147.72 136.8 22.21 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.278 0.631 . . . . 3.41 111.02 176.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -117.75 166.45 12.42 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.223 -1.028 . . . . 2.06 108.223 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 m -151.09 117.69 5.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.421 -1.326 . . . . 2.15 107.421 151.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.71 125.15 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 120.411 1.46 . . . . 3.49 109.894 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.44 129.55 55.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.181 0.593 . . . . 2.19 109.475 172.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.0 -48.17 54.68 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.849 -1.069 . . . . 2.9 111.015 -172.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.03 -51.44 69.68 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.37 0.605 . . . . 2.72 110.534 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.81 -12.82 52.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.482 1.113 . . . . 3.06 111.342 176.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 54.26 28.35 9.1 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 125.157 1.383 . . . . 3.47 109.627 -172.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -121.03 129.41 53.36 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 118.944 0.793 . . . . 2.32 110.846 -160.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.02 120.44 39.84 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.685 1.194 . . . . 1.84 108.715 164.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 127.31 36.09 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 127.002 2.121 . . . . 2.31 105.33 166.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.9 130.2 74.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.029 1.332 . . . . 2.32 108.713 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -104.0 90.25 3.55 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.006 1.723 . . . . 3.55 108.278 167.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.14 179.35 7.27 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.98 1.312 . . . . 3.51 109.535 -175.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.2 124.53 41.04 Favored Pre-proline 0 N--CA 1.445 -0.719 0 O-C-N 123.34 0.4 . . . . 4.18 110.759 174.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.51 -8.79 10.4 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.406 2.738 . . . . 1.7 112.801 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -90.83 -55.1 3.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 119.154 0.888 . . . . 3.49 108.784 -175.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 pt -68.24 -78.68 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.849 0.357 . . . . 2.34 111.871 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.7 tt -69.06 -56.62 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 O-C-N 121.229 -0.92 . . . . 2.47 109.186 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.03 159.07 33.25 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 122.92 0.295 . . . . 0.79 113.1 171.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.66 -38.61 80.47 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.661 2.907 . . . . 0.88 110.979 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -32.16 -64.14 0.18 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.73 2.012 . . . . 11.02 113.487 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -53.98 -58.25 7.99 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.624 1.169 . . . . 2.91 109.906 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 mt -57.2 -59.94 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.271 -0.877 . . . . 2.37 109.899 -176.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.4 mt -49.99 -51.33 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 123.311 0.644 . . . . 2.26 110.273 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -69.31 -32.71 72.01 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.537 0.608 . . . . 3.37 111.689 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.3 m -60.6 -58.66 7.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.942 -0.762 . . . . 1.95 108.942 171.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 mm -59.98 -38.17 75.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.297 1.039 . . . . 2.98 111.474 -174.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -51.72 -65.35 0.57 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.84 1.256 . . . . 2.73 108.809 167.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.8 t -56.96 -27.58 61.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.317 0.647 . . . . 1.81 112.696 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.5 tp -76.17 -5.4 46.58 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.419 1.488 . . . . 3.6 111.57 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.1 45.36 2.85 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 124.345 0.974 . . . . 0.74 111.572 169.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -143.23 172.16 13.11 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.443 1.097 . . . . 3.6 108.11 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -115.76 78.76 7.24 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 123.106 0.562 . . . . 4.68 111.916 -175.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.13 72.78 5.75 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.786 2.991 . . . . 1.55 112.829 -168.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.8 p -69.84 138.98 53.05 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.969 -0.457 . . . . 2.82 110.488 171.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.9 tp . . . . . 0 N--CA 1.451 -0.392 0 N-CA-C 106.742 -1.577 . . . . 4.11 106.742 167.065 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 108.078 -1.082 . . . . 3.7 108.078 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.79 90.34 2.89 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.982 -1.488 . . . . 3.63 106.982 171.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -73.65 119.95 18.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.26 -1.015 . . . . 2.11 108.26 159.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -127.7 150.61 49.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.211 -1.033 . . . . 2.95 108.211 166.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.0 t -96.71 135.71 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.429 -1.693 . . . . 2.14 106.429 171.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.81 176.73 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.483 -0.932 . . . . 2.73 108.483 172.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -134.55 167.07 21.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.942 -2.244 . . . . 7.61 104.942 152.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.93 -3.9 55.89 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.295 -0.725 . . . . 1.09 114.139 176.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.9 mtm -75.7 53.93 0.76 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.72 1.76 . . . . 2.19 111.977 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -80.68 36.27 0.38 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.897 -1.127 . . . . 3.13 113.203 -166.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.7 t -171.04 140.54 1.55 Allowed 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 118.913 0.779 . . . . 3.43 109.424 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.86 -48.82 11.12 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.797 0.839 . . . . 2.09 111.162 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 m -44.84 -38.6 4.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.485 1.114 . . . . 2.31 112.234 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.0 m -54.62 -38.12 66.42 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.372 0.533 . . . . 1.76 110.908 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 86.1 t -52.46 -63.8 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 123.407 0.683 . . . . 1.76 109.487 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -29.28 69.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.908 -0.587 . . . . 1.65 109.715 -175.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -62.66 -55.55 25.87 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.184 -1.413 . . . . 5.57 107.184 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.4 mt -60.09 -53.45 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 107.066 -1.457 . . . . 1.83 107.066 -172.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -41.34 -64.6 0.54 Allowed 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 124.607 1.192 . . . . 4.29 109.768 174.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.2 t -58.19 -43.85 87.74 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.632 0.773 . . . . 2.09 110.259 -173.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.63 -20.84 62.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.313 1.045 . . . . 1.16 111.117 -176.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.72 -57.85 3.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.703 -0.665 . . . . 3.23 110.55 168.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.58 -31.27 64.06 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.231 0.923 . . . . 2.28 111.572 -177.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -37.11 -52.04 0.99 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.494 1.517 . . . . 5.37 112.798 162.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -96.64 140.84 30.66 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 118.899 0.772 . . . . 4.69 111.294 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -67.11 177.09 1.88 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.696 -0.483 . . . . 7.24 109.696 173.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.19 -48.42 3.92 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.935 -1.266 . . . . 1.59 109.935 -174.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.88 141.99 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.641 -0.874 . . . . 2.99 108.641 158.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.3 mt -108.97 -45.37 3.8 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.417 1.487 . . . . 4.51 108.593 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -154.98 155.96 35.14 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.013 0.925 . . . . 3.32 109.756 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.9 t -136.96 146.28 45.2 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.464 -0.939 . . . . 1.99 108.464 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.9 m -150.74 119.34 6.5 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.813 -0.81 . . . . 2.42 108.813 161.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 m -101.21 155.67 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.699 0.8 . . . . 2.88 109.964 170.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.48 134.08 22.12 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.252 0.621 . . . . 2.06 110.971 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.66 -47.61 69.01 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.444 1.097 . . . . 3.61 110.133 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.79 -43.49 80.97 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 123.377 0.671 . . . . 2.66 111.384 -170.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.1 m -94.37 -0.84 54.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.167 0.587 . . . . 3.55 110.593 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.78 34.06 18.29 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.073 1.749 . . . . 3.99 111.528 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -112.14 152.11 28.69 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.567 0.747 . . . . 2.4 110.359 -165.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.39 121.91 43.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.428 1.091 . . . . 1.8 108.224 156.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.97 131.69 42.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.902 -1.518 . . . . 1.42 106.902 160.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.8 mp -118.08 119.23 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.029 -1.471 . . . . 2.36 107.029 172.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -95.88 95.7 8.43 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 126.59 1.956 . . . . 4.26 106.252 172.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -126.8 165.85 18.53 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.024 1.33 . . . . 3.66 109.474 -174.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -86.94 112.47 47.6 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.649 -0.871 . . . . 3.25 108.649 170.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.05 -19.25 45.72 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.612 2.208 . . . . 1.4 113.089 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -69.01 -36.47 77.83 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.021 0.828 . . . . 4.16 110.705 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.6 pt -99.23 -62.55 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 N-CA-C 113.599 0.963 . . . . 1.78 113.599 -165.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 tt -88.42 -47.56 15.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.576 0.703 . . . . 2.57 110.721 -165.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.5 151.6 27.13 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.045 0.831 . . . . 0.85 111.589 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.66 -30.51 34.62 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.828 3.019 . . . . 0.75 112.55 -174.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -50.97 -50.42 58.2 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.983 0.513 . . . . 7.57 111.068 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.24 -54.22 27.86 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.814 0.845 . . . . 2.78 110.285 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.0 mt -57.01 -54.26 32.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 124.69 1.196 . . . . 2.27 111.065 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.6 mt -54.42 -53.15 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.378 -0.601 . . . . 2.1 109.378 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -61.75 -35.42 78.07 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.793 -0.567 . . . . 3.17 112.318 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.0 m -59.81 -48.93 79.7 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 121.045 -1.034 . . . . 2.03 109.508 176.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.6 mt -68.86 -42.64 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.883 -0.511 . . . . 3.24 111.511 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -49.54 -47.16 49.22 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.875 1.27 . . . . 2.78 109.08 171.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.2 t -70.66 -42.33 70.94 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.126 0.971 . . . . 2.37 110.555 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.56 -48.87 57.34 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 124.663 1.185 . . . . 4.01 109.009 174.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.26 45.96 0.28 Allowed Glycine 0 C--N 1.334 0.438 0 N-CA-C 110.179 -1.168 . . . . 1.04 110.179 168.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -127.45 172.71 10.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.561 -1.644 . . . . 2.84 106.561 169.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -110.44 71.77 0.68 Allowed Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 118.689 -0.672 . . . . 4.66 111.876 -165.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.82 136.12 34.67 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.404 2.069 . . . . 1.48 112.337 -169.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.6 p -145.56 129.19 17.1 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.728 1.211 . . . . 2.63 108.258 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 O-C-N 121.219 -0.925 . . . . 4.27 112.685 -173.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 107.207 -1.405 . . . . 3.62 107.207 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 tp -148.23 111.4 4.9 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.275 -1.379 . . . . 3.94 107.275 -172.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -100.37 46.14 0.96 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.657 1.983 . . . . 5.05 109.355 -169.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.02 156.36 39.25 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.964 -0.46 . . . . 2.81 110.031 -165.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.56 129.14 48.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 N-CA-C 107.793 -1.188 . . . . 2.2 107.793 175.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.58 125.4 68.62 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.029 0 N-CA-C 106.528 -1.656 . . . . 2.35 106.528 172.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -104.91 167.97 9.36 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.273 -1.01 . . . . 5.18 108.273 157.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.88 -10.51 29.71 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.783 1.183 . . . . 1.13 111.891 -173.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.0 mtm -68.11 76.14 0.23 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.114 0.957 . . . . 2.15 110.179 172.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.8 p -82.19 -75.07 0.32 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.272 1.029 . . . . 4.22 109.436 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 67.2 m -72.9 128.81 36.6 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.572 -0.899 . . . . 5.02 108.572 -179.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -34.89 -51.79 0.52 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.775 1.63 . . . . 2.16 113.394 -176.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.8 t -40.1 -42.51 1.45 Allowed 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 124.817 1.247 . . . . 3.8 111.385 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.0 m -38.38 -46.3 1.11 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.272 1.029 . . . . 1.75 112.097 177.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.0 t -50.83 -67.28 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 124.172 0.989 . . . . 1.79 110.244 175.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.43 -21.42 66.29 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.443 -0.344 . . . . 3.39 111.847 -179.003 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -68.42 -50.11 55.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.925 -1.509 . . . . 4.52 106.925 -178.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.5 mt -62.05 -57.84 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.374 -1.343 . . . . 1.94 107.374 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -48.19 -57.78 5.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.794 0.838 . . . . 3.32 111.16 179.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.1 t -59.7 -44.25 93.76 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.624 0.726 . . . . 2.08 110.135 -178.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.5 t -60.48 -29.01 68.79 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 118.506 -0.759 . . . . 1.61 111.446 177.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.8 mt -82.63 -47.98 11.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 119.161 0.892 . . . . 3.5 111.772 178.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.8 p -72.75 62.04 0.56 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.37 1.468 . . . . 1.83 110.938 -175.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -168.7 -30.88 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.673 1.989 . . . . 4.41 111.84 -171.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -65.59 19.76 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.247 1.573 . . . . 2.58 115.247 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 61.85 -71.83 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.504 1.521 . . . . 5.79 110.816 -169.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.68 49.47 3.66 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.309 0.956 . . . . 1.78 112.773 -172.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.65 135.16 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 104.789 -2.3 . . . . 3.76 104.789 159.421 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.7 mt -95.4 -37.55 10.89 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.147 0.979 . . . . 4.59 108.925 173.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -168.61 158.9 9.67 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.596 1.158 . . . . 3.13 108.071 177.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.8 m -145.48 155.19 42.95 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 123.669 0.788 . . . . 2.2 109.943 172.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.1 t -162.37 116.99 1.83 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.803 1.241 . . . . 2.63 107.873 167.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -104.05 159.95 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.429 1.013 . . . . 2.9 111.936 170.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.9 135.96 21.22 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.574 0.75 . . . . 1.92 109.981 176.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.23 -43.15 19.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.625 0.77 . . . . 2.68 111.78 -171.111 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.25 -39.25 89.63 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.886 0.474 . . . . 2.4 110.186 -174.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.3 t -98.19 3.67 48.97 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.599 0.76 . . . . 3.13 111.274 176.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.22 48.45 13.09 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 126.252 1.821 . . . . 4.09 110.673 173.141 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -119.55 143.29 47.69 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 125.252 1.421 . . . . 3.18 108.338 -169.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.6 109.57 14.94 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.879 -1.156 . . . . 2.01 107.879 158.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -83.65 110.51 18.33 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 104.557 -2.386 . . . . 2.27 104.557 166.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.8 mt -110.31 143.44 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.292 1.037 . . . . 1.93 108.29 171.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -120.79 133.0 55.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.455 -1.683 . . . . 3.0 106.455 163.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -164.45 167.94 19.01 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.478 0.581 . . . . 3.31 110.911 -163.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -104.02 104.87 45.85 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 108.65 -0.87 . . . . 4.22 108.65 -178.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.64 26.18 0.48 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.89 2.393 . . . . 1.62 113.942 -167.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -127.52 -62.89 1.06 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.424 1.09 . . . . 3.78 108.94 -172.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 pt -57.8 -39.76 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.242 0.617 . . . . 3.22 111.748 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 tt -107.01 -81.74 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.796 0.839 . . . . 2.7 109.244 171.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.15 155.33 9.26 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.144 0.878 . . . . 1.4 111.242 -177.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.35 -41.42 41.71 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.123 2.549 . . . . 1.3 110.52 175.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.5 ttm105 -32.96 -71.1 0.06 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 127.01 2.124 . . . . 8.99 110.768 171.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.8 -45.64 89.43 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.275 1.83 . . . . 4.04 109.949 -171.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.0 mt -58.56 -60.86 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 109.426 -0.583 . . . . 2.24 109.426 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.4 mt -51.08 -48.43 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.958 0.503 . . . . 2.48 109.822 178.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -61.86 -38.38 88.04 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.686 1.194 . . . . 5.05 111.698 -178.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.7 m -65.03 -52.31 56.69 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.117 -0.99 . . . . 1.79 108.633 175.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 mm -63.64 -36.94 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 O-C-N 122.205 -0.31 . . . . 2.62 110.991 -175.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -52.35 -64.06 0.94 Allowed 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.028 1.331 . . . . 2.7 109.036 166.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 t -52.65 -38.15 59.88 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.345 1.058 . . . . 1.88 112.786 -175.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.9 mt -58.25 -25.78 62.14 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.512 -0.742 . . . . 3.06 112.86 176.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.13 49.94 0.8 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.229 0.918 . . . . 1.02 111.131 178.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -137.97 167.51 21.63 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 106.577 -1.638 . . . . 2.93 106.577 172.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -107.49 89.18 4.73 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 119.351 0.978 . . . . 4.21 112.539 172.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.09 70.92 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.967 2.445 . . . . 1.61 111.629 177.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.4 m -79.14 117.61 20.33 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.242 1.417 . . . . 2.59 108.515 177.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.9 tp . . . . . 0 N--CA 1.441 -0.924 0 N-CA-C 107.936 -1.135 . . . . 4.6 107.936 -179.325 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 121.068 0.461 . . . . 3.53 110.319 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.1 tp -74.93 130.95 40.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.897 -0.779 . . . . 3.41 108.897 179.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -103.65 149.59 24.8 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.092 -1.077 . . . . 2.04 108.092 164.327 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.68 123.88 13.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.03 -1.47 . . . . 2.56 107.03 172.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.35 135.42 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 107.497 -1.297 . . . . 1.95 107.497 166.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.0 156.82 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 124.929 1.292 . . . . 2.35 107.63 173.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.4 mtm105 -138.37 177.37 7.93 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.187 -1.783 . . . . 5.52 106.187 168.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.39 -9.23 71.95 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.53 0.586 . . . . 1.36 112.61 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -69.4 157.99 36.0 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.198 0.999 . . . . 2.89 110.206 176.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 t -149.31 140.34 22.94 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.523 -1.288 . . . . 3.87 107.523 167.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 69.2 m 68.67 153.39 0.1 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.842 1.657 . . . . 3.42 112.563 174.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.32 -36.99 22.71 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.744 0.818 . . . . 3.0 110.619 174.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -35.07 -52.16 0.56 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.931 1.692 . . . . 2.28 112.5 170.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.3 m -63.88 -35.56 81.06 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.482 -0.761 . . . . 1.83 111.627 -175.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.2 t -56.68 -59.52 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.605 -0.887 . . . . 2.07 108.605 178.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -31.77 73.17 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.773 -0.649 . . . . 2.05 109.792 -177.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -58.22 -58.91 6.39 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 106.957 -1.498 . . . . 4.94 106.957 176.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.6 mt -59.61 -53.21 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.54 -1.282 . . . . 1.79 107.54 -171.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -46.02 -57.75 4.16 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 124.127 0.892 . . . . 4.23 110.112 177.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -60.88 -46.79 89.2 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.696 0.76 . . . . 2.06 109.804 -175.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 t -60.23 -36.65 78.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.374 1.47 . . . . 0.99 109.079 -175.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.53 -53.08 17.6 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.344 0.658 . . . . 3.34 112.006 174.066 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.9 p -52.48 -29.17 23.5 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.377 0.535 . . . . 2.02 111.991 -173.148 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 10.23 7.23 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.802 1.408 . . . . 4.13 114.802 178.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -89.48 178.43 6.3 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.121 1.328 . . . . 2.66 109.519 165.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -81.09 159.42 24.73 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.553 -0.906 . . . . 7.97 108.553 166.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.88 -55.88 3.88 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.499 0.571 . . . . 1.97 113.162 170.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.03 107.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 117.713 0.756 . . . . 3.72 110.293 -178.139 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 pp -99.52 -25.53 14.4 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.72 1.208 . . . . 3.76 111.732 -174.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -146.96 122.18 10.2 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.297 -1.001 . . . . 4.0 108.297 176.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.2 t -102.0 161.65 13.51 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 107.725 -1.213 . . . . 2.23 107.725 171.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 m -160.36 116.84 2.4 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.208 -1.034 . . . . 2.34 108.208 163.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 m -116.01 165.57 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 122.777 0.431 . . . . 3.11 110.073 169.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.25 135.0 14.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.858 0.863 . . . . 1.72 109.195 170.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.18 -43.91 69.84 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.029 -0.987 . . . . 2.69 110.25 -177.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.34 -49.94 72.92 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.365 0.602 . . . . 1.89 110.512 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -67.74 -11.81 59.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.587 0.755 . . . . 2.62 111.132 178.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 53.8 38.36 28.39 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.799 1.24 . . . . 4.05 108.542 -173.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -133.51 142.58 48.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 O-C-N 122.143 -0.348 . . . . 2.1 111.078 -167.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.3 142.09 47.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.812 1.245 . . . . 1.82 107.928 160.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.03 154.23 48.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.549 0.613 . . . . 1.66 110.316 163.047 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.75 138.62 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.883 -1.154 . . . . 2.19 107.883 178.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -104.12 110.82 23.15 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.035 0.934 . . . . 3.62 108.643 164.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -155.17 158.24 38.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.133 1.373 . . . . 3.89 110.178 -174.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.02 126.01 88.65 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 109.087 -0.709 . . . . 3.62 109.087 165.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.26 -7.98 14.0 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.227 2.618 . . . . 1.21 113.887 -173.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -84.09 -52.68 6.09 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 119.591 1.087 . . . . 4.98 108.439 -179.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.1 pt -62.46 -52.7 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 113.593 0.96 . . . . 1.89 113.593 -168.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.1 tt -97.2 -68.79 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 124.096 0.959 . . . . 2.07 109.658 -178.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.49 162.14 19.49 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.735 0.683 . . . . 0.95 113.697 172.109 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.85 -42.82 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.092 3.195 . . . . 0.96 111.903 -173.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -52.26 -50.09 62.78 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.705 1.241 . . . . 9.57 108.732 -173.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.55 -54.13 41.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.005 2.922 . . . . 5.0 108.536 -176.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.1 mt -61.48 -54.85 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 123.841 0.856 . . . . 1.93 110.284 179.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.7 mm -48.56 -53.27 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 118.5 0.591 . . . . 3.4 109.423 178.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -63.5 -33.15 74.95 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.413 0.523 . . . . 3.8 112.413 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.8 m -59.8 -58.1 10.01 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.221 -0.924 . . . . 1.61 109.78 171.203 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.2 mm -63.89 -32.8 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.6 -0.688 . . . . 2.57 110.921 -174.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.08 -58.49 7.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.696 1.198 . . . . 3.03 108.904 167.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.7 t -55.12 -37.27 66.69 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.501 1.12 . . . . 1.74 112.378 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.0 mt -60.17 -16.45 32.97 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.905 0.706 . . . . 3.19 112.905 175.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.35 38.19 5.13 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.951 -0.86 . . . . 0.94 110.951 177.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -127.53 171.58 11.48 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 107.501 -1.296 . . . . 2.91 107.501 172.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -112.15 70.66 1.02 Allowed Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 114.446 1.276 . . . . 4.02 114.446 -168.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.7 110.73 2.82 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.963 2.442 . . . . 1.09 112.864 -175.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.7 t -71.32 177.76 3.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.694 1.198 . . . . 4.56 109.339 160.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.539 0.528 0 N-CA-C 108.485 -0.931 . . . . 5.05 108.485 158.345 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 105.994 -1.854 . . . . 3.39 105.994 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.4 tp -137.27 134.21 35.9 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 107.951 -1.129 . . . . 2.81 107.951 159.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -101.87 123.72 46.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.023 -1.103 . . . . 2.16 108.023 168.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.71 131.17 44.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 110.121 -0.326 . . . . 2.7 110.121 175.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.99 142.52 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.484 -1.672 . . . . 2.54 106.484 168.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.3 107.75 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.879 -1.526 . . . . 2.51 106.879 173.073 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -76.98 166.04 23.85 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.934 -0.765 . . . . 6.47 108.934 174.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.84 -45.77 3.36 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.778 -0.929 . . . . 1.32 110.778 -177.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -57.01 120.16 7.51 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.837 -0.801 . . . . 3.49 108.837 174.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 t -156.92 19.44 0.31 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.39 0.515 . . . . 4.62 112.39 -166.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.6 t -157.45 148.21 21.27 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 120.781 -1.199 . . . . 3.46 109.141 -179.089 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.76 -41.02 10.27 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.069 0.948 . . . . 2.79 111.535 173.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.8 m -51.29 -55.9 15.83 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.206 0.602 . . . . 2.21 110.513 172.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.9 m -55.97 -51.97 65.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 123.804 0.842 . . . . 1.74 109.464 178.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.9 t -46.8 -61.85 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.001 0.52 . . . . 2.17 109.734 178.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.283 0.0 OUTLIER -64.78 -21.97 66.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.936 -0.575 . . . . 2.35 110.923 -176.175 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -66.73 -47.3 72.72 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.871 -0.789 . . . . 5.12 108.871 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.2 mt -66.73 -52.21 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.769 -1.197 . . . . 1.94 107.769 -178.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -41.83 -66.57 0.33 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.486 0.714 . . . . 3.37 110.328 171.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.6 t -55.88 -49.43 73.41 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.473 1.109 . . . . 2.32 109.815 -172.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.0 t -64.31 -37.4 87.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 118.802 -0.618 . . . . 1.69 111.414 -178.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.71 -41.14 72.3 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.237 0.926 . . . . 2.82 110.33 178.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.1 p -65.18 74.65 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.964 0.906 . . . . 1.78 111.022 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.5 pttm 179.15 -36.23 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 129.521 3.129 . . . . 4.5 109.707 -178.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -53.53 118.59 4.0 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.193 0.597 . . . . 2.45 110.657 -178.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -67.24 82.19 0.14 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.541 1.137 . . . . 5.91 110.252 -171.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.26 -29.24 0.52 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.162 0.887 . . . . 1.31 110.927 -174.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.21 140.06 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.65 1.18 . . . . 2.79 109.239 175.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.3 mt -114.2 -47.6 2.93 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.341 1.456 . . . . 3.89 109.703 168.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -143.3 138.38 29.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.334 0.515 . . . . 4.0 110.94 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -105.49 156.71 17.95 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.656 -1.238 . . . . 2.19 107.656 173.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.1 92.64 1.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.878 -0.786 . . . . 1.94 108.878 162.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.4 t -92.3 144.96 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 125.707 1.603 . . . . 3.56 109.59 176.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.83 134.56 11.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.895 -0.503 . . . . 1.8 111.577 172.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.15 -30.48 62.29 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 123.828 0.851 . . . . 2.47 111.353 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.47 -29.66 69.2 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.396 0.543 . . . . 2.26 110.722 -177.238 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -115.38 5.88 14.69 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.795 1.238 . . . . 3.06 110.836 176.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 45.45 45.49 10.31 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 127.541 2.337 . . . . 4.05 112.45 175.003 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -139.03 161.52 37.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.334 0.494 . . . . 2.91 112.334 -178.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.71 124.81 52.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.769 1.627 . . . . 1.98 106.853 160.04 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 139.22 30.84 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.069 -1.086 . . . . 1.39 108.069 153.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.96 125.95 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.955 -1.498 . . . . 1.97 106.955 174.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -101.95 87.83 3.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.027 1.331 . . . . 3.22 107.952 167.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -125.49 157.12 37.77 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.131 2.173 . . . . 3.58 109.48 178.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -72.28 120.37 80.04 Favored Pre-proline 0 C--N 1.34 0.179 0 N-CA-C 105.987 -1.857 . . . . 3.18 105.987 167.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.8 -67.68 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.48 1.454 . . . . 1.79 113.065 -169.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -52.89 -41.16 64.1 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.349 1.06 . . . . 5.3 112.595 -159.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 pt -51.9 -41.23 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.025 0.93 . . . . 2.4 113.135 -178.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.0 tt -119.9 -48.49 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.422 1.089 . . . . 2.54 111.305 -167.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.38 160.24 35.07 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.1 1.333 . . . . 1.23 112.201 172.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -66.99 -26.52 43.47 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.198 2.599 . . . . 1.72 111.941 179.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.8 ttm105 -51.06 -55.57 16.94 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.741 0.817 . . . . 6.09 110.741 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -47.67 -53.64 14.37 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.552 1.141 . . . . 2.97 110.689 176.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.66 -57.41 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.717 0.807 . . . . 2.13 110.568 -178.397 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.62 -37.03 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 O-C-N 121.661 -0.649 . . . . 5.69 111.795 -175.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -55.4 -49.85 71.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.826 0.739 . . . . 4.18 109.873 169.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.6 m -56.24 -50.93 69.91 Favored 'General case' 0 C--O 1.224 -0.24 0 O-C-N 121.731 -0.606 . . . . 1.76 110.838 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.54 -41.75 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 121.539 -0.725 . . . . 3.09 111.865 -175.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -52.15 -48.21 65.03 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.006 -0.739 . . . . 4.13 109.006 169.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.0 t -64.9 -42.33 94.86 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.819 -0.628 . . . . 2.43 111.321 -177.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.43 -46.29 86.79 Favored 'General case' 0 C--N 1.34 0.172 0 O-C-N 121.485 -0.76 . . . . 2.67 109.994 173.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.34 43.84 0.34 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.132 -0.787 . . . . 0.99 111.132 170.138 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -129.7 155.83 45.26 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.039 -1.837 . . . . 3.03 106.039 170.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -107.82 102.66 46.38 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 118.579 -0.724 . . . . 3.39 110.319 -168.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -85.15 154.33 11.02 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.976 2.451 . . . . 1.72 113.124 -171.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.0 m -162.03 135.67 6.4 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 125.97 1.708 . . . . 3.15 107.953 166.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 109.565 -0.531 . . . . 4.15 109.565 173.26 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 C--O 1.234 0.289 0 N-CA-C 107.628 -1.249 . . . . 3.82 107.628 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.51 89.29 6.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.111 -1.441 . . . . 4.16 107.111 164.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -67.83 133.72 49.69 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.628 -0.879 . . . . 2.47 108.628 156.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 pp -146.13 137.41 24.64 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.51 -1.293 . . . . 2.29 107.51 167.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.71 145.82 13.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 107.966 -1.124 . . . . 2.66 107.966 173.474 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.93 105.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 127.807 2.443 . . . . 2.54 104.489 173.092 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -86.54 163.91 17.21 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.284 -1.006 . . . . 8.45 108.284 166.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.76 -13.58 29.67 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.89 0.757 . . . . 1.22 112.166 -177.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.1 mtm -65.89 88.25 0.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.233 1.016 . . . . 2.0 110.024 172.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 p -68.83 -37.21 79.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.078 0.551 . . . . 3.94 111.599 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.5 t -158.28 169.85 23.57 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.176 0.444 . . . . 4.38 110.247 -169.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.37 -28.06 7.39 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.237 1.815 . . . . 3.01 113.377 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 p -49.81 -63.18 1.19 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.309 -0.626 . . . . 3.16 109.309 169.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.2 m -51.22 -47.83 62.22 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.675 0.79 . . . . 1.71 110.697 179.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.4 t -49.0 -62.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 123.773 0.829 . . . . 1.97 109.927 178.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -26.47 67.69 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 120.835 -0.346 . . . . 1.73 110.468 -177.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -63.32 -50.11 71.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.79 -0.819 . . . . 5.27 108.79 179.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.9 mt -64.88 -53.24 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.815 -1.179 . . . . 1.56 107.815 -178.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -49.36 -58.83 4.41 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.784 0.834 . . . . 3.9 109.625 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.9 t -62.47 -48.19 80.71 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.458 -0.792 . . . . 1.92 109.793 -174.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.6 t -57.7 -36.2 71.66 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.12 -0.491 . . . . 1.71 110.69 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.2 mt -72.43 -47.62 47.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.984 -1.008 . . . . 3.18 111.973 177.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.1 p -62.11 77.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.913 0.885 . . . . 1.79 111.694 -176.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? 169.54 -37.32 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.935 2.494 . . . . 4.15 110.468 -171.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -58.19 126.8 29.07 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.246 -1.02 . . . . 2.98 108.246 171.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -72.42 74.7 1.03 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.873 0.869 . . . . 5.48 111.658 -163.086 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.91 -41.09 0.19 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.404 -1.079 . . . . 1.65 110.404 178.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.67 100.46 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 117.724 0.762 . . . . 3.38 110.186 -176.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.14 -35.49 23.59 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.596 1.158 . . . . 3.51 111.494 -176.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -143.6 116.49 8.8 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.903 0.881 . . . . 3.17 109.275 176.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.2 t -97.48 155.4 16.95 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 107.905 -1.146 . . . . 2.52 107.905 169.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 t -158.24 102.85 1.79 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.887 -1.523 . . . . 2.18 106.887 169.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.54 159.31 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 120.505 0.193 . . . . 2.78 110.708 173.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.48 134.39 21.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.404 1.082 . . . . 2.07 110.061 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.54 -41.97 62.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.527 -1.215 . . . . 2.73 110.942 -173.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.3 -47.26 80.16 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.551 0.691 . . . . 2.34 109.674 -172.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -80.78 -2.55 47.56 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.514 -0.755 . . . . 3.5 110.763 177.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 51.39 49.8 20.23 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.651 1.18 . . . . 3.46 108.769 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -139.53 142.48 37.24 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.09 0.404 . . . . 2.44 111.744 -169.06 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.98 125.03 50.5 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.262 1.425 . . . . 1.75 108.485 163.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.08 119.63 38.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.504 -2.036 . . . . 1.52 105.504 164.426 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.12 120.55 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.04 1.336 . . . . 2.11 108.24 175.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -92.57 97.26 10.7 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.775 -0.824 . . . . 3.96 108.775 163.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.72 143.58 43.4 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.577 -0.897 . . . . 4.18 108.577 174.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.85 127.56 88.13 Favored Pre-proline 0 N--CA 1.452 -0.352 0 N-CA-C 106.196 -1.779 . . . . 3.73 106.196 169.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.63 -59.21 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.663 1.576 . . . . 1.85 112.507 -169.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -50.12 -43.28 51.67 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.06 1.744 . . . . 3.42 112.396 -162.657 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 pt -55.34 -40.16 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.754 0.822 . . . . 2.61 113.128 -177.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.7 tt -123.68 -48.24 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.805 0.842 . . . . 2.86 112.676 -165.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.45 147.56 22.69 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.129 1.347 . . . . 1.16 111.443 178.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.86 -34.42 23.98 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.106 2.538 . . . . 1.02 111.469 -177.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -55.5 -41.73 73.48 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 118.841 -0.599 . . . . 7.83 112.441 -174.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -48.71 -62.18 1.64 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.516 1.151 . . . . 2.72 110.025 174.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 mt -56.65 -56.36 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.209 1.404 . . . . 2.58 110.431 -179.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.31 -47.66 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 122.024 -0.422 . . . . 2.28 110.42 -178.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.7 m170 -60.8 -42.67 98.07 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.832 0.742 . . . . 4.19 110.817 178.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.3 m -57.33 -52.33 65.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.238 -0.653 . . . . 1.99 109.238 177.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.4 mm -68.36 -34.59 66.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 O-C-N 122.09 -0.381 . . . . 3.12 111.777 -175.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -56.41 -59.26 5.22 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.517 1.127 . . . . 2.82 108.026 171.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -52.99 -40.35 63.73 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.349 1.06 . . . . 1.71 111.506 176.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.1 tp -66.4 -10.5 44.28 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.121 0.968 . . . . 3.68 112.446 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.2 45.76 2.33 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 118.68 0.673 . . . . 0.77 112.055 168.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -139.32 177.81 7.65 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 107.794 -1.188 . . . . 3.58 107.794 172.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -112.6 72.49 1.33 Allowed Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 113.198 0.814 . . . . 3.42 113.198 -177.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -63.58 104.45 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.983 3.122 . . . . 1.37 111.814 -177.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.4 p -129.15 124.71 35.35 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.798 1.639 . . . . 2.75 108.735 -172.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tt . . . . . 0 CA--C 1.535 0.381 0 O-C-N 121.261 -0.899 . . . . 4.8 111.092 -171.575 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 t . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 109.739 -0.467 . . . . 3.33 109.739 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.4 tp -70.11 154.47 41.89 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.105 -0.702 . . . . 3.38 109.105 175.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -129.07 148.49 51.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.967 0.907 . . . . 2.54 110.035 170.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.52 133.78 44.19 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 107.247 -1.39 . . . . 2.74 107.247 168.283 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.6 109.39 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 105.729 -1.952 . . . . 1.98 105.729 171.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -104.41 109.08 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.944 -0.762 . . . . 2.9 108.944 -174.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.58 155.24 40.76 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.392 -1.336 . . . . 4.82 107.392 170.196 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.66 -19.85 7.88 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.405 0.526 . . . . 1.25 113.512 168.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.4 mtm -58.96 104.48 0.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.568 1.184 . . . . 2.36 110.725 171.541 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.5 p -91.36 -83.36 0.28 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.058 0.943 . . . . 4.49 110.4 177.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 84.4 m -79.17 -68.29 0.67 Allowed 'General case' 0 CA--C 1.527 0.061 0 C-N-CA 123.245 0.618 . . . . 4.4 111.279 -160.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -174.58 -61.78 0.01 OUTLIER 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 124.401 1.08 . . . . 2.48 108.865 -176.147 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.2 t -41.07 -46.75 3.01 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.315 1.446 . . . . 3.32 111.161 -176.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.3 m -23.62 -52.0 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.133 2.173 . . . . 1.7 113.511 168.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.4 t -49.52 -61.46 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.346 0.659 . . . . 1.65 110.589 176.115 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -28.68 66.03 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.323 0.649 . . . . 1.39 110.208 -177.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.57 -52.55 59.38 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 107.489 -1.3 . . . . 3.89 107.489 175.055 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.84 -60.39 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 107.344 -1.354 . . . . 1.83 107.344 178.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.04 -51.81 16.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.572 0.701 . . . . 2.85 110.583 -171.379 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.1 t -67.38 -56.53 9.31 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.988 0.915 . . . . 2.25 109.739 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.1 t -64.98 -18.09 64.98 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.693 -0.67 . . . . 1.19 112.446 -173.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.44 -47.4 7.47 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 117.672 -1.156 . . . . 3.52 111.548 173.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 p -53.87 -35.13 61.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.606 1.548 . . . . 2.25 111.615 178.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -32.05 -48.84 0.17 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.097 1.359 . . . . 5.77 113.23 163.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -75.13 63.45 1.3 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.288 1.035 . . . . 2.79 110.798 178.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 3.76 -64.0 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 129.5 3.12 . . . . 5.23 117.247 178.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -46.02 -45.99 14.72 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.43 1.014 . . . . 1.61 112.557 178.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -73.3 84.99 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.022 -1.103 . . . . 3.93 108.022 168.515 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.5 pp -65.67 -33.79 76.71 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.988 -0.551 . . . . 4.59 111.299 -175.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -146.64 104.68 3.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.912 0.485 . . . . 4.26 111.566 173.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.3 t -80.19 142.28 34.84 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 106.89 -1.522 . . . . 2.85 106.89 162.067 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -132.73 101.77 5.41 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.719 -1.215 . . . . 1.9 107.719 -178.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.2 t -107.6 142.71 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 124.64 1.176 . . . . 3.84 110.193 -167.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.45 137.31 17.12 Favored 'General case' 0 C--N 1.339 0.109 0 O-C-N 121.481 -0.762 . . . . 2.1 111.353 177.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -81.71 -35.21 30.05 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 124.463 1.105 . . . . 2.4 112.013 -172.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.26 91.52 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 109.572 -0.529 . . . . 2.07 109.572 -177.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -93.26 -5.19 50.41 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.454 -0.794 . . . . 3.18 111.454 173.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 41.19 55.02 3.34 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 126.744 2.018 . . . . 4.02 109.456 -176.387 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -133.76 152.02 51.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.889 -1.05 . . . . 2.91 109.502 -171.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.29 129.1 56.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.646 -1.613 . . . . 1.98 106.646 157.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.72 145.51 25.24 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 107.366 -1.346 . . . . 1.42 107.366 157.543 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.3 mp -127.22 115.37 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.252 -0.647 . . . . 2.92 109.252 -169.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -86.48 81.03 8.45 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.196 -1.038 . . . . 3.6 108.196 165.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.33 167.95 14.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.378 1.071 . . . . 3.46 110.194 176.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -108.72 126.18 30.05 Favored Pre-proline 0 N--CA 1.447 -0.616 0 O-C-N 124.317 1.011 . . . . 3.43 109.084 171.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.5 -20.76 20.31 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.126 2.55 . . . . 1.2 112.72 -177.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -96.48 14.46 24.49 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.986 0.914 . . . . 3.92 111.434 -170.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 pt -126.96 -87.55 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.282 1.033 . . . . 2.01 109.408 163.032 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.9 tt -59.44 -49.4 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.621 1.168 . . . . 2.01 112.008 -176.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.73 159.5 30.61 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.718 -0.553 . . . . 0.99 111.718 -178.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.88 -30.84 8.83 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.052 2.501 . . . . 0.97 111.541 -175.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -54.81 -52.51 62.45 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.657 0.783 . . . . 5.83 110.849 -174.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -49.46 -55.07 14.47 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.51 1.124 . . . . 2.6 109.653 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.38 -59.79 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.877 1.271 . . . . 2.22 110.373 178.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.6 mt -52.63 -41.73 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 119.234 0.924 . . . . 2.42 111.416 -178.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -67.08 -45.52 77.05 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.856 -0.527 . . . . 3.28 109.911 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.3 m -57.94 -50.29 73.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.594 -0.891 . . . . 1.63 108.594 179.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.1 mm -53.54 -52.18 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.547 1.139 . . . . 2.61 109.915 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -47.68 -64.84 0.68 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.258 0.552 . . . . 3.78 109.807 173.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 m -67.57 -26.38 66.26 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.927 -0.578 . . . . 3.67 112.267 -167.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.1 tp -67.0 -12.5 60.02 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.192 1.397 . . . . 3.5 111.663 175.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.48 47.28 0.7 Allowed Glycine 0 C--N 1.339 0.716 0 C-N-CA 124.948 1.261 . . . . 1.18 110.703 168.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -143.41 178.03 8.03 Favored 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 108.853 -0.795 . . . . 3.09 108.853 -178.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.07 101.77 14.92 Favored Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 108.685 -0.857 . . . . 4.54 108.685 173.746 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -83.48 92.0 0.87 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.362 2.708 . . . . 1.23 112.896 -175.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.8 m -79.17 113.15 17.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.733 0.778 . . . . 2.44 109.614 170.011 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 C--N 1.328 -0.367 0 C-N-CA 123.8 0.84 . . . . 4.18 108.966 171.509 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.398 -0.593 . . . . 3.63 109.398 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.29 114.59 28.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.797 -1.927 . . . . 3.64 105.797 168.498 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -92.74 120.93 33.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.125 -1.065 . . . . 2.59 108.125 164.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -122.01 154.55 37.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.286 -1.376 . . . . 2.82 107.286 169.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.25 146.78 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.311 -1.737 . . . . 1.9 106.311 171.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.86 163.89 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.933 2.093 . . . . 2.52 105.426 -179.32 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -143.05 165.05 28.43 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.529 1.059 . . . . 4.91 108.412 173.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.07 -86.06 0.4 Allowed Glycine 0 C--N 1.337 0.587 0 N-CA-C 108.744 -1.742 . . . . 2.42 108.744 177.044 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.3 mpt? 52.12 -158.16 0.13 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.529 1.131 . . . . 4.78 112.26 -173.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -161.23 55.56 0.29 Allowed 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.17 0.988 . . . . 6.21 108.752 179.35 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.8 t 74.69 -45.46 0.58 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.442 1.497 . . . . 4.64 113.486 175.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.2 -71.5 0.23 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.319 0.509 . . . . 2.38 111.043 -179.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -42.88 -44.12 4.39 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.763 1.625 . . . . 2.15 114.48 -162.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.6 m -47.19 -37.19 9.77 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.204 0.602 . . . . 2.53 112.454 179.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -49.7 -61.63 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 123.539 0.735 . . . . 1.88 110.558 174.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -30.35 69.65 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.932 -0.766 . . . . 1.64 108.932 -176.48 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -58.83 -53.43 58.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.299 -1.0 . . . . 5.62 108.299 177.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.66 -50.03 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.991 -1.115 . . . . 1.85 107.991 -173.572 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -47.73 -60.93 2.21 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.927 0.767 . . . . 4.12 109.455 176.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.5 t -57.65 -47.32 82.57 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 122.224 1.012 . . . . 2.16 110.42 -173.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -70.9 -23.86 62.36 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.402 1.481 . . . . 0.99 110.899 -174.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mt -80.39 -43.71 20.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.656 0.662 . . . . 3.57 111.061 171.279 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.2 p -67.95 73.28 0.18 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.029 0.931 . . . . 1.74 110.835 179.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.479 ' HZ2' ' CD2' ' A' ' 29' ' ' HIS . 0.0 OUTLIER 178.92 -34.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.515 2.726 . . . . 5.02 111.289 -176.832 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.479 ' CD2' ' HZ2' ' A' ' 28' ' ' LYS . 4.7 m-70 -35.02 -69.49 0.1 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 126.174 1.789 . . . . 3.54 115.148 -170.397 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -165.17 -51.93 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 108.697 -0.853 . . . . 8.99 108.697 174.065 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -151.02 63.08 0.4 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.38 -1.488 . . . . 2.52 109.38 175.432 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.14 126.28 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 105.709 -1.96 . . . . 3.52 105.709 158.552 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.31 -51.68 9.75 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.139 -1.43 . . . . 3.42 107.139 165.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -155.81 139.51 16.08 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.045 -0.525 . . . . 3.87 110.955 -178.312 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.6 t -109.05 150.29 28.01 Favored 'General case' 0 C--O 1.227 -0.092 0 N-CA-C 107.622 -1.251 . . . . 2.26 107.622 167.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.66 109.7 3.29 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.357 -0.839 . . . . 1.77 109.378 175.235 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.59 155.87 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.466 0.706 . . . . 2.78 111.295 176.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.85 133.74 19.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.353 0.661 . . . . 2.23 109.694 171.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -76.09 -42.58 46.79 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.445 0.698 . . . . 2.51 111.293 -171.014 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.73 -46.32 87.63 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.081 0.552 . . . . 2.64 110.466 179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.47 -15.69 60.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.61 1.164 . . . . 3.1 111.471 175.079 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 52.6 34.81 16.54 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.172 1.789 . . . . 3.85 110.006 -172.521 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -102.82 144.64 30.9 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.659 1.183 . . . . 2.71 108.027 -172.303 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.46 110.35 7.68 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.39 -0.967 . . . . 2.14 108.39 161.221 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.78 144.43 25.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.616 -0.513 . . . . 1.44 109.616 168.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.9 mp -124.43 120.03 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 106.377 -1.712 . . . . 2.07 106.377 175.073 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -96.24 96.17 8.61 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.151 -1.426 . . . . 3.04 107.151 166.553 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -134.61 153.75 51.82 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.501 1.521 . . . . 3.57 107.205 -177.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -82.06 130.66 59.32 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 119.484 -0.886 . . . . 3.35 109.315 168.277 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.5 -40.9 9.62 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.682 2.254 . . . . 1.52 113.087 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -88.52 43.35 1.13 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.572 1.078 . . . . 3.56 110.824 -164.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 pt -142.91 -41.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 126.238 1.815 . . . . 2.69 111.342 172.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.9 tt -121.14 -61.26 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.353 1.061 . . . . 2.15 111.844 -175.319 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.41 157.0 25.84 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.734 1.159 . . . . 0.8 111.537 178.778 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.32 -32.63 12.38 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.486 2.791 . . . . 0.78 112.556 -172.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -51.93 -52.92 46.71 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.345 0.658 . . . . 7.09 111.549 -178.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -48.31 -57.42 6.02 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.487 1.115 . . . . 2.63 110.35 177.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.2 mt -53.51 -63.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.477 1.111 . . . . 2.12 109.436 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.2 mt -49.47 -52.11 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.264 0.625 . . . . 2.24 110.162 -176.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -69.81 -30.49 68.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.764 -0.585 . . . . 4.03 111.999 -175.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 92.1 m -66.71 -51.34 57.12 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.289 -0.882 . . . . 1.92 109.563 173.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mm -55.97 -41.92 69.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 122.809 0.444 . . . . 2.59 110.132 177.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.95 -58.45 7.82 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.023 0.929 . . . . 3.05 109.076 174.247 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.5 m -54.13 -37.47 64.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.149 0.98 . . . . 3.54 112.674 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.8 mt -67.24 -6.21 17.25 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.957 0.725 . . . . 3.02 112.957 177.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.08 48.94 2.15 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.827 -0.909 . . . . 0.78 110.827 173.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -134.61 -179.76 5.79 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.39 1.076 . . . . 3.18 109.621 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -121.8 57.87 8.34 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.069 0.947 . . . . 3.51 112.23 -173.312 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.95 85.25 0.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 124.282 3.322 . . . . 1.15 113.042 -167.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.2 m -97.56 126.24 42.74 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.719 1.608 . . . . 2.66 108.476 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 CA--C 1.532 0.256 0 CA-C-N 118.705 0.684 . . . . 4.37 109.348 170.873 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 107.26 -1.385 . . . . 3.22 107.26 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.0 tp -150.87 147.9 27.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.96 -1.496 . . . . 3.14 106.96 166.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -116.38 128.96 55.98 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.251 -1.388 . . . . 2.56 107.251 174.483 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.87 125.35 44.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.72 -1.585 . . . . 2.69 106.72 177.829 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.1 t -65.03 144.08 15.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 N-CA-C 106.866 -1.531 . . . . 2.04 106.866 168.159 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 m -141.75 86.17 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 119.102 0.865 . . . . 2.35 110.512 -174.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 56.7 mmt-85 -55.69 141.2 38.92 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.309 -1.367 . . . . 6.59 107.309 168.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.86 -26.45 8.87 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.845 0.736 . . . . 1.17 111.504 -175.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.8 mtm -69.73 77.27 0.44 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.936 1.368 . . . . 2.55 111.744 176.188 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -77.09 -33.8 56.94 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.898 0.879 . . . . 2.93 111.943 178.067 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -149.67 158.03 43.79 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.385 0.539 . . . . 3.32 110.766 -163.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.68 -33.1 0.67 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.156 1.782 . . . . 2.88 113.605 173.13 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.1 p -53.27 -53.29 53.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.659 -0.651 . . . . 3.4 110.269 172.21 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.3 m -58.55 -49.09 78.7 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.173 0.589 . . . . 2.17 109.99 178.153 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.1 t -45.27 -63.95 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.351 0.66 . . . . 1.8 109.66 177.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.282 0.0 OUTLIER -63.95 -24.64 67.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.754 -0.657 . . . . 1.85 110.984 -177.233 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -61.41 -53.58 54.74 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 108.263 -1.014 . . . . 4.26 108.263 177.038 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.3 mt -67.07 -56.24 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.434 -1.321 . . . . 2.04 107.434 -175.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -46.39 -58.15 4.0 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.968 0.907 . . . . 3.54 112.362 177.498 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.8 t -66.45 -31.1 71.64 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.19 0.596 . . . . 2.12 110.438 -176.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 t -66.26 -53.07 41.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.571 -0.705 . . . . 1.83 109.379 175.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -52.86 -45.04 67.22 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.805 0.729 . . . . 3.43 112.183 -175.025 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.6 p -62.53 -9.39 8.52 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.705 0.631 . . . . 1.99 112.705 -176.344 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -71.53 -37.15 71.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.752 0.821 . . . . 5.73 111.138 171.081 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -74.71 121.02 21.05 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.306 -0.627 . . . . 2.41 109.306 -167.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -77.84 62.6 2.71 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.164 0.586 . . . . 6.18 111.669 -176.134 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.47 42.8 0.06 OUTLIER Glycine 0 CA--C 1.526 0.719 0 N-CA-C 109.116 -1.593 . . . . 1.75 109.116 174.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.92 142.66 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 104.315 -2.476 . . . . 2.92 104.315 -178.757 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.3 tp -100.63 -45.42 5.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.67 1.188 . . . . 4.43 110.132 -179.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -162.05 151.25 15.74 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.719 -0.845 . . . . 3.03 108.719 -179.092 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.9 p -131.73 157.07 44.76 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 123.887 0.875 . . . . 2.98 108.937 173.227 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.1 t -170.8 121.43 0.57 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.817 -1.549 . . . . 2.46 106.817 176.172 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 m -121.19 130.56 74.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.76 0.709 . . . . 2.8 110.178 178.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.3 133.83 53.33 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.349 1.06 . . . . 2.16 111.566 -173.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.18 -56.14 11.19 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 125.274 1.43 . . . . 3.88 110.665 -176.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.78 -47.61 76.78 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.186 0.594 . . . . 2.43 110.842 -174.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.72 -15.69 62.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.017 1.327 . . . . 2.98 111.29 177.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 48.53 42.34 18.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.134 1.774 . . . . 4.15 110.435 -170.691 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -123.84 132.94 53.86 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 124.092 0.957 . . . . 2.43 109.656 -165.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.4 117.3 34.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.284 1.033 . . . . 1.93 108.567 166.183 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.61 124.01 45.6 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.992 -1.855 . . . . 1.84 105.992 174.067 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.2 mp -121.86 133.73 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.979 -1.119 . . . . 2.35 107.979 171.124 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -103.17 135.82 44.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.21 1.804 . . . . 3.12 106.707 161.205 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -168.66 178.95 4.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.976 1.31 . . . . 3.92 112.199 -165.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -110.34 74.7 0.87 Allowed Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.612 1.165 . . . . 4.17 108.985 -174.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -45.76 -48.17 12.71 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 124.452 3.435 . . . . 1.45 113.467 -165.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.71 -34.31 38.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.024 1.33 . . . . 4.76 112.236 -176.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.7 pt -95.22 -53.77 7.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 N-CA-C 112.228 0.455 . . . . 1.94 112.228 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.5 tt -72.35 -44.97 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 120.917 0.389 . . . . 2.9 111.195 -173.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.24 124.6 1.16 Allowed Glycine 0 CA--C 1.537 1.423 0 N-CA-C 110.846 -0.901 . . . . 1.29 110.846 -176.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -53.76 -33.19 69.37 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.034 2.489 . . . . 0.75 111.614 176.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -51.4 -46.0 62.7 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.809 0.843 . . . . 7.89 112.031 175.024 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -59.48 -56.37 22.81 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.603 0.716 . . . . 2.6 109.449 -176.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 89.1 mt -48.21 -62.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 124.187 0.995 . . . . 1.87 109.337 174.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.8 mt -54.22 -53.59 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 119.286 -0.388 . . . . 2.07 110.513 -173.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -65.12 -33.75 76.76 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.945 0.793 . . . . 3.44 112.365 -178.194 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 92.2 m -65.16 -50.8 64.57 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.362 -0.836 . . . . 1.79 109.473 176.159 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mm -64.08 -42.63 96.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.651 -0.656 . . . . 2.94 110.647 -177.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -48.3 -62.28 1.57 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.445 1.498 . . . . 3.2 109.316 169.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.9 t -52.52 -40.82 62.89 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.596 1.158 . . . . 1.81 112.123 -179.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.46 -3.95 5.07 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.979 1.103 . . . . 3.18 113.979 178.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.76 50.63 1.93 Allowed Glycine 0 C--N 1.335 0.494 0 N-CA-C 110.12 -1.192 . . . . 0.82 110.12 171.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -138.82 169.31 18.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.886 0.875 . . . . 3.05 109.567 178.058 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -112.51 76.98 2.17 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 118.03 -0.986 . . . . 4.42 112.408 177.193 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.01 74.56 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 124.082 3.188 . . . . 1.2 113.151 -175.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.46 115.88 13.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.925 0.89 . . . . 2.67 109.493 173.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 tt . . . . . 0 N--CA 1.451 -0.418 0 C-N-CA 124.587 1.155 . . . . 4.17 108.666 170.564 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 106.063 -1.829 . . . . 3.39 106.063 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.1 tp -91.0 122.44 33.66 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.898 -1.149 . . . . 2.89 107.898 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -88.29 136.46 32.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.218 -1.03 . . . . 2.07 108.218 163.202 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.79 133.97 50.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.087 -1.079 . . . . 3.12 108.087 157.118 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.36 143.12 14.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.564 -1.273 . . . . 2.13 107.564 163.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.7 m -135.79 85.16 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.327 1.051 . . . . 2.63 110.89 -170.196 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -62.29 139.72 58.51 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.007 -1.058 . . . . 7.3 109.864 -174.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.31 -24.67 6.51 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.733 -0.481 . . . . 1.73 112.765 175.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.5 mtm -59.97 152.63 23.23 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.262 1.031 . . . . 2.47 110.738 175.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -161.72 -59.39 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.1 0.56 . . . . 3.97 110.145 177.44 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.8 p -81.15 153.54 27.2 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.9 -0.5 . . . . 4.53 111.116 -176.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.84 -50.32 7.94 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 124.679 1.192 . . . . 2.21 111.656 -178.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 m -43.99 -40.85 5.0 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.072 1.349 . . . . 2.19 112.399 -178.217 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.3 m -47.78 -43.14 27.22 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.762 0.825 . . . . 2.1 110.939 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.4 t -50.89 -68.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 123.632 0.773 . . . . 1.88 108.99 179.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -27.39 69.18 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.76 -0.459 . . . . 1.4 109.76 -175.75 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -59.1 -54.62 45.0 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.808 -0.812 . . . . 4.14 108.808 179.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.8 mt -70.83 -52.68 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.463 -0.94 . . . . 2.09 108.463 -176.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.25 -52.11 29.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.347 0.659 . . . . 3.34 110.744 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -67.44 -47.51 69.96 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.246 0.619 . . . . 1.99 110.407 179.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.0 t -57.46 -25.36 59.58 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.847 -0.533 . . . . 1.59 111.98 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.54 -55.22 4.25 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.7 0.8 . . . . 4.14 112.088 171.401 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.5 p -71.64 66.38 0.51 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.274 1.029 . . . . 2.33 111.039 179.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.21 -43.45 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.279 1.832 . . . . 4.17 110.111 -176.329 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -76.98 142.66 39.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.415 -0.957 . . . . 6.09 108.415 173.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -60.55 165.71 3.61 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.093 -0.706 . . . . 6.97 109.093 173.124 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.41 -35.6 3.79 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-O 118.804 -0.998 . . . . 1.93 111.462 175.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.79 133.44 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 119.039 1.42 . . . . 3.36 107.894 163.417 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.26 -55.15 3.53 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.357 -1.349 . . . . 3.91 107.357 161.211 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -149.84 145.87 26.81 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.129 0.572 . . . . 3.32 110.366 -171.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.3 t -128.64 150.27 50.3 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.434 1.094 . . . . 1.96 108.237 177.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -148.18 132.33 17.34 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.49 -0.93 . . . . 2.29 108.49 153.286 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.0 m -107.12 165.35 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 122.814 0.445 . . . . 2.99 110.623 171.059 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.42 136.69 19.94 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.581 0.752 . . . . 2.38 110.622 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.65 -56.1 6.47 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 123.922 0.889 . . . . 3.87 110.523 -176.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.54 -52.15 60.61 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 123.161 0.584 . . . . 2.7 110.127 -176.388 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 m -77.43 -3.19 39.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.889 0.876 . . . . 3.09 111.336 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 45.75 42.95 9.26 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.197 1.399 . . . . 4.57 110.225 -179.457 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -117.09 145.54 43.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.664 -0.698 . . . . 2.54 109.757 -164.114 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.92 118.77 33.36 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.545 -1.65 . . . . 1.84 106.545 156.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.89 134.57 40.84 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.774 -1.195 . . . . 1.23 107.774 163.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 mp -122.81 119.94 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 106.942 -1.503 . . . . 2.44 106.942 178.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -96.52 98.78 10.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.081 -1.451 . . . . 3.14 107.081 162.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -138.33 178.62 6.99 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.028 0.931 . . . . 3.62 110.935 -177.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -107.0 83.94 1.45 Allowed Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 125.01 1.324 . . . . 3.53 109.831 176.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -52.05 -23.51 17.27 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.187 2.591 . . . . 1.86 113.793 174.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -49.67 -41.14 42.23 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.473 0.579 . . . . 4.44 112.31 172.114 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 pt -107.3 -47.32 8.12 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 N-CA-C 113.701 1.0 . . . . 2.08 113.701 -166.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.2 tt -90.0 -123.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 106.372 -1.714 . . . . 2.09 106.372 172.339 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 177.73 160.18 23.88 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 120.406 1.457 . . . . 2.25 111.681 171.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.88 -42.1 26.33 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.084 3.189 . . . . 1.35 111.114 173.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -51.34 -54.22 28.41 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.018 0.527 . . . . 6.91 110.06 177.216 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.94 -54.84 7.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.093 1.757 . . . . 4.11 109.657 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.1 mt -57.97 -60.68 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.856 0.862 . . . . 1.99 109.972 178.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mp -48.29 -47.21 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.128 0.422 . . . . 3.09 110.39 -178.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -70.59 -33.28 70.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.366 0.666 . . . . 3.12 111.777 -178.174 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.2 m -59.64 -54.89 41.15 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.372 -0.83 . . . . 1.97 108.801 170.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.1 mm -58.09 -44.49 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.625 0.77 . . . . 2.42 111.421 -178.254 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -49.99 -56.63 9.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.001 1.32 . . . . 2.9 109.123 170.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.3 m -58.03 -36.03 72.15 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.793 0.664 . . . . 3.17 112.793 178.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.87 -17.47 64.32 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.543 -0.723 . . . . 3.48 112.209 174.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.17 37.49 9.07 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.665 -0.974 . . . . 1.2 110.665 -178.335 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -125.02 151.26 45.82 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.049 -1.463 . . . . 3.15 107.049 165.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -104.76 101.09 26.8 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 124.835 1.254 . . . . 5.54 110.049 -169.092 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -76.22 158.56 37.35 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.391 1.394 . . . . 1.67 113.147 -171.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.0 m -155.27 133.42 11.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.758 -1.571 . . . . 2.69 106.758 164.047 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 CA--C 1.535 0.384 0 CA-C-N 118.819 0.736 . . . . 4.3 111.221 174.401 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 113.517 0.932 . . . . 3.37 113.517 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.29 104.09 15.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.339 -1.356 . . . . 3.54 107.339 179.061 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -84.15 116.22 22.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.828 -1.175 . . . . 2.13 107.828 162.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.7 pp -115.96 161.51 18.74 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.89 -1.152 . . . . 2.99 107.89 164.23 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -112.3 145.95 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 107.064 -1.458 . . . . 2.05 107.064 171.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -176.41 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.679 1.192 . . . . 3.04 108.517 -176.53 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -135.23 164.81 26.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.197 -2.149 . . . . 5.95 105.197 167.225 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.7 -0.36 89.57 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.575 -0.57 . . . . 1.32 113.731 171.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.4 mtp -73.77 74.33 1.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.817 1.308 . . . . 2.85 108.78 172.543 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 t -88.53 0.27 56.5 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.802 1.038 . . . . 2.8 113.802 -167.208 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.6 t -165.79 159.08 15.76 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 120.004 1.274 . . . . 3.4 110.195 -173.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.32 -38.97 13.77 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.874 1.27 . . . . 2.66 111.092 170.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -44.64 -50.15 9.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.997 0.919 . . . . 2.34 111.023 171.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.3 m -61.31 -45.43 94.49 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.713 -0.617 . . . . 1.63 109.991 -177.528 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.9 t -48.88 -60.08 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 C-N-CA 123.683 0.793 . . . . 1.85 108.897 176.335 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -33.44 75.74 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.579 -0.282 . . . . 1.66 110.359 -176.336 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -60.24 -45.54 92.88 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.64 -0.874 . . . . 3.7 108.64 -178.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.66 -61.47 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 106.18 -1.785 . . . . 1.9 106.18 -178.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -37.19 -64.61 0.36 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.541 1.536 . . . . 4.72 110.701 -179.123 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.9 p -58.42 -41.16 84.38 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.612 -0.722 . . . . 3.26 109.941 -173.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.1 t -71.23 -20.12 62.29 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.914 0.886 . . . . 1.27 112.553 -178.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.32 -57.75 3.35 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 118.634 0.652 . . . . 3.52 110.56 167.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 p -56.5 -32.39 64.99 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.162 0.437 . . . . 1.93 111.103 -176.265 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.5 tptt -37.03 -54.13 0.97 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.911 1.684 . . . . 5.47 113.895 161.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -90.36 149.89 22.11 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.069 0.85 . . . . 5.73 112.621 -165.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -59.02 154.82 14.74 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.803 -0.635 . . . . 8.46 110.535 175.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.11 24.25 66.91 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.5 -0.611 . . . . 1.96 113.339 170.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.43 138.44 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 104.399 -2.445 . . . . 2.87 104.399 156.002 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.3 mt -97.77 -45.86 6.18 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.441 1.096 . . . . 4.5 109.026 178.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -160.36 133.51 6.69 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.286 -0.635 . . . . 2.97 109.286 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.0 t -109.21 143.08 39.12 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.644 -0.873 . . . . 1.97 108.644 176.182 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.1 t -154.64 109.52 3.05 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.033 -0.729 . . . . 2.29 109.033 168.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 m -104.89 145.81 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 123.19 0.596 . . . . 2.95 110.239 172.248 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.36 134.48 46.34 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 124.634 1.174 . . . . 2.22 110.846 -174.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.5 mt -72.23 -49.41 35.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.816 1.247 . . . . 4.07 111.073 -175.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.5 -32.09 68.48 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.037 0.535 . . . . 2.28 111.375 -170.045 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 t -108.32 2.5 22.63 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.313 1.045 . . . . 3.55 111.431 179.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 41.12 41.78 1.43 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.653 1.981 . . . . 5.08 111.067 -172.513 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -99.08 149.8 22.66 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.606 -0.887 . . . . 2.24 108.606 -174.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.48 114.58 21.46 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.69 -1.226 . . . . 1.99 107.69 159.359 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.84 133.36 38.65 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.873 -1.158 . . . . 1.24 107.873 163.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.6 mp -121.59 122.75 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 106.851 -1.537 . . . . 2.06 106.851 172.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -92.2 127.52 37.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.773 -1.936 . . . . 3.97 105.773 157.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -166.82 161.37 15.32 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 126.289 1.836 . . . . 3.32 107.967 -167.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -98.21 95.34 2.78 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.448 0.699 . . . . 4.15 109.833 -174.329 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -58.55 -32.14 95.93 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.637 2.225 . . . . 1.56 111.709 -176.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -61.19 -15.8 38.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.033 1.333 . . . . 3.69 112.955 -178.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 pt -123.49 -49.06 2.3 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 N-CA-C 114.019 1.118 . . . . 2.21 114.019 -178.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.9 tt -90.19 -70.11 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 118.462 0.574 . . . . 2.28 109.97 178.509 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.72 149.09 8.81 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 123.605 0.622 . . . . 0.87 112.12 178.487 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.41 -39.57 9.49 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.72 2.947 . . . . 1.31 111.733 179.509 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -51.27 -56.25 13.93 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 122.595 0.358 . . . . 6.75 110.504 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -49.25 -47.45 46.52 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.014 1.725 . . . . 4.93 110.842 179.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.0 mt -58.32 -54.16 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 118.992 -0.528 . . . . 1.88 110.424 174.003 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.7 mt -52.41 -45.36 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 119.203 0.91 . . . . 2.2 110.703 177.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -58.33 -44.83 88.84 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.288 0.635 . . . . 5.36 110.262 176.249 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 56.7 m -60.17 -54.4 46.25 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.776 -0.577 . . . . 2.1 109.635 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.9 mm -58.8 -42.01 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 121.867 -0.521 . . . . 2.32 110.829 -178.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -53.02 -65.33 0.58 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.683 0.793 . . . . 3.17 109.415 171.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.4 t -54.77 -36.55 64.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.148 1.379 . . . . 1.58 112.457 -174.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.76 -12.6 25.16 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.244 0.831 . . . . 3.26 113.244 176.79 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.26 44.72 1.23 Allowed Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.604 1.097 . . . . 0.8 111.18 169.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -141.62 174.04 10.94 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.554 0.741 . . . . 3.6 109.108 178.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -113.75 76.71 3.19 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 123.706 0.802 . . . . 4.1 112.177 -177.252 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.04 133.37 26.7 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.765 1.643 . . . . 1.4 111.929 -177.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.6 t -139.08 151.91 47.11 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.524 1.129 . . . . 3.72 108.208 167.425 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.5 mt . . . . . 0 N--CA 1.452 -0.375 0 N-CA-C 107.765 -1.198 . . . . 4.19 107.765 161.482 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.634 0.254 . . . . 3.59 111.613 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.9 tp -150.79 156.43 41.25 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.564 1.946 . . . . 3.28 106.34 174.171 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -124.04 155.09 38.92 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.761 0.824 . . . . 2.48 109.577 176.231 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.74 141.98 23.22 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.804 0.842 . . . . 3.7 109.126 175.192 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.6 t -90.97 131.32 38.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 C-N-CA 125.685 1.594 . . . . 2.0 107.142 177.123 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.35 78.43 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 122.454 1.121 . . . . 2.44 110.487 -166.539 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.9 mtm105 -58.34 133.34 55.63 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.041 -1.096 . . . . 6.6 108.041 170.254 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.32 -32.96 3.43 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.578 1.085 . . . . 1.16 110.391 -171.108 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 55.8 mtm -60.85 144.62 52.39 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.327 -1.102 . . . . 2.33 108.489 163.51 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 t -164.42 -65.56 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.777 0.431 . . . . 3.49 110.407 -177.273 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -79.46 -75.69 0.24 Allowed 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.131 -0.356 . . . . 3.75 111.78 -168.809 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -167.67 -66.1 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.322 0.649 . . . . 3.03 109.494 -175.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.6 t -49.53 -38.4 30.59 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.513 0.725 . . . . 3.23 111.52 -171.185 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.4 m -39.25 -37.97 0.47 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.999 1.32 . . . . 2.34 112.68 174.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.0 t -51.74 -71.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.401 0.68 . . . . 2.17 110.251 173.096 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -27.68 69.31 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.12 -0.988 . . . . 1.79 110.626 -176.611 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -54.25 -41.89 69.29 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 124.224 1.009 . . . . 3.93 109.425 174.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.6 mt -78.33 -64.23 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.499 -1.297 . . . . 1.87 107.499 176.071 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -48.86 -57.71 5.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.79 1.236 . . . . 3.19 111.07 -169.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 t -75.25 0.19 17.39 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.863 0.865 . . . . 1.92 112.27 -176.258 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.6 t -98.72 -37.36 9.51 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.662 1.185 . . . . 1.04 109.996 173.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.75 -45.29 90.52 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.844 0.747 . . . . 3.85 111.052 173.323 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.3 p -64.84 80.45 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.194 0.598 . . . . 2.18 110.817 -172.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt 164.95 -33.88 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.853 2.861 . . . . 6.07 110.766 -176.055 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -50.6 118.82 3.31 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.323 0.51 . . . . 2.59 110.036 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -71.09 77.56 0.68 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.009 0.923 . . . . 6.11 110.547 -168.448 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.53 -16.83 0.98 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.658 1.123 . . . . 1.32 111.27 -175.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.84 145.41 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 107.136 -1.431 . . . . 2.82 107.136 162.457 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.5 mt -108.2 -43.83 4.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.496 1.518 . . . . 3.91 108.761 170.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -164.5 159.77 19.71 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 108.578 -0.897 . . . . 3.93 108.578 -178.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.4 p -133.85 160.93 36.16 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.751 1.22 . . . . 2.84 107.919 173.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 m -153.42 117.44 4.81 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.509 -1.293 . . . . 2.5 107.509 161.26 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 p -106.2 153.16 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 118.712 0.687 . . . . 3.4 111.364 174.222 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.83 135.55 22.16 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.683 -0.635 . . . . 1.93 110.404 170.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.35 -37.6 63.47 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 115.45 -0.796 . . . . 2.32 110.493 -178.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.0 84.12 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.13 0.572 . . . . 2.06 110.604 179.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.84 -11.1 59.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.217 1.007 . . . . 2.78 111.107 175.643 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 46.44 40.33 7.85 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.737 2.015 . . . . 4.18 111.696 -167.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -132.25 144.17 50.43 Favored 'General case' 0 C--O 1.228 -0.034 0 CA-C-O 119.375 -0.345 . . . . 2.63 111.126 -167.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.0 136.63 44.11 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.331 -0.989 . . . . 2.03 108.331 155.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.31 145.17 25.83 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.41 -1.329 . . . . 1.74 107.41 148.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.5 mt -125.68 132.71 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.086 -1.449 . . . . 3.44 107.086 167.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -96.87 128.95 44.32 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.382 -2.081 . . . . 3.69 105.382 160.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -166.66 161.36 15.72 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.684 1.594 . . . . 3.82 108.757 -176.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -97.01 109.5 49.46 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 123.419 0.687 . . . . 3.36 109.433 176.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.52 29.07 0.43 Allowed 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.605 2.204 . . . . 1.61 113.254 -176.361 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -123.12 1.36 9.17 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.619 1.168 . . . . 3.56 111.017 -176.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -129.64 -67.88 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.229 0 C-N-CA 123.514 0.726 . . . . 2.76 110.488 178.443 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 tt -80.0 -49.12 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.515 0.674 . . . . 2.95 110.424 -175.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.26 161.35 34.21 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.109 0.862 . . . . 1.1 111.953 174.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.8 -34.94 47.76 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.482 2.788 . . . . 1.12 111.715 -177.4 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -53.44 -58.96 5.28 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.702 0.801 . . . . 6.66 111.284 -175.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -44.96 -57.31 3.89 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.226 1.01 . . . . 2.81 110.752 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 76.9 mt -56.09 -61.63 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 114.588 -1.187 . . . . 2.05 109.835 -177.358 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.0 mt -58.09 -42.66 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 121.937 -0.477 . . . . 2.46 111.098 -176.097 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 57.7 m170 -58.46 -46.58 86.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.778 0.717 . . . . 4.88 109.959 176.116 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 m -58.45 -57.48 12.74 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.414 -0.587 . . . . 2.01 109.414 177.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.5 mm -61.45 -35.23 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.817 0.735 . . . . 2.85 111.662 -174.292 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -53.11 -68.8 0.14 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.293 -0.632 . . . . 3.44 109.293 168.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.6 t -62.38 -21.16 65.13 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.897 0.702 . . . . 2.06 112.897 -174.087 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.4 tp -65.65 -18.44 65.33 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.264 1.425 . . . . 3.68 111.097 174.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.17 43.56 0.6 Allowed Glycine 0 C--N 1.337 0.591 0 C-N-CA 125.285 1.421 . . . . 0.92 110.851 168.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -146.54 178.83 7.98 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 117.394 0.597 . . . . 2.95 110.028 -177.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.99 87.5 47.23 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 123.848 0.859 . . . . 5.44 109.851 172.385 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.16 75.86 4.06 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 124.303 3.335 . . . . 1.86 111.015 -175.379 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.3 t -71.82 150.81 43.98 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.161 -0.681 . . . . 3.53 109.161 175.111 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.2 tp . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 106.919 -1.511 . . . . 4.61 106.919 164.156 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 105.545 -2.02 . . . . 9.13 105.545 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.54 177.29 10.34 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 109.025 -1.63 . . . . 4.1 109.025 -138.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.0 t0 63.4 159.75 0.09 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.05 2.14 . . . . 4.18 112.157 -174.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.55 -179.43 36.95 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.142 -1.183 . . . . 2.54 110.142 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 m -142.46 161.39 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.128 -0.693 . . . . 3.36 109.128 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 tp -144.69 142.32 29.98 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.156 -1.054 . . . . 3.66 108.156 168.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -101.14 132.88 46.39 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.975 0.91 . . . . 2.47 109.487 166.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -132.6 162.18 31.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.934 1.294 . . . . 3.09 107.644 166.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 t -117.7 133.09 65.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 126.166 1.786 . . . . 2.59 107.108 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.48 99.36 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 C-N-CA 124.086 0.954 . . . . 2.41 110.891 -168.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.4 mtt85 -68.84 150.64 47.58 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.924 -1.139 . . . . 6.08 107.924 171.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.72 -5.14 39.95 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.215 0.912 . . . . 1.05 113.67 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 69.7 mtm -74.17 69.2 1.51 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.831 1.315 . . . . 2.1 112.543 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 t -65.82 126.35 28.2 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.214 0.531 . . . . 3.55 111.817 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 t 52.02 82.42 0.07 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.811 2.044 . . . . 4.13 114.391 156.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 50.77 -101.83 0.1 Allowed 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.614 1.166 . . . . 2.26 110.229 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 9.85 -71.65 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 129.99 3.316 . . . . 2.83 115.781 172.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.7 m -36.78 -46.49 0.61 Allowed 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 125.589 1.555 . . . . 1.87 112.516 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.1 t -36.42 -68.12 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.027 1.331 . . . . 2.22 111.579 168.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -29.0 65.78 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.896 -0.503 . . . . 1.48 110.072 -175.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -38.29 77.37 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.531 0.733 . . . . 4.41 109.59 177.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.7 mt -74.41 -68.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 106.422 -1.696 . . . . 1.64 106.422 172.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -48.0 -56.34 7.9 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.311 1.444 . . . . 3.08 111.369 -166.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 t -60.99 -42.3 98.15 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.586 0.708 . . . . 2.0 109.992 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.3 t -65.95 -49.45 67.88 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.224 -0.658 . . . . 1.59 109.224 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.41 -39.44 83.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.023 -1.048 . . . . 3.31 111.301 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.2 p -58.34 -11.24 2.59 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.934 1.087 . . . . 1.74 113.934 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -68.7 -34.95 76.52 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.505 1.048 . . . . 4.53 111.592 170.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -62.71 122.06 14.94 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.784 0.434 . . . . 2.51 110.509 -167.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -76.56 65.9 2.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.209 1.004 . . . . 7.11 110.824 -172.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.78 9.31 0.02 OUTLIER Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.953 1.739 . . . . 1.52 112.504 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -103.19 132.98 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.778 1.631 . . . . 2.6 106.765 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -90.17 -56.87 3.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.51 1.124 . . . . 3.76 108.777 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -148.64 136.58 20.82 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.101 0.56 . . . . 4.12 111.549 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.0 m -106.51 161.78 14.3 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.933 0.893 . . . . 2.13 109.035 172.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.1 m -150.84 96.95 2.41 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.089 0.555 . . . . 2.14 109.675 162.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.58 86.2 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 C-N-CA 126.147 1.779 . . . . 3.54 109.341 176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.86 129.41 34.84 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 121.323 -0.861 . . . . 2.11 110.946 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -77.83 -45.63 23.82 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.516 -0.766 . . . . 3.04 111.063 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.58 -45.88 90.56 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.299 0.571 . . . . 2.31 110.352 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -10.5 59.66 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.463 1.105 . . . . 3.11 111.513 176.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 51.72 31.04 7.46 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.203 1.801 . . . . 3.83 111.802 -171.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -117.21 133.83 55.51 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.641 0.777 . . . . 2.74 109.632 -165.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.94 114.39 28.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.648 -1.242 . . . . 1.87 107.648 161.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.3 142.3 27.86 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.94 -1.133 . . . . 1.33 107.94 159.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 mp -127.93 127.64 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 106.581 -1.637 . . . . 2.14 106.581 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -98.51 80.85 2.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.364 1.466 . . . . 4.08 108.376 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -116.95 165.46 13.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.591 1.556 . . . . 3.7 110.883 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -81.13 115.77 58.3 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 122.589 0.356 . . . . 3.44 110.511 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.88 -13.06 21.79 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.79 2.327 . . . . 1.68 113.92 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -81.93 -45.97 14.69 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 119.316 0.962 . . . . 4.39 108.956 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pt -81.92 -89.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.08 0.4 . . . . 2.33 112.08 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 tt -57.38 -47.02 85.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.806 1.242 . . . . 1.97 111.09 -173.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.42 164.29 28.02 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 121.512 0.507 . . . . 1.3 112.681 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.22 -37.57 31.16 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.058 3.172 . . . . 1.15 112.215 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -60.08 -50.17 74.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.442 0.697 . . . . 8.67 110.902 -168.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -50.21 -56.3 11.65 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.978 0.911 . . . . 2.43 110.037 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.9 mt -53.6 -60.6 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.496 1.118 . . . . 1.65 109.745 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.4 mt -50.69 -43.54 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 118.641 0.655 . . . . 2.8 111.208 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -76.37 -30.94 57.77 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.363 -0.836 . . . . 3.99 112.272 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.6 m -61.67 -49.76 75.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.401 -0.962 . . . . 1.66 108.401 171.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -59.58 -49.03 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.716 1.206 . . . . 2.51 109.814 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -48.84 -61.16 2.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.307 1.443 . . . . 3.53 109.252 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.0 t -59.5 -31.76 69.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.202 1.001 . . . . 1.66 112.646 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.2 mt -67.06 -14.34 62.8 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.63 -0.7 . . . . 3.13 111.526 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.23 49.4 1.14 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.451 -1.06 . . . . 0.85 110.451 168.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -141.37 169.25 17.96 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.355 1.062 . . . . 3.44 108.519 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -108.03 85.56 2.67 Favored Pre-proline 0 CA--C 1.529 0.139 0 CA-C-O 117.361 -1.304 . . . . 3.76 112.943 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 75.52 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.847 2.365 . . . . 1.46 112.133 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.1 m -66.91 143.16 57.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.646 -0.872 . . . . 2.56 108.646 166.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.92 153.89 32.16 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.867 0.841 . . . . 4.23 109.266 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.4 t -87.17 -46.71 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.826 0.85 . . . . 5.29 110.295 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -64.04 -48.35 76.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.044 0.938 . . . . 8.14 110.597 -171.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.51 -173.94 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 127.696 2.398 . . . . 9.28 105.413 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 C--O 1.249 1.04 0 N-CA-C 103.462 -2.792 . . . . 13.52 103.462 158.773 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 119.462 -0.304 . . . . 7.8 111.352 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.11 -177.15 41.85 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 108.733 -1.747 . . . . 3.84 108.733 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -36.48 80.43 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.746 2.818 . . . . 4.69 115.856 -173.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.53 86.06 0.73 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 106.636 -2.585 . . . . 2.69 106.636 157.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.5 t -70.72 67.38 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.595 -0.891 . . . . 3.21 108.595 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -90.18 99.07 12.16 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.905 -1.517 . . . . 4.24 106.905 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.2 142.63 50.63 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.026 -0.361 . . . . 2.58 110.026 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 131.83 55.76 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.133 -1.432 . . . . 2.48 107.133 166.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 t -70.02 133.76 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 105.343 -2.095 . . . . 2.39 105.343 165.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.94 114.69 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.413 1.085 . . . . 2.31 108.093 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -74.05 155.27 38.7 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.429 -0.952 . . . . 6.33 108.429 171.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.6 -20.86 10.86 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.191 -0.783 . . . . 1.02 114.115 164.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -73.63 73.5 1.49 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.537 1.669 . . . . 2.42 109.921 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 t -59.58 -34.72 73.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.869 0.868 . . . . 3.38 111.805 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.1 m -144.83 -167.01 2.55 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.284 -1.006 . . . . 5.08 108.284 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.36 -174.05 0.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.622 0.769 . . . . 2.78 111.057 173.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m 72.52 -58.53 0.59 Allowed 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 125.108 1.363 . . . . 2.22 110.5 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.6 m -40.4 -46.71 2.44 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.714 1.206 . . . . 1.82 110.491 168.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.4 t -38.11 -69.61 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.272 1.029 . . . . 1.74 111.3 169.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -26.51 62.46 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.58 -0.7 . . . . 1.63 111.236 -175.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -50.81 -40.44 55.47 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 108.881 -0.785 . . . . 3.86 108.881 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.6 mt -81.25 -69.14 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 108.065 -1.087 . . . . 1.89 108.065 172.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -46.52 -55.94 6.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.661 1.584 . . . . 3.27 111.928 -169.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 t -62.02 -38.62 89.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.711 0.804 . . . . 1.99 109.973 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.5 t -72.97 -27.55 61.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.992 0.517 . . . . 1.32 110.878 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.89 -44.51 55.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.709 0.804 . . . . 3.13 110.218 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.6 p -65.17 80.55 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.242 0.617 . . . . 2.04 110.373 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 165.91 -26.18 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.773 2.829 . . . . 4.49 111.415 -174.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -66.44 76.25 0.1 Allowed 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.484 1.038 . . . . 2.5 110.378 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -42.17 97.74 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.417 1.887 . . . . 6.33 110.948 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.39 -40.93 0.91 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.386 -1.486 . . . . 1.67 109.386 -165.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.47 154.93 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.941 -0.762 . . . . 4.4 108.941 156.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.05 -23.89 10.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.906 0.883 . . . . 3.58 110.812 165.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -159.44 155.02 25.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.696 0.68 . . . . 3.25 109.3 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.3 t -136.48 147.84 47.36 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.197 1.399 . . . . 2.63 108.014 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.5 m -146.05 131.55 18.74 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.62 -0.881 . . . . 2.41 108.62 151.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.3 m -111.69 163.73 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 123.234 0.614 . . . . 2.67 109.994 173.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.13 137.15 11.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.774 -0.579 . . . . 1.76 111.297 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 pp -72.98 -41.25 64.55 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.948 1.299 . . . . 2.35 111.262 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.45 -27.56 69.2 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.105 0.562 . . . . 1.9 111.376 -171.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 t -114.97 6.64 15.36 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.925 1.29 . . . . 3.14 110.579 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.3 m120 51.2 45.53 27.74 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.741 1.616 . . . . 3.16 111.609 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -141.74 162.13 36.23 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 113.504 0.927 . . . . 3.08 113.504 -174.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.45 120.72 34.75 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.491 1.916 . . . . 1.72 106.889 167.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.21 135.38 39.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.587 -1.264 . . . . 1.56 107.587 161.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -119.27 135.84 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 104.236 -2.505 . . . . 2.11 104.236 168.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -97.46 112.13 24.1 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.141 -1.8 . . . . 4.4 106.141 165.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -150.48 160.79 43.52 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 122.989 0.516 . . . . 3.76 110.029 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -87.61 112.6 49.65 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 108.455 -0.943 . . . . 4.42 108.455 169.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.86 -18.45 36.53 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.078 1.852 . . . . 1.66 112.595 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -69.82 -38.93 76.73 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.683 1.129 . . . . 3.88 110.913 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -83.2 -56.16 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 112.381 0.512 . . . . 2.67 112.381 -172.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 tt -98.13 -51.16 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.268 0.627 . . . . 2.56 110.694 -172.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.73 163.7 37.04 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 115.846 -0.615 . . . . 1.06 113.153 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.84 -37.23 28.21 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 124.161 3.24 . . . . 1.19 112.527 -175.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -52.73 -49.17 65.95 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.902 0.481 . . . . 6.1 112.019 -174.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -48.73 -60.5 2.68 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.925 0.89 . . . . 3.03 110.082 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.4 mt -56.19 -54.31 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.01 1.324 . . . . 1.99 110.35 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.7 mt -54.44 -58.29 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.609 0.764 . . . . 2.35 110.173 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -62.77 -34.73 77.85 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.384 0.611 . . . . 5.73 110.636 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 83.5 m -62.36 -51.71 66.51 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.349 -0.844 . . . . 1.8 109.717 173.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.8 -37.77 80.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 121.299 -0.876 . . . . 2.95 111.649 -175.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -47.79 -50.97 24.23 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.866 0.866 . . . . 2.56 108.767 167.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.8 t -65.26 -45.58 83.99 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.287 0.477 . . . . 1.82 112.287 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.47 -32.03 69.87 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.37 -0.831 . . . . 2.87 110.769 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.23 45.9 0.56 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.196 -0.762 . . . . 1.07 111.196 161.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -136.16 161.14 36.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.035 -1.469 . . . . 3.65 107.035 174.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -106.38 85.66 1.82 Allowed Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 118.045 -0.979 . . . . 4.32 113.139 -165.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.61 134.12 31.88 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.533 2.155 . . . . 1.67 112.889 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.8 t -143.46 172.68 12.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.787 1.635 . . . . 3.24 106.897 162.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.51 175.2 4.98 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.953 0.501 . . . . 6.03 111.416 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.0 -86.89 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 105.972 -1.862 . . . . 4.93 105.972 171.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -158.08 151.85 23.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.723 1.609 . . . . 8.51 107.032 169.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 51.7 mt -80.71 77.14 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 105.719 -1.956 . . . . 10.1 105.719 166.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 . . . . . 0 C--O 1.252 1.202 0 C-N-CA 127.29 2.236 . . . . 12.2 107.474 -165.045 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.468 ' H3 ' ' CG ' ' A' ' 49' ' ' ASP . 55.7 mtt . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 107.791 -1.188 . . . . 10.23 107.791 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.08 -150.75 52.12 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.317 0.484 . . . . 4.42 112.746 170.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -125.86 140.94 52.24 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.002 -1.481 . . . . 4.63 107.002 173.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.1 -22.25 20.62 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.254 1.407 . . . . 3.68 112.241 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t 44.93 70.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 118.655 1.227 . . . . 3.17 110.888 -171.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.98 146.56 51.01 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.466 -1.309 . . . . 3.86 107.466 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -125.85 150.17 48.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.459 -0.941 . . . . 2.21 108.459 159.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.91 118.2 15.62 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.189 -1.412 . . . . 2.71 107.189 172.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.26 122.57 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 106.528 -1.656 . . . . 2.33 106.528 165.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.35 137.43 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.903 0.881 . . . . 3.88 109.576 -172.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -120.7 168.51 11.33 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.684 0.794 . . . . 7.44 110.688 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.56 -19.47 11.46 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 125.101 1.334 . . . . 0.96 112.396 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.3 mtm -60.41 113.35 2.36 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.838 0.819 . . . . 2.55 111.272 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.9 p -77.14 -42.34 38.28 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.771 0.828 . . . . 4.92 111.414 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.4 t -162.64 171.76 16.4 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.579 0.752 . . . . 4.16 109.103 -165.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.07 -35.7 2.24 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.916 1.686 . . . . 2.96 112.661 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -47.98 -53.37 16.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.172 0.589 . . . . 2.38 110.882 171.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.7 m -62.47 -43.99 97.48 Favored 'General case' 0 CA--C 1.522 -0.104 0 O-C-N 121.627 -0.67 . . . . 1.94 110.118 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.6 t -49.2 -59.83 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 109.256 -0.646 . . . . 1.93 109.256 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -26.62 66.33 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.702 -0.399 . . . . 1.94 111.341 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -60.26 -51.58 68.95 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.587 -0.894 . . . . 3.54 108.587 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.5 mt -62.86 -57.15 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.753 -1.573 . . . . 1.91 106.753 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -52.79 -53.63 45.53 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 123.993 0.808 . . . . 3.27 110.073 -173.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.6 t -58.94 -53.2 61.03 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.498 -0.556 . . . . 1.92 109.498 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.9 t -63.98 -20.01 65.58 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 118.571 -0.728 . . . . 0.99 112.609 -176.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.41 -47.74 10.36 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.29 -0.862 . . . . 3.1 111.251 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.3 p -50.88 -26.85 6.35 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.158 0.89 . . . . 1.88 113.025 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -25.11 66.44 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.752 1.39 . . . . 4.06 114.752 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.496 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 28.7 m-70 -67.77 129.14 39.0 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 120.199 1.363 . . . . 2.57 110.594 -174.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.73 71.63 1.45 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.555 -0.715 . . . . 7.93 109.595 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.42 -40.13 0.07 OUTLIER Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.612 -0.549 . . . . 1.62 113.254 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.93 158.01 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.078 0.939 . . . . 4.46 109.594 170.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 pp -107.94 -25.74 11.04 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.708 0.803 . . . . 4.07 110.206 164.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -158.44 149.21 20.41 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 118.773 0.715 . . . . 4.02 109.289 171.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.7 t -117.97 137.6 52.74 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 105.315 -2.106 . . . . 3.14 105.315 163.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.97 103.8 6.5 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.186 -1.413 . . . . 1.78 107.186 173.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.1 p -103.68 151.11 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 118.436 0.562 . . . . 3.42 112.13 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.92 136.24 16.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.11 0.481 . . . . 1.76 110.73 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.05 -31.92 56.52 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.107 0.963 . . . . 2.9 111.335 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.94 -52.86 62.64 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.211 0.604 . . . . 2.19 109.915 175.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.98 -30.41 68.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.845 0.858 . . . . 2.91 109.446 173.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.256 0.0 OUTLIER 52.72 56.29 7.82 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.023 -1.473 . . . . 4.32 107.023 -164.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -140.85 143.61 34.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.613 -1.176 . . . . 2.2 109.086 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.73 129.16 55.64 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.421 -1.326 . . . . 1.71 107.421 155.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.67 145.81 24.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.616 -1.253 . . . . 1.3 107.616 154.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -129.21 117.88 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 106.61 -1.626 . . . . 2.0 106.61 170.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -88.21 125.99 34.92 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.575 -1.639 . . . . 2.9 106.575 167.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -170.45 151.97 3.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.396 0.678 . . . . 3.41 110.331 -167.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.468 ' CG ' ' H3 ' ' A' ' 1' ' ' MET . 35.0 t0 -77.64 118.78 74.27 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.499 -1.297 . . . . 3.56 107.499 168.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.11 -18.61 23.68 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.441 2.094 . . . . 1.23 112.37 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -74.62 -51.27 14.94 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.6 0.636 . . . . 4.28 109.364 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 pt -69.72 -54.96 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 112.566 0.58 . . . . 2.32 112.566 -168.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 tt -98.96 -48.83 11.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 123.662 0.785 . . . . 2.34 110.913 -169.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.33 157.77 26.87 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.226 0.917 . . . . 0.88 111.85 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.02 -25.23 32.22 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 124.026 3.15 . . . . 0.75 113.34 -172.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -55.15 -51.62 65.89 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.316 0.507 . . . . 6.82 111.226 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -42.6 -61.92 1.11 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.192 1.397 . . . . 3.36 109.9 176.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mt -51.44 -63.46 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 124.785 1.234 . . . . 2.13 110.685 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.5 mt -49.93 -43.76 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.573 0.624 . . . . 2.21 111.228 -175.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -75.92 -31.53 59.18 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.064 0.546 . . . . 3.24 111.391 -176.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.496 ' HG1' ' CE1' ' A' ' 29' ' ' HIS . 7.7 m -62.6 -53.23 57.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.808 -0.812 . . . . 2.46 108.808 169.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.7 mm -55.93 -47.9 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.135 0.574 . . . . 2.82 110.2 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -49.13 -66.56 0.38 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.102 1.361 . . . . 2.65 109.753 170.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 t -51.95 -42.88 63.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.445 1.498 . . . . 2.13 112.598 -174.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.03 -14.58 55.34 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.782 -0.627 . . . . 2.8 112.658 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.01 47.4 1.35 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.75 -0.94 . . . . 0.71 110.75 172.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -135.74 168.63 18.94 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.049 0.939 . . . . 3.46 108.805 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -117.38 88.75 29.39 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-O 117.962 -1.018 . . . . 4.4 110.38 -173.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.04 108.93 0.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.181 2.588 . . . . 1.12 111.853 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.1 t -72.41 -165.85 0.22 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.8 0.81 . . . . 3.31 109.128 156.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.89 -159.24 0.71 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.422 1.089 . . . . 5.41 110.71 -174.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.43 73.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.943 1.297 . . . . 8.17 109.08 165.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -55.93 148.77 16.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.195 0.998 . . . . 12.76 110.602 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.6 tt -60.91 134.57 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.335 -0.617 . . . . 8.13 109.335 169.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 . . . . . 0 C--O 1.255 1.359 0 N-CA-C 104.508 -2.404 . . . . 9.93 104.508 178.372 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 105.632 -1.988 . . . . 8.69 105.632 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.29 -150.89 20.61 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 106.569 -2.612 . . . . 3.64 106.569 -167.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.48 97.66 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.146 1.778 . . . . 4.66 111.196 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.03 51.34 4.4 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 109.638 -1.385 . . . . 3.41 109.638 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 m -56.06 143.26 9.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 O-C-N 123.702 0.295 . . . . 3.5 111.666 -157.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.5 tp -138.9 141.68 38.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.36 -0.978 . . . . 2.99 108.36 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -108.02 123.31 48.48 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.052 -1.462 . . . . 2.38 107.052 174.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.5 mt -106.87 122.17 45.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.108 -1.812 . . . . 3.41 106.108 172.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.87 118.56 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 106.082 -1.821 . . . . 2.09 106.082 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.9 m -117.4 115.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 123.573 0.749 . . . . 2.16 109.097 -169.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -83.88 175.0 9.92 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.561 -0.903 . . . . 7.71 108.561 168.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.6 -32.52 7.44 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.452 0.548 . . . . 1.16 112.737 172.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -61.4 138.74 58.27 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.684 1.242 . . . . 2.41 110.336 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -155.49 28.89 0.39 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.001 0.52 . . . . 3.09 111.066 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.2 t -167.87 141.58 3.4 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 107.79 -1.189 . . . . 4.51 107.79 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -38.38 -48.91 1.4 Allowed 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.001 1.32 . . . . 2.18 112.069 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.6 m -42.68 -40.97 2.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.601 1.16 . . . . 2.29 111.827 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.2 m -47.6 -39.61 17.23 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.739 0.816 . . . . 2.25 111.364 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.6 t -53.17 -61.9 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 123.295 0.638 . . . . 2.11 109.943 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -28.83 69.07 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.494 -0.558 . . . . 1.6 109.494 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -59.51 -52.79 64.05 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.958 -1.127 . . . . 3.82 107.958 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.94 -51.23 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.115 -1.068 . . . . 1.97 108.115 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -47.82 -61.97 1.69 Allowed 'General case' 0 C--N 1.341 0.229 0 O-C-N 123.901 0.75 . . . . 4.72 109.16 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -62.76 -43.32 99.1 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.974 0.91 . . . . 2.27 109.97 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.6 t -58.49 -30.02 66.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 118.798 -0.62 . . . . 1.51 111.489 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 mt -85.46 -48.48 8.94 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.253 0.835 . . . . 3.43 113.253 178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.4 p -71.6 66.31 0.5 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.541 1.536 . . . . 1.94 110.742 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.99 -33.91 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.618 2.367 . . . . 4.68 110.832 -171.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -53.87 -29.69 42.6 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.733 1.012 . . . . 3.06 113.733 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? 60.4 67.75 0.82 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.739 -1.208 . . . . 7.25 107.739 -173.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.54 -51.22 0.07 OUTLIER Glycine 0 CA--C 1.52 0.373 0 N-CA-C 107.171 -2.372 . . . . 1.81 107.171 -171.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -42.04 132.01 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 123.486 0.715 . . . . 2.91 109.158 147.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.8 tp -95.4 -46.15 6.82 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.8 2.04 . . . . 3.62 107.9 160.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -154.79 138.16 15.83 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 122.908 0.483 . . . . 3.76 110.306 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -111.15 147.64 34.46 Favored 'General case' 0 CA--C 1.523 -0.084 0 N-CA-C 108.005 -1.109 . . . . 2.09 108.005 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.74 104.43 2.87 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.589 -0.893 . . . . 2.05 108.589 171.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.05 157.43 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 122.873 0.469 . . . . 2.96 111.477 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.62 136.66 17.37 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.611 0.765 . . . . 1.95 109.53 170.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.72 -38.17 64.89 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.622 -0.717 . . . . 2.77 110.722 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.05 -46.5 82.39 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.27 0.628 . . . . 2.13 110.89 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -74.74 -11.42 60.16 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.283 1.033 . . . . 2.89 110.871 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 49.78 41.91 22.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.394 1.878 . . . . 3.65 110.84 -172.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -137.61 147.68 45.19 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.291 -0.413 . . . . 2.16 111.26 -164.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.92 112.26 18.55 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.098 1.759 . . . . 1.92 107.422 164.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.78 143.05 27.16 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.198 -1.038 . . . . 1.27 108.198 166.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.5 mp -127.03 124.08 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 107.259 -1.386 . . . . 1.94 107.259 174.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -97.15 120.65 37.9 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.477 -1.675 . . . . 3.09 106.477 158.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -153.48 157.15 39.43 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.89 1.276 . . . . 3.39 107.773 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -85.51 118.44 70.69 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 107.55 -1.278 . . . . 3.19 107.55 170.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.69 -31.41 40.19 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.714 1.609 . . . . 1.47 111.611 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -86.65 29.11 0.81 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.321 0.964 . . . . 3.64 111.378 -166.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 pt -142.77 -53.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 124.846 1.258 . . . . 2.32 110.384 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.4 tt -98.85 -45.55 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.764 0.826 . . . . 2.06 111.015 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.36 158.98 7.38 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.039 0.828 . . . . 0.97 111.251 -172.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.86 -23.78 40.93 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.804 2.336 . . . . 1.18 111.5 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -56.74 -55.13 38.13 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.571 1.148 . . . . 7.14 111.338 -175.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -52.59 -52.13 56.66 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 122.472 1.129 . . . . 2.62 109.824 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.7 mt -56.99 -57.87 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.049 1.339 . . . . 2.14 110.259 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.9 mt -51.12 -51.54 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 109.964 -0.384 . . . . 2.45 109.964 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -63.17 -34.73 78.26 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.73 0.696 . . . . 3.33 112.393 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.9 m -59.92 -56.83 16.92 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.608 -0.886 . . . . 1.73 108.608 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mm -62.11 -46.34 96.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 119.667 -0.206 . . . . 2.71 110.962 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -42.02 -57.76 2.33 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.461 1.504 . . . . 3.44 109.574 166.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 t -65.41 -9.03 21.76 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.353 1.242 . . . . 1.76 114.353 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.1 mt -83.44 -10.01 58.65 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 120.553 1.524 . . . . 3.15 111.128 170.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.34 40.56 28.16 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.056 -1.218 . . . . 1.21 110.056 -170.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -126.67 151.29 48.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.262 -1.755 . . . . 2.92 106.262 161.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -110.64 84.86 4.35 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 113.59 0.959 . . . . 5.54 113.59 -158.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.61 85.67 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.402 2.735 . . . . 1.2 113.756 -173.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.1 t -70.52 156.54 39.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.624 0.77 . . . . 3.66 109.878 161.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.84 179.49 2.21 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.549 -0.537 . . . . 5.87 109.549 161.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 p -152.45 -48.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.183 0.593 . . . . 4.9 111.703 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -63.72 147.75 50.87 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.059 -0.719 . . . . 9.18 109.059 169.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.5 mm 72.82 116.88 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 126.702 2.001 . . . . 8.48 109.176 -167.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 C--O 1.25 1.111 0 N-CA-C 104.627 -2.36 . . . . 9.14 104.627 -177.4 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 mtt . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 108.844 -0.799 . . . . 7.87 108.844 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 51.95 31.91 33.24 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.996 -0.891 . . . . 4.99 111.434 -163.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.3 t0 168.37 156.2 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.622 1.969 . . . . 3.61 109.085 -173.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.04 173.6 36.16 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 128.045 2.736 . . . . 1.94 107.817 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.7 t -133.67 145.97 32.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.122 -1.066 . . . . 3.34 108.122 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.2 tt -140.71 137.15 33.26 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.561 -0.903 . . . . 3.36 108.561 166.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -103.54 132.04 50.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.059 1.344 . . . . 2.26 109.416 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.08 131.81 42.75 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.67 0.788 . . . . 3.08 109.435 173.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.41 132.97 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.183 -2.155 . . . . 2.28 105.183 165.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.34 129.15 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.298 -1.001 . . . . 2.7 108.298 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -101.38 -176.85 3.27 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.213 -0.662 . . . . 5.11 109.213 170.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.98 -29.01 11.33 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.636 1.112 . . . . 1.5 110.698 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 73.2 mtm -57.71 120.71 8.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.964 -0.754 . . . . 2.11 108.964 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 t -155.84 43.92 0.43 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.831 0.824 . . . . 3.77 110.393 -170.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -164.08 -89.02 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.37 -0.831 . . . . 3.27 110.064 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -175.57 -62.3 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 125.428 1.491 . . . . 2.49 107.299 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 t -41.46 -46.16 3.37 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.706 1.202 . . . . 3.22 110.304 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.4 m -25.46 -48.4 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.63 1.972 . . . . 1.96 114.099 169.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.6 t -51.44 -64.2 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.26 0.624 . . . . 1.78 110.347 174.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -27.83 66.43 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.101 -0.999 . . . . 1.57 110.706 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.93 -44.01 70.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.126 1.37 . . . . 4.11 108.373 176.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.1 mt -72.69 -67.49 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 106.288 -1.745 . . . . 1.6 106.288 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -48.91 -56.17 9.6 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.612 1.165 . . . . 3.55 111.563 -166.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 m -68.95 -20.17 64.19 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.753 1.221 . . . . 3.54 111.792 -174.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.5 t -87.08 -48.89 7.7 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.027 -1.101 . . . . 1.54 108.027 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.27 -35.7 76.14 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.035 -1.041 . . . . 3.28 111.718 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 p -57.69 -18.94 23.63 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.483 0.92 . . . . 1.94 113.483 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.9 mtmt -63.02 -34.21 77.08 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.571 1.078 . . . . 4.71 110.28 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -72.41 107.75 5.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.895 -1.15 . . . . 2.41 107.895 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -52.52 -26.12 12.22 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.006 1.113 . . . . 5.56 114.006 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.09 -21.23 69.71 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 118.198 0.454 . . . . 1.7 113.05 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.76 124.31 14.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 118.965 1.382 . . . . 4.01 108.689 171.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.5 tp -84.45 -45.31 12.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.732 -1.21 . . . . 4.2 107.732 162.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -163.62 114.44 1.36 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 119.152 -0.451 . . . . 4.5 111.042 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.7 m -77.92 161.9 27.21 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.713 -0.847 . . . . 2.15 108.713 166.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -166.18 94.5 0.55 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.399 -0.963 . . . . 3.69 108.399 170.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 p -104.87 147.99 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 123.428 0.691 . . . . 3.38 112.075 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.9 135.02 30.87 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.635 0.774 . . . . 1.76 109.904 174.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.93 -39.87 63.5 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.31 -0.859 . . . . 2.35 110.728 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.36 -46.33 80.07 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.134 0.574 . . . . 1.85 110.349 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.19 -15.49 60.56 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.131 0.972 . . . . 2.69 111.086 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.39 36.32 26.85 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.676 0.79 . . . . 3.52 109.155 -172.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -135.69 135.6 40.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 122.411 0.284 . . . . 2.45 110.575 -168.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.06 124.69 49.96 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.594 -1.262 . . . . 1.73 107.594 160.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.79 147.51 25.99 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.674 -1.232 . . . . 1.72 107.674 155.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.4 mp -130.17 139.15 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 107.139 -1.43 . . . . 2.43 107.139 166.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -97.18 123.73 41.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.79 -1.559 . . . . 3.96 106.79 161.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -168.58 171.43 8.86 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.835 -1.172 . . . . 3.87 107.835 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.74 110.16 30.05 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-N 119.015 0.825 . . . . 3.89 109.364 175.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.28 51.32 3.16 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.694 2.263 . . . . 2.58 110.365 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -145.44 -60.5 0.34 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.922 1.689 . . . . 4.39 107.598 -159.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 pt -94.57 -60.37 2.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 C-N-CA 123.893 0.877 . . . . 2.89 111.469 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.7 tt -72.28 -52.71 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.246 -1.02 . . . . 3.15 108.246 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.8 160.69 24.28 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.287 -0.869 . . . . 0.88 112.02 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -57.37 -39.69 87.53 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.755 2.97 . . . . 0.98 110.909 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -59.44 -53.9 52.8 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.251 0.463 . . . . 7.68 112.251 -171.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -52.67 -46.74 67.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.897 0.856 . . . . 2.55 109.75 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.96 -66.45 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.827 -1.079 . . . . 2.14 110.025 172.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.353 2.7 pp -61.62 -28.88 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 121.075 1.762 . . . . 4.79 114.366 -174.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.49 -51.77 66.13 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 118.819 0.736 . . . . 4.33 109.139 173.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.0 m -57.39 -52.34 65.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.567 -0.531 . . . . 1.6 109.567 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mm -56.35 -49.6 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.516 1.126 . . . . 2.63 110.181 -175.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -48.4 -62.84 1.29 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.39 1.076 . . . . 3.91 109.675 170.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -62.47 -23.89 67.16 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.79 -0.641 . . . . 1.96 112.286 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -82.7 -5.16 58.73 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.951 1.7 . . . . 3.52 110.966 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.38 48.36 1.56 Allowed Glycine 0 CA--C 1.525 0.696 0 C-N-CA 125.103 1.335 . . . . 1.09 111.803 167.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -141.61 162.54 35.23 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.794 0.838 . . . . 3.22 109.902 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -109.66 93.2 13.68 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-O 117.95 -1.024 . . . . 4.41 109.578 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.78 136.78 6.28 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 121.553 1.502 . . . . 1.49 112.826 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.3 m -135.79 117.5 15.01 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 126.02 1.728 . . . . 2.52 107.751 170.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -58.02 135.36 56.95 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.438 0.295 . . . . 4.02 110.482 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.2 m -119.79 -41.34 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 123.273 0.629 . . . . 4.49 110.777 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt 70.73 -56.57 0.61 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.858 1.663 . . . . 8.32 111.56 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.7 pt -93.16 -173.73 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.098 1.359 . . . . 6.24 109.109 168.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 . . . . . 0 C--O 1.256 1.399 0 N-CA-C 103.319 -2.845 . . . . 11.75 103.319 164.886 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 106.368 -1.715 . . . . 9.28 106.368 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.27 58.94 10.4 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 108.72 -1.752 . . . . 4.03 108.72 -165.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -170.15 171.57 6.81 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.547 -1.279 . . . . 4.25 107.547 -137.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.55 -176.38 18.9 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.642 1.591 . . . . 2.32 110.259 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.0 156.12 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.191 -1.411 . . . . 3.06 107.191 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.22 127.27 44.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.678 -1.601 . . . . 3.78 106.678 174.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.37 117.69 35.08 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.72 -1.215 . . . . 2.18 107.72 170.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.12 141.82 42.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.298 -1.371 . . . . 3.12 107.298 172.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.85 135.79 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 106.357 -1.72 . . . . 2.2 106.357 167.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.26 108.74 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 C-N-CA 125.853 1.661 . . . . 2.27 108.869 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -67.48 158.48 31.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.688 -0.856 . . . . 6.48 108.688 160.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.02 -23.58 7.69 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.03 0.824 . . . . 1.21 113.111 163.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -70.44 85.59 0.61 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.819 1.309 . . . . 2.16 112.6 -175.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.3 t -76.79 100.41 5.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.02 0.914 . . . . 3.11 110.845 175.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.4 t 68.62 -76.33 0.06 Allowed 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 115.21 1.559 . . . . 4.15 115.21 164.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.41 170.34 15.99 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 123.864 0.865 . . . . 3.33 108.709 -171.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m 69.7 -58.48 0.52 Allowed 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 124.978 1.311 . . . . 2.47 111.034 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.8 m -44.21 -47.16 9.21 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 124.924 1.289 . . . . 1.82 111.512 -177.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.6 t -42.99 -64.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.45 0.7 . . . . 2.0 110.197 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -25.9 61.11 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.861 -0.524 . . . . 1.75 111.395 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -51.53 -41.61 61.16 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.767 0.827 . . . . 4.1 108.824 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.6 mt -80.23 -65.91 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.682 -1.229 . . . . 1.68 107.682 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.0 -56.62 7.23 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.013 1.325 . . . . 3.29 111.311 -169.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 t -65.23 -45.12 85.9 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.897 0.879 . . . . 2.05 110.12 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 t -62.16 -29.6 70.47 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 119.161 -0.447 . . . . 1.26 111.388 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.39 -55.22 5.04 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.957 -0.544 . . . . 3.73 111.311 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.9 p -68.83 66.08 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.962 1.305 . . . . 2.06 111.956 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.87 -42.33 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.77 1.628 . . . . 5.24 110.779 -170.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -72.99 150.32 42.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.04 -0.726 . . . . 5.02 109.04 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -60.69 160.07 9.86 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.919 -0.401 . . . . 6.17 109.919 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.2 -5.09 81.66 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.028 -0.873 . . . . 1.8 113.111 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.18 146.43 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 106.712 -1.588 . . . . 2.87 106.712 176.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.9 tp -104.53 -48.74 3.73 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.681 1.192 . . . . 3.8 110.603 172.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -164.95 162.4 20.58 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.007 0.923 . . . . 3.72 108.761 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.0 m -138.15 161.34 37.06 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 119.332 0.969 . . . . 1.85 108.538 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.6 t -155.0 133.62 12.01 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.774 -0.824 . . . . 3.09 108.774 150.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 m -115.94 155.81 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.369 0.668 . . . . 2.69 111.036 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.39 137.69 16.6 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.101 0.561 . . . . 2.1 110.88 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -79.24 -34.83 42.36 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 124.559 1.144 . . . . 2.62 112.521 -174.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.82 -41.34 91.05 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 109.596 -0.52 . . . . 2.05 109.596 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.3 t -92.9 -6.36 48.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.533 -0.746 . . . . 3.21 111.297 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.269 0.0 OUTLIER 39.32 60.69 1.48 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 126.576 1.951 . . . . 4.03 109.791 -172.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -131.38 147.13 52.54 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.201 1.4 . . . . 3.18 108.866 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.93 120.71 38.09 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.938 -1.504 . . . . 1.77 106.938 159.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.01 138.18 31.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.043 -1.466 . . . . 1.95 107.043 161.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.63 130.3 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.619 -1.252 . . . . 2.22 107.619 169.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -101.06 139.26 37.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.085 -1.82 . . . . 3.27 106.085 161.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -175.18 177.38 1.91 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.371 1.468 . . . . 3.84 108.777 -160.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -112.85 81.33 4.4 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 125.241 1.416 . . . . 4.09 107.544 -170.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.74 -43.53 55.05 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.421 2.747 . . . . 1.51 113.902 -167.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.33 -23.72 65.94 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.239 0.829 . . . . 3.74 113.239 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.8 pt -100.75 -58.17 4.05 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 118.888 0.767 . . . . 2.29 112.629 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.7 tt -89.32 -45.35 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 121.356 0.598 . . . . 2.13 110.425 -171.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.68 151.47 13.87 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.859 0.742 . . . . 1.14 111.815 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -66.42 -31.42 42.63 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.389 2.726 . . . . 1.63 111.866 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -56.55 -43.17 79.65 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.91 -0.494 . . . . 7.15 111.452 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -53.99 -53.01 58.81 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 121.225 0.536 . . . . 2.71 109.732 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.3 mt -57.58 -49.15 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 124.276 1.03 . . . . 1.89 110.25 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.4 mt -54.85 -56.74 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 110.151 -0.314 . . . . 2.46 110.151 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -60.88 -36.96 80.53 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.742 0.701 . . . . 3.47 112.027 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.7 m -59.21 -51.16 71.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.479 -0.763 . . . . 2.06 109.095 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.7 mt -65.25 -43.03 95.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 121.508 -0.745 . . . . 3.31 111.753 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -49.48 -49.76 44.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.425 1.09 . . . . 3.05 108.356 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 t -64.96 -44.31 89.8 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.57 0.748 . . . . 2.04 111.419 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.6 mt -63.47 -30.41 71.54 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.5 -0.75 . . . . 3.09 110.651 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.07 53.45 0.2 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.44 -0.664 . . . . 1.24 111.44 156.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -137.47 175.28 9.74 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.709 -0.849 . . . . 3.43 108.709 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -106.65 77.15 0.46 Allowed Pre-proline 0 N--CA 1.47 0.547 0 CA-C-O 117.734 -1.127 . . . . 4.35 111.76 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.68 71.79 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.662 2.908 . . . . 1.27 112.37 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.7 m -74.38 117.84 16.65 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.357 1.063 . . . . 2.82 108.49 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tt -76.74 69.64 3.13 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.086 0.954 . . . . 4.09 109.466 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.9 t -82.19 -36.86 14.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 123.378 0.671 . . . . 5.18 111.59 -173.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.461 ' NZ ' ' OE2' ' A' ' 75' ' ' GLU . 1.1 tmtm? -66.14 -46.68 76.62 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.577 -0.849 . . . . 7.43 111.196 -168.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.6 mm -71.55 144.27 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.346 -0.983 . . . . 9.53 108.346 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.461 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 14.2 pt-20 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 105.122 -2.177 . . . . 9.42 105.122 -157.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.2 mtm . . . . . 0 N--CA 1.467 0.396 0 N-CA-C 107.382 -1.34 . . . . 10.86 107.382 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.68 145.75 19.12 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 108.765 -1.734 . . . . 5.33 108.765 -167.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -87.47 -167.4 1.87 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.178 0.591 . . . . 4.99 111.202 -176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.51 47.92 0.5 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.572 -1.011 . . . . 3.96 110.572 170.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.347 1.2 m 20.84 80.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 128.256 2.622 . . . . 4.12 113.161 -177.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -74.07 99.28 3.3 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.557 -1.275 . . . . 3.85 107.557 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -78.22 117.94 19.97 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.848 0.356 . . . . 2.59 110.046 169.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 pp -108.21 133.99 51.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.544 -1.28 . . . . 3.0 107.544 160.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.1 t -85.63 136.67 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 105.563 -2.014 . . . . 2.6 105.563 169.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -156.38 112.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 108.499 -0.926 . . . . 3.73 108.499 -163.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -96.89 178.71 5.2 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.326 -0.99 . . . . 5.49 108.326 174.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.08 -36.99 4.04 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.375 -1.09 . . . . 1.02 110.375 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.6 ptp -57.08 123.11 14.08 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.811 -0.811 . . . . 3.42 108.811 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.0 t -149.07 21.54 0.97 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.368 0.507 . . . . 2.87 112.368 -167.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.5 t -162.98 142.74 9.0 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 106.097 -1.816 . . . . 4.73 106.097 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.58 -49.27 5.46 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.755 1.222 . . . . 2.3 111.817 -173.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -37.2 -47.45 0.79 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.082 1.753 . . . . 2.37 112.45 174.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.7 m -52.62 -43.62 65.5 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 124.102 0.961 . . . . 2.38 110.864 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.9 t -54.62 -61.49 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.479 -0.934 . . . . 2.09 108.479 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -24.66 67.02 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.241 -0.89 . . . . 1.8 109.792 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -65.25 -52.73 52.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.977 0.808 . . . . 5.6 108.96 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.7 mt -58.79 -54.49 32.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.834 -1.173 . . . . 1.73 107.834 -172.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -38.35 -69.34 0.12 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.369 1.468 . . . . 3.16 111.588 165.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -53.21 -50.35 64.89 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.642 1.177 . . . . 2.15 110.71 -171.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -33.13 73.56 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.154 1.382 . . . . 1.27 110.469 -177.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.8 mt -77.25 -47.54 19.86 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.828 0.451 . . . . 3.1 111.155 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.4 p -66.99 74.57 0.11 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.578 1.151 . . . . 1.78 110.079 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 163.13 -9.63 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.501 2.72 . . . . 4.49 113.284 -171.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -69.67 -101.45 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 121.76 2.073 . . . . 3.07 110.01 170.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -167.8 158.85 11.19 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.059 -2.2 . . . . 7.08 105.059 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.11 -58.44 2.3 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.688 -0.565 . . . . 1.99 111.688 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -38.74 99.92 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 126.905 2.082 . . . . 3.26 111.258 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.4 mt -82.46 -44.64 15.76 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.497 1.919 . . . . 3.79 108.694 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -145.36 150.12 36.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.218 1.007 . . . . 3.5 109.926 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -131.24 154.48 48.41 Favored 'General case' 0 C--O 1.231 0.082 0 N-CA-C 107.01 -1.478 . . . . 1.97 107.01 169.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.7 m -152.41 141.93 21.72 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.044 -0.725 . . . . 2.58 109.044 150.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 m -119.59 168.19 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.365 0.666 . . . . 2.69 111.355 170.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.01 139.66 13.78 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.631 0.772 . . . . 1.97 109.853 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.32 -36.05 22.84 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.994 0.918 . . . . 2.66 112.236 -172.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.29 -39.04 81.7 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.67 -0.493 . . . . 2.14 109.67 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 t -97.17 -4.63 38.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.151 -0.928 . . . . 3.36 111.394 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.38 61.3 2.06 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.221 1.808 . . . . 4.01 109.13 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -135.27 145.36 47.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.736 -1.12 . . . . 2.33 108.614 -171.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.84 123.44 35.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.14 -1.43 . . . . 1.8 107.14 164.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -103.92 130.69 51.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.098 -1.075 . . . . 1.82 108.098 169.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.85 124.35 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.746 -0.835 . . . . 2.0 108.746 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -97.48 82.16 3.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.743 0.817 . . . . 2.94 108.869 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -122.77 151.18 41.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.749 1.22 . . . . 3.54 109.956 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.77 114.06 22.01 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 109.511 -0.552 . . . . 3.25 109.511 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.95 -25.85 59.32 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.046 1.831 . . . . 1.19 113.225 -176.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -54.5 -30.36 53.1 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.839 1.256 . . . . 4.11 113.453 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 pt -105.57 -92.74 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.366 0.666 . . . . 2.15 111.854 -172.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 tt -49.7 -52.37 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.982 1.313 . . . . 2.35 112.291 -174.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.44 162.1 35.5 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.992 0.806 . . . . 0.87 111.831 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.2 -36.78 27.31 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.795 2.997 . . . . 0.96 112.776 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -56.64 -45.69 81.44 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.689 0.625 . . . . 7.22 112.689 -173.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -54.42 -57.48 11.14 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 122.15 0.976 . . . . 3.01 109.538 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.4 mt -49.7 -62.46 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.329 1.452 . . . . 1.91 109.725 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.6 mt -52.81 -52.77 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 122.755 0.422 . . . . 2.26 110.201 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -68.7 -30.66 69.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.119 0.418 . . . . 4.11 111.746 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.9 m -65.69 -52.18 53.51 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.567 -0.708 . . . . 2.13 109.313 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 mm -65.31 -33.64 65.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 121.742 -0.599 . . . . 2.91 111.174 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -54.32 -58.64 6.63 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.787 1.235 . . . . 3.0 108.712 166.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.8 t -60.04 -26.5 66.17 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.083 0.953 . . . . 2.03 113.57 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.81 -20.47 61.63 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.382 0.992 . . . . 3.86 111.9 172.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.87 38.75 5.4 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.222 -1.151 . . . . 1.2 110.222 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -126.32 163.2 23.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.082 -1.821 . . . . 3.72 106.082 171.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.14 83.58 8.21 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 119.375 0.989 . . . . 3.9 112.96 -172.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.89 147.51 24.3 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.374 2.049 . . . . 1.56 112.224 -175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.3 m -154.37 144.29 21.79 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.157 1.383 . . . . 2.69 108.311 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.2 mt -61.84 143.94 55.59 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.862 0.465 . . . . 4.65 111.052 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.3 t -67.31 -46.98 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 109.744 -0.465 . . . . 5.44 109.744 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -62.46 135.0 57.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.769 -0.456 . . . . 7.93 109.769 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 72.8 mt -116.06 126.75 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 105.113 -2.18 . . . . 8.9 105.113 169.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 . . . . . 0 C--O 1.252 1.23 0 C-N-CA 124.518 1.127 . . . . 14.49 109.303 -173.641 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptm . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 110.361 -0.237 . . . . 7.69 110.361 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.65 -161.78 38.95 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.843 -0.903 . . . . 5.05 110.843 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -83.66 -40.69 18.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.476 1.11 . . . . 4.79 109.468 168.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.78 74.6 1.19 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 109.767 -1.333 . . . . 2.21 109.767 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 t -79.22 130.73 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.84 -0.8 . . . . 3.4 108.84 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.8 tp -129.86 138.31 50.9 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.407 -1.331 . . . . 2.9 107.407 164.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -110.9 137.69 48.22 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.784 1.234 . . . . 2.46 109.535 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.04 128.15 20.79 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.848 -0.797 . . . . 2.5 108.848 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.0 t -65.35 145.15 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 107.619 -1.252 . . . . 2.24 107.619 167.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.42 98.16 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 125.767 1.627 . . . . 2.48 107.68 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -63.57 162.94 12.0 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.972 -0.751 . . . . 4.9 108.972 160.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.47 -0.32 46.46 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.866 1.222 . . . . 1.42 113.014 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.2 mtm -73.64 75.76 1.52 Allowed 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.336 -1.096 . . . . 2.22 112.097 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.9 p -67.54 81.58 0.17 Allowed 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 121.686 -0.634 . . . . 5.59 109.892 168.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 t 72.75 176.28 0.27 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.04 1.736 . . . . 3.87 112.253 165.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.7 -36.11 4.71 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 126.363 1.865 . . . . 2.64 112.667 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -41.22 -60.63 1.19 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.673 1.189 . . . . 3.41 110.845 168.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.4 m -68.19 -31.54 71.14 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.532 -0.73 . . . . 1.85 111.675 -176.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.0 t -57.04 -56.26 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.887 -0.783 . . . . 2.15 108.887 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -30.49 71.07 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.709 -0.619 . . . . 1.65 110.626 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -50.58 72.42 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.333 -0.988 . . . . 4.64 108.333 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.5 mt -62.52 -65.18 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 107.207 -1.405 . . . . 2.24 107.207 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -46.53 -57.12 5.03 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.855 0.862 . . . . 3.64 110.151 -174.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -56.79 -49.56 74.96 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.354 -0.839 . . . . 2.21 109.283 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.7 t -65.67 -29.38 69.92 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 118.993 -0.527 . . . . 1.23 111.811 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.63 -44.25 67.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.76 0.709 . . . . 3.78 111.648 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.8 p -54.56 -21.54 10.55 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.649 0.981 . . . . 2.13 113.649 -172.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.12 -4.49 58.83 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 115.064 1.505 . . . . 5.39 115.064 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -67.11 122.94 18.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.869 1.213 . . . . 2.63 110.162 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -71.0 73.43 0.61 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.679 1.192 . . . . 8.13 111.176 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.39 -2.42 0.8 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.887 1.232 . . . . 1.27 112.62 -177.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.94 150.14 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 125.075 1.35 . . . . 2.99 108.282 170.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.1 tp -111.4 -48.12 3.12 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.278 1.831 . . . . 4.16 110.055 172.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -157.34 155.14 30.12 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.357 1.063 . . . . 4.15 108.32 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.43 163.95 28.54 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.169 -1.048 . . . . 3.33 108.169 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -162.56 103.14 1.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.82 -1.178 . . . . 2.63 107.82 170.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.7 147.21 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 C-N-CA 124.997 1.319 . . . . 3.02 110.641 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.97 137.14 16.46 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.764 0.792 . . . . 2.15 111.601 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 pp -77.7 -23.22 49.56 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.29 -0.868 . . . . 2.45 111.967 -176.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.14 -41.15 97.98 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.245 -0.65 . . . . 2.2 109.245 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -86.34 -31.21 21.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.565 -0.743 . . . . 3.18 109.909 172.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 77.68 44.3 0.09 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.63 1.972 . . . . 4.04 107.75 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -140.17 146.76 39.18 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.944 -0.391 . . . . 2.54 109.944 -167.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.98 127.1 55.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.136 1.375 . . . . 1.76 107.359 162.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.19 141.74 32.62 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.914 -1.143 . . . . 1.29 107.914 155.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.73 136.47 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 107.572 -1.27 . . . . 2.36 107.572 170.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -100.61 125.37 47.0 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.421 -1.696 . . . . 3.21 106.421 160.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -166.57 142.04 4.47 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 128.126 2.571 . . . . 3.12 107.267 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -71.61 125.54 91.71 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 118.833 -1.147 . . . . 3.83 108.93 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -82.67 -9.78 10.96 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.745 2.296 . . . . 1.3 113.275 -173.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.92 -44.08 11.31 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.255 0.934 . . . . 4.18 109.191 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 pt -67.41 -54.66 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 112.716 0.635 . . . . 2.66 112.716 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.5 tt -105.14 -58.08 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.84 0.856 . . . . 2.8 111.653 -173.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.04 161.6 27.55 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.579 0.609 . . . . 0.77 113.905 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.78 -36.48 6.24 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.048 3.165 . . . . 0.78 112.983 -171.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.5 ttm105 -55.39 -47.11 76.35 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.768 0.427 . . . . 5.8 111.186 -173.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -47.36 -61.4 1.93 Allowed 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.477 1.511 . . . . 2.79 110.312 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.5 mt -51.09 -63.34 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.127 0.971 . . . . 1.81 109.791 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.7 mt -51.86 -52.66 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.235 0.471 . . . . 2.13 110.689 -173.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -64.18 -34.38 77.95 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.99 0.814 . . . . 3.58 112.272 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.4 m -61.01 -53.13 61.01 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.355 -0.841 . . . . 1.88 109.888 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.2 mm -61.56 -38.44 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 O-C-N 121.667 -0.645 . . . . 2.72 110.693 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -55.76 -59.7 4.49 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.954 1.301 . . . . 2.77 108.803 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.5 t -52.37 -40.49 62.08 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.587 1.155 . . . . 1.8 111.739 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.7 mt -70.32 5.38 1.76 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.466 0.913 . . . . 3.01 113.466 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.19 45.98 5.45 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 119.069 0.849 . . . . 0.93 111.249 169.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -135.74 174.69 10.33 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.046 0.938 . . . . 3.13 109.782 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -113.59 68.34 1.4 Allowed Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.892 0.701 . . . . 3.61 112.892 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.76 85.09 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.194 3.263 . . . . 1.1 112.503 -174.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.2 m -101.3 125.54 47.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.726 1.611 . . . . 2.92 108.177 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -56.06 134.86 52.89 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.154 -0.684 . . . . 4.68 109.154 175.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.7 p -74.35 -50.58 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 110.399 -0.222 . . . . 4.82 110.399 -173.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -177.81 177.22 1.11 Allowed 'General case' 0 C--O 1.233 0.216 0 C-N-CA 127.821 2.448 . . . . 8.08 105.693 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.15 155.72 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 106.932 -1.506 . . . . 9.18 106.932 166.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 . . . . . 0 C--O 1.25 1.102 0 N-CA-C 104.448 -2.427 . . . . 11.38 104.448 172.439 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 105.306 -2.109 . . . . 9.88 105.306 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -173.96 50.05 0.15 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 107.68 -2.168 . . . . 4.29 107.68 -177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -165.93 167.7 16.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.548 1.539 . . . . 4.73 108.571 -154.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.97 -130.42 2.2 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 109.539 -1.424 . . . . 3.16 109.539 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 m -136.06 162.73 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.059 -1.459 . . . . 3.29 107.059 157.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tt -153.08 82.3 1.2 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 103.618 -2.734 . . . . 4.04 103.618 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.0 152.81 42.19 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.882 -0.727 . . . . 3.4 110.438 -169.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.39 133.92 50.33 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.125 -1.435 . . . . 2.57 107.125 168.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.61 136.14 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.441 -2.059 . . . . 2.01 105.441 153.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 m -134.92 134.97 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.573 -1.269 . . . . 2.48 107.573 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -117.2 173.73 6.51 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.737 -0.838 . . . . 6.51 108.737 170.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.24 -22.93 37.21 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 110.916 -0.874 . . . . 1.23 110.916 -172.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.2 mtm -60.1 151.81 25.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.554 0.677 . . . . 2.21 109.583 170.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -158.45 -58.27 0.07 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.472 -0.566 . . . . 2.89 109.472 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.3 t -73.38 140.45 46.63 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.206 -0.664 . . . . 4.61 109.206 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.35 -43.94 5.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.022 0.929 . . . . 2.01 111.728 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 m -41.21 -47.32 3.31 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.422 1.089 . . . . 2.27 111.811 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.7 m -45.44 -49.1 13.63 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 118.992 0.815 . . . . 1.79 110.671 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.8 t -52.32 -59.49 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.646 0.778 . . . . 2.38 109.694 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.21 -36.57 71.03 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.418 1.087 . . . . 2.37 109.37 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -61.47 -49.78 75.4 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.375 -0.602 . . . . 5.35 109.375 -174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.9 mt -63.33 -53.27 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.167 -1.049 . . . . 2.17 108.167 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -48.04 -59.98 2.96 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.089 0.956 . . . . 3.15 110.016 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.1 m -66.31 -43.25 86.78 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.027 0.931 . . . . 3.3 109.99 -173.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.5 t -57.23 -38.31 73.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.862 -0.59 . . . . 1.37 110.222 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 mt -75.53 -51.09 13.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.385 -0.817 . . . . 3.56 112.48 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.9 p -68.18 73.28 0.2 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.466 0.706 . . . . 2.1 110.277 -172.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.405 ' HZ3' ' CD2' ' A' ' 29' ' ' HIS . 1.8 pptp? 177.84 -33.93 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.633 2.773 . . . . 4.35 111.638 -171.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.405 ' CD2' ' HZ3' ' A' ' 28' ' ' LYS . 10.2 m-70 -44.41 -76.95 0.02 OUTLIER 'General case' 0 C--N 1.348 0.515 0 N-CA-C 113.904 1.076 . . . . 3.59 113.904 -171.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 ptt85 171.01 134.05 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 104.924 -2.25 . . . . 12.22 104.924 -172.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.76 -59.66 2.98 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 118.774 0.716 . . . . 2.57 113.216 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -33.89 116.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 127.432 2.293 . . . . 2.92 111.605 177.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 72.2 mt -89.03 -46.32 8.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.357 1.063 . . . . 4.17 110.52 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -154.45 152.13 29.78 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.947 0.899 . . . . 3.73 108.946 -173.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.1 m -125.7 160.75 28.93 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.761 -1.2 . . . . 1.88 107.761 168.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.1 t -146.64 120.42 9.25 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.108 -1.071 . . . . 2.54 108.108 155.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 t -102.69 150.87 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 124.519 1.127 . . . . 3.51 108.584 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.16 135.11 20.15 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.598 -0.689 . . . . 1.76 110.465 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -73.35 -49.85 25.13 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.29 -0.868 . . . . 2.83 111.148 -172.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.98 -48.42 80.03 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.586 0.707 . . . . 2.0 110.376 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.64 -16.54 62.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.35 1.06 . . . . 2.58 111.1 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 50.76 42.07 27.09 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.886 1.274 . . . . 3.59 108.117 -171.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -129.32 144.8 51.37 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 122.565 0.346 . . . . 2.32 110.957 -166.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.72 110.49 17.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.094 1.758 . . . . 1.87 107.393 161.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.92 142.7 27.42 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 107.471 -1.307 . . . . 1.66 107.471 166.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.58 128.56 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 108.169 -1.048 . . . . 2.34 108.169 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -93.85 74.72 4.22 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 126.43 1.892 . . . . 3.08 108.926 171.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -119.32 179.43 4.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.437 1.495 . . . . 3.8 113.434 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.18 88.3 31.94 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 130.774 3.63 . . . . 4.07 108.097 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -61.16 -22.23 74.04 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.963 2.442 . . . . 1.58 112.892 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -57.52 -30.74 65.4 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 118.911 -0.566 . . . . 3.03 112.051 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.9 pt -114.15 -54.43 4.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 N-CA-C 113.976 1.102 . . . . 2.23 113.976 -173.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.6 tt -74.02 -63.35 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.496 -0.927 . . . . 2.85 108.496 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.2 147.91 23.38 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.128 -0.942 . . . . 1.13 111.553 173.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -54.11 -43.74 55.65 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.985 3.124 . . . . 1.03 111.753 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -56.61 -51.85 67.08 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.048 0.539 . . . . 6.47 112.35 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -47.32 -55.38 8.9 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.087 1.355 . . . . 2.61 109.391 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.1 mt -56.42 -65.11 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 114.687 -1.142 . . . . 2.17 110.406 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.2 mt -48.37 -52.86 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.259 1.024 . . . . 2.15 109.81 -173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -68.92 -30.41 68.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 111.839 0.311 . . . . 3.87 111.839 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.8 m -67.32 -51.42 52.73 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.613 -0.835 . . . . 2.25 109.905 173.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.2 mm -64.17 -33.67 63.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.748 -0.595 . . . . 3.06 111.092 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -55.11 -60.32 3.54 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.918 1.287 . . . . 2.81 108.607 167.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -52.66 -38.54 60.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.862 1.265 . . . . 1.82 112.759 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -55.22 -22.84 19.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.925 0.713 . . . . 3.99 112.925 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.39 46.66 1.4 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.121 -1.192 . . . . 0.99 110.121 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -132.63 168.49 18.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.333 -1.358 . . . . 2.9 107.333 172.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -112.47 88.14 10.57 Favored Pre-proline 0 N--CA 1.454 -0.231 0 CA-C-O 118.515 -0.755 . . . . 3.88 109.324 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.45 151.65 22.85 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.578 2.185 . . . . 1.58 111.944 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.5 m -157.75 145.97 19.0 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.662 1.585 . . . . 3.18 107.386 170.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mp -55.25 133.93 49.57 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.038 -0.727 . . . . 4.55 109.038 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.46 -49.26 84.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 118.852 0.751 . . . . 5.77 111.161 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.6 tttp 65.77 172.7 0.23 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.234 1.014 . . . . 8.74 110.454 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.4 mt -131.41 -67.06 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.284 -1.376 . . . . 7.24 107.284 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--O 1.253 1.251 0 CA-C-O 115.818 -2.039 . . . . 11.17 109.154 -171.423 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mtp . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 118.771 -0.633 . . . . 7.36 110.031 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -82.64 -74.2 1.2 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.249 -1.54 . . . . 4.77 109.249 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -157.85 175.59 13.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.162 -1.422 . . . . 3.93 107.162 166.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.59 172.7 22.4 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 106.852 -2.499 . . . . 1.86 106.852 161.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.15 146.73 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 108.533 -0.914 . . . . 3.68 108.533 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 tt -134.59 115.5 13.93 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.453 -1.314 . . . . 3.38 107.453 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.407 ' OE1' ' NZ ' ' A' ' 43' ' ' LYS . 51.1 mt-10 -89.74 84.85 6.31 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.071 1.348 . . . . 2.67 108.89 174.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.61 132.04 34.24 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.961 -1.126 . . . . 2.64 107.961 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -74.17 149.57 7.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 106.038 -1.838 . . . . 2.09 106.038 164.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -152.69 54.58 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 127.082 2.153 . . . . 2.21 107.696 -169.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -56.84 157.33 5.67 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.779 -0.646 . . . . 6.5 109.338 171.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.48 -37.99 3.55 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 107.851 -2.099 . . . . 1.24 107.851 -162.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 40.5 mtp -53.03 143.63 16.96 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.331 -0.988 . . . . 2.59 108.331 157.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.9 t -168.08 -56.24 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.422 -0.955 . . . . 4.85 108.422 -174.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.8 t -86.9 171.39 10.85 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.466 -0.938 . . . . 3.05 108.466 172.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.81 -166.07 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.467 -0.568 . . . . 2.81 109.467 160.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.5 m 71.79 -60.23 0.53 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.433 1.093 . . . . 2.79 109.728 -171.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 77.7 m -36.98 -53.04 0.97 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 126.123 1.769 . . . . 1.48 109.875 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.6 t -36.08 -66.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.899 1.28 . . . . 1.84 111.336 173.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -26.02 56.26 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.124 -0.36 . . . . 1.31 111.073 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -51.78 -41.64 61.8 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 124.157 0.983 . . . . 4.07 108.786 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.2 mt -77.7 -70.3 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 107.234 -1.395 . . . . 2.23 107.234 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -47.17 -55.92 7.6 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.746 1.218 . . . . 3.29 112.165 -166.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.8 t -58.15 -49.22 77.76 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.097 -0.705 . . . . 2.11 109.097 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.8 t -62.62 -50.16 72.33 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 122.029 -0.42 . . . . 1.07 110.11 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.02 -36.79 80.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.575 -1.328 . . . . 3.41 111.547 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.1 p -57.67 -17.21 13.59 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.55 0.945 . . . . 1.87 113.55 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -62.25 -33.89 75.47 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.267 0.939 . . . . 4.56 111.641 171.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.504 ' CE1' ' HG1' ' A' ' 61' ' ' THR . 45.5 m-70 -73.34 76.09 1.37 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.127 0.571 . . . . 2.71 110.868 -173.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 mtm105 -42.39 99.87 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.062 1.345 . . . . 6.42 110.668 169.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.39 -44.66 0.86 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.413 -1.875 . . . . 1.74 108.413 -168.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.93 144.83 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 106.303 -1.74 . . . . 2.74 106.303 142.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -105.02 -57.88 1.97 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.969 1.308 . . . . 4.45 107.526 163.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -136.77 144.8 43.95 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.81 0.844 . . . . 2.99 110.886 -172.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.8 m -114.82 158.12 22.34 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 124.488 1.115 . . . . 2.87 108.013 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.0 t -150.97 76.23 1.23 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.697 -0.853 . . . . 3.61 108.697 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.1 t -81.35 136.19 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 125.292 1.437 . . . . 3.53 109.742 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.14 130.23 22.03 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.747 0.819 . . . . 1.93 111.357 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.53 -51.39 36.06 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 124.197 0.999 . . . . 2.62 111.308 -171.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.65 -44.86 90.23 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.537 0.684 . . . . 2.0 110.344 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -13.53 62.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.577 0.751 . . . . 2.62 110.922 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 52.95 33.45 14.65 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.762 1.225 . . . . 3.56 109.561 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.407 ' NZ ' ' OE1' ' A' ' 7' ' ' GLU . 13.0 ttmt -128.83 150.71 50.21 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.673 -0.491 . . . . 2.42 109.673 -164.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.84 123.24 36.86 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.372 -0.973 . . . . 2.08 108.372 153.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 129.65 34.65 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 104.459 -2.423 . . . . 1.59 104.459 159.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.8 mt -114.15 133.97 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 107.425 -1.324 . . . . 3.36 107.425 168.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -118.64 99.13 6.6 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.677 2.791 . . . . 5.28 105.297 -170.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -151.71 157.23 41.77 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 126.633 1.973 . . . . 3.37 109.425 -157.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -82.29 123.09 79.54 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 119.365 0.984 . . . . 3.85 108.553 171.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.08 -2.96 12.42 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.625 2.216 . . . . 1.44 113.61 -173.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -100.23 -51.01 3.77 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.174 0.897 . . . . 3.11 109.196 -176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 pt -69.19 -54.52 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.777 0.323 . . . . 2.28 111.701 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.5 tt -91.06 -49.81 13.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 124.199 1.0 . . . . 2.09 109.739 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.65 154.58 5.75 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 111.667 -0.573 . . . . 0.97 111.667 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.76 -25.35 28.68 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.655 2.237 . . . . 0.87 112.862 -172.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -55.19 -48.91 73.15 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.395 0.543 . . . . 7.22 111.121 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -54.48 -58.53 7.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 122.475 1.131 . . . . 2.78 109.709 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.2 mt -48.82 -56.57 2.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 125.855 1.662 . . . . 2.13 111.711 175.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.7 -50.86 64.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.863 -0.421 . . . . 2.48 109.863 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.08 -39.83 83.38 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.145 0.578 . . . . 6.38 110.921 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.504 ' HG1' ' CE1' ' A' ' 29' ' ' HIS . 36.5 m -58.52 -56.82 17.21 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.542 -0.724 . . . . 2.48 109.57 173.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.9 mt -63.64 -41.12 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 119.031 0.832 . . . . 3.38 111.413 -172.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -45.73 -58.35 3.54 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.256 1.023 . . . . 3.51 108.858 168.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t -61.54 -30.19 70.48 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.87 0.692 . . . . 2.16 112.87 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.92 -34.67 69.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.369 0.986 . . . . 2.85 110.717 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.37 51.34 0.29 Allowed Glycine 0 C--N 1.334 0.445 0 O-C-N 123.863 0.727 . . . . 1.11 112.068 160.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -140.67 170.66 15.36 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 106.345 -1.724 . . . . 3.22 106.345 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.67 86.19 0.42 Allowed Pre-proline 0 N--CA 1.466 0.367 0 CA-C-O 117.167 -1.397 . . . . 4.48 114.248 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.69 76.4 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.504 2.803 . . . . 1.57 112.244 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 p -90.62 128.43 36.61 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.288 1.435 . . . . 2.52 108.669 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 121.4 15.86 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.87 -1.159 . . . . 4.48 107.87 169.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.1 t -142.74 -60.21 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 124.293 1.037 . . . . 4.94 108.61 -174.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt 64.54 -72.17 0.07 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.731 1.213 . . . . 8.41 111.534 -173.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.5 mm -82.27 115.08 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.016 -1.105 . . . . 6.89 108.016 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 C--O 1.25 1.098 0 N-CA-C 103.327 -2.842 . . . . 12.65 103.327 174.534 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 mtt . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 108.802 -0.814 . . . . 10.4 108.802 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.71 -105.02 0.96 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 107.96 -2.056 . . . . 6.23 107.96 -174.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -164.01 158.54 19.66 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.168 1.387 . . . . 4.67 107.426 164.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.93 144.7 18.3 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 107.601 -2.2 . . . . 1.85 107.601 167.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.6 t -127.65 117.76 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.118 -1.438 . . . . 3.72 107.118 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.1 tt -138.03 97.29 3.37 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.06 -1.83 . . . . 3.6 106.06 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -83.2 135.5 34.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.487 -0.324 . . . . 2.41 110.354 -174.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.46 139.04 54.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.532 -0.914 . . . . 3.28 108.532 175.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.16 116.4 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 106.461 -1.681 . . . . 1.92 106.461 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 m -104.38 83.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 106.395 -1.705 . . . . 2.38 106.395 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -65.3 136.52 56.67 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.999 -0.741 . . . . 6.24 108.999 -169.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.76 -2.09 10.09 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.463 -0.632 . . . . 1.66 113.701 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 73.9 mtm -68.64 79.25 0.28 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.981 1.391 . . . . 2.28 111.038 174.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 t -50.39 -52.9 33.42 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.532 1.133 . . . . 3.75 112.661 -172.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -170.04 -103.16 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.346 0.658 . . . . 6.72 109.557 176.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.67 168.98 18.75 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.595 0.634 . . . . 3.05 110.625 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.0 m 69.53 -62.63 0.41 Allowed 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 126.067 1.747 . . . . 2.08 110.004 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.9 m -37.36 -51.42 1.09 Allowed 'General case' 0 N--CA 1.458 -0.044 0 C-N-CA 127.068 2.147 . . . . 2.28 111.492 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.9 t -45.56 -70.77 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.232 1.013 . . . . 2.01 110.156 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -23.76 67.29 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.873 -0.517 . . . . 1.32 111.171 -175.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -59.03 -52.19 66.82 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.718 -1.216 . . . . 3.89 107.718 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.3 mt -75.34 -56.42 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 108.583 -0.895 . . . . 2.16 108.583 -174.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -38.0 -65.87 0.3 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.186 1.394 . . . . 3.49 112.02 170.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.2 t -62.72 -38.58 91.02 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.928 0.491 . . . . 2.42 110.373 -174.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.6 t -65.62 -24.94 67.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 118.973 -0.537 . . . . 1.34 111.702 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.8 mt -86.75 -44.87 11.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.05 0.94 . . . . 3.4 112.277 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.4 p -72.01 61.63 0.43 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.179 0.992 . . . . 2.06 111.183 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.34 -26.67 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.714 1.606 . . . . 4.57 113.132 -165.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -67.99 -128.72 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 119.621 1.1 . . . . 2.6 110.169 172.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -144.97 163.17 34.99 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 129.503 3.121 . . . . 7.0 104.757 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.41 -61.39 2.75 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.192 -0.763 . . . . 2.24 111.192 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -51.52 111.59 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 117.842 0.821 . . . . 3.54 109.102 172.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 pp -107.71 -23.54 12.06 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.602 1.561 . . . . 3.49 110.962 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -145.32 158.97 43.71 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.842 -0.799 . . . . 3.83 108.842 167.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.7 t -153.48 145.97 24.08 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.003 -1.11 . . . . 2.05 108.003 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 p -150.51 132.52 15.22 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.387 -0.968 . . . . 3.41 108.387 169.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.38 125.13 67.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.247 0.619 . . . . 3.18 111.395 170.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.97 128.04 44.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.279 0.632 . . . . 2.47 110.397 172.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -72.95 -52.55 14.13 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.91 -1.041 . . . . 3.09 111.436 -165.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.44 87.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 121.614 0.721 . . . . 3.09 109.72 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -77.17 -6.36 52.66 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.71 -0.677 . . . . 3.01 110.573 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 56.55 31.53 19.22 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 125.235 1.414 . . . . 3.03 110.146 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -108.66 125.64 52.1 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 121.841 -0.537 . . . . 3.24 109.919 -164.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.5 121.98 37.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.454 1.102 . . . . 2.22 108.558 167.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.72 114.21 28.23 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 103.615 -2.735 . . . . 1.72 103.615 168.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.8 mp -111.37 132.5 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 106.392 -1.707 . . . . 2.01 106.392 173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -101.23 98.76 9.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.44 -1.689 . . . . 4.2 106.44 169.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -140.53 155.27 46.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.816 0.846 . . . . 3.7 112.006 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.73 111.01 19.62 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 108.429 -0.952 . . . . 3.09 108.429 166.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.97 -21.8 36.66 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.944 2.429 . . . . 1.31 112.72 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -46.61 -54.62 9.11 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.132 1.373 . . . . 3.49 109.773 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pt -90.36 -71.13 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 124.92 1.288 . . . . 2.55 112.38 -166.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.2 tt -67.01 -62.93 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.912 -0.773 . . . . 2.98 108.912 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.47 159.44 23.5 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 115.701 -0.681 . . . . 1.16 112.205 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -54.83 -40.16 86.44 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 124.08 3.187 . . . . 1.4 111.337 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -35.51 -65.04 0.26 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.582 1.953 . . . . 10.95 113.516 175.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -60.47 -54.01 50.61 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.024 0.93 . . . . 3.03 108.546 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 88.7 mt -49.33 -57.62 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.282 0.633 . . . . 2.22 109.542 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.5 mt -54.81 -52.87 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.76 -0.587 . . . . 2.65 110.835 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -58.72 -45.01 90.54 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.095 0.95 . . . . 4.02 110.55 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 54.2 m -69.31 -50.59 45.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.956 -0.757 . . . . 1.91 108.956 -174.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.61 -33.7 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 118.798 -0.62 . . . . 3.1 110.919 -177.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -53.01 -58.12 8.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.886 -0.783 . . . . 4.09 108.886 165.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.4 t -58.84 -27.5 65.18 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.247 0.832 . . . . 2.24 113.247 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 25.0 mt -69.35 -10.1 56.41 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.511 1.05 . . . . 2.84 112.808 174.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.45 50.43 2.19 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 124.466 1.031 . . . . 1.03 111.256 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -142.07 171.71 13.68 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 124.739 1.216 . . . . 3.56 107.877 172.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -110.74 84.55 4.23 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.68 -0.676 . . . . 4.48 110.992 -175.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.3 128.08 15.91 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.047 2.498 . . . . 1.9 112.52 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.2 p -138.54 129.63 26.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.627 1.571 . . . . 2.69 107.736 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -64.97 141.81 58.65 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.245 -0.65 . . . . 4.36 109.245 177.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.4 t -140.65 -47.33 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 C-N-CA 122.385 0.274 . . . . 4.14 111.191 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp 59.13 -131.71 1.06 Allowed 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.062 -1.458 . . . . 6.75 107.062 -163.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.8 mp -131.57 -71.23 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 121.432 1.924 . . . . 9.57 107.206 171.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 . . . . . 0 C--O 1.25 1.13 0 N-CA-C 102.044 -3.317 . . . . 10.2 102.044 138.583 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.7 ttm . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 108.963 -0.754 . . . . 12.14 108.963 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.85 -152.43 5.84 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 107.135 -2.386 . . . . 4.41 107.135 168.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -161.49 169.09 22.48 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.082 -2.192 . . . . 4.47 105.082 169.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.34 80.42 0.15 Allowed Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 106.328 -2.709 . . . . 2.77 106.328 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.1 t -67.14 73.44 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.966 1.306 . . . . 2.97 108.956 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.82 111.97 21.96 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.73 -1.211 . . . . 3.16 107.73 -170.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -85.21 123.48 30.76 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 123.622 0.576 . . . . 2.42 109.612 169.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.21 124.91 44.07 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.584 -2.006 . . . . 2.91 105.584 167.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -82.93 111.32 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 105.698 -1.964 . . . . 2.39 105.698 171.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 m -96.9 77.38 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 125.062 1.345 . . . . 2.41 109.079 -163.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -67.14 107.21 2.24 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.284 1.034 . . . . 7.76 108.892 -166.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.1 -40.76 0.27 Allowed Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.151 -0.805 . . . . 1.59 113.543 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -62.77 162.88 10.17 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 119.182 1.491 . . . . 2.3 111.169 -178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.9 t -163.98 -56.86 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.245 -1.02 . . . . 3.89 108.245 -175.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.5 m -81.82 172.74 12.99 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.389 0.676 . . . . 4.09 109.818 176.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.88 -172.27 0.17 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.059 -0.519 . . . . 3.14 109.76 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.8 m 71.55 -61.89 0.47 Allowed 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 124.68 1.192 . . . . 2.16 110.286 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.2 m -34.62 -51.74 0.49 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.903 1.681 . . . . 1.78 112.081 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.0 t -48.42 -59.66 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.817 0.847 . . . . 2.24 111.197 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -32.03 73.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.718 -0.613 . . . . 2.12 109.41 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -60.46 -45.75 92.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.553 -0.906 . . . . 4.64 108.553 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.95 -62.16 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.817 -1.549 . . . . 1.92 106.817 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -47.59 -62.09 1.61 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.375 1.083 . . . . 3.96 110.812 -175.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.6 m -63.8 -44.43 93.34 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.835 -1.075 . . . . 3.24 109.34 -168.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.7 t -59.31 -51.63 69.12 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.234 -0.654 . . . . 1.39 109.234 175.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.99 -36.61 77.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.043 -1.036 . . . . 3.43 112.277 -175.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 78.1 p -55.51 -19.56 10.14 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.509 1.05 . . . . 1.98 113.755 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -61.16 -30.94 70.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.573 1.079 . . . . 4.5 111.491 175.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -77.9 63.33 2.9 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 124.495 1.118 . . . . 2.67 110.932 -164.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -28.45 -25.85 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 120.261 3.43 . . . . 7.73 120.261 -164.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.09 -16.3 68.51 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-N 120.64 1.563 . . . . 1.8 111.823 169.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.04 125.87 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 127.435 2.294 . . . . 2.76 108.467 171.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.4 mt -91.45 -48.06 7.09 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.699 1.199 . . . . 4.06 109.274 174.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -154.04 138.45 16.74 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 118.495 -0.764 . . . . 3.26 110.137 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.95 164.56 15.9 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 119.444 1.02 . . . . 2.81 108.664 167.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.0 m -157.44 112.86 2.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.432 -1.321 . . . . 2.46 107.432 162.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.61 154.09 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 O-C-N 123.518 0.511 . . . . 3.16 110.697 166.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.81 137.3 19.93 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 124.008 0.923 . . . . 2.21 110.629 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -74.72 -41.92 59.29 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 122.943 0.497 . . . . 2.45 111.762 -172.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.54 -34.7 74.51 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 122.744 0.418 . . . . 2.49 110.99 -173.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 t -100.86 -7.28 23.7 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.063 0.945 . . . . 3.7 110.791 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 53.19 22.9 2.83 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.282 1.833 . . . . 4.58 112.475 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -94.04 133.97 36.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.09 -1.448 . . . . 2.7 107.09 -172.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.17 112.99 23.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.777 -1.564 . . . . 1.73 106.777 160.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.29 138.46 36.35 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.322 -1.362 . . . . 1.26 107.322 165.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.62 131.14 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 109.132 -0.692 . . . . 2.14 109.132 170.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -103.81 88.51 3.07 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 127.365 2.266 . . . . 4.21 108.061 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -115.79 162.25 17.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.486 1.514 . . . . 3.68 110.282 171.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.04 106.89 4.49 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.187 0.595 . . . . 3.18 109.575 171.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -64.97 -22.53 62.57 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.046 1.831 . . . . 1.47 111.981 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -41.1 -44.49 2.49 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.376 1.87 . . . . 5.6 111.6 170.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.6 pt -113.94 -62.85 2.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 113.34 0.867 . . . . 2.11 113.34 -165.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 tt -88.73 -48.03 14.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.482 0.658 . . . . 2.8 110.4 -165.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.3 159.94 35.04 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 115.474 -0.785 . . . . 0.9 112.676 169.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.02 -42.14 25.18 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.477 3.452 . . . . 0.88 112.263 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -53.0 -51.23 62.3 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.41 0.684 . . . . 6.53 111.48 -172.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -47.97 -57.22 6.03 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.722 0.773 . . . . 2.79 110.435 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.4 mt -61.67 -48.62 87.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 124.821 1.248 . . . . 2.29 111.043 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.2 mt -52.85 -58.56 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.541 -0.541 . . . . 2.26 109.541 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -61.55 -31.74 71.78 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.077 0.551 . . . . 3.6 111.966 -176.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.2 m -58.99 -53.14 61.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.457 -0.777 . . . . 1.78 109.518 173.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.6 mt -73.38 -36.02 47.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 O-C-N 121.617 -0.677 . . . . 3.01 110.647 -173.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -48.39 -50.4 30.91 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.337 1.055 . . . . 3.31 108.924 166.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.4 t -66.27 -42.55 88.28 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.336 0.654 . . . . 1.57 112.001 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -59.37 -40.5 86.68 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.606 0.639 . . . . 2.83 109.897 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.46 46.96 0.47 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.346 -0.702 . . . . 1.14 111.346 164.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -140.91 141.31 34.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.805 -1.924 . . . . 3.96 105.805 168.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -94.27 106.23 21.97 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 118.186 -0.911 . . . . 5.59 112.25 -158.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.75 80.68 1.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.277 2.651 . . . . 1.45 110.838 -174.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.1 m -67.15 111.42 3.9 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.859 -1.163 . . . . 2.58 107.859 168.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 mt -60.42 139.52 57.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.921 -1.14 . . . . 4.51 107.921 166.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 50.5 t -114.5 -94.13 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 O-C-N 123.974 0.796 . . . . 4.06 109.069 -175.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt 71.0 -54.43 0.66 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.163 0.985 . . . . 8.08 109.695 -164.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.37 164.29 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.345 1.458 . . . . 7.32 107.413 159.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 C--O 1.249 1.075 0 N-CA-C 104.34 -2.467 . . . . 10.81 104.34 163.497 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 109.266 -0.642 . . . . 11.75 109.266 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.28 -163.9 54.87 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.209 -0.756 . . . . 3.82 111.209 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -25.02 88.0 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 129.239 3.015 . . . . 4.63 114.885 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.9 126.74 8.32 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 108.601 -1.799 . . . . 1.98 108.601 172.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.4 t -91.87 78.22 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 106.396 -1.705 . . . . 3.66 106.396 168.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.1 tt -84.33 115.21 22.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.672 -0.862 . . . . 3.52 108.672 -172.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -90.18 133.37 34.94 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.292 0.496 . . . . 2.69 111.227 172.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 pp -129.07 130.57 46.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.109 -1.441 . . . . 2.92 107.109 166.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.15 134.48 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.426 -2.065 . . . . 2.46 105.426 170.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.24 82.04 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.668 -1.604 . . . . 2.8 106.668 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -72.37 146.36 47.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.002 -1.481 . . . . 7.3 107.002 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.14 -36.44 4.4 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.87 -0.892 . . . . 1.22 110.87 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.6 ttp -57.72 133.34 55.27 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.286 -1.005 . . . . 3.14 108.286 167.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -153.48 -57.62 0.12 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.536 1.134 . . . . 3.12 110.264 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.2 t -67.46 140.13 57.08 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.314 -0.866 . . . . 4.64 110.342 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.69 -50.3 2.3 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.215 1.006 . . . . 2.51 112.155 175.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -43.72 -43.45 5.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.448 1.099 . . . . 2.09 111.768 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.2 m -46.48 -41.6 14.25 Favored 'General case' 0 C--N 1.338 0.104 0 C-N-CA 124.566 1.147 . . . . 1.83 111.116 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.5 t -54.16 -62.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.157 -0.683 . . . . 2.14 109.157 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -30.31 68.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.507 -0.746 . . . . 1.78 110.061 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.61 -51.41 67.23 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 107.435 -1.32 . . . . 3.92 107.435 177.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -68.84 -54.18 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.712 1.205 . . . . 2.09 108.584 -176.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -50.79 -61.11 2.41 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 108.724 -0.843 . . . . 4.58 108.724 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -60.17 -47.96 83.76 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.808 0.813 . . . . 2.53 109.715 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.4 t -66.96 -22.51 65.92 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 118.415 -0.802 . . . . 1.46 112.087 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.8 mt -82.3 -63.32 1.4 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 118.274 -0.87 . . . . 3.35 111.107 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.2 p -54.11 -28.37 39.15 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.286 0.948 . . . . 2.63 113.109 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -30.72 65.57 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.369 0.878 . . . . 4.83 113.369 173.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -70.9 72.49 0.56 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.694 -0.854 . . . . 2.84 108.694 164.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -13.23 -50.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 129.193 2.997 . . . . 6.46 116.713 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -43.22 -50.62 6.42 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.975 -0.903 . . . . 1.65 113.251 174.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.53 100.94 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.327 -1.36 . . . . 3.88 107.327 170.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.99 -34.65 32.86 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.699 0.4 . . . . 3.8 111.526 -176.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -148.17 120.35 8.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.628 1.171 . . . . 3.35 109.072 -175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 t -99.47 168.43 9.98 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.239 0.927 . . . . 2.53 108.807 170.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.3 m -145.97 66.2 1.21 Allowed 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 120.892 -1.13 . . . . 2.19 108.846 160.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.7 p -58.06 138.47 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.312 -0.858 . . . . 3.12 111.624 161.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.71 137.69 16.33 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.697 1.199 . . . . 2.5 110.31 175.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.12 -34.33 61.67 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.479 0.712 . . . . 2.73 111.365 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.58 -31.35 71.4 Favored 'General case' 0 C--O 1.226 -0.155 0 O-C-N 121.838 -0.539 . . . . 3.02 110.77 -173.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -111.69 5.73 19.41 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.512 1.125 . . . . 3.88 110.998 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.23 44.29 6.44 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 127.889 2.475 . . . . 3.94 112.068 176.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -142.06 169.6 17.29 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 122.23 -0.294 . . . . 3.54 110.808 -175.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.4 132.45 39.4 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 124.416 1.073 . . . . 2.53 108.988 160.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.43 135.46 34.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.538 -1.282 . . . . 1.49 107.538 158.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.68 120.6 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 105.516 -2.031 . . . . 2.8 105.516 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -90.83 99.9 12.85 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.513 -0.921 . . . . 4.22 108.513 166.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.8 159.26 42.49 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.202 0.601 . . . . 3.17 112.284 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -81.98 120.14 76.76 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 106.08 -1.822 . . . . 3.51 106.08 162.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -63.56 -40.43 30.49 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.525 1.484 . . . . 1.29 111.381 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -85.63 30.96 0.61 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.693 1.197 . . . . 3.72 112.067 -160.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.3 pt -134.98 -50.23 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.762 1.225 . . . . 2.4 109.96 172.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 tt -96.79 -41.68 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.921 1.288 . . . . 2.11 111.494 -174.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.68 148.26 5.56 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 111.33 -0.708 . . . . 1.14 111.33 -175.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.11 -36.46 58.4 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.208 2.606 . . . . 0.81 111.554 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -50.65 -50.38 54.64 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.829 0.852 . . . . 7.29 112.256 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -52.28 -56.06 17.25 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 121.765 0.793 . . . . 2.62 109.537 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.0 mt -57.41 -53.54 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.463 1.105 . . . . 2.26 111.56 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.7 mt -57.53 -54.29 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 122.02 -0.425 . . . . 2.47 109.98 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -64.93 -33.04 75.07 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.535 -0.728 . . . . 3.98 111.769 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.3 m -56.81 -52.04 66.59 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 121.565 -0.71 . . . . 1.6 109.091 171.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.7 mt -64.32 -42.08 94.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 119.608 1.094 . . . . 3.48 111.079 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -49.56 -51.73 34.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.159 0.984 . . . . 3.4 109.039 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -64.51 -43.86 92.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.609 0.764 . . . . 1.83 111.387 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.19 -34.6 72.33 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.891 1.676 . . . . 3.68 111.262 -175.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.36 39.46 0.23 Allowed Glycine 0 C--N 1.333 0.416 0 O-C-N 124.685 1.241 . . . . 0.97 111.857 152.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -142.74 174.62 10.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.78 -0.822 . . . . 3.02 108.78 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -108.93 92.07 10.1 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.955 1.302 . . . . 3.96 109.848 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.99 65.85 7.74 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.685 2.924 . . . . 1.78 111.124 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.7 m -74.98 119.9 19.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.575 0.702 . . . . 2.93 110.256 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -70.23 130.24 41.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.177 -0.675 . . . . 5.39 109.177 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.77 -42.21 40.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.115 0 C-N-CA 122.931 0.492 . . . . 4.57 109.901 176.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -56.14 -66.65 0.39 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.726 0.81 . . . . 6.87 110.464 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.1 mt 65.69 -71.76 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.581 1.153 . . . . 10.44 111.502 -172.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 C--O 1.253 1.273 0 N-CA-C 106.745 -1.576 . . . . 13.99 106.745 179.416 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 105.652 -1.981 . . . . 8.95 105.652 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.26 35.91 92.7 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 109.554 -1.418 . . . . 4.78 109.554 -161.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -173.74 164.47 4.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.118 2.167 . . . . 5.5 106.798 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.87 171.42 33.8 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 109.532 -1.427 . . . . 2.53 109.532 171.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 m -138.95 154.72 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 106.835 -1.543 . . . . 3.52 106.835 161.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 tt -150.47 147.29 27.34 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.772 -1.196 . . . . 3.17 107.772 170.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -103.3 150.45 23.74 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.981 1.312 . . . . 2.74 109.431 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.95 138.15 25.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.601 -0.888 . . . . 3.59 108.601 164.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -77.79 143.29 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.256 -1.387 . . . . 1.95 107.256 170.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.28 103.74 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.529 1.532 . . . . 2.52 107.618 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -73.89 166.49 23.25 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.251 -1.018 . . . . 6.51 108.251 165.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.6 -11.34 59.51 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.663 0.649 . . . . 1.02 112.612 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.7 mtm -73.83 65.5 1.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.523 1.161 . . . . 2.3 110.423 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 t -91.18 12.72 19.18 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.352 1.061 . . . . 3.11 112.849 -166.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.4 t -165.52 173.86 10.53 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.428 -0.953 . . . . 3.62 108.428 -173.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.21 -176.01 0.06 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.398 0.545 . . . . 3.17 110.435 164.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.0 p 68.77 -54.37 0.55 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.804 2.042 . . . . 2.98 111.388 -171.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.4 m -24.98 -54.11 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.492 2.717 . . . . 2.42 113.105 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.1 t -43.18 -70.85 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.444 1.098 . . . . 2.06 110.614 172.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -26.74 64.86 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.315 -0.866 . . . . 1.48 111.069 -176.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -51.51 -41.62 61.12 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.158 0.983 . . . . 4.26 109.195 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.9 -65.0 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.454 -1.313 . . . . 2.07 107.454 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -47.85 -56.0 8.48 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.026 1.33 . . . . 3.37 111.645 -169.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 t -62.39 -50.6 70.91 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.676 0.75 . . . . 1.91 109.22 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 t -60.79 -24.43 65.79 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 118.686 -0.673 . . . . 1.07 111.923 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.96 -46.57 14.92 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 117.947 -1.025 . . . . 3.17 111.494 172.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.9 p -51.58 -32.02 26.98 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.612 1.096 . . . . 1.93 112.336 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -47.44 -45.26 25.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.014 1.325 . . . . 5.86 113.475 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -67.69 136.26 54.04 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 119.412 1.005 . . . . 2.44 108.402 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -63.66 -53.06 57.25 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.75 -0.593 . . . . 9.18 112.513 -168.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.05 47.07 3.28 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 117.881 0.309 . . . . 1.71 113.261 -169.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.83 112.85 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.49 -1.3 . . . . 2.78 107.49 177.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 tp -73.53 -48.73 30.88 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.882 0.873 . . . . 4.51 109.025 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -156.94 120.25 4.14 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.843 -0.536 . . . . 4.04 110.825 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.37 157.86 15.83 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.542 -1.281 . . . . 2.58 107.542 168.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.9 t -163.35 113.35 1.34 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.859 -0.793 . . . . 1.94 108.859 168.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -114.93 145.48 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 112.544 0.572 . . . . 3.47 112.544 175.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.57 133.1 44.66 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.869 0.868 . . . . 1.7 110.3 174.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.61 -43.83 65.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.067 -0.97 . . . . 2.48 110.555 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.93 -50.81 71.44 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.316 0.579 . . . . 1.98 110.547 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -65.54 -14.09 60.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.745 0.818 . . . . 2.68 110.967 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 55.02 30.36 14.06 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.264 1.426 . . . . 3.57 109.15 -171.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -132.45 131.12 41.4 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.319 0.509 . . . . 2.43 111.365 -164.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.52 132.63 44.72 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.996 -1.112 . . . . 1.71 107.996 160.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.21 144.88 32.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.535 -1.283 . . . . 1.3 107.535 156.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 55.5 mt -135.72 126.31 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 107.929 -1.137 . . . . 3.13 107.929 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -93.86 72.96 4.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.366 1.466 . . . . 2.88 108.418 172.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -101.58 170.74 7.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.702 0.801 . . . . 3.59 113.147 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -95.33 97.48 2.76 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.365 1.466 . . . . 3.97 108.861 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.86 -33.04 85.45 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.931 2.421 . . . . 1.06 113.636 -166.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.1 mp0 -63.74 -30.21 71.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.244 0.617 . . . . 4.01 112.05 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.0 pt -107.09 -56.14 5.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 112.864 0.691 . . . . 2.15 112.864 -168.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 tt -87.07 -52.03 12.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.46 -0.941 . . . . 2.72 108.46 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.42 167.51 28.8 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 115.482 -0.781 . . . . 0.96 113.099 173.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.72 -38.53 70.6 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.273 3.316 . . . . 0.95 111.838 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -58.76 -60.15 4.29 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.973 0.509 . . . . 6.6 112.061 -172.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -49.85 -52.47 32.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 122.44 1.114 . . . . 2.75 110.173 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 95.0 mt -48.63 -69.72 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 114.08 -1.418 . . . . 1.87 109.894 171.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.8 mt -51.34 -40.92 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.714 0.688 . . . . 2.12 111.535 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 52.8 m170 -63.15 -47.47 82.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.547 0.689 . . . . 4.93 109.456 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.2 m -66.27 -44.73 82.76 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.606 -0.516 . . . . 1.95 109.606 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.4 mm -57.01 -47.59 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.994 0.918 . . . . 2.61 110.081 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -53.09 -58.85 5.6 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.181 -0.674 . . . . 3.62 109.181 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -55.38 -38.68 69.17 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.057 0.943 . . . . 1.66 112.279 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.8 mt -63.62 -14.49 52.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.611 0.764 . . . . 2.99 112.584 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.66 48.24 1.12 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.482 1.039 . . . . 0.77 110.964 168.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -141.74 171.2 14.39 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.399 1.08 . . . . 3.49 108.809 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -109.96 79.89 1.62 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 118.534 -0.746 . . . . 3.89 112.923 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.76 123.73 11.41 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.141 1.894 . . . . 1.25 111.511 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.9 t -148.68 152.69 37.11 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.726 0.81 . . . . 3.32 109.235 172.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.9 mt -86.41 40.36 0.88 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.346 -0.846 . . . . 4.2 111.601 -165.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.4 t -80.44 68.35 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.408 -0.96 . . . . 5.63 108.408 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -55.77 -37.91 69.17 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.718 0.807 . . . . 6.48 111.778 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 pp -136.31 162.05 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.301 -1.74 . . . . 7.26 106.301 170.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 C--O 1.249 1.073 0 N-CA-C 103.557 -2.757 . . . . 12.7 103.557 176.835 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 tpt . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 108.722 -0.844 . . . . 9.04 108.722 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.91 -46.91 58.05 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 108.268 -1.933 . . . . 4.77 108.268 162.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -67.11 165.8 15.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.82 0.848 . . . . 3.98 109.752 166.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.24 -163.32 15.67 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 106.912 -2.475 . . . . 2.37 106.912 170.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m -136.12 149.44 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.802 -1.184 . . . . 4.01 107.802 163.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.63 89.8 3.19 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.43 -2.433 . . . . 3.49 104.43 166.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -70.06 145.94 51.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.506 -0.553 . . . . 2.24 109.506 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.78 139.31 21.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.807 -0.812 . . . . 3.15 108.807 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.7 t -94.44 129.64 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.645 -1.243 . . . . 2.36 107.645 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.6 m -132.26 74.7 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 C-N-CA 125.215 1.406 . . . . 2.21 109.953 -160.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -66.83 153.3 43.75 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.777 -0.823 . . . . 5.72 108.777 175.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.14 -29.56 7.61 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 109.632 -1.387 . . . . 1.16 109.632 -163.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.4 mtp -56.26 144.66 29.31 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.831 -0.805 . . . . 2.65 109.375 166.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 t -166.09 -58.92 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.005 0.522 . . . . 3.02 109.719 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.8 t -77.2 147.23 36.54 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.977 -0.749 . . . . 4.57 108.977 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.29 -43.34 10.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.409 0.684 . . . . 1.89 111.796 174.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.7 p -48.34 -41.27 28.01 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.374 0.67 . . . . 2.8 111.561 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 99.3 m -50.24 -29.04 8.65 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.774 0.83 . . . . 1.91 112.544 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t -55.85 -69.5 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.56 0.618 . . . . 2.09 109.421 169.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -27.98 67.59 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.895 -1.128 . . . . 2.3 111.436 -172.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.63 -33.64 16.01 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.924 1.29 . . . . 4.62 110.375 172.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 98.8 mt -91.07 -60.2 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.123 -1.436 . . . . 1.55 107.123 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -54.44 -64.17 0.92 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.618 1.167 . . . . 3.26 111.267 -170.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.6 m -59.55 -35.27 73.9 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.303 0.641 . . . . 2.95 111.504 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -62.62 -40.49 97.12 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.305 -0.247 . . . . 1.49 110.383 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.4 mt -72.02 -62.33 1.47 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 119.306 -0.378 . . . . 3.28 111.092 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.2 p -66.91 69.83 0.08 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.495 1.918 . . . . 2.33 111.03 -168.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.64 -40.84 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.071 2.148 . . . . 4.77 110.561 -172.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -74.26 150.73 40.1 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.119 0.872 . . . . 5.29 110.371 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -54.14 148.8 10.47 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.045 0.45 . . . . 7.7 110.215 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.22 -31.51 5.37 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.491 -0.616 . . . . 1.77 112.473 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.19 148.58 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 118.005 0.903 . . . . 2.96 108.679 171.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 36.0 mt -114.5 -51.29 2.76 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.821 1.249 . . . . 4.1 109.604 167.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -150.35 161.36 42.62 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.895 0.878 . . . . 3.76 109.881 -175.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.8 m -143.29 168.35 19.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.16 -1.052 . . . . 2.02 108.16 170.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.0 m -148.01 132.21 17.39 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.487 -1.301 . . . . 2.12 107.487 148.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.0 p -104.57 142.25 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 118.433 0.561 . . . . 3.31 110.048 164.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.62 132.26 48.14 Favored 'General case' 0 C--N 1.339 0.15 0 O-C-N 121.864 -0.522 . . . . 1.84 111.407 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.39 -58.96 6.28 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.236 1.014 . . . . 3.87 110.501 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.28 -39.41 69.81 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.59 0.756 . . . . 2.24 112.664 -169.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.6 m -95.63 -8.39 34.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.338 0.655 . . . . 3.46 110.499 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 54.65 23.16 4.5 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.562 1.945 . . . . 4.57 112.577 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -98.96 145.12 27.37 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 119.035 -0.507 . . . . 3.01 110.494 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.16 138.69 40.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.121 -1.437 . . . . 1.67 107.121 154.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -107.82 150.82 26.54 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 106.632 -1.618 . . . . 1.61 106.632 154.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 mp -126.29 122.04 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.172 -1.788 . . . . 2.11 106.172 173.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -94.36 82.43 4.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.356 1.863 . . . . 4.76 106.591 169.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -118.76 164.32 15.56 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.967 2.107 . . . . 3.26 109.775 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -86.89 117.76 69.11 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 107.856 -1.164 . . . . 3.26 107.856 167.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.2 -29.73 38.78 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.162 1.908 . . . . 1.31 112.918 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -86.66 29.23 0.8 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.664 1.12 . . . . 3.55 111.285 -166.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.7 pt -144.47 -50.48 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 123.95 0.9 . . . . 1.98 112.236 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.254 17.6 tt -95.56 -85.26 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.572 -0.899 . . . . 2.42 108.572 174.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.28 166.52 11.71 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.811 0.719 . . . . 1.24 112.955 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.59 -47.43 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.356 3.37 . . . . 0.87 111.305 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.435 ' HE ' ' CG ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -46.43 -48.25 18.88 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.118 0.967 . . . . 9.72 111.392 176.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.435 ' CG ' ' HE ' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -53.48 -56.91 13.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.876 1.271 . . . . 4.62 108.884 179.49 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.7 mt -57.56 -56.07 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.845 0.858 . . . . 1.98 109.965 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.6 mt -50.56 -51.54 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.426 -0.583 . . . . 2.34 109.426 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -36.65 84.47 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.48 0.712 . . . . 5.62 111.056 -178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.9 m -64.58 -53.66 44.26 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.34 -0.85 . . . . 1.78 109.35 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.1 mm -68.78 -33.14 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 121.335 -0.853 . . . . 2.71 111.158 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -49.63 -62.07 1.76 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.12 0.968 . . . . 3.33 109.162 162.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -54.88 -38.7 67.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.763 0.825 . . . . 1.57 112.865 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.24 -14.71 27.92 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.954 -1.091 . . . . 3.31 112.88 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.02 47.01 2.31 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.317 0.961 . . . . 0.69 111.051 175.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -136.02 172.05 13.58 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.194 0.997 . . . . 3.56 108.387 171.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -111.89 84.8 5.8 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 113.098 0.777 . . . . 4.27 113.098 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.03 80.42 0.52 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.633 2.889 . . . . 1.05 114.013 -175.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.9 p -77.13 119.68 21.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.553 -0.749 . . . . 3.04 109.654 169.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tt -65.24 103.25 0.75 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.687 -0.857 . . . . 3.75 108.687 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.1 p -77.59 -44.56 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 122.192 -0.318 . . . . 4.36 111.558 -168.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.481 ' HZ2' ' C ' ' A' ' 75' ' ' GLU . 54.3 tttm 68.99 -55.2 0.55 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.02 1.728 . . . . 7.27 112.374 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.287 0.4 OUTLIER 47.92 44.34 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 126.815 2.046 . . . . 7.82 111.77 179.333 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.481 ' C ' ' HZ2' ' A' ' 73' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.256 1.431 0 N-CA-C 102.515 -3.143 . . . . 11.02 102.515 -172.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mmt . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 107.877 -1.157 . . . . 10.27 107.877 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.42 161.43 2.79 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 109.584 -1.406 . . . . 4.62 109.584 -136.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.5 t0 58.48 158.96 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.958 2.503 . . . . 4.04 114.529 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.73 179.86 30.28 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.287 0.946 . . . . 2.12 113.15 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.04 166.5 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.691 -1.225 . . . . 3.27 107.691 168.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.32 111.68 4.96 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.818 -1.549 . . . . 3.28 106.818 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -92.29 141.38 28.62 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 123.28 0.632 . . . . 2.81 110.047 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.9 137.0 23.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.209 -0.663 . . . . 2.75 109.209 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.02 121.89 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 105.751 -1.944 . . . . 2.09 105.751 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -116.02 100.57 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.722 -1.214 . . . . 2.53 107.722 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -73.45 166.2 23.66 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.233 -1.025 . . . . 6.77 108.233 175.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.78 -10.76 57.5 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.511 -0.605 . . . . 1.02 112.618 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 75.8 mtm -68.05 73.02 0.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.555 1.177 . . . . 1.93 111.686 174.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -71.71 -30.12 65.31 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.533 1.133 . . . . 2.87 112.604 -171.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 82.5 m -143.46 158.92 43.26 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.225 -0.657 . . . . 3.72 109.225 -176.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.23 -45.15 8.34 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.97 1.308 . . . . 1.88 112.205 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 m -43.35 -42.46 4.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.431 1.092 . . . . 2.1 112.163 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.2 m -54.66 -40.05 68.65 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.683 -0.635 . . . . 1.87 111.608 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 t -58.34 -57.9 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.436 -0.95 . . . . 1.94 108.436 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -31.07 72.13 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.48 -0.563 . . . . 1.35 109.48 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -60.16 -51.31 70.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.946 -1.131 . . . . 4.77 107.946 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.7 mt -62.86 -54.83 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.855 -1.165 . . . . 1.96 107.855 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -51.99 -56.83 11.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 123.714 0.634 . . . . 3.09 109.53 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.7 t -59.8 -46.25 89.8 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.244 0.618 . . . . 2.47 110.079 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.3 t -65.13 -29.61 70.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.363 0.665 . . . . 1.06 111.422 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mt -79.87 -45.49 18.55 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.535 -0.745 . . . . 3.49 111.098 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.0 p -65.42 75.84 0.06 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.751 0.82 . . . . 2.09 110.747 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.94 -32.66 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 129.197 2.999 . . . . 4.36 110.301 -175.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -59.68 -23.45 63.11 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.914 0.779 . . . . 2.46 111.527 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 78.57 -42.26 0.32 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.424 1.49 . . . . 9.03 113.383 162.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.15 -20.5 58.29 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 111.735 -0.546 . . . . 1.57 111.735 168.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.72 130.86 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.584 0.753 . . . . 4.34 110.746 176.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.9 mt -74.66 -42.26 58.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.217 1.007 . . . . 3.92 108.748 169.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -161.58 165.28 28.66 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.952 -0.388 . . . . 4.03 109.952 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 p -141.25 59.29 1.52 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 126.481 1.912 . . . . 3.11 110.894 -176.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.32 95.72 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.827 -0.546 . . . . 1.78 111.682 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.32 149.11 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 126.265 1.826 . . . . 3.21 112.83 173.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.98 131.08 10.23 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.06 1.344 . . . . 1.99 112.086 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -65.89 -53.05 44.53 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 115.285 -0.87 . . . . 2.74 111.45 -170.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.0 -45.63 88.14 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.563 0.697 . . . . 2.85 109.435 -168.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.4 t -80.6 1.64 28.95 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.86 -0.59 . . . . 3.9 111.3 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 57.24 31.44 20.08 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.451 1.1 . . . . 3.51 109.828 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -107.1 138.79 42.61 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.453 -0.943 . . . . 2.98 108.453 -167.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.12 141.23 48.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.868 -1.901 . . . . 1.72 105.868 141.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -117.84 158.38 24.92 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 118.211 -1.395 . . . . 2.16 108.04 149.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 mp -119.46 128.93 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 106.32 -1.733 . . . . 2.11 106.32 168.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -95.34 132.32 40.49 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.396 -2.076 . . . . 3.54 105.396 163.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -165.07 167.77 17.97 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.044 0.838 . . . . 3.8 111.514 -168.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -87.71 119.09 70.49 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 107.015 -1.476 . . . . 3.49 107.015 156.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.15 -39.31 18.67 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.043 1.829 . . . . 1.34 111.065 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -89.14 39.17 0.92 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.206 1.002 . . . . 3.94 110.528 -160.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.7 pt -142.24 -49.9 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 126.052 1.741 . . . . 2.3 109.898 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 tt -95.68 -43.13 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.676 1.19 . . . . 2.37 111.373 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.36 150.64 4.93 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 123.911 0.767 . . . . 1.11 111.493 -174.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.66 -29.35 60.37 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.109 2.539 . . . . 0.96 111.775 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -55.92 -52.49 63.94 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.44 0.696 . . . . 6.85 111.458 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -50.28 -54.8 18.72 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 122.226 1.012 . . . . 2.52 109.869 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mt -54.26 -61.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.843 1.257 . . . . 1.77 110.144 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.5 mt -53.59 -47.43 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.42 0.555 . . . . 2.42 110.791 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -62.65 -42.89 99.86 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.298 0.639 . . . . 3.49 109.72 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.9 m -60.83 -54.0 50.46 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.209 -0.663 . . . . 1.77 109.209 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.2 mm -62.74 -37.58 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 119.215 -0.422 . . . . 2.63 111.037 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -52.99 -64.92 0.66 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.206 -0.664 . . . . 3.61 109.206 169.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.6 t -59.86 -24.79 64.51 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.438 0.695 . . . . 1.86 112.791 -176.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.1 tp -72.72 -5.15 35.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.078 1.351 . . . . 3.5 111.548 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.68 47.59 1.62 Allowed Glycine 0 C--N 1.337 0.628 0 C-N-CA 125.229 1.395 . . . . 0.86 110.825 168.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -144.16 172.34 13.04 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 123.949 0.9 . . . . 2.96 109.53 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -114.94 77.92 5.13 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.664 -0.684 . . . . 4.3 111.311 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.36 93.66 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.598 2.198 . . . . 1.06 112.41 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.3 t -97.04 139.65 32.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.895 0.855 . . . . 3.22 109.896 171.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.9 104.36 16.17 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.562 -1.273 . . . . 4.66 107.562 174.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -66.54 -43.5 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 111.802 0.297 . . . . 4.92 111.802 -174.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -170.37 153.84 4.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.129 -1.804 . . . . 7.62 106.129 -172.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.2 pt -101.35 -53.13 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 118.286 -0.864 . . . . 10.23 110.789 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.248 0.99 0 CA-C-N 119.287 0.949 . . . . 11.77 109.102 171.53 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.6 mtp . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 106.686 -1.598 . . . . 9.22 106.686 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.12 32.09 0.09 OUTLIER Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.793 1.663 . . . . 4.0 109.267 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -127.25 153.42 46.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 128.026 2.53 . . . . 5.23 108.455 -156.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.3 -170.43 33.84 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.561 -1.016 . . . . 2.08 110.561 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -130.76 156.45 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 123.584 0.754 . . . . 3.23 108.989 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.1 tp -133.65 141.74 47.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.507 -2.035 . . . . 3.78 105.507 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -129.83 139.47 51.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.278 -1.378 . . . . 2.48 107.278 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.84 148.5 35.59 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.073 -1.084 . . . . 4.28 108.073 176.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.39 133.25 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.893 -1.521 . . . . 1.94 106.893 175.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.09 87.97 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.75 0.82 . . . . 2.64 109.224 -168.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 77.0 mmt-85 -62.77 150.87 40.28 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.544 -0.909 . . . . 6.4 108.544 171.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.26 -4.5 48.26 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.862 -0.966 . . . . 1.19 113.954 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.8 mtp -75.1 49.61 0.45 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.871 1.835 . . . . 2.27 112.249 -176.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 t -82.79 37.22 0.52 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.695 -1.253 . . . . 3.12 113.407 -164.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.3 t -173.41 142.4 0.98 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.615 0.766 . . . . 4.04 108.959 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.38 -50.26 3.81 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.468 1.107 . . . . 2.55 112.456 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 m -46.36 -34.34 4.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.93 1.292 . . . . 1.94 112.866 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.0 m -48.23 -34.98 11.09 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 123.571 0.748 . . . . 2.17 111.029 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.4 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 93.9 t -49.07 -72.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 118.18 0.446 . . . . 2.19 110.115 173.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -27.9 68.47 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.693 -0.629 . . . . 1.72 111.178 -175.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -49.56 -42.84 45.3 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.213 0.605 . . . . 4.31 110.088 173.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.3 mt -83.06 -61.71 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.099 -1.075 . . . . 2.08 108.099 175.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -51.88 -61.31 2.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.39 1.476 . . . . 3.35 111.231 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 t -62.05 -45.49 93.33 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.855 0.862 . . . . 2.25 109.181 -173.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -59.95 -37.16 78.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.777 -0.647 . . . . 1.03 111.302 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mt -75.34 -37.41 60.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.235 -0.888 . . . . 3.37 112.521 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.5 p -64.35 77.6 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.749 0.704 . . . . 1.8 111.218 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 168.32 -31.35 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.762 2.825 . . . . 4.16 111.152 -174.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -52.72 120.75 6.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.881 0.764 . . . . 2.69 110.108 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -70.97 80.26 0.65 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.836 0.855 . . . . 5.7 111.307 -166.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.86 -16.87 1.07 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.933 1.254 . . . . 1.25 110.743 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.5 148.95 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 107.659 -1.238 . . . . 2.74 107.659 163.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 pp -122.11 -29.94 4.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.841 0.856 . . . . 3.6 112.346 167.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -159.64 154.7 24.94 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 119.547 1.067 . . . . 3.63 109.143 174.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -132.94 157.91 43.96 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.314 -0.995 . . . . 1.9 108.314 174.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.6 t -159.67 128.58 5.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.477 -0.934 . . . . 2.43 108.477 159.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.4 ' CG2' ' HA ' ' A' ' 19' ' ' VAL . 1.1 m -121.12 159.93 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 123.203 0.601 . . . . 2.89 110.249 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.22 134.32 17.03 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.118 0.485 . . . . 1.98 110.458 174.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.92 -33.92 68.67 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.152 -0.931 . . . . 2.33 110.462 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.98 80.44 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.547 0.739 . . . . 1.96 111.659 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.6 m -96.56 2.38 52.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.72 0.808 . . . . 3.31 109.974 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 46.67 44.71 14.01 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.453 2.301 . . . . 4.04 112.113 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -133.66 157.79 44.88 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 112.01 0.374 . . . . 3.13 112.01 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.66 135.94 53.37 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.422 -1.325 . . . . 1.86 107.422 162.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.59 149.77 27.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 123.832 0.707 . . . . 1.37 109.783 159.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.65 139.31 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 C-N-CA 127.481 2.312 . . . . 1.95 106.172 175.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -113.45 135.14 54.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.62 -1.993 . . . . 3.15 105.62 161.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -170.97 175.08 4.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.228 1.011 . . . . 3.37 110.569 -164.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -98.09 96.26 3.38 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 125.457 1.503 . . . . 3.3 108.063 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -60.35 -29.75 89.51 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.128 1.885 . . . . 1.11 112.12 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -54.79 -43.93 73.28 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.872 0.869 . . . . 3.96 111.792 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.4 pt -94.77 -86.79 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.877 0.471 . . . . 2.04 112.027 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.7 tt -59.24 -45.83 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.971 0.908 . . . . 2.59 111.381 -171.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.95 161.8 31.26 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 115.329 -0.851 . . . . 0.83 112.342 172.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.27 -35.65 23.61 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.644 2.896 . . . . 0.74 111.865 -174.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -55.23 -49.35 72.22 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.918 0.487 . . . . 6.42 111.742 -174.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.28 -53.75 20.3 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.742 0.782 . . . . 2.78 109.75 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.55 -50.11 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.627 1.171 . . . . 2.09 110.555 -174.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.2 mt -55.18 -52.31 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 109.767 -0.457 . . . . 2.25 109.767 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -62.27 -36.35 81.81 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.376 -0.828 . . . . 3.18 112.22 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 66.6 m -57.21 -50.44 72.85 Favored 'General case' 0 C--O 1.225 -0.21 0 O-C-N 121.262 -0.899 . . . . 2.02 108.937 174.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.5 mt -65.73 -42.85 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.693 -0.63 . . . . 3.23 111.315 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -48.31 -46.1 35.81 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.424 1.09 . . . . 2.7 109.104 171.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.0 t -69.83 -44.07 70.68 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.741 0.817 . . . . 2.27 111.695 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.9 mt -59.38 -28.33 66.79 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.467 -0.77 . . . . 3.01 110.653 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.21 47.65 0.69 Allowed Glycine 0 C--O 1.228 -0.219 0 N-CA-C 110.117 -1.193 . . . . 1.05 110.117 157.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -134.62 171.55 14.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.529 -1.656 . . . . 3.05 106.529 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -108.93 82.01 1.69 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.06 -0.971 . . . . 4.22 111.313 -170.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.74 75.55 1.61 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.515 2.81 . . . . 1.12 112.823 -174.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m -73.51 116.92 14.66 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.959 -0.756 . . . . 2.96 108.959 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.2 tp -76.22 75.75 3.03 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.557 -1.275 . . . . 4.17 107.557 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.7 t -73.82 -62.95 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.778 -0.823 . . . . 5.48 108.778 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt 61.74 169.85 0.11 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.589 1.156 . . . . 8.77 111.944 -175.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.43 -70.98 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 105.446 -2.057 . . . . 8.23 105.446 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 C--O 1.259 1.559 0 N-CA-C 102.507 -3.145 . . . . 10.9 102.507 152.933 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 109.785 -0.45 . . . . 11.36 109.785 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.11 143.95 4.43 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 106.818 -2.513 . . . . 4.22 106.818 174.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -86.66 -124.8 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.102 -0.703 . . . . 3.62 109.102 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.89 157.56 7.27 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 107.523 -2.231 . . . . 1.87 107.523 -171.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.63 156.89 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 117.514 0.657 . . . . 3.27 109.535 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 tt -152.05 136.0 16.44 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.681 -1.97 . . . . 3.87 105.681 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -114.13 130.01 56.6 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.251 1.021 . . . . 2.56 108.452 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.9 131.76 56.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.11 -1.441 . . . . 2.56 107.11 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 t -73.87 103.99 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 105.233 -2.136 . . . . 2.2 105.233 167.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 p -99.57 124.47 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 109.42 -0.585 . . . . 3.79 109.42 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -82.5 104.85 13.09 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.369 -1.715 . . . . 6.16 106.369 164.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.29 -54.32 0.03 OUTLIER Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.76 -0.257 . . . . 3.12 112.93 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -76.68 73.4 3.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.863 -0.787 . . . . 2.75 110.396 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 t -56.51 -39.06 72.66 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.907 0.483 . . . . 3.19 110.222 171.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 65.2 m -143.31 -168.01 2.7 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.743 1.617 . . . . 3.82 107.202 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.39 -168.15 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.537 0.735 . . . . 2.72 111.115 170.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.8 m 69.57 -66.86 0.25 Allowed 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.74 1.216 . . . . 2.18 109.693 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.5 m -40.85 -48.89 3.16 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.887 1.275 . . . . 1.69 110.671 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.0 t -43.26 -67.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.931 1.292 . . . . 1.97 110.968 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -24.54 67.74 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.836 -0.62 . . . . 1.43 109.643 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -65.27 -51.31 61.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.431 -0.951 . . . . 4.66 108.431 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.4 mt -65.12 -53.76 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 107.667 -1.235 . . . . 1.75 107.667 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -45.28 -51.71 10.55 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.455 0.702 . . . . 3.55 112.569 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 53.2 m -63.43 -52.88 59.66 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.684 -0.635 . . . . 2.58 110.167 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.0 t -54.45 -37.32 65.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.388 1.075 . . . . 1.22 111.506 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.07 -44.89 15.98 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.404 1.082 . . . . 2.88 110.954 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.7 p -58.24 -37.67 75.37 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.72 1.146 . . . . 1.96 110.834 176.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -51.25 -29.75 15.47 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.24 1.416 . . . . 5.74 113.057 169.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -78.8 99.45 6.7 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.76 -1.213 . . . . 2.72 110.3 175.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.71 107.83 0.17 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.864 -1.162 . . . . 7.8 107.864 157.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.75 -36.07 1.87 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.672 -1.371 . . . . 1.83 109.672 -170.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.68 142.49 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.697 -1.223 . . . . 3.29 107.697 168.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.0 tp -98.58 -47.4 5.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.639 1.576 . . . . 4.16 108.721 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -154.98 128.69 8.62 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.249 0.62 . . . . 4.62 109.913 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.0 t -108.05 150.44 27.16 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 108.347 -0.983 . . . . 2.12 108.347 171.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.9 t -156.55 129.52 7.88 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.148 -1.426 . . . . 2.47 107.148 162.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.0 m -122.85 144.71 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.89 0.768 . . . . 2.78 110.759 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.26 132.25 35.53 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.727 0.811 . . . . 1.96 111.28 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 pp -68.62 -51.71 39.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.661 1.185 . . . . 2.63 110.994 -174.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.32 -51.32 65.06 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.404 0.621 . . . . 2.25 110.178 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.04 -14.71 61.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.672 1.189 . . . . 2.6 111.738 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 55.52 33.79 21.78 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.198 1.399 . . . . 3.77 108.367 -172.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -126.48 140.72 52.25 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 118.801 0.728 . . . . 2.25 111.264 -162.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.32 120.25 39.0 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.127 -1.064 . . . . 1.8 108.127 161.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -95.27 132.0 40.73 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 126.684 1.994 . . . . 4.37 106.466 173.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.5 mt -130.47 130.32 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.799 -1.186 . . . . 2.73 107.799 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.6 mttp -104.66 131.99 51.44 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 105.967 -1.864 . . . . 3.95 105.967 159.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -162.78 160.8 25.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.601 1.16 . . . . 3.55 109.283 -169.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -82.2 104.5 3.36 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 107.432 -1.321 . . . . 3.65 107.432 172.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -61.78 -45.02 18.43 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.447 2.098 . . . . 1.45 111.923 -166.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -53.32 -40.9 65.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.308 1.443 . . . . 4.41 112.938 -174.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 pt -88.56 -47.51 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 113.838 1.051 . . . . 2.08 113.838 -168.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.2 tt -83.99 -56.71 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 118.142 0.428 . . . . 2.74 111.191 -178.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.41 135.01 8.3 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.002 0.811 . . . . 1.33 112.444 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.65 -45.18 14.66 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.703 2.935 . . . . 0.99 111.059 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -53.55 -52.4 59.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.51 -0.552 . . . . 8.18 109.51 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.94 -46.39 85.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.916 1.686 . . . . 5.32 109.928 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 mt -52.31 -58.86 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 122.696 0.399 . . . . 2.14 110.732 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 mt -50.49 -43.87 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 118.091 0.405 . . . . 2.54 111.184 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -63.4 -36.35 83.43 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.495 -0.753 . . . . 3.12 111.483 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.6 m -62.25 -50.33 72.16 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.282 -0.886 . . . . 1.89 109.273 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.9 mm -59.71 -45.01 94.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.881 -0.512 . . . . 2.28 111.321 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -52.11 -53.74 38.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.115 1.366 . . . . 2.71 109.528 172.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -56.56 -39.42 73.43 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.357 1.063 . . . . 1.69 112.124 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.76 -17.27 34.06 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.573 0.583 . . . . 3.43 112.573 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.45 29.26 11.29 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.344 0.973 . . . . 1.46 110.724 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -120.31 158.68 26.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.645 1.178 . . . . 3.06 108.684 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -105.65 104.11 46.87 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-O 118.029 -0.986 . . . . 4.69 110.271 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -84.54 83.74 1.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.934 3.089 . . . . 1.06 111.552 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 m -72.54 103.67 3.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.877 -0.786 . . . . 2.84 108.877 173.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -66.3 136.49 55.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.237 -1.023 . . . . 4.63 108.237 174.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.6 m -113.4 -56.6 4.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 C-N-CA 123.144 0.578 . . . . 4.65 110.797 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt 64.93 173.07 0.2 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.721 0.808 . . . . 8.55 109.054 -159.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.2 mp 53.33 62.4 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.74 0.816 . . . . 6.62 109.871 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 C--O 1.254 1.311 0 C-N-CA 125.146 1.379 . . . . 10.73 112.081 171.337 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 ttt . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 118.988 -0.529 . . . . 7.73 111.294 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.24 171.87 26.07 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 123.162 0.41 . . . . 4.6 113.581 169.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.7 t0 62.34 160.47 0.07 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.233 2.213 . . . . 3.66 111.681 -167.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.55 107.21 0.2 Allowed Glycine 0 CA--C 1.525 0.677 0 O-C-N 121.156 -0.965 . . . . 2.13 111.157 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -73.18 75.08 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 O-C-N 121.988 -0.713 . . . . 3.11 109.211 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -74.91 111.57 10.25 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.029 -1.1 . . . . 3.69 108.029 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -92.56 122.79 35.33 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.272 -1.381 . . . . 2.94 107.272 169.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -118.66 151.0 38.77 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 108.099 -1.074 . . . . 2.53 108.099 170.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 t -103.78 119.0 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.34 -0.985 . . . . 2.34 108.34 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.56 119.98 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 126.937 2.095 . . . . 2.51 109.406 174.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -82.38 161.63 22.45 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.674 -1.232 . . . . 6.88 107.674 154.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.91 -28.17 5.47 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.185 0.898 . . . . 1.08 112.569 172.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -65.53 113.62 4.3 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.438 1.119 . . . . 2.21 109.845 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 t -67.31 -54.8 17.52 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.567 -0.531 . . . . 3.75 109.567 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 t -177.34 -90.03 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.658 1.183 . . . . 5.46 109.914 170.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.02 160.23 32.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.651 0.38 . . . . 3.23 109.989 -176.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.5 m 68.02 -60.66 0.4 Allowed 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.424 1.49 . . . . 2.04 110.983 -173.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.6 m -39.64 -41.91 1.12 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 126.438 1.895 . . . . 1.67 113.04 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.7 t -51.16 -69.57 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.709 0.29 . . . . 1.86 110.337 173.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.19 -30.73 71.66 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.302 -0.874 . . . . 2.31 110.872 -175.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.28 -40.83 17.62 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.771 1.228 . . . . 4.37 109.49 174.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.9 mt -85.32 -60.44 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 107.352 -1.351 . . . . 1.81 107.352 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -51.36 -62.28 1.72 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.242 1.417 . . . . 3.47 111.52 -170.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -61.93 -43.11 99.53 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.809 0.844 . . . . 3.35 110.144 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.9 t -62.28 -35.2 78.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.079 -0.509 . . . . 1.67 110.858 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.9 mt -70.43 -46.99 62.81 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.32 -0.847 . . . . 3.32 111.041 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.5 p -63.89 77.45 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.257 0.481 . . . . 1.78 110.779 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? 170.72 -24.58 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.654 3.182 . . . . 4.18 111.437 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -70.91 59.24 0.22 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.94 1.245 . . . . 2.83 111.683 172.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 41.04 -73.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 129.454 3.101 . . . . 6.4 115.766 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.43 97.14 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.918 0.771 . . . . 1.94 111.526 -175.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.3 tp -66.65 97.66 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 117.635 0.717 . . . . 3.17 110.877 -175.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 pp -86.5 -32.77 20.58 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.605 1.162 . . . . 4.22 111.721 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -147.72 136.8 22.21 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.278 0.631 . . . . 3.41 111.02 176.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -117.75 166.45 12.42 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.223 -1.028 . . . . 2.06 108.223 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 m -151.09 117.69 5.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.421 -1.326 . . . . 2.15 107.421 151.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.71 125.15 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 120.411 1.46 . . . . 3.49 109.894 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.44 129.55 55.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.181 0.593 . . . . 2.19 109.475 172.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.0 -48.17 54.68 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.849 -1.069 . . . . 2.9 111.015 -172.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.03 -51.44 69.68 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.37 0.605 . . . . 2.72 110.534 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.81 -12.82 52.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.482 1.113 . . . . 3.06 111.342 176.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 54.26 28.35 9.1 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 125.157 1.383 . . . . 3.47 109.627 -172.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -121.03 129.41 53.36 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 118.944 0.793 . . . . 2.32 110.846 -160.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.02 120.44 39.84 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.685 1.194 . . . . 1.84 108.715 164.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 127.31 36.09 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 127.002 2.121 . . . . 2.31 105.33 166.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.9 130.2 74.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.029 1.332 . . . . 2.32 108.713 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -104.0 90.25 3.55 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.006 1.723 . . . . 3.55 108.278 167.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.14 179.35 7.27 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.98 1.312 . . . . 3.51 109.535 -175.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.2 124.53 41.04 Favored Pre-proline 0 N--CA 1.445 -0.719 0 O-C-N 123.34 0.4 . . . . 4.18 110.759 174.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.51 -8.79 10.4 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.406 2.738 . . . . 1.7 112.801 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -90.83 -55.1 3.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 119.154 0.888 . . . . 3.49 108.784 -175.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 pt -68.24 -78.68 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.849 0.357 . . . . 2.34 111.871 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.7 tt -69.06 -56.62 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 O-C-N 121.229 -0.92 . . . . 2.47 109.186 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.03 159.07 33.25 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 122.92 0.295 . . . . 0.79 113.1 171.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.66 -38.61 80.47 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.661 2.907 . . . . 0.88 110.979 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -32.16 -64.14 0.18 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.73 2.012 . . . . 11.02 113.487 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -53.98 -58.25 7.99 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.624 1.169 . . . . 2.91 109.906 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 mt -57.2 -59.94 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.271 -0.877 . . . . 2.37 109.899 -176.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.4 mt -49.99 -51.33 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 123.311 0.644 . . . . 2.26 110.273 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -69.31 -32.71 72.01 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.537 0.608 . . . . 3.37 111.689 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.3 m -60.6 -58.66 7.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.942 -0.762 . . . . 1.95 108.942 171.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 mm -59.98 -38.17 75.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.297 1.039 . . . . 2.98 111.474 -174.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -51.72 -65.35 0.57 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.84 1.256 . . . . 2.73 108.809 167.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.8 t -56.96 -27.58 61.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.317 0.647 . . . . 1.81 112.696 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.5 tp -76.17 -5.4 46.58 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.419 1.488 . . . . 3.6 111.57 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.1 45.36 2.85 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 124.345 0.974 . . . . 0.74 111.572 169.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -143.23 172.16 13.11 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.443 1.097 . . . . 3.6 108.11 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -115.76 78.76 7.24 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 123.106 0.562 . . . . 4.68 111.916 -175.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.13 72.78 5.75 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.786 2.991 . . . . 1.55 112.829 -168.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.8 p -69.84 138.98 53.05 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.969 -0.457 . . . . 2.82 110.488 171.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.9 tp -78.82 116.09 18.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.742 -1.577 . . . . 4.11 106.742 167.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.6 -49.01 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.185 0.994 . . . . 4.85 109.546 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.1 tttm 71.02 -60.08 0.52 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.768 1.627 . . . . 8.87 111.55 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.9 pt -62.85 166.96 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 122.509 0.324 . . . . 7.12 110.674 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.312 -1.327 . . . . 10.97 109.568 -173.13 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 ttp . . . . . 0 N--CA 1.468 0.435 0 N-CA-C 109.279 -0.638 . . . . 9.07 109.279 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.71 155.65 3.74 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 109.511 -1.435 . . . . 4.38 109.511 -166.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -87.77 155.28 19.98 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 117.722 0.761 . . . . 3.9 109.477 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.61 136.72 9.4 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 106.131 -2.788 . . . . 2.08 106.131 168.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.2 t -101.64 87.42 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.078 -1.082 . . . . 3.7 108.078 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.79 90.34 2.89 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.982 -1.488 . . . . 3.63 106.982 171.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -73.65 119.95 18.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.26 -1.015 . . . . 2.11 108.26 159.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -127.7 150.61 49.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.211 -1.033 . . . . 2.95 108.211 166.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.0 t -96.71 135.71 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.429 -1.693 . . . . 2.14 106.429 171.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.81 176.73 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.483 -0.932 . . . . 2.73 108.483 172.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -134.55 167.07 21.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.942 -2.244 . . . . 7.61 104.942 152.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.93 -3.9 55.89 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.295 -0.725 . . . . 1.09 114.139 176.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.9 mtm -75.7 53.93 0.76 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.72 1.76 . . . . 2.19 111.977 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -80.68 36.27 0.38 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.897 -1.127 . . . . 3.13 113.203 -166.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.7 t -171.04 140.54 1.55 Allowed 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 118.913 0.779 . . . . 3.43 109.424 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.86 -48.82 11.12 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.797 0.839 . . . . 2.09 111.162 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 m -44.84 -38.6 4.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.485 1.114 . . . . 2.31 112.234 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.0 m -54.62 -38.12 66.42 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.372 0.533 . . . . 1.76 110.908 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 86.1 t -52.46 -63.8 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 123.407 0.683 . . . . 1.76 109.487 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -29.28 69.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.908 -0.587 . . . . 1.65 109.715 -175.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -62.66 -55.55 25.87 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.184 -1.413 . . . . 5.57 107.184 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.4 mt -60.09 -53.45 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 107.066 -1.457 . . . . 1.83 107.066 -172.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -41.34 -64.6 0.54 Allowed 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 124.607 1.192 . . . . 4.29 109.768 174.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.2 t -58.19 -43.85 87.74 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.632 0.773 . . . . 2.09 110.259 -173.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.63 -20.84 62.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.313 1.045 . . . . 1.16 111.117 -176.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.72 -57.85 3.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.703 -0.665 . . . . 3.23 110.55 168.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.58 -31.27 64.06 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.231 0.923 . . . . 2.28 111.572 -177.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -37.11 -52.04 0.99 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.494 1.517 . . . . 5.37 112.798 162.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -96.64 140.84 30.66 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 118.899 0.772 . . . . 4.69 111.294 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -67.11 177.09 1.88 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.696 -0.483 . . . . 7.24 109.696 173.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.19 -48.42 3.92 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.935 -1.266 . . . . 1.59 109.935 -174.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.88 141.99 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.641 -0.874 . . . . 2.99 108.641 158.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.3 mt -108.97 -45.37 3.8 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.417 1.487 . . . . 4.51 108.593 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -154.98 155.96 35.14 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.013 0.925 . . . . 3.32 109.756 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.9 t -136.96 146.28 45.2 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.464 -0.939 . . . . 1.99 108.464 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.9 m -150.74 119.34 6.5 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.813 -0.81 . . . . 2.42 108.813 161.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.3 m -101.21 155.67 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.699 0.8 . . . . 2.88 109.964 170.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.48 134.08 22.12 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.252 0.621 . . . . 2.06 110.971 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.66 -47.61 69.01 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.444 1.097 . . . . 3.61 110.133 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.79 -43.49 80.97 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 123.377 0.671 . . . . 2.66 111.384 -170.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.1 m -94.37 -0.84 54.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.167 0.587 . . . . 3.55 110.593 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.78 34.06 18.29 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.073 1.749 . . . . 3.99 111.528 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -112.14 152.11 28.69 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.567 0.747 . . . . 2.4 110.359 -165.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.39 121.91 43.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.428 1.091 . . . . 1.8 108.224 156.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.97 131.69 42.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.902 -1.518 . . . . 1.42 106.902 160.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.8 mp -118.08 119.23 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.029 -1.471 . . . . 2.36 107.029 172.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -95.88 95.7 8.43 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 126.59 1.956 . . . . 4.26 106.252 172.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -126.8 165.85 18.53 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.024 1.33 . . . . 3.66 109.474 -174.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -86.94 112.47 47.6 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.649 -0.871 . . . . 3.25 108.649 170.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.05 -19.25 45.72 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.612 2.208 . . . . 1.4 113.089 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -69.01 -36.47 77.83 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.021 0.828 . . . . 4.16 110.705 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.6 pt -99.23 -62.55 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 N-CA-C 113.599 0.963 . . . . 1.78 113.599 -165.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 tt -88.42 -47.56 15.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.576 0.703 . . . . 2.57 110.721 -165.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.5 151.6 27.13 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.045 0.831 . . . . 0.85 111.589 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.66 -30.51 34.62 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.828 3.019 . . . . 0.75 112.55 -174.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -50.97 -50.42 58.2 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.983 0.513 . . . . 7.57 111.068 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.24 -54.22 27.86 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.814 0.845 . . . . 2.78 110.285 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.0 mt -57.01 -54.26 32.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 124.69 1.196 . . . . 2.27 111.065 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.6 mt -54.42 -53.15 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.378 -0.601 . . . . 2.1 109.378 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -61.75 -35.42 78.07 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.793 -0.567 . . . . 3.17 112.318 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.0 m -59.81 -48.93 79.7 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 121.045 -1.034 . . . . 2.03 109.508 176.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.6 mt -68.86 -42.64 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.883 -0.511 . . . . 3.24 111.511 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -49.54 -47.16 49.22 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.875 1.27 . . . . 2.78 109.08 171.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.2 t -70.66 -42.33 70.94 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.126 0.971 . . . . 2.37 110.555 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.56 -48.87 57.34 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 124.663 1.185 . . . . 4.01 109.009 174.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.26 45.96 0.28 Allowed Glycine 0 C--N 1.334 0.438 0 N-CA-C 110.179 -1.168 . . . . 1.04 110.179 168.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -127.45 172.71 10.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.561 -1.644 . . . . 2.84 106.561 169.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -110.44 71.77 0.68 Allowed Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 118.689 -0.672 . . . . 4.66 111.876 -165.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.82 136.12 34.67 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.404 2.069 . . . . 1.48 112.337 -169.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.6 p -145.56 129.19 17.1 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.728 1.211 . . . . 2.63 108.258 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.78 35.16 0.19 Allowed 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.219 -0.925 . . . . 4.27 112.685 -173.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.1 m -82.21 65.92 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 O-C-N 121.278 -0.889 . . . . 6.79 109.294 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -51.44 150.19 3.77 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.469 -0.787 . . . . 6.42 110.562 170.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.0 tp -60.38 143.17 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 108.09 -1.078 . . . . 8.92 108.09 166.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 . . . . . 0 C--O 1.248 0.984 0 N-CA-C 104.342 -2.466 . . . . 9.2 104.342 -179.544 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.507 ' H3 ' ' CG ' ' A' ' 3' ' ' ASP . 59.4 mtt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.664 -0.495 . . . . 10.8 109.664 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 137.12 -70.94 0.48 Allowed Glycine 0 CA--C 1.52 0.345 0 N-CA-C 105.196 -3.162 . . . . 5.17 105.196 -172.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.507 ' CG ' ' H3 ' ' A' ' 1' ' ' MET . 5.0 m-20 60.03 -154.31 0.37 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.216 1.006 . . . . 5.28 110.012 158.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.53 140.99 4.34 Favored Glycine 0 CA--C 1.523 0.581 0 O-C-N 121.403 -0.81 . . . . 2.37 111.763 176.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 m -129.81 156.93 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.207 -1.405 . . . . 3.62 107.207 160.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 tp -148.23 111.4 4.9 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.275 -1.379 . . . . 3.94 107.275 -172.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -100.37 46.14 0.96 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.657 1.983 . . . . 5.05 109.355 -169.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.02 156.36 39.25 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.964 -0.46 . . . . 2.81 110.031 -165.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.56 129.14 48.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 N-CA-C 107.793 -1.188 . . . . 2.2 107.793 175.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.58 125.4 68.62 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.029 0 N-CA-C 106.528 -1.656 . . . . 2.35 106.528 172.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -104.91 167.97 9.36 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.273 -1.01 . . . . 5.18 108.273 157.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.88 -10.51 29.71 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.783 1.183 . . . . 1.13 111.891 -173.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.0 mtm -68.11 76.14 0.23 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.114 0.957 . . . . 2.15 110.179 172.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.8 p -82.19 -75.07 0.32 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.272 1.029 . . . . 4.22 109.436 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 67.2 m -72.9 128.81 36.6 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.572 -0.899 . . . . 5.02 108.572 -179.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -34.89 -51.79 0.52 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.775 1.63 . . . . 2.16 113.394 -176.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.8 t -40.1 -42.51 1.45 Allowed 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 124.817 1.247 . . . . 3.8 111.385 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.0 m -38.38 -46.3 1.11 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.272 1.029 . . . . 1.75 112.097 177.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.0 t -50.83 -67.28 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 124.172 0.989 . . . . 1.79 110.244 175.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.43 -21.42 66.29 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.443 -0.344 . . . . 3.39 111.847 -179.003 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -68.42 -50.11 55.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.925 -1.509 . . . . 4.52 106.925 -178.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.5 mt -62.05 -57.84 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.374 -1.343 . . . . 1.94 107.374 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -48.19 -57.78 5.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.794 0.838 . . . . 3.32 111.16 179.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.1 t -59.7 -44.25 93.76 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.624 0.726 . . . . 2.08 110.135 -178.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.5 t -60.48 -29.01 68.79 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 118.506 -0.759 . . . . 1.61 111.446 177.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.8 mt -82.63 -47.98 11.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 119.161 0.892 . . . . 3.5 111.772 178.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.8 p -72.75 62.04 0.56 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.37 1.468 . . . . 1.83 110.938 -175.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -168.7 -30.88 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.673 1.989 . . . . 4.41 111.84 -171.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -65.59 19.76 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.247 1.573 . . . . 2.58 115.247 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 61.85 -71.83 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.504 1.521 . . . . 5.79 110.816 -169.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.68 49.47 3.66 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.309 0.956 . . . . 1.78 112.773 -172.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.65 135.16 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 104.789 -2.3 . . . . 3.76 104.789 159.421 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.7 mt -95.4 -37.55 10.89 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.147 0.979 . . . . 4.59 108.925 173.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -168.61 158.9 9.67 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.596 1.158 . . . . 3.13 108.071 177.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.8 m -145.48 155.19 42.95 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 123.669 0.788 . . . . 2.2 109.943 172.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.1 t -162.37 116.99 1.83 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.803 1.241 . . . . 2.63 107.873 167.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -104.05 159.95 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.429 1.013 . . . . 2.9 111.936 170.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.9 135.96 21.22 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.574 0.75 . . . . 1.92 109.981 176.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.23 -43.15 19.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.625 0.77 . . . . 2.68 111.78 -171.111 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.25 -39.25 89.63 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.886 0.474 . . . . 2.4 110.186 -174.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.3 t -98.19 3.67 48.97 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.599 0.76 . . . . 3.13 111.274 176.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.22 48.45 13.09 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 126.252 1.821 . . . . 4.09 110.673 173.141 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -119.55 143.29 47.69 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 125.252 1.421 . . . . 3.18 108.338 -169.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.6 109.57 14.94 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.879 -1.156 . . . . 2.01 107.879 158.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -83.65 110.51 18.33 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 104.557 -2.386 . . . . 2.27 104.557 166.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.8 mt -110.31 143.44 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.292 1.037 . . . . 1.93 108.29 171.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -120.79 133.0 55.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.455 -1.683 . . . . 3.0 106.455 163.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -164.45 167.94 19.01 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.478 0.581 . . . . 3.31 110.911 -163.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -104.02 104.87 45.85 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 108.65 -0.87 . . . . 4.22 108.65 -178.01 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.64 26.18 0.48 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.89 2.393 . . . . 1.62 113.942 -167.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -127.52 -62.89 1.06 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.424 1.09 . . . . 3.78 108.94 -172.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 pt -57.8 -39.76 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.242 0.617 . . . . 3.22 111.748 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 tt -107.01 -81.74 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.796 0.839 . . . . 2.7 109.244 171.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 123.15 155.33 9.26 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.144 0.878 . . . . 1.4 111.242 -177.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.35 -41.42 41.71 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.123 2.549 . . . . 1.3 110.52 175.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.5 ttm105 -32.96 -71.1 0.06 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 127.01 2.124 . . . . 8.99 110.768 171.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.8 -45.64 89.43 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.275 1.83 . . . . 4.04 109.949 -171.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.0 mt -58.56 -60.86 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 109.426 -0.583 . . . . 2.24 109.426 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.4 mt -51.08 -48.43 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.958 0.503 . . . . 2.48 109.822 178.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -61.86 -38.38 88.04 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.686 1.194 . . . . 5.05 111.698 -178.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.7 m -65.03 -52.31 56.69 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.117 -0.99 . . . . 1.79 108.633 175.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 mm -63.64 -36.94 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 O-C-N 122.205 -0.31 . . . . 2.62 110.991 -175.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -52.35 -64.06 0.94 Allowed 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.028 1.331 . . . . 2.7 109.036 166.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 t -52.65 -38.15 59.88 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.345 1.058 . . . . 1.88 112.786 -175.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.9 mt -58.25 -25.78 62.14 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.512 -0.742 . . . . 3.06 112.86 176.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.13 49.94 0.8 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.229 0.918 . . . . 1.02 111.131 178.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -137.97 167.51 21.63 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 106.577 -1.638 . . . . 2.93 106.577 172.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -107.49 89.18 4.73 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 119.351 0.978 . . . . 4.21 112.539 172.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.09 70.92 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.967 2.445 . . . . 1.61 111.629 177.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.4 m -79.14 117.61 20.33 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.242 1.417 . . . . 2.59 108.515 177.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.9 tp -84.69 68.59 10.45 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.936 -1.135 . . . . 4.6 107.936 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.3 p -79.71 -25.9 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 115.393 -0.821 . . . . 5.81 108.875 165.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.1 tttt 72.85 -70.94 0.15 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.9 1.68 . . . . 7.74 110.687 176.046 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.7 mm -89.09 -76.29 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 108.99 -0.744 . . . . 6.74 108.99 -173.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.25 1.119 0 N-CA-C 105.307 -2.108 . . . . 10.25 105.307 -176.814 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.5 mtt . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 107.199 -1.408 . . . . 8.72 107.199 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.95 163.72 14.71 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 108.065 -2.014 . . . . 4.75 108.065 144.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -78.24 134.1 37.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.773 0.829 . . . . 5.11 110.36 -174.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.04 78.85 1.96 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 108.412 -1.875 . . . . 2.51 108.412 174.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.34 76.0 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 117.347 0.573 . . . . 3.53 110.319 -177.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.1 tp -74.93 130.95 40.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.897 -0.779 . . . . 3.41 108.897 179.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -103.65 149.59 24.8 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.092 -1.077 . . . . 2.04 108.092 164.327 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.68 123.88 13.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.03 -1.47 . . . . 2.56 107.03 172.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.35 135.42 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 107.497 -1.297 . . . . 1.95 107.497 166.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.0 156.82 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 124.929 1.292 . . . . 2.35 107.63 173.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.4 mtm105 -138.37 177.37 7.93 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.187 -1.783 . . . . 5.52 106.187 168.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.39 -9.23 71.95 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.53 0.586 . . . . 1.36 112.61 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -69.4 157.99 36.0 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.198 0.999 . . . . 2.89 110.206 176.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 t -149.31 140.34 22.94 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.523 -1.288 . . . . 3.87 107.523 167.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 69.2 m 68.67 153.39 0.1 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.842 1.657 . . . . 3.42 112.563 174.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.32 -36.99 22.71 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.744 0.818 . . . . 3.0 110.619 174.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -35.07 -52.16 0.56 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.931 1.692 . . . . 2.28 112.5 170.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.3 m -63.88 -35.56 81.06 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.482 -0.761 . . . . 1.83 111.627 -175.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.2 t -56.68 -59.52 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.605 -0.887 . . . . 2.07 108.605 178.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -31.77 73.17 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.773 -0.649 . . . . 2.05 109.792 -177.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -58.22 -58.91 6.39 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 106.957 -1.498 . . . . 4.94 106.957 176.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.6 mt -59.61 -53.21 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.54 -1.282 . . . . 1.79 107.54 -171.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -46.02 -57.75 4.16 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 124.127 0.892 . . . . 4.23 110.112 177.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -60.88 -46.79 89.2 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.696 0.76 . . . . 2.06 109.804 -175.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 t -60.23 -36.65 78.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.374 1.47 . . . . 0.99 109.079 -175.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.53 -53.08 17.6 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.344 0.658 . . . . 3.34 112.006 174.066 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.9 p -52.48 -29.17 23.5 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.377 0.535 . . . . 2.02 111.991 -173.148 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 10.23 7.23 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.802 1.408 . . . . 4.13 114.802 178.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -89.48 178.43 6.3 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.121 1.328 . . . . 2.66 109.519 165.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -81.09 159.42 24.73 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.553 -0.906 . . . . 7.97 108.553 166.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.88 -55.88 3.88 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.499 0.571 . . . . 1.97 113.162 170.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.03 107.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 117.713 0.756 . . . . 3.72 110.293 -178.139 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.4 pp -99.52 -25.53 14.4 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.72 1.208 . . . . 3.76 111.732 -174.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -146.96 122.18 10.2 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.297 -1.001 . . . . 4.0 108.297 176.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.2 t -102.0 161.65 13.51 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 107.725 -1.213 . . . . 2.23 107.725 171.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 m -160.36 116.84 2.4 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.208 -1.034 . . . . 2.34 108.208 163.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 m -116.01 165.57 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 122.777 0.431 . . . . 3.11 110.073 169.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.25 135.0 14.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.858 0.863 . . . . 1.72 109.195 170.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.18 -43.91 69.84 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.029 -0.987 . . . . 2.69 110.25 -177.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.34 -49.94 72.92 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.365 0.602 . . . . 1.89 110.512 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -67.74 -11.81 59.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.587 0.755 . . . . 2.62 111.132 178.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 53.8 38.36 28.39 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.799 1.24 . . . . 4.05 108.542 -173.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -133.51 142.58 48.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 O-C-N 122.143 -0.348 . . . . 2.1 111.078 -167.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.3 142.09 47.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.812 1.245 . . . . 1.82 107.928 160.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.03 154.23 48.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.549 0.613 . . . . 1.66 110.316 163.047 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.75 138.62 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.883 -1.154 . . . . 2.19 107.883 178.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -104.12 110.82 23.15 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.035 0.934 . . . . 3.62 108.643 164.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -155.17 158.24 38.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.133 1.373 . . . . 3.89 110.178 -174.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.02 126.01 88.65 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 109.087 -0.709 . . . . 3.62 109.087 165.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.26 -7.98 14.0 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.227 2.618 . . . . 1.21 113.887 -173.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -84.09 -52.68 6.09 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 119.591 1.087 . . . . 4.98 108.439 -179.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.1 pt -62.46 -52.7 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 113.593 0.96 . . . . 1.89 113.593 -168.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.1 tt -97.2 -68.79 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 124.096 0.959 . . . . 2.07 109.658 -178.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 109.49 162.14 19.49 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.735 0.683 . . . . 0.95 113.697 172.109 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.85 -42.82 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.092 3.195 . . . . 0.96 111.903 -173.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -52.26 -50.09 62.78 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.705 1.241 . . . . 9.57 108.732 -173.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.55 -54.13 41.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.005 2.922 . . . . 5.0 108.536 -176.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.1 mt -61.48 -54.85 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 123.841 0.856 . . . . 1.93 110.284 179.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.7 mm -48.56 -53.27 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 118.5 0.591 . . . . 3.4 109.423 178.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -63.5 -33.15 74.95 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.413 0.523 . . . . 3.8 112.413 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.8 m -59.8 -58.1 10.01 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.221 -0.924 . . . . 1.61 109.78 171.203 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.2 mm -63.89 -32.8 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.6 -0.688 . . . . 2.57 110.921 -174.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.08 -58.49 7.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.696 1.198 . . . . 3.03 108.904 167.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.7 t -55.12 -37.27 66.69 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.501 1.12 . . . . 1.74 112.378 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.0 mt -60.17 -16.45 32.97 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.905 0.706 . . . . 3.19 112.905 175.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.35 38.19 5.13 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.951 -0.86 . . . . 0.94 110.951 177.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -127.53 171.58 11.48 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 107.501 -1.296 . . . . 2.91 107.501 172.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -112.15 70.66 1.02 Allowed Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 114.446 1.276 . . . . 4.02 114.446 -168.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.7 110.73 2.82 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.963 2.442 . . . . 1.09 112.864 -175.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.7 t -71.32 177.76 3.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.694 1.198 . . . . 4.56 109.339 160.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.25 -163.48 0.44 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.485 -0.931 . . . . 5.05 108.485 158.345 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 m -61.74 74.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.752 1.621 . . . . 8.04 111.661 175.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -60.68 137.5 58.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.528 1.131 . . . . 12.81 110.128 178.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.4 mt -93.28 121.98 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 104.776 -2.305 . . . . 7.01 104.776 163.22 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.274 0 C-N-CA 127.276 2.23 . . . . 9.74 112.178 -177.209 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ttt . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 111.971 0.36 . . . . 11.88 111.971 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.12 -75.49 0.18 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.349 -1.101 . . . . 6.58 110.349 -168.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.7 t0 24.62 55.08 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 128.661 2.784 . . . . 6.51 113.271 -175.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.99 161.31 10.46 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 107.074 -2.41 . . . . 2.58 107.074 -169.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 m -148.55 172.89 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 105.994 -1.854 . . . . 3.39 105.994 174.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.4 tp -137.27 134.21 35.9 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 107.951 -1.129 . . . . 2.81 107.951 159.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -101.87 123.72 46.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.023 -1.103 . . . . 2.16 108.023 168.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.71 131.17 44.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 110.121 -0.326 . . . . 2.7 110.121 175.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.99 142.52 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.484 -1.672 . . . . 2.54 106.484 168.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.3 107.75 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.879 -1.526 . . . . 2.51 106.879 173.073 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -76.98 166.04 23.85 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.934 -0.765 . . . . 6.47 108.934 174.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.84 -45.77 3.36 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.778 -0.929 . . . . 1.32 110.778 -177.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -57.01 120.16 7.51 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.837 -0.801 . . . . 3.49 108.837 174.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 t -156.92 19.44 0.31 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.39 0.515 . . . . 4.62 112.39 -166.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.6 t -157.45 148.21 21.27 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 120.781 -1.199 . . . . 3.46 109.141 -179.089 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.76 -41.02 10.27 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.069 0.948 . . . . 2.79 111.535 173.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.8 m -51.29 -55.9 15.83 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.206 0.602 . . . . 2.21 110.513 172.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.9 m -55.97 -51.97 65.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 123.804 0.842 . . . . 1.74 109.464 178.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.9 t -46.8 -61.85 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.001 0.52 . . . . 2.17 109.734 178.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.283 0.0 OUTLIER -64.78 -21.97 66.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.936 -0.575 . . . . 2.35 110.923 -176.175 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -66.73 -47.3 72.72 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.871 -0.789 . . . . 5.12 108.871 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.2 mt -66.73 -52.21 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.769 -1.197 . . . . 1.94 107.769 -178.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -41.83 -66.57 0.33 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.486 0.714 . . . . 3.37 110.328 171.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.6 t -55.88 -49.43 73.41 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.473 1.109 . . . . 2.32 109.815 -172.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.0 t -64.31 -37.4 87.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 118.802 -0.618 . . . . 1.69 111.414 -178.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.71 -41.14 72.3 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.237 0.926 . . . . 2.82 110.33 178.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.1 p -65.18 74.65 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.964 0.906 . . . . 1.78 111.022 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.5 pttm 179.15 -36.23 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 129.521 3.129 . . . . 4.5 109.707 -178.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -53.53 118.59 4.0 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.193 0.597 . . . . 2.45 110.657 -178.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -67.24 82.19 0.14 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.541 1.137 . . . . 5.91 110.252 -171.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.26 -29.24 0.52 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.162 0.887 . . . . 1.31 110.927 -174.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.21 140.06 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.65 1.18 . . . . 2.79 109.239 175.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.3 mt -114.2 -47.6 2.93 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.341 1.456 . . . . 3.89 109.703 168.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -143.3 138.38 29.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.334 0.515 . . . . 4.0 110.94 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -105.49 156.71 17.95 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.656 -1.238 . . . . 2.19 107.656 173.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.1 92.64 1.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.878 -0.786 . . . . 1.94 108.878 162.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.4 t -92.3 144.96 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 125.707 1.603 . . . . 3.56 109.59 176.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.83 134.56 11.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.895 -0.503 . . . . 1.8 111.577 172.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.15 -30.48 62.29 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 123.828 0.851 . . . . 2.47 111.353 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.47 -29.66 69.2 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.396 0.543 . . . . 2.26 110.722 -177.238 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -115.38 5.88 14.69 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.795 1.238 . . . . 3.06 110.836 176.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 45.45 45.49 10.31 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 127.541 2.337 . . . . 4.05 112.45 175.003 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -139.03 161.52 37.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.334 0.494 . . . . 2.91 112.334 -178.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.71 124.81 52.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.769 1.627 . . . . 1.98 106.853 160.04 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 139.22 30.84 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.069 -1.086 . . . . 1.39 108.069 153.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.96 125.95 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.955 -1.498 . . . . 1.97 106.955 174.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -101.95 87.83 3.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.027 1.331 . . . . 3.22 107.952 167.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -125.49 157.12 37.77 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.131 2.173 . . . . 3.58 109.48 178.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -72.28 120.37 80.04 Favored Pre-proline 0 C--N 1.34 0.179 0 N-CA-C 105.987 -1.857 . . . . 3.18 105.987 167.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.8 -67.68 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.48 1.454 . . . . 1.79 113.065 -169.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -52.89 -41.16 64.1 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.349 1.06 . . . . 5.3 112.595 -159.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 pt -51.9 -41.23 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.025 0.93 . . . . 2.4 113.135 -178.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.0 tt -119.9 -48.49 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.422 1.089 . . . . 2.54 111.305 -167.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.38 160.24 35.07 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.1 1.333 . . . . 1.23 112.201 172.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -66.99 -26.52 43.47 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.198 2.599 . . . . 1.72 111.941 179.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.8 ttm105 -51.06 -55.57 16.94 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.741 0.817 . . . . 6.09 110.741 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -47.67 -53.64 14.37 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.552 1.141 . . . . 2.97 110.689 176.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.66 -57.41 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.717 0.807 . . . . 2.13 110.568 -178.397 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.62 -37.03 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 O-C-N 121.661 -0.649 . . . . 5.69 111.795 -175.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -55.4 -49.85 71.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.826 0.739 . . . . 4.18 109.873 169.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.6 m -56.24 -50.93 69.91 Favored 'General case' 0 C--O 1.224 -0.24 0 O-C-N 121.731 -0.606 . . . . 1.76 110.838 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.54 -41.75 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 121.539 -0.725 . . . . 3.09 111.865 -175.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -52.15 -48.21 65.03 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.006 -0.739 . . . . 4.13 109.006 169.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.0 t -64.9 -42.33 94.86 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.819 -0.628 . . . . 2.43 111.321 -177.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.43 -46.29 86.79 Favored 'General case' 0 C--N 1.34 0.172 0 O-C-N 121.485 -0.76 . . . . 2.67 109.994 173.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.34 43.84 0.34 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.132 -0.787 . . . . 0.99 111.132 170.138 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -129.7 155.83 45.26 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.039 -1.837 . . . . 3.03 106.039 170.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -107.82 102.66 46.38 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 118.579 -0.724 . . . . 3.39 110.319 -168.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -85.15 154.33 11.02 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.976 2.451 . . . . 1.72 113.124 -171.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.0 m -162.03 135.67 6.4 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 125.97 1.708 . . . . 3.15 107.953 166.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -54.27 138.86 37.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.565 -0.531 . . . . 4.15 109.565 173.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.4 p -90.19 -49.04 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.752 -0.462 . . . . 4.87 109.752 -175.122 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.3 tttm 67.32 159.38 0.15 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.338 1.455 . . . . 7.22 110.864 -173.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.18 146.11 34.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 104.041 -2.577 . . . . 8.21 104.041 152.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 C--O 1.255 1.382 0 CA-C-O 116.29 -1.814 . . . . 9.01 112.17 -164.946 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 106.019 -1.845 . . . . 9.55 106.019 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 149.03 -156.68 26.93 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 107.105 -2.398 . . . . 5.55 107.105 -175.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -130.35 171.14 13.26 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 106.677 -1.601 . . . . 7.21 106.677 163.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.53 41.58 0.62 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-O 118.033 -1.426 . . . . 3.98 111.47 158.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -150.78 80.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 118.855 1.327 . . . . 3.82 107.628 172.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.51 89.29 6.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.111 -1.441 . . . . 4.16 107.111 164.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -67.83 133.72 49.69 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.628 -0.879 . . . . 2.47 108.628 156.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 pp -146.13 137.41 24.64 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.51 -1.293 . . . . 2.29 107.51 167.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.71 145.82 13.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 107.966 -1.124 . . . . 2.66 107.966 173.474 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.93 105.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 127.807 2.443 . . . . 2.54 104.489 173.092 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -86.54 163.91 17.21 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.284 -1.006 . . . . 8.45 108.284 166.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.76 -13.58 29.67 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.89 0.757 . . . . 1.22 112.166 -177.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.1 mtm -65.89 88.25 0.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.233 1.016 . . . . 2.0 110.024 172.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 p -68.83 -37.21 79.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.078 0.551 . . . . 3.94 111.599 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.5 t -158.28 169.85 23.57 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.176 0.444 . . . . 4.38 110.247 -169.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.37 -28.06 7.39 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.237 1.815 . . . . 3.01 113.377 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 p -49.81 -63.18 1.19 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.309 -0.626 . . . . 3.16 109.309 169.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.2 m -51.22 -47.83 62.22 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.675 0.79 . . . . 1.71 110.697 179.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.4 t -49.0 -62.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 123.773 0.829 . . . . 1.97 109.927 178.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -26.47 67.69 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 120.835 -0.346 . . . . 1.73 110.468 -177.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -63.32 -50.11 71.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.79 -0.819 . . . . 5.27 108.79 179.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.9 mt -64.88 -53.24 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.815 -1.179 . . . . 1.56 107.815 -178.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -49.36 -58.83 4.41 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.784 0.834 . . . . 3.9 109.625 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.9 t -62.47 -48.19 80.71 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.458 -0.792 . . . . 1.92 109.793 -174.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.6 t -57.7 -36.2 71.66 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.12 -0.491 . . . . 1.71 110.69 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.2 mt -72.43 -47.62 47.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.984 -1.008 . . . . 3.18 111.973 177.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.1 p -62.11 77.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.913 0.885 . . . . 1.79 111.694 -176.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? 169.54 -37.32 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.935 2.494 . . . . 4.15 110.468 -171.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -58.19 126.8 29.07 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.246 -1.02 . . . . 2.98 108.246 171.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -72.42 74.7 1.03 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.873 0.869 . . . . 5.48 111.658 -163.086 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.91 -41.09 0.19 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.404 -1.079 . . . . 1.65 110.404 178.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.67 100.46 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 117.724 0.762 . . . . 3.38 110.186 -176.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.14 -35.49 23.59 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.596 1.158 . . . . 3.51 111.494 -176.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -143.6 116.49 8.8 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.903 0.881 . . . . 3.17 109.275 176.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.2 t -97.48 155.4 16.95 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 107.905 -1.146 . . . . 2.52 107.905 169.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 t -158.24 102.85 1.79 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.887 -1.523 . . . . 2.18 106.887 169.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.54 159.31 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 120.505 0.193 . . . . 2.78 110.708 173.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.48 134.39 21.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.404 1.082 . . . . 2.07 110.061 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.54 -41.97 62.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.527 -1.215 . . . . 2.73 110.942 -173.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.3 -47.26 80.16 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.551 0.691 . . . . 2.34 109.674 -172.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -80.78 -2.55 47.56 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.514 -0.755 . . . . 3.5 110.763 177.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 51.39 49.8 20.23 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.651 1.18 . . . . 3.46 108.769 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -139.53 142.48 37.24 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.09 0.404 . . . . 2.44 111.744 -169.06 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.98 125.03 50.5 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.262 1.425 . . . . 1.75 108.485 163.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.08 119.63 38.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.504 -2.036 . . . . 1.52 105.504 164.426 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.12 120.55 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.04 1.336 . . . . 2.11 108.24 175.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -92.57 97.26 10.7 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.775 -0.824 . . . . 3.96 108.775 163.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.72 143.58 43.4 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.577 -0.897 . . . . 4.18 108.577 174.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.85 127.56 88.13 Favored Pre-proline 0 N--CA 1.452 -0.352 0 N-CA-C 106.196 -1.779 . . . . 3.73 106.196 169.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.63 -59.21 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.663 1.576 . . . . 1.85 112.507 -169.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -50.12 -43.28 51.67 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.06 1.744 . . . . 3.42 112.396 -162.657 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 pt -55.34 -40.16 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.754 0.822 . . . . 2.61 113.128 -177.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.7 tt -123.68 -48.24 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.805 0.842 . . . . 2.86 112.676 -165.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.45 147.56 22.69 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.129 1.347 . . . . 1.16 111.443 178.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.86 -34.42 23.98 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.106 2.538 . . . . 1.02 111.469 -177.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -55.5 -41.73 73.48 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 118.841 -0.599 . . . . 7.83 112.441 -174.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -48.71 -62.18 1.64 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.516 1.151 . . . . 2.72 110.025 174.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 mt -56.65 -56.36 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.209 1.404 . . . . 2.58 110.431 -179.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.31 -47.66 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 122.024 -0.422 . . . . 2.28 110.42 -178.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.7 m170 -60.8 -42.67 98.07 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.832 0.742 . . . . 4.19 110.817 178.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.3 m -57.33 -52.33 65.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.238 -0.653 . . . . 1.99 109.238 177.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.4 mm -68.36 -34.59 66.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 O-C-N 122.09 -0.381 . . . . 3.12 111.777 -175.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -56.41 -59.26 5.22 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.517 1.127 . . . . 2.82 108.026 171.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -52.99 -40.35 63.73 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.349 1.06 . . . . 1.71 111.506 176.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.1 tp -66.4 -10.5 44.28 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.121 0.968 . . . . 3.68 112.446 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.2 45.76 2.33 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 118.68 0.673 . . . . 0.77 112.055 168.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -139.32 177.81 7.65 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 107.794 -1.188 . . . . 3.58 107.794 172.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -112.6 72.49 1.33 Allowed Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 113.198 0.814 . . . . 3.42 113.198 -177.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -63.58 104.45 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.983 3.122 . . . . 1.37 111.814 -177.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.4 p -129.15 124.71 35.35 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.798 1.639 . . . . 2.75 108.735 -172.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tt -76.33 73.52 3.11 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.261 -0.899 . . . . 4.8 111.092 -171.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.9 t -86.47 -37.88 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.408 1.083 . . . . 4.67 111.593 -177.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.1 mttt 52.14 -114.31 0.81 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.654 0.782 . . . . 9.64 111.03 -168.084 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.5 mm -132.46 -64.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 105.519 -2.03 . . . . 9.53 105.519 163.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 C--O 1.26 1.637 0 N-CA-C 101.993 -3.336 . . . . 9.7 101.993 136.507 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttm . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 119.29 -0.386 . . . . 9.01 111.136 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.78 159.33 30.43 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.214 0.435 . . . . 4.21 112.061 -178.541 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 t70 51.38 -172.32 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.203 1.801 . . . . 3.83 111.149 -165.059 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.95 96.9 0.2 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.52 -1.432 . . . . 2.01 109.52 -176.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 t -75.19 70.16 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 117.64 0.72 . . . . 3.33 109.739 178.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.4 tp -70.11 154.47 41.89 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.105 -0.702 . . . . 3.38 109.105 175.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -129.07 148.49 51.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.967 0.907 . . . . 2.54 110.035 170.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.52 133.78 44.19 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 107.247 -1.39 . . . . 2.74 107.247 168.283 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.6 109.39 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 105.729 -1.952 . . . . 1.98 105.729 171.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -104.41 109.08 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.944 -0.762 . . . . 2.9 108.944 -174.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.58 155.24 40.76 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.392 -1.336 . . . . 4.82 107.392 170.196 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.66 -19.85 7.88 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.405 0.526 . . . . 1.25 113.512 168.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.4 mtm -58.96 104.48 0.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.568 1.184 . . . . 2.36 110.725 171.541 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.5 p -91.36 -83.36 0.28 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.058 0.943 . . . . 4.49 110.4 177.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 84.4 m -79.17 -68.29 0.67 Allowed 'General case' 0 CA--C 1.527 0.061 0 C-N-CA 123.245 0.618 . . . . 4.4 111.279 -160.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -174.58 -61.78 0.01 OUTLIER 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 124.401 1.08 . . . . 2.48 108.865 -176.147 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.2 t -41.07 -46.75 3.01 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.315 1.446 . . . . 3.32 111.161 -176.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.3 m -23.62 -52.0 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.133 2.173 . . . . 1.7 113.511 168.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.4 t -49.52 -61.46 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.346 0.659 . . . . 1.65 110.589 176.115 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -28.68 66.03 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.323 0.649 . . . . 1.39 110.208 -177.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.57 -52.55 59.38 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 107.489 -1.3 . . . . 3.89 107.489 175.055 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.6 mt -65.84 -60.39 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 107.344 -1.354 . . . . 1.83 107.344 178.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.04 -51.81 16.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.572 0.701 . . . . 2.85 110.583 -171.379 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.1 t -67.38 -56.53 9.31 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.988 0.915 . . . . 2.25 109.739 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.1 t -64.98 -18.09 64.98 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.693 -0.67 . . . . 1.19 112.446 -173.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.44 -47.4 7.47 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 117.672 -1.156 . . . . 3.52 111.548 173.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 p -53.87 -35.13 61.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.606 1.548 . . . . 2.25 111.615 178.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -32.05 -48.84 0.17 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.097 1.359 . . . . 5.77 113.23 163.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -75.13 63.45 1.3 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.288 1.035 . . . . 2.79 110.798 178.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 3.76 -64.0 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 129.5 3.12 . . . . 5.23 117.247 178.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -46.02 -45.99 14.72 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.43 1.014 . . . . 1.61 112.557 178.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -73.3 84.99 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.022 -1.103 . . . . 3.93 108.022 168.515 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.5 pp -65.67 -33.79 76.71 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.988 -0.551 . . . . 4.59 111.299 -175.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -146.64 104.68 3.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.912 0.485 . . . . 4.26 111.566 173.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.3 t -80.19 142.28 34.84 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 106.89 -1.522 . . . . 2.85 106.89 162.067 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -132.73 101.77 5.41 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.719 -1.215 . . . . 1.9 107.719 -178.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.2 t -107.6 142.71 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 124.64 1.176 . . . . 3.84 110.193 -167.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.45 137.31 17.12 Favored 'General case' 0 C--N 1.339 0.109 0 O-C-N 121.481 -0.762 . . . . 2.1 111.353 177.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -81.71 -35.21 30.05 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 124.463 1.105 . . . . 2.4 112.013 -172.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.26 91.52 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 109.572 -0.529 . . . . 2.07 109.572 -177.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -93.26 -5.19 50.41 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.454 -0.794 . . . . 3.18 111.454 173.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 41.19 55.02 3.34 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 126.744 2.018 . . . . 4.02 109.456 -176.387 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -133.76 152.02 51.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.889 -1.05 . . . . 2.91 109.502 -171.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.29 129.1 56.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.646 -1.613 . . . . 1.98 106.646 157.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.72 145.51 25.24 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 107.366 -1.346 . . . . 1.42 107.366 157.543 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.3 mp -127.22 115.37 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.252 -0.647 . . . . 2.92 109.252 -169.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -86.48 81.03 8.45 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.196 -1.038 . . . . 3.6 108.196 165.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.33 167.95 14.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.378 1.071 . . . . 3.46 110.194 176.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -108.72 126.18 30.05 Favored Pre-proline 0 N--CA 1.447 -0.616 0 O-C-N 124.317 1.011 . . . . 3.43 109.084 171.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.5 -20.76 20.31 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.126 2.55 . . . . 1.2 112.72 -177.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -96.48 14.46 24.49 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.986 0.914 . . . . 3.92 111.434 -170.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 pt -126.96 -87.55 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.282 1.033 . . . . 2.01 109.408 163.032 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.9 tt -59.44 -49.4 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.621 1.168 . . . . 2.01 112.008 -176.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.73 159.5 30.61 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.718 -0.553 . . . . 0.99 111.718 -178.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.88 -30.84 8.83 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.052 2.501 . . . . 0.97 111.541 -175.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -54.81 -52.51 62.45 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.657 0.783 . . . . 5.83 110.849 -174.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -49.46 -55.07 14.47 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.51 1.124 . . . . 2.6 109.653 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.38 -59.79 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.877 1.271 . . . . 2.22 110.373 178.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.6 mt -52.63 -41.73 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 119.234 0.924 . . . . 2.42 111.416 -178.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -67.08 -45.52 77.05 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.856 -0.527 . . . . 3.28 109.911 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.3 m -57.94 -50.29 73.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.594 -0.891 . . . . 1.63 108.594 179.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.1 mm -53.54 -52.18 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.547 1.139 . . . . 2.61 109.915 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -47.68 -64.84 0.68 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.258 0.552 . . . . 3.78 109.807 173.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 m -67.57 -26.38 66.26 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.927 -0.578 . . . . 3.67 112.267 -167.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.1 tp -67.0 -12.5 60.02 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.192 1.397 . . . . 3.5 111.663 175.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.48 47.28 0.7 Allowed Glycine 0 C--N 1.339 0.716 0 C-N-CA 124.948 1.261 . . . . 1.18 110.703 168.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -143.41 178.03 8.03 Favored 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 108.853 -0.795 . . . . 3.09 108.853 -178.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.07 101.77 14.92 Favored Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 108.685 -0.857 . . . . 4.54 108.685 173.746 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -83.48 92.0 0.87 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.362 2.708 . . . . 1.23 112.896 -175.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.8 m -79.17 113.15 17.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.733 0.778 . . . . 2.44 109.614 170.011 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tt -76.76 71.69 3.34 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.8 0.84 . . . . 4.18 108.966 171.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.7 t -64.52 -43.41 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 122.99 0.516 . . . . 5.12 111.333 -173.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.295 0.0 OUTLIER 42.65 -154.46 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.829 1.651 . . . . 8.14 112.566 -169.395 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 tp -70.28 143.56 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.588 -0.695 . . . . 7.44 109.352 168.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 . . . . . 0 C--O 1.256 1.442 0 N-CA-C 103.343 -2.836 . . . . 10.5 103.343 164.883 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 108.259 -1.015 . . . . 10.41 108.259 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.32 156.32 15.79 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 107.702 -2.159 . . . . 3.99 107.702 168.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.1 t70 46.79 -131.57 1.27 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.51 1.124 . . . . 3.99 109.983 -175.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.24 174.3 49.66 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.776 -1.33 . . . . 2.47 109.776 -170.085 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.69 146.16 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 O-C-N 122.074 -0.662 . . . . 3.63 109.398 -176.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.29 114.59 28.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.797 -1.927 . . . . 3.64 105.797 168.498 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -92.74 120.93 33.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.125 -1.065 . . . . 2.59 108.125 164.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -122.01 154.55 37.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.286 -1.376 . . . . 2.82 107.286 169.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.25 146.78 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.311 -1.737 . . . . 1.9 106.311 171.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.86 163.89 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.933 2.093 . . . . 2.52 105.426 -179.32 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -143.05 165.05 28.43 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.529 1.059 . . . . 4.91 108.412 173.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.07 -86.06 0.4 Allowed Glycine 0 C--N 1.337 0.587 0 N-CA-C 108.744 -1.742 . . . . 2.42 108.744 177.044 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.3 mpt? 52.12 -158.16 0.13 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.529 1.131 . . . . 4.78 112.26 -173.826 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -161.23 55.56 0.29 Allowed 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.17 0.988 . . . . 6.21 108.752 179.35 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.8 t 74.69 -45.46 0.58 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.442 1.497 . . . . 4.64 113.486 175.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.2 -71.5 0.23 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.319 0.509 . . . . 2.38 111.043 -179.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -42.88 -44.12 4.39 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.763 1.625 . . . . 2.15 114.48 -162.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.6 m -47.19 -37.19 9.77 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.204 0.602 . . . . 2.53 112.454 179.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -49.7 -61.63 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 123.539 0.735 . . . . 1.88 110.558 174.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -30.35 69.65 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.932 -0.766 . . . . 1.64 108.932 -176.48 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -58.83 -53.43 58.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.299 -1.0 . . . . 5.62 108.299 177.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.66 -50.03 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.991 -1.115 . . . . 1.85 107.991 -173.572 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -47.73 -60.93 2.21 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.927 0.767 . . . . 4.12 109.455 176.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.5 t -57.65 -47.32 82.57 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 122.224 1.012 . . . . 2.16 110.42 -173.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -70.9 -23.86 62.36 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.402 1.481 . . . . 0.99 110.899 -174.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mt -80.39 -43.71 20.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.656 0.662 . . . . 3.57 111.061 171.279 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.2 p -67.95 73.28 0.18 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.029 0.931 . . . . 1.74 110.835 179.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.479 ' HZ2' ' CD2' ' A' ' 29' ' ' HIS . 0.0 OUTLIER 178.92 -34.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.515 2.726 . . . . 5.02 111.289 -176.832 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.479 ' CD2' ' HZ2' ' A' ' 28' ' ' LYS . 4.7 m-70 -35.02 -69.49 0.1 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 126.174 1.789 . . . . 3.54 115.148 -170.397 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -165.17 -51.93 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 108.697 -0.853 . . . . 8.99 108.697 174.065 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -151.02 63.08 0.4 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.38 -1.488 . . . . 2.52 109.38 175.432 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -73.14 126.28 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 105.709 -1.96 . . . . 3.52 105.709 158.552 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.31 -51.68 9.75 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.139 -1.43 . . . . 3.42 107.139 165.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -155.81 139.51 16.08 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.045 -0.525 . . . . 3.87 110.955 -178.312 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.6 t -109.05 150.29 28.01 Favored 'General case' 0 C--O 1.227 -0.092 0 N-CA-C 107.622 -1.251 . . . . 2.26 107.622 167.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.66 109.7 3.29 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.357 -0.839 . . . . 1.77 109.378 175.235 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 m -113.59 155.87 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.466 0.706 . . . . 2.78 111.295 176.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.85 133.74 19.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.353 0.661 . . . . 2.23 109.694 171.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -76.09 -42.58 46.79 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.445 0.698 . . . . 2.51 111.293 -171.014 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.73 -46.32 87.63 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.081 0.552 . . . . 2.64 110.466 179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.47 -15.69 60.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.61 1.164 . . . . 3.1 111.471 175.079 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 52.6 34.81 16.54 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.172 1.789 . . . . 3.85 110.006 -172.521 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -102.82 144.64 30.9 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.659 1.183 . . . . 2.71 108.027 -172.303 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.46 110.35 7.68 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.39 -0.967 . . . . 2.14 108.39 161.221 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.78 144.43 25.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.616 -0.513 . . . . 1.44 109.616 168.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.9 mp -124.43 120.03 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 106.377 -1.712 . . . . 2.07 106.377 175.073 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -96.24 96.17 8.61 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.151 -1.426 . . . . 3.04 107.151 166.553 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -134.61 153.75 51.82 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.501 1.521 . . . . 3.57 107.205 -177.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -82.06 130.66 59.32 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 119.484 -0.886 . . . . 3.35 109.315 168.277 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.5 -40.9 9.62 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.682 2.254 . . . . 1.52 113.087 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -88.52 43.35 1.13 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.572 1.078 . . . . 3.56 110.824 -164.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 pt -142.91 -41.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 126.238 1.815 . . . . 2.69 111.342 172.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.9 tt -121.14 -61.26 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.353 1.061 . . . . 2.15 111.844 -175.319 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.41 157.0 25.84 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.734 1.159 . . . . 0.8 111.537 178.778 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.32 -32.63 12.38 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.486 2.791 . . . . 0.78 112.556 -172.592 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -51.93 -52.92 46.71 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.345 0.658 . . . . 7.09 111.549 -178.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -48.31 -57.42 6.02 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.487 1.115 . . . . 2.63 110.35 177.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.2 mt -53.51 -63.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.477 1.111 . . . . 2.12 109.436 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.2 mt -49.47 -52.11 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.264 0.625 . . . . 2.24 110.162 -176.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -69.81 -30.49 68.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.764 -0.585 . . . . 4.03 111.999 -175.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 92.1 m -66.71 -51.34 57.12 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.289 -0.882 . . . . 1.92 109.563 173.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mm -55.97 -41.92 69.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 122.809 0.444 . . . . 2.59 110.132 177.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.95 -58.45 7.82 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.023 0.929 . . . . 3.05 109.076 174.247 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.5 m -54.13 -37.47 64.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.149 0.98 . . . . 3.54 112.674 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.8 mt -67.24 -6.21 17.25 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.957 0.725 . . . . 3.02 112.957 177.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.08 48.94 2.15 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.827 -0.909 . . . . 0.78 110.827 173.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -134.61 -179.76 5.79 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.39 1.076 . . . . 3.18 109.621 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -121.8 57.87 8.34 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.069 0.947 . . . . 3.51 112.23 -173.312 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.95 85.25 0.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 124.282 3.322 . . . . 1.15 113.042 -167.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.2 m -97.56 126.24 42.74 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.719 1.608 . . . . 2.66 108.476 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 pp -62.06 151.32 35.79 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.705 0.684 . . . . 4.37 109.348 170.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.0 t -136.07 -54.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 122.753 0.421 . . . . 4.16 111.689 -179.262 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.24 150.98 28.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 121.188 -0.205 . . . . 8.51 111.347 -171.263 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 75.4 mt -122.28 -66.37 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 104.746 -2.316 . . . . 7.63 104.746 173.055 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--O 1.25 1.109 0 N-CA-C 104.882 -2.266 . . . . 11.76 104.882 137.271 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 106.638 -1.615 . . . . 11.75 106.638 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.97 -64.76 0.45 Allowed Glycine 0 CA--C 1.52 0.399 0 N-CA-C 105.285 -3.126 . . . . 5.07 105.285 -173.026 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 56.75 -148.02 0.51 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.52 1.128 . . . . 4.91 109.395 162.23 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.65 155.26 8.32 Favored Glycine 0 CA--C 1.522 0.481 0 O-C-N 121.765 -0.584 . . . . 2.11 112.052 171.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m -139.84 161.95 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.26 -1.385 . . . . 3.22 107.26 167.008 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.0 tp -150.87 147.9 27.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.96 -1.496 . . . . 3.14 106.96 166.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -116.38 128.96 55.98 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.251 -1.388 . . . . 2.56 107.251 174.483 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.87 125.35 44.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.72 -1.585 . . . . 2.69 106.72 177.829 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.1 t -65.03 144.08 15.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 N-CA-C 106.866 -1.531 . . . . 2.04 106.866 168.159 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 m -141.75 86.17 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 119.102 0.865 . . . . 2.35 110.512 -174.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 56.7 mmt-85 -55.69 141.2 38.92 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.309 -1.367 . . . . 6.59 107.309 168.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.86 -26.45 8.87 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.845 0.736 . . . . 1.17 111.504 -175.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.8 mtm -69.73 77.27 0.44 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.936 1.368 . . . . 2.55 111.744 176.188 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -77.09 -33.8 56.94 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.898 0.879 . . . . 2.93 111.943 178.067 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -149.67 158.03 43.79 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.385 0.539 . . . . 3.32 110.766 -163.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.68 -33.1 0.67 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.156 1.782 . . . . 2.88 113.605 173.13 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.1 p -53.27 -53.29 53.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.659 -0.651 . . . . 3.4 110.269 172.21 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.3 m -58.55 -49.09 78.7 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.173 0.589 . . . . 2.17 109.99 178.153 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.1 t -45.27 -63.95 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.351 0.66 . . . . 1.8 109.66 177.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.282 0.0 OUTLIER -63.95 -24.64 67.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.754 -0.657 . . . . 1.85 110.984 -177.233 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -61.41 -53.58 54.74 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 108.263 -1.014 . . . . 4.26 108.263 177.038 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.3 mt -67.07 -56.24 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.434 -1.321 . . . . 2.04 107.434 -175.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -46.39 -58.15 4.0 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.968 0.907 . . . . 3.54 112.362 177.498 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.8 t -66.45 -31.1 71.64 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.19 0.596 . . . . 2.12 110.438 -176.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 t -66.26 -53.07 41.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.571 -0.705 . . . . 1.83 109.379 175.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -52.86 -45.04 67.22 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.805 0.729 . . . . 3.43 112.183 -175.025 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.6 p -62.53 -9.39 8.52 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.705 0.631 . . . . 1.99 112.705 -176.344 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -71.53 -37.15 71.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.752 0.821 . . . . 5.73 111.138 171.081 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -74.71 121.02 21.05 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.306 -0.627 . . . . 2.41 109.306 -167.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -77.84 62.6 2.71 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.164 0.586 . . . . 6.18 111.669 -176.134 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.47 42.8 0.06 OUTLIER Glycine 0 CA--C 1.526 0.719 0 N-CA-C 109.116 -1.593 . . . . 1.75 109.116 174.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.92 142.66 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 104.315 -2.476 . . . . 2.92 104.315 -178.757 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.3 tp -100.63 -45.42 5.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.67 1.188 . . . . 4.43 110.132 -179.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -162.05 151.25 15.74 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.719 -0.845 . . . . 3.03 108.719 -179.092 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.9 p -131.73 157.07 44.76 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 123.887 0.875 . . . . 2.98 108.937 173.227 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.1 t -170.8 121.43 0.57 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.817 -1.549 . . . . 2.46 106.817 176.172 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 m -121.19 130.56 74.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.76 0.709 . . . . 2.8 110.178 178.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.3 133.83 53.33 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.349 1.06 . . . . 2.16 111.566 -173.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.18 -56.14 11.19 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 125.274 1.43 . . . . 3.88 110.665 -176.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.78 -47.61 76.78 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.186 0.594 . . . . 2.43 110.842 -174.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.72 -15.69 62.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.017 1.327 . . . . 2.98 111.29 177.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 48.53 42.34 18.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.134 1.774 . . . . 4.15 110.435 -170.691 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -123.84 132.94 53.86 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 124.092 0.957 . . . . 2.43 109.656 -165.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.4 117.3 34.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.284 1.033 . . . . 1.93 108.567 166.183 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.61 124.01 45.6 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.992 -1.855 . . . . 1.84 105.992 174.067 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.2 mp -121.86 133.73 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.979 -1.119 . . . . 2.35 107.979 171.124 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -103.17 135.82 44.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.21 1.804 . . . . 3.12 106.707 161.205 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -168.66 178.95 4.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.976 1.31 . . . . 3.92 112.199 -165.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -110.34 74.7 0.87 Allowed Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.612 1.165 . . . . 4.17 108.985 -174.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -45.76 -48.17 12.71 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 124.452 3.435 . . . . 1.45 113.467 -165.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.71 -34.31 38.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.024 1.33 . . . . 4.76 112.236 -176.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.7 pt -95.22 -53.77 7.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 N-CA-C 112.228 0.455 . . . . 1.94 112.228 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.5 tt -72.35 -44.97 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 120.917 0.389 . . . . 2.9 111.195 -173.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.24 124.6 1.16 Allowed Glycine 0 CA--C 1.537 1.423 0 N-CA-C 110.846 -0.901 . . . . 1.29 110.846 -176.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -53.76 -33.19 69.37 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.034 2.489 . . . . 0.75 111.614 176.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -51.4 -46.0 62.7 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.809 0.843 . . . . 7.89 112.031 175.024 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -59.48 -56.37 22.81 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.603 0.716 . . . . 2.6 109.449 -176.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 89.1 mt -48.21 -62.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 124.187 0.995 . . . . 1.87 109.337 174.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.8 mt -54.22 -53.59 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 119.286 -0.388 . . . . 2.07 110.513 -173.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -65.12 -33.75 76.76 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.945 0.793 . . . . 3.44 112.365 -178.194 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 92.2 m -65.16 -50.8 64.57 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.362 -0.836 . . . . 1.79 109.473 176.159 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mm -64.08 -42.63 96.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.651 -0.656 . . . . 2.94 110.647 -177.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -48.3 -62.28 1.57 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.445 1.498 . . . . 3.2 109.316 169.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.9 t -52.52 -40.82 62.89 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.596 1.158 . . . . 1.81 112.123 -179.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.46 -3.95 5.07 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.979 1.103 . . . . 3.18 113.979 178.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.76 50.63 1.93 Allowed Glycine 0 C--N 1.335 0.494 0 N-CA-C 110.12 -1.192 . . . . 0.82 110.12 171.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -138.82 169.31 18.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.886 0.875 . . . . 3.05 109.567 178.058 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -112.51 76.98 2.17 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 118.03 -0.986 . . . . 4.42 112.408 177.193 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.01 74.56 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 124.082 3.188 . . . . 1.2 113.151 -175.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.46 115.88 13.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.925 0.89 . . . . 2.67 109.493 173.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.99 76.52 0.22 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.587 1.155 . . . . 4.17 108.666 170.564 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -44.07 -67.61 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 126.529 1.932 . . . . 4.28 112.048 -174.886 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.4 tttm 80.31 140.68 0.07 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.544 1.537 . . . . 7.92 109.839 176.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.6 mm 61.57 67.2 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 106.476 -1.675 . . . . 6.8 106.476 -160.46 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 C--O 1.252 1.223 0 C-N-CA 125.718 1.607 . . . . 10.53 109.952 -157.961 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 109.648 -0.501 . . . . 11.43 109.648 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.58 -42.12 55.86 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 108.744 -1.743 . . . . 5.69 108.744 167.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -67.4 158.19 32.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 129.248 3.019 . . . . 5.92 110.453 160.05 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.99 115.59 0.67 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.832 -0.507 . . . . 2.26 111.832 173.008 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -84.84 81.92 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.242 0 N-CA-C 106.063 -1.829 . . . . 3.39 106.063 156.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.1 tp -91.0 122.44 33.66 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.898 -1.149 . . . . 2.89 107.898 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -88.29 136.46 32.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.218 -1.03 . . . . 2.07 108.218 163.202 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.79 133.97 50.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.087 -1.079 . . . . 3.12 108.087 157.118 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.36 143.12 14.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.564 -1.273 . . . . 2.13 107.564 163.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.7 m -135.79 85.16 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.327 1.051 . . . . 2.63 110.89 -170.196 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -62.29 139.72 58.51 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.007 -1.058 . . . . 7.3 109.864 -174.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.31 -24.67 6.51 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.733 -0.481 . . . . 1.73 112.765 175.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.5 mtm -59.97 152.63 23.23 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.262 1.031 . . . . 2.47 110.738 175.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -161.72 -59.39 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.1 0.56 . . . . 3.97 110.145 177.44 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.8 p -81.15 153.54 27.2 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.9 -0.5 . . . . 4.53 111.116 -176.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.84 -50.32 7.94 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 124.679 1.192 . . . . 2.21 111.656 -178.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 m -43.99 -40.85 5.0 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.072 1.349 . . . . 2.19 112.399 -178.217 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.3 m -47.78 -43.14 27.22 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.762 0.825 . . . . 2.1 110.939 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.4 t -50.89 -68.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 123.632 0.773 . . . . 1.88 108.99 179.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -27.39 69.18 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.76 -0.459 . . . . 1.4 109.76 -175.75 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -59.1 -54.62 45.0 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.808 -0.812 . . . . 4.14 108.808 179.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.8 mt -70.83 -52.68 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.463 -0.94 . . . . 2.09 108.463 -176.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.25 -52.11 29.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.347 0.659 . . . . 3.34 110.744 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -67.44 -47.51 69.96 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.246 0.619 . . . . 1.99 110.407 179.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.0 t -57.46 -25.36 59.58 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.847 -0.533 . . . . 1.59 111.98 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.54 -55.22 4.25 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.7 0.8 . . . . 4.14 112.088 171.401 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.5 p -71.64 66.38 0.51 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.274 1.029 . . . . 2.33 111.039 179.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.21 -43.45 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.279 1.832 . . . . 4.17 110.111 -176.329 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -76.98 142.66 39.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.415 -0.957 . . . . 6.09 108.415 173.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -60.55 165.71 3.61 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.093 -0.706 . . . . 6.97 109.093 173.124 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.41 -35.6 3.79 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-O 118.804 -0.998 . . . . 1.93 111.462 175.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.79 133.44 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 119.039 1.42 . . . . 3.36 107.894 163.417 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.26 -55.15 3.53 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.357 -1.349 . . . . 3.91 107.357 161.211 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -149.84 145.87 26.81 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.129 0.572 . . . . 3.32 110.366 -171.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.3 t -128.64 150.27 50.3 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.434 1.094 . . . . 1.96 108.237 177.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -148.18 132.33 17.34 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.49 -0.93 . . . . 2.29 108.49 153.286 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.0 m -107.12 165.35 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 122.814 0.445 . . . . 2.99 110.623 171.059 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.42 136.69 19.94 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.581 0.752 . . . . 2.38 110.622 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.65 -56.1 6.47 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 123.922 0.889 . . . . 3.87 110.523 -176.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.54 -52.15 60.61 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 123.161 0.584 . . . . 2.7 110.127 -176.388 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 m -77.43 -3.19 39.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.889 0.876 . . . . 3.09 111.336 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 45.75 42.95 9.26 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.197 1.399 . . . . 4.57 110.225 -179.457 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -117.09 145.54 43.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.664 -0.698 . . . . 2.54 109.757 -164.114 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.92 118.77 33.36 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.545 -1.65 . . . . 1.84 106.545 156.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.89 134.57 40.84 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.774 -1.195 . . . . 1.23 107.774 163.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 mp -122.81 119.94 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 106.942 -1.503 . . . . 2.44 106.942 178.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -96.52 98.78 10.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.081 -1.451 . . . . 3.14 107.081 162.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -138.33 178.62 6.99 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.028 0.931 . . . . 3.62 110.935 -177.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -107.0 83.94 1.45 Allowed Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 125.01 1.324 . . . . 3.53 109.831 176.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -52.05 -23.51 17.27 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.187 2.591 . . . . 1.86 113.793 174.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -49.67 -41.14 42.23 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.473 0.579 . . . . 4.44 112.31 172.114 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 pt -107.3 -47.32 8.12 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 N-CA-C 113.701 1.0 . . . . 2.08 113.701 -166.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.2 tt -90.0 -123.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 106.372 -1.714 . . . . 2.09 106.372 172.339 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 177.73 160.18 23.88 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 120.406 1.457 . . . . 2.25 111.681 171.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.88 -42.1 26.33 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.084 3.189 . . . . 1.35 111.114 173.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -51.34 -54.22 28.41 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.018 0.527 . . . . 6.91 110.06 177.216 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.94 -54.84 7.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.093 1.757 . . . . 4.11 109.657 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.1 mt -57.97 -60.68 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.856 0.862 . . . . 1.99 109.972 178.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mp -48.29 -47.21 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.128 0.422 . . . . 3.09 110.39 -178.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -70.59 -33.28 70.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.366 0.666 . . . . 3.12 111.777 -178.174 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.2 m -59.64 -54.89 41.15 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.372 -0.83 . . . . 1.97 108.801 170.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.1 mm -58.09 -44.49 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.625 0.77 . . . . 2.42 111.421 -178.254 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -49.99 -56.63 9.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.001 1.32 . . . . 2.9 109.123 170.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.3 m -58.03 -36.03 72.15 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.793 0.664 . . . . 3.17 112.793 178.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.87 -17.47 64.32 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.543 -0.723 . . . . 3.48 112.209 174.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.17 37.49 9.07 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.665 -0.974 . . . . 1.2 110.665 -178.335 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -125.02 151.26 45.82 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.049 -1.463 . . . . 3.15 107.049 165.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -104.76 101.09 26.8 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 124.835 1.254 . . . . 5.54 110.049 -169.092 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -76.22 158.56 37.35 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.391 1.394 . . . . 1.67 113.147 -171.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.493 ' CB ' ' HZ1' ' A' ' 73' ' ' LYS . 42.0 m -155.27 133.42 11.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.758 -1.571 . . . . 2.69 106.758 164.047 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 pp -53.67 148.19 10.2 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.819 0.736 . . . . 4.3 111.221 174.401 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 t 20.84 90.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 129.072 2.949 . . . . 7.83 114.065 166.147 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.493 ' HZ1' ' CB ' ' A' ' 70' ' ' SER . 33.6 mtpt -138.91 174.68 10.27 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.368 1.467 . . . . 12.8 108.744 176.201 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.6 pt -87.94 -170.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.078 1.351 . . . . 10.66 109.891 174.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 117.673 -1.156 . . . . 15.1 113.011 -169.113 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.402 ' N ' ' OE2' ' A' ' 51' ' ' GLU . 74.6 mtm . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 108.903 -0.777 . . . . 9.31 108.903 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.88 39.19 64.93 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.529 -0.595 . . . . 4.55 113.047 172.591 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -175.92 166.85 3.05 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.903 2.481 . . . . 4.8 106.468 157.356 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.3 -8.01 0.89 Allowed Glycine 0 CA--C 1.54 1.612 0 C-N-CA 126.25 1.881 . . . . 3.72 114.859 168.025 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t 31.29 70.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 120.442 2.121 . . . . 3.37 113.517 -174.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.29 104.09 15.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.339 -1.356 . . . . 3.54 107.339 179.061 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -84.15 116.22 22.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.828 -1.175 . . . . 2.13 107.828 162.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.7 pp -115.96 161.51 18.74 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.89 -1.152 . . . . 2.99 107.89 164.23 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -112.3 145.95 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 107.064 -1.458 . . . . 2.05 107.064 171.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -176.41 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.679 1.192 . . . . 3.04 108.517 -176.53 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -135.23 164.81 26.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.197 -2.149 . . . . 5.95 105.197 167.225 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.7 -0.36 89.57 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.575 -0.57 . . . . 1.32 113.731 171.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.4 mtp -73.77 74.33 1.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.817 1.308 . . . . 2.85 108.78 172.543 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 t -88.53 0.27 56.5 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.802 1.038 . . . . 2.8 113.802 -167.208 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.6 t -165.79 159.08 15.76 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 120.004 1.274 . . . . 3.4 110.195 -173.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.32 -38.97 13.77 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.874 1.27 . . . . 2.66 111.092 170.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -44.64 -50.15 9.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.997 0.919 . . . . 2.34 111.023 171.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.3 m -61.31 -45.43 94.49 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.713 -0.617 . . . . 1.63 109.991 -177.528 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.9 t -48.88 -60.08 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 C-N-CA 123.683 0.793 . . . . 1.85 108.897 176.335 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -33.44 75.74 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.579 -0.282 . . . . 1.66 110.359 -176.336 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -60.24 -45.54 92.88 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.64 -0.874 . . . . 3.7 108.64 -178.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.66 -61.47 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 106.18 -1.785 . . . . 1.9 106.18 -178.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -37.19 -64.61 0.36 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.541 1.536 . . . . 4.72 110.701 -179.123 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.9 p -58.42 -41.16 84.38 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.612 -0.722 . . . . 3.26 109.941 -173.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.1 t -71.23 -20.12 62.29 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.914 0.886 . . . . 1.27 112.553 -178.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.32 -57.75 3.35 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 118.634 0.652 . . . . 3.52 110.56 167.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 p -56.5 -32.39 64.99 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.162 0.437 . . . . 1.93 111.103 -176.265 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.5 tptt -37.03 -54.13 0.97 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.911 1.684 . . . . 5.47 113.895 161.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -90.36 149.89 22.11 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.069 0.85 . . . . 5.73 112.621 -165.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -59.02 154.82 14.74 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.803 -0.635 . . . . 8.46 110.535 175.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.11 24.25 66.91 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.5 -0.611 . . . . 1.96 113.339 170.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.43 138.44 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 104.399 -2.445 . . . . 2.87 104.399 156.002 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.3 mt -97.77 -45.86 6.18 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.441 1.096 . . . . 4.5 109.026 178.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -160.36 133.51 6.69 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.286 -0.635 . . . . 2.97 109.286 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.0 t -109.21 143.08 39.12 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.644 -0.873 . . . . 1.97 108.644 176.182 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.1 t -154.64 109.52 3.05 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.033 -0.729 . . . . 2.29 109.033 168.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 m -104.89 145.81 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 123.19 0.596 . . . . 2.95 110.239 172.248 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.36 134.48 46.34 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 124.634 1.174 . . . . 2.22 110.846 -174.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.5 mt -72.23 -49.41 35.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.816 1.247 . . . . 4.07 111.073 -175.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.5 -32.09 68.48 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.037 0.535 . . . . 2.28 111.375 -170.045 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 t -108.32 2.5 22.63 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.313 1.045 . . . . 3.55 111.431 179.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 41.12 41.78 1.43 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.653 1.981 . . . . 5.08 111.067 -172.513 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -99.08 149.8 22.66 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.606 -0.887 . . . . 2.24 108.606 -174.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.48 114.58 21.46 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.69 -1.226 . . . . 1.99 107.69 159.359 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.84 133.36 38.65 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.873 -1.158 . . . . 1.24 107.873 163.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.6 mp -121.59 122.75 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 106.851 -1.537 . . . . 2.06 106.851 172.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -92.2 127.52 37.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.773 -1.936 . . . . 3.97 105.773 157.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -166.82 161.37 15.32 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 126.289 1.836 . . . . 3.32 107.967 -167.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -98.21 95.34 2.78 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.448 0.699 . . . . 4.15 109.833 -174.329 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -58.55 -32.14 95.93 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.637 2.225 . . . . 1.56 111.709 -176.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.402 ' OE2' ' N ' ' A' ' 1' ' ' MET . 33.2 mt-10 -61.19 -15.8 38.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.033 1.333 . . . . 3.69 112.955 -178.918 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 pt -123.49 -49.06 2.3 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 N-CA-C 114.019 1.118 . . . . 2.21 114.019 -178.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.9 tt -90.19 -70.11 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 118.462 0.574 . . . . 2.28 109.97 178.509 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.72 149.09 8.81 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 123.605 0.622 . . . . 0.87 112.12 178.487 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.41 -39.57 9.49 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.72 2.947 . . . . 1.31 111.733 179.509 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -51.27 -56.25 13.93 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 122.595 0.358 . . . . 6.75 110.504 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -49.25 -47.45 46.52 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.014 1.725 . . . . 4.93 110.842 179.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.0 mt -58.32 -54.16 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 118.992 -0.528 . . . . 1.88 110.424 174.003 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.7 mt -52.41 -45.36 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 119.203 0.91 . . . . 2.2 110.703 177.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -58.33 -44.83 88.84 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.288 0.635 . . . . 5.36 110.262 176.249 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 56.7 m -60.17 -54.4 46.25 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.776 -0.577 . . . . 2.1 109.635 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.9 mm -58.8 -42.01 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 121.867 -0.521 . . . . 2.32 110.829 -178.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -53.02 -65.33 0.58 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.683 0.793 . . . . 3.17 109.415 171.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.4 t -54.77 -36.55 64.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.148 1.379 . . . . 1.58 112.457 -174.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.76 -12.6 25.16 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.244 0.831 . . . . 3.26 113.244 176.79 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.26 44.72 1.23 Allowed Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.604 1.097 . . . . 0.8 111.18 169.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -141.62 174.04 10.94 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.554 0.741 . . . . 3.6 109.108 178.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -113.75 76.71 3.19 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 123.706 0.802 . . . . 4.1 112.177 -177.252 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.04 133.37 26.7 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.765 1.643 . . . . 1.4 111.929 -177.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.6 t -139.08 151.91 47.11 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.524 1.129 . . . . 3.72 108.208 167.425 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.5 mt -66.68 145.1 55.92 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.765 -1.198 . . . . 4.19 107.765 161.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.2 t -145.39 -77.54 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 105.297 -2.112 . . . . 4.8 105.297 175.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt 64.39 -73.04 0.06 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.08 1.352 . . . . 7.57 111.665 -179.126 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.1 mm -111.31 65.87 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 107.378 -1.342 . . . . 7.0 107.378 -176.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 124.639 1.175 . . . . 10.95 110.8 -173.852 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 108.542 -0.91 . . . . 13.89 108.542 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.69 62.59 0.82 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 106.846 -2.502 . . . . 6.21 106.846 -169.006 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -109.57 -128.97 0.28 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.963 0.905 . . . . 8.2 109.786 -153.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.07 -38.07 1.06 Allowed Glycine 0 C--N 1.335 0.507 0 N-CA-C 109.499 -1.44 . . . . 4.13 109.499 179.534 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.6 159.11 34.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 C-N-CA 123.306 0.643 . . . . 3.59 111.613 -176.774 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.9 tp -150.79 156.43 41.25 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.564 1.946 . . . . 3.28 106.34 174.171 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -124.04 155.09 38.92 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.761 0.824 . . . . 2.48 109.577 176.231 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.74 141.98 23.22 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.804 0.842 . . . . 3.7 109.126 175.192 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.6 t -90.97 131.32 38.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 C-N-CA 125.685 1.594 . . . . 2.0 107.142 177.123 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.35 78.43 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 122.454 1.121 . . . . 2.44 110.487 -166.539 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.9 mtm105 -58.34 133.34 55.63 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.041 -1.096 . . . . 6.6 108.041 170.254 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.32 -32.96 3.43 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.578 1.085 . . . . 1.16 110.391 -171.108 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 55.8 mtm -60.85 144.62 52.39 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.327 -1.102 . . . . 2.33 108.489 163.51 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 t -164.42 -65.56 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.777 0.431 . . . . 3.49 110.407 -177.273 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -79.46 -75.69 0.24 Allowed 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.131 -0.356 . . . . 3.75 111.78 -168.809 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -167.67 -66.1 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.322 0.649 . . . . 3.03 109.494 -175.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.6 t -49.53 -38.4 30.59 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.513 0.725 . . . . 3.23 111.52 -171.185 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.4 m -39.25 -37.97 0.47 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.999 1.32 . . . . 2.34 112.68 174.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.0 t -51.74 -71.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.401 0.68 . . . . 2.17 110.251 173.096 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -27.68 69.31 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.12 -0.988 . . . . 1.79 110.626 -176.611 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -54.25 -41.89 69.29 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 124.224 1.009 . . . . 3.93 109.425 174.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.6 mt -78.33 -64.23 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.499 -1.297 . . . . 1.87 107.499 176.071 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -48.86 -57.71 5.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.79 1.236 . . . . 3.19 111.07 -169.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 t -75.25 0.19 17.39 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.863 0.865 . . . . 1.92 112.27 -176.258 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.6 t -98.72 -37.36 9.51 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.662 1.185 . . . . 1.04 109.996 173.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.75 -45.29 90.52 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.844 0.747 . . . . 3.85 111.052 173.323 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.3 p -64.84 80.45 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.194 0.598 . . . . 2.18 110.817 -172.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt 164.95 -33.88 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.853 2.861 . . . . 6.07 110.766 -176.055 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -50.6 118.82 3.31 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.323 0.51 . . . . 2.59 110.036 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -71.09 77.56 0.68 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.009 0.923 . . . . 6.11 110.547 -168.448 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.53 -16.83 0.98 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.658 1.123 . . . . 1.32 111.27 -175.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.84 145.41 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 107.136 -1.431 . . . . 2.82 107.136 162.457 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.5 mt -108.2 -43.83 4.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.496 1.518 . . . . 3.91 108.761 170.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -164.5 159.77 19.71 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 108.578 -0.897 . . . . 3.93 108.578 -178.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.4 p -133.85 160.93 36.16 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.751 1.22 . . . . 2.84 107.919 173.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 m -153.42 117.44 4.81 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.509 -1.293 . . . . 2.5 107.509 161.26 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 p -106.2 153.16 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 118.712 0.687 . . . . 3.4 111.364 174.222 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.83 135.55 22.16 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.683 -0.635 . . . . 1.93 110.404 170.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.35 -37.6 63.47 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 115.45 -0.796 . . . . 2.32 110.493 -178.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.0 84.12 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.13 0.572 . . . . 2.06 110.604 179.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.84 -11.1 59.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.217 1.007 . . . . 2.78 111.107 175.643 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 46.44 40.33 7.85 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.737 2.015 . . . . 4.18 111.696 -167.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -132.25 144.17 50.43 Favored 'General case' 0 C--O 1.228 -0.034 0 CA-C-O 119.375 -0.345 . . . . 2.63 111.126 -167.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.0 136.63 44.11 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.331 -0.989 . . . . 2.03 108.331 155.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.31 145.17 25.83 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.41 -1.329 . . . . 1.74 107.41 148.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.5 mt -125.68 132.71 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.086 -1.449 . . . . 3.44 107.086 167.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -96.87 128.95 44.32 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.382 -2.081 . . . . 3.69 105.382 160.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -166.66 161.36 15.72 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.684 1.594 . . . . 3.82 108.757 -176.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -97.01 109.5 49.46 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 123.419 0.687 . . . . 3.36 109.433 176.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.52 29.07 0.43 Allowed 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.605 2.204 . . . . 1.61 113.254 -176.361 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -123.12 1.36 9.17 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.619 1.168 . . . . 3.56 111.017 -176.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -129.64 -67.88 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.229 0 C-N-CA 123.514 0.726 . . . . 2.76 110.488 178.443 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 tt -80.0 -49.12 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.515 0.674 . . . . 2.95 110.424 -175.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.26 161.35 34.21 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.109 0.862 . . . . 1.1 111.953 174.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.8 -34.94 47.76 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.482 2.788 . . . . 1.12 111.715 -177.4 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -53.44 -58.96 5.28 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.702 0.801 . . . . 6.66 111.284 -175.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -44.96 -57.31 3.89 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.226 1.01 . . . . 2.81 110.752 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 76.9 mt -56.09 -61.63 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 114.588 -1.187 . . . . 2.05 109.835 -177.358 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.0 mt -58.09 -42.66 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 121.937 -0.477 . . . . 2.46 111.098 -176.097 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 57.7 m170 -58.46 -46.58 86.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.778 0.717 . . . . 4.88 109.959 176.116 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 m -58.45 -57.48 12.74 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.414 -0.587 . . . . 2.01 109.414 177.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.5 mm -61.45 -35.23 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.817 0.735 . . . . 2.85 111.662 -174.292 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -53.11 -68.8 0.14 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.293 -0.632 . . . . 3.44 109.293 168.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.6 t -62.38 -21.16 65.13 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.897 0.702 . . . . 2.06 112.897 -174.087 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.4 tp -65.65 -18.44 65.33 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.264 1.425 . . . . 3.68 111.097 174.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.17 43.56 0.6 Allowed Glycine 0 C--N 1.337 0.591 0 C-N-CA 125.285 1.421 . . . . 0.92 110.851 168.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -146.54 178.83 7.98 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 117.394 0.597 . . . . 2.95 110.028 -177.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.99 87.5 47.23 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 123.848 0.859 . . . . 5.44 109.851 172.385 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.16 75.86 4.06 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 124.303 3.335 . . . . 1.86 111.015 -175.379 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.3 t -71.82 150.81 43.98 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.161 -0.681 . . . . 3.53 109.161 175.111 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.2 tp -60.27 144.92 49.24 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.919 -1.511 . . . . 4.61 106.919 164.156 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.3 t -59.7 -57.01 13.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 N-CA-C 109.83 -0.433 . . . . 5.61 109.83 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.9 tptp 66.89 129.25 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.713 2.005 . . . . 9.24 110.814 -168.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 44.6 mm -73.85 118.4 19.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.262 -1.384 . . . . 6.73 107.262 171.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 . . . . . 0 C--O 1.248 1.022 0 C-N-CA 129.559 3.143 . . . . 10.41 103.932 178.894 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.455 -0.184 0 N-CA-C 109.128 -0.693 . . . . 2.33 109.128 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 tp -144.69 142.32 29.98 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.156 -1.054 . . . . 2.47 108.156 168.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -101.14 132.88 46.39 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.975 0.91 . . . . 2.47 109.487 166.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -132.6 162.18 31.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.934 1.294 . . . . 1.88 107.644 166.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 t -117.7 133.09 65.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 126.166 1.786 . . . . 1.26 107.108 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.48 99.36 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 C-N-CA 124.086 0.954 . . . . 1.34 110.891 -168.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.4 mtt85 -68.84 150.64 47.58 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.924 -1.139 . . . . 5.02 107.924 171.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.72 -5.14 39.95 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.215 0.912 . . . . 0.97 113.67 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 69.7 mtm -74.17 69.2 1.51 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.831 1.315 . . . . 2.1 112.543 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 t -65.82 126.35 28.2 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.214 0.531 . . . . 3.55 111.817 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 t 52.02 82.42 0.07 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.811 2.044 . . . . 3.15 114.391 156.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 50.77 -101.83 0.1 Allowed 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.614 1.166 . . . . 2.04 110.229 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 9.85 -71.65 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 129.99 3.316 . . . . 1.83 115.781 172.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.7 m -36.78 -46.49 0.61 Allowed 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 125.589 1.555 . . . . 0.99 112.516 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.1 t -36.42 -68.12 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.027 1.331 . . . . 0.89 111.579 168.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -29.0 65.78 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.896 -0.503 . . . . 1.19 110.072 -175.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -38.29 77.37 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.531 0.733 . . . . 3.37 109.59 177.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.477 HD12 HG11 ' A' ' 37' ' ' VAL . 95.7 mt -74.41 -68.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 106.422 -1.696 . . . . 0.89 106.422 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -48.0 -56.34 7.9 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.311 1.444 . . . . 3.08 111.369 -166.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 t -60.99 -42.3 98.15 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.586 0.708 . . . . 1.39 109.992 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.3 t -65.95 -49.45 67.88 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.224 -0.658 . . . . 0.99 109.224 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.41 -39.44 83.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.023 -1.048 . . . . 2.4 111.301 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.2 p -58.34 -11.24 2.59 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.934 1.087 . . . . 1.67 113.934 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -68.7 -34.95 76.52 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.505 1.048 . . . . 3.79 111.592 170.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -62.71 122.06 14.94 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.784 0.434 . . . . 1.87 110.509 -167.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -76.56 65.9 2.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.209 1.004 . . . . 6.12 110.824 -172.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.78 9.31 0.02 OUTLIER Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.953 1.739 . . . . 1.13 112.504 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -103.19 132.98 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.778 1.631 . . . . 1.77 106.765 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -90.17 -56.87 3.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.51 1.124 . . . . 2.79 108.777 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -148.64 136.58 20.82 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.101 0.56 . . . . 2.67 111.549 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.0 m -106.51 161.78 14.3 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.933 0.893 . . . . 1.76 109.035 172.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.1 m -150.84 96.95 2.41 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.089 0.555 . . . . 1.67 109.675 162.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.477 HG11 HD12 ' A' ' 22' ' ' ILE . 38.9 t -90.58 86.2 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 C-N-CA 126.147 1.779 . . . . 2.33 109.341 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.86 129.41 34.84 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 121.323 -0.861 . . . . 1.02 110.946 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -77.83 -45.63 23.82 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.516 -0.766 . . . . 2.04 111.063 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.58 -45.88 90.56 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.299 0.571 . . . . 1.42 110.352 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -10.5 59.66 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.463 1.105 . . . . 2.58 111.513 176.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 51.72 31.04 7.46 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.203 1.801 . . . . 2.69 111.802 -171.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -117.21 133.83 55.51 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.641 0.777 . . . . 1.89 109.632 -165.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.94 114.39 28.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.648 -1.242 . . . . 0.7 107.648 161.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.3 142.3 27.86 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.94 -1.133 . . . . 1.04 107.94 159.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 mp -127.93 127.64 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 106.581 -1.637 . . . . 1.05 106.581 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -98.51 80.85 2.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.364 1.466 . . . . 3.26 108.376 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -116.95 165.46 13.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.591 1.556 . . . . 2.31 110.883 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -81.13 115.77 58.3 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 122.589 0.356 . . . . 3.44 110.511 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.88 -13.06 21.79 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.79 2.327 . . . . 1.68 113.92 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -81.93 -45.97 14.69 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 119.316 0.962 . . . . 4.39 108.956 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pt -81.92 -89.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.08 0.4 . . . . 2.05 112.08 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 tt -57.38 -47.02 85.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.806 1.242 . . . . 1.2 111.09 -173.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.42 164.29 28.02 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 121.512 0.507 . . . . 1.19 112.681 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.22 -37.57 31.16 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.058 3.172 . . . . 1.1 112.215 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.418 ' HE ' ' CD2' ' A' ' 60' ' ' HIS . 1.8 tpm_? -60.08 -50.17 74.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.442 0.697 . . . . 7.35 110.902 -168.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -50.21 -56.3 11.65 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.978 0.911 . . . . 2.43 110.037 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.9 mt -53.6 -60.6 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.496 1.118 . . . . 0.74 109.745 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.4 mt -50.69 -43.54 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 118.641 0.655 . . . . 1.68 111.208 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.418 ' CD2' ' HE ' ' A' ' 56' ' ' ARG . 61.5 m-70 -76.37 -30.94 57.77 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.363 -0.836 . . . . 3.18 112.272 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.6 m -61.67 -49.76 75.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.401 -0.962 . . . . 0.82 108.401 171.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -59.58 -49.03 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.716 1.206 . . . . 1.51 109.814 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -48.84 -61.16 2.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.307 1.443 . . . . 3.53 109.252 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.0 t -59.5 -31.76 69.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.202 1.001 . . . . 1.2 112.646 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.2 mt -67.06 -14.34 62.8 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.63 -0.7 . . . . 1.99 111.526 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.23 49.4 1.14 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.451 -1.06 . . . . 0.74 110.451 168.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -141.37 169.25 17.96 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.355 1.062 . . . . 2.0 108.519 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -108.03 85.56 2.67 Favored Pre-proline 0 CA--C 1.529 0.139 0 CA-C-O 117.361 -1.304 . . . . 3.76 112.943 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 75.52 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.847 2.365 . . . . 1.46 112.133 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.1 m -66.91 143.16 57.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.646 -0.872 . . . . 2.04 108.646 166.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.4 mt . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 121.867 0.841 . . . . 3.13 109.266 171.942 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.5 t . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 108.595 -0.891 . . . . 2.33 108.595 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -90.18 99.07 12.16 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.905 -1.517 . . . . 3.27 106.905 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.2 142.63 50.63 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.026 -0.361 . . . . 2.58 110.026 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 131.83 55.76 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.133 -1.432 . . . . 1.59 107.133 166.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 t -70.02 133.76 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 105.343 -2.095 . . . . 1.29 105.343 165.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.94 114.69 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.413 1.085 . . . . 1.24 108.093 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -74.05 155.27 38.7 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.429 -0.952 . . . . 5.4 108.429 171.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.6 -20.86 10.86 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.191 -0.783 . . . . 0.99 114.115 164.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -73.63 73.5 1.49 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.537 1.669 . . . . 1.93 109.921 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 t -59.58 -34.72 73.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.869 0.868 . . . . 2.97 111.805 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.1 m -144.83 -167.01 2.55 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.284 -1.006 . . . . 3.99 108.284 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.36 -174.05 0.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.622 0.769 . . . . 2.78 111.057 173.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m 72.52 -58.53 0.59 Allowed 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 125.108 1.363 . . . . 1.95 110.5 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.6 m -40.4 -46.71 2.44 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.714 1.206 . . . . 0.86 110.491 168.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.4 t -38.11 -69.61 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.272 1.029 . . . . 0.8 111.3 169.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -26.51 62.46 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.58 -0.7 . . . . 1.28 111.236 -175.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -50.81 -40.44 55.47 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 108.881 -0.785 . . . . 3.13 108.881 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.6 mt -81.25 -69.14 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 108.065 -1.087 . . . . 0.81 108.065 172.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -46.52 -55.94 6.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.661 1.584 . . . . 3.27 111.928 -169.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 t -62.02 -38.62 89.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.711 0.804 . . . . 1.44 109.973 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.5 t -72.97 -27.55 61.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.992 0.517 . . . . 1.01 110.878 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.89 -44.51 55.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.709 0.804 . . . . 1.96 110.218 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.6 p -65.17 80.55 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.242 0.617 . . . . 1.78 110.373 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 165.91 -26.18 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.773 2.829 . . . . 3.69 111.415 -174.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -66.44 76.25 0.1 Allowed 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.484 1.038 . . . . 2.22 110.378 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -42.17 97.74 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.417 1.887 . . . . 5.73 110.948 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.39 -40.93 0.91 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.386 -1.486 . . . . 1.48 109.386 -165.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.47 154.93 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.941 -0.762 . . . . 3.22 108.941 156.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.05 -23.89 10.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.906 0.883 . . . . 2.52 110.812 165.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -159.44 155.02 25.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.696 0.68 . . . . 2.04 109.3 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.3 t -136.48 147.84 47.36 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.197 1.399 . . . . 2.05 108.014 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.5 m -146.05 131.55 18.74 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.62 -0.881 . . . . 1.78 108.62 151.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.3 m -111.69 163.73 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 123.234 0.614 . . . . 1.69 109.994 173.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.13 137.15 11.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.774 -0.579 . . . . 0.89 111.297 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 pp -72.98 -41.25 64.55 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.948 1.299 . . . . 1.42 111.262 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.45 -27.56 69.2 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.105 0.562 . . . . 1.09 111.376 -171.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.445 HG23 ' HG2' ' A' ' 43' ' ' LYS . 4.4 t -114.97 6.64 15.36 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.925 1.29 . . . . 2.15 110.579 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.3 m120 51.2 45.53 27.74 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.741 1.616 . . . . 2.86 111.609 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HG2' HG23 ' A' ' 41' ' ' THR . 15.6 ptpt -141.74 162.13 36.23 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 113.504 0.927 . . . . 1.77 113.504 -174.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.45 120.72 34.75 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.491 1.916 . . . . 0.8 106.889 167.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.21 135.38 39.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.587 -1.264 . . . . 1.26 107.587 161.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -119.27 135.84 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 104.236 -2.505 . . . . 1.04 104.236 168.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -97.46 112.13 24.1 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.141 -1.8 . . . . 3.48 106.141 165.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -150.48 160.79 43.52 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 122.989 0.516 . . . . 2.36 110.029 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -87.61 112.6 49.65 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 108.455 -0.943 . . . . 4.42 108.455 169.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.86 -18.45 36.53 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.078 1.852 . . . . 1.48 112.595 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -69.82 -38.93 76.73 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.683 1.129 . . . . 3.88 110.913 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -83.2 -56.16 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 112.381 0.512 . . . . 1.72 112.381 -172.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 tt -98.13 -51.16 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.268 0.627 . . . . 1.31 110.694 -172.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.73 163.7 37.04 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 115.846 -0.615 . . . . 0.87 113.153 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.84 -37.23 28.21 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 124.161 3.24 . . . . 1.01 112.527 -175.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -52.73 -49.17 65.95 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.902 0.481 . . . . 5.22 112.019 -174.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -48.73 -60.5 2.68 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.925 0.89 . . . . 3.03 110.082 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.4 mt -56.19 -54.31 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.01 1.324 . . . . 0.78 110.35 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.7 mt -54.44 -58.29 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.609 0.764 . . . . 1.33 110.173 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -62.77 -34.73 77.85 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.384 0.611 . . . . 5.06 110.636 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 83.5 m -62.36 -51.71 66.51 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.349 -0.844 . . . . 0.67 109.717 173.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.8 -37.77 80.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 121.299 -0.876 . . . . 1.75 111.649 -175.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -47.79 -50.97 24.23 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.866 0.866 . . . . 2.56 108.767 167.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.8 t -65.26 -45.58 83.99 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.287 0.477 . . . . 1.46 112.287 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.47 -32.03 69.87 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.37 -0.831 . . . . 1.9 110.769 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.23 45.9 0.56 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.196 -0.762 . . . . 0.91 111.196 161.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -136.16 161.14 36.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.035 -1.469 . . . . 2.21 107.035 174.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -106.38 85.66 1.82 Allowed Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 118.045 -0.979 . . . . 4.32 113.139 -165.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.61 134.12 31.88 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.533 2.155 . . . . 1.67 112.889 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.8 t -143.46 172.68 12.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.787 1.635 . . . . 2.52 106.897 162.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 CA--C 1.534 0.334 0 C-N-CA 122.953 0.501 . . . . 4.92 111.416 -177.58 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 121.616 0.722 . . . . 2.33 110.888 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.98 146.56 51.01 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.466 -1.309 . . . . 2.86 107.466 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -125.85 150.17 48.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.459 -0.941 . . . . 2.21 108.459 159.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.427 ' CD1' ' HB3' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -135.91 118.2 15.62 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.189 -1.412 . . . . 1.61 107.189 172.41 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.26 122.57 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 106.528 -1.656 . . . . 1.41 106.528 165.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.35 137.43 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.903 0.881 . . . . 2.45 109.576 -172.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -120.7 168.51 11.33 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.684 0.794 . . . . 6.51 110.688 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.56 -19.47 11.46 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 125.101 1.334 . . . . 0.87 112.396 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.3 mtm -60.41 113.35 2.36 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.838 0.819 . . . . 1.6 111.272 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.9 p -77.14 -42.34 38.28 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.771 0.828 . . . . 4.12 111.414 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.4 t -162.64 171.76 16.4 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.579 0.752 . . . . 3.34 109.103 -165.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.07 -35.7 2.24 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.916 1.686 . . . . 2.34 112.661 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -47.98 -53.37 16.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.172 0.589 . . . . 1.93 110.882 171.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.7 m -62.47 -43.99 97.48 Favored 'General case' 0 CA--C 1.522 -0.104 0 O-C-N 121.627 -0.67 . . . . 0.83 110.118 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.6 t -49.2 -59.83 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 109.256 -0.646 . . . . 0.85 109.256 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -26.62 66.33 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.702 -0.399 . . . . 1.51 111.341 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -60.26 -51.58 68.95 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.587 -0.894 . . . . 2.79 108.587 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.5 mt -62.86 -57.15 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.753 -1.573 . . . . 0.61 106.753 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -52.79 -53.63 45.53 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 123.993 0.808 . . . . 3.27 110.073 -173.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.6 t -58.94 -53.2 61.03 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.498 -0.556 . . . . 1.36 109.498 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.9 t -63.98 -20.01 65.58 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 118.571 -0.728 . . . . 0.9 112.609 -176.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.41 -47.74 10.36 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.29 -0.862 . . . . 2.14 111.251 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.3 p -50.88 -26.85 6.35 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.158 0.89 . . . . 1.8 113.025 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -25.11 66.44 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.752 1.39 . . . . 3.23 114.752 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -67.77 129.14 39.0 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 120.199 1.363 . . . . 1.92 110.594 -174.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.73 71.63 1.45 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.555 -0.715 . . . . 7.12 109.595 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.42 -40.13 0.07 OUTLIER Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.612 -0.549 . . . . 1.18 113.254 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.93 158.01 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.078 0.939 . . . . 3.33 109.594 170.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 pp -107.94 -25.74 11.04 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.708 0.803 . . . . 2.99 110.206 164.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -158.44 149.21 20.41 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 118.773 0.715 . . . . 2.84 109.289 171.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.7 t -117.97 137.6 52.74 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 105.315 -2.106 . . . . 2.51 105.315 163.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.97 103.8 6.5 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.186 -1.413 . . . . 1.25 107.186 173.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 44' ' ' ALA . 1.1 p -103.68 151.11 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 118.436 0.562 . . . . 2.26 112.13 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.92 136.24 16.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.11 0.481 . . . . 0.78 110.73 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.05 -31.92 56.52 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.107 0.963 . . . . 1.87 111.335 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.94 -52.86 62.64 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.211 0.604 . . . . 1.14 109.915 175.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.98 -30.41 68.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.845 0.858 . . . . 1.94 109.446 173.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.256 0.0 OUTLIER 52.72 56.29 7.82 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.023 -1.473 . . . . 3.08 107.023 -164.675 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -140.85 143.61 34.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.613 -1.176 . . . . 1.39 109.086 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.464 ' HB2' HG23 ' A' ' 37' ' ' VAL . . . -109.73 129.16 55.64 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.421 -1.326 . . . . 0.7 107.421 155.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.67 145.81 24.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.616 -1.253 . . . . 0.96 107.616 154.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -129.21 117.88 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 106.61 -1.626 . . . . 0.89 106.61 170.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -88.21 125.99 34.92 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.575 -1.639 . . . . 2.1 106.575 167.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -170.45 151.97 3.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.396 0.678 . . . . 2.17 110.331 -167.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -77.64 118.78 74.27 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.499 -1.297 . . . . 3.56 107.499 168.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.11 -18.61 23.68 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.441 2.094 . . . . 1.09 112.37 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -74.62 -51.27 14.94 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.6 0.636 . . . . 4.28 109.364 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 pt -69.72 -54.96 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 112.566 0.58 . . . . 1.21 112.566 -168.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 tt -98.96 -48.83 11.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 123.662 0.785 . . . . 1.33 110.913 -169.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.33 157.77 26.87 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.226 0.917 . . . . 0.71 111.85 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.02 -25.23 32.22 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 124.026 3.15 . . . . 0.66 113.34 -172.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -55.15 -51.62 65.89 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.316 0.507 . . . . 5.61 111.226 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -42.6 -61.92 1.11 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.192 1.397 . . . . 3.36 109.9 176.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mt -51.44 -63.46 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 124.785 1.234 . . . . 0.81 110.685 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.5 mt -49.93 -43.76 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.573 0.624 . . . . 1.32 111.228 -175.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -75.92 -31.53 59.18 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.064 0.546 . . . . 2.43 111.391 -176.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.7 m -62.6 -53.23 57.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.808 -0.812 . . . . 1.16 108.808 169.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.7 mm -55.93 -47.9 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.135 0.574 . . . . 1.55 110.2 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -49.13 -66.56 0.38 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.102 1.361 . . . . 2.65 109.753 170.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 t -51.95 -42.88 63.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.445 1.498 . . . . 1.19 112.598 -174.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.03 -14.58 55.34 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.782 -0.627 . . . . 1.79 112.658 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.01 47.4 1.35 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.75 -0.94 . . . . 0.62 110.75 172.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -135.74 168.63 18.94 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.049 0.939 . . . . 2.02 108.805 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -117.38 88.75 29.39 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-O 117.962 -1.018 . . . . 4.4 110.38 -173.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.04 108.93 0.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.181 2.588 . . . . 1.12 111.853 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.1 t -72.41 -165.85 0.22 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.8 0.81 . . . . 2.68 109.128 156.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.237 0.406 0 C-N-CA 124.422 1.089 . . . . 4.33 110.71 -174.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.125 0 N-CA-C 111.666 0.247 . . . . 2.46 111.666 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.5 tp -138.9 141.68 38.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.36 -0.978 . . . . 2.09 108.36 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -108.02 123.31 48.48 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.052 -1.462 . . . . 2.38 107.052 174.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.5 mt -106.87 122.17 45.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.108 -1.812 . . . . 2.26 106.108 172.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.87 118.56 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 106.082 -1.821 . . . . 0.92 106.082 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.9 m -117.4 115.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 123.573 0.749 . . . . 1.25 109.097 -169.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -83.88 175.0 9.92 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.561 -0.903 . . . . 6.36 108.561 168.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.6 -32.52 7.44 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.452 0.548 . . . . 1.14 112.737 172.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -61.4 138.74 58.27 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.684 1.242 . . . . 2.18 110.336 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -155.49 28.89 0.39 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.001 0.52 . . . . 3.09 111.066 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.2 t -167.87 141.58 3.4 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 107.79 -1.189 . . . . 3.47 107.79 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -38.38 -48.91 1.4 Allowed 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.001 1.32 . . . . 1.93 112.069 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.6 m -42.68 -40.97 2.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.601 1.16 . . . . 1.57 111.827 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.2 m -47.6 -39.61 17.23 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.739 0.816 . . . . 0.83 111.364 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.6 t -53.17 -61.9 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 123.295 0.638 . . . . 0.94 109.943 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -28.83 69.07 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.494 -0.558 . . . . 1.27 109.494 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -59.51 -52.79 64.05 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.958 -1.127 . . . . 2.92 107.958 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.94 -51.23 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.115 -1.068 . . . . 0.64 108.115 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -47.82 -61.97 1.69 Allowed 'General case' 0 C--N 1.341 0.229 0 O-C-N 123.901 0.75 . . . . 4.72 109.16 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -62.76 -43.32 99.1 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.974 0.91 . . . . 1.79 109.97 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.6 t -58.49 -30.02 66.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 118.798 -0.62 . . . . 1.12 111.489 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.446 HD21 HG23 ' A' ' 58' ' ' ILE . 6.1 mt -85.46 -48.48 8.94 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.253 0.835 . . . . 2.42 113.253 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.4 p -71.6 66.31 0.5 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.541 1.536 . . . . 1.86 110.742 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.99 -33.91 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.618 2.367 . . . . 3.82 110.832 -171.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -53.87 -29.69 42.6 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.733 1.012 . . . . 3.06 113.733 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? 60.4 67.75 0.82 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.739 -1.208 . . . . 6.33 107.739 -173.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.54 -51.22 0.07 OUTLIER Glycine 0 CA--C 1.52 0.373 0 N-CA-C 107.171 -2.372 . . . . 1.18 107.171 -171.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.556 HD11 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -42.04 132.01 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 123.486 0.715 . . . . 2.0 109.158 147.332 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.8 tp -95.4 -46.15 6.82 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.8 2.04 . . . . 2.58 107.9 160.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -154.79 138.16 15.83 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 122.908 0.483 . . . . 2.32 110.306 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -111.15 147.64 34.46 Favored 'General case' 0 CA--C 1.523 -0.084 0 N-CA-C 108.005 -1.109 . . . . 2.02 108.005 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.74 104.43 2.87 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.589 -0.893 . . . . 1.36 108.589 171.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.05 157.43 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 122.873 0.469 . . . . 1.81 111.477 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.62 136.66 17.37 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.611 0.765 . . . . 0.9 109.53 170.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.72 -38.17 64.89 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.622 -0.717 . . . . 1.53 110.722 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.05 -46.5 82.39 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.27 0.628 . . . . 1.24 110.89 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -74.74 -11.42 60.16 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.283 1.033 . . . . 2.52 110.871 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.4 t30 49.78 41.91 22.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.394 1.878 . . . . 2.45 110.84 -172.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -137.61 147.68 45.19 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.291 -0.413 . . . . 1.2 111.26 -164.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.92 112.26 18.55 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.098 1.759 . . . . 0.69 107.422 164.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.78 143.05 27.16 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 166.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.653 HG21 HD13 ' A' ' 58' ' ' ILE . 4.5 mp -127.03 124.08 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 107.259 -1.386 . . . . 1.05 107.259 174.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -97.15 120.65 37.9 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.477 -1.675 . . . . 2.25 106.477 158.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.45 ' CD1' HG22 ' A' ' 46' ' ' ILE . 12.4 p90 -153.48 157.15 39.43 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.89 1.276 . . . . 2.07 107.773 -174.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -85.51 118.44 70.69 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 107.55 -1.278 . . . . 3.19 107.55 170.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.69 -31.41 40.19 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.714 1.609 . . . . 1.47 111.611 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -86.65 29.11 0.81 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.321 0.964 . . . . 3.64 111.378 -166.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 pt -142.77 -53.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 124.846 1.258 . . . . 1.26 110.384 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.4 tt -98.85 -45.55 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.764 0.826 . . . . 1.08 111.015 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.36 158.98 7.38 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.039 0.828 . . . . 0.76 111.251 -172.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.86 -23.78 40.93 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.804 2.336 . . . . 1.04 111.5 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -56.74 -55.13 38.13 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.571 1.148 . . . . 6.08 111.338 -175.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -52.59 -52.13 56.66 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 122.472 1.129 . . . . 2.62 109.824 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.653 HD13 HG21 ' A' ' 46' ' ' ILE . 51.7 mt -56.99 -57.87 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.049 1.339 . . . . 0.94 110.259 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.9 mt -51.12 -51.54 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 109.964 -0.384 . . . . 1.42 109.964 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -63.17 -34.73 78.26 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.73 0.696 . . . . 2.53 112.393 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.9 m -59.92 -56.83 16.92 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.608 -0.886 . . . . 0.64 108.608 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mm -62.11 -46.34 96.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 119.667 -0.206 . . . . 1.63 110.962 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -42.02 -57.76 2.33 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.461 1.504 . . . . 3.44 109.574 166.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 t -65.41 -9.03 21.76 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.353 1.242 . . . . 1.02 114.353 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.1 mt -83.44 -10.01 58.65 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 120.553 1.524 . . . . 2.02 111.128 170.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.34 40.56 28.16 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.056 -1.218 . . . . 0.96 110.056 -170.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -126.67 151.29 48.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.262 -1.755 . . . . 1.76 106.262 161.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -110.64 84.86 4.35 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 113.59 0.959 . . . . 5.54 113.59 -158.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.61 85.67 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.402 2.735 . . . . 1.2 113.756 -173.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.1 t -70.52 156.54 39.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.624 0.77 . . . . 2.53 109.878 161.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 109.549 -0.537 . . . . 4.64 109.549 161.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.7 t . . . . . 0 C--O 1.232 0.139 0 N-CA-C 108.122 -1.066 . . . . 2.05 108.122 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.2 tt -140.71 137.15 33.26 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.561 -0.903 . . . . 2.23 108.561 166.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -103.54 132.04 50.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.059 1.344 . . . . 2.26 109.416 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.08 131.81 42.75 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.67 0.788 . . . . 1.78 109.435 173.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.41 132.97 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.183 -2.155 . . . . 1.06 105.183 165.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.34 129.15 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.298 -1.001 . . . . 1.66 108.298 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -101.38 -176.85 3.27 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.213 -0.662 . . . . 4.25 109.213 170.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.98 -29.01 11.33 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.636 1.112 . . . . 1.26 110.698 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 73.2 mtm -57.71 120.71 8.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.964 -0.754 . . . . 2.0 108.964 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 t -155.84 43.92 0.43 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.831 0.824 . . . . 3.51 110.393 -170.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -164.08 -89.02 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.37 -0.831 . . . . 3.27 110.064 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -175.57 -62.3 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 125.428 1.491 . . . . 1.93 107.299 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 t -41.46 -46.16 3.37 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.706 1.202 . . . . 2.86 110.304 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.4 m -25.46 -48.4 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.63 1.972 . . . . 0.69 114.099 169.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.6 t -51.44 -64.2 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.26 0.624 . . . . 0.69 110.347 174.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -27.83 66.43 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.101 -0.999 . . . . 1.2 110.706 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.93 -44.01 70.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.126 1.37 . . . . 3.25 108.373 176.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.1 mt -72.69 -67.49 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 106.288 -1.745 . . . . 0.57 106.288 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -48.91 -56.17 9.6 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.612 1.165 . . . . 3.55 111.563 -166.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 m -68.95 -20.17 64.19 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.753 1.221 . . . . 2.83 111.792 -174.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.5 t -87.08 -48.89 7.7 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.027 -1.101 . . . . 1.18 108.027 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.27 -35.7 76.14 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.035 -1.041 . . . . 2.28 111.718 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 p -57.69 -18.94 23.63 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.483 0.92 . . . . 1.94 113.483 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.9 mtmt -63.02 -34.21 77.08 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.571 1.078 . . . . 3.84 110.28 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.44 ' HB3' HD12 ' A' ' 53' ' ' ILE . 16.8 m-70 -72.41 107.75 5.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.895 -1.15 . . . . 2.14 107.895 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -52.52 -26.12 12.22 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.006 1.113 . . . . 4.81 114.006 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.09 -21.23 69.71 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 118.198 0.454 . . . . 1.18 113.05 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.76 124.31 14.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 118.965 1.382 . . . . 2.97 108.689 171.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.5 tp -84.45 -45.31 12.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.732 -1.21 . . . . 3.26 107.732 162.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -163.62 114.44 1.36 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 119.152 -0.451 . . . . 3.07 111.042 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.7 m -77.92 161.9 27.21 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.713 -0.847 . . . . 2.13 108.713 166.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -166.18 94.5 0.55 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.399 -0.963 . . . . 2.33 108.399 170.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 p -104.87 147.99 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 123.428 0.691 . . . . 2.11 112.075 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.9 135.02 30.87 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.635 0.774 . . . . 0.69 109.904 174.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.93 -39.87 63.5 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.31 -0.859 . . . . 1.41 110.728 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.36 -46.33 80.07 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.134 0.574 . . . . 0.96 110.349 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.19 -15.49 60.56 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.131 0.972 . . . . 1.95 111.086 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.39 36.32 26.85 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.676 0.79 . . . . 2.69 109.155 -172.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -135.69 135.6 40.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 122.411 0.284 . . . . 1.5 110.575 -168.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.06 124.69 49.96 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.594 -1.262 . . . . 0.77 107.594 160.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.79 147.51 25.99 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.674 -1.232 . . . . 1.43 107.674 155.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.4 mp -130.17 139.15 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 107.139 -1.43 . . . . 1.05 107.139 166.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -97.18 123.73 41.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.79 -1.559 . . . . 2.91 106.79 161.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -168.58 171.43 8.86 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.835 -1.172 . . . . 2.51 107.835 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.74 110.16 30.05 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-N 119.015 0.825 . . . . 3.89 109.364 175.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.28 51.32 3.16 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.694 2.263 . . . . 2.58 110.365 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -145.44 -60.5 0.34 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.922 1.689 . . . . 4.39 107.598 -159.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 pt -94.57 -60.37 2.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 C-N-CA 123.893 0.877 . . . . 1.49 111.469 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.44 HD12 ' HB3' ' A' ' 29' ' ' HIS . 10.7 tt -72.28 -52.71 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.246 -1.02 . . . . 1.9 108.246 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.8 160.69 24.28 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.287 -0.869 . . . . 0.82 112.02 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -57.37 -39.69 87.53 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.755 2.97 . . . . 0.78 110.909 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -59.44 -53.9 52.8 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.251 0.463 . . . . 6.77 112.251 -171.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -52.67 -46.74 67.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.897 0.856 . . . . 2.55 109.75 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.96 -66.45 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.827 -1.079 . . . . 1.0 110.025 172.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.353 2.7 pp -61.62 -28.88 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 121.075 1.762 . . . . 3.82 114.366 -174.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.49 -51.77 66.13 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 118.819 0.736 . . . . 3.23 109.139 173.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.0 m -57.39 -52.34 65.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.567 -0.531 . . . . 0.63 109.567 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mm -56.35 -49.6 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.516 1.126 . . . . 1.4 110.181 -175.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -48.4 -62.84 1.29 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.39 1.076 . . . . 3.91 109.675 170.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -62.47 -23.89 67.16 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.79 -0.641 . . . . 1.18 112.286 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -82.7 -5.16 58.73 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.951 1.7 . . . . 2.32 110.966 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.38 48.36 1.56 Allowed Glycine 0 CA--C 1.525 0.696 0 C-N-CA 125.103 1.335 . . . . 0.94 111.803 167.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -141.61 162.54 35.23 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.794 0.838 . . . . 2.03 109.902 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -109.66 93.2 13.68 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-O 117.95 -1.024 . . . . 4.41 109.578 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.78 136.78 6.28 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 121.553 1.502 . . . . 1.49 112.826 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.3 m -135.79 117.5 15.01 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 126.02 1.728 . . . . 1.92 107.751 170.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 CA--C 1.531 0.215 0 C-N-CA 122.438 0.295 . . . . 3.18 110.482 175.255 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 107.191 -1.411 . . . . 1.96 107.191 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.409 HD12 HD23 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -127.22 127.27 44.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.678 -1.601 . . . . 2.55 106.678 174.354 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.37 117.69 35.08 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.72 -1.215 . . . . 2.18 107.72 170.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.409 HD23 HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -110.12 141.82 42.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.298 -1.371 . . . . 1.88 107.298 172.009 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.85 135.79 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 106.357 -1.72 . . . . 0.85 106.357 167.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.26 108.74 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 C-N-CA 125.853 1.661 . . . . 1.26 108.869 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -67.48 158.48 31.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.688 -0.856 . . . . 5.67 108.688 160.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.02 -23.58 7.69 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.03 0.824 . . . . 1.14 113.111 163.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -70.44 85.59 0.61 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.819 1.309 . . . . 2.16 112.6 -175.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.3 t -76.79 100.41 5.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.02 0.914 . . . . 3.09 110.845 175.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.4 t 68.62 -76.33 0.06 Allowed 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 115.21 1.559 . . . . 3.99 115.21 164.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.41 170.34 15.99 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 123.864 0.865 . . . . 3.33 108.709 -171.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m 69.7 -58.48 0.52 Allowed 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 124.978 1.311 . . . . 1.84 111.034 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.8 m -44.21 -47.16 9.21 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 124.924 1.289 . . . . 0.85 111.512 -177.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.6 t -42.99 -64.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.45 0.7 . . . . 0.88 110.197 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -25.9 61.11 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.861 -0.524 . . . . 1.44 111.395 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -51.53 -41.61 61.16 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.767 0.827 . . . . 3.24 108.824 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.6 mt -80.23 -65.91 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.682 -1.229 . . . . 0.64 107.682 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.0 -56.62 7.23 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.013 1.325 . . . . 3.29 111.311 -169.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 t -65.23 -45.12 85.9 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.897 0.879 . . . . 1.36 110.12 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 t -62.16 -29.6 70.47 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 119.161 -0.447 . . . . 0.89 111.388 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.39 -55.22 5.04 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.957 -0.544 . . . . 2.61 111.311 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.9 p -68.83 66.08 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.962 1.305 . . . . 2.06 111.956 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.87 -42.33 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.77 1.628 . . . . 4.27 110.779 -170.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -72.99 150.32 42.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.04 -0.726 . . . . 3.63 109.04 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -60.69 160.07 9.86 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.919 -0.401 . . . . 5.4 109.919 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.2 -5.09 81.66 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.028 -0.873 . . . . 1.8 113.111 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.553 HD11 ' SG ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -99.18 146.43 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 106.712 -1.588 . . . . 1.93 106.712 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.9 tp -104.53 -48.74 3.73 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.681 1.192 . . . . 2.77 110.603 172.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -164.95 162.4 20.58 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.007 0.923 . . . . 2.5 108.761 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' HD11 ' A' ' 32' ' ' ILE . 56.0 m -138.15 161.34 37.06 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 119.332 0.969 . . . . 1.85 108.538 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.6 t -155.0 133.62 12.01 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.774 -0.824 . . . . 2.35 108.774 150.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 m -115.94 155.81 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.369 0.668 . . . . 1.73 111.036 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.39 137.69 16.6 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.101 0.561 . . . . 1.01 110.88 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -79.24 -34.83 42.36 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 124.559 1.144 . . . . 1.72 112.521 -174.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.82 -41.34 91.05 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 109.596 -0.52 . . . . 1.11 109.596 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.3 t -92.9 -6.36 48.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.533 -0.746 . . . . 2.07 111.297 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.269 0.0 OUTLIER 39.32 60.69 1.48 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 126.576 1.951 . . . . 2.83 109.791 -172.89 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -131.38 147.13 52.54 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.201 1.4 . . . . 2.05 108.866 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.93 120.71 38.09 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.938 -1.504 . . . . 0.63 106.938 159.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.01 138.18 31.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.043 -1.466 . . . . 1.58 107.043 161.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.63 130.3 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.619 -1.252 . . . . 1.05 107.619 169.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -101.06 139.26 37.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.085 -1.82 . . . . 2.4 106.085 161.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -175.18 177.38 1.91 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.371 1.468 . . . . 2.49 108.777 -160.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -112.85 81.33 4.4 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 125.241 1.416 . . . . 4.09 107.544 -170.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.74 -43.53 55.05 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.421 2.747 . . . . 1.23 113.902 -167.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.33 -23.72 65.94 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.239 0.829 . . . . 3.72 113.239 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.8 pt -100.75 -58.17 4.05 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 118.888 0.767 . . . . 1.52 112.629 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.7 tt -89.32 -45.35 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 121.356 0.598 . . . . 1.2 110.425 -171.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.68 151.47 13.87 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.859 0.742 . . . . 1.02 111.815 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -66.42 -31.42 42.63 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.389 2.726 . . . . 1.48 111.866 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -56.55 -43.17 79.65 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.91 -0.494 . . . . 6.16 111.452 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -53.99 -53.01 58.81 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 121.225 0.536 . . . . 2.71 109.732 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.3 mt -57.58 -49.15 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 124.276 1.03 . . . . 0.82 110.25 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.4 mt -54.85 -56.74 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 110.151 -0.314 . . . . 1.44 110.151 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -60.88 -36.96 80.53 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.742 0.701 . . . . 2.63 112.027 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.7 m -59.21 -51.16 71.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.479 -0.763 . . . . 0.91 109.095 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.7 mt -65.25 -43.03 95.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 121.508 -0.745 . . . . 2.22 111.753 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -49.48 -49.76 44.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.425 1.09 . . . . 3.05 108.356 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 t -64.96 -44.31 89.8 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.57 0.748 . . . . 1.04 111.419 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.6 mt -63.47 -30.41 71.54 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.5 -0.75 . . . . 2.16 110.651 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.07 53.45 0.2 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.44 -0.664 . . . . 0.95 111.44 156.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -137.47 175.28 9.74 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.709 -0.849 . . . . 1.98 108.709 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -106.65 77.15 0.46 Allowed Pre-proline 0 N--CA 1.47 0.547 0 CA-C-O 117.734 -1.127 . . . . 4.35 111.76 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.68 71.79 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.662 2.908 . . . . 1.27 112.37 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.7 m -74.38 117.84 16.65 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.357 1.063 . . . . 2.08 108.49 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tt . . . . . 0 N--CA 1.451 -0.393 0 C-N-CA 124.086 0.954 . . . . 3.09 109.466 -179.941 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.347 1.2 m . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 122.796 1.284 . . . . 3.04 113.161 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -74.07 99.28 3.3 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.557 -1.275 . . . . 2.57 107.557 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -78.22 117.94 19.97 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.848 0.356 . . . . 2.59 110.046 169.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 pp -108.21 133.99 51.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.544 -1.28 . . . . 1.87 107.544 160.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.1 t -85.63 136.67 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 105.563 -2.014 . . . . 1.38 105.563 169.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -156.38 112.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 108.499 -0.926 . . . . 2.33 108.499 -163.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -96.89 178.71 5.2 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.326 -0.99 . . . . 4.56 108.326 174.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.08 -36.99 4.04 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.375 -1.09 . . . . 0.95 110.375 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.6 ptp -57.08 123.11 14.08 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.811 -0.811 . . . . 2.06 108.811 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.0 t -149.07 21.54 0.97 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.368 0.507 . . . . 2.87 112.368 -167.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.5 t -162.98 142.74 9.0 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 106.097 -1.816 . . . . 3.75 106.097 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.58 -49.27 5.46 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.755 1.222 . . . . 2.02 111.817 -173.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -37.2 -47.45 0.79 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.082 1.753 . . . . 1.65 112.45 174.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.7 m -52.62 -43.62 65.5 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 124.102 0.961 . . . . 0.96 110.864 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.9 t -54.62 -61.49 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.479 -0.934 . . . . 0.75 108.479 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -24.66 67.02 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.241 -0.89 . . . . 1.47 109.792 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -65.25 -52.73 52.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.977 0.808 . . . . 4.57 108.96 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.7 mt -58.79 -54.49 32.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.834 -1.173 . . . . 0.63 107.834 -172.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -38.35 -69.34 0.12 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.369 1.468 . . . . 3.16 111.588 165.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -53.21 -50.35 64.89 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.642 1.177 . . . . 1.73 110.71 -171.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -33.13 73.56 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.154 1.382 . . . . 0.99 110.469 -177.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.8 mt -77.25 -47.54 19.86 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.828 0.451 . . . . 2.21 111.155 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.4 p -66.99 74.57 0.11 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.578 1.151 . . . . 1.75 110.079 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 163.13 -9.63 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.501 2.72 . . . . 3.63 113.284 -171.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -69.67 -101.45 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 121.76 2.073 . . . . 3.07 110.01 170.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -167.8 158.85 11.19 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.059 -2.2 . . . . 6.2 105.059 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.11 -58.44 2.3 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.688 -0.565 . . . . 1.88 111.688 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -38.74 99.92 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 126.905 2.082 . . . . 2.08 111.258 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.4 mt -82.46 -44.64 15.76 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.497 1.919 . . . . 2.94 108.694 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -145.36 150.12 36.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.218 1.007 . . . . 2.28 109.926 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -131.24 154.48 48.41 Favored 'General case' 0 C--O 1.231 0.082 0 N-CA-C 107.01 -1.478 . . . . 1.97 107.01 169.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.7 m -152.41 141.93 21.72 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.044 -0.725 . . . . 2.05 109.044 150.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.43 HG12 ' CB ' ' A' ' 44' ' ' ALA . 1.5 m -119.59 168.19 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.365 0.666 . . . . 1.73 111.355 170.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.01 139.66 13.78 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.631 0.772 . . . . 0.88 109.853 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.32 -36.05 22.84 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.994 0.918 . . . . 1.63 112.236 -172.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.29 -39.04 81.7 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.67 -0.493 . . . . 1.12 109.67 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 t -97.17 -4.63 38.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.151 -0.928 . . . . 2.14 111.394 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.38 61.3 2.06 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.221 1.808 . . . . 2.81 109.13 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -135.27 145.36 47.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.736 -1.12 . . . . 1.45 108.614 -171.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.43 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -127.84 123.44 35.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.14 -1.43 . . . . 0.66 107.14 164.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -103.92 130.69 51.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.098 -1.075 . . . . 1.39 108.098 169.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.85 124.35 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.746 -0.835 . . . . 0.91 108.746 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -97.48 82.16 3.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.743 0.817 . . . . 2.19 108.869 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -122.77 151.18 41.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.749 1.22 . . . . 2.22 109.956 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.77 114.06 22.01 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 109.511 -0.552 . . . . 3.25 109.511 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.95 -25.85 59.32 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.046 1.831 . . . . 1.19 113.225 -176.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -54.5 -30.36 53.1 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.839 1.256 . . . . 4.11 113.453 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 pt -105.57 -92.74 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.366 0.666 . . . . 2.15 111.854 -172.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 tt -49.7 -52.37 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.982 1.313 . . . . 1.37 112.291 -174.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.44 162.1 35.5 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.992 0.806 . . . . 0.78 111.831 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.2 -36.78 27.31 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.795 2.997 . . . . 0.85 112.776 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -56.64 -45.69 81.44 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.689 0.625 . . . . 6.16 112.689 -173.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -54.42 -57.48 11.14 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 122.15 0.976 . . . . 3.01 109.538 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.4 mt -49.7 -62.46 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.329 1.452 . . . . 0.79 109.725 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.6 mt -52.81 -52.77 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 122.755 0.422 . . . . 1.33 110.201 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -68.7 -30.66 69.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.119 0.418 . . . . 3.17 111.746 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.9 m -65.69 -52.18 53.51 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.567 -0.708 . . . . 0.98 109.313 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 mm -65.31 -33.64 65.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 121.742 -0.599 . . . . 1.89 111.174 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -54.32 -58.64 6.63 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.787 1.235 . . . . 3.0 108.712 166.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.8 t -60.04 -26.5 66.17 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.083 0.953 . . . . 1.32 113.57 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.81 -20.47 61.63 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.382 0.992 . . . . 2.75 111.9 172.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.87 38.75 5.4 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.222 -1.151 . . . . 1.09 110.222 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -126.32 163.2 23.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.082 -1.821 . . . . 2.27 106.082 171.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.14 83.58 8.21 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 119.375 0.989 . . . . 3.9 112.96 -172.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.89 147.51 24.3 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.374 2.049 . . . . 1.56 112.224 -175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.3 m -154.37 144.29 21.79 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.157 1.383 . . . . 2.01 108.311 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--N 1.333 -0.114 0 C-N-CA 122.862 0.465 . . . . 3.74 111.052 -177.48 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 108.84 -0.8 . . . . 2.19 108.84 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.8 tp -129.86 138.31 50.9 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.407 -1.331 . . . . 1.95 107.407 164.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -110.9 137.69 48.22 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.784 1.234 . . . . 2.46 109.535 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.04 128.15 20.79 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.848 -0.797 . . . . 1.49 108.848 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.0 t -65.35 145.15 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 107.619 -1.252 . . . . 1.09 107.619 167.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.42 98.16 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 125.767 1.627 . . . . 1.36 107.68 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -63.57 162.94 12.0 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.972 -0.751 . . . . 4.16 108.972 160.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.47 -0.32 46.46 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.866 1.222 . . . . 1.42 113.014 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.2 mtm -73.64 75.76 1.52 Allowed 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.336 -1.096 . . . . 2.22 112.097 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.9 p -67.54 81.58 0.17 Allowed 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 121.686 -0.634 . . . . 4.79 109.892 168.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 t 72.75 176.28 0.27 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.04 1.736 . . . . 3.51 112.253 165.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.7 -36.11 4.71 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 126.363 1.865 . . . . 2.27 112.667 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -41.22 -60.63 1.19 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.673 1.189 . . . . 2.37 110.845 168.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.4 m -68.19 -31.54 71.14 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.532 -0.73 . . . . 1.43 111.675 -176.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.0 t -57.04 -56.26 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.887 -0.783 . . . . 0.9 108.887 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -30.49 71.07 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.709 -0.619 . . . . 1.27 110.626 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -50.58 72.42 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.333 -0.988 . . . . 3.7 108.333 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.5 mt -62.52 -65.18 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 107.207 -1.405 . . . . 1.03 107.207 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -46.53 -57.12 5.03 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.855 0.862 . . . . 3.64 110.151 -174.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -56.79 -49.56 74.96 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.354 -0.839 . . . . 1.44 109.283 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.7 t -65.67 -29.38 69.92 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 118.993 -0.527 . . . . 0.88 111.811 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 26' ' ' LEU . 2.8 mm? -70.63 -44.25 67.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.76 0.709 . . . . 2.64 111.648 174.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.8 p -54.56 -21.54 10.55 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.649 0.981 . . . . 2.13 113.649 -172.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.12 -4.49 58.83 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 115.064 1.505 . . . . 4.54 115.064 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -67.11 122.94 18.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.869 1.213 . . . . 2.11 110.162 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -71.0 73.43 0.61 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.679 1.192 . . . . 7.34 111.176 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.39 -2.42 0.8 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.887 1.232 . . . . 1.23 112.62 -177.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.94 150.14 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 125.075 1.35 . . . . 1.97 108.282 170.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.1 tp -111.4 -48.12 3.12 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.278 1.831 . . . . 3.1 110.055 172.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -157.34 155.14 30.12 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.357 1.063 . . . . 2.71 108.32 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.43 163.95 28.54 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.169 -1.048 . . . . 2.34 108.169 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -162.56 103.14 1.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.82 -1.178 . . . . 1.66 107.82 170.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.7 147.21 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 C-N-CA 124.997 1.319 . . . . 1.95 110.641 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.97 137.14 16.46 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.764 0.792 . . . . 1.06 111.601 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 pp -77.7 -23.22 49.56 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.29 -0.868 . . . . 1.5 111.967 -176.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.14 -41.15 97.98 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.245 -0.65 . . . . 1.27 109.245 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -86.34 -31.21 21.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.565 -0.743 . . . . 2.17 109.909 172.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 77.68 44.3 0.09 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.63 1.972 . . . . 3.08 107.75 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -140.17 146.76 39.18 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.944 -0.391 . . . . 1.64 109.944 -167.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.98 127.1 55.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.136 1.375 . . . . 0.65 107.359 162.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.19 141.74 32.62 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.914 -1.143 . . . . 1.01 107.914 155.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.73 136.47 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 107.572 -1.27 . . . . 1.25 107.572 170.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -100.61 125.37 47.0 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.421 -1.696 . . . . 2.35 106.421 160.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -166.57 142.04 4.47 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 128.126 2.571 . . . . 1.85 107.267 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -71.61 125.54 91.71 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 118.833 -1.147 . . . . 3.83 108.93 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -82.67 -9.78 10.96 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.745 2.296 . . . . 1.3 113.275 -173.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.92 -44.08 11.31 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.255 0.934 . . . . 4.18 109.191 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 pt -67.41 -54.66 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 112.716 0.635 . . . . 1.46 112.716 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.5 tt -105.14 -58.08 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.84 0.856 . . . . 1.65 111.653 -173.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.04 161.6 27.55 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.579 0.609 . . . . 0.62 113.905 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.78 -36.48 6.24 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.048 3.165 . . . . 0.7 112.983 -171.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.5 ttm105 -55.39 -47.11 76.35 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.768 0.427 . . . . 4.89 111.186 -173.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -47.36 -61.4 1.93 Allowed 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.477 1.511 . . . . 2.79 110.312 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.5 mt -51.09 -63.34 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.127 0.971 . . . . 0.69 109.791 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.7 mt -51.86 -52.66 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.235 0.471 . . . . 1.28 110.689 -173.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -64.18 -34.38 77.95 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.99 0.814 . . . . 2.71 112.272 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.4 m -61.01 -53.13 61.01 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.355 -0.841 . . . . 0.7 109.888 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.2 mm -61.56 -38.44 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 O-C-N 121.667 -0.645 . . . . 1.63 110.693 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -55.76 -59.7 4.49 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.954 1.301 . . . . 2.77 108.803 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.5 t -52.37 -40.49 62.08 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.587 1.155 . . . . 1.03 111.739 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.7 mt -70.32 5.38 1.76 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.466 0.913 . . . . 1.96 113.466 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.19 45.98 5.45 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 119.069 0.849 . . . . 0.65 111.249 169.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -135.74 174.69 10.33 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.046 0.938 . . . . 1.92 109.782 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -113.59 68.34 1.4 Allowed Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.892 0.701 . . . . 3.61 112.892 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.76 85.09 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.194 3.263 . . . . 1.1 112.503 -174.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.2 m -101.3 125.54 47.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.726 1.611 . . . . 2.28 108.177 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 109.154 -0.684 . . . . 3.58 109.154 175.239 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 107.059 -1.459 . . . . 2.29 107.059 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tt -153.08 82.3 1.2 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 103.618 -2.734 . . . . 3.02 103.618 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.0 152.81 42.19 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.882 -0.727 . . . . 3.4 110.438 -169.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.39 133.92 50.33 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.125 -1.435 . . . . 1.73 107.125 168.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.61 136.14 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.441 -2.059 . . . . 0.89 105.441 153.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 m -134.92 134.97 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.573 -1.269 . . . . 1.34 107.573 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -117.2 173.73 6.51 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.737 -0.838 . . . . 5.68 108.737 170.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.24 -22.93 37.21 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 110.916 -0.874 . . . . 1.23 110.916 -172.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.2 mtm -60.1 151.81 25.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.554 0.677 . . . . 2.21 109.583 170.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -158.45 -58.27 0.07 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.472 -0.566 . . . . 2.4 109.472 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.3 t -73.38 140.45 46.63 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.206 -0.664 . . . . 3.49 109.206 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.35 -43.94 5.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.022 0.929 . . . . 1.9 111.728 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 m -41.21 -47.32 3.31 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.422 1.089 . . . . 1.51 111.811 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.7 m -45.44 -49.1 13.63 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 118.992 0.815 . . . . 0.74 110.671 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.8 t -52.32 -59.49 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.646 0.778 . . . . 1.25 109.694 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.21 -36.57 71.03 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.418 1.087 . . . . 1.7 109.37 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -61.47 -49.78 75.4 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.375 -0.602 . . . . 4.35 109.375 -174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.9 mt -63.33 -53.27 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.167 -1.049 . . . . 0.73 108.167 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -48.04 -59.98 2.96 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.089 0.956 . . . . 3.15 110.016 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.1 m -66.31 -43.25 86.78 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.027 0.931 . . . . 2.3 109.99 -173.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.5 t -57.23 -38.31 73.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.862 -0.59 . . . . 0.88 110.222 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 mt -75.53 -51.09 13.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.385 -0.817 . . . . 2.62 112.48 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.9 p -68.18 73.28 0.2 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.466 0.706 . . . . 1.61 110.277 -172.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? 177.84 -33.93 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.633 2.773 . . . . 3.47 111.638 -171.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -44.41 -76.95 0.02 OUTLIER 'General case' 0 C--N 1.348 0.515 0 N-CA-C 113.904 1.076 . . . . 3.59 113.904 -171.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 ptt85 171.01 134.05 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 104.924 -2.25 . . . . 11.14 104.924 -172.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.76 -59.66 2.98 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 118.774 0.716 . . . . 2.57 113.216 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -33.89 116.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 127.432 2.293 . . . . 1.92 111.605 177.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 72.2 mt -89.03 -46.32 8.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.357 1.063 . . . . 3.17 110.52 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -154.45 152.13 29.78 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.947 0.899 . . . . 2.56 108.946 -173.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.1 m -125.7 160.75 28.93 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.761 -1.2 . . . . 1.88 107.761 168.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.1 t -146.64 120.42 9.25 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.108 -1.071 . . . . 1.82 108.108 155.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 t -102.69 150.87 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 124.519 1.127 . . . . 2.31 108.584 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.16 135.11 20.15 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.598 -0.689 . . . . 0.72 110.465 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -73.35 -49.85 25.13 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.29 -0.868 . . . . 1.56 111.148 -172.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.98 -48.42 80.03 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.586 0.707 . . . . 1.15 110.376 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.64 -16.54 62.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.35 1.06 . . . . 2.24 111.1 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 50.76 42.07 27.09 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.886 1.274 . . . . 2.77 108.117 -171.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -129.32 144.8 51.37 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 122.565 0.346 . . . . 1.41 110.957 -166.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.72 110.49 17.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.094 1.758 . . . . 0.87 107.393 161.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.92 142.7 27.42 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 107.471 -1.307 . . . . 1.36 107.471 166.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.58 128.56 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 108.169 -1.048 . . . . 1.1 108.169 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -93.85 74.72 4.22 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 126.43 1.892 . . . . 2.24 108.926 171.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -119.32 179.43 4.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.437 1.495 . . . . 2.45 113.434 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.18 88.3 31.94 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 130.774 3.63 . . . . 4.07 108.097 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -61.16 -22.23 74.04 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.963 2.442 . . . . 1.35 112.892 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -57.52 -30.74 65.4 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 118.911 -0.566 . . . . 3.03 112.051 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.9 pt -114.15 -54.43 4.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 N-CA-C 113.976 1.102 . . . . 1.37 113.976 -173.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.6 tt -74.02 -63.35 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.496 -0.927 . . . . 1.8 108.496 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.2 147.91 23.38 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.128 -0.942 . . . . 0.96 111.553 173.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -54.11 -43.74 55.65 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.985 3.124 . . . . 0.81 111.753 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -56.61 -51.85 67.08 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.048 0.539 . . . . 5.58 112.35 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -47.32 -55.38 8.9 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.087 1.355 . . . . 2.61 109.391 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.1 mt -56.42 -65.11 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 114.687 -1.142 . . . . 0.96 110.406 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.2 mt -48.37 -52.86 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.259 1.024 . . . . 1.25 109.81 -173.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -68.92 -30.41 68.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 111.839 0.311 . . . . 2.92 111.839 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.8 m -67.32 -51.42 52.73 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.613 -0.835 . . . . 0.95 109.905 173.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.2 mm -64.17 -33.67 63.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.748 -0.595 . . . . 2.09 111.092 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -55.11 -60.32 3.54 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.918 1.287 . . . . 2.81 108.607 167.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -52.66 -38.54 60.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.862 1.265 . . . . 1.05 112.759 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -55.22 -22.84 19.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.925 0.713 . . . . 2.86 112.925 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.39 46.66 1.4 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.121 -1.192 . . . . 0.92 110.121 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -132.63 168.49 18.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.333 -1.358 . . . . 1.74 107.333 172.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -112.47 88.14 10.57 Favored Pre-proline 0 N--CA 1.454 -0.231 0 CA-C-O 118.515 -0.755 . . . . 3.88 109.324 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.45 151.65 22.85 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.578 2.185 . . . . 1.58 111.944 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.5 m -157.75 145.97 19.0 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.662 1.585 . . . . 2.48 107.386 170.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 109.038 -0.727 . . . . 3.6 109.038 179.315 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 108.533 -0.914 . . . . 2.55 108.533 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 tt -134.59 115.5 13.93 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.453 -1.314 . . . . 2.41 107.453 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -89.74 84.85 6.31 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.071 1.348 . . . . 2.67 108.89 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.61 132.04 34.24 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.961 -1.126 . . . . 1.65 107.961 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -74.17 149.57 7.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 106.038 -1.838 . . . . 1.17 106.038 164.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -152.69 54.58 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 127.082 2.153 . . . . 1.65 107.696 -169.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -56.84 157.33 5.67 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.779 -0.646 . . . . 5.79 109.338 171.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.48 -37.99 3.55 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 107.851 -2.099 . . . . 1.24 107.851 -162.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 40.5 mtp -53.03 143.63 16.96 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.331 -0.988 . . . . 2.59 108.331 157.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.9 t -168.08 -56.24 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.422 -0.955 . . . . 3.93 108.422 -174.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.8 t -86.9 171.39 10.85 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.466 -0.938 . . . . 2.8 108.466 172.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.81 -166.07 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.467 -0.568 . . . . 2.81 109.467 160.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.5 m 71.79 -60.23 0.53 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.433 1.093 . . . . 1.8 109.728 -171.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 77.7 m -36.98 -53.04 0.97 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 126.123 1.769 . . . . 1.21 109.875 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.6 t -36.08 -66.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.899 1.28 . . . . 0.67 111.336 173.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -26.02 56.26 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.124 -0.36 . . . . 1.04 111.073 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -51.78 -41.64 61.8 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 124.157 0.983 . . . . 3.16 108.786 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.465 ' HB ' HG21 ' A' ' 37' ' ' VAL . 11.2 mt -77.7 -70.3 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 107.234 -1.395 . . . . 0.74 107.234 172.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -47.17 -55.92 7.6 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.746 1.218 . . . . 3.29 112.165 -166.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.8 t -58.15 -49.22 77.76 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.097 -0.705 . . . . 1.3 109.097 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.8 t -62.62 -50.16 72.33 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 122.029 -0.42 . . . . 1.07 110.11 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.02 -36.79 80.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.575 -1.328 . . . . 2.52 111.547 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.1 p -57.67 -17.21 13.59 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.55 0.945 . . . . 1.87 113.55 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -62.25 -33.89 75.47 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.267 0.939 . . . . 3.76 111.641 171.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -73.34 76.09 1.37 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.127 0.571 . . . . 2.03 110.868 -173.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 mtm105 -42.39 99.87 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.062 1.345 . . . . 5.64 110.668 169.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.39 -44.66 0.86 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.413 -1.875 . . . . 1.34 108.413 -168.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.93 144.83 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 106.303 -1.74 . . . . 1.68 106.303 142.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -105.02 -57.88 1.97 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.969 1.308 . . . . 3.31 107.526 163.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -136.77 144.8 43.95 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.81 0.844 . . . . 1.87 110.886 -172.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.8 m -114.82 158.12 22.34 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 124.488 1.115 . . . . 1.97 108.013 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.0 t -150.97 76.23 1.23 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.697 -0.853 . . . . 2.41 108.697 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.465 HG21 ' HB ' ' A' ' 22' ' ' ILE . 22.1 t -81.35 136.19 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 125.292 1.437 . . . . 2.4 109.742 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.14 130.23 22.03 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.747 0.819 . . . . 0.82 111.357 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.53 -51.39 36.06 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 124.197 0.999 . . . . 1.56 111.308 -171.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.65 -44.86 90.23 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.537 0.684 . . . . 1.19 110.344 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -13.53 62.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.577 0.751 . . . . 1.99 110.922 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 52.95 33.45 14.65 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.762 1.225 . . . . 2.68 109.561 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -128.83 150.71 50.21 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.673 -0.491 . . . . 1.56 109.673 -164.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.84 123.24 36.86 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.372 -0.973 . . . . 0.9 108.372 153.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 129.65 34.65 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 104.459 -2.423 . . . . 1.34 104.459 159.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.8 mt -114.15 133.97 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 107.425 -1.324 . . . . 2.05 107.425 168.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -118.64 99.13 6.6 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.677 2.791 . . . . 4.26 105.297 -170.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -151.71 157.23 41.77 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 126.633 1.973 . . . . 2.1 109.425 -157.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -82.29 123.09 79.54 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 119.365 0.984 . . . . 3.85 108.553 171.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.08 -2.96 12.42 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.625 2.216 . . . . 1.44 113.61 -173.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -100.23 -51.01 3.77 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.174 0.897 . . . . 3.11 109.196 -176.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 pt -69.19 -54.52 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.777 0.323 . . . . 1.18 111.701 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.5 tt -91.06 -49.81 13.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 124.199 1.0 . . . . 1.1 109.739 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.65 154.58 5.75 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 111.667 -0.573 . . . . 0.76 111.667 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.76 -25.35 28.68 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.655 2.237 . . . . 0.76 112.862 -172.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -55.19 -48.91 73.15 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.395 0.543 . . . . 5.96 111.121 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -54.48 -58.53 7.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 122.475 1.131 . . . . 2.78 109.709 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.2 mt -48.82 -56.57 2.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 125.855 1.662 . . . . 0.91 111.711 175.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.7 -50.86 64.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.863 -0.421 . . . . 1.35 109.863 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.08 -39.83 83.38 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.145 0.578 . . . . 5.43 110.921 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.5 m -58.52 -56.82 17.21 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.542 -0.724 . . . . 1.02 109.57 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.9 mt -63.64 -41.12 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 119.031 0.832 . . . . 2.29 111.413 -172.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -45.73 -58.35 3.54 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.256 1.023 . . . . 3.51 108.858 168.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t -61.54 -30.19 70.48 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.87 0.692 . . . . 1.29 112.87 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.92 -34.67 69.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.369 0.986 . . . . 1.89 110.717 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.37 51.34 0.29 Allowed Glycine 0 C--N 1.334 0.445 0 O-C-N 123.863 0.727 . . . . 0.82 112.068 160.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -140.67 170.66 15.36 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 106.345 -1.724 . . . . 2.03 106.345 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.67 86.19 0.42 Allowed Pre-proline 0 N--CA 1.466 0.367 0 CA-C-O 117.167 -1.397 . . . . 4.48 114.248 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.69 76.4 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.504 2.803 . . . . 1.57 112.244 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 p -90.62 128.43 36.61 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.288 1.435 . . . . 2.13 108.669 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 107.87 -1.159 . . . . 3.61 107.87 169.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 107.118 -1.438 . . . . 2.44 107.118 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.1 tt -138.03 97.29 3.37 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.06 -1.83 . . . . 2.78 106.06 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -83.2 135.5 34.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.487 -0.324 . . . . 2.41 110.354 -174.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.46 139.04 54.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.532 -0.914 . . . . 2.11 108.532 175.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.16 116.4 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 106.461 -1.681 . . . . 1.09 106.461 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 m -104.38 83.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 106.395 -1.705 . . . . 1.69 106.395 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -65.3 136.52 56.67 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.999 -0.741 . . . . 5.52 108.999 -169.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.76 -2.09 10.09 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.463 -0.632 . . . . 1.2 113.701 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.561 ' SD ' HD12 ' A' ' 22' ' ' ILE . 73.9 mtm -68.64 79.25 0.28 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.981 1.391 . . . . 2.21 111.038 174.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 t -50.39 -52.9 33.42 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.532 1.133 . . . . 3.24 112.661 -172.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -170.04 -103.16 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.346 0.658 . . . . 5.95 109.557 176.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.67 168.98 18.75 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.595 0.634 . . . . 2.79 110.625 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.0 m 69.53 -62.63 0.41 Allowed 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 126.067 1.747 . . . . 1.51 110.004 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.9 m -37.36 -51.42 1.09 Allowed 'General case' 0 N--CA 1.458 -0.044 0 C-N-CA 127.068 2.147 . . . . 0.99 111.492 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.9 t -45.56 -70.77 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.232 1.013 . . . . 0.76 110.156 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -23.76 67.29 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.873 -0.517 . . . . 1.03 111.171 -175.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -59.03 -52.19 66.82 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.718 -1.216 . . . . 3.12 107.718 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.561 HD12 ' SD ' ' A' ' 13' ' ' MET . 30.3 mt -75.34 -56.42 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 108.583 -0.895 . . . . 0.94 108.583 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -38.0 -65.87 0.3 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.186 1.394 . . . . 3.49 112.02 170.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.2 t -62.72 -38.58 91.02 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.928 0.491 . . . . 1.46 110.373 -174.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.6 t -65.62 -24.94 67.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 118.973 -0.537 . . . . 0.87 111.702 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.8 mt -86.75 -44.87 11.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.05 0.94 . . . . 2.39 112.277 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.4 p -72.01 61.63 0.43 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.179 0.992 . . . . 1.53 111.183 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.34 -26.67 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.714 1.606 . . . . 3.68 113.132 -165.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -67.99 -128.72 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 119.621 1.1 . . . . 2.6 110.169 172.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -144.97 163.17 34.99 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 129.503 3.121 . . . . 5.61 104.757 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.41 -61.39 2.75 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.192 -0.763 . . . . 1.58 111.192 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.537 ' C ' HD13 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -51.52 111.59 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 117.842 0.821 . . . . 2.27 109.102 172.634 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 pp -107.71 -23.54 12.06 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.602 1.561 . . . . 2.41 110.962 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -145.32 158.97 43.71 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.842 -0.799 . . . . 2.4 108.842 167.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.7 t -153.48 145.97 24.08 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.003 -1.11 . . . . 1.85 108.003 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 p -150.51 132.52 15.22 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.387 -0.968 . . . . 2.15 108.387 169.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.38 125.13 67.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.247 0.619 . . . . 1.97 111.395 170.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.97 128.04 44.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.279 0.632 . . . . 1.28 110.397 172.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -72.95 -52.55 14.13 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.91 -1.041 . . . . 2.01 111.436 -165.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.44 87.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 121.614 0.721 . . . . 2.29 109.72 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -77.17 -6.36 52.66 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.71 -0.677 . . . . 3.01 110.573 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 56.55 31.53 19.22 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 125.235 1.414 . . . . 3.03 110.146 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -108.66 125.64 52.1 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 121.841 -0.537 . . . . 2.25 109.919 -164.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.5 121.98 37.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.454 1.102 . . . . 0.88 108.558 167.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.72 114.21 28.23 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 103.615 -2.735 . . . . 1.42 103.615 168.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.8 mp -111.37 132.5 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 106.392 -1.707 . . . . 0.97 106.392 173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -101.23 98.76 9.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.44 -1.689 . . . . 3.19 106.44 169.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -140.53 155.27 46.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.816 0.846 . . . . 2.31 112.006 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.73 111.01 19.62 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 108.429 -0.952 . . . . 3.09 108.429 166.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.97 -21.8 36.66 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.944 2.429 . . . . 1.31 112.72 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -46.61 -54.62 9.11 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.132 1.373 . . . . 3.49 109.773 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pt -90.36 -71.13 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 124.92 1.288 . . . . 1.73 112.38 -166.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.401 HG23 ' H ' ' A' ' 54' ' ' GLY . 14.2 tt -67.01 -62.93 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.912 -0.773 . . . . 2.02 108.912 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.401 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 81.47 159.44 23.5 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 115.701 -0.681 . . . . 1.04 112.205 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -54.83 -40.16 86.44 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 124.08 3.187 . . . . 1.1 111.337 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -35.51 -65.04 0.26 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.582 1.953 . . . . 9.77 113.516 175.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -60.47 -54.01 50.61 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.024 0.93 . . . . 3.03 108.546 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 88.7 mt -49.33 -57.62 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.282 0.633 . . . . 1.23 109.542 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.5 mt -54.81 -52.87 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.76 -0.587 . . . . 1.51 110.835 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -58.72 -45.01 90.54 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.095 0.95 . . . . 2.86 110.55 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 54.2 m -69.31 -50.59 45.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.956 -0.757 . . . . 1.03 108.956 -174.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.61 -33.7 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 118.798 -0.62 . . . . 1.98 110.919 -177.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -53.01 -58.12 8.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.886 -0.783 . . . . 4.09 108.886 165.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.4 t -58.84 -27.5 65.18 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.247 0.832 . . . . 1.33 113.247 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 25.0 mt -69.35 -10.1 56.41 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.511 1.05 . . . . 1.76 112.808 174.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.45 50.43 2.19 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 124.466 1.031 . . . . 0.9 111.256 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.495 ' CD2' HD11 ' A' ' 22' ' ' ILE . 69.3 m-85 -142.07 171.71 13.68 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 124.739 1.216 . . . . 2.12 107.877 172.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -110.74 84.55 4.23 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.68 -0.676 . . . . 4.48 110.992 -175.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.3 128.08 15.91 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.047 2.498 . . . . 1.9 112.52 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.2 p -138.54 129.63 26.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.627 1.571 . . . . 1.99 107.736 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 CA--C 1.53 0.196 0 N-CA-C 109.245 -0.65 . . . . 3.36 109.245 177.19 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.1 t . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 108.956 -0.757 . . . . 2.04 108.956 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.82 111.97 21.96 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.73 -1.211 . . . . 2.08 107.73 -170.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -85.21 123.48 30.76 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 123.622 0.576 . . . . 2.42 109.612 169.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.21 124.91 44.07 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.584 -2.006 . . . . 1.76 105.584 167.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -82.93 111.32 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 105.698 -1.964 . . . . 1.42 105.698 171.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.472 HG23 ' SD ' ' A' ' 13' ' ' MET . 2.5 m -96.9 77.38 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 125.062 1.345 . . . . 1.53 109.079 -163.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -67.14 107.21 2.24 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.284 1.034 . . . . 6.78 108.892 -166.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.1 -40.76 0.27 Allowed Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.151 -0.805 . . . . 1.59 113.543 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.472 ' SD ' HG23 ' A' ' 10' ' ' VAL . 2.2 mpp? -62.77 162.88 10.17 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 119.182 1.491 . . . . 2.19 111.169 -178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.9 t -163.98 -56.86 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.245 -1.02 . . . . 3.07 108.245 -175.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.5 m -81.82 172.74 12.99 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.389 0.676 . . . . 3.99 109.818 176.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.88 -172.27 0.17 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.059 -0.519 . . . . 3.14 109.76 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.8 m 71.55 -61.89 0.47 Allowed 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 124.68 1.192 . . . . 1.73 110.286 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.2 m -34.62 -51.74 0.49 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.903 1.681 . . . . 0.85 112.081 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.0 t -48.42 -59.66 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.817 0.847 . . . . 0.88 111.197 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -32.03 73.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.718 -0.613 . . . . 1.49 109.41 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -60.46 -45.75 92.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.553 -0.906 . . . . 3.71 108.553 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.63 ' HB ' HG11 ' A' ' 37' ' ' VAL . 96.6 mt -65.95 -62.16 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.817 -1.549 . . . . 0.55 106.817 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -47.59 -62.09 1.61 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.375 1.083 . . . . 3.96 110.812 -175.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.6 m -63.8 -44.43 93.34 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.835 -1.075 . . . . 2.36 109.34 -168.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.7 t -59.31 -51.63 69.12 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.234 -0.654 . . . . 1.06 109.234 175.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.99 -36.61 77.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.043 -1.036 . . . . 2.4 112.277 -175.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 78.1 p -55.51 -19.56 10.14 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.509 1.05 . . . . 1.98 113.755 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -61.16 -30.94 70.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.573 1.079 . . . . 3.7 111.491 175.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -77.9 63.33 2.9 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 124.495 1.118 . . . . 2.04 110.932 -164.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -28.45 -25.85 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 120.261 3.43 . . . . 6.95 120.261 -164.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.09 -16.3 68.51 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-N 120.64 1.563 . . . . 1.22 111.823 169.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.04 125.87 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 127.435 2.294 . . . . 1.84 108.467 171.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.4 mt -91.45 -48.06 7.09 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.699 1.199 . . . . 2.87 109.274 174.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -154.04 138.45 16.74 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 118.495 -0.764 . . . . 2.1 110.137 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.95 164.56 15.9 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 119.444 1.02 . . . . 2.23 108.664 167.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.0 m -157.44 112.86 2.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.432 -1.321 . . . . 1.77 107.432 162.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.63 HG11 ' HB ' ' A' ' 22' ' ' ILE . 7.9 p -102.61 154.09 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 O-C-N 123.518 0.511 . . . . 1.96 110.697 166.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.81 137.3 19.93 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 124.008 0.923 . . . . 1.08 110.629 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -74.72 -41.92 59.29 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 122.943 0.497 . . . . 1.42 111.762 -172.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.54 -34.7 74.51 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 122.744 0.418 . . . . 1.39 110.99 -173.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 t -100.86 -7.28 23.7 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.063 0.945 . . . . 2.44 110.791 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 53.19 22.9 2.83 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.282 1.833 . . . . 3.31 112.475 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -94.04 133.97 36.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.09 -1.448 . . . . 1.59 107.09 -172.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.17 112.99 23.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.777 -1.564 . . . . 0.61 106.777 160.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.29 138.46 36.35 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.322 -1.362 . . . . 0.99 107.322 165.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.62 131.14 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 109.132 -0.692 . . . . 0.92 109.132 170.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -103.81 88.51 3.07 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 127.365 2.266 . . . . 3.27 108.061 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -115.79 162.25 17.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.486 1.514 . . . . 2.33 110.282 171.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.04 106.89 4.49 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.187 0.595 . . . . 3.18 109.575 171.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -64.97 -22.53 62.57 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.046 1.831 . . . . 1.47 111.981 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -41.1 -44.49 2.49 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.376 1.87 . . . . 5.6 111.6 170.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.6 pt -113.94 -62.85 2.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 113.34 0.867 . . . . 1.15 113.34 -165.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 tt -88.73 -48.03 14.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.482 0.658 . . . . 1.72 110.4 -165.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.3 159.94 35.04 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 115.474 -0.785 . . . . 0.74 112.676 169.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.02 -42.14 25.18 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.477 3.452 . . . . 0.79 112.263 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -53.0 -51.23 62.3 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.41 0.684 . . . . 5.63 111.48 -172.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -47.97 -57.22 6.03 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.722 0.773 . . . . 2.79 110.435 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.4 mt -61.67 -48.62 87.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 124.821 1.248 . . . . 0.99 111.043 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.2 mt -52.85 -58.56 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.541 -0.541 . . . . 1.36 109.541 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -61.55 -31.74 71.78 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.077 0.551 . . . . 2.71 111.966 -176.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.2 m -58.99 -53.14 61.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.457 -0.777 . . . . 0.81 109.518 173.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.6 mt -73.38 -36.02 47.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 O-C-N 121.617 -0.677 . . . . 1.93 110.647 -173.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -48.39 -50.4 30.91 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.337 1.055 . . . . 3.31 108.924 166.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.4 t -66.27 -42.55 88.28 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.336 0.654 . . . . 1.03 112.001 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -59.37 -40.5 86.68 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.606 0.639 . . . . 1.79 109.897 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.46 46.96 0.47 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.346 -0.702 . . . . 0.86 111.346 164.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -140.91 141.31 34.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.805 -1.924 . . . . 2.53 105.805 168.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -94.27 106.23 21.97 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 118.186 -0.911 . . . . 5.59 112.25 -158.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.75 80.68 1.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.277 2.651 . . . . 1.45 110.838 -174.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.1 m -67.15 111.42 3.9 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.859 -1.163 . . . . 2.08 107.859 168.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 107.921 -1.14 . . . . 3.47 107.921 166.516 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 106.396 -1.705 . . . . 2.55 106.396 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.1 tt -84.33 115.21 22.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.672 -0.862 . . . . 2.42 108.672 -172.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -90.18 133.37 34.94 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.292 0.496 . . . . 2.69 111.227 172.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 pp -129.07 130.57 46.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.109 -1.441 . . . . 1.81 107.109 166.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.15 134.48 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.426 -2.065 . . . . 1.4 105.426 170.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.24 82.04 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.668 -1.604 . . . . 1.78 106.668 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -72.37 146.36 47.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.002 -1.481 . . . . 6.35 107.002 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.14 -36.44 4.4 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.87 -0.892 . . . . 1.1 110.87 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.6 ttp -57.72 133.34 55.27 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.286 -1.005 . . . . 2.33 108.286 167.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -153.48 -57.62 0.12 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.536 1.134 . . . . 2.87 110.264 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.2 t -67.46 140.13 57.08 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.314 -0.866 . . . . 3.56 110.342 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.69 -50.3 2.3 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.215 1.006 . . . . 1.84 112.155 175.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -43.72 -43.45 5.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.448 1.099 . . . . 1.6 111.768 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.2 m -46.48 -41.6 14.25 Favored 'General case' 0 C--N 1.338 0.104 0 C-N-CA 124.566 1.147 . . . . 0.75 111.116 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.5 t -54.16 -62.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.157 -0.683 . . . . 0.9 109.157 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -30.31 68.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.507 -0.746 . . . . 1.46 110.061 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.61 -51.41 67.23 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 107.435 -1.32 . . . . 3.06 107.435 177.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -68.84 -54.18 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.712 1.205 . . . . 0.73 108.584 -176.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -50.79 -61.11 2.41 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 108.724 -0.843 . . . . 4.58 108.724 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -60.17 -47.96 83.76 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.808 0.813 . . . . 1.46 109.715 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.4 t -66.96 -22.51 65.92 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 118.415 -0.802 . . . . 1.46 112.087 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.8 mt -82.3 -63.32 1.4 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 118.274 -0.87 . . . . 2.35 111.107 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.2 p -54.11 -28.37 39.15 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.286 0.948 . . . . 2.63 113.109 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -30.72 65.57 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.369 0.878 . . . . 3.98 113.369 173.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -70.9 72.49 0.56 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.694 -0.854 . . . . 2.21 108.694 164.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -13.23 -50.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 129.193 2.997 . . . . 5.82 116.713 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -43.22 -50.62 6.42 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.975 -0.903 . . . . 1.37 113.251 174.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.635 HD13 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -71.53 100.94 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.327 -1.36 . . . . 2.8 107.327 170.609 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.99 -34.65 32.86 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.699 0.4 . . . . 2.56 111.526 -176.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -148.17 120.35 8.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.628 1.171 . . . . 2.15 109.072 -175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 t -99.47 168.43 9.98 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.239 0.927 . . . . 2.53 108.807 170.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.3 m -145.97 66.2 1.21 Allowed 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 120.892 -1.13 . . . . 1.61 108.846 160.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.7 p -58.06 138.47 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.312 -0.858 . . . . 2.21 111.624 161.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.71 137.69 16.33 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.697 1.199 . . . . 1.37 110.31 175.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.12 -34.33 61.67 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.479 0.712 . . . . 1.8 111.365 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.58 -31.35 71.4 Favored 'General case' 0 C--O 1.226 -0.155 0 O-C-N 121.838 -0.539 . . . . 2.3 110.77 -173.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -111.69 5.73 19.41 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.512 1.125 . . . . 2.63 110.998 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.23 44.29 6.44 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 127.889 2.475 . . . . 3.51 112.068 176.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -142.06 169.6 17.29 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 122.23 -0.294 . . . . 2.18 110.808 -175.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.4 132.45 39.4 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 124.416 1.073 . . . . 1.38 108.988 160.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.43 135.46 34.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.538 -1.282 . . . . 1.22 107.538 158.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.635 HG23 HD13 ' A' ' 32' ' ' ILE . 1.7 mp -112.68 120.6 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 105.516 -2.031 . . . . 1.43 105.516 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -90.83 99.9 12.85 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.513 -0.921 . . . . 3.28 108.513 166.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.8 159.26 42.49 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.202 0.601 . . . . 1.88 112.284 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -81.98 120.14 76.76 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 106.08 -1.822 . . . . 3.51 106.08 162.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -63.56 -40.43 30.49 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.525 1.484 . . . . 1.29 111.381 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -85.63 30.96 0.61 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.693 1.197 . . . . 3.72 112.067 -160.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.3 pt -134.98 -50.23 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.762 1.225 . . . . 1.21 109.96 172.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 tt -96.79 -41.68 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.921 1.288 . . . . 1.17 111.494 -174.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.68 148.26 5.56 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 111.33 -0.708 . . . . 0.83 111.33 -175.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.11 -36.46 58.4 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.208 2.606 . . . . 0.73 111.554 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -50.65 -50.38 54.64 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.829 0.852 . . . . 6.2 112.256 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -52.28 -56.06 17.25 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 121.765 0.793 . . . . 2.62 109.537 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.0 mt -57.41 -53.54 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.463 1.105 . . . . 1.01 111.56 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.7 mt -57.53 -54.29 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 122.02 -0.425 . . . . 1.4 109.98 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -64.93 -33.04 75.07 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.535 -0.728 . . . . 3.13 111.769 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.3 m -56.81 -52.04 66.59 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 121.565 -0.71 . . . . 0.68 109.091 171.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.7 mt -64.32 -42.08 94.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 119.608 1.094 . . . . 2.37 111.079 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -49.56 -51.73 34.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.159 0.984 . . . . 3.4 109.039 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -64.51 -43.86 92.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.609 0.764 . . . . 1.0 111.387 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.19 -34.6 72.33 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.891 1.676 . . . . 2.43 111.262 -175.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.36 39.46 0.23 Allowed Glycine 0 C--N 1.333 0.416 0 O-C-N 124.685 1.241 . . . . 0.75 111.857 152.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -142.74 174.62 10.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.78 -0.822 . . . . 1.85 108.78 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -108.93 92.07 10.1 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.955 1.302 . . . . 3.96 109.848 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.99 65.85 7.74 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.685 2.924 . . . . 1.78 111.124 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.7 m -74.98 119.9 19.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.575 0.702 . . . . 2.14 110.256 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 C--N 1.33 -0.254 0 N-CA-C 109.177 -0.675 . . . . 4.32 109.177 177.947 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 106.835 -1.543 . . . . 2.46 106.835 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 tt -150.47 147.29 27.34 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.772 -1.196 . . . . 2.19 107.772 170.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -103.3 150.45 23.74 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.981 1.312 . . . . 2.74 109.431 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.95 138.15 25.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.601 -0.888 . . . . 2.49 108.601 164.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -77.79 143.29 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.256 -1.387 . . . . 0.97 107.256 170.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.28 103.74 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.529 1.532 . . . . 1.41 107.618 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -73.89 166.49 23.25 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.251 -1.018 . . . . 5.52 108.251 165.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.6 -11.34 59.51 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.663 0.649 . . . . 0.9 112.612 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.7 mtm -73.83 65.5 1.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.523 1.161 . . . . 1.69 110.423 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 t -91.18 12.72 19.18 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.352 1.061 . . . . 3.11 112.849 -166.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.4 t -165.52 173.86 10.53 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.428 -0.953 . . . . 3.03 108.428 -173.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.21 -176.01 0.06 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.398 0.545 . . . . 3.17 110.435 164.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.0 p 68.77 -54.37 0.55 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.804 2.042 . . . . 2.55 111.388 -171.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.4 m -24.98 -54.11 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.492 2.717 . . . . 1.24 113.105 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.1 t -43.18 -70.85 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.444 1.098 . . . . 0.92 110.614 172.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -26.74 64.86 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.315 -0.866 . . . . 1.17 111.069 -176.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -51.51 -41.62 61.12 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.158 0.983 . . . . 3.47 109.195 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.485 ' HB ' HG11 ' A' ' 37' ' ' VAL . 83.5 mt -80.9 -65.0 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.454 -1.313 . . . . 0.75 107.454 175.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -47.85 -56.0 8.48 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.026 1.33 . . . . 3.37 111.645 -169.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 t -62.39 -50.6 70.91 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.676 0.75 . . . . 1.39 109.22 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 t -60.79 -24.43 65.79 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 118.686 -0.673 . . . . 0.71 111.923 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.96 -46.57 14.92 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 117.947 -1.025 . . . . 2.06 111.494 172.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.9 p -51.58 -32.02 26.98 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.612 1.096 . . . . 1.93 112.336 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -47.44 -45.26 25.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.014 1.325 . . . . 5.09 113.475 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.424 ' HB3' HD12 ' A' ' 53' ' ' ILE . 17.6 m-70 -67.69 136.26 54.04 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 119.412 1.005 . . . . 2.09 108.402 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -63.66 -53.06 57.25 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.75 -0.593 . . . . 7.77 112.513 -168.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.05 47.07 3.28 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 117.881 0.309 . . . . 1.32 113.261 -169.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -123.83 112.85 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.49 -1.3 . . . . 1.82 107.49 177.358 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 tp -73.53 -48.73 30.88 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.882 0.873 . . . . 3.31 109.025 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -156.94 120.25 4.14 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.843 -0.536 . . . . 2.61 110.825 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.37 157.86 15.83 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.542 -1.281 . . . . 2.58 107.542 168.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.9 t -163.35 113.35 1.34 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.859 -0.793 . . . . 1.31 108.859 168.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.485 HG11 ' HB ' ' A' ' 22' ' ' ILE . 7.5 p -114.93 145.48 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 112.544 0.572 . . . . 2.18 112.544 175.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.57 133.1 44.66 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.869 0.868 . . . . 0.77 110.3 174.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.61 -43.83 65.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.067 -0.97 . . . . 1.44 110.555 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.93 -50.81 71.44 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.316 0.579 . . . . 1.18 110.547 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -65.54 -14.09 60.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.745 0.818 . . . . 1.92 110.967 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 55.02 30.36 14.06 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.264 1.426 . . . . 2.78 109.15 -171.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -132.45 131.12 41.4 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.319 0.509 . . . . 1.6 111.365 -164.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.52 132.63 44.72 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.996 -1.112 . . . . 0.69 107.996 160.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.21 144.88 32.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.535 -1.283 . . . . 1.03 107.535 156.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 32' ' ' ILE . 55.5 mt -135.72 126.31 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 107.929 -1.137 . . . . 1.75 107.929 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -93.86 72.96 4.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.366 1.466 . . . . 2.18 108.418 172.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -101.58 170.74 7.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.702 0.801 . . . . 2.23 113.147 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -95.33 97.48 2.76 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.365 1.466 . . . . 3.97 108.861 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.86 -33.04 85.45 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.931 2.421 . . . . 1.06 113.636 -166.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.1 mp0 -63.74 -30.21 71.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.244 0.617 . . . . 4.01 112.05 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.0 pt -107.09 -56.14 5.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 112.864 0.691 . . . . 1.31 112.864 -168.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 29' ' ' HIS . 6.1 tt -87.07 -52.03 12.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.46 -0.941 . . . . 1.67 108.46 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.42 167.51 28.8 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 115.482 -0.781 . . . . 0.83 113.099 173.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.72 -38.53 70.6 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.273 3.316 . . . . 0.77 111.838 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -58.76 -60.15 4.29 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.973 0.509 . . . . 5.66 112.061 -172.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -49.85 -52.47 32.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 122.44 1.114 . . . . 2.75 110.173 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 95.0 mt -48.63 -69.72 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 114.08 -1.418 . . . . 0.73 109.894 171.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.8 mt -51.34 -40.92 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.714 0.688 . . . . 1.24 111.535 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 52.8 m170 -63.15 -47.47 82.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.547 0.689 . . . . 3.55 109.456 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.2 m -66.27 -44.73 82.76 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.606 -0.516 . . . . 0.7 109.606 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.4 mm -57.01 -47.59 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.994 0.918 . . . . 1.42 110.081 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -53.09 -58.85 5.6 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.181 -0.674 . . . . 3.62 109.181 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -55.38 -38.68 69.17 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.057 0.943 . . . . 1.1 112.279 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.8 mt -63.62 -14.49 52.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.611 0.764 . . . . 1.98 112.584 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.66 48.24 1.12 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.482 1.039 . . . . 0.67 110.964 168.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -141.74 171.2 14.39 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.399 1.08 . . . . 2.05 108.809 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -109.96 79.89 1.62 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 118.534 -0.746 . . . . 3.89 112.923 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.76 123.73 11.41 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.141 1.894 . . . . 1.25 111.511 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.9 t -148.68 152.69 37.11 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.726 0.81 . . . . 2.71 109.235 172.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 N--CA 1.466 0.352 0 O-C-N 121.346 -0.846 . . . . 3.28 111.601 -165.337 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 107.802 -1.184 . . . . 2.77 107.802 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.63 89.8 3.19 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.43 -2.433 . . . . 2.54 104.43 166.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -70.06 145.94 51.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.506 -0.553 . . . . 2.24 109.506 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 69' ' ' PRO . 0.3 OUTLIER -149.78 139.31 21.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.807 -0.812 . . . . 2.17 108.807 178.16 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.7 t -94.44 129.64 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.645 -1.243 . . . . 1.1 107.645 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.406 HG23 ' SD ' ' A' ' 13' ' ' MET . 1.6 m -132.26 74.7 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 C-N-CA 125.215 1.406 . . . . 1.86 109.953 -160.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -66.83 153.3 43.75 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.777 -0.823 . . . . 5.04 108.777 175.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.14 -29.56 7.61 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 109.632 -1.387 . . . . 0.98 109.632 -163.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.406 ' SD ' HG23 ' A' ' 10' ' ' VAL . 56.4 mtp -56.26 144.66 29.31 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.831 -0.805 . . . . 1.97 109.375 166.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 t -166.09 -58.92 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.005 0.522 . . . . 2.37 109.719 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.8 t -77.2 147.23 36.54 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.977 -0.749 . . . . 3.49 108.977 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.29 -43.34 10.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.409 0.684 . . . . 1.89 111.796 174.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.7 p -48.34 -41.27 28.01 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.374 0.67 . . . . 2.08 111.561 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 99.3 m -50.24 -29.04 8.65 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.774 0.83 . . . . 0.85 112.544 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t -55.85 -69.5 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.56 0.618 . . . . 0.76 109.421 169.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -27.98 67.59 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.895 -1.128 . . . . 1.75 111.436 -172.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.63 -33.64 16.01 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.924 1.29 . . . . 3.88 110.375 172.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 98.8 mt -91.07 -60.2 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.123 -1.436 . . . . 0.59 107.123 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -54.44 -64.17 0.92 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.618 1.167 . . . . 3.26 111.267 -170.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.6 m -59.55 -35.27 73.9 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.303 0.641 . . . . 2.35 111.504 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -62.62 -40.49 97.12 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.305 -0.247 . . . . 0.76 110.383 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.4 mt -72.02 -62.33 1.47 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 119.306 -0.378 . . . . 2.11 111.092 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.2 p -66.91 69.83 0.08 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.495 1.918 . . . . 2.33 111.03 -168.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.64 -40.84 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.071 2.148 . . . . 3.85 110.561 -172.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -74.26 150.73 40.1 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.119 0.872 . . . . 3.87 110.371 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -54.14 148.8 10.47 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.045 0.45 . . . . 6.62 110.215 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.22 -31.51 5.37 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.491 -0.616 . . . . 1.16 112.473 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -70.19 148.58 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 118.005 0.903 . . . . 1.96 108.679 171.85 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 36.0 mt -114.5 -51.29 2.76 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.821 1.249 . . . . 3.15 109.604 167.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -150.35 161.36 42.62 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.895 0.878 . . . . 2.32 109.881 -175.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.8 m -143.29 168.35 19.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.16 -1.052 . . . . 2.02 108.16 170.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.0 m -148.01 132.21 17.39 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.487 -1.301 . . . . 1.54 107.487 148.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.0 p -104.57 142.25 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 118.433 0.561 . . . . 2.15 110.048 164.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.62 132.26 48.14 Favored 'General case' 0 C--N 1.339 0.15 0 O-C-N 121.864 -0.522 . . . . 0.93 111.407 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.39 -58.96 6.28 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.236 1.014 . . . . 2.67 110.501 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.28 -39.41 69.81 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.59 0.756 . . . . 1.25 112.664 -169.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.6 m -95.63 -8.39 34.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.338 0.655 . . . . 2.3 110.499 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 54.65 23.16 4.5 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.562 1.945 . . . . 3.34 112.577 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -98.96 145.12 27.37 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 119.035 -0.507 . . . . 1.67 110.494 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.16 138.69 40.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.121 -1.437 . . . . 0.57 107.121 154.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -107.82 150.82 26.54 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 106.632 -1.618 . . . . 1.24 106.632 154.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 32' ' ' ILE . 4.6 mp -126.29 122.04 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.172 -1.788 . . . . 1.05 106.172 173.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -94.36 82.43 4.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.356 1.863 . . . . 3.68 106.591 169.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -118.76 164.32 15.56 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.967 2.107 . . . . 2.0 109.775 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -86.89 117.76 69.11 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 107.856 -1.164 . . . . 3.26 107.856 167.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.2 -29.73 38.78 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.162 1.908 . . . . 1.31 112.918 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -86.66 29.23 0.8 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.664 1.12 . . . . 3.55 111.285 -166.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.7 pt -144.47 -50.48 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 123.95 0.9 . . . . 1.28 112.236 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.619 HG23 ' H ' ' A' ' 54' ' ' GLY 0.254 17.6 tt -95.56 -85.26 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.572 -0.899 . . . . 1.31 108.572 174.771 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.619 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 131.28 166.52 11.71 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.811 0.719 . . . . 0.75 112.955 173.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.59 -47.43 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.356 3.37 . . . . 0.74 111.305 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.455 ' HE ' ' CG ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -46.43 -48.25 18.88 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.118 0.967 . . . . 8.61 111.392 176.627 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.455 ' CG ' ' HE ' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -53.48 -56.91 13.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.876 1.271 . . . . 4.62 108.884 179.49 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.7 mt -57.56 -56.07 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.845 0.858 . . . . 0.85 109.965 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.6 mt -50.56 -51.54 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.426 -0.583 . . . . 1.4 109.426 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -36.65 84.47 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.48 0.712 . . . . 4.42 111.056 -178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.9 m -64.58 -53.66 44.26 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.34 -0.85 . . . . 0.74 109.35 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.403 HG21 HG11 ' A' ' 10' ' ' VAL . 13.1 mm -68.78 -33.14 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 121.335 -0.853 . . . . 1.59 111.158 -173.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -49.63 -62.07 1.76 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.12 0.968 . . . . 3.33 109.162 162.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -54.88 -38.7 67.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.763 0.825 . . . . 1.03 112.865 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.24 -14.71 27.92 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.954 -1.091 . . . . 2.22 112.88 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.02 47.01 2.31 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.317 0.961 . . . . 0.59 111.051 175.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -136.02 172.05 13.58 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.194 0.997 . . . . 2.07 108.387 171.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -111.89 84.8 5.8 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 113.098 0.777 . . . . 4.27 113.098 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.411 ' HB2' HD12 ' A' ' 8' ' ' LEU . 34.2 Cg_endo -68.03 80.42 0.52 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.633 2.889 . . . . 1.05 114.013 -175.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.9 p -77.13 119.68 21.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.553 -0.749 . . . . 2.54 109.654 169.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 108.687 -0.857 . . . . 2.86 108.687 178.412 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 107.691 -1.225 . . . . 2.08 107.691 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.32 111.68 4.96 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.818 -1.549 . . . . 2.14 106.818 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -92.29 141.38 28.62 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 123.28 0.632 . . . . 2.81 110.047 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.9 137.0 23.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.209 -0.663 . . . . 1.62 109.209 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.02 121.89 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 105.751 -1.944 . . . . 1.08 105.751 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -116.02 100.57 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.722 -1.214 . . . . 1.52 107.722 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -73.45 166.2 23.66 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.233 -1.025 . . . . 5.72 108.233 175.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.78 -10.76 57.5 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.511 -0.605 . . . . 1.02 112.618 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 75.8 mtm -68.05 73.02 0.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.555 1.177 . . . . 1.81 111.686 174.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -71.71 -30.12 65.31 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.533 1.133 . . . . 2.58 112.604 -171.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 82.5 m -143.46 158.92 43.26 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.225 -0.657 . . . . 3.53 109.225 -176.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.23 -45.15 8.34 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.97 1.308 . . . . 1.81 112.205 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 m -43.35 -42.46 4.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.431 1.092 . . . . 1.6 112.163 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.2 m -54.66 -40.05 68.65 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.683 -0.635 . . . . 0.72 111.608 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 t -58.34 -57.9 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.436 -0.95 . . . . 0.68 108.436 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -31.07 72.13 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.48 -0.563 . . . . 1.04 109.48 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -60.16 -51.31 70.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.946 -1.131 . . . . 3.78 107.946 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.7 mt -62.86 -54.83 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.855 -1.165 . . . . 0.73 107.855 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -51.99 -56.83 11.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 123.714 0.634 . . . . 3.09 109.53 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.7 t -59.8 -46.25 89.8 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.244 0.618 . . . . 1.52 110.079 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.3 t -65.13 -29.61 70.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.363 0.665 . . . . 0.75 111.422 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mt -79.87 -45.49 18.55 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.535 -0.745 . . . . 2.38 111.098 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.426 HG23 ' SG ' ' A' ' 35' ' ' CYS . 47.0 p -65.42 75.84 0.06 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.751 0.82 . . . . 1.98 110.747 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.94 -32.66 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 129.197 2.999 . . . . 3.45 110.301 -175.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -59.68 -23.45 63.11 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.914 0.779 . . . . 2.21 111.527 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 78.57 -42.26 0.32 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.424 1.49 . . . . 7.55 113.383 162.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.15 -20.5 58.29 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 111.735 -0.546 . . . . 1.21 111.735 168.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.72 130.86 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.584 0.753 . . . . 3.11 110.746 176.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.9 mt -74.66 -42.26 58.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.217 1.007 . . . . 2.87 108.748 169.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -161.58 165.28 28.66 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.952 -0.388 . . . . 2.86 109.952 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.426 ' SG ' HG23 ' A' ' 27' ' ' THR . 1.7 p -141.25 59.29 1.52 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 126.481 1.912 . . . . 3.11 110.894 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.32 95.72 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.827 -0.546 . . . . 1.31 111.682 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.32 149.11 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 126.265 1.826 . . . . 2.11 112.83 173.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.98 131.08 10.23 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.06 1.344 . . . . 1.02 112.086 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -65.89 -53.05 44.53 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 115.285 -0.87 . . . . 1.76 111.45 -170.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.0 -45.63 88.14 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.563 0.697 . . . . 1.67 109.435 -168.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.4 t -80.6 1.64 28.95 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.86 -0.59 . . . . 2.59 111.3 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 57.24 31.44 20.08 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.451 1.1 . . . . 2.64 109.828 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -107.1 138.79 42.61 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.453 -0.943 . . . . 1.75 108.453 -167.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.12 141.23 48.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.868 -1.901 . . . . 0.92 105.868 141.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -117.84 158.38 24.92 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 118.211 -1.395 . . . . 1.61 108.04 149.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 mp -119.46 128.93 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 106.32 -1.733 . . . . 0.94 106.32 168.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -95.34 132.32 40.49 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.396 -2.076 . . . . 2.51 105.396 163.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -165.07 167.77 17.97 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.044 0.838 . . . . 2.44 111.514 -168.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -87.71 119.09 70.49 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 107.015 -1.476 . . . . 3.49 107.015 156.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.15 -39.31 18.67 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.043 1.829 . . . . 1.34 111.065 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -89.14 39.17 0.92 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.206 1.002 . . . . 3.94 110.528 -160.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.7 pt -142.24 -49.9 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 126.052 1.741 . . . . 1.14 109.898 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 tt -95.68 -43.13 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.676 1.19 . . . . 1.3 111.373 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.36 150.64 4.93 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 123.911 0.767 . . . . 0.82 111.493 -174.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.66 -29.35 60.37 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.109 2.539 . . . . 0.87 111.775 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -55.92 -52.49 63.94 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.44 0.696 . . . . 5.95 111.458 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -50.28 -54.8 18.72 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 122.226 1.012 . . . . 2.52 109.869 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mt -54.26 -61.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.843 1.257 . . . . 0.72 110.144 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.5 mt -53.59 -47.43 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.42 0.555 . . . . 1.38 110.791 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -62.65 -42.89 99.86 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.298 0.639 . . . . 2.55 109.72 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.9 m -60.83 -54.0 50.46 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.209 -0.663 . . . . 0.61 109.209 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.2 mm -62.74 -37.58 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 119.215 -0.422 . . . . 1.67 111.037 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -52.99 -64.92 0.66 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.206 -0.664 . . . . 3.61 109.206 169.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.6 t -59.86 -24.79 64.51 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.438 0.695 . . . . 1.2 112.791 -176.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.1 tp -72.72 -5.15 35.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.078 1.351 . . . . 2.3 111.548 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.68 47.59 1.62 Allowed Glycine 0 C--N 1.337 0.628 0 C-N-CA 125.229 1.395 . . . . 0.76 110.825 168.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -144.16 172.34 13.04 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 123.949 0.9 . . . . 1.76 109.53 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -114.94 77.92 5.13 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.664 -0.684 . . . . 4.3 111.311 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.36 93.66 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.598 2.198 . . . . 1.06 112.41 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.3 t -97.04 139.65 32.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.895 0.855 . . . . 2.17 109.896 171.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 107.562 -1.273 . . . . 3.63 107.562 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 108.989 -0.745 . . . . 2.01 108.989 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.1 tp -133.65 141.74 47.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.507 -2.035 . . . . 2.8 105.507 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -129.83 139.47 51.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.278 -1.378 . . . . 2.48 107.278 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.404 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -143.84 148.5 35.59 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.073 -1.084 . . . . 3.12 108.073 176.169 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.39 133.25 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.893 -1.521 . . . . 0.99 106.893 175.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.09 87.97 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.75 0.82 . . . . 1.57 109.224 -168.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 77.0 mmt-85 -62.77 150.87 40.28 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.544 -0.909 . . . . 5.14 108.544 171.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.26 -4.5 48.26 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.862 -0.966 . . . . 0.98 113.954 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.8 mtp -75.1 49.61 0.45 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.871 1.835 . . . . 1.95 112.249 -176.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 t -82.79 37.22 0.52 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.695 -1.253 . . . . 3.02 113.407 -164.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.3 t -173.41 142.4 0.98 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.615 0.766 . . . . 3.1 108.959 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.38 -50.26 3.81 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.468 1.107 . . . . 2.01 112.456 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 m -46.36 -34.34 4.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.93 1.292 . . . . 1.54 112.866 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.0 m -48.23 -34.98 11.09 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 123.571 0.748 . . . . 1.02 111.029 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.439 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 93.9 t -49.07 -72.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 118.18 0.446 . . . . 0.88 110.115 173.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -27.9 68.47 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.693 -0.629 . . . . 1.29 111.178 -175.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -49.56 -42.84 45.3 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.213 0.605 . . . . 3.43 110.088 173.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.3 mt -83.06 -61.71 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.099 -1.075 . . . . 0.75 108.099 175.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -51.88 -61.31 2.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.39 1.476 . . . . 3.35 111.231 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 t -62.05 -45.49 93.33 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.855 0.862 . . . . 1.45 109.181 -173.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -59.95 -37.16 78.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.777 -0.647 . . . . 0.9 111.302 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mt -75.34 -37.41 60.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.235 -0.888 . . . . 2.34 112.521 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.5 p -64.35 77.6 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.749 0.704 . . . . 1.68 111.218 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HZ1' ' CD2' ' A' ' 29' ' ' HIS . 0.9 OUTLIER 168.32 -31.35 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.762 2.825 . . . . 3.3 111.152 -174.349 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.403 ' CD2' ' HZ1' ' A' ' 28' ' ' LYS . 24.7 m-70 -52.72 120.75 6.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.881 0.764 . . . . 1.96 110.108 177.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -70.97 80.26 0.65 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.836 0.855 . . . . 4.93 111.307 -166.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.86 -16.87 1.07 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.933 1.254 . . . . 1.2 110.743 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.496 HD11 ' SG ' ' A' ' 35' ' ' CYS . 0.3 OUTLIER -60.5 148.95 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 107.659 -1.238 . . . . 1.82 107.659 163.83 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 pp -122.11 -29.94 4.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.841 0.856 . . . . 2.66 112.346 167.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -159.64 154.7 24.94 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 119.547 1.067 . . . . 2.25 109.143 174.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.496 ' SG ' HD11 ' A' ' 32' ' ' ILE . 1.3 m -132.94 157.91 43.96 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.314 -0.995 . . . . 1.9 108.314 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.6 t -159.67 128.58 5.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.477 -0.934 . . . . 1.68 108.477 159.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 19' ' ' VAL . 1.1 m -121.12 159.93 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 123.203 0.601 . . . . 1.65 110.249 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.22 134.32 17.03 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.83 110.458 174.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.92 -33.92 68.67 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.152 -0.931 . . . . 1.38 110.462 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.98 80.44 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.547 0.739 . . . . 1.1 111.659 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.6 m -96.56 2.38 52.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.72 0.808 . . . . 2.14 109.974 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 46.67 44.71 14.01 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.453 2.301 . . . . 2.88 112.113 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -133.66 157.79 44.88 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 112.01 0.374 . . . . 1.73 112.01 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.66 135.94 53.37 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.422 -1.325 . . . . 0.69 107.422 162.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -107.59 149.77 27.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 123.832 0.707 . . . . 1.1 109.783 159.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.65 139.31 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 C-N-CA 127.481 2.312 . . . . 0.92 106.172 175.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' O ' HD13 ' A' ' 32' ' ' ILE . 76.4 mttt -113.45 135.14 54.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.62 -1.993 . . . . 2.3 105.62 161.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -170.97 175.08 4.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.228 1.011 . . . . 2.11 110.569 -164.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -98.09 96.26 3.38 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 125.457 1.503 . . . . 3.3 108.063 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -60.35 -29.75 89.51 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.128 1.885 . . . . 1.11 112.12 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -54.79 -43.93 73.28 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.872 0.869 . . . . 3.96 111.792 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.4 pt -94.77 -86.79 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.877 0.471 . . . . 1.8 112.027 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.7 tt -59.24 -45.83 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.971 0.908 . . . . 1.39 111.381 -171.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.95 161.8 31.26 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 115.329 -0.851 . . . . 0.66 112.342 172.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.27 -35.65 23.61 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.644 2.896 . . . . 0.66 111.865 -174.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -55.23 -49.35 72.22 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.918 0.487 . . . . 5.21 111.742 -174.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.28 -53.75 20.3 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.742 0.782 . . . . 2.78 109.75 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.55 -50.11 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.627 1.171 . . . . 1.04 110.555 -174.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.2 mt -55.18 -52.31 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 109.767 -0.457 . . . . 1.29 109.767 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -62.27 -36.35 81.81 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.376 -0.828 . . . . 2.36 112.22 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 66.6 m -57.21 -50.44 72.85 Favored 'General case' 0 C--O 1.225 -0.21 0 O-C-N 121.262 -0.899 . . . . 0.78 108.937 174.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.5 mt -65.73 -42.85 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.693 -0.63 . . . . 2.11 111.315 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -48.31 -46.1 35.81 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.424 1.09 . . . . 2.7 109.104 171.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.0 t -69.83 -44.07 70.68 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.741 0.817 . . . . 1.39 111.695 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.9 mt -59.38 -28.33 66.79 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.467 -0.77 . . . . 2.04 110.653 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.21 47.65 0.69 Allowed Glycine 0 C--O 1.228 -0.219 0 N-CA-C 110.117 -1.193 . . . . 0.8 110.117 157.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -134.62 171.55 14.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.529 -1.656 . . . . 1.87 106.529 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -108.93 82.01 1.69 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.06 -0.971 . . . . 4.22 111.313 -170.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.74 75.55 1.61 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.515 2.81 . . . . 1.12 112.823 -174.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m -73.51 116.92 14.66 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.959 -0.756 . . . . 2.35 108.959 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.2 tp . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.557 -1.275 . . . . 3.35 107.557 176.179 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 109.535 -0.543 . . . . 2.19 109.535 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 7' ' ' GLU . 3.1 tt -152.05 136.0 16.44 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.681 -1.97 . . . . 2.72 105.681 173.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.4 ' N ' HD23 ' A' ' 6' ' ' LEU . 63.6 mt-10 -114.13 130.01 56.6 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.251 1.021 . . . . 2.56 108.452 175.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.9 131.76 56.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.11 -1.441 . . . . 1.61 107.11 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 t -73.87 103.99 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 105.233 -2.136 . . . . 1.23 105.233 167.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 p -99.57 124.47 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 109.42 -0.585 . . . . 2.61 109.42 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -82.5 104.85 13.09 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.369 -1.715 . . . . 5.45 106.369 164.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.29 -54.32 0.03 OUTLIER Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.76 -0.257 . . . . 2.47 112.93 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -76.68 73.4 3.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.863 -0.787 . . . . 2.15 110.396 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 t -56.51 -39.06 72.66 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.907 0.483 . . . . 2.8 110.222 171.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 65.2 m -143.31 -168.01 2.7 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.743 1.617 . . . . 3.81 107.202 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.39 -168.15 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.537 0.735 . . . . 2.72 111.115 170.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.8 m 69.57 -66.86 0.25 Allowed 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.74 1.216 . . . . 1.61 109.693 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.5 m -40.85 -48.89 3.16 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.887 1.275 . . . . 0.89 110.671 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.0 t -43.26 -67.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.931 1.292 . . . . 0.71 110.968 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -24.54 67.74 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.836 -0.62 . . . . 1.13 109.643 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -65.27 -51.31 61.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.431 -0.951 . . . . 3.71 108.431 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.4 mt -65.12 -53.76 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 107.667 -1.235 . . . . 0.67 107.667 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -45.28 -51.71 10.55 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.455 0.702 . . . . 3.55 112.569 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 53.2 m -63.43 -52.88 59.66 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.684 -0.635 . . . . 1.55 110.167 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.0 t -54.45 -37.32 65.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.388 1.075 . . . . 1.22 111.506 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.07 -44.89 15.98 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.404 1.082 . . . . 1.85 110.954 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.7 p -58.24 -37.67 75.37 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.72 1.146 . . . . 1.96 110.834 176.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -51.25 -29.75 15.47 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.24 1.416 . . . . 4.8 113.057 169.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -78.8 99.45 6.7 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.76 -1.213 . . . . 2.15 110.3 175.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.71 107.83 0.17 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.864 -1.162 . . . . 6.72 107.864 157.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.75 -36.07 1.87 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.672 -1.371 . . . . 1.25 109.672 -170.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -70.68 142.49 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.697 -1.223 . . . . 2.11 107.697 168.016 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.0 tp -98.58 -47.4 5.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.639 1.576 . . . . 3.22 108.721 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -154.98 128.69 8.62 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.249 0.62 . . . . 3.2 109.913 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.0 t -108.05 150.44 27.16 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 108.347 -0.983 . . . . 2.12 108.347 171.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.9 t -156.55 129.52 7.88 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.148 -1.426 . . . . 1.81 107.148 162.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.0 m -122.85 144.71 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.89 0.768 . . . . 1.64 110.759 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.26 132.25 35.53 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.727 0.811 . . . . 0.81 111.28 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 pp -68.62 -51.71 39.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.661 1.185 . . . . 1.51 110.994 -174.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.32 -51.32 65.06 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.404 0.621 . . . . 1.17 110.178 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.04 -14.71 61.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.672 1.189 . . . . 2.03 111.738 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 55.52 33.79 21.78 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.198 1.399 . . . . 2.84 108.367 -172.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -126.48 140.72 52.25 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 118.801 0.728 . . . . 1.38 111.264 -162.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.32 120.25 39.0 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.127 -1.064 . . . . 0.74 108.127 161.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -95.27 132.0 40.73 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 126.684 1.994 . . . . 3.01 106.466 173.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.543 HG22 ' CD1' ' A' ' 48' ' ' TYR . 97.5 mt -130.47 130.32 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.799 -1.186 . . . . 1.44 107.799 173.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.486 ' O ' HD13 ' A' ' 32' ' ' ILE . 41.6 mttp -104.66 131.99 51.44 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 105.967 -1.864 . . . . 2.95 105.967 159.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.543 ' CD1' HG22 ' A' ' 46' ' ' ILE . 18.3 p90 -162.78 160.8 25.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.601 1.16 . . . . 2.19 109.283 -169.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -82.2 104.5 3.36 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 107.432 -1.321 . . . . 3.65 107.432 172.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -61.78 -45.02 18.43 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.447 2.098 . . . . 1.45 111.923 -166.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -53.32 -40.9 65.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.308 1.443 . . . . 4.41 112.938 -174.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 pt -88.56 -47.51 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 113.838 1.051 . . . . 1.48 113.838 -168.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.2 tt -83.99 -56.71 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 118.142 0.428 . . . . 1.67 111.191 -178.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.41 135.01 8.3 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.002 0.811 . . . . 1.06 112.444 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.65 -45.18 14.66 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.703 2.935 . . . . 0.9 111.059 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -53.55 -52.4 59.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.51 -0.552 . . . . 7.08 109.51 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.94 -46.39 85.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.916 1.686 . . . . 5.32 109.928 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 mt -52.31 -58.86 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 122.696 0.399 . . . . 0.96 110.732 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 mt -50.49 -43.87 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 118.091 0.405 . . . . 1.55 111.184 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -63.4 -36.35 83.43 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.495 -0.753 . . . . 2.36 111.483 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.6 m -62.25 -50.33 72.16 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.282 -0.886 . . . . 0.91 109.273 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.9 mm -59.71 -45.01 94.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.881 -0.512 . . . . 1.32 111.321 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -52.11 -53.74 38.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.115 1.366 . . . . 2.71 109.528 172.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -56.56 -39.42 73.43 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.357 1.063 . . . . 1.5 112.124 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.76 -17.27 34.06 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.573 0.583 . . . . 2.38 112.573 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.45 29.26 11.29 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.344 0.973 . . . . 1.46 110.724 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -120.31 158.68 26.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.645 1.178 . . . . 1.91 108.684 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -105.65 104.11 46.87 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-O 118.029 -0.986 . . . . 4.69 110.271 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -84.54 83.74 1.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.934 3.089 . . . . 1.06 111.552 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 m -72.54 103.67 3.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.877 -0.786 . . . . 2.51 108.877 173.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--N 1.327 -0.402 0 N-CA-C 108.237 -1.023 . . . . 3.74 108.237 174.084 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 CA--C 1.531 0.244 0 N-CA-C 109.211 -0.663 . . . . 2.18 109.211 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -74.91 111.57 10.25 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.029 -1.1 . . . . 2.43 108.029 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -92.56 122.79 35.33 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.272 -1.381 . . . . 2.94 107.272 169.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -118.66 151.0 38.77 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 108.099 -1.074 . . . . 1.54 108.099 170.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 t -103.78 119.0 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.34 -0.985 . . . . 1.11 108.34 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.56 119.98 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 126.937 2.095 . . . . 1.39 109.406 174.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -82.38 161.63 22.45 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.674 -1.232 . . . . 5.78 107.674 154.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.91 -28.17 5.47 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.185 0.898 . . . . 0.89 112.569 172.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -65.53 113.62 4.3 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.438 1.119 . . . . 2.09 109.845 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 t -67.31 -54.8 17.52 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.567 -0.531 . . . . 2.9 109.567 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 t -177.34 -90.03 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.658 1.183 . . . . 5.46 109.914 170.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.02 160.23 32.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.651 0.38 . . . . 3.23 109.989 -176.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.5 m 68.02 -60.66 0.4 Allowed 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.424 1.49 . . . . 1.56 110.983 -173.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.6 m -39.64 -41.91 1.12 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 126.438 1.895 . . . . 0.79 113.04 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.7 t -51.16 -69.57 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.709 0.29 . . . . 0.59 110.337 173.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.19 -30.73 71.66 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.302 -0.874 . . . . 1.65 110.872 -175.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.28 -40.83 17.62 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.771 1.228 . . . . 3.59 109.49 174.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.9 mt -85.32 -60.44 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 107.352 -1.351 . . . . 0.54 107.352 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -51.36 -62.28 1.72 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.242 1.417 . . . . 3.47 111.52 -170.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -61.93 -43.11 99.53 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.809 0.844 . . . . 2.76 110.144 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.9 t -62.28 -35.2 78.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.079 -0.509 . . . . 0.9 110.858 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.9 mt -70.43 -46.99 62.81 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.32 -0.847 . . . . 2.03 111.041 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.5 p -63.89 77.45 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.257 0.481 . . . . 1.78 110.779 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? 170.72 -24.58 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.654 3.182 . . . . 3.42 111.437 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -70.91 59.24 0.22 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.94 1.245 . . . . 2.19 111.683 172.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 41.04 -73.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 129.454 3.101 . . . . 5.77 115.766 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.43 97.14 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.918 0.771 . . . . 1.94 111.526 -175.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.666 HD13 HG23 ' A' ' 46' ' ' ILE . 1.3 tp -66.65 97.66 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 117.635 0.717 . . . . 2.23 110.877 -175.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 pp -86.5 -32.77 20.58 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.605 1.162 . . . . 3.01 111.721 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -147.72 136.8 22.21 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.278 0.631 . . . . 2.27 111.02 176.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -117.75 166.45 12.42 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.223 -1.028 . . . . 1.99 108.223 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 m -151.09 117.69 5.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.421 -1.326 . . . . 1.56 107.421 151.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.71 125.15 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 120.411 1.46 . . . . 2.37 109.894 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.44 129.55 55.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.181 0.593 . . . . 1.16 109.475 172.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.0 -48.17 54.68 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.849 -1.069 . . . . 1.77 111.015 -172.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.03 -51.44 69.68 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.37 0.605 . . . . 1.71 110.534 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.81 -12.82 52.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.482 1.113 . . . . 2.11 111.342 176.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 54.26 28.35 9.1 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 125.157 1.383 . . . . 2.73 109.627 -172.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -121.03 129.41 53.36 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 118.944 0.793 . . . . 1.44 110.846 -160.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.02 120.44 39.84 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.685 1.194 . . . . 0.8 108.715 164.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 127.31 36.09 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 127.002 2.121 . . . . 1.62 105.33 166.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.666 HG23 HD13 ' A' ' 32' ' ' ILE . 4.6 mp -120.9 130.2 74.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.029 1.332 . . . . 1.2 108.713 174.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -104.0 90.25 3.55 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.006 1.723 . . . . 2.58 108.278 167.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.14 179.35 7.27 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.98 1.312 . . . . 2.2 109.535 -175.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.2 124.53 41.04 Favored Pre-proline 0 N--CA 1.445 -0.719 0 O-C-N 123.34 0.4 . . . . 4.18 110.759 174.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.51 -8.79 10.4 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.406 2.738 . . . . 1.7 112.801 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -90.83 -55.1 3.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 119.154 0.888 . . . . 3.49 108.784 -175.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 pt -68.24 -78.68 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.849 0.357 . . . . 1.46 111.871 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.7 tt -69.06 -56.62 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 O-C-N 121.229 -0.92 . . . . 1.34 109.186 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.03 159.07 33.25 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 122.92 0.295 . . . . 0.64 113.1 171.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.66 -38.61 80.47 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.661 2.907 . . . . 0.83 110.979 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -32.16 -64.14 0.18 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.73 2.012 . . . . 9.91 113.487 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -53.98 -58.25 7.99 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.624 1.169 . . . . 2.91 109.906 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 mt -57.2 -59.94 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.271 -0.877 . . . . 1.22 109.899 -176.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.4 mt -49.99 -51.33 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 123.311 0.644 . . . . 1.25 110.273 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -69.31 -32.71 72.01 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.537 0.608 . . . . 2.51 111.689 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.3 m -60.6 -58.66 7.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.942 -0.762 . . . . 0.69 108.942 171.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 mm -59.98 -38.17 75.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.297 1.039 . . . . 1.83 111.474 -174.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -51.72 -65.35 0.57 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.84 1.256 . . . . 2.73 108.809 167.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.8 t -56.96 -27.58 61.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.317 0.647 . . . . 1.15 112.696 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.5 tp -76.17 -5.4 46.58 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.419 1.488 . . . . 2.28 111.57 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.1 45.36 2.85 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 124.345 0.974 . . . . 0.64 111.572 169.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -143.23 172.16 13.11 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.443 1.097 . . . . 2.15 108.11 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -115.76 78.76 7.24 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 123.106 0.562 . . . . 4.68 111.916 -175.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.13 72.78 5.75 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.786 2.991 . . . . 1.55 112.829 -168.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.8 p -69.84 138.98 53.05 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.969 -0.457 . . . . 2.08 110.488 171.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.9 tp . . . . . 0 N--CA 1.451 -0.392 0 N-CA-C 106.742 -1.577 . . . . 3.2 106.742 167.065 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 108.078 -1.082 . . . . 2.46 108.078 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.79 90.34 2.89 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.982 -1.488 . . . . 2.48 106.982 171.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -73.65 119.95 18.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.26 -1.015 . . . . 2.11 108.26 159.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -127.7 150.61 49.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.211 -1.033 . . . . 1.84 108.211 166.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.0 t -96.71 135.71 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.429 -1.693 . . . . 0.91 106.429 171.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.81 176.73 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.483 -0.932 . . . . 2.55 108.483 172.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -134.55 167.07 21.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.942 -2.244 . . . . 6.17 104.942 152.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.93 -3.9 55.89 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.295 -0.725 . . . . 1.09 114.139 176.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.9 mtm -75.7 53.93 0.76 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.72 1.76 . . . . 2.06 111.977 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -80.68 36.27 0.38 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.897 -1.127 . . . . 3.13 113.203 -166.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.7 t -171.04 140.54 1.55 Allowed 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 118.913 0.779 . . . . 3.43 109.424 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.86 -48.82 11.12 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.797 0.839 . . . . 1.94 111.162 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 m -44.84 -38.6 4.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.485 1.114 . . . . 1.56 112.234 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.0 m -54.62 -38.12 66.42 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.372 0.533 . . . . 0.8 110.908 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 86.1 t -52.46 -63.8 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 123.407 0.683 . . . . 0.75 109.487 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -29.28 69.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.908 -0.587 . . . . 1.35 109.715 -175.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -62.66 -55.55 25.87 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.184 -1.413 . . . . 4.56 107.184 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.456 HG22 HD23 ' A' ' 26' ' ' LEU . 65.4 mt -60.09 -53.45 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 107.066 -1.457 . . . . 0.69 107.066 -172.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -41.34 -64.6 0.54 Allowed 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 124.607 1.192 . . . . 4.29 109.768 174.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.2 t -58.19 -43.85 87.74 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.632 0.773 . . . . 1.41 110.259 -173.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.63 -20.84 62.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.313 1.045 . . . . 1.01 111.117 -176.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.456 HD23 HG22 ' A' ' 22' ' ' ILE . 2.4 mm? -82.72 -57.85 3.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.703 -0.665 . . . . 2.04 110.55 168.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.58 -31.27 64.06 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.231 0.923 . . . . 1.61 111.572 -177.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -37.11 -52.04 0.99 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.494 1.517 . . . . 4.62 112.798 162.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -96.64 140.84 30.66 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 118.899 0.772 . . . . 3.37 111.294 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -67.11 177.09 1.88 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.696 -0.483 . . . . 6.54 109.696 173.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.19 -48.42 3.92 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.935 -1.266 . . . . 1.39 109.935 -174.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.856 HD11 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -57.88 141.99 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.641 -0.874 . . . . 1.83 108.641 158.513 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.3 mt -108.97 -45.37 3.8 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.417 1.487 . . . . 3.41 108.593 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -154.98 155.96 35.14 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.013 0.925 . . . . 2.16 109.756 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.9 t -136.96 146.28 45.2 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.464 -0.939 . . . . 1.99 108.464 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.9 m -150.74 119.34 6.5 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.813 -0.81 . . . . 1.75 108.813 161.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 22' ' ' ILE . 11.3 m -101.21 155.67 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.699 0.8 . . . . 1.68 109.964 170.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.48 134.08 22.12 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.252 0.621 . . . . 1.01 110.971 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.66 -47.61 69.01 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.444 1.097 . . . . 2.35 110.133 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.79 -43.49 80.97 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 123.377 0.671 . . . . 1.69 111.384 -170.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.1 m -94.37 -0.84 54.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.167 0.587 . . . . 2.57 110.593 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.78 34.06 18.29 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.073 1.749 . . . . 2.99 111.528 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -112.14 152.11 28.69 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.567 0.747 . . . . 1.49 110.359 -165.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.417 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -116.39 121.91 43.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.428 1.091 . . . . 0.68 108.224 156.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.97 131.69 42.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.902 -1.518 . . . . 1.13 106.902 160.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.856 HG23 HD11 ' A' ' 32' ' ' ILE . 4.8 mp -118.08 119.23 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.029 -1.471 . . . . 1.11 107.029 172.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -95.88 95.7 8.43 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 126.59 1.956 . . . . 3.29 106.252 172.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -126.8 165.85 18.53 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.024 1.33 . . . . 2.33 109.474 -174.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -86.94 112.47 47.6 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.649 -0.871 . . . . 3.25 108.649 170.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.05 -19.25 45.72 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.612 2.208 . . . . 1.4 113.089 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -69.01 -36.47 77.83 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.021 0.828 . . . . 4.16 110.705 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.6 pt -99.23 -62.55 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 N-CA-C 113.599 0.963 . . . . 1.29 113.599 -165.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 tt -88.42 -47.56 15.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.576 0.703 . . . . 1.44 110.721 -165.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.5 151.6 27.13 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.045 0.831 . . . . 0.72 111.589 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.66 -30.51 34.62 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.828 3.019 . . . . 0.65 112.55 -174.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.426 HH21 ' CE1' ' A' ' 60' ' ' HIS . 2.3 mmp_? -50.97 -50.42 58.2 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.983 0.513 . . . . 6.38 111.068 176.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.24 -54.22 27.86 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.814 0.845 . . . . 2.78 110.285 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.0 mt -57.01 -54.26 32.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 124.69 1.196 . . . . 0.96 111.065 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.6 mt -54.42 -53.15 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.378 -0.601 . . . . 1.27 109.378 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.426 ' CE1' HH21 ' A' ' 56' ' ' ARG . 74.4 m-70 -61.75 -35.42 78.07 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.793 -0.567 . . . . 2.37 112.318 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.0 m -59.81 -48.93 79.7 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 121.045 -1.034 . . . . 0.87 109.508 176.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.6 mt -68.86 -42.64 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.883 -0.511 . . . . 2.12 111.511 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -49.54 -47.16 49.22 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.875 1.27 . . . . 2.78 109.08 171.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.2 t -70.66 -42.33 70.94 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.126 0.971 . . . . 1.29 110.555 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.56 -48.87 57.34 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 124.663 1.185 . . . . 3.1 109.009 174.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.26 45.96 0.28 Allowed Glycine 0 C--N 1.334 0.438 0 N-CA-C 110.179 -1.168 . . . . 0.76 110.179 168.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -127.45 172.71 10.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.561 -1.644 . . . . 1.67 106.561 169.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -110.44 71.77 0.68 Allowed Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 118.689 -0.672 . . . . 4.66 111.876 -165.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.82 136.12 34.67 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.404 2.069 . . . . 1.48 112.337 -169.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.6 p -145.56 129.19 17.1 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.728 1.211 . . . . 1.92 108.258 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 O-C-N 121.219 -0.925 . . . . 3.36 112.685 -173.308 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 107.207 -1.405 . . . . 2.43 107.207 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 tp -148.23 111.4 4.9 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.275 -1.379 . . . . 2.67 107.275 -172.222 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -100.37 46.14 0.96 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.657 1.983 . . . . 5.05 109.355 -169.466 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.02 156.36 39.25 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.964 -0.46 . . . . 1.75 110.031 -165.238 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.56 129.14 48.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 N-CA-C 107.793 -1.188 . . . . 1.0 107.793 175.141 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.58 125.4 68.62 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.029 0 N-CA-C 106.528 -1.656 . . . . 1.63 106.528 172.06 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -104.91 167.97 9.36 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.273 -1.01 . . . . 4.48 108.273 157.455 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.88 -10.51 29.71 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.783 1.183 . . . . 0.96 111.891 -173.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.0 mtm -68.11 76.14 0.23 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.114 0.957 . . . . 1.85 110.179 172.944 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.8 p -82.19 -75.07 0.32 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.272 1.029 . . . . 3.35 109.436 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 67.2 m -72.9 128.81 36.6 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.572 -0.899 . . . . 4.54 108.572 -179.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -34.89 -51.79 0.52 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.775 1.63 . . . . 1.76 113.394 -176.355 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.8 t -40.1 -42.51 1.45 Allowed 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 124.817 1.247 . . . . 3.16 111.385 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.0 m -38.38 -46.3 1.11 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.272 1.029 . . . . 0.8 112.097 177.343 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.0 t -50.83 -67.28 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 124.172 0.989 . . . . 0.6 110.244 175.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.43 -21.42 66.29 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.443 -0.344 . . . . 2.56 111.847 -179.003 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -68.42 -50.11 55.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.925 -1.509 . . . . 3.45 106.925 -178.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.477 HG21 HG11 ' A' ' 37' ' ' VAL . 63.5 mt -62.05 -57.84 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.374 -1.343 . . . . 0.58 107.374 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -48.19 -57.78 5.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.794 0.838 . . . . 3.32 111.16 179.155 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.1 t -59.7 -44.25 93.76 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.624 0.726 . . . . 1.56 110.135 -178.395 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.5 t -60.48 -29.01 68.79 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 118.506 -0.759 . . . . 1.09 111.446 177.369 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.44 HD12 HG22 ' A' ' 22' ' ' ILE . 11.8 mt -82.63 -47.98 11.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 119.161 0.892 . . . . 2.36 111.772 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.8 p -72.75 62.04 0.56 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.37 1.468 . . . . 1.73 110.938 -175.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -168.7 -30.88 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.673 1.989 . . . . 3.68 111.84 -171.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -65.59 19.76 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.247 1.573 . . . . 2.42 115.247 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 61.85 -71.83 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.504 1.521 . . . . 4.95 110.816 -169.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.68 49.47 3.66 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.309 0.956 . . . . 1.78 112.773 -172.009 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.65 135.16 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 104.789 -2.3 . . . . 2.69 104.789 159.421 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.7 mt -95.4 -37.55 10.89 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.147 0.979 . . . . 3.63 108.925 173.452 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -168.61 158.9 9.67 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.596 1.158 . . . . 2.04 108.071 177.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.8 m -145.48 155.19 42.95 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 123.669 0.788 . . . . 2.2 109.943 172.111 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.1 t -162.37 116.99 1.83 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.803 1.241 . . . . 1.83 107.873 167.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.477 HG11 HG21 ' A' ' 22' ' ' ILE . 2.7 m -104.05 159.95 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.429 1.013 . . . . 1.67 111.936 170.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.9 135.96 21.22 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.574 0.75 . . . . 0.79 109.981 176.215 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.23 -43.15 19.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.625 0.77 . . . . 1.61 111.78 -171.111 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.25 -39.25 89.63 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.886 0.474 . . . . 1.36 110.186 -174.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.3 t -98.19 3.67 48.97 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.599 0.76 . . . . 2.22 111.274 176.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.22 48.45 13.09 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 126.252 1.821 . . . . 3.26 110.673 173.141 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -119.55 143.29 47.69 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 125.252 1.421 . . . . 2.09 108.338 -169.478 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.6 109.57 14.94 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.879 -1.156 . . . . 0.9 107.879 158.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -83.65 110.51 18.33 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 104.557 -2.386 . . . . 1.54 104.557 166.294 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.8 mt -110.31 143.44 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.292 1.037 . . . . 0.97 108.29 171.293 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -120.79 133.0 55.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.455 -1.683 . . . . 2.17 106.455 163.299 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -164.45 167.94 19.01 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.478 0.581 . . . . 2.03 110.911 -163.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -104.02 104.87 45.85 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 108.65 -0.87 . . . . 4.22 108.65 -178.01 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.64 26.18 0.48 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.89 2.393 . . . . 1.45 113.942 -167.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -127.52 -62.89 1.06 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.424 1.09 . . . . 3.78 108.94 -172.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 pt -57.8 -39.76 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.242 0.617 . . . . 2.65 111.748 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.425 HG23 ' H ' ' A' ' 54' ' ' GLY . 6.3 tt -107.01 -81.74 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.796 0.839 . . . . 1.54 109.244 171.544 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.425 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 123.15 155.33 9.26 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.144 0.878 . . . . 1.09 111.242 -177.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.35 -41.42 41.71 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.123 2.549 . . . . 1.1 110.52 175.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.5 ttm105 -32.96 -71.1 0.06 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 127.01 2.124 . . . . 7.67 110.768 171.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.8 -45.64 89.43 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.275 1.83 . . . . 4.04 109.949 -171.209 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.0 mt -58.56 -60.86 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 109.426 -0.583 . . . . 0.91 109.426 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.4 mt -51.08 -48.43 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.958 0.503 . . . . 1.56 109.822 178.486 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -61.86 -38.38 88.04 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.686 1.194 . . . . 4.02 111.698 -178.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.7 m -65.03 -52.31 56.69 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.117 -0.99 . . . . 0.61 108.633 175.654 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 mm -63.64 -36.94 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 O-C-N 122.205 -0.31 . . . . 1.53 110.991 -175.095 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -52.35 -64.06 0.94 Allowed 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.028 1.331 . . . . 2.7 109.036 166.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 t -52.65 -38.15 59.88 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.345 1.058 . . . . 1.1 112.786 -175.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.9 mt -58.25 -25.78 62.14 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.512 -0.742 . . . . 1.93 112.86 176.537 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.13 49.94 0.8 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.229 0.918 . . . . 0.9 111.131 178.055 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -137.97 167.51 21.63 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 106.577 -1.638 . . . . 1.77 106.577 172.378 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -107.49 89.18 4.73 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 119.351 0.978 . . . . 4.21 112.539 172.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.09 70.92 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.967 2.445 . . . . 1.61 111.629 177.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.4 m -79.14 117.61 20.33 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.242 1.417 . . . . 2.04 108.515 177.949 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.9 tp . . . . . 0 N--CA 1.441 -0.924 0 N-CA-C 107.936 -1.135 . . . . 3.74 107.936 -179.325 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 121.068 0.461 . . . . 2.66 110.319 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.1 tp -74.93 130.95 40.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.897 -0.779 . . . . 2.23 108.897 179.483 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -103.65 149.59 24.8 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.092 -1.077 . . . . 2.04 108.092 164.327 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.68 123.88 13.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.03 -1.47 . . . . 1.64 107.03 172.281 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.35 135.42 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 107.497 -1.297 . . . . 1.12 107.497 166.734 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.0 156.82 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 124.929 1.292 . . . . 2.08 107.63 173.476 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.4 mtm105 -138.37 177.37 7.93 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.187 -1.783 . . . . 4.43 106.187 168.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.39 -9.23 71.95 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.53 0.586 . . . . 1.36 112.61 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -69.4 157.99 36.0 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.198 0.999 . . . . 2.89 110.206 176.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 t -149.31 140.34 22.94 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.523 -1.288 . . . . 3.87 107.523 167.573 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 69.2 m 68.67 153.39 0.1 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.842 1.657 . . . . 2.73 112.563 174.192 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.32 -36.99 22.71 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.744 0.818 . . . . 2.44 110.619 174.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -35.07 -52.16 0.56 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.931 1.692 . . . . 1.95 112.5 170.209 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.3 m -63.88 -35.56 81.06 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.482 -0.761 . . . . 0.98 111.627 -175.582 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.2 t -56.68 -59.52 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 178.567 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -31.77 73.17 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.773 -0.649 . . . . 1.64 109.792 -177.573 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -58.22 -58.91 6.39 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 106.957 -1.498 . . . . 4.03 106.957 176.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.537 HG21 HG11 ' A' ' 37' ' ' VAL . 60.6 mt -59.61 -53.21 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.54 -1.282 . . . . 0.66 107.54 -171.651 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -46.02 -57.75 4.16 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 124.127 0.892 . . . . 4.23 110.112 177.37 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -60.88 -46.79 89.2 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.696 0.76 . . . . 1.41 109.804 -175.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 t -60.23 -36.65 78.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.374 1.47 . . . . 0.94 109.079 -175.579 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.472 HD23 HG22 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -70.53 -53.08 17.6 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.344 0.658 . . . . 2.16 112.006 174.066 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.9 p -52.48 -29.17 23.5 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.377 0.535 . . . . 1.83 111.991 -173.148 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 10.23 7.23 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.802 1.408 . . . . 3.26 114.802 178.373 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -89.48 178.43 6.3 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.121 1.328 . . . . 2.41 109.519 165.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -81.09 159.42 24.73 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.553 -0.906 . . . . 6.63 108.553 166.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.88 -55.88 3.88 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.499 0.571 . . . . 1.97 113.162 170.006 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.583 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -63.03 107.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 117.713 0.756 . . . . 2.51 110.293 -178.139 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 32' ' ' ILE . 2.4 pp -99.52 -25.53 14.4 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.72 1.208 . . . . 2.82 111.732 -174.226 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -146.96 122.18 10.2 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.297 -1.001 . . . . 2.53 108.297 176.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.2 t -102.0 161.65 13.51 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 107.725 -1.213 . . . . 1.94 107.725 171.377 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 m -160.36 116.84 2.4 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.208 -1.034 . . . . 1.64 108.208 163.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 22' ' ' ILE . 2.2 m -116.01 165.57 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 122.777 0.431 . . . . 1.85 110.073 169.695 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.25 135.0 14.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.858 0.863 . . . . 0.71 109.195 170.089 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.18 -43.91 69.84 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.029 -0.987 . . . . 1.59 110.25 -177.282 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.34 -49.94 72.92 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.365 0.602 . . . . 1.15 110.512 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -67.74 -11.81 59.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.587 0.755 . . . . 2.1 111.132 178.593 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 53.8 38.36 28.39 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.799 1.24 . . . . 3.28 108.542 -173.067 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -133.51 142.58 48.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 O-C-N 122.143 -0.348 . . . . 1.38 111.078 -167.184 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.3 142.09 47.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.812 1.245 . . . . 0.71 107.928 160.428 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.03 154.23 48.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.549 0.613 . . . . 1.24 110.316 163.047 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.514 HG23 HD13 ' A' ' 32' ' ' ILE . 4.8 mp -127.75 138.62 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.883 -1.154 . . . . 1.18 107.883 178.085 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -104.12 110.82 23.15 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.035 0.934 . . . . 2.64 108.643 164.192 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -155.17 158.24 38.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.133 1.373 . . . . 2.55 110.178 -174.578 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.02 126.01 88.65 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 109.087 -0.709 . . . . 3.62 109.087 165.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.26 -7.98 14.0 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.227 2.618 . . . . 1.04 113.887 -173.379 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -84.09 -52.68 6.09 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 119.591 1.087 . . . . 4.98 108.439 -179.051 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.1 pt -62.46 -52.7 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 113.593 0.96 . . . . 1.38 113.593 -168.021 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.526 HG23 ' H ' ' A' ' 54' ' ' GLY . 13.1 tt -97.2 -68.79 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 124.096 0.959 . . . . 1.09 109.658 -178.823 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.526 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 109.49 162.14 19.49 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.735 0.683 . . . . 0.72 113.697 172.109 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.85 -42.82 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.092 3.195 . . . . 0.81 111.903 -173.298 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -52.26 -50.09 62.78 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.705 1.241 . . . . 8.17 108.732 -173.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.55 -54.13 41.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.005 2.922 . . . . 5.0 108.536 -176.887 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.1 mt -61.48 -54.85 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 123.841 0.856 . . . . 0.8 110.284 179.161 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.7 mm -48.56 -53.27 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 118.5 0.591 . . . . 2.2 109.423 178.472 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -63.5 -33.15 74.95 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.413 0.523 . . . . 2.93 112.413 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.8 m -59.8 -58.1 10.01 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.221 -0.924 . . . . 0.79 109.78 171.203 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.2 mm -63.89 -32.8 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.6 -0.688 . . . . 1.49 110.921 -174.057 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.08 -58.49 7.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.696 1.198 . . . . 3.03 108.904 167.783 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.7 t -55.12 -37.27 66.69 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.501 1.12 . . . . 1.0 112.378 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.0 mt -60.17 -16.45 32.97 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.905 0.706 . . . . 2.04 112.905 175.102 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.35 38.19 5.13 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.951 -0.86 . . . . 0.83 110.951 177.325 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -127.53 171.58 11.48 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 107.501 -1.296 . . . . 1.71 107.501 172.798 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -112.15 70.66 1.02 Allowed Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 114.446 1.276 . . . . 4.02 114.446 -168.137 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.7 110.73 2.82 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.963 2.442 . . . . 1.09 112.864 -175.221 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.7 t -71.32 177.76 3.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.694 1.198 . . . . 3.41 109.339 160.282 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.43 HD23 ' H ' ' A' ' 71' ' ' LEU . 0.6 OUTLIER . . . . . 0 CA--C 1.539 0.528 0 N-CA-C 108.485 -0.931 . . . . 3.93 108.485 158.345 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 105.994 -1.854 . . . . 2.14 105.994 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.4 tp -137.27 134.21 35.9 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 107.951 -1.129 . . . . 1.91 107.951 159.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -101.87 123.72 46.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.023 -1.103 . . . . 2.16 108.023 168.278 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.71 131.17 44.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 110.121 -0.326 . . . . 1.53 110.121 175.16 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.99 142.52 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.484 -1.672 . . . . 1.3 106.484 168.198 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.3 107.75 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.879 -1.526 . . . . 1.26 106.879 173.073 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -76.98 166.04 23.85 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.934 -0.765 . . . . 5.68 108.934 174.661 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.84 -45.77 3.36 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.778 -0.929 . . . . 1.06 110.778 -177.334 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -57.01 120.16 7.51 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.837 -0.801 . . . . 2.4 108.837 174.314 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 t -156.92 19.44 0.31 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.39 0.515 . . . . 3.64 112.39 -166.105 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.6 t -157.45 148.21 21.27 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 120.781 -1.199 . . . . 2.98 109.141 -179.089 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.76 -41.02 10.27 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.069 0.948 . . . . 2.38 111.535 173.241 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.8 m -51.29 -55.9 15.83 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.206 0.602 . . . . 1.72 110.513 172.538 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.9 m -55.97 -51.97 65.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 123.804 0.842 . . . . 0.77 109.464 178.591 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.9 t -46.8 -61.85 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.001 0.52 . . . . 0.98 109.734 178.817 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.283 0.0 OUTLIER -64.78 -21.97 66.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.936 -0.575 . . . . 1.84 110.923 -176.175 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -66.73 -47.3 72.72 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.871 -0.789 . . . . 4.06 108.871 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.429 ' HB ' HG21 ' A' ' 37' ' ' VAL . 15.2 mt -66.73 -52.21 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.769 -1.197 . . . . 0.72 107.769 -178.746 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -41.83 -66.57 0.33 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.486 0.714 . . . . 3.37 110.328 171.785 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.6 t -55.88 -49.43 73.41 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.473 1.109 . . . . 1.49 109.815 -172.401 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.0 t -64.31 -37.4 87.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 118.802 -0.618 . . . . 0.71 111.414 -178.273 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.71 -41.14 72.3 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.237 0.926 . . . . 1.88 110.33 178.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.1 p -65.18 74.65 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.964 0.906 . . . . 1.78 111.022 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.5 pttm 179.15 -36.23 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 129.521 3.129 . . . . 3.73 109.707 -178.226 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -53.53 118.59 4.0 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.193 0.597 . . . . 1.93 110.657 -178.292 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -67.24 82.19 0.14 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.541 1.137 . . . . 5.06 110.252 -171.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.26 -29.24 0.52 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.162 0.887 . . . . 1.23 110.927 -174.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.21 140.06 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.65 1.18 . . . . 1.86 109.239 175.714 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.3 mt -114.2 -47.6 2.93 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.341 1.456 . . . . 3.0 109.703 168.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -143.3 138.38 29.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.334 0.515 . . . . 2.56 110.94 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -105.49 156.71 17.95 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.656 -1.238 . . . . 2.13 107.656 173.618 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.1 92.64 1.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.878 -0.786 . . . . 1.35 108.878 162.693 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 22' ' ' ILE . 46.4 t -92.3 144.96 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 125.707 1.603 . . . . 2.39 109.59 176.387 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.83 134.56 11.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.895 -0.503 . . . . 0.8 111.577 172.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.15 -30.48 62.29 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 123.828 0.851 . . . . 1.44 111.353 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.47 -29.66 69.2 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.396 0.543 . . . . 1.28 110.722 -177.238 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.428 HG23 ' HG2' ' A' ' 43' ' ' LYS . 5.0 t -115.38 5.88 14.69 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.795 1.238 . . . . 2.26 110.836 176.367 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 45.45 45.49 10.31 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 127.541 2.337 . . . . 3.14 112.45 175.003 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.428 ' HG2' HG23 ' A' ' 41' ' ' THR . 16.8 ptpt -139.03 161.52 37.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.334 0.494 . . . . 1.54 112.334 -178.128 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.71 124.81 52.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.769 1.627 . . . . 0.74 106.853 160.04 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 139.22 30.84 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.069 -1.086 . . . . 1.08 108.069 153.584 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.96 125.95 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.955 -1.498 . . . . 1.01 106.955 174.627 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -101.95 87.83 3.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.027 1.331 . . . . 2.25 107.952 167.363 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -125.49 157.12 37.77 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.131 2.173 . . . . 2.22 109.48 178.053 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.435 ' HB2' HD11 ' A' ' 52' ' ' ILE . 2.6 m-20 -72.28 120.37 80.04 Favored Pre-proline 0 C--N 1.34 0.179 0 N-CA-C 105.987 -1.857 . . . . 3.18 105.987 167.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.8 -67.68 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.48 1.454 . . . . 1.79 113.065 -169.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -52.89 -41.16 64.1 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.349 1.06 . . . . 5.3 112.595 -159.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 49' ' ' ASP . 10.7 pt -51.9 -41.23 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.025 0.93 . . . . 1.5 113.135 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.0 tt -119.9 -48.49 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.422 1.089 . . . . 1.39 111.305 -167.41 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.38 160.24 35.07 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.1 1.333 . . . . 1.1 112.201 172.662 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -66.99 -26.52 43.47 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.198 2.599 . . . . 1.51 111.941 179.305 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.8 ttm105 -51.06 -55.57 16.94 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.741 0.817 . . . . 5.09 110.741 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -47.67 -53.64 14.37 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.552 1.141 . . . . 2.97 110.689 176.512 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.66 -57.41 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.717 0.807 . . . . 1.11 110.568 -178.397 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.62 -37.03 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 O-C-N 121.661 -0.649 . . . . 4.45 111.795 -175.063 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -55.4 -49.85 71.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.826 0.739 . . . . 3.07 109.873 169.72 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.6 m -56.24 -50.93 69.91 Favored 'General case' 0 C--O 1.224 -0.24 0 O-C-N 121.731 -0.606 . . . . 0.89 110.838 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.54 -41.75 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 121.539 -0.725 . . . . 1.94 111.865 -175.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -52.15 -48.21 65.03 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.006 -0.739 . . . . 4.13 109.006 169.67 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.0 t -64.9 -42.33 94.86 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.819 -0.628 . . . . 1.64 111.321 -177.607 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.43 -46.29 86.79 Favored 'General case' 0 C--N 1.34 0.172 0 O-C-N 121.485 -0.76 . . . . 1.8 109.994 173.255 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.34 43.84 0.34 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.132 -0.787 . . . . 0.85 111.132 170.138 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -129.7 155.83 45.26 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.039 -1.837 . . . . 1.9 106.039 170.617 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -107.82 102.66 46.38 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 118.579 -0.724 . . . . 3.39 110.319 -168.359 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -85.15 154.33 11.02 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.976 2.451 . . . . 1.72 113.124 -171.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.0 m -162.03 135.67 6.4 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 125.97 1.708 . . . . 2.5 107.953 166.739 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 109.565 -0.531 . . . . 3.02 109.565 173.26 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 C--O 1.234 0.289 0 N-CA-C 107.628 -1.249 . . . . 2.76 107.628 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.51 89.29 6.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.111 -1.441 . . . . 3.0 107.111 164.699 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -67.83 133.72 49.69 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.628 -0.879 . . . . 2.47 108.628 156.442 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 pp -146.13 137.41 24.64 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.51 -1.293 . . . . 1.44 107.51 167.575 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.71 145.82 13.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 107.966 -1.124 . . . . 1.32 107.966 173.474 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.93 105.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 127.807 2.443 . . . . 1.34 104.489 173.092 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -86.54 163.91 17.21 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.284 -1.006 . . . . 7.24 108.284 166.285 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.76 -13.58 29.67 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.89 0.757 . . . . 1.02 112.166 -177.079 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.1 mtm -65.89 88.25 0.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.233 1.016 . . . . 1.9 110.024 172.074 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 p -68.83 -37.21 79.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.078 0.551 . . . . 3.33 111.599 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.5 t -158.28 169.85 23.57 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.176 0.444 . . . . 3.44 110.247 -169.672 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.37 -28.06 7.39 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.237 1.815 . . . . 2.47 113.377 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 p -49.81 -63.18 1.19 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.309 -0.626 . . . . 2.56 109.309 169.759 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.2 m -51.22 -47.83 62.22 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.675 0.79 . . . . 0.73 110.697 179.614 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.4 t -49.0 -62.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 123.773 0.829 . . . . 0.75 109.927 178.552 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -26.47 67.69 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 120.835 -0.346 . . . . 1.35 110.468 -177.586 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -63.32 -50.11 71.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.79 -0.819 . . . . 4.34 108.79 179.639 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.9 mt -64.88 -53.24 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.815 -1.179 . . . . 0.54 107.815 -178.113 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -49.36 -58.83 4.41 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.784 0.834 . . . . 3.9 109.625 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.9 t -62.47 -48.19 80.71 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.458 -0.792 . . . . 1.32 109.793 -174.029 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.6 t -57.7 -36.2 71.66 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.72 110.69 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.2 mt -72.43 -47.62 47.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.984 -1.008 . . . . 1.96 111.973 177.947 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.1 p -62.11 77.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.913 0.885 . . . . 1.77 111.694 -176.058 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? 169.54 -37.32 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.935 2.494 . . . . 3.37 110.468 -171.705 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -58.19 126.8 29.07 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.246 -1.02 . . . . 2.27 108.246 171.302 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -72.42 74.7 1.03 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.873 0.869 . . . . 4.75 111.658 -163.086 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.91 -41.09 0.19 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.404 -1.079 . . . . 1.57 110.404 178.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.684 HD13 HG23 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -69.67 100.46 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 117.724 0.762 . . . . 2.29 110.186 -176.972 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.14 -35.49 23.59 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.596 1.158 . . . . 2.36 111.494 -176.477 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -143.6 116.49 8.8 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.903 0.881 . . . . 2.03 109.275 176.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.2 t -97.48 155.4 16.95 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 107.905 -1.146 . . . . 2.16 107.905 169.505 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 t -158.24 102.85 1.79 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.887 -1.523 . . . . 1.48 106.887 169.667 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.54 159.31 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 120.505 0.193 . . . . 1.71 110.708 173.305 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.48 134.39 21.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.404 1.082 . . . . 0.86 110.061 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.54 -41.97 62.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.527 -1.215 . . . . 1.63 110.942 -173.083 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.3 -47.26 80.16 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.551 0.691 . . . . 1.4 109.674 -172.424 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -80.78 -2.55 47.56 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.514 -0.755 . . . . 2.72 110.763 177.896 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 51.39 49.8 20.23 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.651 1.18 . . . . 2.62 108.769 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -139.53 142.48 37.24 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.09 0.404 . . . . 1.61 111.744 -169.06 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.98 125.03 50.5 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.262 1.425 . . . . 0.66 108.485 163.781 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.08 119.63 38.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.504 -2.036 . . . . 1.02 105.504 164.426 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.684 HG23 HD13 ' A' ' 32' ' ' ILE . 5.2 mp -112.12 120.55 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.04 1.336 . . . . 1.0 108.24 175.518 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -92.57 97.26 10.7 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.775 -0.824 . . . . 3.12 108.775 163.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.72 143.58 43.4 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.577 -0.897 . . . . 2.73 108.577 174.366 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.85 127.56 88.13 Favored Pre-proline 0 N--CA 1.452 -0.352 0 N-CA-C 106.196 -1.779 . . . . 3.73 106.196 169.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.63 -59.21 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.663 1.576 . . . . 1.85 112.507 -169.152 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -50.12 -43.28 51.67 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.06 1.744 . . . . 3.42 112.396 -162.657 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 pt -55.34 -40.16 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.754 0.822 . . . . 1.78 113.128 -177.731 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.7 tt -123.68 -48.24 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.805 0.842 . . . . 1.67 112.676 -165.058 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.45 147.56 22.69 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.129 1.347 . . . . 1.01 111.443 178.111 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.86 -34.42 23.98 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.106 2.538 . . . . 0.93 111.469 -177.308 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -55.5 -41.73 73.48 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 118.841 -0.599 . . . . 6.51 112.441 -174.305 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -48.71 -62.18 1.64 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.516 1.151 . . . . 2.72 110.025 174.14 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 mt -56.65 -56.36 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.209 1.404 . . . . 1.38 110.431 -179.077 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.31 -47.66 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 122.024 -0.422 . . . . 1.31 110.42 -178.334 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.7 m170 -60.8 -42.67 98.07 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.832 0.742 . . . . 2.84 110.817 178.003 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.3 m -57.33 -52.33 65.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.238 -0.653 . . . . 0.76 109.238 177.683 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.4 mm -68.36 -34.59 66.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 O-C-N 122.09 -0.381 . . . . 2.01 111.777 -175.234 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -56.41 -59.26 5.22 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.517 1.127 . . . . 2.82 108.026 171.691 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -52.99 -40.35 63.73 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.349 1.06 . . . . 1.12 111.506 176.854 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.1 tp -66.4 -10.5 44.28 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.121 0.968 . . . . 2.47 112.446 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.2 45.76 2.33 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 118.68 0.673 . . . . 0.68 112.055 168.12 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -139.32 177.81 7.65 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 107.794 -1.188 . . . . 2.14 107.794 172.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -112.6 72.49 1.33 Allowed Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 113.198 0.814 . . . . 3.42 113.198 -177.795 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -63.58 104.45 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.983 3.122 . . . . 1.37 111.814 -177.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.4 p -129.15 124.71 35.35 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.798 1.639 . . . . 2.11 108.735 -172.794 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tt . . . . . 0 CA--C 1.535 0.381 0 O-C-N 121.261 -0.899 . . . . 3.71 111.092 -171.575 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 t . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 109.739 -0.467 . . . . 2.58 109.739 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.4 tp -70.11 154.47 41.89 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.105 -0.702 . . . . 2.32 109.105 175.66 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -129.07 148.49 51.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.967 0.907 . . . . 2.54 110.035 170.793 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.52 133.78 44.19 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 107.247 -1.39 . . . . 1.79 107.247 168.283 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.6 109.39 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 105.729 -1.952 . . . . 1.06 105.729 171.35 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -104.41 109.08 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.944 -0.762 . . . . 1.79 108.944 -174.385 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.58 155.24 40.76 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.392 -1.336 . . . . 4.0 107.392 170.196 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.66 -19.85 7.88 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.405 0.526 . . . . 1.09 113.512 168.398 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.4 mtm -58.96 104.48 0.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.568 1.184 . . . . 2.19 110.725 171.541 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.5 p -91.36 -83.36 0.28 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.058 0.943 . . . . 3.67 110.4 177.157 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 84.4 m -79.17 -68.29 0.67 Allowed 'General case' 0 CA--C 1.527 0.061 0 C-N-CA 123.245 0.618 . . . . 3.91 111.279 -160.783 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -174.58 -61.78 0.01 OUTLIER 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 124.401 1.08 . . . . 1.77 108.865 -176.147 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.2 t -41.07 -46.75 3.01 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.315 1.446 . . . . 2.91 111.161 -176.213 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.3 m -23.62 -52.0 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.133 2.173 . . . . 0.85 113.511 168.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.4 t -49.52 -61.46 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.346 0.659 . . . . 0.6 110.589 176.115 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -28.68 66.03 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.323 0.649 . . . . 1.08 110.208 -177.378 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.57 -52.55 59.38 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 107.489 -1.3 . . . . 3.03 107.489 175.055 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.49 HD12 HG11 ' A' ' 37' ' ' VAL . 93.6 mt -65.84 -60.39 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 107.344 -1.354 . . . . 0.56 107.344 178.65 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.04 -51.81 16.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.572 0.701 . . . . 2.85 110.583 -171.379 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.1 t -67.38 -56.53 9.31 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.988 0.915 . . . . 1.6 109.739 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.1 t -64.98 -18.09 64.98 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.693 -0.67 . . . . 1.16 112.446 -173.205 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.44 -47.4 7.47 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 117.672 -1.156 . . . . 2.72 111.548 173.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 p -53.87 -35.13 61.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.606 1.548 . . . . 2.25 111.615 178.347 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -32.05 -48.84 0.17 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.097 1.359 . . . . 4.92 113.23 163.405 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -75.13 63.45 1.3 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.288 1.035 . . . . 2.21 110.798 178.931 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 3.76 -64.0 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 129.5 3.12 . . . . 4.58 117.247 178.665 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -46.02 -45.99 14.72 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.43 1.014 . . . . 1.35 112.557 178.492 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.609 HD13 HG23 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -73.3 84.99 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.022 -1.103 . . . . 2.87 108.022 168.515 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.5 pp -65.67 -33.79 76.71 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.988 -0.551 . . . . 3.32 111.299 -175.764 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -146.64 104.68 3.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.912 0.485 . . . . 3.1 111.566 173.817 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.3 t -80.19 142.28 34.84 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 106.89 -1.522 . . . . 2.61 106.89 162.067 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -132.73 101.77 5.41 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.719 -1.215 . . . . 1.3 107.719 -178.676 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.49 HG11 HD12 ' A' ' 22' ' ' ILE . 6.2 t -107.6 142.71 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 124.64 1.176 . . . . 2.59 110.193 -167.307 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.45 137.31 17.12 Favored 'General case' 0 C--N 1.339 0.109 0 O-C-N 121.481 -0.762 . . . . 0.92 111.353 177.026 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -81.71 -35.21 30.05 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 124.463 1.105 . . . . 1.35 112.013 -172.498 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.26 91.52 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 109.572 -0.529 . . . . 1.14 109.572 -177.556 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -93.26 -5.19 50.41 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.454 -0.794 . . . . 2.13 111.454 173.844 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 41.19 55.02 3.34 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 126.744 2.018 . . . . 2.79 109.456 -176.387 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -133.76 152.02 51.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.889 -1.05 . . . . 2.0 109.502 -171.214 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.29 129.1 56.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.646 -1.613 . . . . 0.87 106.646 157.029 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.72 145.51 25.24 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 107.366 -1.346 . . . . 1.13 107.366 157.543 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.609 HG23 HD13 ' A' ' 32' ' ' ILE . 5.3 mp -127.22 115.37 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.252 -0.647 . . . . 2.08 109.252 -169.549 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -86.48 81.03 8.45 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.196 -1.038 . . . . 2.53 108.196 165.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.33 167.95 14.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.378 1.071 . . . . 2.1 110.194 176.425 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -108.72 126.18 30.05 Favored Pre-proline 0 N--CA 1.447 -0.616 0 O-C-N 124.317 1.011 . . . . 3.43 109.084 171.111 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.5 -20.76 20.31 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.126 2.55 . . . . 1.2 112.72 -177.338 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -96.48 14.46 24.49 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.986 0.914 . . . . 3.92 111.434 -170.273 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 pt -126.96 -87.55 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.282 1.033 . . . . 1.23 109.408 163.032 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.9 tt -59.44 -49.4 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.621 1.168 . . . . 1.09 112.008 -176.661 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.73 159.5 30.61 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.718 -0.553 . . . . 0.82 111.718 -178.429 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.88 -30.84 8.83 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.052 2.501 . . . . 0.86 111.541 -175.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -54.81 -52.51 62.45 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.657 0.783 . . . . 5.01 110.849 -174.312 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -49.46 -55.07 14.47 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.51 1.124 . . . . 2.6 109.653 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.38 -59.79 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.877 1.271 . . . . 0.92 110.373 178.413 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.6 mt -52.63 -41.73 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 119.234 0.924 . . . . 1.49 111.416 -178.465 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -67.08 -45.52 77.05 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.856 -0.527 . . . . 2.4 109.911 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.3 m -57.94 -50.29 73.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.594 -0.891 . . . . 0.58 108.594 179.243 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.1 mm -53.54 -52.18 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.547 1.139 . . . . 1.55 109.915 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -47.68 -64.84 0.68 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.258 0.552 . . . . 3.78 109.807 173.619 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 m -67.57 -26.38 66.26 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.927 -0.578 . . . . 2.7 112.267 -167.105 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.1 tp -67.0 -12.5 60.02 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.192 1.397 . . . . 2.32 111.663 175.686 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.48 47.28 0.7 Allowed Glycine 0 C--N 1.339 0.716 0 C-N-CA 124.948 1.261 . . . . 1.03 110.703 168.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -143.41 178.03 8.03 Favored 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 108.853 -0.795 . . . . 1.91 108.853 -178.209 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.07 101.77 14.92 Favored Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 108.685 -0.857 . . . . 4.54 108.685 173.746 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -83.48 92.0 0.87 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.362 2.708 . . . . 1.23 112.896 -175.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.8 m -79.17 113.15 17.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.733 0.778 . . . . 2.09 109.614 170.011 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 C--N 1.328 -0.367 0 C-N-CA 123.8 0.84 . . . . 3.2 108.966 171.509 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.398 -0.593 . . . . 2.4 109.398 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.29 114.59 28.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.797 -1.927 . . . . 2.47 105.797 168.498 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -92.74 120.93 33.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.125 -1.065 . . . . 2.59 108.125 164.897 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -122.01 154.55 37.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.286 -1.376 . . . . 1.65 107.286 169.489 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.25 146.78 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.311 -1.737 . . . . 0.85 106.311 171.185 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.86 163.89 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.933 2.093 . . . . 1.6 105.426 -179.32 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -143.05 165.05 28.43 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.529 1.059 . . . . 4.21 108.412 173.952 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.07 -86.06 0.4 Allowed Glycine 0 C--N 1.337 0.587 0 N-CA-C 108.744 -1.742 . . . . 2.42 108.744 177.044 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.3 mpt? 52.12 -158.16 0.13 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.529 1.131 . . . . 4.78 112.26 -173.826 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.445 HG22 ' SG ' ' A' ' 18' ' ' CYS . 10.2 t -161.23 55.56 0.29 Allowed 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.17 0.988 . . . . 5.65 108.752 179.35 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.8 t 74.69 -45.46 0.58 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.442 1.497 . . . . 4.14 113.486 175.525 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.2 -71.5 0.23 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.319 0.509 . . . . 1.74 111.043 -179.648 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -42.88 -44.12 4.39 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.763 1.625 . . . . 1.65 114.48 -162.903 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.445 ' SG ' HG22 ' A' ' 14' ' ' THR . 1.6 m -47.19 -37.19 9.77 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.204 0.602 . . . . 1.78 112.454 179.748 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -49.7 -61.63 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 123.539 0.735 . . . . 0.69 110.558 174.256 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -30.35 69.65 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.932 -0.766 . . . . 1.33 108.932 -176.48 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -58.83 -53.43 58.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.299 -1.0 . . . . 4.52 108.299 177.676 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.4 HG21 HG11 ' A' ' 37' ' ' VAL . 61.2 mt -62.66 -50.03 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.991 -1.115 . . . . 0.7 107.991 -173.572 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -47.73 -60.93 2.21 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.927 0.767 . . . . 4.12 109.455 176.492 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.5 t -57.65 -47.32 82.57 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 122.224 1.012 . . . . 1.48 110.42 -173.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -70.9 -23.86 62.36 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.402 1.481 . . . . 0.85 110.899 -174.688 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mt -80.39 -43.71 20.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.656 0.662 . . . . 2.47 111.061 171.279 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.2 p -67.95 73.28 0.18 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.029 0.931 . . . . 1.6 110.835 179.512 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.92 -34.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.515 2.726 . . . . 4.22 111.289 -176.832 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -35.02 -69.49 0.1 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 126.174 1.789 . . . . 3.54 115.148 -170.397 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -165.17 -51.93 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 108.697 -0.853 . . . . 7.95 108.697 174.065 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -151.02 63.08 0.4 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.38 -1.488 . . . . 1.54 109.38 175.432 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.823 HD11 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -73.14 126.28 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 105.709 -1.96 . . . . 2.54 105.709 158.552 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.31 -51.68 9.75 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.139 -1.43 . . . . 2.46 107.139 165.915 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -155.81 139.51 16.08 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.045 -0.525 . . . . 2.45 110.955 -178.312 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.6 t -109.05 150.29 28.01 Favored 'General case' 0 C--O 1.227 -0.092 0 N-CA-C 107.622 -1.251 . . . . 2.26 107.622 167.689 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.66 109.7 3.29 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.357 -0.839 . . . . 1.3 109.378 175.235 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' A' ' 44' ' ' ALA . 3.2 m -113.59 155.87 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.466 0.706 . . . . 1.67 111.295 176.934 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.85 133.74 19.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.353 0.661 . . . . 0.97 109.694 171.322 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -76.09 -42.58 46.79 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.445 0.698 . . . . 1.6 111.293 -171.014 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.73 -46.32 87.63 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.081 0.552 . . . . 1.62 110.466 179.923 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.47 -15.69 60.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.61 1.164 . . . . 2.44 111.471 175.079 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 52.6 34.81 16.54 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.172 1.789 . . . . 2.8 110.006 -172.521 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -102.82 144.64 30.9 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.659 1.183 . . . . 1.67 108.027 -172.303 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.447 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -137.46 110.35 7.68 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.39 -0.967 . . . . 1.05 108.39 161.221 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.78 144.43 25.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.616 -0.513 . . . . 1.16 109.616 168.798 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.823 HG23 HD11 ' A' ' 32' ' ' ILE . 4.9 mp -124.43 120.03 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 106.377 -1.712 . . . . 1.18 106.377 175.073 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.58 ' O ' HD13 ' A' ' 32' ' ' ILE . 60.3 mttt -96.24 96.17 8.61 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.151 -1.426 . . . . 2.2 107.151 166.553 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -134.61 153.75 51.82 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.501 1.521 . . . . 2.18 107.205 -177.76 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -82.06 130.66 59.32 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 119.484 -0.886 . . . . 3.35 109.315 168.277 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.5 -40.9 9.62 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.682 2.254 . . . . 1.52 113.087 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -88.52 43.35 1.13 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.572 1.078 . . . . 3.56 110.824 -164.699 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 pt -142.91 -41.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 126.238 1.815 . . . . 1.66 111.342 172.387 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.9 tt -121.14 -61.26 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.353 1.061 . . . . 1.2 111.844 -175.319 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.41 157.0 25.84 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.734 1.159 . . . . 0.7 111.537 178.778 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.32 -32.63 12.38 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.486 2.791 . . . . 0.69 112.556 -172.592 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -51.93 -52.92 46.71 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.345 0.658 . . . . 5.95 111.549 -178.513 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -48.31 -57.42 6.02 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.487 1.115 . . . . 2.63 110.35 177.83 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.2 mt -53.51 -63.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.477 1.111 . . . . 0.91 109.436 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.2 mt -49.47 -52.11 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.264 0.625 . . . . 1.31 110.162 -176.828 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -69.81 -30.49 68.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.764 -0.585 . . . . 3.12 111.999 -175.71 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 92.1 m -66.71 -51.34 57.12 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.289 -0.882 . . . . 0.83 109.563 173.424 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mm -55.97 -41.92 69.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 122.809 0.444 . . . . 1.53 110.132 177.359 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.95 -58.45 7.82 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.023 0.929 . . . . 3.05 109.076 174.247 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.5 m -54.13 -37.47 64.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.149 0.98 . . . . 2.42 112.674 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.8 mt -67.24 -6.21 17.25 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.957 0.725 . . . . 1.83 112.957 177.745 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.08 48.94 2.15 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.827 -0.909 . . . . 0.63 110.827 173.37 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -134.61 -179.76 5.79 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.39 1.076 . . . . 2.01 109.621 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -121.8 57.87 8.34 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.069 0.947 . . . . 3.51 112.23 -173.312 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.95 85.25 0.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 124.282 3.322 . . . . 1.15 113.042 -167.766 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.2 m -97.56 126.24 42.74 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.719 1.608 . . . . 2.04 108.476 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 CA--C 1.532 0.256 0 CA-C-N 118.705 0.684 . . . . 3.29 109.348 170.873 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 107.26 -1.385 . . . . 2.0 107.26 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.0 tp -150.87 147.9 27.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.96 -1.496 . . . . 2.09 106.96 166.878 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -116.38 128.96 55.98 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.251 -1.388 . . . . 2.56 107.251 174.483 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.87 125.35 44.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.72 -1.585 . . . . 1.51 106.72 177.829 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.1 t -65.03 144.08 15.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 N-CA-C 106.866 -1.531 . . . . 0.99 106.866 168.159 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 m -141.75 86.17 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 119.102 0.865 . . . . 1.52 110.512 -174.906 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 56.7 mmt-85 -55.69 141.2 38.92 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.309 -1.367 . . . . 5.19 107.309 168.184 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.86 -26.45 8.87 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.845 0.736 . . . . 1.08 111.504 -175.665 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.402 ' SD ' HD12 ' A' ' 22' ' ' ILE . 26.8 mtm -69.73 77.27 0.44 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.936 1.368 . . . . 1.93 111.744 176.188 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -77.09 -33.8 56.94 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.898 0.879 . . . . 2.44 111.943 178.067 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -149.67 158.03 43.79 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.385 0.539 . . . . 2.98 110.766 -163.72 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.68 -33.1 0.67 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.156 1.782 . . . . 2.35 113.605 173.13 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.1 p -53.27 -53.29 53.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.659 -0.651 . . . . 2.69 110.269 172.21 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.3 m -58.55 -49.09 78.7 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.173 0.589 . . . . 0.88 109.99 178.153 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.1 t -45.27 -63.95 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.351 0.66 . . . . 0.64 109.66 177.059 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.282 0.0 OUTLIER -63.95 -24.64 67.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.754 -0.657 . . . . 1.41 110.984 -177.233 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -61.41 -53.58 54.74 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 108.263 -1.014 . . . . 3.38 108.263 177.038 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.402 HD12 ' SD ' ' A' ' 13' ' ' MET . 11.3 mt -67.07 -56.24 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.434 -1.321 . . . . 0.82 107.434 -175.72 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -46.39 -58.15 4.0 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.968 0.907 . . . . 3.54 112.362 177.498 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.8 t -66.45 -31.1 71.64 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.19 0.596 . . . . 1.32 110.438 -176.363 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 t -66.26 -53.07 41.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.571 -0.705 . . . . 1.34 109.379 175.314 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 26' ' ' LEU . 1.9 mm? -52.86 -45.04 67.22 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.805 0.729 . . . . 2.22 112.183 -175.025 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.6 p -62.53 -9.39 8.52 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.705 0.631 . . . . 1.65 112.705 -176.344 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -71.53 -37.15 71.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.752 0.821 . . . . 5.02 111.138 171.081 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -74.71 121.02 21.05 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.306 -0.627 . . . . 1.84 109.306 -167.621 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -77.84 62.6 2.71 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.164 0.586 . . . . 5.48 111.669 -176.134 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.47 42.8 0.06 OUTLIER Glycine 0 CA--C 1.526 0.719 0 N-CA-C 109.116 -1.593 . . . . 1.75 109.116 174.138 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.92 142.66 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 104.315 -2.476 . . . . 1.99 104.315 -178.757 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.3 tp -100.63 -45.42 5.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.67 1.188 . . . . 3.46 110.132 -179.425 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -162.05 151.25 15.74 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.719 -0.845 . . . . 1.87 108.719 -179.092 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.9 p -131.73 157.07 44.76 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 123.887 0.875 . . . . 2.98 108.937 173.227 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.1 t -170.8 121.43 0.57 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.817 -1.549 . . . . 1.75 106.817 176.172 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 44' ' ' ALA . 3.2 m -121.19 130.56 74.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.76 0.709 . . . . 1.66 110.178 178.311 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.3 133.83 53.33 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.349 1.06 . . . . 1.04 111.566 -173.566 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.18 -56.14 11.19 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 125.274 1.43 . . . . 2.55 110.665 -176.939 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.78 -47.61 76.78 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.186 0.594 . . . . 1.33 110.842 -174.684 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.72 -15.69 62.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.017 1.327 . . . . 1.97 111.29 177.866 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 48.53 42.34 18.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.134 1.774 . . . . 2.96 110.435 -170.691 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -123.84 132.94 53.86 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 124.092 0.957 . . . . 1.4 109.656 -165.833 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -102.4 117.3 34.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.284 1.033 . . . . 0.85 108.567 166.183 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.61 124.01 45.6 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.992 -1.855 . . . . 1.19 105.992 174.067 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 46' ' ' ILE . 3.2 mp -121.86 133.73 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.979 -1.119 . . . . 1.22 107.979 171.124 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -103.17 135.82 44.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.21 1.804 . . . . 2.17 106.707 161.205 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -168.66 178.95 4.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.976 1.31 . . . . 2.53 112.199 -165.777 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -110.34 74.7 0.87 Allowed Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.612 1.165 . . . . 4.17 108.985 -174.385 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -45.76 -48.17 12.71 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 124.452 3.435 . . . . 1.45 113.467 -165.872 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.71 -34.31 38.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.024 1.33 . . . . 4.76 112.236 -176.343 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.7 pt -95.22 -53.77 7.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 N-CA-C 112.228 0.455 . . . . 1.17 112.228 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.5 tt -72.35 -44.97 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 120.917 0.389 . . . . 1.78 111.195 -173.64 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.24 124.6 1.16 Allowed Glycine 0 CA--C 1.537 1.423 0 N-CA-C 110.846 -0.901 . . . . 0.94 110.846 -176.28 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -53.76 -33.19 69.37 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.034 2.489 . . . . 0.65 111.614 176.835 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -51.4 -46.0 62.7 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.809 0.843 . . . . 6.62 112.031 175.024 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -59.48 -56.37 22.81 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.603 0.716 . . . . 2.6 109.449 -176.549 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 89.1 mt -48.21 -62.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 124.187 0.995 . . . . 0.82 109.337 174.314 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.8 mt -54.22 -53.59 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 119.286 -0.388 . . . . 1.27 110.513 -173.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -65.12 -33.75 76.76 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.945 0.793 . . . . 2.6 112.365 -178.194 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 92.2 m -65.16 -50.8 64.57 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.362 -0.836 . . . . 0.7 109.473 176.159 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mm -64.08 -42.63 96.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.651 -0.656 . . . . 1.83 110.647 -177.756 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -48.3 -62.28 1.57 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.445 1.498 . . . . 3.2 109.316 169.145 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.9 t -52.52 -40.82 62.89 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.596 1.158 . . . . 1.01 112.123 -179.711 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.46 -3.95 5.07 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.979 1.103 . . . . 2.01 113.979 178.102 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.76 50.63 1.93 Allowed Glycine 0 C--N 1.335 0.494 0 N-CA-C 110.12 -1.192 . . . . 0.63 110.12 171.435 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -138.82 169.31 18.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.886 0.875 . . . . 1.85 109.567 178.058 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -112.51 76.98 2.17 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 118.03 -0.986 . . . . 4.42 112.408 177.193 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.01 74.56 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 124.082 3.188 . . . . 1.2 113.151 -175.597 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.46 115.88 13.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.925 0.89 . . . . 2.36 109.493 173.956 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 tt . . . . . 0 N--CA 1.451 -0.418 0 C-N-CA 124.587 1.155 . . . . 3.18 108.666 170.564 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 106.063 -1.829 . . . . 2.47 106.063 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.1 tp -91.0 122.44 33.66 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.898 -1.149 . . . . 1.93 107.898 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -88.29 136.46 32.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.218 -1.03 . . . . 2.07 108.218 163.202 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.464 HD21 HD13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -126.79 133.97 50.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.087 -1.079 . . . . 1.89 108.087 157.118 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.36 143.12 14.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.564 -1.273 . . . . 1.16 107.564 163.905 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.7 m -135.79 85.16 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.327 1.051 . . . . 1.7 110.89 -170.196 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -62.29 139.72 58.51 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.007 -1.058 . . . . 5.94 109.864 -174.79 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.31 -24.67 6.51 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.733 -0.481 . . . . 1.63 112.765 175.831 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.457 ' SD ' HD12 ' A' ' 22' ' ' ILE . 64.5 mtm -59.97 152.63 23.23 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.262 1.031 . . . . 2.47 110.738 175.165 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -161.72 -59.39 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.1 0.56 . . . . 3.09 110.145 177.44 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.8 p -81.15 153.54 27.2 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.9 -0.5 . . . . 4.23 111.116 -176.481 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.84 -50.32 7.94 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 124.679 1.192 . . . . 1.96 111.656 -178.909 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 m -43.99 -40.85 5.0 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.072 1.349 . . . . 1.61 112.399 -178.217 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.3 m -47.78 -43.14 27.22 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.762 0.825 . . . . 1.46 110.939 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.4 t -50.89 -68.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 123.632 0.773 . . . . 0.76 108.99 179.426 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -27.39 69.18 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.76 -0.459 . . . . 1.1 109.76 -175.75 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -59.1 -54.62 45.0 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.808 -0.812 . . . . 3.19 108.808 179.415 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.52 ' HB ' HG11 ' A' ' 37' ' ' VAL . 19.8 mt -70.83 -52.68 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.463 -0.94 . . . . 0.97 108.463 -176.786 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.25 -52.11 29.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.347 0.659 . . . . 3.34 110.744 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -67.44 -47.51 69.96 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.246 0.619 . . . . 1.37 110.407 179.796 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.0 t -57.46 -25.36 59.58 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.847 -0.533 . . . . 1.29 111.98 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.54 -55.22 4.25 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.7 0.8 . . . . 2.98 112.088 171.401 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.5 p -71.64 66.38 0.51 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.274 1.029 . . . . 2.33 111.039 179.024 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.21 -43.45 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.279 1.832 . . . . 3.37 110.111 -176.329 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -76.98 142.66 39.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.415 -0.957 . . . . 4.52 108.415 173.55 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -60.55 165.71 3.61 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.093 -0.706 . . . . 6.35 109.093 173.124 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.41 -35.6 3.79 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-O 118.804 -0.998 . . . . 1.08 111.462 175.97 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.79 133.44 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 119.039 1.42 . . . . 2.28 107.894 163.417 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.26 -55.15 3.53 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.357 -1.349 . . . . 2.96 107.357 161.211 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -149.84 145.87 26.81 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.129 0.572 . . . . 2.18 110.366 -171.498 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.3 t -128.64 150.27 50.3 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.434 1.094 . . . . 1.96 108.237 177.948 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -148.18 132.33 17.34 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.49 -0.93 . . . . 1.75 108.49 153.286 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 44' ' ' ALA . 18.0 m -107.12 165.35 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 122.814 0.445 . . . . 1.76 110.623 171.059 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.42 136.69 19.94 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.581 0.752 . . . . 1.12 110.622 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.65 -56.1 6.47 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 123.922 0.889 . . . . 2.66 110.523 -176.715 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.54 -52.15 60.61 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 123.161 0.584 . . . . 1.55 110.127 -176.388 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 m -77.43 -3.19 39.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.889 0.876 . . . . 2.21 111.336 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 45.75 42.95 9.26 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.197 1.399 . . . . 3.29 110.225 -179.457 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -117.09 145.54 43.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.664 -0.698 . . . . 1.47 109.757 -164.114 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -116.92 118.77 33.36 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.545 -1.65 . . . . 0.75 106.545 156.922 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.89 134.57 40.84 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.774 -1.195 . . . . 0.96 107.774 163.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.464 HD13 HD21 ' A' ' 8' ' ' LEU . 4.6 mp -122.81 119.94 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 106.942 -1.503 . . . . 1.26 106.942 178.086 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -96.52 98.78 10.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.081 -1.451 . . . . 2.29 107.081 162.998 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -138.33 178.62 6.99 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.028 0.931 . . . . 2.31 110.935 -177.714 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -107.0 83.94 1.45 Allowed Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 125.01 1.324 . . . . 3.53 109.831 176.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -52.05 -23.51 17.27 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.187 2.591 . . . . 1.47 113.793 174.351 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -49.67 -41.14 42.23 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.473 0.579 . . . . 4.44 112.31 172.114 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 pt -107.3 -47.32 8.12 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 N-CA-C 113.701 1.0 . . . . 1.62 113.701 -166.895 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.2 tt -90.0 -123.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 106.372 -1.714 . . . . 2.02 106.372 172.339 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 177.73 160.18 23.88 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 120.406 1.457 . . . . 1.25 111.681 171.779 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.88 -42.1 26.33 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.084 3.189 . . . . 1.15 111.114 173.799 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -51.34 -54.22 28.41 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.018 0.527 . . . . 5.73 110.06 177.216 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.94 -54.84 7.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.093 1.757 . . . . 4.11 109.657 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.1 mt -57.97 -60.68 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.856 0.862 . . . . 0.87 109.972 178.409 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mp -48.29 -47.21 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.128 0.422 . . . . 1.74 110.39 -178.444 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -70.59 -33.28 70.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.366 0.666 . . . . 2.33 111.777 -178.174 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.2 m -59.64 -54.89 41.15 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.372 -0.83 . . . . 0.8 108.801 170.91 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.1 mm -58.09 -44.49 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.625 0.77 . . . . 1.34 111.421 -178.254 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -49.99 -56.63 9.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.001 1.32 . . . . 2.9 109.123 170.265 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.3 m -58.03 -36.03 72.15 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.793 0.664 . . . . 1.91 112.793 178.956 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.87 -17.47 64.32 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.543 -0.723 . . . . 2.35 112.209 174.461 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.17 37.49 9.07 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.665 -0.974 . . . . 1.2 110.665 -178.335 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CD2' HD11 ' A' ' 22' ' ' ILE . 27.0 m-85 -125.02 151.26 45.82 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.049 -1.463 . . . . 1.97 107.049 165.923 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -104.76 101.09 26.8 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 124.835 1.254 . . . . 5.54 110.049 -169.092 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -76.22 158.56 37.35 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.391 1.394 . . . . 1.67 113.147 -171.86 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.0 m -155.27 133.42 11.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.758 -1.571 . . . . 1.9 106.758 164.047 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 CA--C 1.535 0.384 0 CA-C-N 118.819 0.736 . . . . 3.32 111.221 174.401 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 113.517 0.932 . . . . 2.11 113.517 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.29 104.09 15.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.339 -1.356 . . . . 2.31 107.339 179.061 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -84.15 116.22 22.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.828 -1.175 . . . . 2.13 107.828 162.793 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.7 pp -115.96 161.51 18.74 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.89 -1.152 . . . . 1.86 107.89 164.23 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -112.3 145.95 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 107.064 -1.458 . . . . 0.94 107.064 171.812 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -176.41 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.679 1.192 . . . . 2.57 108.517 -176.53 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -135.23 164.81 26.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.197 -2.149 . . . . 4.98 105.197 167.225 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.7 -0.36 89.57 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.575 -0.57 . . . . 1.05 113.731 171.908 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.4 mtp -73.77 74.33 1.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.817 1.308 . . . . 2.02 108.78 172.543 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 t -88.53 0.27 56.5 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.802 1.038 . . . . 2.26 113.802 -167.208 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.6 t -165.79 159.08 15.76 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 120.004 1.274 . . . . 2.97 110.195 -173.432 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.32 -38.97 13.77 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.874 1.27 . . . . 2.35 111.092 170.962 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -44.64 -50.15 9.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.997 0.919 . . . . 1.71 111.023 171.512 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.3 m -61.31 -45.43 94.49 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.713 -0.617 . . . . 0.84 109.991 -177.528 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.9 t -48.88 -60.08 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 C-N-CA 123.683 0.793 . . . . 0.68 108.897 176.335 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -33.44 75.74 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.579 -0.282 . . . . 1.28 110.359 -176.336 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -60.24 -45.54 92.88 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.64 -0.874 . . . . 2.82 108.64 -178.432 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.545 HG22 HD23 ' A' ' 26' ' ' LEU . 78.2 mt -70.66 -61.47 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 106.18 -1.785 . . . . 0.58 106.18 -178.441 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -37.19 -64.61 0.36 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.541 1.536 . . . . 4.72 110.701 -179.123 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.9 p -58.42 -41.16 84.38 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.612 -0.722 . . . . 2.39 109.941 -173.415 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.1 t -71.23 -20.12 62.29 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.914 0.886 . . . . 0.8 112.553 -178.415 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.545 HD23 HG22 ' A' ' 22' ' ' ILE . 3.7 mm? -81.32 -57.75 3.35 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 118.634 0.652 . . . . 2.26 110.56 167.925 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 p -56.5 -32.39 64.99 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.162 0.437 . . . . 1.6 111.103 -176.265 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.5 tptt -37.03 -54.13 0.97 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.911 1.684 . . . . 4.59 113.895 161.571 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -90.36 149.89 22.11 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.069 0.85 . . . . 4.23 112.621 -165.549 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -59.02 154.82 14.74 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.803 -0.635 . . . . 7.69 110.535 175.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.11 24.25 66.91 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.5 -0.611 . . . . 1.63 113.339 170.853 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.4 HD11 HG23 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -98.43 138.44 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 104.399 -2.445 . . . . 1.93 104.399 156.002 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.3 mt -97.77 -45.86 6.18 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.441 1.096 . . . . 3.45 109.026 178.765 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -160.36 133.51 6.69 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.286 -0.635 . . . . 1.82 109.286 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.0 t -109.21 143.08 39.12 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.644 -0.873 . . . . 1.95 108.644 176.182 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.1 t -154.64 109.52 3.05 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.033 -0.729 . . . . 1.47 109.033 168.594 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.543 HG11 HG21 ' A' ' 22' ' ' ILE . 3.1 m -104.89 145.81 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 123.19 0.596 . . . . 1.83 110.239 172.248 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.36 134.48 46.34 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 124.634 1.174 . . . . 1.17 110.846 -174.95 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.5 mt -72.23 -49.41 35.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.816 1.247 . . . . 2.83 111.073 -175.519 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.5 -32.09 68.48 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.037 0.535 . . . . 1.38 111.375 -170.045 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 t -108.32 2.5 22.63 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.313 1.045 . . . . 2.87 111.431 179.298 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 41.12 41.78 1.43 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.653 1.981 . . . . 3.93 111.067 -172.513 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -99.08 149.8 22.66 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.606 -0.887 . . . . 1.41 108.606 -174.349 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.48 114.58 21.46 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.69 -1.226 . . . . 0.71 107.69 159.359 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.84 133.36 38.65 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.873 -1.158 . . . . 0.95 107.873 163.806 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.4 HG23 HD11 ' A' ' 32' ' ' ILE . 3.6 mp -121.59 122.75 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 106.851 -1.537 . . . . 1.06 106.851 172.207 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -92.2 127.52 37.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.773 -1.936 . . . . 3.11 105.773 157.732 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -166.82 161.37 15.32 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 126.289 1.836 . . . . 2.0 107.967 -167.0 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -98.21 95.34 2.78 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.448 0.699 . . . . 4.15 109.833 -174.329 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -58.55 -32.14 95.93 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.637 2.225 . . . . 1.56 111.709 -176.526 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -61.19 -15.8 38.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.033 1.333 . . . . 3.69 112.955 -178.918 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 pt -123.49 -49.06 2.3 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 N-CA-C 114.019 1.118 . . . . 1.37 114.019 -178.951 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.426 HG23 ' H ' ' A' ' 54' ' ' GLY . 17.9 tt -90.19 -70.11 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 118.462 0.574 . . . . 1.18 109.97 178.509 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.426 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 117.72 149.09 8.81 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 123.605 0.622 . . . . 0.7 112.12 178.487 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.41 -39.57 9.49 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.72 2.947 . . . . 1.1 111.733 179.509 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -51.27 -56.25 13.93 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 122.595 0.358 . . . . 5.67 110.504 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -49.25 -47.45 46.52 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.014 1.725 . . . . 4.93 110.842 179.226 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.0 mt -58.32 -54.16 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 118.992 -0.528 . . . . 0.83 110.424 174.003 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.7 mt -52.41 -45.36 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 119.203 0.91 . . . . 1.43 110.703 177.896 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -58.33 -44.83 88.84 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.288 0.635 . . . . 3.89 110.262 176.249 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 56.7 m -60.17 -54.4 46.25 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.776 -0.577 . . . . 1.01 109.635 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.9 mm -58.8 -42.01 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 121.867 -0.521 . . . . 1.33 110.829 -178.209 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -53.02 -65.33 0.58 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.683 0.793 . . . . 3.17 109.415 171.875 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.4 t -54.77 -36.55 64.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.148 1.379 . . . . 1.1 112.457 -174.564 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.76 -12.6 25.16 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.244 0.831 . . . . 2.25 113.244 176.79 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.26 44.72 1.23 Allowed Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.604 1.097 . . . . 0.68 111.18 169.687 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -141.62 174.04 10.94 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.554 0.741 . . . . 2.14 109.108 178.285 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -113.75 76.71 3.19 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 123.706 0.802 . . . . 4.1 112.177 -177.252 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.04 133.37 26.7 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.765 1.643 . . . . 1.4 111.929 -177.732 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.6 t -139.08 151.91 47.11 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.524 1.129 . . . . 2.83 108.208 167.425 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.5 mt . . . . . 0 N--CA 1.452 -0.375 0 N-CA-C 107.765 -1.198 . . . . 3.26 107.765 161.482 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.634 0.254 . . . . 2.66 111.613 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.9 tp -150.79 156.43 41.25 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.564 1.946 . . . . 2.15 106.34 174.171 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -124.04 155.09 38.92 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.761 0.824 . . . . 2.48 109.577 176.231 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.422 HD13 ' N ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -150.74 141.98 23.22 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.804 0.842 . . . . 2.72 109.126 175.192 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.6 t -90.97 131.32 38.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 C-N-CA 125.685 1.594 . . . . 0.85 107.142 177.123 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.619 HG12 ' HB3' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -126.35 78.43 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 122.454 1.121 . . . . 1.45 110.487 -166.539 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.9 mtm105 -58.34 133.34 55.63 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.041 -1.096 . . . . 5.57 108.041 170.254 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.32 -32.96 3.43 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.578 1.085 . . . . 0.96 110.391 -171.108 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 55.8 mtm -60.85 144.62 52.39 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.327 -1.102 . . . . 2.33 108.489 163.51 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 t -164.42 -65.56 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.777 0.431 . . . . 3.05 110.407 -177.273 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -79.46 -75.69 0.24 Allowed 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.131 -0.356 . . . . 3.75 111.78 -168.809 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -167.67 -66.1 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.322 0.649 . . . . 1.95 109.494 -175.573 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.6 t -49.53 -38.4 30.59 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.513 0.725 . . . . 2.25 111.52 -171.185 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.4 m -39.25 -37.97 0.47 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.999 1.32 . . . . 0.94 112.68 174.841 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.0 t -51.74 -71.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.401 0.68 . . . . 0.93 110.251 173.096 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -27.68 69.31 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.12 -0.988 . . . . 1.48 110.626 -176.611 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -54.25 -41.89 69.29 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 124.224 1.009 . . . . 3.04 109.425 174.878 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.6 mt -78.33 -64.23 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.499 -1.297 . . . . 0.82 107.499 176.071 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -48.86 -57.71 5.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.79 1.236 . . . . 3.19 111.07 -169.826 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 t -75.25 0.19 17.39 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.863 0.865 . . . . 1.84 112.27 -176.258 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.6 t -98.72 -37.36 9.51 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.662 1.185 . . . . 0.83 109.996 173.885 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.75 -45.29 90.52 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.844 0.747 . . . . 2.51 111.052 173.323 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.3 p -64.84 80.45 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.194 0.598 . . . . 2.04 110.817 -172.246 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt 164.95 -33.88 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.853 2.861 . . . . 5.06 110.766 -176.055 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -50.6 118.82 3.31 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.323 0.51 . . . . 1.92 110.036 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -71.09 77.56 0.68 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.009 0.923 . . . . 5.4 110.547 -168.448 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.53 -16.83 0.98 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.658 1.123 . . . . 1.17 111.27 -175.94 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.84 145.41 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 107.136 -1.431 . . . . 1.92 107.136 162.457 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.5 mt -108.2 -43.83 4.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.496 1.518 . . . . 2.89 108.761 170.275 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -164.5 159.77 19.71 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 108.578 -0.897 . . . . 2.73 108.578 -178.386 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.4 p -133.85 160.93 36.16 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.751 1.22 . . . . 2.84 107.919 173.603 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 m -153.42 117.44 4.81 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.509 -1.293 . . . . 1.96 107.509 161.26 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 p -106.2 153.16 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 118.712 0.687 . . . . 2.34 111.364 174.222 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.83 135.55 22.16 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.683 -0.635 . . . . 0.91 110.404 170.239 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.35 -37.6 63.47 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 115.45 -0.796 . . . . 1.37 110.493 -178.673 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.0 84.12 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.13 0.572 . . . . 1.15 110.604 179.806 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.84 -11.1 59.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.217 1.007 . . . . 2.38 111.107 175.643 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 46.44 40.33 7.85 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.737 2.015 . . . . 2.95 111.696 -167.604 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -132.25 144.17 50.43 Favored 'General case' 0 C--O 1.228 -0.034 0 CA-C-O 119.375 -0.345 . . . . 1.63 111.126 -167.622 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.0 136.63 44.11 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.331 -0.989 . . . . 0.86 108.331 155.826 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.31 145.17 25.83 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.41 -1.329 . . . . 1.46 107.41 148.99 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.5 mt -125.68 132.71 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.086 -1.449 . . . . 2.02 107.086 167.948 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -96.87 128.95 44.32 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.382 -2.081 . . . . 2.63 105.382 160.502 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -166.66 161.36 15.72 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.684 1.594 . . . . 2.43 108.757 -176.686 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -97.01 109.5 49.46 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 123.419 0.687 . . . . 3.36 109.433 176.574 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.52 29.07 0.43 Allowed 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.605 2.204 . . . . 1.61 113.254 -176.361 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -123.12 1.36 9.17 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.619 1.168 . . . . 3.48 111.017 -176.866 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -129.64 -67.88 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.229 0 C-N-CA 123.514 0.726 . . . . 1.47 110.488 178.443 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 tt -80.0 -49.12 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.515 0.674 . . . . 1.72 110.424 -175.139 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.26 161.35 34.21 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.109 0.862 . . . . 0.97 111.953 174.935 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.8 -34.94 47.76 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.482 2.788 . . . . 1.05 111.715 -177.4 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -53.44 -58.96 5.28 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.702 0.801 . . . . 5.65 111.284 -175.586 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -44.96 -57.31 3.89 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.226 1.01 . . . . 2.81 110.752 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 76.9 mt -56.09 -61.63 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 114.588 -1.187 . . . . 1.04 109.835 -177.358 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.0 mt -58.09 -42.66 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 121.937 -0.477 . . . . 1.41 111.098 -176.097 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 57.7 m170 -58.46 -46.58 86.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.778 0.717 . . . . 3.51 109.959 176.116 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 m -58.45 -57.48 12.74 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.414 -0.587 . . . . 0.77 109.414 177.857 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.5 mm -61.45 -35.23 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.817 0.735 . . . . 1.83 111.662 -174.292 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -53.11 -68.8 0.14 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.293 -0.632 . . . . 3.44 109.293 168.372 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.6 t -62.38 -21.16 65.13 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.897 0.702 . . . . 1.43 112.897 -174.087 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.4 tp -65.65 -18.44 65.33 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.264 1.425 . . . . 2.47 111.097 174.923 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.17 43.56 0.6 Allowed Glycine 0 C--N 1.337 0.591 0 C-N-CA 125.285 1.421 . . . . 0.69 110.851 168.975 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.619 ' HB3' HG12 ' A' ' 10' ' ' VAL . 64.1 m-85 -146.54 178.83 7.98 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 117.394 0.597 . . . . 1.77 110.028 -177.998 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.99 87.5 47.23 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 123.848 0.859 . . . . 5.44 109.851 172.385 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.16 75.86 4.06 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 124.303 3.335 . . . . 1.86 111.015 -175.379 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.3 t -71.82 150.81 43.98 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.161 -0.681 . . . . 2.38 109.161 175.111 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.2 tp . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 106.919 -1.511 . . . . 3.46 106.919 164.156 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 105.545 -2.02 . . . . 8.15 105.545 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.54 177.29 10.34 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 109.025 -1.63 . . . . 3.36 109.025 -138.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.0 t0 63.4 159.75 0.09 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.05 2.14 . . . . 4.18 112.157 -174.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.55 -179.43 36.95 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.142 -1.183 . . . . 2.54 110.142 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 m -142.46 161.39 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.128 -0.693 . . . . 2.33 109.128 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 tp -144.69 142.32 29.98 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.156 -1.054 . . . . 2.47 108.156 168.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -101.14 132.88 46.39 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.975 0.91 . . . . 2.47 109.487 166.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -132.6 162.18 31.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.934 1.294 . . . . 1.88 107.644 166.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 t -117.7 133.09 65.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 126.166 1.786 . . . . 1.26 107.108 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.48 99.36 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 C-N-CA 124.086 0.954 . . . . 1.34 110.891 -168.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.4 mtt85 -68.84 150.64 47.58 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.924 -1.139 . . . . 5.02 107.924 171.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.72 -5.14 39.95 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.215 0.912 . . . . 0.97 113.67 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 69.7 mtm -74.17 69.2 1.51 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.831 1.315 . . . . 2.1 112.543 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 t -65.82 126.35 28.2 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.214 0.531 . . . . 3.55 111.817 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 t 52.02 82.42 0.07 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.811 2.044 . . . . 3.15 114.391 156.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 50.77 -101.83 0.1 Allowed 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.614 1.166 . . . . 2.04 110.229 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 9.85 -71.65 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 129.99 3.316 . . . . 1.83 115.781 172.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.7 m -36.78 -46.49 0.61 Allowed 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 125.589 1.555 . . . . 0.99 112.516 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.1 t -36.42 -68.12 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.027 1.331 . . . . 0.89 111.579 168.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -29.0 65.78 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.896 -0.503 . . . . 1.19 110.072 -175.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -38.29 77.37 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.531 0.733 . . . . 3.37 109.59 177.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.477 HD12 HG11 ' A' ' 37' ' ' VAL . 95.7 mt -74.41 -68.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 106.422 -1.696 . . . . 0.89 106.422 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -48.0 -56.34 7.9 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.311 1.444 . . . . 3.08 111.369 -166.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 t -60.99 -42.3 98.15 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.586 0.708 . . . . 1.39 109.992 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.3 t -65.95 -49.45 67.88 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.224 -0.658 . . . . 0.99 109.224 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.41 -39.44 83.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.023 -1.048 . . . . 2.4 111.301 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.2 p -58.34 -11.24 2.59 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.934 1.087 . . . . 1.67 113.934 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -68.7 -34.95 76.52 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.505 1.048 . . . . 3.79 111.592 170.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -62.71 122.06 14.94 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.784 0.434 . . . . 1.87 110.509 -167.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -76.56 65.9 2.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.209 1.004 . . . . 6.12 110.824 -172.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.78 9.31 0.02 OUTLIER Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.953 1.739 . . . . 1.13 112.504 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -103.19 132.98 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.778 1.631 . . . . 1.77 106.765 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -90.17 -56.87 3.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.51 1.124 . . . . 2.79 108.777 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -148.64 136.58 20.82 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.101 0.56 . . . . 2.67 111.549 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.0 m -106.51 161.78 14.3 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.933 0.893 . . . . 1.76 109.035 172.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.1 m -150.84 96.95 2.41 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.089 0.555 . . . . 1.67 109.675 162.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.477 HG11 HD12 ' A' ' 22' ' ' ILE . 38.9 t -90.58 86.2 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 C-N-CA 126.147 1.779 . . . . 2.33 109.341 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.86 129.41 34.84 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 121.323 -0.861 . . . . 1.02 110.946 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -77.83 -45.63 23.82 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.516 -0.766 . . . . 2.04 111.063 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.58 -45.88 90.56 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.299 0.571 . . . . 1.42 110.352 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -10.5 59.66 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.463 1.105 . . . . 2.58 111.513 176.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 51.72 31.04 7.46 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.203 1.801 . . . . 2.69 111.802 -171.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -117.21 133.83 55.51 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.641 0.777 . . . . 1.89 109.632 -165.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.94 114.39 28.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.648 -1.242 . . . . 0.7 107.648 161.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.3 142.3 27.86 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.94 -1.133 . . . . 1.04 107.94 159.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 mp -127.93 127.64 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 106.581 -1.637 . . . . 1.05 106.581 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -98.51 80.85 2.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.364 1.466 . . . . 3.26 108.376 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -116.95 165.46 13.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.591 1.556 . . . . 2.31 110.883 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -81.13 115.77 58.3 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 122.589 0.356 . . . . 3.44 110.511 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.88 -13.06 21.79 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.79 2.327 . . . . 1.68 113.92 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -81.93 -45.97 14.69 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 119.316 0.962 . . . . 4.39 108.956 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pt -81.92 -89.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.08 0.4 . . . . 2.05 112.08 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 tt -57.38 -47.02 85.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.806 1.242 . . . . 1.2 111.09 -173.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.42 164.29 28.02 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 121.512 0.507 . . . . 1.19 112.681 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.22 -37.57 31.16 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.058 3.172 . . . . 1.1 112.215 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.418 ' HE ' ' CD2' ' A' ' 60' ' ' HIS . 1.8 tpm_? -60.08 -50.17 74.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.442 0.697 . . . . 7.35 110.902 -168.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -50.21 -56.3 11.65 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.978 0.911 . . . . 2.43 110.037 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.9 mt -53.6 -60.6 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.496 1.118 . . . . 0.74 109.745 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.4 mt -50.69 -43.54 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 118.641 0.655 . . . . 1.68 111.208 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.418 ' CD2' ' HE ' ' A' ' 56' ' ' ARG . 61.5 m-70 -76.37 -30.94 57.77 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.363 -0.836 . . . . 3.18 112.272 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.6 m -61.67 -49.76 75.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.401 -0.962 . . . . 0.82 108.401 171.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -59.58 -49.03 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.716 1.206 . . . . 1.51 109.814 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -48.84 -61.16 2.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.307 1.443 . . . . 3.53 109.252 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.0 t -59.5 -31.76 69.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.202 1.001 . . . . 1.2 112.646 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.2 mt -67.06 -14.34 62.8 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.63 -0.7 . . . . 1.99 111.526 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.23 49.4 1.14 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.451 -1.06 . . . . 0.74 110.451 168.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -141.37 169.25 17.96 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.355 1.062 . . . . 2.0 108.519 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -108.03 85.56 2.67 Favored Pre-proline 0 CA--C 1.529 0.139 0 CA-C-O 117.361 -1.304 . . . . 3.76 112.943 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 75.52 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.847 2.365 . . . . 1.46 112.133 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.1 m -66.91 143.16 57.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.646 -0.872 . . . . 2.04 108.646 166.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.92 153.89 32.16 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.867 0.841 . . . . 3.13 109.266 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.4 t -87.17 -46.71 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.826 0.85 . . . . 4.12 110.295 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -64.04 -48.35 76.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.044 0.938 . . . . 7.54 110.597 -171.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.51 -173.94 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 127.696 2.398 . . . . 8.38 105.413 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 C--O 1.249 1.04 0 N-CA-C 103.462 -2.792 . . . . 13.52 103.462 158.773 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 119.462 -0.304 . . . . 7.02 111.352 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.11 -177.15 41.85 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 108.733 -1.747 . . . . 3.46 108.733 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -36.48 80.43 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.746 2.818 . . . . 4.69 115.856 -173.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.53 86.06 0.73 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 106.636 -2.585 . . . . 2.69 106.636 157.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.5 t -70.72 67.38 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.595 -0.891 . . . . 2.33 108.595 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -90.18 99.07 12.16 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.905 -1.517 . . . . 3.27 106.905 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.2 142.63 50.63 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.026 -0.361 . . . . 2.58 110.026 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 131.83 55.76 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.133 -1.432 . . . . 1.59 107.133 166.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 t -70.02 133.76 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 105.343 -2.095 . . . . 1.29 105.343 165.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.94 114.69 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.413 1.085 . . . . 1.24 108.093 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -74.05 155.27 38.7 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.429 -0.952 . . . . 5.4 108.429 171.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.6 -20.86 10.86 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.191 -0.783 . . . . 0.99 114.115 164.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -73.63 73.5 1.49 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.537 1.669 . . . . 1.93 109.921 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 t -59.58 -34.72 73.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.869 0.868 . . . . 2.97 111.805 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.1 m -144.83 -167.01 2.55 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.284 -1.006 . . . . 3.99 108.284 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.36 -174.05 0.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.622 0.769 . . . . 2.78 111.057 173.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m 72.52 -58.53 0.59 Allowed 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 125.108 1.363 . . . . 1.95 110.5 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.6 m -40.4 -46.71 2.44 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.714 1.206 . . . . 0.86 110.491 168.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.4 t -38.11 -69.61 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.272 1.029 . . . . 0.8 111.3 169.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -26.51 62.46 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.58 -0.7 . . . . 1.28 111.236 -175.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -50.81 -40.44 55.47 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 108.881 -0.785 . . . . 3.13 108.881 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.6 mt -81.25 -69.14 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 108.065 -1.087 . . . . 0.81 108.065 172.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -46.52 -55.94 6.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.661 1.584 . . . . 3.27 111.928 -169.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 t -62.02 -38.62 89.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.711 0.804 . . . . 1.44 109.973 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.5 t -72.97 -27.55 61.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.992 0.517 . . . . 1.01 110.878 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.89 -44.51 55.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.709 0.804 . . . . 1.96 110.218 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.6 p -65.17 80.55 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.242 0.617 . . . . 1.78 110.373 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 165.91 -26.18 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.773 2.829 . . . . 3.69 111.415 -174.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -66.44 76.25 0.1 Allowed 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.484 1.038 . . . . 2.22 110.378 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -42.17 97.74 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.417 1.887 . . . . 5.73 110.948 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.39 -40.93 0.91 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.386 -1.486 . . . . 1.48 109.386 -165.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.47 154.93 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.941 -0.762 . . . . 3.22 108.941 156.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.05 -23.89 10.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.906 0.883 . . . . 2.52 110.812 165.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -159.44 155.02 25.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.696 0.68 . . . . 2.04 109.3 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.3 t -136.48 147.84 47.36 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.197 1.399 . . . . 2.05 108.014 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.5 m -146.05 131.55 18.74 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.62 -0.881 . . . . 1.78 108.62 151.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.3 m -111.69 163.73 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 123.234 0.614 . . . . 1.69 109.994 173.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.13 137.15 11.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.774 -0.579 . . . . 0.89 111.297 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 pp -72.98 -41.25 64.55 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.948 1.299 . . . . 1.42 111.262 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.45 -27.56 69.2 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.105 0.562 . . . . 1.09 111.376 -171.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.445 HG23 ' HG2' ' A' ' 43' ' ' LYS . 4.4 t -114.97 6.64 15.36 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.925 1.29 . . . . 2.15 110.579 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.3 m120 51.2 45.53 27.74 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.741 1.616 . . . . 2.86 111.609 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HG2' HG23 ' A' ' 41' ' ' THR . 15.6 ptpt -141.74 162.13 36.23 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 113.504 0.927 . . . . 1.77 113.504 -174.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.45 120.72 34.75 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.491 1.916 . . . . 0.8 106.889 167.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.21 135.38 39.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.587 -1.264 . . . . 1.26 107.587 161.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -119.27 135.84 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 104.236 -2.505 . . . . 1.04 104.236 168.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -97.46 112.13 24.1 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.141 -1.8 . . . . 3.48 106.141 165.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -150.48 160.79 43.52 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 122.989 0.516 . . . . 2.36 110.029 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -87.61 112.6 49.65 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 108.455 -0.943 . . . . 4.42 108.455 169.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.86 -18.45 36.53 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.078 1.852 . . . . 1.48 112.595 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -69.82 -38.93 76.73 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.683 1.129 . . . . 3.88 110.913 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -83.2 -56.16 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 112.381 0.512 . . . . 1.72 112.381 -172.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 tt -98.13 -51.16 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.268 0.627 . . . . 1.31 110.694 -172.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.73 163.7 37.04 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 115.846 -0.615 . . . . 0.87 113.153 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.84 -37.23 28.21 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 124.161 3.24 . . . . 1.01 112.527 -175.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -52.73 -49.17 65.95 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.902 0.481 . . . . 5.22 112.019 -174.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -48.73 -60.5 2.68 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.925 0.89 . . . . 3.03 110.082 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.4 mt -56.19 -54.31 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.01 1.324 . . . . 0.78 110.35 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.7 mt -54.44 -58.29 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.609 0.764 . . . . 1.33 110.173 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -62.77 -34.73 77.85 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.384 0.611 . . . . 5.06 110.636 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 83.5 m -62.36 -51.71 66.51 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.349 -0.844 . . . . 0.67 109.717 173.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.8 -37.77 80.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 121.299 -0.876 . . . . 1.75 111.649 -175.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -47.79 -50.97 24.23 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.866 0.866 . . . . 2.56 108.767 167.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.8 t -65.26 -45.58 83.99 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.287 0.477 . . . . 1.46 112.287 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.47 -32.03 69.87 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.37 -0.831 . . . . 1.9 110.769 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.23 45.9 0.56 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.196 -0.762 . . . . 0.91 111.196 161.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -136.16 161.14 36.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.035 -1.469 . . . . 2.21 107.035 174.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -106.38 85.66 1.82 Allowed Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 118.045 -0.979 . . . . 4.32 113.139 -165.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.61 134.12 31.88 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.533 2.155 . . . . 1.67 112.889 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.8 t -143.46 172.68 12.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.787 1.635 . . . . 2.52 106.897 162.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.51 175.2 4.98 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.953 0.501 . . . . 4.92 111.416 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.0 -86.89 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 105.972 -1.862 . . . . 3.98 105.972 171.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.4 ' NZ ' ' O ' ' A' ' 75' ' ' GLU . 8.9 mtmp? -158.08 151.85 23.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.723 1.609 . . . . 7.6 107.032 169.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 51.7 mt -80.71 77.14 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 105.719 -1.956 . . . . 9.42 105.719 166.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.4 ' O ' ' NZ ' ' A' ' 73' ' ' LYS . 27.6 tt0 . . . . . 0 C--O 1.252 1.202 0 C-N-CA 127.29 2.236 . . . . 12.2 107.474 -165.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 mtt . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 107.791 -1.188 . . . . 9.45 107.791 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.08 -150.75 52.12 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.317 0.484 . . . . 3.7 112.746 170.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -125.86 140.94 52.24 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.002 -1.481 . . . . 4.63 107.002 173.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.1 -22.25 20.62 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.254 1.407 . . . . 3.68 112.241 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t 44.93 70.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 118.655 1.227 . . . . 2.33 110.888 -171.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.98 146.56 51.01 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.466 -1.309 . . . . 2.86 107.466 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -125.85 150.17 48.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.459 -0.941 . . . . 2.21 108.459 159.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.427 ' CD1' ' HB3' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -135.91 118.2 15.62 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.189 -1.412 . . . . 1.61 107.189 172.41 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.26 122.57 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 106.528 -1.656 . . . . 1.41 106.528 165.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.35 137.43 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.903 0.881 . . . . 2.45 109.576 -172.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -120.7 168.51 11.33 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.684 0.794 . . . . 6.51 110.688 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.56 -19.47 11.46 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 125.101 1.334 . . . . 0.87 112.396 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.3 mtm -60.41 113.35 2.36 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.838 0.819 . . . . 1.6 111.272 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.9 p -77.14 -42.34 38.28 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.771 0.828 . . . . 4.12 111.414 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.4 t -162.64 171.76 16.4 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.579 0.752 . . . . 3.34 109.103 -165.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.07 -35.7 2.24 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.916 1.686 . . . . 2.34 112.661 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -47.98 -53.37 16.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.172 0.589 . . . . 1.93 110.882 171.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.7 m -62.47 -43.99 97.48 Favored 'General case' 0 CA--C 1.522 -0.104 0 O-C-N 121.627 -0.67 . . . . 0.83 110.118 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.6 t -49.2 -59.83 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 109.256 -0.646 . . . . 0.85 109.256 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -26.62 66.33 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.702 -0.399 . . . . 1.51 111.341 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -60.26 -51.58 68.95 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.587 -0.894 . . . . 2.79 108.587 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.5 mt -62.86 -57.15 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.753 -1.573 . . . . 0.61 106.753 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -52.79 -53.63 45.53 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 123.993 0.808 . . . . 3.27 110.073 -173.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.6 t -58.94 -53.2 61.03 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.498 -0.556 . . . . 1.36 109.498 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.9 t -63.98 -20.01 65.58 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 118.571 -0.728 . . . . 0.9 112.609 -176.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.41 -47.74 10.36 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.29 -0.862 . . . . 2.14 111.251 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.3 p -50.88 -26.85 6.35 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.158 0.89 . . . . 1.8 113.025 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -25.11 66.44 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.752 1.39 . . . . 3.23 114.752 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -67.77 129.14 39.0 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 120.199 1.363 . . . . 1.92 110.594 -174.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.73 71.63 1.45 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.555 -0.715 . . . . 7.12 109.595 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.42 -40.13 0.07 OUTLIER Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.612 -0.549 . . . . 1.18 113.254 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.93 158.01 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.078 0.939 . . . . 3.33 109.594 170.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 pp -107.94 -25.74 11.04 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.708 0.803 . . . . 2.99 110.206 164.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -158.44 149.21 20.41 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 118.773 0.715 . . . . 2.84 109.289 171.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.7 t -117.97 137.6 52.74 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 105.315 -2.106 . . . . 2.51 105.315 163.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.97 103.8 6.5 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.186 -1.413 . . . . 1.25 107.186 173.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 44' ' ' ALA . 1.1 p -103.68 151.11 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 118.436 0.562 . . . . 2.26 112.13 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.92 136.24 16.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.11 0.481 . . . . 0.78 110.73 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.05 -31.92 56.52 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.107 0.963 . . . . 1.87 111.335 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.94 -52.86 62.64 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.211 0.604 . . . . 1.14 109.915 175.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.98 -30.41 68.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.845 0.858 . . . . 1.94 109.446 173.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.256 0.0 OUTLIER 52.72 56.29 7.82 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.023 -1.473 . . . . 3.08 107.023 -164.675 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -140.85 143.61 34.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.613 -1.176 . . . . 1.39 109.086 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.464 ' HB2' HG23 ' A' ' 37' ' ' VAL . . . -109.73 129.16 55.64 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.421 -1.326 . . . . 0.7 107.421 155.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.67 145.81 24.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.616 -1.253 . . . . 0.96 107.616 154.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -129.21 117.88 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 106.61 -1.626 . . . . 0.89 106.61 170.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -88.21 125.99 34.92 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.575 -1.639 . . . . 2.1 106.575 167.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -170.45 151.97 3.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.396 0.678 . . . . 2.17 110.331 -167.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -77.64 118.78 74.27 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.499 -1.297 . . . . 3.56 107.499 168.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.11 -18.61 23.68 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.441 2.094 . . . . 1.09 112.37 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -74.62 -51.27 14.94 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.6 0.636 . . . . 4.28 109.364 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 pt -69.72 -54.96 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 112.566 0.58 . . . . 1.21 112.566 -168.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 tt -98.96 -48.83 11.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 123.662 0.785 . . . . 1.33 110.913 -169.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.33 157.77 26.87 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.226 0.917 . . . . 0.71 111.85 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.02 -25.23 32.22 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 124.026 3.15 . . . . 0.66 113.34 -172.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -55.15 -51.62 65.89 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.316 0.507 . . . . 5.61 111.226 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -42.6 -61.92 1.11 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.192 1.397 . . . . 3.36 109.9 176.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mt -51.44 -63.46 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 124.785 1.234 . . . . 0.81 110.685 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.5 mt -49.93 -43.76 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.573 0.624 . . . . 1.32 111.228 -175.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -75.92 -31.53 59.18 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.064 0.546 . . . . 2.43 111.391 -176.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.7 m -62.6 -53.23 57.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.808 -0.812 . . . . 1.16 108.808 169.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.7 mm -55.93 -47.9 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.135 0.574 . . . . 1.55 110.2 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -49.13 -66.56 0.38 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.102 1.361 . . . . 2.65 109.753 170.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 t -51.95 -42.88 63.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.445 1.498 . . . . 1.19 112.598 -174.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.03 -14.58 55.34 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.782 -0.627 . . . . 1.79 112.658 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.01 47.4 1.35 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.75 -0.94 . . . . 0.62 110.75 172.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -135.74 168.63 18.94 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.049 0.939 . . . . 2.02 108.805 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -117.38 88.75 29.39 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-O 117.962 -1.018 . . . . 4.4 110.38 -173.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.04 108.93 0.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.181 2.588 . . . . 1.12 111.853 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.1 t -72.41 -165.85 0.22 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.8 0.81 . . . . 2.68 109.128 156.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.89 -159.24 0.71 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.422 1.089 . . . . 4.33 110.71 -174.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.43 73.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.943 1.297 . . . . 7.0 109.08 165.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -55.93 148.77 16.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.195 0.998 . . . . 11.75 110.602 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.6 tt -60.91 134.57 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.335 -0.617 . . . . 7.46 109.335 169.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 . . . . . 0 C--O 1.255 1.359 0 N-CA-C 104.508 -2.404 . . . . 9.93 104.508 178.372 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 105.632 -1.988 . . . . 7.93 105.632 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.29 -150.89 20.61 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 106.569 -2.612 . . . . 2.92 106.569 -167.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.48 97.66 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.146 1.778 . . . . 4.66 111.196 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.03 51.34 4.4 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 109.638 -1.385 . . . . 3.41 109.638 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 m -56.06 143.26 9.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 O-C-N 123.702 0.295 . . . . 2.46 111.666 -157.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.5 tp -138.9 141.68 38.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.36 -0.978 . . . . 2.09 108.36 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.406 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 32.9 mt-10 -108.02 123.31 48.48 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.052 -1.462 . . . . 2.38 107.052 174.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.5 mt -106.87 122.17 45.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.108 -1.812 . . . . 2.26 106.108 172.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.87 118.56 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 106.082 -1.821 . . . . 0.92 106.082 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.9 m -117.4 115.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 123.573 0.749 . . . . 1.25 109.097 -169.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -83.88 175.0 9.92 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.561 -0.903 . . . . 6.36 108.561 168.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.6 -32.52 7.44 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.452 0.548 . . . . 1.14 112.737 172.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -61.4 138.74 58.27 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.684 1.242 . . . . 2.18 110.336 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -155.49 28.89 0.39 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.001 0.52 . . . . 3.09 111.066 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.2 t -167.87 141.58 3.4 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 107.79 -1.189 . . . . 3.47 107.79 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -38.38 -48.91 1.4 Allowed 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.001 1.32 . . . . 1.93 112.069 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.6 m -42.68 -40.97 2.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.601 1.16 . . . . 1.57 111.827 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.2 m -47.6 -39.61 17.23 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.739 0.816 . . . . 0.83 111.364 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.6 t -53.17 -61.9 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 123.295 0.638 . . . . 0.94 109.943 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -28.83 69.07 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.494 -0.558 . . . . 1.27 109.494 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -59.51 -52.79 64.05 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.958 -1.127 . . . . 2.92 107.958 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.94 -51.23 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.115 -1.068 . . . . 0.64 108.115 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -47.82 -61.97 1.69 Allowed 'General case' 0 C--N 1.341 0.229 0 O-C-N 123.901 0.75 . . . . 4.72 109.16 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -62.76 -43.32 99.1 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.974 0.91 . . . . 1.79 109.97 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.6 t -58.49 -30.02 66.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 118.798 -0.62 . . . . 1.12 111.489 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.446 HD21 HG23 ' A' ' 58' ' ' ILE . 6.1 mt -85.46 -48.48 8.94 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.253 0.835 . . . . 2.42 113.253 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.4 p -71.6 66.31 0.5 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.541 1.536 . . . . 1.86 110.742 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.99 -33.91 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.618 2.367 . . . . 3.82 110.832 -171.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -53.87 -29.69 42.6 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.733 1.012 . . . . 3.06 113.733 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? 60.4 67.75 0.82 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.739 -1.208 . . . . 6.33 107.739 -173.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.54 -51.22 0.07 OUTLIER Glycine 0 CA--C 1.52 0.373 0 N-CA-C 107.171 -2.372 . . . . 1.18 107.171 -171.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.556 HD11 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -42.04 132.01 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 123.486 0.715 . . . . 2.0 109.158 147.332 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.8 tp -95.4 -46.15 6.82 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.8 2.04 . . . . 2.58 107.9 160.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -154.79 138.16 15.83 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 122.908 0.483 . . . . 2.32 110.306 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -111.15 147.64 34.46 Favored 'General case' 0 CA--C 1.523 -0.084 0 N-CA-C 108.005 -1.109 . . . . 2.02 108.005 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.74 104.43 2.87 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.589 -0.893 . . . . 1.36 108.589 171.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.05 157.43 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 122.873 0.469 . . . . 1.81 111.477 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.62 136.66 17.37 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.611 0.765 . . . . 0.9 109.53 170.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.72 -38.17 64.89 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.622 -0.717 . . . . 1.53 110.722 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.05 -46.5 82.39 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.27 0.628 . . . . 1.24 110.89 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -74.74 -11.42 60.16 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.283 1.033 . . . . 2.52 110.871 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.4 t30 49.78 41.91 22.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.394 1.878 . . . . 2.45 110.84 -172.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -137.61 147.68 45.19 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.291 -0.413 . . . . 1.2 111.26 -164.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.92 112.26 18.55 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.098 1.759 . . . . 0.69 107.422 164.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.78 143.05 27.16 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 166.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.653 HG21 HD13 ' A' ' 58' ' ' ILE . 4.5 mp -127.03 124.08 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 107.259 -1.386 . . . . 1.05 107.259 174.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -97.15 120.65 37.9 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.477 -1.675 . . . . 2.25 106.477 158.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.45 ' CD1' HG22 ' A' ' 46' ' ' ILE . 12.4 p90 -153.48 157.15 39.43 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.89 1.276 . . . . 2.07 107.773 -174.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -85.51 118.44 70.69 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 107.55 -1.278 . . . . 3.19 107.55 170.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.69 -31.41 40.19 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.714 1.609 . . . . 1.47 111.611 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -86.65 29.11 0.81 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.321 0.964 . . . . 3.64 111.378 -166.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 pt -142.77 -53.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 124.846 1.258 . . . . 1.26 110.384 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.4 tt -98.85 -45.55 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.764 0.826 . . . . 1.08 111.015 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.36 158.98 7.38 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.039 0.828 . . . . 0.76 111.251 -172.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.86 -23.78 40.93 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.804 2.336 . . . . 1.04 111.5 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -56.74 -55.13 38.13 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.571 1.148 . . . . 6.08 111.338 -175.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -52.59 -52.13 56.66 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 122.472 1.129 . . . . 2.62 109.824 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.653 HD13 HG21 ' A' ' 46' ' ' ILE . 51.7 mt -56.99 -57.87 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.049 1.339 . . . . 0.94 110.259 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.9 mt -51.12 -51.54 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 109.964 -0.384 . . . . 1.42 109.964 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -63.17 -34.73 78.26 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.73 0.696 . . . . 2.53 112.393 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.9 m -59.92 -56.83 16.92 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.608 -0.886 . . . . 0.64 108.608 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mm -62.11 -46.34 96.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 119.667 -0.206 . . . . 1.63 110.962 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -42.02 -57.76 2.33 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.461 1.504 . . . . 3.44 109.574 166.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 t -65.41 -9.03 21.76 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.353 1.242 . . . . 1.02 114.353 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.1 mt -83.44 -10.01 58.65 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 120.553 1.524 . . . . 2.02 111.128 170.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.34 40.56 28.16 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.056 -1.218 . . . . 0.96 110.056 -170.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -126.67 151.29 48.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.262 -1.755 . . . . 1.76 106.262 161.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -110.64 84.86 4.35 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 113.59 0.959 . . . . 5.54 113.59 -158.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.61 85.67 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.402 2.735 . . . . 1.2 113.756 -173.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.1 t -70.52 156.54 39.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.624 0.77 . . . . 2.53 109.878 161.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.84 179.49 2.21 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.549 -0.537 . . . . 4.64 109.549 161.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 p -152.45 -48.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.183 0.593 . . . . 4.07 111.703 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.406 ' NZ ' ' OE2' ' A' ' 7' ' ' GLU . 9.9 mptt -63.72 147.75 50.87 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.059 -0.719 . . . . 8.52 109.059 169.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.5 mm 72.82 116.88 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 126.702 2.001 . . . . 7.43 109.176 -167.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 C--O 1.25 1.111 0 N-CA-C 104.627 -2.36 . . . . 9.14 104.627 -177.4 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 mtt . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 108.844 -0.799 . . . . 7.28 108.844 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 51.95 31.91 33.24 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.996 -0.891 . . . . 4.52 111.434 -163.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.3 t0 168.37 156.2 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.622 1.969 . . . . 3.61 109.085 -173.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.04 173.6 36.16 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 128.045 2.736 . . . . 1.94 107.817 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.7 t -133.67 145.97 32.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.122 -1.066 . . . . 2.05 108.122 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.2 tt -140.71 137.15 33.26 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.561 -0.903 . . . . 2.23 108.561 166.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -103.54 132.04 50.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.059 1.344 . . . . 2.26 109.416 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.08 131.81 42.75 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.67 0.788 . . . . 1.78 109.435 173.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.41 132.97 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.183 -2.155 . . . . 1.06 105.183 165.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.34 129.15 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.298 -1.001 . . . . 1.66 108.298 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -101.38 -176.85 3.27 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.213 -0.662 . . . . 4.25 109.213 170.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.98 -29.01 11.33 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.636 1.112 . . . . 1.26 110.698 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 73.2 mtm -57.71 120.71 8.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.964 -0.754 . . . . 2.0 108.964 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 t -155.84 43.92 0.43 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.831 0.824 . . . . 3.51 110.393 -170.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -164.08 -89.02 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.37 -0.831 . . . . 3.27 110.064 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -175.57 -62.3 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 125.428 1.491 . . . . 1.93 107.299 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 t -41.46 -46.16 3.37 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.706 1.202 . . . . 2.86 110.304 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.4 m -25.46 -48.4 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.63 1.972 . . . . 0.69 114.099 169.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.6 t -51.44 -64.2 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.26 0.624 . . . . 0.69 110.347 174.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -27.83 66.43 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.101 -0.999 . . . . 1.2 110.706 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.93 -44.01 70.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.126 1.37 . . . . 3.25 108.373 176.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.1 mt -72.69 -67.49 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 106.288 -1.745 . . . . 0.57 106.288 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -48.91 -56.17 9.6 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.612 1.165 . . . . 3.55 111.563 -166.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 m -68.95 -20.17 64.19 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.753 1.221 . . . . 2.83 111.792 -174.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.5 t -87.08 -48.89 7.7 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.027 -1.101 . . . . 1.18 108.027 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.27 -35.7 76.14 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.035 -1.041 . . . . 2.28 111.718 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 p -57.69 -18.94 23.63 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.483 0.92 . . . . 1.94 113.483 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.9 mtmt -63.02 -34.21 77.08 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.571 1.078 . . . . 3.84 110.28 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.44 ' HB3' HD12 ' A' ' 53' ' ' ILE . 16.8 m-70 -72.41 107.75 5.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.895 -1.15 . . . . 2.14 107.895 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -52.52 -26.12 12.22 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.006 1.113 . . . . 4.81 114.006 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.09 -21.23 69.71 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 118.198 0.454 . . . . 1.18 113.05 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.76 124.31 14.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 118.965 1.382 . . . . 2.97 108.689 171.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.5 tp -84.45 -45.31 12.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.732 -1.21 . . . . 3.26 107.732 162.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -163.62 114.44 1.36 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 119.152 -0.451 . . . . 3.07 111.042 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.7 m -77.92 161.9 27.21 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.713 -0.847 . . . . 2.13 108.713 166.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -166.18 94.5 0.55 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.399 -0.963 . . . . 2.33 108.399 170.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 p -104.87 147.99 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 123.428 0.691 . . . . 2.11 112.075 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.9 135.02 30.87 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.635 0.774 . . . . 0.69 109.904 174.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.93 -39.87 63.5 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.31 -0.859 . . . . 1.41 110.728 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.36 -46.33 80.07 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.134 0.574 . . . . 0.96 110.349 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.19 -15.49 60.56 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.131 0.972 . . . . 1.95 111.086 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.39 36.32 26.85 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.676 0.79 . . . . 2.69 109.155 -172.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -135.69 135.6 40.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 122.411 0.284 . . . . 1.5 110.575 -168.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.06 124.69 49.96 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.594 -1.262 . . . . 0.77 107.594 160.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.79 147.51 25.99 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.674 -1.232 . . . . 1.43 107.674 155.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.4 mp -130.17 139.15 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 107.139 -1.43 . . . . 1.05 107.139 166.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -97.18 123.73 41.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.79 -1.559 . . . . 2.91 106.79 161.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -168.58 171.43 8.86 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.835 -1.172 . . . . 2.51 107.835 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.74 110.16 30.05 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-N 119.015 0.825 . . . . 3.89 109.364 175.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.28 51.32 3.16 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.694 2.263 . . . . 2.58 110.365 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -145.44 -60.5 0.34 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.922 1.689 . . . . 4.39 107.598 -159.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 pt -94.57 -60.37 2.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 C-N-CA 123.893 0.877 . . . . 1.49 111.469 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.44 HD12 ' HB3' ' A' ' 29' ' ' HIS . 10.7 tt -72.28 -52.71 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.246 -1.02 . . . . 1.9 108.246 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.8 160.69 24.28 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.287 -0.869 . . . . 0.82 112.02 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -57.37 -39.69 87.53 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.755 2.97 . . . . 0.78 110.909 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -59.44 -53.9 52.8 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.251 0.463 . . . . 6.77 112.251 -171.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -52.67 -46.74 67.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.897 0.856 . . . . 2.55 109.75 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.96 -66.45 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.827 -1.079 . . . . 1.0 110.025 172.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.353 2.7 pp -61.62 -28.88 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 121.075 1.762 . . . . 3.82 114.366 -174.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.49 -51.77 66.13 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 118.819 0.736 . . . . 3.23 109.139 173.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.0 m -57.39 -52.34 65.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.567 -0.531 . . . . 0.63 109.567 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mm -56.35 -49.6 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.516 1.126 . . . . 1.4 110.181 -175.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -48.4 -62.84 1.29 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.39 1.076 . . . . 3.91 109.675 170.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -62.47 -23.89 67.16 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.79 -0.641 . . . . 1.18 112.286 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -82.7 -5.16 58.73 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.951 1.7 . . . . 2.32 110.966 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.38 48.36 1.56 Allowed Glycine 0 CA--C 1.525 0.696 0 C-N-CA 125.103 1.335 . . . . 0.94 111.803 167.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -141.61 162.54 35.23 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.794 0.838 . . . . 2.03 109.902 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -109.66 93.2 13.68 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-O 117.95 -1.024 . . . . 4.41 109.578 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.78 136.78 6.28 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 121.553 1.502 . . . . 1.49 112.826 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.3 m -135.79 117.5 15.01 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 126.02 1.728 . . . . 1.92 107.751 170.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -58.02 135.36 56.95 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.438 0.295 . . . . 3.18 110.482 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.2 m -119.79 -41.34 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 123.273 0.629 . . . . 3.62 110.777 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt 70.73 -56.57 0.61 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.858 1.663 . . . . 7.64 111.56 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.7 pt -93.16 -173.73 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.098 1.359 . . . . 5.56 109.109 168.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 . . . . . 0 C--O 1.256 1.399 0 N-CA-C 103.319 -2.845 . . . . 11.75 103.319 164.886 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 106.368 -1.715 . . . . 8.61 106.368 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.27 58.94 10.4 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 108.72 -1.752 . . . . 3.55 108.72 -165.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -170.15 171.57 6.81 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.547 -1.279 . . . . 4.25 107.547 -137.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.55 -176.38 18.9 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.642 1.591 . . . . 2.12 110.259 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.0 156.12 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.191 -1.411 . . . . 1.96 107.191 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.409 HD12 HD23 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -127.22 127.27 44.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.678 -1.601 . . . . 2.55 106.678 174.354 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.37 117.69 35.08 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.72 -1.215 . . . . 2.18 107.72 170.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.409 HD23 HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -110.12 141.82 42.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.298 -1.371 . . . . 1.88 107.298 172.009 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.85 135.79 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 106.357 -1.72 . . . . 0.85 106.357 167.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.26 108.74 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 C-N-CA 125.853 1.661 . . . . 1.26 108.869 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -67.48 158.48 31.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.688 -0.856 . . . . 5.67 108.688 160.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.02 -23.58 7.69 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.03 0.824 . . . . 1.14 113.111 163.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -70.44 85.59 0.61 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.819 1.309 . . . . 2.16 112.6 -175.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.3 t -76.79 100.41 5.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.02 0.914 . . . . 3.09 110.845 175.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.4 t 68.62 -76.33 0.06 Allowed 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 115.21 1.559 . . . . 3.99 115.21 164.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.41 170.34 15.99 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 123.864 0.865 . . . . 3.33 108.709 -171.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m 69.7 -58.48 0.52 Allowed 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 124.978 1.311 . . . . 1.84 111.034 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.8 m -44.21 -47.16 9.21 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 124.924 1.289 . . . . 0.85 111.512 -177.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.6 t -42.99 -64.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.45 0.7 . . . . 0.88 110.197 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -25.9 61.11 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.861 -0.524 . . . . 1.44 111.395 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -51.53 -41.61 61.16 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.767 0.827 . . . . 3.24 108.824 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.6 mt -80.23 -65.91 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.682 -1.229 . . . . 0.64 107.682 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.0 -56.62 7.23 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.013 1.325 . . . . 3.29 111.311 -169.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 t -65.23 -45.12 85.9 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.897 0.879 . . . . 1.36 110.12 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 t -62.16 -29.6 70.47 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 119.161 -0.447 . . . . 0.89 111.388 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.39 -55.22 5.04 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.957 -0.544 . . . . 2.61 111.311 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.9 p -68.83 66.08 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.962 1.305 . . . . 2.06 111.956 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.87 -42.33 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.77 1.628 . . . . 4.27 110.779 -170.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -72.99 150.32 42.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.04 -0.726 . . . . 3.63 109.04 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -60.69 160.07 9.86 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.919 -0.401 . . . . 5.4 109.919 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.2 -5.09 81.66 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.028 -0.873 . . . . 1.8 113.111 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.553 HD11 ' SG ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -99.18 146.43 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 106.712 -1.588 . . . . 1.93 106.712 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.9 tp -104.53 -48.74 3.73 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.681 1.192 . . . . 2.77 110.603 172.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -164.95 162.4 20.58 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.007 0.923 . . . . 2.5 108.761 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' HD11 ' A' ' 32' ' ' ILE . 56.0 m -138.15 161.34 37.06 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 119.332 0.969 . . . . 1.85 108.538 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.6 t -155.0 133.62 12.01 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.774 -0.824 . . . . 2.35 108.774 150.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 m -115.94 155.81 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.369 0.668 . . . . 1.73 111.036 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.39 137.69 16.6 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.101 0.561 . . . . 1.01 110.88 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -79.24 -34.83 42.36 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 124.559 1.144 . . . . 1.72 112.521 -174.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.82 -41.34 91.05 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 109.596 -0.52 . . . . 1.11 109.596 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.3 t -92.9 -6.36 48.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.533 -0.746 . . . . 2.07 111.297 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.269 0.0 OUTLIER 39.32 60.69 1.48 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 126.576 1.951 . . . . 2.83 109.791 -172.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -131.38 147.13 52.54 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.201 1.4 . . . . 2.05 108.866 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.93 120.71 38.09 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.938 -1.504 . . . . 0.63 106.938 159.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.01 138.18 31.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.043 -1.466 . . . . 1.58 107.043 161.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.63 130.3 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.619 -1.252 . . . . 1.05 107.619 169.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -101.06 139.26 37.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.085 -1.82 . . . . 2.4 106.085 161.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -175.18 177.38 1.91 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.371 1.468 . . . . 2.49 108.777 -160.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -112.85 81.33 4.4 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 125.241 1.416 . . . . 4.09 107.544 -170.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.74 -43.53 55.05 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.421 2.747 . . . . 1.23 113.902 -167.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.33 -23.72 65.94 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.239 0.829 . . . . 3.72 113.239 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.8 pt -100.75 -58.17 4.05 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 118.888 0.767 . . . . 1.52 112.629 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.7 tt -89.32 -45.35 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 121.356 0.598 . . . . 1.2 110.425 -171.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.68 151.47 13.87 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.859 0.742 . . . . 1.02 111.815 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -66.42 -31.42 42.63 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.389 2.726 . . . . 1.48 111.866 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -56.55 -43.17 79.65 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.91 -0.494 . . . . 6.16 111.452 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -53.99 -53.01 58.81 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 121.225 0.536 . . . . 2.71 109.732 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.3 mt -57.58 -49.15 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 124.276 1.03 . . . . 0.82 110.25 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.4 mt -54.85 -56.74 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 110.151 -0.314 . . . . 1.44 110.151 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -60.88 -36.96 80.53 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.742 0.701 . . . . 2.63 112.027 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.7 m -59.21 -51.16 71.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.479 -0.763 . . . . 0.91 109.095 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.7 mt -65.25 -43.03 95.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 121.508 -0.745 . . . . 2.22 111.753 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -49.48 -49.76 44.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.425 1.09 . . . . 3.05 108.356 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 t -64.96 -44.31 89.8 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.57 0.748 . . . . 1.04 111.419 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.6 mt -63.47 -30.41 71.54 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.5 -0.75 . . . . 2.16 110.651 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.07 53.45 0.2 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.44 -0.664 . . . . 0.95 111.44 156.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -137.47 175.28 9.74 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.709 -0.849 . . . . 1.98 108.709 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -106.65 77.15 0.46 Allowed Pre-proline 0 N--CA 1.47 0.547 0 CA-C-O 117.734 -1.127 . . . . 4.35 111.76 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.68 71.79 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.662 2.908 . . . . 1.27 112.37 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.7 m -74.38 117.84 16.65 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.357 1.063 . . . . 2.08 108.49 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tt -76.74 69.64 3.13 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.086 0.954 . . . . 3.09 109.466 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.9 t -82.19 -36.86 14.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 123.378 0.671 . . . . 4.34 111.59 -173.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.461 ' NZ ' ' OE2' ' A' ' 75' ' ' GLU . 1.1 tmtm? -66.14 -46.68 76.62 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.577 -0.849 . . . . 6.61 111.196 -168.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.6 mm -71.55 144.27 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.346 -0.983 . . . . 8.42 108.346 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.461 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 14.2 pt-20 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 105.122 -2.177 . . . . 9.42 105.122 -157.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.2 mtm . . . . . 0 N--CA 1.467 0.396 0 N-CA-C 107.382 -1.34 . . . . 9.94 107.382 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.68 145.75 19.12 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 108.765 -1.734 . . . . 4.06 108.765 -167.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -87.47 -167.4 1.87 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.178 0.591 . . . . 4.99 111.202 -176.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.51 47.92 0.5 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.572 -1.011 . . . . 3.96 110.572 170.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.347 1.2 m 20.84 80.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 128.256 2.622 . . . . 3.04 113.161 -177.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -74.07 99.28 3.3 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.557 -1.275 . . . . 2.57 107.557 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -78.22 117.94 19.97 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.848 0.356 . . . . 2.59 110.046 169.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 pp -108.21 133.99 51.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.544 -1.28 . . . . 1.87 107.544 160.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.1 t -85.63 136.67 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 105.563 -2.014 . . . . 1.38 105.563 169.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -156.38 112.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 108.499 -0.926 . . . . 2.33 108.499 -163.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -96.89 178.71 5.2 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.326 -0.99 . . . . 4.56 108.326 174.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.08 -36.99 4.04 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.375 -1.09 . . . . 0.95 110.375 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.6 ptp -57.08 123.11 14.08 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.811 -0.811 . . . . 2.06 108.811 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.0 t -149.07 21.54 0.97 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.368 0.507 . . . . 2.87 112.368 -167.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.5 t -162.98 142.74 9.0 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 106.097 -1.816 . . . . 3.75 106.097 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.58 -49.27 5.46 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.755 1.222 . . . . 2.02 111.817 -173.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -37.2 -47.45 0.79 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.082 1.753 . . . . 1.65 112.45 174.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.7 m -52.62 -43.62 65.5 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 124.102 0.961 . . . . 0.96 110.864 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.9 t -54.62 -61.49 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.479 -0.934 . . . . 0.75 108.479 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -24.66 67.02 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.241 -0.89 . . . . 1.47 109.792 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -65.25 -52.73 52.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.977 0.808 . . . . 4.57 108.96 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.7 mt -58.79 -54.49 32.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.834 -1.173 . . . . 0.63 107.834 -172.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -38.35 -69.34 0.12 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.369 1.468 . . . . 3.16 111.588 165.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -53.21 -50.35 64.89 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.642 1.177 . . . . 1.73 110.71 -171.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -33.13 73.56 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.154 1.382 . . . . 0.99 110.469 -177.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.8 mt -77.25 -47.54 19.86 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.828 0.451 . . . . 2.21 111.155 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.4 p -66.99 74.57 0.11 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.578 1.151 . . . . 1.75 110.079 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 163.13 -9.63 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.501 2.72 . . . . 3.63 113.284 -171.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -69.67 -101.45 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 121.76 2.073 . . . . 3.07 110.01 170.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -167.8 158.85 11.19 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.059 -2.2 . . . . 6.2 105.059 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.11 -58.44 2.3 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.688 -0.565 . . . . 1.88 111.688 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -38.74 99.92 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 126.905 2.082 . . . . 2.08 111.258 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.4 mt -82.46 -44.64 15.76 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.497 1.919 . . . . 2.94 108.694 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -145.36 150.12 36.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.218 1.007 . . . . 2.28 109.926 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -131.24 154.48 48.41 Favored 'General case' 0 C--O 1.231 0.082 0 N-CA-C 107.01 -1.478 . . . . 1.97 107.01 169.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.7 m -152.41 141.93 21.72 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.044 -0.725 . . . . 2.05 109.044 150.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.43 HG12 ' CB ' ' A' ' 44' ' ' ALA . 1.5 m -119.59 168.19 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.365 0.666 . . . . 1.73 111.355 170.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.01 139.66 13.78 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.631 0.772 . . . . 0.88 109.853 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.32 -36.05 22.84 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.994 0.918 . . . . 1.63 112.236 -172.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.29 -39.04 81.7 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.67 -0.493 . . . . 1.12 109.67 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 t -97.17 -4.63 38.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.151 -0.928 . . . . 2.14 111.394 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.38 61.3 2.06 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.221 1.808 . . . . 2.81 109.13 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -135.27 145.36 47.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.736 -1.12 . . . . 1.45 108.614 -171.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.43 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -127.84 123.44 35.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.14 -1.43 . . . . 0.66 107.14 164.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -103.92 130.69 51.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.098 -1.075 . . . . 1.39 108.098 169.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.85 124.35 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.746 -0.835 . . . . 0.91 108.746 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -97.48 82.16 3.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.743 0.817 . . . . 2.19 108.869 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -122.77 151.18 41.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.749 1.22 . . . . 2.22 109.956 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.77 114.06 22.01 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 109.511 -0.552 . . . . 3.25 109.511 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.95 -25.85 59.32 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.046 1.831 . . . . 1.19 113.225 -176.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -54.5 -30.36 53.1 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.839 1.256 . . . . 4.11 113.453 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 pt -105.57 -92.74 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.366 0.666 . . . . 2.15 111.854 -172.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 tt -49.7 -52.37 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.982 1.313 . . . . 1.37 112.291 -174.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.44 162.1 35.5 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.992 0.806 . . . . 0.78 111.831 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.2 -36.78 27.31 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.795 2.997 . . . . 0.85 112.776 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -56.64 -45.69 81.44 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.689 0.625 . . . . 6.16 112.689 -173.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -54.42 -57.48 11.14 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 122.15 0.976 . . . . 3.01 109.538 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.4 mt -49.7 -62.46 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.329 1.452 . . . . 0.79 109.725 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.6 mt -52.81 -52.77 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 122.755 0.422 . . . . 1.33 110.201 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -68.7 -30.66 69.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.119 0.418 . . . . 3.17 111.746 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.9 m -65.69 -52.18 53.51 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.567 -0.708 . . . . 0.98 109.313 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 mm -65.31 -33.64 65.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 121.742 -0.599 . . . . 1.89 111.174 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -54.32 -58.64 6.63 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.787 1.235 . . . . 3.0 108.712 166.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.8 t -60.04 -26.5 66.17 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.083 0.953 . . . . 1.32 113.57 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.81 -20.47 61.63 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.382 0.992 . . . . 2.75 111.9 172.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.87 38.75 5.4 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.222 -1.151 . . . . 1.09 110.222 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -126.32 163.2 23.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.082 -1.821 . . . . 2.27 106.082 171.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.14 83.58 8.21 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 119.375 0.989 . . . . 3.9 112.96 -172.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.89 147.51 24.3 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.374 2.049 . . . . 1.56 112.224 -175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.3 m -154.37 144.29 21.79 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.157 1.383 . . . . 2.01 108.311 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.2 mt -61.84 143.94 55.59 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.862 0.465 . . . . 3.74 111.052 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.3 t -67.31 -46.98 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 109.744 -0.465 . . . . 4.4 109.744 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -62.46 135.0 57.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.769 -0.456 . . . . 7.28 109.769 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 72.8 mt -116.06 126.75 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 105.113 -2.18 . . . . 8.08 105.113 169.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 . . . . . 0 C--O 1.252 1.23 0 C-N-CA 124.518 1.127 . . . . 14.49 109.303 -173.641 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptm . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 110.361 -0.237 . . . . 6.99 110.361 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.65 -161.78 38.95 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.843 -0.903 . . . . 3.84 110.843 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -83.66 -40.69 18.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.476 1.11 . . . . 4.79 109.468 168.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.78 74.6 1.19 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 109.767 -1.333 . . . . 2.08 109.767 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 t -79.22 130.73 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.84 -0.8 . . . . 2.19 108.84 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.8 tp -129.86 138.31 50.9 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.407 -1.331 . . . . 1.95 107.407 164.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -110.9 137.69 48.22 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.784 1.234 . . . . 2.46 109.535 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.04 128.15 20.79 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.848 -0.797 . . . . 1.49 108.848 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.0 t -65.35 145.15 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 107.619 -1.252 . . . . 1.09 107.619 167.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.42 98.16 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 125.767 1.627 . . . . 1.36 107.68 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -63.57 162.94 12.0 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.972 -0.751 . . . . 4.16 108.972 160.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.47 -0.32 46.46 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.866 1.222 . . . . 1.42 113.014 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.2 mtm -73.64 75.76 1.52 Allowed 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.336 -1.096 . . . . 2.22 112.097 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.9 p -67.54 81.58 0.17 Allowed 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 121.686 -0.634 . . . . 4.79 109.892 168.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 t 72.75 176.28 0.27 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.04 1.736 . . . . 3.51 112.253 165.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.7 -36.11 4.71 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 126.363 1.865 . . . . 2.27 112.667 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -41.22 -60.63 1.19 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.673 1.189 . . . . 2.37 110.845 168.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.4 m -68.19 -31.54 71.14 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.532 -0.73 . . . . 1.43 111.675 -176.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.0 t -57.04 -56.26 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.887 -0.783 . . . . 0.9 108.887 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -30.49 71.07 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.709 -0.619 . . . . 1.27 110.626 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -50.58 72.42 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.333 -0.988 . . . . 3.7 108.333 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.5 mt -62.52 -65.18 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 107.207 -1.405 . . . . 1.03 107.207 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -46.53 -57.12 5.03 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.855 0.862 . . . . 3.64 110.151 -174.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -56.79 -49.56 74.96 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.354 -0.839 . . . . 1.44 109.283 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.7 t -65.67 -29.38 69.92 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 118.993 -0.527 . . . . 0.88 111.811 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 26' ' ' LEU . 2.8 mm? -70.63 -44.25 67.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.76 0.709 . . . . 2.64 111.648 174.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.8 p -54.56 -21.54 10.55 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.649 0.981 . . . . 2.13 113.649 -172.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.12 -4.49 58.83 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 115.064 1.505 . . . . 4.54 115.064 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -67.11 122.94 18.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.869 1.213 . . . . 2.11 110.162 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -71.0 73.43 0.61 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.679 1.192 . . . . 7.34 111.176 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.39 -2.42 0.8 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.887 1.232 . . . . 1.23 112.62 -177.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.94 150.14 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 125.075 1.35 . . . . 1.97 108.282 170.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.1 tp -111.4 -48.12 3.12 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.278 1.831 . . . . 3.1 110.055 172.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -157.34 155.14 30.12 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.357 1.063 . . . . 2.71 108.32 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.43 163.95 28.54 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.169 -1.048 . . . . 2.34 108.169 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -162.56 103.14 1.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.82 -1.178 . . . . 1.66 107.82 170.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.7 147.21 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 C-N-CA 124.997 1.319 . . . . 1.95 110.641 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.97 137.14 16.46 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.764 0.792 . . . . 1.06 111.601 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 pp -77.7 -23.22 49.56 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.29 -0.868 . . . . 1.5 111.967 -176.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.14 -41.15 97.98 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.245 -0.65 . . . . 1.27 109.245 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -86.34 -31.21 21.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.565 -0.743 . . . . 2.17 109.909 172.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 77.68 44.3 0.09 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.63 1.972 . . . . 3.08 107.75 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -140.17 146.76 39.18 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.944 -0.391 . . . . 1.64 109.944 -167.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.98 127.1 55.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.136 1.375 . . . . 0.65 107.359 162.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.19 141.74 32.62 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.914 -1.143 . . . . 1.01 107.914 155.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.73 136.47 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 107.572 -1.27 . . . . 1.25 107.572 170.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -100.61 125.37 47.0 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.421 -1.696 . . . . 2.35 106.421 160.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -166.57 142.04 4.47 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 128.126 2.571 . . . . 1.85 107.267 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -71.61 125.54 91.71 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 118.833 -1.147 . . . . 3.83 108.93 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -82.67 -9.78 10.96 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.745 2.296 . . . . 1.3 113.275 -173.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.92 -44.08 11.31 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.255 0.934 . . . . 4.18 109.191 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 pt -67.41 -54.66 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 112.716 0.635 . . . . 1.46 112.716 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.5 tt -105.14 -58.08 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.84 0.856 . . . . 1.65 111.653 -173.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.04 161.6 27.55 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.579 0.609 . . . . 0.62 113.905 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.78 -36.48 6.24 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.048 3.165 . . . . 0.7 112.983 -171.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.5 ttm105 -55.39 -47.11 76.35 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.768 0.427 . . . . 4.89 111.186 -173.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -47.36 -61.4 1.93 Allowed 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.477 1.511 . . . . 2.79 110.312 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.5 mt -51.09 -63.34 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.127 0.971 . . . . 0.69 109.791 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.7 mt -51.86 -52.66 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.235 0.471 . . . . 1.28 110.689 -173.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -64.18 -34.38 77.95 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.99 0.814 . . . . 2.71 112.272 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.4 m -61.01 -53.13 61.01 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.355 -0.841 . . . . 0.7 109.888 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.2 mm -61.56 -38.44 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 O-C-N 121.667 -0.645 . . . . 1.63 110.693 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -55.76 -59.7 4.49 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.954 1.301 . . . . 2.77 108.803 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.5 t -52.37 -40.49 62.08 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.587 1.155 . . . . 1.03 111.739 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.7 mt -70.32 5.38 1.76 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.466 0.913 . . . . 1.96 113.466 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.19 45.98 5.45 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 119.069 0.849 . . . . 0.65 111.249 169.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -135.74 174.69 10.33 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.046 0.938 . . . . 1.92 109.782 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -113.59 68.34 1.4 Allowed Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.892 0.701 . . . . 3.61 112.892 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.76 85.09 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.194 3.263 . . . . 1.1 112.503 -174.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.2 m -101.3 125.54 47.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.726 1.611 . . . . 2.28 108.177 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -56.06 134.86 52.89 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.154 -0.684 . . . . 3.58 109.154 175.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.7 p -74.35 -50.58 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 110.399 -0.222 . . . . 3.87 110.399 -173.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -177.81 177.22 1.11 Allowed 'General case' 0 C--O 1.233 0.216 0 C-N-CA 127.821 2.448 . . . . 7.34 105.693 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.15 155.72 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 106.932 -1.506 . . . . 8.03 106.932 166.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 . . . . . 0 C--O 1.25 1.102 0 N-CA-C 104.448 -2.427 . . . . 11.38 104.448 172.439 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 105.306 -2.109 . . . . 9.07 105.306 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -173.96 50.05 0.15 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 107.68 -2.168 . . . . 3.67 107.68 -177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -165.93 167.7 16.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.548 1.539 . . . . 4.73 108.571 -154.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.97 -130.42 2.2 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 109.539 -1.424 . . . . 2.62 109.539 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 m -136.06 162.73 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.059 -1.459 . . . . 2.29 107.059 157.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tt -153.08 82.3 1.2 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 103.618 -2.734 . . . . 3.02 103.618 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.0 152.81 42.19 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.882 -0.727 . . . . 3.4 110.438 -169.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.39 133.92 50.33 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.125 -1.435 . . . . 1.73 107.125 168.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.61 136.14 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.441 -2.059 . . . . 0.89 105.441 153.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 m -134.92 134.97 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.573 -1.269 . . . . 1.34 107.573 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -117.2 173.73 6.51 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.737 -0.838 . . . . 5.68 108.737 170.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.24 -22.93 37.21 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 110.916 -0.874 . . . . 1.23 110.916 -172.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.2 mtm -60.1 151.81 25.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.554 0.677 . . . . 2.21 109.583 170.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -158.45 -58.27 0.07 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.472 -0.566 . . . . 2.4 109.472 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.3 t -73.38 140.45 46.63 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.206 -0.664 . . . . 3.49 109.206 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.35 -43.94 5.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.022 0.929 . . . . 1.9 111.728 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 m -41.21 -47.32 3.31 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.422 1.089 . . . . 1.51 111.811 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.7 m -45.44 -49.1 13.63 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 118.992 0.815 . . . . 0.74 110.671 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.8 t -52.32 -59.49 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.646 0.778 . . . . 1.25 109.694 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -57.21 -36.57 71.03 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.418 1.087 . . . . 1.7 109.37 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -61.47 -49.78 75.4 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.375 -0.602 . . . . 4.35 109.375 -174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.9 mt -63.33 -53.27 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.167 -1.049 . . . . 0.73 108.167 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -48.04 -59.98 2.96 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.089 0.956 . . . . 3.15 110.016 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.1 m -66.31 -43.25 86.78 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.027 0.931 . . . . 2.3 109.99 -173.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.5 t -57.23 -38.31 73.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.862 -0.59 . . . . 0.88 110.222 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 mt -75.53 -51.09 13.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.385 -0.817 . . . . 2.62 112.48 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.9 p -68.18 73.28 0.2 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.466 0.706 . . . . 1.61 110.277 -172.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? 177.84 -33.93 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.633 2.773 . . . . 3.47 111.638 -171.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -44.41 -76.95 0.02 OUTLIER 'General case' 0 C--N 1.348 0.515 0 N-CA-C 113.904 1.076 . . . . 3.59 113.904 -171.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 ptt85 171.01 134.05 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 104.924 -2.25 . . . . 11.14 104.924 -172.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.76 -59.66 2.98 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 118.774 0.716 . . . . 2.57 113.216 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -33.89 116.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 127.432 2.293 . . . . 1.92 111.605 177.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 72.2 mt -89.03 -46.32 8.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.357 1.063 . . . . 3.17 110.52 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -154.45 152.13 29.78 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.947 0.899 . . . . 2.56 108.946 -173.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.1 m -125.7 160.75 28.93 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.761 -1.2 . . . . 1.88 107.761 168.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.1 t -146.64 120.42 9.25 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.108 -1.071 . . . . 1.82 108.108 155.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 t -102.69 150.87 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 124.519 1.127 . . . . 2.31 108.584 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.16 135.11 20.15 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.598 -0.689 . . . . 0.72 110.465 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -73.35 -49.85 25.13 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.29 -0.868 . . . . 1.56 111.148 -172.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.98 -48.42 80.03 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.586 0.707 . . . . 1.15 110.376 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.64 -16.54 62.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.35 1.06 . . . . 2.24 111.1 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 50.76 42.07 27.09 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.886 1.274 . . . . 2.77 108.117 -171.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -129.32 144.8 51.37 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 122.565 0.346 . . . . 1.41 110.957 -166.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.72 110.49 17.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.094 1.758 . . . . 0.87 107.393 161.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.92 142.7 27.42 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 107.471 -1.307 . . . . 1.36 107.471 166.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.58 128.56 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 108.169 -1.048 . . . . 1.1 108.169 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -93.85 74.72 4.22 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 126.43 1.892 . . . . 2.24 108.926 171.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -119.32 179.43 4.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.437 1.495 . . . . 2.45 113.434 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.18 88.3 31.94 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 130.774 3.63 . . . . 4.07 108.097 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -61.16 -22.23 74.04 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.963 2.442 . . . . 1.35 112.892 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -57.52 -30.74 65.4 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 118.911 -0.566 . . . . 3.03 112.051 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.9 pt -114.15 -54.43 4.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 N-CA-C 113.976 1.102 . . . . 1.37 113.976 -173.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.6 tt -74.02 -63.35 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.496 -0.927 . . . . 1.8 108.496 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.2 147.91 23.38 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.128 -0.942 . . . . 0.96 111.553 173.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -54.11 -43.74 55.65 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.985 3.124 . . . . 0.81 111.753 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -56.61 -51.85 67.08 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.048 0.539 . . . . 5.58 112.35 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -47.32 -55.38 8.9 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.087 1.355 . . . . 2.61 109.391 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.1 mt -56.42 -65.11 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 114.687 -1.142 . . . . 0.96 110.406 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.2 mt -48.37 -52.86 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.259 1.024 . . . . 1.25 109.81 -173.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -68.92 -30.41 68.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 111.839 0.311 . . . . 2.92 111.839 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.8 m -67.32 -51.42 52.73 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.613 -0.835 . . . . 0.95 109.905 173.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.2 mm -64.17 -33.67 63.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.748 -0.595 . . . . 2.09 111.092 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -55.11 -60.32 3.54 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.918 1.287 . . . . 2.81 108.607 167.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -52.66 -38.54 60.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.862 1.265 . . . . 1.05 112.759 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -55.22 -22.84 19.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.925 0.713 . . . . 2.86 112.925 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.39 46.66 1.4 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.121 -1.192 . . . . 0.92 110.121 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -132.63 168.49 18.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.333 -1.358 . . . . 1.74 107.333 172.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -112.47 88.14 10.57 Favored Pre-proline 0 N--CA 1.454 -0.231 0 CA-C-O 118.515 -0.755 . . . . 3.88 109.324 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.45 151.65 22.85 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.578 2.185 . . . . 1.58 111.944 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.5 m -157.75 145.97 19.0 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.662 1.585 . . . . 2.48 107.386 170.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mp -55.25 133.93 49.57 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.038 -0.727 . . . . 3.6 109.038 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.46 -49.26 84.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 118.852 0.751 . . . . 4.63 111.161 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.6 tttp 65.77 172.7 0.23 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.234 1.014 . . . . 8.03 110.454 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.4 mt -131.41 -67.06 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.284 -1.376 . . . . 6.66 107.284 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--O 1.253 1.251 0 CA-C-O 115.818 -2.039 . . . . 11.17 109.154 -171.423 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mtp . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 118.771 -0.633 . . . . 6.8 110.031 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -82.64 -74.2 1.2 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.249 -1.54 . . . . 4.3 109.249 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -157.85 175.59 13.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.162 -1.422 . . . . 3.93 107.162 166.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.59 172.7 22.4 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 106.852 -2.499 . . . . 1.86 106.852 161.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.15 146.73 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 108.533 -0.914 . . . . 2.55 108.533 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 tt -134.59 115.5 13.93 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.453 -1.314 . . . . 2.41 107.453 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -89.74 84.85 6.31 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.071 1.348 . . . . 2.67 108.89 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.61 132.04 34.24 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.961 -1.126 . . . . 1.65 107.961 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -74.17 149.57 7.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 106.038 -1.838 . . . . 1.17 106.038 164.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -152.69 54.58 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 127.082 2.153 . . . . 1.65 107.696 -169.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -56.84 157.33 5.67 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.779 -0.646 . . . . 5.79 109.338 171.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.48 -37.99 3.55 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 107.851 -2.099 . . . . 1.24 107.851 -162.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 40.5 mtp -53.03 143.63 16.96 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.331 -0.988 . . . . 2.59 108.331 157.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.9 t -168.08 -56.24 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.422 -0.955 . . . . 3.93 108.422 -174.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.8 t -86.9 171.39 10.85 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.466 -0.938 . . . . 2.8 108.466 172.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.81 -166.07 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.467 -0.568 . . . . 2.81 109.467 160.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.5 m 71.79 -60.23 0.53 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.433 1.093 . . . . 1.8 109.728 -171.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 77.7 m -36.98 -53.04 0.97 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 126.123 1.769 . . . . 1.21 109.875 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.6 t -36.08 -66.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.899 1.28 . . . . 0.67 111.336 173.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -26.02 56.26 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.124 -0.36 . . . . 1.04 111.073 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -51.78 -41.64 61.8 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 124.157 0.983 . . . . 3.16 108.786 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.465 ' HB ' HG21 ' A' ' 37' ' ' VAL . 11.2 mt -77.7 -70.3 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 107.234 -1.395 . . . . 0.74 107.234 172.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -47.17 -55.92 7.6 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.746 1.218 . . . . 3.29 112.165 -166.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.8 t -58.15 -49.22 77.76 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.097 -0.705 . . . . 1.3 109.097 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.8 t -62.62 -50.16 72.33 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 122.029 -0.42 . . . . 1.07 110.11 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.02 -36.79 80.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.575 -1.328 . . . . 2.52 111.547 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.1 p -57.67 -17.21 13.59 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.55 0.945 . . . . 1.87 113.55 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -62.25 -33.89 75.47 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.267 0.939 . . . . 3.76 111.641 171.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -73.34 76.09 1.37 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.127 0.571 . . . . 2.03 110.868 -173.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 mtm105 -42.39 99.87 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.062 1.345 . . . . 5.64 110.668 169.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.39 -44.66 0.86 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.413 -1.875 . . . . 1.34 108.413 -168.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.93 144.83 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 106.303 -1.74 . . . . 1.68 106.303 142.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -105.02 -57.88 1.97 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.969 1.308 . . . . 3.31 107.526 163.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -136.77 144.8 43.95 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.81 0.844 . . . . 1.87 110.886 -172.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.8 m -114.82 158.12 22.34 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 124.488 1.115 . . . . 1.97 108.013 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.0 t -150.97 76.23 1.23 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.697 -0.853 . . . . 2.41 108.697 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.465 HG21 ' HB ' ' A' ' 22' ' ' ILE . 22.1 t -81.35 136.19 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 125.292 1.437 . . . . 2.4 109.742 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.14 130.23 22.03 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.747 0.819 . . . . 0.82 111.357 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.53 -51.39 36.06 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 124.197 0.999 . . . . 1.56 111.308 -171.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.65 -44.86 90.23 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.537 0.684 . . . . 1.19 110.344 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -13.53 62.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.577 0.751 . . . . 1.99 110.922 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 52.95 33.45 14.65 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.762 1.225 . . . . 2.68 109.561 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -128.83 150.71 50.21 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.673 -0.491 . . . . 1.56 109.673 -164.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.84 123.24 36.86 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.372 -0.973 . . . . 0.9 108.372 153.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 129.65 34.65 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 104.459 -2.423 . . . . 1.34 104.459 159.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.8 mt -114.15 133.97 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 107.425 -1.324 . . . . 2.05 107.425 168.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -118.64 99.13 6.6 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.677 2.791 . . . . 4.26 105.297 -170.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -151.71 157.23 41.77 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 126.633 1.973 . . . . 2.1 109.425 -157.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -82.29 123.09 79.54 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 119.365 0.984 . . . . 3.85 108.553 171.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.08 -2.96 12.42 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.625 2.216 . . . . 1.44 113.61 -173.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -100.23 -51.01 3.77 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.174 0.897 . . . . 3.11 109.196 -176.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 pt -69.19 -54.52 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.777 0.323 . . . . 1.18 111.701 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.5 tt -91.06 -49.81 13.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 124.199 1.0 . . . . 1.1 109.739 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.65 154.58 5.75 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 111.667 -0.573 . . . . 0.76 111.667 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.76 -25.35 28.68 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.655 2.237 . . . . 0.76 112.862 -172.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -55.19 -48.91 73.15 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.395 0.543 . . . . 5.96 111.121 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -54.48 -58.53 7.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 122.475 1.131 . . . . 2.78 109.709 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.2 mt -48.82 -56.57 2.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 125.855 1.662 . . . . 0.91 111.711 175.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.7 -50.86 64.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.863 -0.421 . . . . 1.35 109.863 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.08 -39.83 83.38 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.145 0.578 . . . . 5.43 110.921 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.5 m -58.52 -56.82 17.21 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.542 -0.724 . . . . 1.02 109.57 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.9 mt -63.64 -41.12 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 119.031 0.832 . . . . 2.29 111.413 -172.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -45.73 -58.35 3.54 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.256 1.023 . . . . 3.51 108.858 168.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t -61.54 -30.19 70.48 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.87 0.692 . . . . 1.29 112.87 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.92 -34.67 69.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.369 0.986 . . . . 1.89 110.717 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.37 51.34 0.29 Allowed Glycine 0 C--N 1.334 0.445 0 O-C-N 123.863 0.727 . . . . 0.82 112.068 160.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -140.67 170.66 15.36 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 106.345 -1.724 . . . . 2.03 106.345 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.67 86.19 0.42 Allowed Pre-proline 0 N--CA 1.466 0.367 0 CA-C-O 117.167 -1.397 . . . . 4.48 114.248 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.69 76.4 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.504 2.803 . . . . 1.57 112.244 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 p -90.62 128.43 36.61 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.288 1.435 . . . . 2.13 108.669 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 121.4 15.86 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.87 -1.159 . . . . 3.61 107.87 169.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.1 t -142.74 -60.21 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 124.293 1.037 . . . . 4.16 108.61 -174.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt 64.54 -72.17 0.07 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.731 1.213 . . . . 7.56 111.534 -173.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.5 mm -82.27 115.08 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.016 -1.105 . . . . 6.06 108.016 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 C--O 1.25 1.098 0 N-CA-C 103.327 -2.842 . . . . 12.65 103.327 174.534 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 mtt . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 108.802 -0.814 . . . . 9.74 108.802 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.71 -105.02 0.96 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 107.96 -2.056 . . . . 5.23 107.96 -174.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -164.01 158.54 19.66 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.168 1.387 . . . . 4.67 107.426 164.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.93 144.7 18.3 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 107.601 -2.2 . . . . 1.85 107.601 167.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.6 t -127.65 117.76 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.118 -1.438 . . . . 2.44 107.118 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.1 tt -138.03 97.29 3.37 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.06 -1.83 . . . . 2.78 106.06 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -83.2 135.5 34.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.487 -0.324 . . . . 2.41 110.354 -174.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.46 139.04 54.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.532 -0.914 . . . . 2.11 108.532 175.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.16 116.4 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 106.461 -1.681 . . . . 1.09 106.461 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 m -104.38 83.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 106.395 -1.705 . . . . 1.69 106.395 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -65.3 136.52 56.67 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.999 -0.741 . . . . 5.52 108.999 -169.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.76 -2.09 10.09 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.463 -0.632 . . . . 1.2 113.701 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.561 ' SD ' HD12 ' A' ' 22' ' ' ILE . 73.9 mtm -68.64 79.25 0.28 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.981 1.391 . . . . 2.21 111.038 174.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 t -50.39 -52.9 33.42 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.532 1.133 . . . . 3.24 112.661 -172.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -170.04 -103.16 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.346 0.658 . . . . 5.95 109.557 176.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.67 168.98 18.75 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.595 0.634 . . . . 2.79 110.625 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.0 m 69.53 -62.63 0.41 Allowed 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 126.067 1.747 . . . . 1.51 110.004 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.9 m -37.36 -51.42 1.09 Allowed 'General case' 0 N--CA 1.458 -0.044 0 C-N-CA 127.068 2.147 . . . . 0.99 111.492 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.9 t -45.56 -70.77 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.232 1.013 . . . . 0.76 110.156 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -23.76 67.29 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.873 -0.517 . . . . 1.03 111.171 -175.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -59.03 -52.19 66.82 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.718 -1.216 . . . . 3.12 107.718 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.561 HD12 ' SD ' ' A' ' 13' ' ' MET . 30.3 mt -75.34 -56.42 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 108.583 -0.895 . . . . 0.94 108.583 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -38.0 -65.87 0.3 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.186 1.394 . . . . 3.49 112.02 170.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.2 t -62.72 -38.58 91.02 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.928 0.491 . . . . 1.46 110.373 -174.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.6 t -65.62 -24.94 67.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 118.973 -0.537 . . . . 0.87 111.702 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.8 mt -86.75 -44.87 11.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.05 0.94 . . . . 2.39 112.277 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.4 p -72.01 61.63 0.43 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.179 0.992 . . . . 1.53 111.183 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.34 -26.67 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.714 1.606 . . . . 3.68 113.132 -165.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -67.99 -128.72 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 119.621 1.1 . . . . 2.6 110.169 172.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -144.97 163.17 34.99 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 129.503 3.121 . . . . 5.61 104.757 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.41 -61.39 2.75 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.192 -0.763 . . . . 1.58 111.192 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.537 ' C ' HD13 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -51.52 111.59 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 117.842 0.821 . . . . 2.27 109.102 172.634 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 pp -107.71 -23.54 12.06 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.602 1.561 . . . . 2.41 110.962 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -145.32 158.97 43.71 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.842 -0.799 . . . . 2.4 108.842 167.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.7 t -153.48 145.97 24.08 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.003 -1.11 . . . . 1.85 108.003 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 p -150.51 132.52 15.22 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.387 -0.968 . . . . 2.15 108.387 169.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.38 125.13 67.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.247 0.619 . . . . 1.97 111.395 170.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.97 128.04 44.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.279 0.632 . . . . 1.28 110.397 172.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -72.95 -52.55 14.13 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.91 -1.041 . . . . 2.01 111.436 -165.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.44 87.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 121.614 0.721 . . . . 2.29 109.72 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -77.17 -6.36 52.66 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.71 -0.677 . . . . 3.01 110.573 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 56.55 31.53 19.22 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 125.235 1.414 . . . . 3.03 110.146 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -108.66 125.64 52.1 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 121.841 -0.537 . . . . 2.25 109.919 -164.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.5 121.98 37.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.454 1.102 . . . . 0.88 108.558 167.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.72 114.21 28.23 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 103.615 -2.735 . . . . 1.42 103.615 168.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.8 mp -111.37 132.5 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 106.392 -1.707 . . . . 0.97 106.392 173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -101.23 98.76 9.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.44 -1.689 . . . . 3.19 106.44 169.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -140.53 155.27 46.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.816 0.846 . . . . 2.31 112.006 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.73 111.01 19.62 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 108.429 -0.952 . . . . 3.09 108.429 166.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.97 -21.8 36.66 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.944 2.429 . . . . 1.31 112.72 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -46.61 -54.62 9.11 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.132 1.373 . . . . 3.49 109.773 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pt -90.36 -71.13 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 124.92 1.288 . . . . 1.73 112.38 -166.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.401 HG23 ' H ' ' A' ' 54' ' ' GLY . 14.2 tt -67.01 -62.93 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.912 -0.773 . . . . 2.02 108.912 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.401 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 81.47 159.44 23.5 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 115.701 -0.681 . . . . 1.04 112.205 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -54.83 -40.16 86.44 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 124.08 3.187 . . . . 1.1 111.337 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -35.51 -65.04 0.26 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.582 1.953 . . . . 9.77 113.516 175.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -60.47 -54.01 50.61 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.024 0.93 . . . . 3.03 108.546 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 88.7 mt -49.33 -57.62 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.282 0.633 . . . . 1.23 109.542 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.5 mt -54.81 -52.87 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.76 -0.587 . . . . 1.51 110.835 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -58.72 -45.01 90.54 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.095 0.95 . . . . 2.86 110.55 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 54.2 m -69.31 -50.59 45.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.956 -0.757 . . . . 1.03 108.956 -174.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.61 -33.7 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 118.798 -0.62 . . . . 1.98 110.919 -177.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -53.01 -58.12 8.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.886 -0.783 . . . . 4.09 108.886 165.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.4 t -58.84 -27.5 65.18 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.247 0.832 . . . . 1.33 113.247 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 25.0 mt -69.35 -10.1 56.41 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.511 1.05 . . . . 1.76 112.808 174.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.45 50.43 2.19 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 124.466 1.031 . . . . 0.9 111.256 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.495 ' CD2' HD11 ' A' ' 22' ' ' ILE . 69.3 m-85 -142.07 171.71 13.68 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 124.739 1.216 . . . . 2.12 107.877 172.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -110.74 84.55 4.23 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.68 -0.676 . . . . 4.48 110.992 -175.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.3 128.08 15.91 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.047 2.498 . . . . 1.9 112.52 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.2 p -138.54 129.63 26.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.627 1.571 . . . . 1.99 107.736 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -64.97 141.81 58.65 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.245 -0.65 . . . . 3.36 109.245 177.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.4 t -140.65 -47.33 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 C-N-CA 122.385 0.274 . . . . 3.47 111.191 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp 59.13 -131.71 1.06 Allowed 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.062 -1.458 . . . . 6.16 107.062 -163.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.8 mp -131.57 -71.23 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 121.432 1.924 . . . . 8.31 107.206 171.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 . . . . . 0 C--O 1.25 1.13 0 N-CA-C 102.044 -3.317 . . . . 10.2 102.044 138.583 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.7 ttm . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 108.963 -0.754 . . . . 11.35 108.963 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.85 -152.43 5.84 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 107.135 -2.386 . . . . 3.57 107.135 168.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -161.49 169.09 22.48 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.082 -2.192 . . . . 4.47 105.082 169.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.34 80.42 0.15 Allowed Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 106.328 -2.709 . . . . 2.77 106.328 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.1 t -67.14 73.44 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.966 1.306 . . . . 2.04 108.956 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.82 111.97 21.96 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.73 -1.211 . . . . 2.08 107.73 -170.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -85.21 123.48 30.76 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 123.622 0.576 . . . . 2.42 109.612 169.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.21 124.91 44.07 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.584 -2.006 . . . . 1.76 105.584 167.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -82.93 111.32 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 105.698 -1.964 . . . . 1.42 105.698 171.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.472 HG23 ' SD ' ' A' ' 13' ' ' MET . 2.5 m -96.9 77.38 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 125.062 1.345 . . . . 1.53 109.079 -163.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -67.14 107.21 2.24 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.284 1.034 . . . . 6.78 108.892 -166.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.1 -40.76 0.27 Allowed Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.151 -0.805 . . . . 1.59 113.543 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.472 ' SD ' HG23 ' A' ' 10' ' ' VAL . 2.2 mpp? -62.77 162.88 10.17 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 119.182 1.491 . . . . 2.19 111.169 -178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.9 t -163.98 -56.86 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.245 -1.02 . . . . 3.07 108.245 -175.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.5 m -81.82 172.74 12.99 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.389 0.676 . . . . 3.99 109.818 176.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.88 -172.27 0.17 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.059 -0.519 . . . . 3.14 109.76 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.8 m 71.55 -61.89 0.47 Allowed 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 124.68 1.192 . . . . 1.73 110.286 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.2 m -34.62 -51.74 0.49 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.903 1.681 . . . . 0.85 112.081 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.0 t -48.42 -59.66 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.817 0.847 . . . . 0.88 111.197 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -32.03 73.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.718 -0.613 . . . . 1.49 109.41 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -60.46 -45.75 92.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.553 -0.906 . . . . 3.71 108.553 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.63 ' HB ' HG11 ' A' ' 37' ' ' VAL . 96.6 mt -65.95 -62.16 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.817 -1.549 . . . . 0.55 106.817 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -47.59 -62.09 1.61 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.375 1.083 . . . . 3.96 110.812 -175.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.6 m -63.8 -44.43 93.34 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.835 -1.075 . . . . 2.36 109.34 -168.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.7 t -59.31 -51.63 69.12 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.234 -0.654 . . . . 1.06 109.234 175.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.99 -36.61 77.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.043 -1.036 . . . . 2.4 112.277 -175.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 78.1 p -55.51 -19.56 10.14 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.509 1.05 . . . . 1.98 113.755 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -61.16 -30.94 70.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.573 1.079 . . . . 3.7 111.491 175.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -77.9 63.33 2.9 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 124.495 1.118 . . . . 2.04 110.932 -164.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -28.45 -25.85 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 120.261 3.43 . . . . 6.95 120.261 -164.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.09 -16.3 68.51 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-N 120.64 1.563 . . . . 1.22 111.823 169.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.04 125.87 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 127.435 2.294 . . . . 1.84 108.467 171.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.4 mt -91.45 -48.06 7.09 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.699 1.199 . . . . 2.87 109.274 174.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -154.04 138.45 16.74 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 118.495 -0.764 . . . . 2.1 110.137 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.95 164.56 15.9 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 119.444 1.02 . . . . 2.23 108.664 167.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.0 m -157.44 112.86 2.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.432 -1.321 . . . . 1.77 107.432 162.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.63 HG11 ' HB ' ' A' ' 22' ' ' ILE . 7.9 p -102.61 154.09 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 O-C-N 123.518 0.511 . . . . 1.96 110.697 166.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.81 137.3 19.93 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 124.008 0.923 . . . . 1.08 110.629 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -74.72 -41.92 59.29 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 122.943 0.497 . . . . 1.42 111.762 -172.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.54 -34.7 74.51 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 122.744 0.418 . . . . 1.39 110.99 -173.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 t -100.86 -7.28 23.7 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.063 0.945 . . . . 2.44 110.791 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 53.19 22.9 2.83 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.282 1.833 . . . . 3.31 112.475 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -94.04 133.97 36.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.09 -1.448 . . . . 1.59 107.09 -172.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.17 112.99 23.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.777 -1.564 . . . . 0.61 106.777 160.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.29 138.46 36.35 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.322 -1.362 . . . . 0.99 107.322 165.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.62 131.14 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 109.132 -0.692 . . . . 0.92 109.132 170.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -103.81 88.51 3.07 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 127.365 2.266 . . . . 3.27 108.061 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -115.79 162.25 17.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.486 1.514 . . . . 2.33 110.282 171.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.04 106.89 4.49 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.187 0.595 . . . . 3.18 109.575 171.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -64.97 -22.53 62.57 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.046 1.831 . . . . 1.47 111.981 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -41.1 -44.49 2.49 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.376 1.87 . . . . 5.6 111.6 170.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.6 pt -113.94 -62.85 2.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 113.34 0.867 . . . . 1.15 113.34 -165.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 tt -88.73 -48.03 14.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.482 0.658 . . . . 1.72 110.4 -165.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.3 159.94 35.04 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 115.474 -0.785 . . . . 0.74 112.676 169.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.02 -42.14 25.18 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.477 3.452 . . . . 0.79 112.263 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -53.0 -51.23 62.3 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.41 0.684 . . . . 5.63 111.48 -172.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -47.97 -57.22 6.03 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.722 0.773 . . . . 2.79 110.435 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.4 mt -61.67 -48.62 87.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 124.821 1.248 . . . . 0.99 111.043 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.2 mt -52.85 -58.56 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.541 -0.541 . . . . 1.36 109.541 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -61.55 -31.74 71.78 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.077 0.551 . . . . 2.71 111.966 -176.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.2 m -58.99 -53.14 61.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.457 -0.777 . . . . 0.81 109.518 173.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.6 mt -73.38 -36.02 47.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 O-C-N 121.617 -0.677 . . . . 1.93 110.647 -173.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -48.39 -50.4 30.91 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.337 1.055 . . . . 3.31 108.924 166.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.4 t -66.27 -42.55 88.28 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.336 0.654 . . . . 1.03 112.001 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -59.37 -40.5 86.68 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.606 0.639 . . . . 1.79 109.897 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.46 46.96 0.47 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.346 -0.702 . . . . 0.86 111.346 164.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -140.91 141.31 34.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.805 -1.924 . . . . 2.53 105.805 168.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -94.27 106.23 21.97 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 118.186 -0.911 . . . . 5.59 112.25 -158.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.75 80.68 1.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.277 2.651 . . . . 1.45 110.838 -174.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.1 m -67.15 111.42 3.9 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.859 -1.163 . . . . 2.08 107.859 168.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 mt -60.42 139.52 57.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.921 -1.14 . . . . 3.47 107.921 166.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 50.5 t -114.5 -94.13 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 O-C-N 123.974 0.796 . . . . 3.19 109.069 -175.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt 71.0 -54.43 0.66 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.163 0.985 . . . . 7.41 109.695 -164.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -133.37 164.29 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.345 1.458 . . . . 6.38 107.413 159.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 C--O 1.249 1.075 0 N-CA-C 104.34 -2.467 . . . . 10.81 104.34 163.497 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 109.266 -0.642 . . . . 10.58 109.266 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.28 -163.9 54.87 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.209 -0.756 . . . . 3.45 111.209 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -25.02 88.0 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 129.239 3.015 . . . . 4.63 114.885 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.9 126.74 8.32 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 108.601 -1.799 . . . . 1.98 108.601 172.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.4 t -91.87 78.22 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 106.396 -1.705 . . . . 2.55 106.396 168.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.1 tt -84.33 115.21 22.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.672 -0.862 . . . . 2.42 108.672 -172.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -90.18 133.37 34.94 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.292 0.496 . . . . 2.69 111.227 172.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 pp -129.07 130.57 46.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.109 -1.441 . . . . 1.81 107.109 166.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.15 134.48 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.426 -2.065 . . . . 1.4 105.426 170.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.24 82.04 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.668 -1.604 . . . . 1.78 106.668 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -72.37 146.36 47.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.002 -1.481 . . . . 6.35 107.002 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.14 -36.44 4.4 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.87 -0.892 . . . . 1.1 110.87 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.6 ttp -57.72 133.34 55.27 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.286 -1.005 . . . . 2.33 108.286 167.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -153.48 -57.62 0.12 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.536 1.134 . . . . 2.87 110.264 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.2 t -67.46 140.13 57.08 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.314 -0.866 . . . . 3.56 110.342 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.69 -50.3 2.3 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.215 1.006 . . . . 1.84 112.155 175.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -43.72 -43.45 5.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.448 1.099 . . . . 1.6 111.768 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.2 m -46.48 -41.6 14.25 Favored 'General case' 0 C--N 1.338 0.104 0 C-N-CA 124.566 1.147 . . . . 0.75 111.116 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.5 t -54.16 -62.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.157 -0.683 . . . . 0.9 109.157 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -30.31 68.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.507 -0.746 . . . . 1.46 110.061 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.61 -51.41 67.23 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 107.435 -1.32 . . . . 3.06 107.435 177.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -68.84 -54.18 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.712 1.205 . . . . 0.73 108.584 -176.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -50.79 -61.11 2.41 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 108.724 -0.843 . . . . 4.58 108.724 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -60.17 -47.96 83.76 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.808 0.813 . . . . 1.46 109.715 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.4 t -66.96 -22.51 65.92 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 118.415 -0.802 . . . . 1.46 112.087 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.8 mt -82.3 -63.32 1.4 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 118.274 -0.87 . . . . 2.35 111.107 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.2 p -54.11 -28.37 39.15 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.286 0.948 . . . . 2.63 113.109 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -30.72 65.57 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.369 0.878 . . . . 3.98 113.369 173.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -70.9 72.49 0.56 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.694 -0.854 . . . . 2.21 108.694 164.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -13.23 -50.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 129.193 2.997 . . . . 5.82 116.713 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -43.22 -50.62 6.42 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.975 -0.903 . . . . 1.37 113.251 174.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.635 HD13 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -71.53 100.94 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.327 -1.36 . . . . 2.8 107.327 170.609 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.99 -34.65 32.86 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.699 0.4 . . . . 2.56 111.526 -176.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -148.17 120.35 8.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.628 1.171 . . . . 2.15 109.072 -175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 t -99.47 168.43 9.98 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.239 0.927 . . . . 2.53 108.807 170.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.3 m -145.97 66.2 1.21 Allowed 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 120.892 -1.13 . . . . 1.61 108.846 160.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.7 p -58.06 138.47 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.312 -0.858 . . . . 2.21 111.624 161.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.71 137.69 16.33 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.697 1.199 . . . . 1.37 110.31 175.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.12 -34.33 61.67 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.479 0.712 . . . . 1.8 111.365 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.58 -31.35 71.4 Favored 'General case' 0 C--O 1.226 -0.155 0 O-C-N 121.838 -0.539 . . . . 2.3 110.77 -173.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -111.69 5.73 19.41 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.512 1.125 . . . . 2.63 110.998 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.23 44.29 6.44 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 127.889 2.475 . . . . 3.51 112.068 176.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -142.06 169.6 17.29 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 122.23 -0.294 . . . . 2.18 110.808 -175.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.4 132.45 39.4 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 124.416 1.073 . . . . 1.38 108.988 160.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.43 135.46 34.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.538 -1.282 . . . . 1.22 107.538 158.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.635 HG23 HD13 ' A' ' 32' ' ' ILE . 1.7 mp -112.68 120.6 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 105.516 -2.031 . . . . 1.43 105.516 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -90.83 99.9 12.85 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.513 -0.921 . . . . 3.28 108.513 166.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.8 159.26 42.49 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.202 0.601 . . . . 1.88 112.284 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -81.98 120.14 76.76 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 106.08 -1.822 . . . . 3.51 106.08 162.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -63.56 -40.43 30.49 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.525 1.484 . . . . 1.29 111.381 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -85.63 30.96 0.61 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.693 1.197 . . . . 3.72 112.067 -160.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.3 pt -134.98 -50.23 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.762 1.225 . . . . 1.21 109.96 172.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 tt -96.79 -41.68 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.921 1.288 . . . . 1.17 111.494 -174.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.68 148.26 5.56 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 111.33 -0.708 . . . . 0.83 111.33 -175.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.11 -36.46 58.4 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.208 2.606 . . . . 0.73 111.554 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -50.65 -50.38 54.64 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.829 0.852 . . . . 6.2 112.256 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -52.28 -56.06 17.25 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 121.765 0.793 . . . . 2.62 109.537 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.0 mt -57.41 -53.54 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.463 1.105 . . . . 1.01 111.56 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.7 mt -57.53 -54.29 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 122.02 -0.425 . . . . 1.4 109.98 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -64.93 -33.04 75.07 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.535 -0.728 . . . . 3.13 111.769 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.3 m -56.81 -52.04 66.59 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 121.565 -0.71 . . . . 0.68 109.091 171.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.7 mt -64.32 -42.08 94.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 119.608 1.094 . . . . 2.37 111.079 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -49.56 -51.73 34.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.159 0.984 . . . . 3.4 109.039 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -64.51 -43.86 92.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.609 0.764 . . . . 1.0 111.387 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.19 -34.6 72.33 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.891 1.676 . . . . 2.43 111.262 -175.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.36 39.46 0.23 Allowed Glycine 0 C--N 1.333 0.416 0 O-C-N 124.685 1.241 . . . . 0.75 111.857 152.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -142.74 174.62 10.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.78 -0.822 . . . . 1.85 108.78 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -108.93 92.07 10.1 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.955 1.302 . . . . 3.96 109.848 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.99 65.85 7.74 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.685 2.924 . . . . 1.78 111.124 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.7 m -74.98 119.9 19.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.575 0.702 . . . . 2.14 110.256 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -70.23 130.24 41.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.177 -0.675 . . . . 4.32 109.177 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.77 -42.21 40.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.115 0 C-N-CA 122.931 0.492 . . . . 3.66 109.901 176.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -56.14 -66.65 0.39 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.726 0.81 . . . . 6.29 110.464 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.1 mt 65.69 -71.76 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.581 1.153 . . . . 9.61 111.502 -172.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 C--O 1.253 1.273 0 N-CA-C 106.745 -1.576 . . . . 13.99 106.745 179.416 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 105.652 -1.981 . . . . 7.97 105.652 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.26 35.91 92.7 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 109.554 -1.418 . . . . 4.57 109.554 -161.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -173.74 164.47 4.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.118 2.167 . . . . 5.5 106.798 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.87 171.42 33.8 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 109.532 -1.427 . . . . 2.53 109.532 171.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 m -138.95 154.72 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 106.835 -1.543 . . . . 2.46 106.835 161.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 tt -150.47 147.29 27.34 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.772 -1.196 . . . . 2.19 107.772 170.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -103.3 150.45 23.74 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.981 1.312 . . . . 2.74 109.431 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.95 138.15 25.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.601 -0.888 . . . . 2.49 108.601 164.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -77.79 143.29 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.256 -1.387 . . . . 0.97 107.256 170.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.28 103.74 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.529 1.532 . . . . 1.41 107.618 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -73.89 166.49 23.25 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.251 -1.018 . . . . 5.52 108.251 165.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.6 -11.34 59.51 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.663 0.649 . . . . 0.9 112.612 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.7 mtm -73.83 65.5 1.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.523 1.161 . . . . 1.69 110.423 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 t -91.18 12.72 19.18 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.352 1.061 . . . . 3.11 112.849 -166.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.4 t -165.52 173.86 10.53 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.428 -0.953 . . . . 3.03 108.428 -173.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.21 -176.01 0.06 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.398 0.545 . . . . 3.17 110.435 164.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.0 p 68.77 -54.37 0.55 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.804 2.042 . . . . 2.55 111.388 -171.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.4 m -24.98 -54.11 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.492 2.717 . . . . 1.24 113.105 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.1 t -43.18 -70.85 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.444 1.098 . . . . 0.92 110.614 172.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -26.74 64.86 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.315 -0.866 . . . . 1.17 111.069 -176.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -51.51 -41.62 61.12 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.158 0.983 . . . . 3.47 109.195 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.485 ' HB ' HG11 ' A' ' 37' ' ' VAL . 83.5 mt -80.9 -65.0 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.454 -1.313 . . . . 0.75 107.454 175.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -47.85 -56.0 8.48 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.026 1.33 . . . . 3.37 111.645 -169.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 t -62.39 -50.6 70.91 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.676 0.75 . . . . 1.39 109.22 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 t -60.79 -24.43 65.79 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 118.686 -0.673 . . . . 0.71 111.923 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.96 -46.57 14.92 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 117.947 -1.025 . . . . 2.06 111.494 172.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.9 p -51.58 -32.02 26.98 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.612 1.096 . . . . 1.93 112.336 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -47.44 -45.26 25.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.014 1.325 . . . . 5.09 113.475 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.424 ' HB3' HD12 ' A' ' 53' ' ' ILE . 17.6 m-70 -67.69 136.26 54.04 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 119.412 1.005 . . . . 2.09 108.402 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -63.66 -53.06 57.25 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.75 -0.593 . . . . 7.77 112.513 -168.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.05 47.07 3.28 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 117.881 0.309 . . . . 1.32 113.261 -169.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -123.83 112.85 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.49 -1.3 . . . . 1.82 107.49 177.358 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 tp -73.53 -48.73 30.88 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.882 0.873 . . . . 3.31 109.025 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -156.94 120.25 4.14 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.843 -0.536 . . . . 2.61 110.825 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.37 157.86 15.83 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.542 -1.281 . . . . 2.58 107.542 168.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.9 t -163.35 113.35 1.34 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.859 -0.793 . . . . 1.31 108.859 168.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.485 HG11 ' HB ' ' A' ' 22' ' ' ILE . 7.5 p -114.93 145.48 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 112.544 0.572 . . . . 2.18 112.544 175.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.57 133.1 44.66 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.869 0.868 . . . . 0.77 110.3 174.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.61 -43.83 65.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.067 -0.97 . . . . 1.44 110.555 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.93 -50.81 71.44 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.316 0.579 . . . . 1.18 110.547 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -65.54 -14.09 60.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.745 0.818 . . . . 1.92 110.967 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 55.02 30.36 14.06 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.264 1.426 . . . . 2.78 109.15 -171.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -132.45 131.12 41.4 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.319 0.509 . . . . 1.6 111.365 -164.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.52 132.63 44.72 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.996 -1.112 . . . . 0.69 107.996 160.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.21 144.88 32.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.535 -1.283 . . . . 1.03 107.535 156.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 32' ' ' ILE . 55.5 mt -135.72 126.31 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 107.929 -1.137 . . . . 1.75 107.929 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -93.86 72.96 4.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.366 1.466 . . . . 2.18 108.418 172.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -101.58 170.74 7.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.702 0.801 . . . . 2.23 113.147 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -95.33 97.48 2.76 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.365 1.466 . . . . 3.97 108.861 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.86 -33.04 85.45 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.931 2.421 . . . . 1.06 113.636 -166.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.1 mp0 -63.74 -30.21 71.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.244 0.617 . . . . 4.01 112.05 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.0 pt -107.09 -56.14 5.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 112.864 0.691 . . . . 1.31 112.864 -168.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 29' ' ' HIS . 6.1 tt -87.07 -52.03 12.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.46 -0.941 . . . . 1.67 108.46 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.42 167.51 28.8 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 115.482 -0.781 . . . . 0.83 113.099 173.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.72 -38.53 70.6 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.273 3.316 . . . . 0.77 111.838 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -58.76 -60.15 4.29 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.973 0.509 . . . . 5.66 112.061 -172.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -49.85 -52.47 32.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 122.44 1.114 . . . . 2.75 110.173 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 95.0 mt -48.63 -69.72 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 114.08 -1.418 . . . . 0.73 109.894 171.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.8 mt -51.34 -40.92 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.714 0.688 . . . . 1.24 111.535 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 52.8 m170 -63.15 -47.47 82.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.547 0.689 . . . . 3.55 109.456 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.2 m -66.27 -44.73 82.76 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.606 -0.516 . . . . 0.7 109.606 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.4 mm -57.01 -47.59 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.994 0.918 . . . . 1.42 110.081 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -53.09 -58.85 5.6 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.181 -0.674 . . . . 3.62 109.181 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -55.38 -38.68 69.17 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.057 0.943 . . . . 1.1 112.279 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.8 mt -63.62 -14.49 52.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.611 0.764 . . . . 1.98 112.584 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.66 48.24 1.12 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.482 1.039 . . . . 0.67 110.964 168.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -141.74 171.2 14.39 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.399 1.08 . . . . 2.05 108.809 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -109.96 79.89 1.62 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 118.534 -0.746 . . . . 3.89 112.923 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.76 123.73 11.41 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.141 1.894 . . . . 1.25 111.511 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.9 t -148.68 152.69 37.11 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.726 0.81 . . . . 2.71 109.235 172.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.9 mt -86.41 40.36 0.88 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.346 -0.846 . . . . 3.28 111.601 -165.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.4 t -80.44 68.35 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.408 -0.96 . . . . 4.87 108.408 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -55.77 -37.91 69.17 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.718 0.807 . . . . 5.89 111.778 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 pp -136.31 162.05 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.301 -1.74 . . . . 6.42 106.301 170.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 C--O 1.249 1.073 0 N-CA-C 103.557 -2.757 . . . . 12.7 103.557 176.835 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 tpt . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 108.722 -0.844 . . . . 8.44 108.722 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.91 -46.91 58.05 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 108.268 -1.933 . . . . 4.08 108.268 162.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -67.11 165.8 15.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.82 0.848 . . . . 3.98 109.752 166.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.24 -163.32 15.67 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 106.912 -2.475 . . . . 1.93 106.912 170.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m -136.12 149.44 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.802 -1.184 . . . . 2.77 107.802 163.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.63 89.8 3.19 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.43 -2.433 . . . . 2.54 104.43 166.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -70.06 145.94 51.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.506 -0.553 . . . . 2.24 109.506 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 69' ' ' PRO . 0.3 OUTLIER -149.78 139.31 21.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.807 -0.812 . . . . 2.17 108.807 178.16 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.7 t -94.44 129.64 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.645 -1.243 . . . . 1.1 107.645 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.406 HG23 ' SD ' ' A' ' 13' ' ' MET . 1.6 m -132.26 74.7 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 C-N-CA 125.215 1.406 . . . . 1.86 109.953 -160.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -66.83 153.3 43.75 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.777 -0.823 . . . . 5.04 108.777 175.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.14 -29.56 7.61 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 109.632 -1.387 . . . . 0.98 109.632 -163.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.406 ' SD ' HG23 ' A' ' 10' ' ' VAL . 56.4 mtp -56.26 144.66 29.31 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.831 -0.805 . . . . 1.97 109.375 166.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 t -166.09 -58.92 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.005 0.522 . . . . 2.37 109.719 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.8 t -77.2 147.23 36.54 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.977 -0.749 . . . . 3.49 108.977 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.29 -43.34 10.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.409 0.684 . . . . 1.89 111.796 174.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.7 p -48.34 -41.27 28.01 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.374 0.67 . . . . 2.08 111.561 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 99.3 m -50.24 -29.04 8.65 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.774 0.83 . . . . 0.85 112.544 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t -55.85 -69.5 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.56 0.618 . . . . 0.76 109.421 169.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -27.98 67.59 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.895 -1.128 . . . . 1.75 111.436 -172.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.63 -33.64 16.01 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.924 1.29 . . . . 3.88 110.375 172.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 98.8 mt -91.07 -60.2 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.123 -1.436 . . . . 0.59 107.123 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -54.44 -64.17 0.92 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.618 1.167 . . . . 3.26 111.267 -170.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.6 m -59.55 -35.27 73.9 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.303 0.641 . . . . 2.35 111.504 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -62.62 -40.49 97.12 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.305 -0.247 . . . . 0.76 110.383 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.4 mt -72.02 -62.33 1.47 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 119.306 -0.378 . . . . 2.11 111.092 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.2 p -66.91 69.83 0.08 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.495 1.918 . . . . 2.33 111.03 -168.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.64 -40.84 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.071 2.148 . . . . 3.85 110.561 -172.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -74.26 150.73 40.1 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.119 0.872 . . . . 3.87 110.371 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -54.14 148.8 10.47 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.045 0.45 . . . . 6.62 110.215 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.22 -31.51 5.37 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.491 -0.616 . . . . 1.16 112.473 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -70.19 148.58 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 118.005 0.903 . . . . 1.96 108.679 171.85 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 36.0 mt -114.5 -51.29 2.76 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.821 1.249 . . . . 3.15 109.604 167.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -150.35 161.36 42.62 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.895 0.878 . . . . 2.32 109.881 -175.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.8 m -143.29 168.35 19.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.16 -1.052 . . . . 2.02 108.16 170.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.0 m -148.01 132.21 17.39 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.487 -1.301 . . . . 1.54 107.487 148.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.0 p -104.57 142.25 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 118.433 0.561 . . . . 2.15 110.048 164.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.62 132.26 48.14 Favored 'General case' 0 C--N 1.339 0.15 0 O-C-N 121.864 -0.522 . . . . 0.93 111.407 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.39 -58.96 6.28 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.236 1.014 . . . . 2.67 110.501 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.28 -39.41 69.81 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.59 0.756 . . . . 1.25 112.664 -169.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.6 m -95.63 -8.39 34.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.338 0.655 . . . . 2.3 110.499 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 54.65 23.16 4.5 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.562 1.945 . . . . 3.34 112.577 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -98.96 145.12 27.37 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 119.035 -0.507 . . . . 1.67 110.494 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.16 138.69 40.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.121 -1.437 . . . . 0.57 107.121 154.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -107.82 150.82 26.54 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 106.632 -1.618 . . . . 1.24 106.632 154.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 32' ' ' ILE . 4.6 mp -126.29 122.04 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.172 -1.788 . . . . 1.05 106.172 173.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -94.36 82.43 4.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.356 1.863 . . . . 3.68 106.591 169.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -118.76 164.32 15.56 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.967 2.107 . . . . 2.0 109.775 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -86.89 117.76 69.11 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 107.856 -1.164 . . . . 3.26 107.856 167.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.2 -29.73 38.78 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.162 1.908 . . . . 1.31 112.918 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -86.66 29.23 0.8 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.664 1.12 . . . . 3.55 111.285 -166.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.7 pt -144.47 -50.48 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 123.95 0.9 . . . . 1.28 112.236 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.619 HG23 ' H ' ' A' ' 54' ' ' GLY 0.254 17.6 tt -95.56 -85.26 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.572 -0.899 . . . . 1.31 108.572 174.771 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.619 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 131.28 166.52 11.71 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.811 0.719 . . . . 0.75 112.955 173.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.59 -47.43 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.356 3.37 . . . . 0.74 111.305 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.455 ' HE ' ' CG ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -46.43 -48.25 18.88 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.118 0.967 . . . . 8.61 111.392 176.627 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.455 ' CG ' ' HE ' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -53.48 -56.91 13.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.876 1.271 . . . . 4.62 108.884 179.49 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.7 mt -57.56 -56.07 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.845 0.858 . . . . 0.85 109.965 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.6 mt -50.56 -51.54 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.426 -0.583 . . . . 1.4 109.426 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -36.65 84.47 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.48 0.712 . . . . 4.42 111.056 -178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.9 m -64.58 -53.66 44.26 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.34 -0.85 . . . . 0.74 109.35 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.403 HG21 HG11 ' A' ' 10' ' ' VAL . 13.1 mm -68.78 -33.14 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 121.335 -0.853 . . . . 1.59 111.158 -173.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -49.63 -62.07 1.76 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.12 0.968 . . . . 3.33 109.162 162.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -54.88 -38.7 67.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.763 0.825 . . . . 1.03 112.865 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.24 -14.71 27.92 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.954 -1.091 . . . . 2.22 112.88 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.02 47.01 2.31 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.317 0.961 . . . . 0.59 111.051 175.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -136.02 172.05 13.58 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.194 0.997 . . . . 2.07 108.387 171.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -111.89 84.8 5.8 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 113.098 0.777 . . . . 4.27 113.098 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.411 ' HB2' HD12 ' A' ' 8' ' ' LEU . 34.2 Cg_endo -68.03 80.42 0.52 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.633 2.889 . . . . 1.05 114.013 -175.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.9 p -77.13 119.68 21.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.553 -0.749 . . . . 2.54 109.654 169.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tt -65.24 103.25 0.75 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.687 -0.857 . . . . 2.86 108.687 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.1 p -77.59 -44.56 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 122.192 -0.318 . . . . 3.65 111.558 -168.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HZ2' ' C ' ' A' ' 75' ' ' GLU . 54.3 tttm 68.99 -55.2 0.55 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.02 1.728 . . . . 6.5 112.374 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.287 0.4 OUTLIER 47.92 44.34 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 126.815 2.046 . . . . 7.21 111.77 179.333 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.423 ' C ' ' HZ2' ' A' ' 73' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.256 1.431 0 N-CA-C 102.515 -3.143 . . . . 11.02 102.515 -172.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mmt . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 107.877 -1.157 . . . . 9.3 107.877 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.42 161.43 2.79 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 109.584 -1.406 . . . . 3.93 109.584 -136.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.5 t0 58.48 158.96 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.958 2.503 . . . . 3.95 114.529 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.73 179.86 30.28 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.287 0.946 . . . . 2.12 113.15 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.04 166.5 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.691 -1.225 . . . . 2.08 107.691 168.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.32 111.68 4.96 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.818 -1.549 . . . . 2.14 106.818 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -92.29 141.38 28.62 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 123.28 0.632 . . . . 2.81 110.047 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.9 137.0 23.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.209 -0.663 . . . . 1.62 109.209 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.02 121.89 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 105.751 -1.944 . . . . 1.08 105.751 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -116.02 100.57 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.722 -1.214 . . . . 1.52 107.722 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -73.45 166.2 23.66 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.233 -1.025 . . . . 5.72 108.233 175.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.78 -10.76 57.5 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.511 -0.605 . . . . 1.02 112.618 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 75.8 mtm -68.05 73.02 0.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.555 1.177 . . . . 1.81 111.686 174.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -71.71 -30.12 65.31 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.533 1.133 . . . . 2.58 112.604 -171.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 82.5 m -143.46 158.92 43.26 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.225 -0.657 . . . . 3.53 109.225 -176.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.23 -45.15 8.34 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.97 1.308 . . . . 1.81 112.205 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 m -43.35 -42.46 4.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.431 1.092 . . . . 1.6 112.163 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.2 m -54.66 -40.05 68.65 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.683 -0.635 . . . . 0.72 111.608 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 t -58.34 -57.9 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.436 -0.95 . . . . 0.68 108.436 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -31.07 72.13 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.48 -0.563 . . . . 1.04 109.48 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -60.16 -51.31 70.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.946 -1.131 . . . . 3.78 107.946 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.7 mt -62.86 -54.83 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.855 -1.165 . . . . 0.73 107.855 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -51.99 -56.83 11.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 123.714 0.634 . . . . 3.09 109.53 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.7 t -59.8 -46.25 89.8 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.244 0.618 . . . . 1.52 110.079 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.3 t -65.13 -29.61 70.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.363 0.665 . . . . 0.75 111.422 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mt -79.87 -45.49 18.55 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.535 -0.745 . . . . 2.38 111.098 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.426 HG23 ' SG ' ' A' ' 35' ' ' CYS . 47.0 p -65.42 75.84 0.06 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.751 0.82 . . . . 1.98 110.747 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.94 -32.66 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 129.197 2.999 . . . . 3.45 110.301 -175.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -59.68 -23.45 63.11 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.914 0.779 . . . . 2.21 111.527 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 78.57 -42.26 0.32 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.424 1.49 . . . . 7.55 113.383 162.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.15 -20.5 58.29 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 111.735 -0.546 . . . . 1.21 111.735 168.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.72 130.86 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.584 0.753 . . . . 3.11 110.746 176.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.9 mt -74.66 -42.26 58.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.217 1.007 . . . . 2.87 108.748 169.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -161.58 165.28 28.66 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.952 -0.388 . . . . 2.86 109.952 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.426 ' SG ' HG23 ' A' ' 27' ' ' THR . 1.7 p -141.25 59.29 1.52 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 126.481 1.912 . . . . 3.11 110.894 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.32 95.72 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.827 -0.546 . . . . 1.31 111.682 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.32 149.11 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 126.265 1.826 . . . . 2.11 112.83 173.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.98 131.08 10.23 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.06 1.344 . . . . 1.02 112.086 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -65.89 -53.05 44.53 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 115.285 -0.87 . . . . 1.76 111.45 -170.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.0 -45.63 88.14 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.563 0.697 . . . . 1.67 109.435 -168.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.4 t -80.6 1.64 28.95 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.86 -0.59 . . . . 2.59 111.3 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 57.24 31.44 20.08 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.451 1.1 . . . . 2.64 109.828 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -107.1 138.79 42.61 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.453 -0.943 . . . . 1.75 108.453 -167.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.12 141.23 48.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.868 -1.901 . . . . 0.92 105.868 141.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -117.84 158.38 24.92 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 118.211 -1.395 . . . . 1.61 108.04 149.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 mp -119.46 128.93 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 106.32 -1.733 . . . . 0.94 106.32 168.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -95.34 132.32 40.49 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.396 -2.076 . . . . 2.51 105.396 163.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -165.07 167.77 17.97 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.044 0.838 . . . . 2.44 111.514 -168.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -87.71 119.09 70.49 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 107.015 -1.476 . . . . 3.49 107.015 156.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.15 -39.31 18.67 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.043 1.829 . . . . 1.34 111.065 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -89.14 39.17 0.92 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.206 1.002 . . . . 3.94 110.528 -160.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.7 pt -142.24 -49.9 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 126.052 1.741 . . . . 1.14 109.898 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 tt -95.68 -43.13 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.676 1.19 . . . . 1.3 111.373 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.36 150.64 4.93 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 123.911 0.767 . . . . 0.82 111.493 -174.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.66 -29.35 60.37 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.109 2.539 . . . . 0.87 111.775 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -55.92 -52.49 63.94 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.44 0.696 . . . . 5.95 111.458 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -50.28 -54.8 18.72 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 122.226 1.012 . . . . 2.52 109.869 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mt -54.26 -61.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.843 1.257 . . . . 0.72 110.144 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.5 mt -53.59 -47.43 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.42 0.555 . . . . 1.38 110.791 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -62.65 -42.89 99.86 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.298 0.639 . . . . 2.55 109.72 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.9 m -60.83 -54.0 50.46 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.209 -0.663 . . . . 0.61 109.209 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.2 mm -62.74 -37.58 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 119.215 -0.422 . . . . 1.67 111.037 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -52.99 -64.92 0.66 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.206 -0.664 . . . . 3.61 109.206 169.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.6 t -59.86 -24.79 64.51 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.438 0.695 . . . . 1.2 112.791 -176.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.1 tp -72.72 -5.15 35.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.078 1.351 . . . . 2.3 111.548 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.68 47.59 1.62 Allowed Glycine 0 C--N 1.337 0.628 0 C-N-CA 125.229 1.395 . . . . 0.76 110.825 168.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -144.16 172.34 13.04 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 123.949 0.9 . . . . 1.76 109.53 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -114.94 77.92 5.13 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.664 -0.684 . . . . 4.3 111.311 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.36 93.66 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.598 2.198 . . . . 1.06 112.41 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.3 t -97.04 139.65 32.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.895 0.855 . . . . 2.17 109.896 171.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.9 104.36 16.17 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.562 -1.273 . . . . 3.63 107.562 174.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -66.54 -43.5 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 111.802 0.297 . . . . 3.84 111.802 -174.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -170.37 153.84 4.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.129 -1.804 . . . . 6.93 106.129 -172.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.2 pt -101.35 -53.13 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 118.286 -0.864 . . . . 9.53 110.789 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.248 0.99 0 CA-C-N 119.287 0.949 . . . . 11.77 109.102 171.53 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.6 mtp . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 106.686 -1.598 . . . . 8.61 106.686 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.12 32.09 0.09 OUTLIER Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.793 1.663 . . . . 3.78 109.267 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -127.25 153.42 46.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 128.026 2.53 . . . . 5.23 108.455 -156.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.3 -170.43 33.84 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.561 -1.016 . . . . 2.08 110.561 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -130.76 156.45 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 123.584 0.754 . . . . 2.01 108.989 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.1 tp -133.65 141.74 47.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.507 -2.035 . . . . 2.8 105.507 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -129.83 139.47 51.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.278 -1.378 . . . . 2.48 107.278 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.404 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -143.84 148.5 35.59 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.073 -1.084 . . . . 3.12 108.073 176.169 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.39 133.25 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.893 -1.521 . . . . 0.99 106.893 175.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.09 87.97 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.75 0.82 . . . . 1.57 109.224 -168.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 77.0 mmt-85 -62.77 150.87 40.28 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.544 -0.909 . . . . 5.14 108.544 171.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.26 -4.5 48.26 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.862 -0.966 . . . . 0.98 113.954 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.8 mtp -75.1 49.61 0.45 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.871 1.835 . . . . 1.95 112.249 -176.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 t -82.79 37.22 0.52 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.695 -1.253 . . . . 3.02 113.407 -164.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.3 t -173.41 142.4 0.98 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.615 0.766 . . . . 3.1 108.959 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.38 -50.26 3.81 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.468 1.107 . . . . 2.01 112.456 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 m -46.36 -34.34 4.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.93 1.292 . . . . 1.54 112.866 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.0 m -48.23 -34.98 11.09 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 123.571 0.748 . . . . 1.02 111.029 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.439 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 93.9 t -49.07 -72.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 118.18 0.446 . . . . 0.88 110.115 173.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -27.9 68.47 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.693 -0.629 . . . . 1.29 111.178 -175.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -49.56 -42.84 45.3 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.213 0.605 . . . . 3.43 110.088 173.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.3 mt -83.06 -61.71 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.099 -1.075 . . . . 0.75 108.099 175.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -51.88 -61.31 2.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.39 1.476 . . . . 3.35 111.231 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 t -62.05 -45.49 93.33 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.855 0.862 . . . . 1.45 109.181 -173.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -59.95 -37.16 78.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.777 -0.647 . . . . 0.9 111.302 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mt -75.34 -37.41 60.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.235 -0.888 . . . . 2.34 112.521 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.5 p -64.35 77.6 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.749 0.704 . . . . 1.68 111.218 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HZ1' ' CD2' ' A' ' 29' ' ' HIS . 0.9 OUTLIER 168.32 -31.35 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.762 2.825 . . . . 3.3 111.152 -174.349 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.403 ' CD2' ' HZ1' ' A' ' 28' ' ' LYS . 24.7 m-70 -52.72 120.75 6.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.881 0.764 . . . . 1.96 110.108 177.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -70.97 80.26 0.65 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.836 0.855 . . . . 4.93 111.307 -166.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.86 -16.87 1.07 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.933 1.254 . . . . 1.2 110.743 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.496 HD11 ' SG ' ' A' ' 35' ' ' CYS . 0.3 OUTLIER -60.5 148.95 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 107.659 -1.238 . . . . 1.82 107.659 163.83 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 pp -122.11 -29.94 4.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.841 0.856 . . . . 2.66 112.346 167.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -159.64 154.7 24.94 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 119.547 1.067 . . . . 2.25 109.143 174.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.496 ' SG ' HD11 ' A' ' 32' ' ' ILE . 1.3 m -132.94 157.91 43.96 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.314 -0.995 . . . . 1.9 108.314 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.6 t -159.67 128.58 5.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.477 -0.934 . . . . 1.68 108.477 159.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 19' ' ' VAL . 1.1 m -121.12 159.93 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 123.203 0.601 . . . . 1.65 110.249 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.22 134.32 17.03 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.83 110.458 174.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.92 -33.92 68.67 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.152 -0.931 . . . . 1.38 110.462 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.98 80.44 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.547 0.739 . . . . 1.1 111.659 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.6 m -96.56 2.38 52.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.72 0.808 . . . . 2.14 109.974 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 46.67 44.71 14.01 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.453 2.301 . . . . 2.88 112.113 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -133.66 157.79 44.88 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 112.01 0.374 . . . . 1.73 112.01 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.66 135.94 53.37 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.422 -1.325 . . . . 0.69 107.422 162.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -107.59 149.77 27.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 123.832 0.707 . . . . 1.1 109.783 159.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.65 139.31 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 C-N-CA 127.481 2.312 . . . . 0.92 106.172 175.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' O ' HD13 ' A' ' 32' ' ' ILE . 76.4 mttt -113.45 135.14 54.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.62 -1.993 . . . . 2.3 105.62 161.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -170.97 175.08 4.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.228 1.011 . . . . 2.11 110.569 -164.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -98.09 96.26 3.38 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 125.457 1.503 . . . . 3.3 108.063 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -60.35 -29.75 89.51 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.128 1.885 . . . . 1.11 112.12 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -54.79 -43.93 73.28 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.872 0.869 . . . . 3.96 111.792 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.4 pt -94.77 -86.79 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.877 0.471 . . . . 1.8 112.027 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.7 tt -59.24 -45.83 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.971 0.908 . . . . 1.39 111.381 -171.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.95 161.8 31.26 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 115.329 -0.851 . . . . 0.66 112.342 172.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.27 -35.65 23.61 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.644 2.896 . . . . 0.66 111.865 -174.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -55.23 -49.35 72.22 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.918 0.487 . . . . 5.21 111.742 -174.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.28 -53.75 20.3 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.742 0.782 . . . . 2.78 109.75 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.55 -50.11 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.627 1.171 . . . . 1.04 110.555 -174.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.2 mt -55.18 -52.31 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 109.767 -0.457 . . . . 1.29 109.767 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -62.27 -36.35 81.81 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.376 -0.828 . . . . 2.36 112.22 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 66.6 m -57.21 -50.44 72.85 Favored 'General case' 0 C--O 1.225 -0.21 0 O-C-N 121.262 -0.899 . . . . 0.78 108.937 174.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.5 mt -65.73 -42.85 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.693 -0.63 . . . . 2.11 111.315 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -48.31 -46.1 35.81 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.424 1.09 . . . . 2.7 109.104 171.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.0 t -69.83 -44.07 70.68 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.741 0.817 . . . . 1.39 111.695 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.9 mt -59.38 -28.33 66.79 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.467 -0.77 . . . . 2.04 110.653 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.21 47.65 0.69 Allowed Glycine 0 C--O 1.228 -0.219 0 N-CA-C 110.117 -1.193 . . . . 0.8 110.117 157.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -134.62 171.55 14.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.529 -1.656 . . . . 1.87 106.529 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -108.93 82.01 1.69 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.06 -0.971 . . . . 4.22 111.313 -170.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.74 75.55 1.61 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.515 2.81 . . . . 1.12 112.823 -174.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m -73.51 116.92 14.66 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.959 -0.756 . . . . 2.35 108.959 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.2 tp -76.22 75.75 3.03 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.557 -1.275 . . . . 3.35 107.557 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.7 t -73.82 -62.95 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.778 -0.823 . . . . 4.62 108.778 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt 61.74 169.85 0.11 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.589 1.156 . . . . 7.7 111.944 -175.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.43 -70.98 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 105.446 -2.057 . . . . 7.31 105.446 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 C--O 1.259 1.559 0 N-CA-C 102.507 -3.145 . . . . 10.9 102.507 152.933 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 109.785 -0.45 . . . . 10.39 109.785 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.11 143.95 4.43 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 106.818 -2.513 . . . . 3.46 106.818 174.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -86.66 -124.8 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.102 -0.703 . . . . 3.62 109.102 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.89 157.56 7.27 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 107.523 -2.231 . . . . 1.87 107.523 -171.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.63 156.89 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 117.514 0.657 . . . . 2.19 109.535 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 7' ' ' GLU . 3.1 tt -152.05 136.0 16.44 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.681 -1.97 . . . . 2.72 105.681 173.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.4 ' N ' HD23 ' A' ' 6' ' ' LEU . 63.6 mt-10 -114.13 130.01 56.6 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.251 1.021 . . . . 2.56 108.452 175.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.9 131.76 56.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.11 -1.441 . . . . 1.61 107.11 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 t -73.87 103.99 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 105.233 -2.136 . . . . 1.23 105.233 167.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 p -99.57 124.47 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 109.42 -0.585 . . . . 2.61 109.42 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -82.5 104.85 13.09 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.369 -1.715 . . . . 5.45 106.369 164.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.29 -54.32 0.03 OUTLIER Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.76 -0.257 . . . . 2.47 112.93 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -76.68 73.4 3.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.863 -0.787 . . . . 2.15 110.396 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 t -56.51 -39.06 72.66 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.907 0.483 . . . . 2.8 110.222 171.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 65.2 m -143.31 -168.01 2.7 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.743 1.617 . . . . 3.81 107.202 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.39 -168.15 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.537 0.735 . . . . 2.72 111.115 170.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.8 m 69.57 -66.86 0.25 Allowed 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.74 1.216 . . . . 1.61 109.693 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.5 m -40.85 -48.89 3.16 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.887 1.275 . . . . 0.89 110.671 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.0 t -43.26 -67.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.931 1.292 . . . . 0.71 110.968 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -24.54 67.74 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.836 -0.62 . . . . 1.13 109.643 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -65.27 -51.31 61.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.431 -0.951 . . . . 3.71 108.431 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.4 mt -65.12 -53.76 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 107.667 -1.235 . . . . 0.67 107.667 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -45.28 -51.71 10.55 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.455 0.702 . . . . 3.55 112.569 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 53.2 m -63.43 -52.88 59.66 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.684 -0.635 . . . . 1.55 110.167 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.0 t -54.45 -37.32 65.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.388 1.075 . . . . 1.22 111.506 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.07 -44.89 15.98 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.404 1.082 . . . . 1.85 110.954 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.7 p -58.24 -37.67 75.37 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.72 1.146 . . . . 1.96 110.834 176.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -51.25 -29.75 15.47 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.24 1.416 . . . . 4.8 113.057 169.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -78.8 99.45 6.7 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.76 -1.213 . . . . 2.15 110.3 175.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.71 107.83 0.17 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.864 -1.162 . . . . 6.72 107.864 157.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.75 -36.07 1.87 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.672 -1.371 . . . . 1.25 109.672 -170.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -70.68 142.49 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.697 -1.223 . . . . 2.11 107.697 168.016 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.0 tp -98.58 -47.4 5.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.639 1.576 . . . . 3.22 108.721 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -154.98 128.69 8.62 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.249 0.62 . . . . 3.2 109.913 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.0 t -108.05 150.44 27.16 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 108.347 -0.983 . . . . 2.12 108.347 171.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.9 t -156.55 129.52 7.88 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.148 -1.426 . . . . 1.81 107.148 162.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.0 m -122.85 144.71 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.89 0.768 . . . . 1.64 110.759 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.26 132.25 35.53 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.727 0.811 . . . . 0.81 111.28 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 pp -68.62 -51.71 39.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.661 1.185 . . . . 1.51 110.994 -174.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.32 -51.32 65.06 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.404 0.621 . . . . 1.17 110.178 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.04 -14.71 61.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.672 1.189 . . . . 2.03 111.738 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 55.52 33.79 21.78 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.198 1.399 . . . . 2.84 108.367 -172.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -126.48 140.72 52.25 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 118.801 0.728 . . . . 1.38 111.264 -162.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.32 120.25 39.0 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.127 -1.064 . . . . 0.74 108.127 161.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -95.27 132.0 40.73 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 126.684 1.994 . . . . 3.01 106.466 173.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.543 HG22 ' CD1' ' A' ' 48' ' ' TYR . 97.5 mt -130.47 130.32 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.799 -1.186 . . . . 1.44 107.799 173.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.486 ' O ' HD13 ' A' ' 32' ' ' ILE . 41.6 mttp -104.66 131.99 51.44 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 105.967 -1.864 . . . . 2.95 105.967 159.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.543 ' CD1' HG22 ' A' ' 46' ' ' ILE . 18.3 p90 -162.78 160.8 25.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.601 1.16 . . . . 2.19 109.283 -169.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -82.2 104.5 3.36 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 107.432 -1.321 . . . . 3.65 107.432 172.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -61.78 -45.02 18.43 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.447 2.098 . . . . 1.45 111.923 -166.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -53.32 -40.9 65.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.308 1.443 . . . . 4.41 112.938 -174.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 pt -88.56 -47.51 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 113.838 1.051 . . . . 1.48 113.838 -168.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.2 tt -83.99 -56.71 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 118.142 0.428 . . . . 1.67 111.191 -178.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.41 135.01 8.3 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.002 0.811 . . . . 1.06 112.444 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.65 -45.18 14.66 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.703 2.935 . . . . 0.9 111.059 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -53.55 -52.4 59.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.51 -0.552 . . . . 7.08 109.51 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.94 -46.39 85.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.916 1.686 . . . . 5.32 109.928 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 mt -52.31 -58.86 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 122.696 0.399 . . . . 0.96 110.732 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 mt -50.49 -43.87 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 118.091 0.405 . . . . 1.55 111.184 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -63.4 -36.35 83.43 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.495 -0.753 . . . . 2.36 111.483 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.6 m -62.25 -50.33 72.16 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.282 -0.886 . . . . 0.91 109.273 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.9 mm -59.71 -45.01 94.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.881 -0.512 . . . . 1.32 111.321 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -52.11 -53.74 38.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.115 1.366 . . . . 2.71 109.528 172.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -56.56 -39.42 73.43 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.357 1.063 . . . . 1.5 112.124 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.76 -17.27 34.06 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.573 0.583 . . . . 2.38 112.573 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.45 29.26 11.29 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.344 0.973 . . . . 1.46 110.724 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -120.31 158.68 26.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.645 1.178 . . . . 1.91 108.684 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -105.65 104.11 46.87 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-O 118.029 -0.986 . . . . 4.69 110.271 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -84.54 83.74 1.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.934 3.089 . . . . 1.06 111.552 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 m -72.54 103.67 3.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.877 -0.786 . . . . 2.51 108.877 173.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -66.3 136.49 55.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.237 -1.023 . . . . 3.74 108.237 174.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.6 m -113.4 -56.6 4.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 C-N-CA 123.144 0.578 . . . . 3.65 110.797 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt 64.93 173.07 0.2 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.721 0.808 . . . . 7.9 109.054 -159.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.2 mp 53.33 62.4 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.74 0.816 . . . . 5.73 109.871 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 C--O 1.254 1.311 0 C-N-CA 125.146 1.379 . . . . 10.73 112.081 171.337 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 ttt . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 118.988 -0.529 . . . . 6.98 111.294 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.24 171.87 26.07 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 123.162 0.41 . . . . 3.8 113.581 169.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.7 t0 62.34 160.47 0.07 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.233 2.213 . . . . 3.66 111.681 -167.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.55 107.21 0.2 Allowed Glycine 0 CA--C 1.525 0.677 0 O-C-N 121.156 -0.965 . . . . 2.13 111.157 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -73.18 75.08 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 O-C-N 121.988 -0.713 . . . . 2.18 109.211 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -74.91 111.57 10.25 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.029 -1.1 . . . . 2.43 108.029 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -92.56 122.79 35.33 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.272 -1.381 . . . . 2.94 107.272 169.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -118.66 151.0 38.77 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 108.099 -1.074 . . . . 1.54 108.099 170.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 t -103.78 119.0 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.34 -0.985 . . . . 1.11 108.34 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.56 119.98 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 126.937 2.095 . . . . 1.39 109.406 174.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -82.38 161.63 22.45 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.674 -1.232 . . . . 5.78 107.674 154.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.91 -28.17 5.47 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.185 0.898 . . . . 0.89 112.569 172.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -65.53 113.62 4.3 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.438 1.119 . . . . 2.09 109.845 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 t -67.31 -54.8 17.52 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.567 -0.531 . . . . 2.9 109.567 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 t -177.34 -90.03 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.658 1.183 . . . . 5.46 109.914 170.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.02 160.23 32.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.651 0.38 . . . . 3.23 109.989 -176.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.5 m 68.02 -60.66 0.4 Allowed 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.424 1.49 . . . . 1.56 110.983 -173.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.6 m -39.64 -41.91 1.12 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 126.438 1.895 . . . . 0.79 113.04 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.7 t -51.16 -69.57 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.709 0.29 . . . . 0.59 110.337 173.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.19 -30.73 71.66 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.302 -0.874 . . . . 1.65 110.872 -175.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.28 -40.83 17.62 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.771 1.228 . . . . 3.59 109.49 174.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.9 mt -85.32 -60.44 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 107.352 -1.351 . . . . 0.54 107.352 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -51.36 -62.28 1.72 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.242 1.417 . . . . 3.47 111.52 -170.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -61.93 -43.11 99.53 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.809 0.844 . . . . 2.76 110.144 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.9 t -62.28 -35.2 78.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.079 -0.509 . . . . 0.9 110.858 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.9 mt -70.43 -46.99 62.81 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.32 -0.847 . . . . 2.03 111.041 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.5 p -63.89 77.45 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.257 0.481 . . . . 1.78 110.779 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? 170.72 -24.58 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.654 3.182 . . . . 3.42 111.437 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -70.91 59.24 0.22 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.94 1.245 . . . . 2.19 111.683 172.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 41.04 -73.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 129.454 3.101 . . . . 5.77 115.766 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.43 97.14 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.918 0.771 . . . . 1.94 111.526 -175.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.666 HD13 HG23 ' A' ' 46' ' ' ILE . 1.3 tp -66.65 97.66 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 117.635 0.717 . . . . 2.23 110.877 -175.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 pp -86.5 -32.77 20.58 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.605 1.162 . . . . 3.01 111.721 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -147.72 136.8 22.21 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.278 0.631 . . . . 2.27 111.02 176.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -117.75 166.45 12.42 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.223 -1.028 . . . . 1.99 108.223 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 m -151.09 117.69 5.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.421 -1.326 . . . . 1.56 107.421 151.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.71 125.15 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 120.411 1.46 . . . . 2.37 109.894 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.44 129.55 55.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.181 0.593 . . . . 1.16 109.475 172.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.0 -48.17 54.68 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.849 -1.069 . . . . 1.77 111.015 -172.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.03 -51.44 69.68 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.37 0.605 . . . . 1.71 110.534 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.81 -12.82 52.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.482 1.113 . . . . 2.11 111.342 176.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 54.26 28.35 9.1 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 125.157 1.383 . . . . 2.73 109.627 -172.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -121.03 129.41 53.36 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 118.944 0.793 . . . . 1.44 110.846 -160.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.02 120.44 39.84 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.685 1.194 . . . . 0.8 108.715 164.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 127.31 36.09 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 127.002 2.121 . . . . 1.62 105.33 166.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.666 HG23 HD13 ' A' ' 32' ' ' ILE . 4.6 mp -120.9 130.2 74.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.029 1.332 . . . . 1.2 108.713 174.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -104.0 90.25 3.55 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.006 1.723 . . . . 2.58 108.278 167.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.14 179.35 7.27 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.98 1.312 . . . . 2.2 109.535 -175.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.2 124.53 41.04 Favored Pre-proline 0 N--CA 1.445 -0.719 0 O-C-N 123.34 0.4 . . . . 4.18 110.759 174.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.51 -8.79 10.4 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.406 2.738 . . . . 1.7 112.801 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -90.83 -55.1 3.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 119.154 0.888 . . . . 3.49 108.784 -175.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 pt -68.24 -78.68 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.849 0.357 . . . . 1.46 111.871 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.7 tt -69.06 -56.62 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 O-C-N 121.229 -0.92 . . . . 1.34 109.186 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.03 159.07 33.25 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 122.92 0.295 . . . . 0.64 113.1 171.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.66 -38.61 80.47 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.661 2.907 . . . . 0.83 110.979 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -32.16 -64.14 0.18 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.73 2.012 . . . . 9.91 113.487 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -53.98 -58.25 7.99 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.624 1.169 . . . . 2.91 109.906 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 mt -57.2 -59.94 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.271 -0.877 . . . . 1.22 109.899 -176.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.4 mt -49.99 -51.33 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 123.311 0.644 . . . . 1.25 110.273 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -69.31 -32.71 72.01 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.537 0.608 . . . . 2.51 111.689 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.3 m -60.6 -58.66 7.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.942 -0.762 . . . . 0.69 108.942 171.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 mm -59.98 -38.17 75.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.297 1.039 . . . . 1.83 111.474 -174.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -51.72 -65.35 0.57 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.84 1.256 . . . . 2.73 108.809 167.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.8 t -56.96 -27.58 61.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.317 0.647 . . . . 1.15 112.696 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.5 tp -76.17 -5.4 46.58 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.419 1.488 . . . . 2.28 111.57 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.1 45.36 2.85 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 124.345 0.974 . . . . 0.64 111.572 169.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -143.23 172.16 13.11 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.443 1.097 . . . . 2.15 108.11 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -115.76 78.76 7.24 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 123.106 0.562 . . . . 4.68 111.916 -175.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.13 72.78 5.75 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.786 2.991 . . . . 1.55 112.829 -168.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.8 p -69.84 138.98 53.05 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.969 -0.457 . . . . 2.08 110.488 171.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.9 tp -78.82 116.09 18.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.742 -1.577 . . . . 3.2 106.742 167.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.6 -49.01 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.185 0.994 . . . . 4.01 109.546 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.1 tttm 71.02 -60.08 0.52 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.768 1.627 . . . . 7.91 111.55 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.9 pt -62.85 166.96 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 122.509 0.324 . . . . 6.48 110.674 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.312 -1.327 . . . . 10.97 109.568 -173.13 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 ttp . . . . . 0 N--CA 1.468 0.435 0 N-CA-C 109.279 -0.638 . . . . 8.35 109.279 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.71 155.65 3.74 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 109.511 -1.435 . . . . 3.33 109.511 -166.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -87.77 155.28 19.98 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 117.722 0.761 . . . . 3.9 109.477 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.61 136.72 9.4 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 106.131 -2.788 . . . . 2.08 106.131 168.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.2 t -101.64 87.42 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.078 -1.082 . . . . 2.46 108.078 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.79 90.34 2.89 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.982 -1.488 . . . . 2.48 106.982 171.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -73.65 119.95 18.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.26 -1.015 . . . . 2.11 108.26 159.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -127.7 150.61 49.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.211 -1.033 . . . . 1.84 108.211 166.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.0 t -96.71 135.71 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.429 -1.693 . . . . 0.91 106.429 171.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.81 176.73 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.483 -0.932 . . . . 2.55 108.483 172.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -134.55 167.07 21.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.942 -2.244 . . . . 6.17 104.942 152.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.93 -3.9 55.89 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.295 -0.725 . . . . 1.09 114.139 176.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.9 mtm -75.7 53.93 0.76 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.72 1.76 . . . . 2.06 111.977 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -80.68 36.27 0.38 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.897 -1.127 . . . . 3.13 113.203 -166.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.7 t -171.04 140.54 1.55 Allowed 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 118.913 0.779 . . . . 3.43 109.424 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.86 -48.82 11.12 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.797 0.839 . . . . 1.94 111.162 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 m -44.84 -38.6 4.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.485 1.114 . . . . 1.56 112.234 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.0 m -54.62 -38.12 66.42 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.372 0.533 . . . . 0.8 110.908 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 86.1 t -52.46 -63.8 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 123.407 0.683 . . . . 0.75 109.487 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -29.28 69.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.908 -0.587 . . . . 1.35 109.715 -175.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -62.66 -55.55 25.87 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.184 -1.413 . . . . 4.56 107.184 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.456 HG22 HD23 ' A' ' 26' ' ' LEU . 65.4 mt -60.09 -53.45 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 107.066 -1.457 . . . . 0.69 107.066 -172.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -41.34 -64.6 0.54 Allowed 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 124.607 1.192 . . . . 4.29 109.768 174.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.2 t -58.19 -43.85 87.74 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.632 0.773 . . . . 1.41 110.259 -173.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.63 -20.84 62.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.313 1.045 . . . . 1.01 111.117 -176.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.456 HD23 HG22 ' A' ' 22' ' ' ILE . 2.4 mm? -82.72 -57.85 3.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.703 -0.665 . . . . 2.04 110.55 168.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.58 -31.27 64.06 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.231 0.923 . . . . 1.61 111.572 -177.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -37.11 -52.04 0.99 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.494 1.517 . . . . 4.62 112.798 162.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -96.64 140.84 30.66 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 118.899 0.772 . . . . 3.37 111.294 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -67.11 177.09 1.88 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.696 -0.483 . . . . 6.54 109.696 173.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.19 -48.42 3.92 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.935 -1.266 . . . . 1.39 109.935 -174.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.856 HD11 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -57.88 141.99 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.641 -0.874 . . . . 1.83 108.641 158.513 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.3 mt -108.97 -45.37 3.8 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.417 1.487 . . . . 3.41 108.593 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -154.98 155.96 35.14 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.013 0.925 . . . . 2.16 109.756 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.9 t -136.96 146.28 45.2 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.464 -0.939 . . . . 1.99 108.464 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.9 m -150.74 119.34 6.5 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.813 -0.81 . . . . 1.75 108.813 161.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 22' ' ' ILE . 11.3 m -101.21 155.67 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.699 0.8 . . . . 1.68 109.964 170.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.48 134.08 22.12 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.252 0.621 . . . . 1.01 110.971 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.66 -47.61 69.01 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.444 1.097 . . . . 2.35 110.133 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.79 -43.49 80.97 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 123.377 0.671 . . . . 1.69 111.384 -170.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.1 m -94.37 -0.84 54.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.167 0.587 . . . . 2.57 110.593 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.78 34.06 18.29 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.073 1.749 . . . . 2.99 111.528 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -112.14 152.11 28.69 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.567 0.747 . . . . 1.49 110.359 -165.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.417 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -116.39 121.91 43.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.428 1.091 . . . . 0.68 108.224 156.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.97 131.69 42.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.902 -1.518 . . . . 1.13 106.902 160.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.856 HG23 HD11 ' A' ' 32' ' ' ILE . 4.8 mp -118.08 119.23 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.029 -1.471 . . . . 1.11 107.029 172.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -95.88 95.7 8.43 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 126.59 1.956 . . . . 3.29 106.252 172.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -126.8 165.85 18.53 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.024 1.33 . . . . 2.33 109.474 -174.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -86.94 112.47 47.6 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.649 -0.871 . . . . 3.25 108.649 170.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.05 -19.25 45.72 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.612 2.208 . . . . 1.4 113.089 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -69.01 -36.47 77.83 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.021 0.828 . . . . 4.16 110.705 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.6 pt -99.23 -62.55 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 N-CA-C 113.599 0.963 . . . . 1.29 113.599 -165.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 tt -88.42 -47.56 15.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.576 0.703 . . . . 1.44 110.721 -165.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.5 151.6 27.13 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.045 0.831 . . . . 0.72 111.589 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.66 -30.51 34.62 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.828 3.019 . . . . 0.65 112.55 -174.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.426 HH21 ' CE1' ' A' ' 60' ' ' HIS . 2.3 mmp_? -50.97 -50.42 58.2 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.983 0.513 . . . . 6.38 111.068 176.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.24 -54.22 27.86 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.814 0.845 . . . . 2.78 110.285 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.0 mt -57.01 -54.26 32.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 124.69 1.196 . . . . 0.96 111.065 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.6 mt -54.42 -53.15 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.378 -0.601 . . . . 1.27 109.378 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.426 ' CE1' HH21 ' A' ' 56' ' ' ARG . 74.4 m-70 -61.75 -35.42 78.07 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.793 -0.567 . . . . 2.37 112.318 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.0 m -59.81 -48.93 79.7 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 121.045 -1.034 . . . . 0.87 109.508 176.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.6 mt -68.86 -42.64 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.883 -0.511 . . . . 2.12 111.511 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -49.54 -47.16 49.22 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.875 1.27 . . . . 2.78 109.08 171.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.2 t -70.66 -42.33 70.94 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.126 0.971 . . . . 1.29 110.555 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.56 -48.87 57.34 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 124.663 1.185 . . . . 3.1 109.009 174.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.26 45.96 0.28 Allowed Glycine 0 C--N 1.334 0.438 0 N-CA-C 110.179 -1.168 . . . . 0.76 110.179 168.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -127.45 172.71 10.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.561 -1.644 . . . . 1.67 106.561 169.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -110.44 71.77 0.68 Allowed Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 118.689 -0.672 . . . . 4.66 111.876 -165.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.82 136.12 34.67 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.404 2.069 . . . . 1.48 112.337 -169.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.6 p -145.56 129.19 17.1 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.728 1.211 . . . . 1.92 108.258 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.78 35.16 0.19 Allowed 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.219 -0.925 . . . . 3.36 112.685 -173.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.1 m -82.21 65.92 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 O-C-N 121.278 -0.889 . . . . 5.87 109.294 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -51.44 150.19 3.77 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.469 -0.787 . . . . 5.92 110.562 170.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.0 tp -60.38 143.17 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 108.09 -1.078 . . . . 8.06 108.09 166.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 . . . . . 0 C--O 1.248 0.984 0 N-CA-C 104.342 -2.466 . . . . 9.2 104.342 -179.544 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 mtt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.664 -0.495 . . . . 9.99 109.664 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 137.12 -70.94 0.48 Allowed Glycine 0 CA--C 1.52 0.345 0 N-CA-C 105.196 -3.162 . . . . 4.06 105.196 -172.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 60.03 -154.31 0.37 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.216 1.006 . . . . 5.28 110.012 158.446 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.53 140.99 4.34 Favored Glycine 0 CA--C 1.523 0.581 0 O-C-N 121.403 -0.81 . . . . 2.16 111.763 176.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 m -129.81 156.93 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.207 -1.405 . . . . 2.43 107.207 160.674 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 tp -148.23 111.4 4.9 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.275 -1.379 . . . . 2.67 107.275 -172.222 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -100.37 46.14 0.96 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.657 1.983 . . . . 5.05 109.355 -169.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.02 156.36 39.25 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.964 -0.46 . . . . 1.75 110.031 -165.238 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.56 129.14 48.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 N-CA-C 107.793 -1.188 . . . . 1.0 107.793 175.141 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.58 125.4 68.62 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.029 0 N-CA-C 106.528 -1.656 . . . . 1.63 106.528 172.06 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -104.91 167.97 9.36 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.273 -1.01 . . . . 4.48 108.273 157.455 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.88 -10.51 29.71 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.783 1.183 . . . . 0.96 111.891 -173.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.0 mtm -68.11 76.14 0.23 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.114 0.957 . . . . 1.85 110.179 172.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.8 p -82.19 -75.07 0.32 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.272 1.029 . . . . 3.35 109.436 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 67.2 m -72.9 128.81 36.6 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.572 -0.899 . . . . 4.54 108.572 -179.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -34.89 -51.79 0.52 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.775 1.63 . . . . 1.76 113.394 -176.355 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.8 t -40.1 -42.51 1.45 Allowed 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 124.817 1.247 . . . . 3.16 111.385 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.0 m -38.38 -46.3 1.11 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.272 1.029 . . . . 0.8 112.097 177.343 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.0 t -50.83 -67.28 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 124.172 0.989 . . . . 0.6 110.244 175.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.43 -21.42 66.29 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.443 -0.344 . . . . 2.56 111.847 -179.003 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -68.42 -50.11 55.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.925 -1.509 . . . . 3.45 106.925 -178.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.477 HG21 HG11 ' A' ' 37' ' ' VAL . 63.5 mt -62.05 -57.84 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.374 -1.343 . . . . 0.58 107.374 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -48.19 -57.78 5.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.794 0.838 . . . . 3.32 111.16 179.155 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.1 t -59.7 -44.25 93.76 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.624 0.726 . . . . 1.56 110.135 -178.395 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.5 t -60.48 -29.01 68.79 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 118.506 -0.759 . . . . 1.09 111.446 177.369 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.44 HD12 HG22 ' A' ' 22' ' ' ILE . 11.8 mt -82.63 -47.98 11.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 119.161 0.892 . . . . 2.36 111.772 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.8 p -72.75 62.04 0.56 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.37 1.468 . . . . 1.73 110.938 -175.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -168.7 -30.88 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.673 1.989 . . . . 3.68 111.84 -171.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -65.59 19.76 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.247 1.573 . . . . 2.42 115.247 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 61.85 -71.83 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.504 1.521 . . . . 4.95 110.816 -169.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.68 49.47 3.66 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.309 0.956 . . . . 1.78 112.773 -172.009 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.65 135.16 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 104.789 -2.3 . . . . 2.69 104.789 159.421 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.7 mt -95.4 -37.55 10.89 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.147 0.979 . . . . 3.63 108.925 173.452 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -168.61 158.9 9.67 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.596 1.158 . . . . 2.04 108.071 177.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.8 m -145.48 155.19 42.95 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 123.669 0.788 . . . . 2.2 109.943 172.111 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.1 t -162.37 116.99 1.83 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.803 1.241 . . . . 1.83 107.873 167.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.477 HG11 HG21 ' A' ' 22' ' ' ILE . 2.7 m -104.05 159.95 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.429 1.013 . . . . 1.67 111.936 170.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.9 135.96 21.22 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.574 0.75 . . . . 0.79 109.981 176.215 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.23 -43.15 19.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.625 0.77 . . . . 1.61 111.78 -171.111 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.25 -39.25 89.63 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.886 0.474 . . . . 1.36 110.186 -174.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.3 t -98.19 3.67 48.97 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.599 0.76 . . . . 2.22 111.274 176.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.22 48.45 13.09 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 126.252 1.821 . . . . 3.26 110.673 173.141 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -119.55 143.29 47.69 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 125.252 1.421 . . . . 2.09 108.338 -169.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.6 109.57 14.94 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.879 -1.156 . . . . 0.9 107.879 158.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -83.65 110.51 18.33 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 104.557 -2.386 . . . . 1.54 104.557 166.294 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.8 mt -110.31 143.44 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.292 1.037 . . . . 0.97 108.29 171.293 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -120.79 133.0 55.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.455 -1.683 . . . . 2.17 106.455 163.299 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -164.45 167.94 19.01 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.478 0.581 . . . . 2.03 110.911 -163.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -104.02 104.87 45.85 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 108.65 -0.87 . . . . 4.22 108.65 -178.01 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.64 26.18 0.48 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.89 2.393 . . . . 1.45 113.942 -167.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -127.52 -62.89 1.06 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.424 1.09 . . . . 3.78 108.94 -172.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 pt -57.8 -39.76 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.242 0.617 . . . . 2.65 111.748 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.425 HG23 ' H ' ' A' ' 54' ' ' GLY . 6.3 tt -107.01 -81.74 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.796 0.839 . . . . 1.54 109.244 171.544 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.425 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 123.15 155.33 9.26 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.144 0.878 . . . . 1.09 111.242 -177.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.35 -41.42 41.71 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.123 2.549 . . . . 1.1 110.52 175.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.5 ttm105 -32.96 -71.1 0.06 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 127.01 2.124 . . . . 7.67 110.768 171.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.8 -45.64 89.43 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.275 1.83 . . . . 4.04 109.949 -171.209 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.0 mt -58.56 -60.86 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 109.426 -0.583 . . . . 0.91 109.426 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.4 mt -51.08 -48.43 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.958 0.503 . . . . 1.56 109.822 178.486 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -61.86 -38.38 88.04 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.686 1.194 . . . . 4.02 111.698 -178.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.7 m -65.03 -52.31 56.69 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.117 -0.99 . . . . 0.61 108.633 175.654 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 mm -63.64 -36.94 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 O-C-N 122.205 -0.31 . . . . 1.53 110.991 -175.095 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -52.35 -64.06 0.94 Allowed 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.028 1.331 . . . . 2.7 109.036 166.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 t -52.65 -38.15 59.88 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.345 1.058 . . . . 1.1 112.786 -175.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.9 mt -58.25 -25.78 62.14 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.512 -0.742 . . . . 1.93 112.86 176.537 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.13 49.94 0.8 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.229 0.918 . . . . 0.9 111.131 178.055 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -137.97 167.51 21.63 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 106.577 -1.638 . . . . 1.77 106.577 172.378 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -107.49 89.18 4.73 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 119.351 0.978 . . . . 4.21 112.539 172.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.09 70.92 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.967 2.445 . . . . 1.61 111.629 177.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.4 m -79.14 117.61 20.33 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.242 1.417 . . . . 2.04 108.515 177.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.9 tp -84.69 68.59 10.45 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.936 -1.135 . . . . 3.74 107.936 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.3 p -79.71 -25.9 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 115.393 -0.821 . . . . 4.98 108.875 165.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.1 tttt 72.85 -70.94 0.15 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.9 1.68 . . . . 7.0 110.687 176.046 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.7 mm -89.09 -76.29 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 108.99 -0.744 . . . . 6.62 108.99 -173.744 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.25 1.119 0 N-CA-C 105.307 -2.108 . . . . 10.25 105.307 -176.814 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.5 mtt . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 107.199 -1.408 . . . . 8.11 107.199 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.95 163.72 14.71 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 108.065 -2.014 . . . . 3.58 108.065 144.118 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -78.24 134.1 37.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.773 0.829 . . . . 5.11 110.36 -174.205 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.04 78.85 1.96 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 108.412 -1.875 . . . . 2.51 108.412 174.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.34 76.0 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 117.347 0.573 . . . . 2.66 110.319 -177.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.1 tp -74.93 130.95 40.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.897 -0.779 . . . . 2.23 108.897 179.483 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -103.65 149.59 24.8 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.092 -1.077 . . . . 2.04 108.092 164.327 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.68 123.88 13.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.03 -1.47 . . . . 1.64 107.03 172.281 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.35 135.42 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 107.497 -1.297 . . . . 1.12 107.497 166.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.0 156.82 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 124.929 1.292 . . . . 2.08 107.63 173.476 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.4 mtm105 -138.37 177.37 7.93 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.187 -1.783 . . . . 4.43 106.187 168.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.39 -9.23 71.95 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.53 0.586 . . . . 1.36 112.61 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -69.4 157.99 36.0 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.198 0.999 . . . . 2.89 110.206 176.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 t -149.31 140.34 22.94 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.523 -1.288 . . . . 3.87 107.523 167.573 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 69.2 m 68.67 153.39 0.1 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.842 1.657 . . . . 2.73 112.563 174.192 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.32 -36.99 22.71 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.744 0.818 . . . . 2.44 110.619 174.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -35.07 -52.16 0.56 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.931 1.692 . . . . 1.95 112.5 170.209 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.3 m -63.88 -35.56 81.06 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.482 -0.761 . . . . 0.98 111.627 -175.582 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.2 t -56.68 -59.52 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 178.567 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -31.77 73.17 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.773 -0.649 . . . . 1.64 109.792 -177.573 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -58.22 -58.91 6.39 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 106.957 -1.498 . . . . 4.03 106.957 176.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.537 HG21 HG11 ' A' ' 37' ' ' VAL . 60.6 mt -59.61 -53.21 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.54 -1.282 . . . . 0.66 107.54 -171.651 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -46.02 -57.75 4.16 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 124.127 0.892 . . . . 4.23 110.112 177.37 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -60.88 -46.79 89.2 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.696 0.76 . . . . 1.41 109.804 -175.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 t -60.23 -36.65 78.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.374 1.47 . . . . 0.94 109.079 -175.579 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.472 HD23 HG22 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -70.53 -53.08 17.6 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.344 0.658 . . . . 2.16 112.006 174.066 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.9 p -52.48 -29.17 23.5 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.377 0.535 . . . . 1.83 111.991 -173.148 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 10.23 7.23 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.802 1.408 . . . . 3.26 114.802 178.373 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -89.48 178.43 6.3 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.121 1.328 . . . . 2.41 109.519 165.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -81.09 159.42 24.73 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.553 -0.906 . . . . 6.63 108.553 166.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.88 -55.88 3.88 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.499 0.571 . . . . 1.97 113.162 170.006 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.583 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -63.03 107.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 117.713 0.756 . . . . 2.51 110.293 -178.139 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 32' ' ' ILE . 2.4 pp -99.52 -25.53 14.4 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.72 1.208 . . . . 2.82 111.732 -174.226 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -146.96 122.18 10.2 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.297 -1.001 . . . . 2.53 108.297 176.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.2 t -102.0 161.65 13.51 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 107.725 -1.213 . . . . 1.94 107.725 171.377 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 m -160.36 116.84 2.4 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.208 -1.034 . . . . 1.64 108.208 163.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 22' ' ' ILE . 2.2 m -116.01 165.57 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 122.777 0.431 . . . . 1.85 110.073 169.695 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.25 135.0 14.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.858 0.863 . . . . 0.71 109.195 170.089 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.18 -43.91 69.84 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.029 -0.987 . . . . 1.59 110.25 -177.282 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.34 -49.94 72.92 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.365 0.602 . . . . 1.15 110.512 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -67.74 -11.81 59.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.587 0.755 . . . . 2.1 111.132 178.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 53.8 38.36 28.39 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.799 1.24 . . . . 3.28 108.542 -173.067 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -133.51 142.58 48.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 O-C-N 122.143 -0.348 . . . . 1.38 111.078 -167.184 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.3 142.09 47.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.812 1.245 . . . . 0.71 107.928 160.428 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.03 154.23 48.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.549 0.613 . . . . 1.24 110.316 163.047 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.514 HG23 HD13 ' A' ' 32' ' ' ILE . 4.8 mp -127.75 138.62 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.883 -1.154 . . . . 1.18 107.883 178.085 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -104.12 110.82 23.15 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.035 0.934 . . . . 2.64 108.643 164.192 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -155.17 158.24 38.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.133 1.373 . . . . 2.55 110.178 -174.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.02 126.01 88.65 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 109.087 -0.709 . . . . 3.62 109.087 165.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.26 -7.98 14.0 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.227 2.618 . . . . 1.04 113.887 -173.379 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -84.09 -52.68 6.09 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 119.591 1.087 . . . . 4.98 108.439 -179.051 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.1 pt -62.46 -52.7 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 113.593 0.96 . . . . 1.38 113.593 -168.021 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.526 HG23 ' H ' ' A' ' 54' ' ' GLY . 13.1 tt -97.2 -68.79 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 124.096 0.959 . . . . 1.09 109.658 -178.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.526 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 109.49 162.14 19.49 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.735 0.683 . . . . 0.72 113.697 172.109 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.85 -42.82 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.092 3.195 . . . . 0.81 111.903 -173.298 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -52.26 -50.09 62.78 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.705 1.241 . . . . 8.17 108.732 -173.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.55 -54.13 41.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.005 2.922 . . . . 5.0 108.536 -176.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.1 mt -61.48 -54.85 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 123.841 0.856 . . . . 0.8 110.284 179.161 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.7 mm -48.56 -53.27 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 118.5 0.591 . . . . 2.2 109.423 178.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -63.5 -33.15 74.95 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.413 0.523 . . . . 2.93 112.413 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.8 m -59.8 -58.1 10.01 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.221 -0.924 . . . . 0.79 109.78 171.203 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.2 mm -63.89 -32.8 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.6 -0.688 . . . . 1.49 110.921 -174.057 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.08 -58.49 7.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.696 1.198 . . . . 3.03 108.904 167.783 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.7 t -55.12 -37.27 66.69 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.501 1.12 . . . . 1.0 112.378 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.0 mt -60.17 -16.45 32.97 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.905 0.706 . . . . 2.04 112.905 175.102 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.35 38.19 5.13 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.951 -0.86 . . . . 0.83 110.951 177.325 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -127.53 171.58 11.48 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 107.501 -1.296 . . . . 1.71 107.501 172.798 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -112.15 70.66 1.02 Allowed Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 114.446 1.276 . . . . 4.02 114.446 -168.137 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.7 110.73 2.82 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.963 2.442 . . . . 1.09 112.864 -175.221 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.7 t -71.32 177.76 3.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.694 1.198 . . . . 3.41 109.339 160.282 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.43 HD23 ' H ' ' A' ' 71' ' ' LEU . 0.6 OUTLIER -78.25 -163.48 0.44 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.485 -0.931 . . . . 3.93 108.485 158.345 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 m -61.74 74.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.752 1.621 . . . . 7.05 111.661 175.108 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -60.68 137.5 58.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.528 1.131 . . . . 11.75 110.128 178.371 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.4 mt -93.28 121.98 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 104.776 -2.305 . . . . 6.47 104.776 163.22 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.274 0 C-N-CA 127.276 2.23 . . . . 9.68 112.178 -177.209 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ttt . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 111.971 0.36 . . . . 10.87 111.971 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.12 -75.49 0.18 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.349 -1.101 . . . . 5.87 110.349 -168.524 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.7 t0 24.62 55.08 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 128.661 2.784 . . . . 6.51 113.271 -175.463 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.99 161.31 10.46 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 107.074 -2.41 . . . . 2.36 107.074 -169.315 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 m -148.55 172.89 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 105.994 -1.854 . . . . 2.14 105.994 174.334 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.4 tp -137.27 134.21 35.9 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 107.951 -1.129 . . . . 1.91 107.951 159.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -101.87 123.72 46.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.023 -1.103 . . . . 2.16 108.023 168.278 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.71 131.17 44.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 110.121 -0.326 . . . . 1.53 110.121 175.16 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.99 142.52 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.484 -1.672 . . . . 1.3 106.484 168.198 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.3 107.75 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.879 -1.526 . . . . 1.26 106.879 173.073 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -76.98 166.04 23.85 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.934 -0.765 . . . . 5.68 108.934 174.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.84 -45.77 3.36 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.778 -0.929 . . . . 1.06 110.778 -177.334 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -57.01 120.16 7.51 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.837 -0.801 . . . . 2.4 108.837 174.314 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 t -156.92 19.44 0.31 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.39 0.515 . . . . 3.64 112.39 -166.105 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.6 t -157.45 148.21 21.27 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 120.781 -1.199 . . . . 2.98 109.141 -179.089 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.76 -41.02 10.27 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.069 0.948 . . . . 2.38 111.535 173.241 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.8 m -51.29 -55.9 15.83 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.206 0.602 . . . . 1.72 110.513 172.538 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.9 m -55.97 -51.97 65.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 123.804 0.842 . . . . 0.77 109.464 178.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.9 t -46.8 -61.85 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.001 0.52 . . . . 0.98 109.734 178.817 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.283 0.0 OUTLIER -64.78 -21.97 66.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.936 -0.575 . . . . 1.84 110.923 -176.175 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -66.73 -47.3 72.72 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.871 -0.789 . . . . 4.06 108.871 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.429 ' HB ' HG21 ' A' ' 37' ' ' VAL . 15.2 mt -66.73 -52.21 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.769 -1.197 . . . . 0.72 107.769 -178.746 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -41.83 -66.57 0.33 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.486 0.714 . . . . 3.37 110.328 171.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.6 t -55.88 -49.43 73.41 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.473 1.109 . . . . 1.49 109.815 -172.401 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.0 t -64.31 -37.4 87.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 118.802 -0.618 . . . . 0.71 111.414 -178.273 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.71 -41.14 72.3 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.237 0.926 . . . . 1.88 110.33 178.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.1 p -65.18 74.65 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.964 0.906 . . . . 1.78 111.022 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.5 pttm 179.15 -36.23 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 129.521 3.129 . . . . 3.73 109.707 -178.226 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -53.53 118.59 4.0 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.193 0.597 . . . . 1.93 110.657 -178.292 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -67.24 82.19 0.14 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.541 1.137 . . . . 5.06 110.252 -171.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.26 -29.24 0.52 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.162 0.887 . . . . 1.23 110.927 -174.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.21 140.06 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.65 1.18 . . . . 1.86 109.239 175.714 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.3 mt -114.2 -47.6 2.93 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.341 1.456 . . . . 3.0 109.703 168.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -143.3 138.38 29.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.334 0.515 . . . . 2.56 110.94 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -105.49 156.71 17.95 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.656 -1.238 . . . . 2.13 107.656 173.618 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.1 92.64 1.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.878 -0.786 . . . . 1.35 108.878 162.693 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 22' ' ' ILE . 46.4 t -92.3 144.96 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 125.707 1.603 . . . . 2.39 109.59 176.387 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.83 134.56 11.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.895 -0.503 . . . . 0.8 111.577 172.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.15 -30.48 62.29 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 123.828 0.851 . . . . 1.44 111.353 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.47 -29.66 69.2 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.396 0.543 . . . . 1.28 110.722 -177.238 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.428 HG23 ' HG2' ' A' ' 43' ' ' LYS . 5.0 t -115.38 5.88 14.69 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.795 1.238 . . . . 2.26 110.836 176.367 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 45.45 45.49 10.31 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 127.541 2.337 . . . . 3.14 112.45 175.003 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.428 ' HG2' HG23 ' A' ' 41' ' ' THR . 16.8 ptpt -139.03 161.52 37.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.334 0.494 . . . . 1.54 112.334 -178.128 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.71 124.81 52.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.769 1.627 . . . . 0.74 106.853 160.04 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 139.22 30.84 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.069 -1.086 . . . . 1.08 108.069 153.584 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.96 125.95 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.955 -1.498 . . . . 1.01 106.955 174.627 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -101.95 87.83 3.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.027 1.331 . . . . 2.25 107.952 167.363 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -125.49 157.12 37.77 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.131 2.173 . . . . 2.22 109.48 178.053 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.435 ' HB2' HD11 ' A' ' 52' ' ' ILE . 2.6 m-20 -72.28 120.37 80.04 Favored Pre-proline 0 C--N 1.34 0.179 0 N-CA-C 105.987 -1.857 . . . . 3.18 105.987 167.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.8 -67.68 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.48 1.454 . . . . 1.79 113.065 -169.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -52.89 -41.16 64.1 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.349 1.06 . . . . 5.3 112.595 -159.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 49' ' ' ASP . 10.7 pt -51.9 -41.23 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.025 0.93 . . . . 1.5 113.135 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.0 tt -119.9 -48.49 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.422 1.089 . . . . 1.39 111.305 -167.41 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.38 160.24 35.07 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.1 1.333 . . . . 1.1 112.201 172.662 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -66.99 -26.52 43.47 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.198 2.599 . . . . 1.51 111.941 179.305 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.8 ttm105 -51.06 -55.57 16.94 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.741 0.817 . . . . 5.09 110.741 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -47.67 -53.64 14.37 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.552 1.141 . . . . 2.97 110.689 176.512 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.66 -57.41 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.717 0.807 . . . . 1.11 110.568 -178.397 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.62 -37.03 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 O-C-N 121.661 -0.649 . . . . 4.45 111.795 -175.063 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -55.4 -49.85 71.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.826 0.739 . . . . 3.07 109.873 169.72 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.6 m -56.24 -50.93 69.91 Favored 'General case' 0 C--O 1.224 -0.24 0 O-C-N 121.731 -0.606 . . . . 0.89 110.838 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.54 -41.75 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 121.539 -0.725 . . . . 1.94 111.865 -175.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -52.15 -48.21 65.03 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.006 -0.739 . . . . 4.13 109.006 169.67 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.0 t -64.9 -42.33 94.86 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.819 -0.628 . . . . 1.64 111.321 -177.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.43 -46.29 86.79 Favored 'General case' 0 C--N 1.34 0.172 0 O-C-N 121.485 -0.76 . . . . 1.8 109.994 173.255 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.34 43.84 0.34 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.132 -0.787 . . . . 0.85 111.132 170.138 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -129.7 155.83 45.26 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.039 -1.837 . . . . 1.9 106.039 170.617 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -107.82 102.66 46.38 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 118.579 -0.724 . . . . 3.39 110.319 -168.359 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -85.15 154.33 11.02 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.976 2.451 . . . . 1.72 113.124 -171.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.0 m -162.03 135.67 6.4 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 125.97 1.708 . . . . 2.5 107.953 166.739 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -54.27 138.86 37.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.565 -0.531 . . . . 3.02 109.565 173.26 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.4 p -90.19 -49.04 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.752 -0.462 . . . . 3.87 109.752 -175.122 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.3 tttm 67.32 159.38 0.15 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.338 1.455 . . . . 6.54 110.864 -173.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.18 146.11 34.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 104.041 -2.577 . . . . 7.4 104.041 152.741 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 C--O 1.255 1.382 0 CA-C-O 116.29 -1.814 . . . . 9.01 112.17 -164.946 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 106.019 -1.845 . . . . 8.83 106.019 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 149.03 -156.68 26.93 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 107.105 -2.398 . . . . 5.55 107.105 -175.354 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -130.35 171.14 13.26 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 106.677 -1.601 . . . . 7.21 106.677 163.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.53 41.58 0.62 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-O 118.033 -1.426 . . . . 3.28 111.47 158.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -150.78 80.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 118.855 1.327 . . . . 2.76 107.628 172.558 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.51 89.29 6.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.111 -1.441 . . . . 3.0 107.111 164.699 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -67.83 133.72 49.69 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.628 -0.879 . . . . 2.47 108.628 156.442 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 pp -146.13 137.41 24.64 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.51 -1.293 . . . . 1.44 107.51 167.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.71 145.82 13.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 107.966 -1.124 . . . . 1.32 107.966 173.474 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.93 105.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 127.807 2.443 . . . . 1.34 104.489 173.092 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -86.54 163.91 17.21 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.284 -1.006 . . . . 7.24 108.284 166.285 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.76 -13.58 29.67 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.89 0.757 . . . . 1.02 112.166 -177.079 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.1 mtm -65.89 88.25 0.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.233 1.016 . . . . 1.9 110.024 172.074 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 p -68.83 -37.21 79.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.078 0.551 . . . . 3.33 111.599 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.5 t -158.28 169.85 23.57 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.176 0.444 . . . . 3.44 110.247 -169.672 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.37 -28.06 7.39 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.237 1.815 . . . . 2.47 113.377 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 p -49.81 -63.18 1.19 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.309 -0.626 . . . . 2.56 109.309 169.759 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.2 m -51.22 -47.83 62.22 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.675 0.79 . . . . 0.73 110.697 179.614 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.4 t -49.0 -62.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 123.773 0.829 . . . . 0.75 109.927 178.552 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -26.47 67.69 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 120.835 -0.346 . . . . 1.35 110.468 -177.586 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -63.32 -50.11 71.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.79 -0.819 . . . . 4.34 108.79 179.639 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.9 mt -64.88 -53.24 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.815 -1.179 . . . . 0.54 107.815 -178.113 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -49.36 -58.83 4.41 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.784 0.834 . . . . 3.9 109.625 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.9 t -62.47 -48.19 80.71 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.458 -0.792 . . . . 1.32 109.793 -174.029 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.6 t -57.7 -36.2 71.66 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.72 110.69 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.2 mt -72.43 -47.62 47.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.984 -1.008 . . . . 1.96 111.973 177.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.1 p -62.11 77.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.913 0.885 . . . . 1.77 111.694 -176.058 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? 169.54 -37.32 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.935 2.494 . . . . 3.37 110.468 -171.705 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -58.19 126.8 29.07 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.246 -1.02 . . . . 2.27 108.246 171.302 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -72.42 74.7 1.03 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.873 0.869 . . . . 4.75 111.658 -163.086 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.91 -41.09 0.19 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.404 -1.079 . . . . 1.57 110.404 178.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.684 HD13 HG23 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -69.67 100.46 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 117.724 0.762 . . . . 2.29 110.186 -176.972 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.14 -35.49 23.59 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.596 1.158 . . . . 2.36 111.494 -176.477 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -143.6 116.49 8.8 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.903 0.881 . . . . 2.03 109.275 176.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.2 t -97.48 155.4 16.95 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 107.905 -1.146 . . . . 2.16 107.905 169.505 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 t -158.24 102.85 1.79 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.887 -1.523 . . . . 1.48 106.887 169.667 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.54 159.31 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 120.505 0.193 . . . . 1.71 110.708 173.305 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.48 134.39 21.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.404 1.082 . . . . 0.86 110.061 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.54 -41.97 62.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.527 -1.215 . . . . 1.63 110.942 -173.083 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.3 -47.26 80.16 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.551 0.691 . . . . 1.4 109.674 -172.424 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -80.78 -2.55 47.56 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.514 -0.755 . . . . 2.72 110.763 177.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 51.39 49.8 20.23 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.651 1.18 . . . . 2.62 108.769 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -139.53 142.48 37.24 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.09 0.404 . . . . 1.61 111.744 -169.06 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.98 125.03 50.5 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.262 1.425 . . . . 0.66 108.485 163.781 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.08 119.63 38.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.504 -2.036 . . . . 1.02 105.504 164.426 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.684 HG23 HD13 ' A' ' 32' ' ' ILE . 5.2 mp -112.12 120.55 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.04 1.336 . . . . 1.0 108.24 175.518 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -92.57 97.26 10.7 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.775 -0.824 . . . . 3.12 108.775 163.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.72 143.58 43.4 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.577 -0.897 . . . . 2.73 108.577 174.366 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.85 127.56 88.13 Favored Pre-proline 0 N--CA 1.452 -0.352 0 N-CA-C 106.196 -1.779 . . . . 3.73 106.196 169.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.63 -59.21 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.663 1.576 . . . . 1.85 112.507 -169.152 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -50.12 -43.28 51.67 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.06 1.744 . . . . 3.42 112.396 -162.657 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 pt -55.34 -40.16 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.754 0.822 . . . . 1.78 113.128 -177.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.7 tt -123.68 -48.24 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.805 0.842 . . . . 1.67 112.676 -165.058 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.45 147.56 22.69 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.129 1.347 . . . . 1.01 111.443 178.111 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.86 -34.42 23.98 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.106 2.538 . . . . 0.93 111.469 -177.308 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -55.5 -41.73 73.48 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 118.841 -0.599 . . . . 6.51 112.441 -174.305 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -48.71 -62.18 1.64 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.516 1.151 . . . . 2.72 110.025 174.14 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 mt -56.65 -56.36 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.209 1.404 . . . . 1.38 110.431 -179.077 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.31 -47.66 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 122.024 -0.422 . . . . 1.31 110.42 -178.334 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.7 m170 -60.8 -42.67 98.07 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.832 0.742 . . . . 2.84 110.817 178.003 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.3 m -57.33 -52.33 65.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.238 -0.653 . . . . 0.76 109.238 177.683 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.4 mm -68.36 -34.59 66.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 O-C-N 122.09 -0.381 . . . . 2.01 111.777 -175.234 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -56.41 -59.26 5.22 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.517 1.127 . . . . 2.82 108.026 171.691 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -52.99 -40.35 63.73 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.349 1.06 . . . . 1.12 111.506 176.854 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.1 tp -66.4 -10.5 44.28 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.121 0.968 . . . . 2.47 112.446 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.2 45.76 2.33 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 118.68 0.673 . . . . 0.68 112.055 168.12 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -139.32 177.81 7.65 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 107.794 -1.188 . . . . 2.14 107.794 172.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -112.6 72.49 1.33 Allowed Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 113.198 0.814 . . . . 3.42 113.198 -177.795 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -63.58 104.45 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.983 3.122 . . . . 1.37 111.814 -177.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.4 p -129.15 124.71 35.35 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.798 1.639 . . . . 2.11 108.735 -172.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tt -76.33 73.52 3.11 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.261 -0.899 . . . . 3.71 111.092 -171.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.9 t -86.47 -37.88 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.408 1.083 . . . . 3.99 111.593 -177.231 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.1 mttt 52.14 -114.31 0.81 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.654 0.782 . . . . 8.6 111.03 -168.084 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.5 mm -132.46 -64.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 105.519 -2.03 . . . . 8.34 105.519 163.523 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 C--O 1.26 1.637 0 N-CA-C 101.993 -3.336 . . . . 9.7 101.993 136.507 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttm . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 119.29 -0.386 . . . . 8.33 111.136 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.78 159.33 30.43 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.214 0.435 . . . . 3.38 112.061 -178.541 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 t70 51.38 -172.32 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.203 1.801 . . . . 3.83 111.149 -165.059 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.95 96.9 0.2 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.52 -1.432 . . . . 2.01 109.52 -176.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 t -75.19 70.16 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 117.64 0.72 . . . . 2.58 109.739 178.174 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.4 tp -70.11 154.47 41.89 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.105 -0.702 . . . . 2.32 109.105 175.66 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -129.07 148.49 51.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.967 0.907 . . . . 2.54 110.035 170.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.52 133.78 44.19 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 107.247 -1.39 . . . . 1.79 107.247 168.283 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.6 109.39 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 105.729 -1.952 . . . . 1.06 105.729 171.35 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -104.41 109.08 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.944 -0.762 . . . . 1.79 108.944 -174.385 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.58 155.24 40.76 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.392 -1.336 . . . . 4.0 107.392 170.196 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.66 -19.85 7.88 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.405 0.526 . . . . 1.09 113.512 168.398 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.4 mtm -58.96 104.48 0.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.568 1.184 . . . . 2.19 110.725 171.541 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.5 p -91.36 -83.36 0.28 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.058 0.943 . . . . 3.67 110.4 177.157 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 84.4 m -79.17 -68.29 0.67 Allowed 'General case' 0 CA--C 1.527 0.061 0 C-N-CA 123.245 0.618 . . . . 3.91 111.279 -160.783 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -174.58 -61.78 0.01 OUTLIER 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 124.401 1.08 . . . . 1.77 108.865 -176.147 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.2 t -41.07 -46.75 3.01 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.315 1.446 . . . . 2.91 111.161 -176.213 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.3 m -23.62 -52.0 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.133 2.173 . . . . 0.85 113.511 168.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.4 t -49.52 -61.46 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.346 0.659 . . . . 0.6 110.589 176.115 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -28.68 66.03 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.323 0.649 . . . . 1.08 110.208 -177.378 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.57 -52.55 59.38 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 107.489 -1.3 . . . . 3.03 107.489 175.055 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.49 HD12 HG11 ' A' ' 37' ' ' VAL . 93.6 mt -65.84 -60.39 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 107.344 -1.354 . . . . 0.56 107.344 178.65 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.04 -51.81 16.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.572 0.701 . . . . 2.85 110.583 -171.379 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.1 t -67.38 -56.53 9.31 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.988 0.915 . . . . 1.6 109.739 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.1 t -64.98 -18.09 64.98 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.693 -0.67 . . . . 1.16 112.446 -173.205 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.44 -47.4 7.47 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 117.672 -1.156 . . . . 2.72 111.548 173.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 p -53.87 -35.13 61.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.606 1.548 . . . . 2.25 111.615 178.347 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -32.05 -48.84 0.17 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.097 1.359 . . . . 4.92 113.23 163.405 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -75.13 63.45 1.3 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.288 1.035 . . . . 2.21 110.798 178.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 3.76 -64.0 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 129.5 3.12 . . . . 4.58 117.247 178.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -46.02 -45.99 14.72 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.43 1.014 . . . . 1.35 112.557 178.492 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.609 HD13 HG23 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -73.3 84.99 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.022 -1.103 . . . . 2.87 108.022 168.515 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.5 pp -65.67 -33.79 76.71 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.988 -0.551 . . . . 3.32 111.299 -175.764 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -146.64 104.68 3.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.912 0.485 . . . . 3.1 111.566 173.817 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.3 t -80.19 142.28 34.84 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 106.89 -1.522 . . . . 2.61 106.89 162.067 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -132.73 101.77 5.41 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.719 -1.215 . . . . 1.3 107.719 -178.676 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.49 HG11 HD12 ' A' ' 22' ' ' ILE . 6.2 t -107.6 142.71 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 124.64 1.176 . . . . 2.59 110.193 -167.307 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.45 137.31 17.12 Favored 'General case' 0 C--N 1.339 0.109 0 O-C-N 121.481 -0.762 . . . . 0.92 111.353 177.026 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -81.71 -35.21 30.05 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 124.463 1.105 . . . . 1.35 112.013 -172.498 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.26 91.52 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 109.572 -0.529 . . . . 1.14 109.572 -177.556 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -93.26 -5.19 50.41 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.454 -0.794 . . . . 2.13 111.454 173.844 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 41.19 55.02 3.34 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 126.744 2.018 . . . . 2.79 109.456 -176.387 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -133.76 152.02 51.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.889 -1.05 . . . . 2.0 109.502 -171.214 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.29 129.1 56.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.646 -1.613 . . . . 0.87 106.646 157.029 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.72 145.51 25.24 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 107.366 -1.346 . . . . 1.13 107.366 157.543 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.609 HG23 HD13 ' A' ' 32' ' ' ILE . 5.3 mp -127.22 115.37 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.252 -0.647 . . . . 2.08 109.252 -169.549 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -86.48 81.03 8.45 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.196 -1.038 . . . . 2.53 108.196 165.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.33 167.95 14.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.378 1.071 . . . . 2.1 110.194 176.425 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -108.72 126.18 30.05 Favored Pre-proline 0 N--CA 1.447 -0.616 0 O-C-N 124.317 1.011 . . . . 3.43 109.084 171.111 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.5 -20.76 20.31 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.126 2.55 . . . . 1.2 112.72 -177.338 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -96.48 14.46 24.49 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.986 0.914 . . . . 3.92 111.434 -170.273 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 pt -126.96 -87.55 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.282 1.033 . . . . 1.23 109.408 163.032 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.9 tt -59.44 -49.4 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.621 1.168 . . . . 1.09 112.008 -176.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.73 159.5 30.61 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.718 -0.553 . . . . 0.82 111.718 -178.429 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.88 -30.84 8.83 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.052 2.501 . . . . 0.86 111.541 -175.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -54.81 -52.51 62.45 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.657 0.783 . . . . 5.01 110.849 -174.312 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -49.46 -55.07 14.47 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.51 1.124 . . . . 2.6 109.653 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.38 -59.79 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.877 1.271 . . . . 0.92 110.373 178.413 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.6 mt -52.63 -41.73 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 119.234 0.924 . . . . 1.49 111.416 -178.465 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -67.08 -45.52 77.05 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.856 -0.527 . . . . 2.4 109.911 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.3 m -57.94 -50.29 73.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.594 -0.891 . . . . 0.58 108.594 179.243 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.1 mm -53.54 -52.18 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.547 1.139 . . . . 1.55 109.915 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -47.68 -64.84 0.68 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.258 0.552 . . . . 3.78 109.807 173.619 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 m -67.57 -26.38 66.26 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.927 -0.578 . . . . 2.7 112.267 -167.105 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.1 tp -67.0 -12.5 60.02 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.192 1.397 . . . . 2.32 111.663 175.686 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.48 47.28 0.7 Allowed Glycine 0 C--N 1.339 0.716 0 C-N-CA 124.948 1.261 . . . . 1.03 110.703 168.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -143.41 178.03 8.03 Favored 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 108.853 -0.795 . . . . 1.91 108.853 -178.209 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.07 101.77 14.92 Favored Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 108.685 -0.857 . . . . 4.54 108.685 173.746 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -83.48 92.0 0.87 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.362 2.708 . . . . 1.23 112.896 -175.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.8 m -79.17 113.15 17.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.733 0.778 . . . . 2.09 109.614 170.011 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tt -76.76 71.69 3.34 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.8 0.84 . . . . 3.2 108.966 171.509 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.7 t -64.52 -43.41 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 122.99 0.516 . . . . 4.18 111.333 -173.303 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 75' ' ' GLU 0.295 0.0 OUTLIER 42.65 -154.46 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.829 1.651 . . . . 7.36 112.566 -169.395 . . . . . . . . 4 4 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 tp -70.28 143.56 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.588 -0.695 . . . . 6.54 109.352 168.344 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 21.5 mm-40 . . . . . 0 C--O 1.256 1.442 0 N-CA-C 103.343 -2.836 . . . . 10.5 103.343 164.883 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 108.259 -1.015 . . . . 9.49 108.259 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.32 156.32 15.79 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 107.702 -2.159 . . . . 3.43 107.702 168.85 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.1 t70 46.79 -131.57 1.27 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.51 1.124 . . . . 3.99 109.983 -175.261 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.24 174.3 49.66 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.776 -1.33 . . . . 1.89 109.776 -170.085 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.69 146.16 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 O-C-N 122.074 -0.662 . . . . 2.4 109.398 -176.697 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.29 114.59 28.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.797 -1.927 . . . . 2.47 105.797 168.498 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -92.74 120.93 33.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.125 -1.065 . . . . 2.59 108.125 164.897 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -122.01 154.55 37.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.286 -1.376 . . . . 1.65 107.286 169.489 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.25 146.78 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.311 -1.737 . . . . 0.85 106.311 171.185 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.86 163.89 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.933 2.093 . . . . 1.6 105.426 -179.32 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -143.05 165.05 28.43 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.529 1.059 . . . . 4.21 108.412 173.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.07 -86.06 0.4 Allowed Glycine 0 C--N 1.337 0.587 0 N-CA-C 108.744 -1.742 . . . . 2.42 108.744 177.044 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.3 mpt? 52.12 -158.16 0.13 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.529 1.131 . . . . 4.78 112.26 -173.826 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.445 HG22 ' SG ' ' A' ' 18' ' ' CYS . 10.2 t -161.23 55.56 0.29 Allowed 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.17 0.988 . . . . 5.65 108.752 179.35 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.8 t 74.69 -45.46 0.58 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.442 1.497 . . . . 4.14 113.486 175.525 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.2 -71.5 0.23 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.319 0.509 . . . . 1.74 111.043 -179.648 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -42.88 -44.12 4.39 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.763 1.625 . . . . 1.65 114.48 -162.903 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.445 ' SG ' HG22 ' A' ' 14' ' ' THR . 1.6 m -47.19 -37.19 9.77 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.204 0.602 . . . . 1.78 112.454 179.748 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -49.7 -61.63 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 123.539 0.735 . . . . 0.69 110.558 174.256 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -30.35 69.65 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.932 -0.766 . . . . 1.33 108.932 -176.48 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -58.83 -53.43 58.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.299 -1.0 . . . . 4.52 108.299 177.676 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.4 HG21 HG11 ' A' ' 37' ' ' VAL . 61.2 mt -62.66 -50.03 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.991 -1.115 . . . . 0.7 107.991 -173.572 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -47.73 -60.93 2.21 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.927 0.767 . . . . 4.12 109.455 176.492 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.5 t -57.65 -47.32 82.57 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 122.224 1.012 . . . . 1.48 110.42 -173.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -70.9 -23.86 62.36 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.402 1.481 . . . . 0.85 110.899 -174.688 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mt -80.39 -43.71 20.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.656 0.662 . . . . 2.47 111.061 171.279 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.2 p -67.95 73.28 0.18 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.029 0.931 . . . . 1.6 110.835 179.512 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.92 -34.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.515 2.726 . . . . 4.22 111.289 -176.832 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -35.02 -69.49 0.1 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 126.174 1.789 . . . . 3.54 115.148 -170.397 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -165.17 -51.93 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 108.697 -0.853 . . . . 7.95 108.697 174.065 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -151.02 63.08 0.4 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.38 -1.488 . . . . 1.54 109.38 175.432 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.823 HD11 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -73.14 126.28 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 105.709 -1.96 . . . . 2.54 105.709 158.552 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.31 -51.68 9.75 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.139 -1.43 . . . . 2.46 107.139 165.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -155.81 139.51 16.08 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.045 -0.525 . . . . 2.45 110.955 -178.312 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.6 t -109.05 150.29 28.01 Favored 'General case' 0 C--O 1.227 -0.092 0 N-CA-C 107.622 -1.251 . . . . 2.26 107.622 167.689 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.66 109.7 3.29 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.357 -0.839 . . . . 1.3 109.378 175.235 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' A' ' 44' ' ' ALA . 3.2 m -113.59 155.87 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.466 0.706 . . . . 1.67 111.295 176.934 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.85 133.74 19.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.353 0.661 . . . . 0.97 109.694 171.322 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -76.09 -42.58 46.79 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.445 0.698 . . . . 1.6 111.293 -171.014 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.73 -46.32 87.63 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.081 0.552 . . . . 1.62 110.466 179.923 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.47 -15.69 60.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.61 1.164 . . . . 2.44 111.471 175.079 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 52.6 34.81 16.54 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.172 1.789 . . . . 2.8 110.006 -172.521 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -102.82 144.64 30.9 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.659 1.183 . . . . 1.67 108.027 -172.303 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.447 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -137.46 110.35 7.68 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.39 -0.967 . . . . 1.05 108.39 161.221 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.78 144.43 25.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.616 -0.513 . . . . 1.16 109.616 168.798 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.823 HG23 HD11 ' A' ' 32' ' ' ILE . 4.9 mp -124.43 120.03 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 106.377 -1.712 . . . . 1.18 106.377 175.073 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.58 ' O ' HD13 ' A' ' 32' ' ' ILE . 60.3 mttt -96.24 96.17 8.61 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.151 -1.426 . . . . 2.2 107.151 166.553 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -134.61 153.75 51.82 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.501 1.521 . . . . 2.18 107.205 -177.76 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -82.06 130.66 59.32 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 119.484 -0.886 . . . . 3.35 109.315 168.277 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.5 -40.9 9.62 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.682 2.254 . . . . 1.52 113.087 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -88.52 43.35 1.13 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.572 1.078 . . . . 3.56 110.824 -164.699 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 pt -142.91 -41.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 126.238 1.815 . . . . 1.66 111.342 172.387 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.9 tt -121.14 -61.26 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.353 1.061 . . . . 1.2 111.844 -175.319 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.41 157.0 25.84 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.734 1.159 . . . . 0.7 111.537 178.778 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.32 -32.63 12.38 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.486 2.791 . . . . 0.69 112.556 -172.592 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -51.93 -52.92 46.71 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.345 0.658 . . . . 5.95 111.549 -178.513 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -48.31 -57.42 6.02 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.487 1.115 . . . . 2.63 110.35 177.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.2 mt -53.51 -63.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.477 1.111 . . . . 0.91 109.436 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.2 mt -49.47 -52.11 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.264 0.625 . . . . 1.31 110.162 -176.828 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -69.81 -30.49 68.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.764 -0.585 . . . . 3.12 111.999 -175.71 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 92.1 m -66.71 -51.34 57.12 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.289 -0.882 . . . . 0.83 109.563 173.424 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mm -55.97 -41.92 69.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 122.809 0.444 . . . . 1.53 110.132 177.359 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.95 -58.45 7.82 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.023 0.929 . . . . 3.05 109.076 174.247 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.5 m -54.13 -37.47 64.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.149 0.98 . . . . 2.42 112.674 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.8 mt -67.24 -6.21 17.25 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.957 0.725 . . . . 1.83 112.957 177.745 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.08 48.94 2.15 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.827 -0.909 . . . . 0.63 110.827 173.37 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -134.61 -179.76 5.79 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.39 1.076 . . . . 2.01 109.621 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -121.8 57.87 8.34 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.069 0.947 . . . . 3.51 112.23 -173.312 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.95 85.25 0.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 124.282 3.322 . . . . 1.15 113.042 -167.766 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.2 m -97.56 126.24 42.74 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.719 1.608 . . . . 2.04 108.476 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 pp -62.06 151.32 35.79 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.705 0.684 . . . . 3.29 109.348 170.873 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.0 t -136.07 -54.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 122.753 0.421 . . . . 3.32 111.689 -179.262 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.24 150.98 28.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 121.188 -0.205 . . . . 7.64 111.347 -171.263 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 75.4 mt -122.28 -66.37 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 104.746 -2.316 . . . . 7.63 104.746 173.055 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--O 1.25 1.109 0 N-CA-C 104.882 -2.266 . . . . 11.76 104.882 137.271 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 106.638 -1.615 . . . . 11.09 106.638 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.97 -64.76 0.45 Allowed Glycine 0 CA--C 1.52 0.399 0 N-CA-C 105.285 -3.126 . . . . 4.01 105.285 -173.026 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 56.75 -148.02 0.51 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.52 1.128 . . . . 4.91 109.395 162.23 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.65 155.26 8.32 Favored Glycine 0 CA--C 1.522 0.481 0 O-C-N 121.765 -0.584 . . . . 2.11 112.052 171.752 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m -139.84 161.95 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.26 -1.385 . . . . 2.0 107.26 167.008 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.0 tp -150.87 147.9 27.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.96 -1.496 . . . . 2.09 106.96 166.878 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -116.38 128.96 55.98 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.251 -1.388 . . . . 2.56 107.251 174.483 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.87 125.35 44.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.72 -1.585 . . . . 1.51 106.72 177.829 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.1 t -65.03 144.08 15.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 N-CA-C 106.866 -1.531 . . . . 0.99 106.866 168.159 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 m -141.75 86.17 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 119.102 0.865 . . . . 1.52 110.512 -174.906 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 56.7 mmt-85 -55.69 141.2 38.92 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.309 -1.367 . . . . 5.19 107.309 168.184 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.86 -26.45 8.87 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.845 0.736 . . . . 1.08 111.504 -175.665 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.402 ' SD ' HD12 ' A' ' 22' ' ' ILE . 26.8 mtm -69.73 77.27 0.44 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.936 1.368 . . . . 1.93 111.744 176.188 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -77.09 -33.8 56.94 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.898 0.879 . . . . 2.44 111.943 178.067 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -149.67 158.03 43.79 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.385 0.539 . . . . 2.98 110.766 -163.72 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.68 -33.1 0.67 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.156 1.782 . . . . 2.35 113.605 173.13 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.1 p -53.27 -53.29 53.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.659 -0.651 . . . . 2.69 110.269 172.21 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.3 m -58.55 -49.09 78.7 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.173 0.589 . . . . 0.88 109.99 178.153 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.1 t -45.27 -63.95 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.351 0.66 . . . . 0.64 109.66 177.059 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.282 0.0 OUTLIER -63.95 -24.64 67.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.754 -0.657 . . . . 1.41 110.984 -177.233 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -61.41 -53.58 54.74 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 108.263 -1.014 . . . . 3.38 108.263 177.038 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.402 HD12 ' SD ' ' A' ' 13' ' ' MET . 11.3 mt -67.07 -56.24 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.434 -1.321 . . . . 0.82 107.434 -175.72 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -46.39 -58.15 4.0 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.968 0.907 . . . . 3.54 112.362 177.498 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.8 t -66.45 -31.1 71.64 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.19 0.596 . . . . 1.32 110.438 -176.363 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 t -66.26 -53.07 41.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.571 -0.705 . . . . 1.34 109.379 175.314 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 26' ' ' LEU . 1.9 mm? -52.86 -45.04 67.22 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.805 0.729 . . . . 2.22 112.183 -175.025 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.6 p -62.53 -9.39 8.52 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.705 0.631 . . . . 1.65 112.705 -176.344 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -71.53 -37.15 71.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.752 0.821 . . . . 5.02 111.138 171.081 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -74.71 121.02 21.05 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.306 -0.627 . . . . 1.84 109.306 -167.621 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -77.84 62.6 2.71 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.164 0.586 . . . . 5.48 111.669 -176.134 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.47 42.8 0.06 OUTLIER Glycine 0 CA--C 1.526 0.719 0 N-CA-C 109.116 -1.593 . . . . 1.75 109.116 174.138 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.92 142.66 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 104.315 -2.476 . . . . 1.99 104.315 -178.757 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.3 tp -100.63 -45.42 5.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.67 1.188 . . . . 3.46 110.132 -179.425 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -162.05 151.25 15.74 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.719 -0.845 . . . . 1.87 108.719 -179.092 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.9 p -131.73 157.07 44.76 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 123.887 0.875 . . . . 2.98 108.937 173.227 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.1 t -170.8 121.43 0.57 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.817 -1.549 . . . . 1.75 106.817 176.172 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 44' ' ' ALA . 3.2 m -121.19 130.56 74.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.76 0.709 . . . . 1.66 110.178 178.311 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.3 133.83 53.33 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.349 1.06 . . . . 1.04 111.566 -173.566 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.18 -56.14 11.19 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 125.274 1.43 . . . . 2.55 110.665 -176.939 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.78 -47.61 76.78 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.186 0.594 . . . . 1.33 110.842 -174.684 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.72 -15.69 62.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.017 1.327 . . . . 1.97 111.29 177.866 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 48.53 42.34 18.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.134 1.774 . . . . 2.96 110.435 -170.691 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -123.84 132.94 53.86 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 124.092 0.957 . . . . 1.4 109.656 -165.833 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -102.4 117.3 34.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.284 1.033 . . . . 0.85 108.567 166.183 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.61 124.01 45.6 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.992 -1.855 . . . . 1.19 105.992 174.067 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 46' ' ' ILE . 3.2 mp -121.86 133.73 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.979 -1.119 . . . . 1.22 107.979 171.124 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -103.17 135.82 44.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.21 1.804 . . . . 2.17 106.707 161.205 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -168.66 178.95 4.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.976 1.31 . . . . 2.53 112.199 -165.777 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -110.34 74.7 0.87 Allowed Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.612 1.165 . . . . 4.17 108.985 -174.385 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -45.76 -48.17 12.71 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 124.452 3.435 . . . . 1.45 113.467 -165.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.71 -34.31 38.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.024 1.33 . . . . 4.76 112.236 -176.343 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.7 pt -95.22 -53.77 7.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 N-CA-C 112.228 0.455 . . . . 1.17 112.228 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.5 tt -72.35 -44.97 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 120.917 0.389 . . . . 1.78 111.195 -173.64 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.24 124.6 1.16 Allowed Glycine 0 CA--C 1.537 1.423 0 N-CA-C 110.846 -0.901 . . . . 0.94 110.846 -176.28 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -53.76 -33.19 69.37 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.034 2.489 . . . . 0.65 111.614 176.835 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -51.4 -46.0 62.7 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.809 0.843 . . . . 6.62 112.031 175.024 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -59.48 -56.37 22.81 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.603 0.716 . . . . 2.6 109.449 -176.549 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 89.1 mt -48.21 -62.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 124.187 0.995 . . . . 0.82 109.337 174.314 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.8 mt -54.22 -53.59 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 119.286 -0.388 . . . . 1.27 110.513 -173.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -65.12 -33.75 76.76 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.945 0.793 . . . . 2.6 112.365 -178.194 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 92.2 m -65.16 -50.8 64.57 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.362 -0.836 . . . . 0.7 109.473 176.159 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mm -64.08 -42.63 96.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.651 -0.656 . . . . 1.83 110.647 -177.756 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -48.3 -62.28 1.57 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.445 1.498 . . . . 3.2 109.316 169.145 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.9 t -52.52 -40.82 62.89 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.596 1.158 . . . . 1.01 112.123 -179.711 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.46 -3.95 5.07 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.979 1.103 . . . . 2.01 113.979 178.102 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.76 50.63 1.93 Allowed Glycine 0 C--N 1.335 0.494 0 N-CA-C 110.12 -1.192 . . . . 0.63 110.12 171.435 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -138.82 169.31 18.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.886 0.875 . . . . 1.85 109.567 178.058 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -112.51 76.98 2.17 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 118.03 -0.986 . . . . 4.42 112.408 177.193 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.01 74.56 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 124.082 3.188 . . . . 1.2 113.151 -175.597 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.46 115.88 13.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.925 0.89 . . . . 2.36 109.493 173.956 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.99 76.52 0.22 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.587 1.155 . . . . 3.18 108.666 170.564 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -44.07 -67.61 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 126.529 1.932 . . . . 3.47 112.048 -174.886 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.4 tttm 80.31 140.68 0.07 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.544 1.537 . . . . 7.25 109.839 176.956 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.6 mm 61.57 67.2 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 106.476 -1.675 . . . . 6.1 106.476 -160.46 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 C--O 1.252 1.223 0 C-N-CA 125.718 1.607 . . . . 10.53 109.952 -157.961 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 109.648 -0.501 . . . . 10.29 109.648 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.58 -42.12 55.86 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 108.744 -1.743 . . . . 4.62 108.744 167.767 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -67.4 158.19 32.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 129.248 3.019 . . . . 5.92 110.453 160.05 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.99 115.59 0.67 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.832 -0.507 . . . . 2.03 111.832 173.008 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -84.84 81.92 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.242 0 N-CA-C 106.063 -1.829 . . . . 2.47 106.063 156.097 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.1 tp -91.0 122.44 33.66 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.898 -1.149 . . . . 1.93 107.898 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -88.29 136.46 32.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.218 -1.03 . . . . 2.07 108.218 163.202 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.464 HD21 HD13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -126.79 133.97 50.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.087 -1.079 . . . . 1.89 108.087 157.118 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.36 143.12 14.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.564 -1.273 . . . . 1.16 107.564 163.905 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.7 m -135.79 85.16 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.327 1.051 . . . . 1.7 110.89 -170.196 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -62.29 139.72 58.51 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.007 -1.058 . . . . 5.94 109.864 -174.79 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.31 -24.67 6.51 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.733 -0.481 . . . . 1.63 112.765 175.831 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.457 ' SD ' HD12 ' A' ' 22' ' ' ILE . 64.5 mtm -59.97 152.63 23.23 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.262 1.031 . . . . 2.47 110.738 175.165 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -161.72 -59.39 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.1 0.56 . . . . 3.09 110.145 177.44 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.8 p -81.15 153.54 27.2 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.9 -0.5 . . . . 4.23 111.116 -176.481 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.84 -50.32 7.94 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 124.679 1.192 . . . . 1.96 111.656 -178.909 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 m -43.99 -40.85 5.0 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.072 1.349 . . . . 1.61 112.399 -178.217 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.3 m -47.78 -43.14 27.22 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.762 0.825 . . . . 1.46 110.939 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.4 t -50.89 -68.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 123.632 0.773 . . . . 0.76 108.99 179.426 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -27.39 69.18 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.76 -0.459 . . . . 1.1 109.76 -175.75 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -59.1 -54.62 45.0 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.808 -0.812 . . . . 3.19 108.808 179.415 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.52 ' HB ' HG11 ' A' ' 37' ' ' VAL . 19.8 mt -70.83 -52.68 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.463 -0.94 . . . . 0.97 108.463 -176.786 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.25 -52.11 29.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.347 0.659 . . . . 3.34 110.744 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -67.44 -47.51 69.96 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.246 0.619 . . . . 1.37 110.407 179.796 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.0 t -57.46 -25.36 59.58 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.847 -0.533 . . . . 1.29 111.98 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.54 -55.22 4.25 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.7 0.8 . . . . 2.98 112.088 171.401 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.5 p -71.64 66.38 0.51 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.274 1.029 . . . . 2.33 111.039 179.024 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.21 -43.45 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.279 1.832 . . . . 3.37 110.111 -176.329 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -76.98 142.66 39.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.415 -0.957 . . . . 4.52 108.415 173.55 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -60.55 165.71 3.61 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.093 -0.706 . . . . 6.35 109.093 173.124 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.41 -35.6 3.79 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-O 118.804 -0.998 . . . . 1.08 111.462 175.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.79 133.44 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 119.039 1.42 . . . . 2.28 107.894 163.417 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.26 -55.15 3.53 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.357 -1.349 . . . . 2.96 107.357 161.211 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -149.84 145.87 26.81 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.129 0.572 . . . . 2.18 110.366 -171.498 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.3 t -128.64 150.27 50.3 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.434 1.094 . . . . 1.96 108.237 177.948 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -148.18 132.33 17.34 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.49 -0.93 . . . . 1.75 108.49 153.286 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 44' ' ' ALA . 18.0 m -107.12 165.35 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 122.814 0.445 . . . . 1.76 110.623 171.059 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.42 136.69 19.94 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.581 0.752 . . . . 1.12 110.622 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.65 -56.1 6.47 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 123.922 0.889 . . . . 2.66 110.523 -176.715 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.54 -52.15 60.61 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 123.161 0.584 . . . . 1.55 110.127 -176.388 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 m -77.43 -3.19 39.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.889 0.876 . . . . 2.21 111.336 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 45.75 42.95 9.26 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.197 1.399 . . . . 3.29 110.225 -179.457 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -117.09 145.54 43.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.664 -0.698 . . . . 1.47 109.757 -164.114 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -116.92 118.77 33.36 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.545 -1.65 . . . . 0.75 106.545 156.922 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.89 134.57 40.84 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.774 -1.195 . . . . 0.96 107.774 163.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.464 HD13 HD21 ' A' ' 8' ' ' LEU . 4.6 mp -122.81 119.94 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 106.942 -1.503 . . . . 1.26 106.942 178.086 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -96.52 98.78 10.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.081 -1.451 . . . . 2.29 107.081 162.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -138.33 178.62 6.99 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.028 0.931 . . . . 2.31 110.935 -177.714 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -107.0 83.94 1.45 Allowed Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 125.01 1.324 . . . . 3.53 109.831 176.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -52.05 -23.51 17.27 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.187 2.591 . . . . 1.47 113.793 174.351 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -49.67 -41.14 42.23 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.473 0.579 . . . . 4.44 112.31 172.114 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 pt -107.3 -47.32 8.12 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 N-CA-C 113.701 1.0 . . . . 1.62 113.701 -166.895 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.2 tt -90.0 -123.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 106.372 -1.714 . . . . 2.02 106.372 172.339 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 177.73 160.18 23.88 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 120.406 1.457 . . . . 1.25 111.681 171.779 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.88 -42.1 26.33 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.084 3.189 . . . . 1.15 111.114 173.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -51.34 -54.22 28.41 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.018 0.527 . . . . 5.73 110.06 177.216 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.94 -54.84 7.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.093 1.757 . . . . 4.11 109.657 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.1 mt -57.97 -60.68 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.856 0.862 . . . . 0.87 109.972 178.409 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mp -48.29 -47.21 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.128 0.422 . . . . 1.74 110.39 -178.444 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -70.59 -33.28 70.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.366 0.666 . . . . 2.33 111.777 -178.174 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.2 m -59.64 -54.89 41.15 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.372 -0.83 . . . . 0.8 108.801 170.91 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.1 mm -58.09 -44.49 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.625 0.77 . . . . 1.34 111.421 -178.254 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -49.99 -56.63 9.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.001 1.32 . . . . 2.9 109.123 170.265 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.3 m -58.03 -36.03 72.15 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.793 0.664 . . . . 1.91 112.793 178.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.87 -17.47 64.32 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.543 -0.723 . . . . 2.35 112.209 174.461 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.17 37.49 9.07 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.665 -0.974 . . . . 1.2 110.665 -178.335 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CD2' HD11 ' A' ' 22' ' ' ILE . 27.0 m-85 -125.02 151.26 45.82 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.049 -1.463 . . . . 1.97 107.049 165.923 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -104.76 101.09 26.8 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 124.835 1.254 . . . . 5.54 110.049 -169.092 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -76.22 158.56 37.35 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.391 1.394 . . . . 1.67 113.147 -171.86 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.0 m -155.27 133.42 11.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.758 -1.571 . . . . 1.9 106.758 164.047 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 pp -53.67 148.19 10.2 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.819 0.736 . . . . 3.32 111.221 174.401 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 t 20.84 90.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 129.072 2.949 . . . . 6.71 114.065 166.147 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -138.91 174.68 10.27 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.368 1.467 . . . . 11.89 108.744 176.201 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.6 pt -87.94 -170.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.078 1.351 . . . . 10.05 109.891 174.986 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 117.673 -1.156 . . . . 15.1 113.011 -169.113 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.402 ' N ' ' OE2' ' A' ' 51' ' ' GLU . 74.6 mtm . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 108.903 -0.777 . . . . 8.39 108.903 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.88 39.19 64.93 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.529 -0.595 . . . . 4.26 113.047 172.591 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -175.92 166.85 3.05 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.903 2.481 . . . . 4.8 106.468 157.356 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.3 -8.01 0.89 Allowed Glycine 0 CA--C 1.54 1.612 0 C-N-CA 126.25 1.881 . . . . 3.72 114.859 168.025 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t 31.29 70.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 120.442 2.121 . . . . 2.11 113.517 -174.155 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.29 104.09 15.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.339 -1.356 . . . . 2.31 107.339 179.061 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -84.15 116.22 22.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.828 -1.175 . . . . 2.13 107.828 162.793 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.7 pp -115.96 161.51 18.74 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.89 -1.152 . . . . 1.86 107.89 164.23 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -112.3 145.95 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 107.064 -1.458 . . . . 0.94 107.064 171.812 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -176.41 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.679 1.192 . . . . 2.57 108.517 -176.53 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -135.23 164.81 26.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.197 -2.149 . . . . 4.98 105.197 167.225 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.7 -0.36 89.57 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.575 -0.57 . . . . 1.05 113.731 171.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.4 mtp -73.77 74.33 1.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.817 1.308 . . . . 2.02 108.78 172.543 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 t -88.53 0.27 56.5 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.802 1.038 . . . . 2.26 113.802 -167.208 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.6 t -165.79 159.08 15.76 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 120.004 1.274 . . . . 2.97 110.195 -173.432 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.32 -38.97 13.77 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.874 1.27 . . . . 2.35 111.092 170.962 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -44.64 -50.15 9.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.997 0.919 . . . . 1.71 111.023 171.512 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.3 m -61.31 -45.43 94.49 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.713 -0.617 . . . . 0.84 109.991 -177.528 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.9 t -48.88 -60.08 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 C-N-CA 123.683 0.793 . . . . 0.68 108.897 176.335 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -33.44 75.74 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.579 -0.282 . . . . 1.28 110.359 -176.336 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -60.24 -45.54 92.88 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.64 -0.874 . . . . 2.82 108.64 -178.432 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.545 HG22 HD23 ' A' ' 26' ' ' LEU . 78.2 mt -70.66 -61.47 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 106.18 -1.785 . . . . 0.58 106.18 -178.441 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -37.19 -64.61 0.36 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.541 1.536 . . . . 4.72 110.701 -179.123 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.9 p -58.42 -41.16 84.38 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.612 -0.722 . . . . 2.39 109.941 -173.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.1 t -71.23 -20.12 62.29 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.914 0.886 . . . . 0.8 112.553 -178.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.545 HD23 HG22 ' A' ' 22' ' ' ILE . 3.7 mm? -81.32 -57.75 3.35 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 118.634 0.652 . . . . 2.26 110.56 167.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 p -56.5 -32.39 64.99 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.162 0.437 . . . . 1.6 111.103 -176.265 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.5 tptt -37.03 -54.13 0.97 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.911 1.684 . . . . 4.59 113.895 161.571 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -90.36 149.89 22.11 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.069 0.85 . . . . 4.23 112.621 -165.549 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -59.02 154.82 14.74 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.803 -0.635 . . . . 7.69 110.535 175.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.11 24.25 66.91 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.5 -0.611 . . . . 1.63 113.339 170.853 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.4 HD11 HG23 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -98.43 138.44 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 104.399 -2.445 . . . . 1.93 104.399 156.002 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.3 mt -97.77 -45.86 6.18 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.441 1.096 . . . . 3.45 109.026 178.765 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -160.36 133.51 6.69 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.286 -0.635 . . . . 1.82 109.286 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.0 t -109.21 143.08 39.12 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.644 -0.873 . . . . 1.95 108.644 176.182 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.1 t -154.64 109.52 3.05 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.033 -0.729 . . . . 1.47 109.033 168.594 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.543 HG11 HG21 ' A' ' 22' ' ' ILE . 3.1 m -104.89 145.81 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 123.19 0.596 . . . . 1.83 110.239 172.248 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.36 134.48 46.34 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 124.634 1.174 . . . . 1.17 110.846 -174.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.5 mt -72.23 -49.41 35.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.816 1.247 . . . . 2.83 111.073 -175.519 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.5 -32.09 68.48 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.037 0.535 . . . . 1.38 111.375 -170.045 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 t -108.32 2.5 22.63 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.313 1.045 . . . . 2.87 111.431 179.298 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 41.12 41.78 1.43 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.653 1.981 . . . . 3.93 111.067 -172.513 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -99.08 149.8 22.66 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.606 -0.887 . . . . 1.41 108.606 -174.349 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.48 114.58 21.46 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.69 -1.226 . . . . 0.71 107.69 159.359 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.84 133.36 38.65 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.873 -1.158 . . . . 0.95 107.873 163.806 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.4 HG23 HD11 ' A' ' 32' ' ' ILE . 3.6 mp -121.59 122.75 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 106.851 -1.537 . . . . 1.06 106.851 172.207 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -92.2 127.52 37.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.773 -1.936 . . . . 3.11 105.773 157.732 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -166.82 161.37 15.32 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 126.289 1.836 . . . . 2.0 107.967 -167.0 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -98.21 95.34 2.78 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.448 0.699 . . . . 4.15 109.833 -174.329 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -58.55 -32.14 95.93 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.637 2.225 . . . . 1.56 111.709 -176.526 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.402 ' OE2' ' N ' ' A' ' 1' ' ' MET . 33.2 mt-10 -61.19 -15.8 38.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.033 1.333 . . . . 3.69 112.955 -178.918 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 pt -123.49 -49.06 2.3 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 N-CA-C 114.019 1.118 . . . . 1.37 114.019 -178.951 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.426 HG23 ' H ' ' A' ' 54' ' ' GLY . 17.9 tt -90.19 -70.11 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 118.462 0.574 . . . . 1.18 109.97 178.509 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.426 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 117.72 149.09 8.81 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 123.605 0.622 . . . . 0.7 112.12 178.487 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.41 -39.57 9.49 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.72 2.947 . . . . 1.1 111.733 179.509 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -51.27 -56.25 13.93 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 122.595 0.358 . . . . 5.67 110.504 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -49.25 -47.45 46.52 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.014 1.725 . . . . 4.93 110.842 179.226 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.0 mt -58.32 -54.16 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 118.992 -0.528 . . . . 0.83 110.424 174.003 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.7 mt -52.41 -45.36 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 119.203 0.91 . . . . 1.43 110.703 177.896 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -58.33 -44.83 88.84 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.288 0.635 . . . . 3.89 110.262 176.249 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 56.7 m -60.17 -54.4 46.25 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.776 -0.577 . . . . 1.01 109.635 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.9 mm -58.8 -42.01 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 121.867 -0.521 . . . . 1.33 110.829 -178.209 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -53.02 -65.33 0.58 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.683 0.793 . . . . 3.17 109.415 171.875 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.4 t -54.77 -36.55 64.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.148 1.379 . . . . 1.1 112.457 -174.564 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.76 -12.6 25.16 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.244 0.831 . . . . 2.25 113.244 176.79 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.26 44.72 1.23 Allowed Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.604 1.097 . . . . 0.68 111.18 169.687 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -141.62 174.04 10.94 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.554 0.741 . . . . 2.14 109.108 178.285 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -113.75 76.71 3.19 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 123.706 0.802 . . . . 4.1 112.177 -177.252 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.04 133.37 26.7 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.765 1.643 . . . . 1.4 111.929 -177.732 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.6 t -139.08 151.91 47.11 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.524 1.129 . . . . 2.83 108.208 167.425 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.5 mt -66.68 145.1 55.92 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.765 -1.198 . . . . 3.26 107.765 161.482 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.2 t -145.39 -77.54 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 105.297 -2.112 . . . . 4.0 105.297 175.824 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt 64.39 -73.04 0.06 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.08 1.352 . . . . 6.74 111.665 -179.126 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.1 mm -111.31 65.87 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 107.378 -1.342 . . . . 6.16 107.378 -176.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 124.639 1.175 . . . . 10.95 110.8 -173.852 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 108.542 -0.91 . . . . 13.23 108.542 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.69 62.59 0.82 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 106.846 -2.502 . . . . 6.02 106.846 -169.006 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -109.57 -128.97 0.28 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.963 0.905 . . . . 8.2 109.786 -153.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.07 -38.07 1.06 Allowed Glycine 0 C--N 1.335 0.507 0 N-CA-C 109.499 -1.44 . . . . 2.86 109.499 179.534 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.6 159.11 34.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 C-N-CA 123.306 0.643 . . . . 2.66 111.613 -176.774 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.9 tp -150.79 156.43 41.25 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.564 1.946 . . . . 2.15 106.34 174.171 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -124.04 155.09 38.92 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.761 0.824 . . . . 2.48 109.577 176.231 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.422 HD13 ' N ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -150.74 141.98 23.22 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.804 0.842 . . . . 2.72 109.126 175.192 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.6 t -90.97 131.32 38.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 C-N-CA 125.685 1.594 . . . . 0.85 107.142 177.123 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.619 HG12 ' HB3' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -126.35 78.43 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 122.454 1.121 . . . . 1.45 110.487 -166.539 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.9 mtm105 -58.34 133.34 55.63 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.041 -1.096 . . . . 5.57 108.041 170.254 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.32 -32.96 3.43 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.578 1.085 . . . . 0.96 110.391 -171.108 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 55.8 mtm -60.85 144.62 52.39 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.327 -1.102 . . . . 2.33 108.489 163.51 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 t -164.42 -65.56 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.777 0.431 . . . . 3.05 110.407 -177.273 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -79.46 -75.69 0.24 Allowed 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.131 -0.356 . . . . 3.75 111.78 -168.809 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -167.67 -66.1 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.322 0.649 . . . . 1.95 109.494 -175.573 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.6 t -49.53 -38.4 30.59 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.513 0.725 . . . . 2.25 111.52 -171.185 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.4 m -39.25 -37.97 0.47 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.999 1.32 . . . . 0.94 112.68 174.841 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.0 t -51.74 -71.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.401 0.68 . . . . 0.93 110.251 173.096 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -27.68 69.31 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.12 -0.988 . . . . 1.48 110.626 -176.611 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -54.25 -41.89 69.29 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 124.224 1.009 . . . . 3.04 109.425 174.878 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.6 mt -78.33 -64.23 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.499 -1.297 . . . . 0.82 107.499 176.071 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -48.86 -57.71 5.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.79 1.236 . . . . 3.19 111.07 -169.826 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 t -75.25 0.19 17.39 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.863 0.865 . . . . 1.84 112.27 -176.258 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.6 t -98.72 -37.36 9.51 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.662 1.185 . . . . 0.83 109.996 173.885 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.75 -45.29 90.52 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.844 0.747 . . . . 2.51 111.052 173.323 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.3 p -64.84 80.45 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.194 0.598 . . . . 2.04 110.817 -172.246 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt 164.95 -33.88 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.853 2.861 . . . . 5.06 110.766 -176.055 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -50.6 118.82 3.31 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.323 0.51 . . . . 1.92 110.036 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -71.09 77.56 0.68 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.009 0.923 . . . . 5.4 110.547 -168.448 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.53 -16.83 0.98 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.658 1.123 . . . . 1.17 111.27 -175.94 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.84 145.41 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 107.136 -1.431 . . . . 1.92 107.136 162.457 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.5 mt -108.2 -43.83 4.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.496 1.518 . . . . 2.89 108.761 170.275 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -164.5 159.77 19.71 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 108.578 -0.897 . . . . 2.73 108.578 -178.386 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.4 p -133.85 160.93 36.16 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.751 1.22 . . . . 2.84 107.919 173.603 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 m -153.42 117.44 4.81 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.509 -1.293 . . . . 1.96 107.509 161.26 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 p -106.2 153.16 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 118.712 0.687 . . . . 2.34 111.364 174.222 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.83 135.55 22.16 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.683 -0.635 . . . . 0.91 110.404 170.239 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.35 -37.6 63.47 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 115.45 -0.796 . . . . 1.37 110.493 -178.673 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.0 84.12 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.13 0.572 . . . . 1.15 110.604 179.806 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.84 -11.1 59.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.217 1.007 . . . . 2.38 111.107 175.643 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 46.44 40.33 7.85 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.737 2.015 . . . . 2.95 111.696 -167.604 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -132.25 144.17 50.43 Favored 'General case' 0 C--O 1.228 -0.034 0 CA-C-O 119.375 -0.345 . . . . 1.63 111.126 -167.622 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.0 136.63 44.11 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.331 -0.989 . . . . 0.86 108.331 155.826 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.31 145.17 25.83 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.41 -1.329 . . . . 1.46 107.41 148.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.5 mt -125.68 132.71 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.086 -1.449 . . . . 2.02 107.086 167.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -96.87 128.95 44.32 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.382 -2.081 . . . . 2.63 105.382 160.502 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -166.66 161.36 15.72 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.684 1.594 . . . . 2.43 108.757 -176.686 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -97.01 109.5 49.46 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 123.419 0.687 . . . . 3.36 109.433 176.574 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.52 29.07 0.43 Allowed 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.605 2.204 . . . . 1.61 113.254 -176.361 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -123.12 1.36 9.17 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.619 1.168 . . . . 3.48 111.017 -176.866 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -129.64 -67.88 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.229 0 C-N-CA 123.514 0.726 . . . . 1.47 110.488 178.443 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 tt -80.0 -49.12 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.515 0.674 . . . . 1.72 110.424 -175.139 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.26 161.35 34.21 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.109 0.862 . . . . 0.97 111.953 174.935 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.8 -34.94 47.76 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.482 2.788 . . . . 1.05 111.715 -177.4 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -53.44 -58.96 5.28 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.702 0.801 . . . . 5.65 111.284 -175.586 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -44.96 -57.31 3.89 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.226 1.01 . . . . 2.81 110.752 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 76.9 mt -56.09 -61.63 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 114.588 -1.187 . . . . 1.04 109.835 -177.358 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.0 mt -58.09 -42.66 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 121.937 -0.477 . . . . 1.41 111.098 -176.097 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 57.7 m170 -58.46 -46.58 86.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.778 0.717 . . . . 3.51 109.959 176.116 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 m -58.45 -57.48 12.74 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.414 -0.587 . . . . 0.77 109.414 177.857 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.5 mm -61.45 -35.23 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.817 0.735 . . . . 1.83 111.662 -174.292 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -53.11 -68.8 0.14 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.293 -0.632 . . . . 3.44 109.293 168.372 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.6 t -62.38 -21.16 65.13 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.897 0.702 . . . . 1.43 112.897 -174.087 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.4 tp -65.65 -18.44 65.33 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.264 1.425 . . . . 2.47 111.097 174.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.17 43.56 0.6 Allowed Glycine 0 C--N 1.337 0.591 0 C-N-CA 125.285 1.421 . . . . 0.69 110.851 168.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.619 ' HB3' HG12 ' A' ' 10' ' ' VAL . 64.1 m-85 -146.54 178.83 7.98 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 117.394 0.597 . . . . 1.77 110.028 -177.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.99 87.5 47.23 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 123.848 0.859 . . . . 5.44 109.851 172.385 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.16 75.86 4.06 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 124.303 3.335 . . . . 1.86 111.015 -175.379 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.3 t -71.82 150.81 43.98 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.161 -0.681 . . . . 2.38 109.161 175.111 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.2 tp -60.27 144.92 49.24 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.919 -1.511 . . . . 3.46 106.919 164.156 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.3 t -59.7 -57.01 13.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 N-CA-C 109.83 -0.433 . . . . 4.58 109.83 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.9 tptp 66.89 129.25 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.713 2.005 . . . . 8.44 110.814 -168.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 44.6 mm -73.85 118.4 19.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.262 -1.384 . . . . 5.91 107.262 171.543 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 . . . . . 0 C--O 1.248 1.022 0 C-N-CA 129.559 3.143 . . . . 10.41 103.932 178.894 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.455 -0.184 0 N-CA-C 109.128 -0.693 . . . . 2.33 109.128 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 tp -144.69 142.32 29.98 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.156 -1.054 . . . . 2.47 108.156 168.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -101.14 132.88 46.39 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.975 0.91 . . . . 2.47 109.487 166.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -132.6 162.18 31.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.934 1.294 . . . . 1.88 107.644 166.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 t -117.7 133.09 65.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 126.166 1.786 . . . . 1.26 107.108 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.48 99.36 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 C-N-CA 124.086 0.954 . . . . 1.34 110.891 -168.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.4 mtt85 -68.84 150.64 47.58 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.924 -1.139 . . . . 5.02 107.924 171.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.72 -5.14 39.95 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.215 0.912 . . . . 0.97 113.67 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 69.7 mtm -74.17 69.2 1.51 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.831 1.315 . . . . 2.1 112.543 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 t -65.82 126.35 28.2 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.214 0.531 . . . . 3.55 111.817 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 t 52.02 82.42 0.07 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.811 2.044 . . . . 3.15 114.391 156.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 50.77 -101.83 0.1 Allowed 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.614 1.166 . . . . 2.04 110.229 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 9.85 -71.65 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 129.99 3.316 . . . . 1.83 115.781 172.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.7 m -36.78 -46.49 0.61 Allowed 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 125.589 1.555 . . . . 0.99 112.516 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.1 t -36.42 -68.12 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.027 1.331 . . . . 0.89 111.579 168.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -29.0 65.78 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.896 -0.503 . . . . 1.19 110.072 -175.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -38.29 77.37 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.531 0.733 . . . . 3.37 109.59 177.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.477 HD12 HG11 ' A' ' 37' ' ' VAL . 95.7 mt -74.41 -68.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 106.422 -1.696 . . . . 0.89 106.422 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -48.0 -56.34 7.9 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.311 1.444 . . . . 3.08 111.369 -166.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 t -60.99 -42.3 98.15 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.586 0.708 . . . . 1.39 109.992 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.3 t -65.95 -49.45 67.88 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.224 -0.658 . . . . 0.99 109.224 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.41 -39.44 83.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.023 -1.048 . . . . 2.4 111.301 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.2 p -58.34 -11.24 2.59 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.934 1.087 . . . . 1.67 113.934 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -68.7 -34.95 76.52 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.505 1.048 . . . . 3.79 111.592 170.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -62.71 122.06 14.94 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.784 0.434 . . . . 1.87 110.509 -167.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -76.56 65.9 2.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.209 1.004 . . . . 6.12 110.824 -172.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.78 9.31 0.02 OUTLIER Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.953 1.739 . . . . 1.13 112.504 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -103.19 132.98 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.778 1.631 . . . . 1.77 106.765 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -90.17 -56.87 3.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.51 1.124 . . . . 2.79 108.777 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -148.64 136.58 20.82 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.101 0.56 . . . . 2.67 111.549 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.0 m -106.51 161.78 14.3 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.933 0.893 . . . . 1.76 109.035 172.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.1 m -150.84 96.95 2.41 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.089 0.555 . . . . 1.67 109.675 162.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.477 HG11 HD12 ' A' ' 22' ' ' ILE . 38.9 t -90.58 86.2 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 C-N-CA 126.147 1.779 . . . . 2.33 109.341 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.86 129.41 34.84 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 121.323 -0.861 . . . . 1.02 110.946 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -77.83 -45.63 23.82 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.516 -0.766 . . . . 2.04 111.063 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.58 -45.88 90.56 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.299 0.571 . . . . 1.42 110.352 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -10.5 59.66 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.463 1.105 . . . . 2.58 111.513 176.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 51.72 31.04 7.46 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.203 1.801 . . . . 2.69 111.802 -171.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -117.21 133.83 55.51 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.641 0.777 . . . . 1.89 109.632 -165.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.94 114.39 28.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.648 -1.242 . . . . 0.7 107.648 161.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.3 142.3 27.86 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.94 -1.133 . . . . 1.04 107.94 159.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 mp -127.93 127.64 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 106.581 -1.637 . . . . 1.05 106.581 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -98.51 80.85 2.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.364 1.466 . . . . 3.26 108.376 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -116.95 165.46 13.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.591 1.556 . . . . 2.31 110.883 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -81.13 115.77 58.3 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 122.589 0.356 . . . . 3.44 110.511 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.88 -13.06 21.79 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.79 2.327 . . . . 1.68 113.92 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -81.93 -45.97 14.69 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 119.316 0.962 . . . . 4.39 108.956 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pt -81.92 -89.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.08 0.4 . . . . 2.05 112.08 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 tt -57.38 -47.02 85.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.806 1.242 . . . . 1.2 111.09 -173.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.42 164.29 28.02 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 121.512 0.507 . . . . 1.19 112.681 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.22 -37.57 31.16 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.058 3.172 . . . . 1.1 112.215 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.418 ' HE ' ' CD2' ' A' ' 60' ' ' HIS . 1.8 tpm_? -60.08 -50.17 74.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.442 0.697 . . . . 7.35 110.902 -168.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -50.21 -56.3 11.65 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.978 0.911 . . . . 2.43 110.037 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.9 mt -53.6 -60.6 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.496 1.118 . . . . 0.74 109.745 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.4 mt -50.69 -43.54 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 118.641 0.655 . . . . 1.68 111.208 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.418 ' CD2' ' HE ' ' A' ' 56' ' ' ARG . 61.5 m-70 -76.37 -30.94 57.77 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.363 -0.836 . . . . 3.18 112.272 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.6 m -61.67 -49.76 75.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.401 -0.962 . . . . 0.82 108.401 171.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -59.58 -49.03 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.716 1.206 . . . . 1.51 109.814 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -48.84 -61.16 2.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.307 1.443 . . . . 3.53 109.252 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.0 t -59.5 -31.76 69.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.202 1.001 . . . . 1.2 112.646 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.2 mt -67.06 -14.34 62.8 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.63 -0.7 . . . . 1.99 111.526 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.23 49.4 1.14 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.451 -1.06 . . . . 0.74 110.451 168.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -141.37 169.25 17.96 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.355 1.062 . . . . 2.0 108.519 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -108.03 85.56 2.67 Favored Pre-proline 0 CA--C 1.529 0.139 0 CA-C-O 117.361 -1.304 . . . . 3.76 112.943 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 75.52 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.847 2.365 . . . . 1.46 112.133 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.1 m -66.91 143.16 57.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.646 -0.872 . . . . 2.04 108.646 166.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.4 mt . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 121.867 0.841 . . . . 3.13 109.266 171.942 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.5 t . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 108.595 -0.891 . . . . 2.33 108.595 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -90.18 99.07 12.16 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.905 -1.517 . . . . 3.27 106.905 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.2 142.63 50.63 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.026 -0.361 . . . . 2.58 110.026 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 131.83 55.76 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.133 -1.432 . . . . 1.59 107.133 166.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 t -70.02 133.76 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 105.343 -2.095 . . . . 1.29 105.343 165.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.94 114.69 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.413 1.085 . . . . 1.24 108.093 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -74.05 155.27 38.7 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.429 -0.952 . . . . 5.4 108.429 171.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.6 -20.86 10.86 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.191 -0.783 . . . . 0.99 114.115 164.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -73.63 73.5 1.49 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.537 1.669 . . . . 1.93 109.921 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 t -59.58 -34.72 73.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.869 0.868 . . . . 2.97 111.805 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.1 m -144.83 -167.01 2.55 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.284 -1.006 . . . . 3.99 108.284 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.36 -174.05 0.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.622 0.769 . . . . 2.78 111.057 173.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m 72.52 -58.53 0.59 Allowed 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 125.108 1.363 . . . . 1.95 110.5 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.6 m -40.4 -46.71 2.44 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.714 1.206 . . . . 0.86 110.491 168.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.4 t -38.11 -69.61 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.272 1.029 . . . . 0.8 111.3 169.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -26.51 62.46 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.58 -0.7 . . . . 1.28 111.236 -175.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -50.81 -40.44 55.47 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 108.881 -0.785 . . . . 3.13 108.881 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.6 mt -81.25 -69.14 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 108.065 -1.087 . . . . 0.81 108.065 172.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -46.52 -55.94 6.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.661 1.584 . . . . 3.27 111.928 -169.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 t -62.02 -38.62 89.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.711 0.804 . . . . 1.44 109.973 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.5 t -72.97 -27.55 61.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.992 0.517 . . . . 1.01 110.878 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.89 -44.51 55.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.709 0.804 . . . . 1.96 110.218 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.6 p -65.17 80.55 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.242 0.617 . . . . 1.78 110.373 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 165.91 -26.18 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.773 2.829 . . . . 3.69 111.415 -174.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -66.44 76.25 0.1 Allowed 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.484 1.038 . . . . 2.22 110.378 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -42.17 97.74 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.417 1.887 . . . . 5.73 110.948 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.39 -40.93 0.91 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.386 -1.486 . . . . 1.48 109.386 -165.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.47 154.93 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.941 -0.762 . . . . 3.22 108.941 156.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.05 -23.89 10.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.906 0.883 . . . . 2.52 110.812 165.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -159.44 155.02 25.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.696 0.68 . . . . 2.04 109.3 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.3 t -136.48 147.84 47.36 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.197 1.399 . . . . 2.05 108.014 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.5 m -146.05 131.55 18.74 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.62 -0.881 . . . . 1.78 108.62 151.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.3 m -111.69 163.73 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 123.234 0.614 . . . . 1.69 109.994 173.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.13 137.15 11.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.774 -0.579 . . . . 0.89 111.297 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 pp -72.98 -41.25 64.55 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.948 1.299 . . . . 1.42 111.262 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.45 -27.56 69.2 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.105 0.562 . . . . 1.09 111.376 -171.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.445 HG23 ' HG2' ' A' ' 43' ' ' LYS . 4.4 t -114.97 6.64 15.36 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.925 1.29 . . . . 2.15 110.579 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.3 m120 51.2 45.53 27.74 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.741 1.616 . . . . 2.86 111.609 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HG2' HG23 ' A' ' 41' ' ' THR . 15.6 ptpt -141.74 162.13 36.23 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 113.504 0.927 . . . . 1.77 113.504 -174.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.45 120.72 34.75 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.491 1.916 . . . . 0.8 106.889 167.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.21 135.38 39.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.587 -1.264 . . . . 1.26 107.587 161.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -119.27 135.84 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 104.236 -2.505 . . . . 1.04 104.236 168.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -97.46 112.13 24.1 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.141 -1.8 . . . . 3.48 106.141 165.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -150.48 160.79 43.52 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 122.989 0.516 . . . . 2.36 110.029 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -87.61 112.6 49.65 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 108.455 -0.943 . . . . 4.42 108.455 169.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.86 -18.45 36.53 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.078 1.852 . . . . 1.48 112.595 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -69.82 -38.93 76.73 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.683 1.129 . . . . 3.88 110.913 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -83.2 -56.16 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 112.381 0.512 . . . . 1.72 112.381 -172.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 tt -98.13 -51.16 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.268 0.627 . . . . 1.31 110.694 -172.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.73 163.7 37.04 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 115.846 -0.615 . . . . 0.87 113.153 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.84 -37.23 28.21 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 124.161 3.24 . . . . 1.01 112.527 -175.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -52.73 -49.17 65.95 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.902 0.481 . . . . 5.22 112.019 -174.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -48.73 -60.5 2.68 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.925 0.89 . . . . 3.03 110.082 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.4 mt -56.19 -54.31 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.01 1.324 . . . . 0.78 110.35 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.7 mt -54.44 -58.29 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.609 0.764 . . . . 1.33 110.173 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -62.77 -34.73 77.85 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.384 0.611 . . . . 5.06 110.636 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 83.5 m -62.36 -51.71 66.51 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.349 -0.844 . . . . 0.67 109.717 173.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.8 -37.77 80.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 121.299 -0.876 . . . . 1.75 111.649 -175.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -47.79 -50.97 24.23 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.866 0.866 . . . . 2.56 108.767 167.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.8 t -65.26 -45.58 83.99 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.287 0.477 . . . . 1.46 112.287 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.47 -32.03 69.87 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.37 -0.831 . . . . 1.9 110.769 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.23 45.9 0.56 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.196 -0.762 . . . . 0.91 111.196 161.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -136.16 161.14 36.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.035 -1.469 . . . . 2.21 107.035 174.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -106.38 85.66 1.82 Allowed Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 118.045 -0.979 . . . . 4.32 113.139 -165.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.61 134.12 31.88 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.533 2.155 . . . . 1.67 112.889 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.8 t -143.46 172.68 12.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.787 1.635 . . . . 2.52 106.897 162.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 CA--C 1.534 0.334 0 C-N-CA 122.953 0.501 . . . . 4.92 111.416 -177.58 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 121.616 0.722 . . . . 2.33 110.888 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.98 146.56 51.01 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.466 -1.309 . . . . 2.86 107.466 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -125.85 150.17 48.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.459 -0.941 . . . . 2.21 108.459 159.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.427 ' CD1' ' HB3' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -135.91 118.2 15.62 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.189 -1.412 . . . . 1.61 107.189 172.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.26 122.57 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 106.528 -1.656 . . . . 1.41 106.528 165.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.35 137.43 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.903 0.881 . . . . 2.45 109.576 -172.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -120.7 168.51 11.33 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.684 0.794 . . . . 6.51 110.688 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.56 -19.47 11.46 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 125.101 1.334 . . . . 0.87 112.396 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.3 mtm -60.41 113.35 2.36 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.838 0.819 . . . . 1.6 111.272 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.9 p -77.14 -42.34 38.28 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.771 0.828 . . . . 4.12 111.414 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.4 t -162.64 171.76 16.4 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.579 0.752 . . . . 3.34 109.103 -165.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.07 -35.7 2.24 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.916 1.686 . . . . 2.34 112.661 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -47.98 -53.37 16.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.172 0.589 . . . . 1.93 110.882 171.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.7 m -62.47 -43.99 97.48 Favored 'General case' 0 CA--C 1.522 -0.104 0 O-C-N 121.627 -0.67 . . . . 0.83 110.118 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.6 t -49.2 -59.83 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 109.256 -0.646 . . . . 0.85 109.256 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -26.62 66.33 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.702 -0.399 . . . . 1.51 111.341 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -60.26 -51.58 68.95 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.587 -0.894 . . . . 2.79 108.587 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.5 mt -62.86 -57.15 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.753 -1.573 . . . . 0.61 106.753 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -52.79 -53.63 45.53 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 123.993 0.808 . . . . 3.27 110.073 -173.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.6 t -58.94 -53.2 61.03 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.498 -0.556 . . . . 1.36 109.498 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.9 t -63.98 -20.01 65.58 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 118.571 -0.728 . . . . 0.9 112.609 -176.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.41 -47.74 10.36 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.29 -0.862 . . . . 2.14 111.251 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.3 p -50.88 -26.85 6.35 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.158 0.89 . . . . 1.8 113.025 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -25.11 66.44 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.752 1.39 . . . . 3.23 114.752 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -67.77 129.14 39.0 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 120.199 1.363 . . . . 1.92 110.594 -174.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.73 71.63 1.45 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.555 -0.715 . . . . 7.12 109.595 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.42 -40.13 0.07 OUTLIER Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.612 -0.549 . . . . 1.18 113.254 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.93 158.01 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.078 0.939 . . . . 3.33 109.594 170.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 pp -107.94 -25.74 11.04 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.708 0.803 . . . . 2.99 110.206 164.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -158.44 149.21 20.41 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 118.773 0.715 . . . . 2.84 109.289 171.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.7 t -117.97 137.6 52.74 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 105.315 -2.106 . . . . 2.51 105.315 163.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.97 103.8 6.5 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.186 -1.413 . . . . 1.25 107.186 173.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 44' ' ' ALA . 1.1 p -103.68 151.11 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 118.436 0.562 . . . . 2.26 112.13 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.92 136.24 16.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.11 0.481 . . . . 0.78 110.73 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.05 -31.92 56.52 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.107 0.963 . . . . 1.87 111.335 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.94 -52.86 62.64 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.211 0.604 . . . . 1.14 109.915 175.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.98 -30.41 68.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.845 0.858 . . . . 1.94 109.446 173.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.256 0.0 OUTLIER 52.72 56.29 7.82 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.023 -1.473 . . . . 3.08 107.023 -164.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -140.85 143.61 34.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.613 -1.176 . . . . 1.39 109.086 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.464 ' HB2' HG23 ' A' ' 37' ' ' VAL . . . -109.73 129.16 55.64 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.421 -1.326 . . . . 0.7 107.421 155.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.67 145.81 24.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.616 -1.253 . . . . 0.96 107.616 154.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -129.21 117.88 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 106.61 -1.626 . . . . 0.89 106.61 170.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -88.21 125.99 34.92 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.575 -1.639 . . . . 2.1 106.575 167.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -170.45 151.97 3.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.396 0.678 . . . . 2.17 110.331 -167.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -77.64 118.78 74.27 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.499 -1.297 . . . . 3.56 107.499 168.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.11 -18.61 23.68 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.441 2.094 . . . . 1.09 112.37 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -74.62 -51.27 14.94 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.6 0.636 . . . . 4.28 109.364 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 pt -69.72 -54.96 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 112.566 0.58 . . . . 1.21 112.566 -168.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 tt -98.96 -48.83 11.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 123.662 0.785 . . . . 1.33 110.913 -169.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.33 157.77 26.87 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.226 0.917 . . . . 0.71 111.85 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.02 -25.23 32.22 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 124.026 3.15 . . . . 0.66 113.34 -172.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -55.15 -51.62 65.89 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.316 0.507 . . . . 5.61 111.226 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -42.6 -61.92 1.11 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.192 1.397 . . . . 3.36 109.9 176.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mt -51.44 -63.46 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 124.785 1.234 . . . . 0.81 110.685 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.5 mt -49.93 -43.76 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.573 0.624 . . . . 1.32 111.228 -175.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -75.92 -31.53 59.18 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.064 0.546 . . . . 2.43 111.391 -176.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.7 m -62.6 -53.23 57.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.808 -0.812 . . . . 1.16 108.808 169.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.7 mm -55.93 -47.9 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.135 0.574 . . . . 1.55 110.2 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -49.13 -66.56 0.38 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.102 1.361 . . . . 2.65 109.753 170.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 t -51.95 -42.88 63.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.445 1.498 . . . . 1.19 112.598 -174.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.03 -14.58 55.34 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.782 -0.627 . . . . 1.79 112.658 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.01 47.4 1.35 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.75 -0.94 . . . . 0.62 110.75 172.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -135.74 168.63 18.94 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.049 0.939 . . . . 2.02 108.805 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -117.38 88.75 29.39 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-O 117.962 -1.018 . . . . 4.4 110.38 -173.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.04 108.93 0.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.181 2.588 . . . . 1.12 111.853 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.1 t -72.41 -165.85 0.22 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.8 0.81 . . . . 2.68 109.128 156.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.237 0.406 0 C-N-CA 124.422 1.089 . . . . 4.33 110.71 -174.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.231 0.125 0 N-CA-C 111.666 0.247 . . . . 2.46 111.666 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.5 tp -138.9 141.68 38.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.36 -0.978 . . . . 2.09 108.36 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -108.02 123.31 48.48 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.052 -1.462 . . . . 2.38 107.052 174.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.5 mt -106.87 122.17 45.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.108 -1.812 . . . . 2.26 106.108 172.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.87 118.56 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 106.082 -1.821 . . . . 0.92 106.082 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.9 m -117.4 115.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 123.573 0.749 . . . . 1.25 109.097 -169.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -83.88 175.0 9.92 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.561 -0.903 . . . . 6.36 108.561 168.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.6 -32.52 7.44 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.452 0.548 . . . . 1.14 112.737 172.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -61.4 138.74 58.27 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.684 1.242 . . . . 2.18 110.336 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -155.49 28.89 0.39 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.001 0.52 . . . . 3.09 111.066 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.2 t -167.87 141.58 3.4 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 107.79 -1.189 . . . . 3.47 107.79 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -38.38 -48.91 1.4 Allowed 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.001 1.32 . . . . 1.93 112.069 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.6 m -42.68 -40.97 2.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.601 1.16 . . . . 1.57 111.827 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.2 m -47.6 -39.61 17.23 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.739 0.816 . . . . 0.83 111.364 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.6 t -53.17 -61.9 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 123.295 0.638 . . . . 0.94 109.943 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -28.83 69.07 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.494 -0.558 . . . . 1.27 109.494 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -59.51 -52.79 64.05 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.958 -1.127 . . . . 2.92 107.958 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.94 -51.23 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.115 -1.068 . . . . 0.64 108.115 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -47.82 -61.97 1.69 Allowed 'General case' 0 C--N 1.341 0.229 0 O-C-N 123.901 0.75 . . . . 4.72 109.16 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -62.76 -43.32 99.1 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.974 0.91 . . . . 1.79 109.97 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.6 t -58.49 -30.02 66.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 118.798 -0.62 . . . . 1.12 111.489 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.446 HD21 HG23 ' A' ' 58' ' ' ILE . 6.1 mt -85.46 -48.48 8.94 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.253 0.835 . . . . 2.42 113.253 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.4 p -71.6 66.31 0.5 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.541 1.536 . . . . 1.86 110.742 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.99 -33.91 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.618 2.367 . . . . 3.82 110.832 -171.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -53.87 -29.69 42.6 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.733 1.012 . . . . 3.06 113.733 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? 60.4 67.75 0.82 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.739 -1.208 . . . . 6.33 107.739 -173.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.54 -51.22 0.07 OUTLIER Glycine 0 CA--C 1.52 0.373 0 N-CA-C 107.171 -2.372 . . . . 1.18 107.171 -171.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.556 HD11 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -42.04 132.01 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 123.486 0.715 . . . . 2.0 109.158 147.332 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.8 tp -95.4 -46.15 6.82 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.8 2.04 . . . . 2.58 107.9 160.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -154.79 138.16 15.83 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 122.908 0.483 . . . . 2.32 110.306 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -111.15 147.64 34.46 Favored 'General case' 0 CA--C 1.523 -0.084 0 N-CA-C 108.005 -1.109 . . . . 2.02 108.005 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.74 104.43 2.87 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.589 -0.893 . . . . 1.36 108.589 171.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.05 157.43 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 122.873 0.469 . . . . 1.81 111.477 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.62 136.66 17.37 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.611 0.765 . . . . 0.9 109.53 170.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.72 -38.17 64.89 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.622 -0.717 . . . . 1.53 110.722 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.05 -46.5 82.39 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.27 0.628 . . . . 1.24 110.89 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -74.74 -11.42 60.16 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.283 1.033 . . . . 2.52 110.871 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 49.78 41.91 22.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.394 1.878 . . . . 2.45 110.84 -172.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -137.61 147.68 45.19 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.291 -0.413 . . . . 1.2 111.26 -164.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.92 112.26 18.55 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.098 1.759 . . . . 0.69 107.422 164.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.78 143.05 27.16 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 166.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.653 HG21 HD13 ' A' ' 58' ' ' ILE . 4.5 mp -127.03 124.08 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 107.259 -1.386 . . . . 1.05 107.259 174.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -97.15 120.65 37.9 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.477 -1.675 . . . . 2.25 106.477 158.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.45 ' CD1' HG22 ' A' ' 46' ' ' ILE . 12.4 p90 -153.48 157.15 39.43 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.89 1.276 . . . . 2.07 107.773 -174.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -85.51 118.44 70.69 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 107.55 -1.278 . . . . 3.19 107.55 170.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.69 -31.41 40.19 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.714 1.609 . . . . 1.47 111.611 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -86.65 29.11 0.81 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.321 0.964 . . . . 3.64 111.378 -166.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 pt -142.77 -53.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 124.846 1.258 . . . . 1.26 110.384 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.4 tt -98.85 -45.55 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.764 0.826 . . . . 1.08 111.015 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.36 158.98 7.38 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.039 0.828 . . . . 0.76 111.251 -172.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.86 -23.78 40.93 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.804 2.336 . . . . 1.04 111.5 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -56.74 -55.13 38.13 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.571 1.148 . . . . 6.08 111.338 -175.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -52.59 -52.13 56.66 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 122.472 1.129 . . . . 2.62 109.824 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.653 HD13 HG21 ' A' ' 46' ' ' ILE . 51.7 mt -56.99 -57.87 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.049 1.339 . . . . 0.94 110.259 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.9 mt -51.12 -51.54 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 109.964 -0.384 . . . . 1.42 109.964 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -63.17 -34.73 78.26 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.73 0.696 . . . . 2.53 112.393 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.9 m -59.92 -56.83 16.92 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.608 -0.886 . . . . 0.64 108.608 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mm -62.11 -46.34 96.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 119.667 -0.206 . . . . 1.63 110.962 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -42.02 -57.76 2.33 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.461 1.504 . . . . 3.44 109.574 166.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 t -65.41 -9.03 21.76 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.353 1.242 . . . . 1.02 114.353 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.1 mt -83.44 -10.01 58.65 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 120.553 1.524 . . . . 2.02 111.128 170.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.34 40.56 28.16 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.056 -1.218 . . . . 0.96 110.056 -170.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -126.67 151.29 48.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.262 -1.755 . . . . 1.76 106.262 161.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -110.64 84.86 4.35 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 113.59 0.959 . . . . 5.54 113.59 -158.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.61 85.67 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.402 2.735 . . . . 1.2 113.756 -173.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.1 t -70.52 156.54 39.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.624 0.77 . . . . 2.53 109.878 161.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 109.549 -0.537 . . . . 4.64 109.549 161.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.7 t . . . . . 0 C--O 1.232 0.139 0 N-CA-C 108.122 -1.066 . . . . 2.05 108.122 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.2 tt -140.71 137.15 33.26 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.561 -0.903 . . . . 2.23 108.561 166.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -103.54 132.04 50.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.059 1.344 . . . . 2.26 109.416 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.08 131.81 42.75 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.67 0.788 . . . . 1.78 109.435 173.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.41 132.97 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.183 -2.155 . . . . 1.06 105.183 165.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.34 129.15 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.298 -1.001 . . . . 1.66 108.298 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -101.38 -176.85 3.27 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.213 -0.662 . . . . 4.25 109.213 170.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.98 -29.01 11.33 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.636 1.112 . . . . 1.26 110.698 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 73.2 mtm -57.71 120.71 8.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.964 -0.754 . . . . 2.0 108.964 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 t -155.84 43.92 0.43 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.831 0.824 . . . . 3.51 110.393 -170.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -164.08 -89.02 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.37 -0.831 . . . . 3.27 110.064 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -175.57 -62.3 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 125.428 1.491 . . . . 1.93 107.299 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 t -41.46 -46.16 3.37 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.706 1.202 . . . . 2.86 110.304 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.4 m -25.46 -48.4 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.63 1.972 . . . . 0.69 114.099 169.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.6 t -51.44 -64.2 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.26 0.624 . . . . 0.69 110.347 174.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -27.83 66.43 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.101 -0.999 . . . . 1.2 110.706 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.93 -44.01 70.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.126 1.37 . . . . 3.25 108.373 176.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.1 mt -72.69 -67.49 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 106.288 -1.745 . . . . 0.57 106.288 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -48.91 -56.17 9.6 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.612 1.165 . . . . 3.55 111.563 -166.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 m -68.95 -20.17 64.19 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.753 1.221 . . . . 2.83 111.792 -174.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.5 t -87.08 -48.89 7.7 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.027 -1.101 . . . . 1.18 108.027 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.27 -35.7 76.14 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.035 -1.041 . . . . 2.28 111.718 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 p -57.69 -18.94 23.63 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.483 0.92 . . . . 1.94 113.483 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.9 mtmt -63.02 -34.21 77.08 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.571 1.078 . . . . 3.84 110.28 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.44 ' HB3' HD12 ' A' ' 53' ' ' ILE . 16.8 m-70 -72.41 107.75 5.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.895 -1.15 . . . . 2.14 107.895 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -52.52 -26.12 12.22 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.006 1.113 . . . . 4.81 114.006 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.09 -21.23 69.71 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 118.198 0.454 . . . . 1.18 113.05 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.76 124.31 14.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 118.965 1.382 . . . . 2.97 108.689 171.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.5 tp -84.45 -45.31 12.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.732 -1.21 . . . . 3.26 107.732 162.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -163.62 114.44 1.36 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 119.152 -0.451 . . . . 3.07 111.042 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.7 m -77.92 161.9 27.21 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.713 -0.847 . . . . 2.13 108.713 166.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -166.18 94.5 0.55 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.399 -0.963 . . . . 2.33 108.399 170.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 p -104.87 147.99 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 123.428 0.691 . . . . 2.11 112.075 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.9 135.02 30.87 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.635 0.774 . . . . 0.69 109.904 174.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.93 -39.87 63.5 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.31 -0.859 . . . . 1.41 110.728 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.36 -46.33 80.07 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.134 0.574 . . . . 0.96 110.349 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.19 -15.49 60.56 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.131 0.972 . . . . 1.95 111.086 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.39 36.32 26.85 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.676 0.79 . . . . 2.69 109.155 -172.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -135.69 135.6 40.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 122.411 0.284 . . . . 1.5 110.575 -168.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.06 124.69 49.96 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.594 -1.262 . . . . 0.77 107.594 160.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.79 147.51 25.99 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.674 -1.232 . . . . 1.43 107.674 155.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.4 mp -130.17 139.15 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 107.139 -1.43 . . . . 1.05 107.139 166.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -97.18 123.73 41.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.79 -1.559 . . . . 2.91 106.79 161.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -168.58 171.43 8.86 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.835 -1.172 . . . . 2.51 107.835 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.74 110.16 30.05 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-N 119.015 0.825 . . . . 3.89 109.364 175.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.28 51.32 3.16 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.694 2.263 . . . . 2.58 110.365 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -145.44 -60.5 0.34 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.922 1.689 . . . . 4.39 107.598 -159.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 pt -94.57 -60.37 2.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 C-N-CA 123.893 0.877 . . . . 1.49 111.469 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.44 HD12 ' HB3' ' A' ' 29' ' ' HIS . 10.7 tt -72.28 -52.71 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.246 -1.02 . . . . 1.9 108.246 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.8 160.69 24.28 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.287 -0.869 . . . . 0.82 112.02 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -57.37 -39.69 87.53 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.755 2.97 . . . . 0.78 110.909 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -59.44 -53.9 52.8 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.251 0.463 . . . . 6.77 112.251 -171.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -52.67 -46.74 67.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.897 0.856 . . . . 2.55 109.75 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.96 -66.45 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.827 -1.079 . . . . 1.0 110.025 172.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.353 2.7 pp -61.62 -28.88 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 121.075 1.762 . . . . 3.82 114.366 -174.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.49 -51.77 66.13 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 118.819 0.736 . . . . 3.23 109.139 173.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.0 m -57.39 -52.34 65.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.567 -0.531 . . . . 0.63 109.567 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mm -56.35 -49.6 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.516 1.126 . . . . 1.4 110.181 -175.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -48.4 -62.84 1.29 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.39 1.076 . . . . 3.91 109.675 170.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -62.47 -23.89 67.16 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.79 -0.641 . . . . 1.18 112.286 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -82.7 -5.16 58.73 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.951 1.7 . . . . 2.32 110.966 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.38 48.36 1.56 Allowed Glycine 0 CA--C 1.525 0.696 0 C-N-CA 125.103 1.335 . . . . 0.94 111.803 167.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -141.61 162.54 35.23 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.794 0.838 . . . . 2.03 109.902 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -109.66 93.2 13.68 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-O 117.95 -1.024 . . . . 4.41 109.578 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.78 136.78 6.28 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 121.553 1.502 . . . . 1.49 112.826 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.3 m -135.79 117.5 15.01 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 126.02 1.728 . . . . 1.92 107.751 170.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 CA--C 1.531 0.215 0 C-N-CA 122.438 0.295 . . . . 3.18 110.482 175.255 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 107.191 -1.411 . . . . 1.96 107.191 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.409 HD12 HD23 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -127.22 127.27 44.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.678 -1.601 . . . . 2.55 106.678 174.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.37 117.69 35.08 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.72 -1.215 . . . . 2.18 107.72 170.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.409 HD23 HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -110.12 141.82 42.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.298 -1.371 . . . . 1.88 107.298 172.009 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.85 135.79 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 106.357 -1.72 . . . . 0.85 106.357 167.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.26 108.74 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 C-N-CA 125.853 1.661 . . . . 1.26 108.869 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -67.48 158.48 31.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.688 -0.856 . . . . 5.67 108.688 160.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.02 -23.58 7.69 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.03 0.824 . . . . 1.14 113.111 163.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -70.44 85.59 0.61 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.819 1.309 . . . . 2.16 112.6 -175.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.3 t -76.79 100.41 5.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.02 0.914 . . . . 3.09 110.845 175.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.4 t 68.62 -76.33 0.06 Allowed 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 115.21 1.559 . . . . 3.99 115.21 164.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.41 170.34 15.99 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 123.864 0.865 . . . . 3.33 108.709 -171.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m 69.7 -58.48 0.52 Allowed 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 124.978 1.311 . . . . 1.84 111.034 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.8 m -44.21 -47.16 9.21 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 124.924 1.289 . . . . 0.85 111.512 -177.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.6 t -42.99 -64.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.45 0.7 . . . . 0.88 110.197 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -25.9 61.11 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.861 -0.524 . . . . 1.44 111.395 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -51.53 -41.61 61.16 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.767 0.827 . . . . 3.24 108.824 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.6 mt -80.23 -65.91 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.682 -1.229 . . . . 0.64 107.682 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.0 -56.62 7.23 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.013 1.325 . . . . 3.29 111.311 -169.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 t -65.23 -45.12 85.9 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.897 0.879 . . . . 1.36 110.12 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 t -62.16 -29.6 70.47 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 119.161 -0.447 . . . . 0.89 111.388 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.39 -55.22 5.04 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.957 -0.544 . . . . 2.61 111.311 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.9 p -68.83 66.08 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.962 1.305 . . . . 2.06 111.956 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.87 -42.33 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.77 1.628 . . . . 4.27 110.779 -170.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -72.99 150.32 42.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.04 -0.726 . . . . 3.63 109.04 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -60.69 160.07 9.86 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.919 -0.401 . . . . 5.4 109.919 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.2 -5.09 81.66 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.028 -0.873 . . . . 1.8 113.111 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.553 HD11 ' SG ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -99.18 146.43 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 106.712 -1.588 . . . . 1.93 106.712 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.9 tp -104.53 -48.74 3.73 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.681 1.192 . . . . 2.77 110.603 172.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -164.95 162.4 20.58 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.007 0.923 . . . . 2.5 108.761 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' HD11 ' A' ' 32' ' ' ILE . 56.0 m -138.15 161.34 37.06 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 119.332 0.969 . . . . 1.85 108.538 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.6 t -155.0 133.62 12.01 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.774 -0.824 . . . . 2.35 108.774 150.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 m -115.94 155.81 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.369 0.668 . . . . 1.73 111.036 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.39 137.69 16.6 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.101 0.561 . . . . 1.01 110.88 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -79.24 -34.83 42.36 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 124.559 1.144 . . . . 1.72 112.521 -174.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.82 -41.34 91.05 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 109.596 -0.52 . . . . 1.11 109.596 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.3 t -92.9 -6.36 48.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.533 -0.746 . . . . 2.07 111.297 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.269 0.0 OUTLIER 39.32 60.69 1.48 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 126.576 1.951 . . . . 2.83 109.791 -172.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -131.38 147.13 52.54 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.201 1.4 . . . . 2.05 108.866 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.93 120.71 38.09 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.938 -1.504 . . . . 0.63 106.938 159.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.01 138.18 31.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.043 -1.466 . . . . 1.58 107.043 161.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.63 130.3 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.619 -1.252 . . . . 1.05 107.619 169.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -101.06 139.26 37.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.085 -1.82 . . . . 2.4 106.085 161.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -175.18 177.38 1.91 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.371 1.468 . . . . 2.49 108.777 -160.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -112.85 81.33 4.4 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 125.241 1.416 . . . . 4.09 107.544 -170.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.74 -43.53 55.05 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.421 2.747 . . . . 1.23 113.902 -167.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.33 -23.72 65.94 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.239 0.829 . . . . 3.72 113.239 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.8 pt -100.75 -58.17 4.05 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 118.888 0.767 . . . . 1.52 112.629 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.7 tt -89.32 -45.35 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 121.356 0.598 . . . . 1.2 110.425 -171.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.68 151.47 13.87 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.859 0.742 . . . . 1.02 111.815 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -66.42 -31.42 42.63 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.389 2.726 . . . . 1.48 111.866 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -56.55 -43.17 79.65 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.91 -0.494 . . . . 6.16 111.452 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -53.99 -53.01 58.81 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 121.225 0.536 . . . . 2.71 109.732 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.3 mt -57.58 -49.15 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 124.276 1.03 . . . . 0.82 110.25 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.4 mt -54.85 -56.74 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 110.151 -0.314 . . . . 1.44 110.151 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -60.88 -36.96 80.53 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.742 0.701 . . . . 2.63 112.027 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.7 m -59.21 -51.16 71.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.479 -0.763 . . . . 0.91 109.095 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.7 mt -65.25 -43.03 95.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 121.508 -0.745 . . . . 2.22 111.753 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -49.48 -49.76 44.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.425 1.09 . . . . 3.05 108.356 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 t -64.96 -44.31 89.8 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.57 0.748 . . . . 1.04 111.419 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.6 mt -63.47 -30.41 71.54 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.5 -0.75 . . . . 2.16 110.651 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.07 53.45 0.2 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.44 -0.664 . . . . 0.95 111.44 156.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -137.47 175.28 9.74 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.709 -0.849 . . . . 1.98 108.709 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -106.65 77.15 0.46 Allowed Pre-proline 0 N--CA 1.47 0.547 0 CA-C-O 117.734 -1.127 . . . . 4.35 111.76 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.68 71.79 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.662 2.908 . . . . 1.27 112.37 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.7 m -74.38 117.84 16.65 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.357 1.063 . . . . 2.08 108.49 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tt . . . . . 0 N--CA 1.451 -0.393 0 C-N-CA 124.086 0.954 . . . . 3.09 109.466 -179.941 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.347 1.2 m . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 122.796 1.284 . . . . 3.04 113.161 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -74.07 99.28 3.3 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.557 -1.275 . . . . 2.57 107.557 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -78.22 117.94 19.97 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.848 0.356 . . . . 2.59 110.046 169.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 pp -108.21 133.99 51.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.544 -1.28 . . . . 1.87 107.544 160.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.1 t -85.63 136.67 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 105.563 -2.014 . . . . 1.38 105.563 169.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -156.38 112.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 108.499 -0.926 . . . . 2.33 108.499 -163.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -96.89 178.71 5.2 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.326 -0.99 . . . . 4.56 108.326 174.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.08 -36.99 4.04 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.375 -1.09 . . . . 0.95 110.375 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.6 ptp -57.08 123.11 14.08 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.811 -0.811 . . . . 2.06 108.811 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.0 t -149.07 21.54 0.97 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.368 0.507 . . . . 2.87 112.368 -167.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.5 t -162.98 142.74 9.0 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 106.097 -1.816 . . . . 3.75 106.097 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.58 -49.27 5.46 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.755 1.222 . . . . 2.02 111.817 -173.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -37.2 -47.45 0.79 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.082 1.753 . . . . 1.65 112.45 174.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.7 m -52.62 -43.62 65.5 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 124.102 0.961 . . . . 0.96 110.864 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.9 t -54.62 -61.49 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.479 -0.934 . . . . 0.75 108.479 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -24.66 67.02 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.241 -0.89 . . . . 1.47 109.792 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -65.25 -52.73 52.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.977 0.808 . . . . 4.57 108.96 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.7 mt -58.79 -54.49 32.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.834 -1.173 . . . . 0.63 107.834 -172.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -38.35 -69.34 0.12 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.369 1.468 . . . . 3.16 111.588 165.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -53.21 -50.35 64.89 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.642 1.177 . . . . 1.73 110.71 -171.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -33.13 73.56 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.154 1.382 . . . . 0.99 110.469 -177.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.8 mt -77.25 -47.54 19.86 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.828 0.451 . . . . 2.21 111.155 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.4 p -66.99 74.57 0.11 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.578 1.151 . . . . 1.75 110.079 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 163.13 -9.63 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.501 2.72 . . . . 3.63 113.284 -171.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -69.67 -101.45 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 121.76 2.073 . . . . 3.07 110.01 170.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -167.8 158.85 11.19 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.059 -2.2 . . . . 6.2 105.059 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.11 -58.44 2.3 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.688 -0.565 . . . . 1.88 111.688 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -38.74 99.92 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 126.905 2.082 . . . . 2.08 111.258 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.4 mt -82.46 -44.64 15.76 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.497 1.919 . . . . 2.94 108.694 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -145.36 150.12 36.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.218 1.007 . . . . 2.28 109.926 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -131.24 154.48 48.41 Favored 'General case' 0 C--O 1.231 0.082 0 N-CA-C 107.01 -1.478 . . . . 1.97 107.01 169.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.7 m -152.41 141.93 21.72 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.044 -0.725 . . . . 2.05 109.044 150.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.43 HG12 ' CB ' ' A' ' 44' ' ' ALA . 1.5 m -119.59 168.19 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.365 0.666 . . . . 1.73 111.355 170.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.01 139.66 13.78 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.631 0.772 . . . . 0.88 109.853 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.32 -36.05 22.84 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.994 0.918 . . . . 1.63 112.236 -172.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.29 -39.04 81.7 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.67 -0.493 . . . . 1.12 109.67 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 t -97.17 -4.63 38.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.151 -0.928 . . . . 2.14 111.394 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.38 61.3 2.06 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.221 1.808 . . . . 2.81 109.13 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -135.27 145.36 47.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.736 -1.12 . . . . 1.45 108.614 -171.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.43 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -127.84 123.44 35.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.14 -1.43 . . . . 0.66 107.14 164.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -103.92 130.69 51.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.098 -1.075 . . . . 1.39 108.098 169.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.85 124.35 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.746 -0.835 . . . . 0.91 108.746 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -97.48 82.16 3.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.743 0.817 . . . . 2.19 108.869 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -122.77 151.18 41.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.749 1.22 . . . . 2.22 109.956 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.77 114.06 22.01 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 109.511 -0.552 . . . . 3.25 109.511 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.95 -25.85 59.32 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.046 1.831 . . . . 1.19 113.225 -176.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -54.5 -30.36 53.1 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.839 1.256 . . . . 4.11 113.453 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 pt -105.57 -92.74 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.366 0.666 . . . . 2.15 111.854 -172.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 tt -49.7 -52.37 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.982 1.313 . . . . 1.37 112.291 -174.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.44 162.1 35.5 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.992 0.806 . . . . 0.78 111.831 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.2 -36.78 27.31 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.795 2.997 . . . . 0.85 112.776 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -56.64 -45.69 81.44 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.689 0.625 . . . . 6.16 112.689 -173.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -54.42 -57.48 11.14 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 122.15 0.976 . . . . 3.01 109.538 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.4 mt -49.7 -62.46 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.329 1.452 . . . . 0.79 109.725 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.6 mt -52.81 -52.77 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 122.755 0.422 . . . . 1.33 110.201 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -68.7 -30.66 69.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.119 0.418 . . . . 3.17 111.746 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.9 m -65.69 -52.18 53.51 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.567 -0.708 . . . . 0.98 109.313 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 mm -65.31 -33.64 65.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 121.742 -0.599 . . . . 1.89 111.174 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -54.32 -58.64 6.63 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.787 1.235 . . . . 3.0 108.712 166.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.8 t -60.04 -26.5 66.17 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.083 0.953 . . . . 1.32 113.57 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.81 -20.47 61.63 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.382 0.992 . . . . 2.75 111.9 172.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.87 38.75 5.4 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.222 -1.151 . . . . 1.09 110.222 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -126.32 163.2 23.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.082 -1.821 . . . . 2.27 106.082 171.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.14 83.58 8.21 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 119.375 0.989 . . . . 3.9 112.96 -172.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.89 147.51 24.3 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.374 2.049 . . . . 1.56 112.224 -175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.3 m -154.37 144.29 21.79 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.157 1.383 . . . . 2.01 108.311 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--N 1.333 -0.114 0 C-N-CA 122.862 0.465 . . . . 3.74 111.052 -177.48 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 108.84 -0.8 . . . . 2.19 108.84 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.8 tp -129.86 138.31 50.9 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.407 -1.331 . . . . 1.95 107.407 164.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -110.9 137.69 48.22 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.784 1.234 . . . . 2.46 109.535 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.04 128.15 20.79 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.848 -0.797 . . . . 1.49 108.848 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.0 t -65.35 145.15 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 107.619 -1.252 . . . . 1.09 107.619 167.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.42 98.16 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 125.767 1.627 . . . . 1.36 107.68 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -63.57 162.94 12.0 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.972 -0.751 . . . . 4.16 108.972 160.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.47 -0.32 46.46 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.866 1.222 . . . . 1.42 113.014 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.2 mtm -73.64 75.76 1.52 Allowed 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.336 -1.096 . . . . 2.22 112.097 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.9 p -67.54 81.58 0.17 Allowed 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 121.686 -0.634 . . . . 4.79 109.892 168.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 t 72.75 176.28 0.27 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.04 1.736 . . . . 3.51 112.253 165.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.7 -36.11 4.71 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 126.363 1.865 . . . . 2.27 112.667 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -41.22 -60.63 1.19 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.673 1.189 . . . . 2.37 110.845 168.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.4 m -68.19 -31.54 71.14 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.532 -0.73 . . . . 1.43 111.675 -176.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.0 t -57.04 -56.26 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.887 -0.783 . . . . 0.9 108.887 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -30.49 71.07 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.709 -0.619 . . . . 1.27 110.626 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -50.58 72.42 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.333 -0.988 . . . . 3.7 108.333 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.5 mt -62.52 -65.18 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 107.207 -1.405 . . . . 1.03 107.207 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -46.53 -57.12 5.03 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.855 0.862 . . . . 3.64 110.151 -174.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -56.79 -49.56 74.96 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.354 -0.839 . . . . 1.44 109.283 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.7 t -65.67 -29.38 69.92 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 118.993 -0.527 . . . . 0.88 111.811 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 26' ' ' LEU . 2.8 mm? -70.63 -44.25 67.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.76 0.709 . . . . 2.64 111.648 174.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.8 p -54.56 -21.54 10.55 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.649 0.981 . . . . 2.13 113.649 -172.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.12 -4.49 58.83 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 115.064 1.505 . . . . 4.54 115.064 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -67.11 122.94 18.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.869 1.213 . . . . 2.11 110.162 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -71.0 73.43 0.61 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.679 1.192 . . . . 7.34 111.176 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.39 -2.42 0.8 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.887 1.232 . . . . 1.23 112.62 -177.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.94 150.14 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 125.075 1.35 . . . . 1.97 108.282 170.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.1 tp -111.4 -48.12 3.12 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.278 1.831 . . . . 3.1 110.055 172.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -157.34 155.14 30.12 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.357 1.063 . . . . 2.71 108.32 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.43 163.95 28.54 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.169 -1.048 . . . . 2.34 108.169 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -162.56 103.14 1.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.82 -1.178 . . . . 1.66 107.82 170.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.7 147.21 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 C-N-CA 124.997 1.319 . . . . 1.95 110.641 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.97 137.14 16.46 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.764 0.792 . . . . 1.06 111.601 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 pp -77.7 -23.22 49.56 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.29 -0.868 . . . . 1.5 111.967 -176.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.14 -41.15 97.98 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.245 -0.65 . . . . 1.27 109.245 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -86.34 -31.21 21.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.565 -0.743 . . . . 2.17 109.909 172.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 77.68 44.3 0.09 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.63 1.972 . . . . 3.08 107.75 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -140.17 146.76 39.18 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.944 -0.391 . . . . 1.64 109.944 -167.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.98 127.1 55.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.136 1.375 . . . . 0.65 107.359 162.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.19 141.74 32.62 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.914 -1.143 . . . . 1.01 107.914 155.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.73 136.47 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 107.572 -1.27 . . . . 1.25 107.572 170.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -100.61 125.37 47.0 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.421 -1.696 . . . . 2.35 106.421 160.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -166.57 142.04 4.47 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 128.126 2.571 . . . . 1.85 107.267 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -71.61 125.54 91.71 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 118.833 -1.147 . . . . 3.83 108.93 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -82.67 -9.78 10.96 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.745 2.296 . . . . 1.3 113.275 -173.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.92 -44.08 11.31 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.255 0.934 . . . . 4.18 109.191 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 pt -67.41 -54.66 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 112.716 0.635 . . . . 1.46 112.716 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.5 tt -105.14 -58.08 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.84 0.856 . . . . 1.65 111.653 -173.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.04 161.6 27.55 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.579 0.609 . . . . 0.62 113.905 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.78 -36.48 6.24 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.048 3.165 . . . . 0.7 112.983 -171.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.5 ttm105 -55.39 -47.11 76.35 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.768 0.427 . . . . 4.89 111.186 -173.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -47.36 -61.4 1.93 Allowed 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.477 1.511 . . . . 2.79 110.312 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.5 mt -51.09 -63.34 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.127 0.971 . . . . 0.69 109.791 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.7 mt -51.86 -52.66 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.235 0.471 . . . . 1.28 110.689 -173.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -64.18 -34.38 77.95 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.99 0.814 . . . . 2.71 112.272 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.4 m -61.01 -53.13 61.01 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.355 -0.841 . . . . 0.7 109.888 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.2 mm -61.56 -38.44 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 O-C-N 121.667 -0.645 . . . . 1.63 110.693 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -55.76 -59.7 4.49 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.954 1.301 . . . . 2.77 108.803 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.5 t -52.37 -40.49 62.08 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.587 1.155 . . . . 1.03 111.739 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.7 mt -70.32 5.38 1.76 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.466 0.913 . . . . 1.96 113.466 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.19 45.98 5.45 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 119.069 0.849 . . . . 0.65 111.249 169.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -135.74 174.69 10.33 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.046 0.938 . . . . 1.92 109.782 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -113.59 68.34 1.4 Allowed Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.892 0.701 . . . . 3.61 112.892 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.76 85.09 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.194 3.263 . . . . 1.1 112.503 -174.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.2 m -101.3 125.54 47.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.726 1.611 . . . . 2.28 108.177 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 109.154 -0.684 . . . . 3.58 109.154 175.239 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 107.059 -1.459 . . . . 2.29 107.059 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tt -153.08 82.3 1.2 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 103.618 -2.734 . . . . 3.02 103.618 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.0 152.81 42.19 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.882 -0.727 . . . . 3.4 110.438 -169.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.39 133.92 50.33 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.125 -1.435 . . . . 1.73 107.125 168.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.61 136.14 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.441 -2.059 . . . . 0.89 105.441 153.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 m -134.92 134.97 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.573 -1.269 . . . . 1.34 107.573 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -117.2 173.73 6.51 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.737 -0.838 . . . . 5.68 108.737 170.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.24 -22.93 37.21 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 110.916 -0.874 . . . . 1.23 110.916 -172.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.2 mtm -60.1 151.81 25.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.554 0.677 . . . . 2.21 109.583 170.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -158.45 -58.27 0.07 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.472 -0.566 . . . . 2.4 109.472 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.3 t -73.38 140.45 46.63 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.206 -0.664 . . . . 3.49 109.206 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.35 -43.94 5.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.022 0.929 . . . . 1.9 111.728 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 m -41.21 -47.32 3.31 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.422 1.089 . . . . 1.51 111.811 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.7 m -45.44 -49.1 13.63 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 118.992 0.815 . . . . 0.74 110.671 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.8 t -52.32 -59.49 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.646 0.778 . . . . 1.25 109.694 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.21 -36.57 71.03 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.418 1.087 . . . . 1.7 109.37 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -61.47 -49.78 75.4 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.375 -0.602 . . . . 4.35 109.375 -174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.9 mt -63.33 -53.27 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.167 -1.049 . . . . 0.73 108.167 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -48.04 -59.98 2.96 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.089 0.956 . . . . 3.15 110.016 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.1 m -66.31 -43.25 86.78 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.027 0.931 . . . . 2.3 109.99 -173.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.5 t -57.23 -38.31 73.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.862 -0.59 . . . . 0.88 110.222 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 mt -75.53 -51.09 13.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.385 -0.817 . . . . 2.62 112.48 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.9 p -68.18 73.28 0.2 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.466 0.706 . . . . 1.61 110.277 -172.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? 177.84 -33.93 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.633 2.773 . . . . 3.47 111.638 -171.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -44.41 -76.95 0.02 OUTLIER 'General case' 0 C--N 1.348 0.515 0 N-CA-C 113.904 1.076 . . . . 3.59 113.904 -171.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 ptt85 171.01 134.05 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 104.924 -2.25 . . . . 11.14 104.924 -172.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.76 -59.66 2.98 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 118.774 0.716 . . . . 2.57 113.216 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -33.89 116.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 127.432 2.293 . . . . 1.92 111.605 177.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 72.2 mt -89.03 -46.32 8.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.357 1.063 . . . . 3.17 110.52 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -154.45 152.13 29.78 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.947 0.899 . . . . 2.56 108.946 -173.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.1 m -125.7 160.75 28.93 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.761 -1.2 . . . . 1.88 107.761 168.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.1 t -146.64 120.42 9.25 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.108 -1.071 . . . . 1.82 108.108 155.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 t -102.69 150.87 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 124.519 1.127 . . . . 2.31 108.584 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.16 135.11 20.15 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.598 -0.689 . . . . 0.72 110.465 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -73.35 -49.85 25.13 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.29 -0.868 . . . . 1.56 111.148 -172.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.98 -48.42 80.03 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.586 0.707 . . . . 1.15 110.376 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.64 -16.54 62.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.35 1.06 . . . . 2.24 111.1 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 50.76 42.07 27.09 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.886 1.274 . . . . 2.77 108.117 -171.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -129.32 144.8 51.37 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 122.565 0.346 . . . . 1.41 110.957 -166.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.72 110.49 17.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.094 1.758 . . . . 0.87 107.393 161.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.92 142.7 27.42 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 107.471 -1.307 . . . . 1.36 107.471 166.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.58 128.56 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 108.169 -1.048 . . . . 1.1 108.169 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -93.85 74.72 4.22 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 126.43 1.892 . . . . 2.24 108.926 171.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -119.32 179.43 4.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.437 1.495 . . . . 2.45 113.434 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.18 88.3 31.94 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 130.774 3.63 . . . . 4.07 108.097 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -61.16 -22.23 74.04 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.963 2.442 . . . . 1.35 112.892 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -57.52 -30.74 65.4 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 118.911 -0.566 . . . . 3.03 112.051 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.9 pt -114.15 -54.43 4.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 N-CA-C 113.976 1.102 . . . . 1.37 113.976 -173.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.6 tt -74.02 -63.35 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.496 -0.927 . . . . 1.8 108.496 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.2 147.91 23.38 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.128 -0.942 . . . . 0.96 111.553 173.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -54.11 -43.74 55.65 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.985 3.124 . . . . 0.81 111.753 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -56.61 -51.85 67.08 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.048 0.539 . . . . 5.58 112.35 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -47.32 -55.38 8.9 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.087 1.355 . . . . 2.61 109.391 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.1 mt -56.42 -65.11 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 114.687 -1.142 . . . . 0.96 110.406 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.2 mt -48.37 -52.86 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.259 1.024 . . . . 1.25 109.81 -173.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -68.92 -30.41 68.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 111.839 0.311 . . . . 2.92 111.839 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.8 m -67.32 -51.42 52.73 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.613 -0.835 . . . . 0.95 109.905 173.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.2 mm -64.17 -33.67 63.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.748 -0.595 . . . . 2.09 111.092 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -55.11 -60.32 3.54 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.918 1.287 . . . . 2.81 108.607 167.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -52.66 -38.54 60.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.862 1.265 . . . . 1.05 112.759 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -55.22 -22.84 19.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.925 0.713 . . . . 2.86 112.925 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.39 46.66 1.4 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.121 -1.192 . . . . 0.92 110.121 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -132.63 168.49 18.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.333 -1.358 . . . . 1.74 107.333 172.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -112.47 88.14 10.57 Favored Pre-proline 0 N--CA 1.454 -0.231 0 CA-C-O 118.515 -0.755 . . . . 3.88 109.324 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.45 151.65 22.85 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.578 2.185 . . . . 1.58 111.944 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.5 m -157.75 145.97 19.0 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.662 1.585 . . . . 2.48 107.386 170.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 CA--C 1.531 0.235 0 N-CA-C 109.038 -0.727 . . . . 3.6 109.038 179.315 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 108.533 -0.914 . . . . 2.55 108.533 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 tt -134.59 115.5 13.93 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.453 -1.314 . . . . 2.41 107.453 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -89.74 84.85 6.31 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.071 1.348 . . . . 2.67 108.89 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.61 132.04 34.24 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.961 -1.126 . . . . 1.65 107.961 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -74.17 149.57 7.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 106.038 -1.838 . . . . 1.17 106.038 164.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -152.69 54.58 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 127.082 2.153 . . . . 1.65 107.696 -169.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -56.84 157.33 5.67 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.779 -0.646 . . . . 5.79 109.338 171.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.48 -37.99 3.55 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 107.851 -2.099 . . . . 1.24 107.851 -162.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 40.5 mtp -53.03 143.63 16.96 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.331 -0.988 . . . . 2.59 108.331 157.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.9 t -168.08 -56.24 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.422 -0.955 . . . . 3.93 108.422 -174.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.8 t -86.9 171.39 10.85 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.466 -0.938 . . . . 2.8 108.466 172.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.81 -166.07 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.467 -0.568 . . . . 2.81 109.467 160.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.5 m 71.79 -60.23 0.53 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.433 1.093 . . . . 1.8 109.728 -171.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 77.7 m -36.98 -53.04 0.97 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 126.123 1.769 . . . . 1.21 109.875 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.6 t -36.08 -66.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.899 1.28 . . . . 0.67 111.336 173.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -26.02 56.26 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.124 -0.36 . . . . 1.04 111.073 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -51.78 -41.64 61.8 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 124.157 0.983 . . . . 3.16 108.786 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.465 ' HB ' HG21 ' A' ' 37' ' ' VAL . 11.2 mt -77.7 -70.3 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 107.234 -1.395 . . . . 0.74 107.234 172.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -47.17 -55.92 7.6 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.746 1.218 . . . . 3.29 112.165 -166.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.8 t -58.15 -49.22 77.76 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.097 -0.705 . . . . 1.3 109.097 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.8 t -62.62 -50.16 72.33 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 122.029 -0.42 . . . . 1.07 110.11 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.02 -36.79 80.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.575 -1.328 . . . . 2.52 111.547 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.1 p -57.67 -17.21 13.59 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.55 0.945 . . . . 1.87 113.55 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -62.25 -33.89 75.47 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.267 0.939 . . . . 3.76 111.641 171.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -73.34 76.09 1.37 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.127 0.571 . . . . 2.03 110.868 -173.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 mtm105 -42.39 99.87 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.062 1.345 . . . . 5.64 110.668 169.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.39 -44.66 0.86 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.413 -1.875 . . . . 1.34 108.413 -168.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.93 144.83 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 106.303 -1.74 . . . . 1.68 106.303 142.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -105.02 -57.88 1.97 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.969 1.308 . . . . 3.31 107.526 163.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -136.77 144.8 43.95 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.81 0.844 . . . . 1.87 110.886 -172.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.8 m -114.82 158.12 22.34 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 124.488 1.115 . . . . 1.97 108.013 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.0 t -150.97 76.23 1.23 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.697 -0.853 . . . . 2.41 108.697 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.465 HG21 ' HB ' ' A' ' 22' ' ' ILE . 22.1 t -81.35 136.19 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 125.292 1.437 . . . . 2.4 109.742 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.14 130.23 22.03 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.747 0.819 . . . . 0.82 111.357 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.53 -51.39 36.06 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 124.197 0.999 . . . . 1.56 111.308 -171.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.65 -44.86 90.23 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.537 0.684 . . . . 1.19 110.344 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -13.53 62.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.577 0.751 . . . . 1.99 110.922 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 52.95 33.45 14.65 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.762 1.225 . . . . 2.68 109.561 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -128.83 150.71 50.21 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.673 -0.491 . . . . 1.56 109.673 -164.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.84 123.24 36.86 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.372 -0.973 . . . . 0.9 108.372 153.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 129.65 34.65 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 104.459 -2.423 . . . . 1.34 104.459 159.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.8 mt -114.15 133.97 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 107.425 -1.324 . . . . 2.05 107.425 168.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -118.64 99.13 6.6 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.677 2.791 . . . . 4.26 105.297 -170.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -151.71 157.23 41.77 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 126.633 1.973 . . . . 2.1 109.425 -157.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -82.29 123.09 79.54 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 119.365 0.984 . . . . 3.85 108.553 171.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.08 -2.96 12.42 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.625 2.216 . . . . 1.44 113.61 -173.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -100.23 -51.01 3.77 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.174 0.897 . . . . 3.11 109.196 -176.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 pt -69.19 -54.52 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.777 0.323 . . . . 1.18 111.701 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.5 tt -91.06 -49.81 13.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 124.199 1.0 . . . . 1.1 109.739 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.65 154.58 5.75 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 111.667 -0.573 . . . . 0.76 111.667 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.76 -25.35 28.68 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.655 2.237 . . . . 0.76 112.862 -172.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -55.19 -48.91 73.15 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.395 0.543 . . . . 5.96 111.121 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -54.48 -58.53 7.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 122.475 1.131 . . . . 2.78 109.709 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.2 mt -48.82 -56.57 2.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 125.855 1.662 . . . . 0.91 111.711 175.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.7 -50.86 64.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.863 -0.421 . . . . 1.35 109.863 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.08 -39.83 83.38 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.145 0.578 . . . . 5.43 110.921 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.5 m -58.52 -56.82 17.21 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.542 -0.724 . . . . 1.02 109.57 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.9 mt -63.64 -41.12 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 119.031 0.832 . . . . 2.29 111.413 -172.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -45.73 -58.35 3.54 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.256 1.023 . . . . 3.51 108.858 168.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t -61.54 -30.19 70.48 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.87 0.692 . . . . 1.29 112.87 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.92 -34.67 69.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.369 0.986 . . . . 1.89 110.717 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.37 51.34 0.29 Allowed Glycine 0 C--N 1.334 0.445 0 O-C-N 123.863 0.727 . . . . 0.82 112.068 160.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -140.67 170.66 15.36 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 106.345 -1.724 . . . . 2.03 106.345 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.67 86.19 0.42 Allowed Pre-proline 0 N--CA 1.466 0.367 0 CA-C-O 117.167 -1.397 . . . . 4.48 114.248 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.69 76.4 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.504 2.803 . . . . 1.57 112.244 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 p -90.62 128.43 36.61 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.288 1.435 . . . . 2.13 108.669 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 107.87 -1.159 . . . . 3.61 107.87 169.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 107.118 -1.438 . . . . 2.44 107.118 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.1 tt -138.03 97.29 3.37 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.06 -1.83 . . . . 2.78 106.06 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -83.2 135.5 34.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.487 -0.324 . . . . 2.41 110.354 -174.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.46 139.04 54.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.532 -0.914 . . . . 2.11 108.532 175.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.16 116.4 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 106.461 -1.681 . . . . 1.09 106.461 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 m -104.38 83.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 106.395 -1.705 . . . . 1.69 106.395 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -65.3 136.52 56.67 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.999 -0.741 . . . . 5.52 108.999 -169.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.76 -2.09 10.09 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.463 -0.632 . . . . 1.2 113.701 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.561 ' SD ' HD12 ' A' ' 22' ' ' ILE . 73.9 mtm -68.64 79.25 0.28 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.981 1.391 . . . . 2.21 111.038 174.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 t -50.39 -52.9 33.42 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.532 1.133 . . . . 3.24 112.661 -172.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -170.04 -103.16 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.346 0.658 . . . . 5.95 109.557 176.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.67 168.98 18.75 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.595 0.634 . . . . 2.79 110.625 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.0 m 69.53 -62.63 0.41 Allowed 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 126.067 1.747 . . . . 1.51 110.004 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.9 m -37.36 -51.42 1.09 Allowed 'General case' 0 N--CA 1.458 -0.044 0 C-N-CA 127.068 2.147 . . . . 0.99 111.492 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.9 t -45.56 -70.77 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.232 1.013 . . . . 0.76 110.156 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -23.76 67.29 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.873 -0.517 . . . . 1.03 111.171 -175.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -59.03 -52.19 66.82 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.718 -1.216 . . . . 3.12 107.718 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.561 HD12 ' SD ' ' A' ' 13' ' ' MET . 30.3 mt -75.34 -56.42 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 108.583 -0.895 . . . . 0.94 108.583 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -38.0 -65.87 0.3 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.186 1.394 . . . . 3.49 112.02 170.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.2 t -62.72 -38.58 91.02 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.928 0.491 . . . . 1.46 110.373 -174.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.6 t -65.62 -24.94 67.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 118.973 -0.537 . . . . 0.87 111.702 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.8 mt -86.75 -44.87 11.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.05 0.94 . . . . 2.39 112.277 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.4 p -72.01 61.63 0.43 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.179 0.992 . . . . 1.53 111.183 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.34 -26.67 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.714 1.606 . . . . 3.68 113.132 -165.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -67.99 -128.72 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 119.621 1.1 . . . . 2.6 110.169 172.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -144.97 163.17 34.99 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 129.503 3.121 . . . . 5.61 104.757 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.41 -61.39 2.75 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.192 -0.763 . . . . 1.58 111.192 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.537 ' C ' HD13 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -51.52 111.59 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 117.842 0.821 . . . . 2.27 109.102 172.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 pp -107.71 -23.54 12.06 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.602 1.561 . . . . 2.41 110.962 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -145.32 158.97 43.71 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.842 -0.799 . . . . 2.4 108.842 167.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.7 t -153.48 145.97 24.08 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.003 -1.11 . . . . 1.85 108.003 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 p -150.51 132.52 15.22 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.387 -0.968 . . . . 2.15 108.387 169.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.38 125.13 67.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.247 0.619 . . . . 1.97 111.395 170.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.97 128.04 44.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.279 0.632 . . . . 1.28 110.397 172.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -72.95 -52.55 14.13 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.91 -1.041 . . . . 2.01 111.436 -165.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.44 87.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 121.614 0.721 . . . . 2.29 109.72 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -77.17 -6.36 52.66 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.71 -0.677 . . . . 3.01 110.573 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 56.55 31.53 19.22 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 125.235 1.414 . . . . 3.03 110.146 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -108.66 125.64 52.1 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 121.841 -0.537 . . . . 2.25 109.919 -164.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.5 121.98 37.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.454 1.102 . . . . 0.88 108.558 167.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.72 114.21 28.23 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 103.615 -2.735 . . . . 1.42 103.615 168.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.8 mp -111.37 132.5 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 106.392 -1.707 . . . . 0.97 106.392 173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -101.23 98.76 9.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.44 -1.689 . . . . 3.19 106.44 169.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -140.53 155.27 46.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.816 0.846 . . . . 2.31 112.006 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.73 111.01 19.62 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 108.429 -0.952 . . . . 3.09 108.429 166.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.97 -21.8 36.66 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.944 2.429 . . . . 1.31 112.72 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -46.61 -54.62 9.11 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.132 1.373 . . . . 3.49 109.773 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pt -90.36 -71.13 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 124.92 1.288 . . . . 1.73 112.38 -166.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.401 HG23 ' H ' ' A' ' 54' ' ' GLY . 14.2 tt -67.01 -62.93 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.912 -0.773 . . . . 2.02 108.912 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.401 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 81.47 159.44 23.5 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 115.701 -0.681 . . . . 1.04 112.205 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -54.83 -40.16 86.44 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 124.08 3.187 . . . . 1.1 111.337 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -35.51 -65.04 0.26 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.582 1.953 . . . . 9.77 113.516 175.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -60.47 -54.01 50.61 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.024 0.93 . . . . 3.03 108.546 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 88.7 mt -49.33 -57.62 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.282 0.633 . . . . 1.23 109.542 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.5 mt -54.81 -52.87 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.76 -0.587 . . . . 1.51 110.835 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -58.72 -45.01 90.54 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.095 0.95 . . . . 2.86 110.55 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 54.2 m -69.31 -50.59 45.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.956 -0.757 . . . . 1.03 108.956 -174.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.61 -33.7 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 118.798 -0.62 . . . . 1.98 110.919 -177.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -53.01 -58.12 8.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.886 -0.783 . . . . 4.09 108.886 165.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.4 t -58.84 -27.5 65.18 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.247 0.832 . . . . 1.33 113.247 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 25.0 mt -69.35 -10.1 56.41 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.511 1.05 . . . . 1.76 112.808 174.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.45 50.43 2.19 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 124.466 1.031 . . . . 0.9 111.256 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.495 ' CD2' HD11 ' A' ' 22' ' ' ILE . 69.3 m-85 -142.07 171.71 13.68 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 124.739 1.216 . . . . 2.12 107.877 172.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -110.74 84.55 4.23 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.68 -0.676 . . . . 4.48 110.992 -175.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.3 128.08 15.91 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.047 2.498 . . . . 1.9 112.52 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.2 p -138.54 129.63 26.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.627 1.571 . . . . 1.99 107.736 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 CA--C 1.53 0.196 0 N-CA-C 109.245 -0.65 . . . . 3.36 109.245 177.19 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.1 t . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 108.956 -0.757 . . . . 2.04 108.956 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.82 111.97 21.96 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.73 -1.211 . . . . 2.08 107.73 -170.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -85.21 123.48 30.76 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 123.622 0.576 . . . . 2.42 109.612 169.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.21 124.91 44.07 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.584 -2.006 . . . . 1.76 105.584 167.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -82.93 111.32 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 105.698 -1.964 . . . . 1.42 105.698 171.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.472 HG23 ' SD ' ' A' ' 13' ' ' MET . 2.5 m -96.9 77.38 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 125.062 1.345 . . . . 1.53 109.079 -163.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -67.14 107.21 2.24 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.284 1.034 . . . . 6.78 108.892 -166.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.1 -40.76 0.27 Allowed Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.151 -0.805 . . . . 1.59 113.543 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.472 ' SD ' HG23 ' A' ' 10' ' ' VAL . 2.2 mpp? -62.77 162.88 10.17 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 119.182 1.491 . . . . 2.19 111.169 -178.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.9 t -163.98 -56.86 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.245 -1.02 . . . . 3.07 108.245 -175.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.5 m -81.82 172.74 12.99 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.389 0.676 . . . . 3.99 109.818 176.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.88 -172.27 0.17 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.059 -0.519 . . . . 3.14 109.76 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.8 m 71.55 -61.89 0.47 Allowed 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 124.68 1.192 . . . . 1.73 110.286 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.2 m -34.62 -51.74 0.49 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.903 1.681 . . . . 0.85 112.081 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.0 t -48.42 -59.66 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.817 0.847 . . . . 0.88 111.197 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -32.03 73.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.718 -0.613 . . . . 1.49 109.41 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -60.46 -45.75 92.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.553 -0.906 . . . . 3.71 108.553 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.63 ' HB ' HG11 ' A' ' 37' ' ' VAL . 96.6 mt -65.95 -62.16 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.817 -1.549 . . . . 0.55 106.817 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -47.59 -62.09 1.61 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.375 1.083 . . . . 3.96 110.812 -175.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.6 m -63.8 -44.43 93.34 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.835 -1.075 . . . . 2.36 109.34 -168.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.7 t -59.31 -51.63 69.12 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.234 -0.654 . . . . 1.06 109.234 175.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.99 -36.61 77.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.043 -1.036 . . . . 2.4 112.277 -175.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 78.1 p -55.51 -19.56 10.14 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.509 1.05 . . . . 1.98 113.755 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -61.16 -30.94 70.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.573 1.079 . . . . 3.7 111.491 175.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -77.9 63.33 2.9 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 124.495 1.118 . . . . 2.04 110.932 -164.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -28.45 -25.85 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 120.261 3.43 . . . . 6.95 120.261 -164.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.09 -16.3 68.51 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-N 120.64 1.563 . . . . 1.22 111.823 169.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.04 125.87 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 127.435 2.294 . . . . 1.84 108.467 171.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.4 mt -91.45 -48.06 7.09 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.699 1.199 . . . . 2.87 109.274 174.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -154.04 138.45 16.74 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 118.495 -0.764 . . . . 2.1 110.137 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.95 164.56 15.9 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 119.444 1.02 . . . . 2.23 108.664 167.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.0 m -157.44 112.86 2.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.432 -1.321 . . . . 1.77 107.432 162.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.63 HG11 ' HB ' ' A' ' 22' ' ' ILE . 7.9 p -102.61 154.09 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 O-C-N 123.518 0.511 . . . . 1.96 110.697 166.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.81 137.3 19.93 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 124.008 0.923 . . . . 1.08 110.629 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -74.72 -41.92 59.29 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 122.943 0.497 . . . . 1.42 111.762 -172.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.54 -34.7 74.51 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 122.744 0.418 . . . . 1.39 110.99 -173.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 t -100.86 -7.28 23.7 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.063 0.945 . . . . 2.44 110.791 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 53.19 22.9 2.83 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.282 1.833 . . . . 3.31 112.475 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -94.04 133.97 36.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.09 -1.448 . . . . 1.59 107.09 -172.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.17 112.99 23.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.777 -1.564 . . . . 0.61 106.777 160.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.29 138.46 36.35 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.322 -1.362 . . . . 0.99 107.322 165.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.62 131.14 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 109.132 -0.692 . . . . 0.92 109.132 170.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -103.81 88.51 3.07 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 127.365 2.266 . . . . 3.27 108.061 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -115.79 162.25 17.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.486 1.514 . . . . 2.33 110.282 171.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.04 106.89 4.49 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.187 0.595 . . . . 3.18 109.575 171.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -64.97 -22.53 62.57 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.046 1.831 . . . . 1.47 111.981 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -41.1 -44.49 2.49 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.376 1.87 . . . . 5.6 111.6 170.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.6 pt -113.94 -62.85 2.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 113.34 0.867 . . . . 1.15 113.34 -165.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 tt -88.73 -48.03 14.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.482 0.658 . . . . 1.72 110.4 -165.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.3 159.94 35.04 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 115.474 -0.785 . . . . 0.74 112.676 169.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.02 -42.14 25.18 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.477 3.452 . . . . 0.79 112.263 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -53.0 -51.23 62.3 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.41 0.684 . . . . 5.63 111.48 -172.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -47.97 -57.22 6.03 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.722 0.773 . . . . 2.79 110.435 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.4 mt -61.67 -48.62 87.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 124.821 1.248 . . . . 0.99 111.043 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.2 mt -52.85 -58.56 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.541 -0.541 . . . . 1.36 109.541 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -61.55 -31.74 71.78 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.077 0.551 . . . . 2.71 111.966 -176.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.2 m -58.99 -53.14 61.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.457 -0.777 . . . . 0.81 109.518 173.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.6 mt -73.38 -36.02 47.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 O-C-N 121.617 -0.677 . . . . 1.93 110.647 -173.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -48.39 -50.4 30.91 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.337 1.055 . . . . 3.31 108.924 166.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.4 t -66.27 -42.55 88.28 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.336 0.654 . . . . 1.03 112.001 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -59.37 -40.5 86.68 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.606 0.639 . . . . 1.79 109.897 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.46 46.96 0.47 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.346 -0.702 . . . . 0.86 111.346 164.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -140.91 141.31 34.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.805 -1.924 . . . . 2.53 105.805 168.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -94.27 106.23 21.97 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 118.186 -0.911 . . . . 5.59 112.25 -158.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.75 80.68 1.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.277 2.651 . . . . 1.45 110.838 -174.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.1 m -67.15 111.42 3.9 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.859 -1.163 . . . . 2.08 107.859 168.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 107.921 -1.14 . . . . 3.47 107.921 166.516 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 106.396 -1.705 . . . . 2.55 106.396 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.1 tt -84.33 115.21 22.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.672 -0.862 . . . . 2.42 108.672 -172.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -90.18 133.37 34.94 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.292 0.496 . . . . 2.69 111.227 172.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 pp -129.07 130.57 46.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.109 -1.441 . . . . 1.81 107.109 166.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.15 134.48 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.426 -2.065 . . . . 1.4 105.426 170.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.24 82.04 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.668 -1.604 . . . . 1.78 106.668 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -72.37 146.36 47.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.002 -1.481 . . . . 6.35 107.002 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.14 -36.44 4.4 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.87 -0.892 . . . . 1.1 110.87 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.6 ttp -57.72 133.34 55.27 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.286 -1.005 . . . . 2.33 108.286 167.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -153.48 -57.62 0.12 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.536 1.134 . . . . 2.87 110.264 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.2 t -67.46 140.13 57.08 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.314 -0.866 . . . . 3.56 110.342 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.69 -50.3 2.3 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.215 1.006 . . . . 1.84 112.155 175.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -43.72 -43.45 5.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.448 1.099 . . . . 1.6 111.768 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.2 m -46.48 -41.6 14.25 Favored 'General case' 0 C--N 1.338 0.104 0 C-N-CA 124.566 1.147 . . . . 0.75 111.116 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.5 t -54.16 -62.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.157 -0.683 . . . . 0.9 109.157 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -30.31 68.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.507 -0.746 . . . . 1.46 110.061 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.61 -51.41 67.23 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 107.435 -1.32 . . . . 3.06 107.435 177.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -68.84 -54.18 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.712 1.205 . . . . 0.73 108.584 -176.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -50.79 -61.11 2.41 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 108.724 -0.843 . . . . 4.58 108.724 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -60.17 -47.96 83.76 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.808 0.813 . . . . 1.46 109.715 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.4 t -66.96 -22.51 65.92 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 118.415 -0.802 . . . . 1.46 112.087 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.8 mt -82.3 -63.32 1.4 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 118.274 -0.87 . . . . 2.35 111.107 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.2 p -54.11 -28.37 39.15 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.286 0.948 . . . . 2.63 113.109 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -30.72 65.57 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.369 0.878 . . . . 3.98 113.369 173.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -70.9 72.49 0.56 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.694 -0.854 . . . . 2.21 108.694 164.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -13.23 -50.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 129.193 2.997 . . . . 5.82 116.713 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -43.22 -50.62 6.42 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.975 -0.903 . . . . 1.37 113.251 174.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.635 HD13 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -71.53 100.94 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.327 -1.36 . . . . 2.8 107.327 170.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.99 -34.65 32.86 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.699 0.4 . . . . 2.56 111.526 -176.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -148.17 120.35 8.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.628 1.171 . . . . 2.15 109.072 -175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 t -99.47 168.43 9.98 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.239 0.927 . . . . 2.53 108.807 170.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.3 m -145.97 66.2 1.21 Allowed 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 120.892 -1.13 . . . . 1.61 108.846 160.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.7 p -58.06 138.47 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.312 -0.858 . . . . 2.21 111.624 161.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.71 137.69 16.33 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.697 1.199 . . . . 1.37 110.31 175.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.12 -34.33 61.67 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.479 0.712 . . . . 1.8 111.365 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.58 -31.35 71.4 Favored 'General case' 0 C--O 1.226 -0.155 0 O-C-N 121.838 -0.539 . . . . 2.3 110.77 -173.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -111.69 5.73 19.41 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.512 1.125 . . . . 2.63 110.998 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.23 44.29 6.44 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 127.889 2.475 . . . . 3.51 112.068 176.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -142.06 169.6 17.29 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 122.23 -0.294 . . . . 2.18 110.808 -175.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.4 132.45 39.4 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 124.416 1.073 . . . . 1.38 108.988 160.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.43 135.46 34.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.538 -1.282 . . . . 1.22 107.538 158.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.635 HG23 HD13 ' A' ' 32' ' ' ILE . 1.7 mp -112.68 120.6 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 105.516 -2.031 . . . . 1.43 105.516 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -90.83 99.9 12.85 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.513 -0.921 . . . . 3.28 108.513 166.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.8 159.26 42.49 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.202 0.601 . . . . 1.88 112.284 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -81.98 120.14 76.76 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 106.08 -1.822 . . . . 3.51 106.08 162.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -63.56 -40.43 30.49 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.525 1.484 . . . . 1.29 111.381 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -85.63 30.96 0.61 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.693 1.197 . . . . 3.72 112.067 -160.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.3 pt -134.98 -50.23 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.762 1.225 . . . . 1.21 109.96 172.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 tt -96.79 -41.68 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.921 1.288 . . . . 1.17 111.494 -174.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.68 148.26 5.56 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 111.33 -0.708 . . . . 0.83 111.33 -175.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.11 -36.46 58.4 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.208 2.606 . . . . 0.73 111.554 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -50.65 -50.38 54.64 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.829 0.852 . . . . 6.2 112.256 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -52.28 -56.06 17.25 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 121.765 0.793 . . . . 2.62 109.537 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.0 mt -57.41 -53.54 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.463 1.105 . . . . 1.01 111.56 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.7 mt -57.53 -54.29 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 122.02 -0.425 . . . . 1.4 109.98 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -64.93 -33.04 75.07 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.535 -0.728 . . . . 3.13 111.769 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.3 m -56.81 -52.04 66.59 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 121.565 -0.71 . . . . 0.68 109.091 171.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.7 mt -64.32 -42.08 94.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 119.608 1.094 . . . . 2.37 111.079 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -49.56 -51.73 34.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.159 0.984 . . . . 3.4 109.039 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -64.51 -43.86 92.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.609 0.764 . . . . 1.0 111.387 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.19 -34.6 72.33 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.891 1.676 . . . . 2.43 111.262 -175.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.36 39.46 0.23 Allowed Glycine 0 C--N 1.333 0.416 0 O-C-N 124.685 1.241 . . . . 0.75 111.857 152.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -142.74 174.62 10.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.78 -0.822 . . . . 1.85 108.78 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -108.93 92.07 10.1 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.955 1.302 . . . . 3.96 109.848 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.99 65.85 7.74 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.685 2.924 . . . . 1.78 111.124 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.7 m -74.98 119.9 19.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.575 0.702 . . . . 2.14 110.256 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 C--N 1.33 -0.254 0 N-CA-C 109.177 -0.675 . . . . 4.32 109.177 177.947 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 106.835 -1.543 . . . . 2.46 106.835 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 tt -150.47 147.29 27.34 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.772 -1.196 . . . . 2.19 107.772 170.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -103.3 150.45 23.74 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.981 1.312 . . . . 2.74 109.431 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.95 138.15 25.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.601 -0.888 . . . . 2.49 108.601 164.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -77.79 143.29 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.256 -1.387 . . . . 0.97 107.256 170.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.28 103.74 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.529 1.532 . . . . 1.41 107.618 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -73.89 166.49 23.25 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.251 -1.018 . . . . 5.52 108.251 165.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.6 -11.34 59.51 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.663 0.649 . . . . 0.9 112.612 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.7 mtm -73.83 65.5 1.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.523 1.161 . . . . 1.69 110.423 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 t -91.18 12.72 19.18 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.352 1.061 . . . . 3.11 112.849 -166.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.4 t -165.52 173.86 10.53 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.428 -0.953 . . . . 3.03 108.428 -173.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.21 -176.01 0.06 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.398 0.545 . . . . 3.17 110.435 164.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.0 p 68.77 -54.37 0.55 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.804 2.042 . . . . 2.55 111.388 -171.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.4 m -24.98 -54.11 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.492 2.717 . . . . 1.24 113.105 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.1 t -43.18 -70.85 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.444 1.098 . . . . 0.92 110.614 172.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -26.74 64.86 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.315 -0.866 . . . . 1.17 111.069 -176.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -51.51 -41.62 61.12 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.158 0.983 . . . . 3.47 109.195 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.485 ' HB ' HG11 ' A' ' 37' ' ' VAL . 83.5 mt -80.9 -65.0 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.454 -1.313 . . . . 0.75 107.454 175.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -47.85 -56.0 8.48 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.026 1.33 . . . . 3.37 111.645 -169.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 t -62.39 -50.6 70.91 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.676 0.75 . . . . 1.39 109.22 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 t -60.79 -24.43 65.79 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 118.686 -0.673 . . . . 0.71 111.923 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.96 -46.57 14.92 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 117.947 -1.025 . . . . 2.06 111.494 172.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.9 p -51.58 -32.02 26.98 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.612 1.096 . . . . 1.93 112.336 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -47.44 -45.26 25.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.014 1.325 . . . . 5.09 113.475 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.424 ' HB3' HD12 ' A' ' 53' ' ' ILE . 17.6 m-70 -67.69 136.26 54.04 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 119.412 1.005 . . . . 2.09 108.402 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -63.66 -53.06 57.25 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.75 -0.593 . . . . 7.77 112.513 -168.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.05 47.07 3.28 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 117.881 0.309 . . . . 1.32 113.261 -169.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -123.83 112.85 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.49 -1.3 . . . . 1.82 107.49 177.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 tp -73.53 -48.73 30.88 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.882 0.873 . . . . 3.31 109.025 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -156.94 120.25 4.14 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.843 -0.536 . . . . 2.61 110.825 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.37 157.86 15.83 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.542 -1.281 . . . . 2.58 107.542 168.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.9 t -163.35 113.35 1.34 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.859 -0.793 . . . . 1.31 108.859 168.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.485 HG11 ' HB ' ' A' ' 22' ' ' ILE . 7.5 p -114.93 145.48 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 112.544 0.572 . . . . 2.18 112.544 175.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.57 133.1 44.66 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.869 0.868 . . . . 0.77 110.3 174.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.61 -43.83 65.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.067 -0.97 . . . . 1.44 110.555 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.93 -50.81 71.44 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.316 0.579 . . . . 1.18 110.547 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -65.54 -14.09 60.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.745 0.818 . . . . 1.92 110.967 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 55.02 30.36 14.06 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.264 1.426 . . . . 2.78 109.15 -171.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -132.45 131.12 41.4 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.319 0.509 . . . . 1.6 111.365 -164.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.52 132.63 44.72 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.996 -1.112 . . . . 0.69 107.996 160.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.21 144.88 32.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.535 -1.283 . . . . 1.03 107.535 156.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 32' ' ' ILE . 55.5 mt -135.72 126.31 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 107.929 -1.137 . . . . 1.75 107.929 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -93.86 72.96 4.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.366 1.466 . . . . 2.18 108.418 172.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -101.58 170.74 7.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.702 0.801 . . . . 2.23 113.147 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -95.33 97.48 2.76 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.365 1.466 . . . . 3.97 108.861 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.86 -33.04 85.45 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.931 2.421 . . . . 1.06 113.636 -166.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.1 mp0 -63.74 -30.21 71.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.244 0.617 . . . . 4.01 112.05 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.0 pt -107.09 -56.14 5.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 112.864 0.691 . . . . 1.31 112.864 -168.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 29' ' ' HIS . 6.1 tt -87.07 -52.03 12.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.46 -0.941 . . . . 1.67 108.46 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.42 167.51 28.8 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 115.482 -0.781 . . . . 0.83 113.099 173.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.72 -38.53 70.6 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.273 3.316 . . . . 0.77 111.838 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -58.76 -60.15 4.29 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.973 0.509 . . . . 5.66 112.061 -172.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -49.85 -52.47 32.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 122.44 1.114 . . . . 2.75 110.173 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 95.0 mt -48.63 -69.72 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 114.08 -1.418 . . . . 0.73 109.894 171.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.8 mt -51.34 -40.92 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.714 0.688 . . . . 1.24 111.535 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 52.8 m170 -63.15 -47.47 82.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.547 0.689 . . . . 3.55 109.456 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.2 m -66.27 -44.73 82.76 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.606 -0.516 . . . . 0.7 109.606 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.4 mm -57.01 -47.59 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.994 0.918 . . . . 1.42 110.081 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -53.09 -58.85 5.6 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.181 -0.674 . . . . 3.62 109.181 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -55.38 -38.68 69.17 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.057 0.943 . . . . 1.1 112.279 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.8 mt -63.62 -14.49 52.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.611 0.764 . . . . 1.98 112.584 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.66 48.24 1.12 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.482 1.039 . . . . 0.67 110.964 168.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -141.74 171.2 14.39 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.399 1.08 . . . . 2.05 108.809 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -109.96 79.89 1.62 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 118.534 -0.746 . . . . 3.89 112.923 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.76 123.73 11.41 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.141 1.894 . . . . 1.25 111.511 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.9 t -148.68 152.69 37.11 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.726 0.81 . . . . 2.71 109.235 172.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 N--CA 1.466 0.352 0 O-C-N 121.346 -0.846 . . . . 3.28 111.601 -165.337 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 107.802 -1.184 . . . . 2.77 107.802 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.63 89.8 3.19 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.43 -2.433 . . . . 2.54 104.43 166.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -70.06 145.94 51.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.506 -0.553 . . . . 2.24 109.506 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 69' ' ' PRO . 0.3 OUTLIER -149.78 139.31 21.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.807 -0.812 . . . . 2.17 108.807 178.16 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.7 t -94.44 129.64 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.645 -1.243 . . . . 1.1 107.645 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.406 HG23 ' SD ' ' A' ' 13' ' ' MET . 1.6 m -132.26 74.7 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 C-N-CA 125.215 1.406 . . . . 1.86 109.953 -160.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -66.83 153.3 43.75 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.777 -0.823 . . . . 5.04 108.777 175.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.14 -29.56 7.61 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 109.632 -1.387 . . . . 0.98 109.632 -163.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.406 ' SD ' HG23 ' A' ' 10' ' ' VAL . 56.4 mtp -56.26 144.66 29.31 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.831 -0.805 . . . . 1.97 109.375 166.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 t -166.09 -58.92 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.005 0.522 . . . . 2.37 109.719 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.8 t -77.2 147.23 36.54 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.977 -0.749 . . . . 3.49 108.977 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.29 -43.34 10.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.409 0.684 . . . . 1.89 111.796 174.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.7 p -48.34 -41.27 28.01 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.374 0.67 . . . . 2.08 111.561 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 99.3 m -50.24 -29.04 8.65 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.774 0.83 . . . . 0.85 112.544 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t -55.85 -69.5 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.56 0.618 . . . . 0.76 109.421 169.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -27.98 67.59 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.895 -1.128 . . . . 1.75 111.436 -172.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.63 -33.64 16.01 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.924 1.29 . . . . 3.88 110.375 172.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 98.8 mt -91.07 -60.2 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.123 -1.436 . . . . 0.59 107.123 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -54.44 -64.17 0.92 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.618 1.167 . . . . 3.26 111.267 -170.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.6 m -59.55 -35.27 73.9 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.303 0.641 . . . . 2.35 111.504 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -62.62 -40.49 97.12 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.305 -0.247 . . . . 0.76 110.383 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.4 mt -72.02 -62.33 1.47 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 119.306 -0.378 . . . . 2.11 111.092 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.2 p -66.91 69.83 0.08 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.495 1.918 . . . . 2.33 111.03 -168.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.64 -40.84 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.071 2.148 . . . . 3.85 110.561 -172.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -74.26 150.73 40.1 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.119 0.872 . . . . 3.87 110.371 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -54.14 148.8 10.47 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.045 0.45 . . . . 6.62 110.215 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.22 -31.51 5.37 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.491 -0.616 . . . . 1.16 112.473 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -70.19 148.58 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 118.005 0.903 . . . . 1.96 108.679 171.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 36.0 mt -114.5 -51.29 2.76 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.821 1.249 . . . . 3.15 109.604 167.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -150.35 161.36 42.62 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.895 0.878 . . . . 2.32 109.881 -175.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.8 m -143.29 168.35 19.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.16 -1.052 . . . . 2.02 108.16 170.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.0 m -148.01 132.21 17.39 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.487 -1.301 . . . . 1.54 107.487 148.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.0 p -104.57 142.25 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 118.433 0.561 . . . . 2.15 110.048 164.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.62 132.26 48.14 Favored 'General case' 0 C--N 1.339 0.15 0 O-C-N 121.864 -0.522 . . . . 0.93 111.407 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.39 -58.96 6.28 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.236 1.014 . . . . 2.67 110.501 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.28 -39.41 69.81 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.59 0.756 . . . . 1.25 112.664 -169.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.6 m -95.63 -8.39 34.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.338 0.655 . . . . 2.3 110.499 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 54.65 23.16 4.5 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.562 1.945 . . . . 3.34 112.577 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -98.96 145.12 27.37 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 119.035 -0.507 . . . . 1.67 110.494 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.16 138.69 40.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.121 -1.437 . . . . 0.57 107.121 154.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -107.82 150.82 26.54 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 106.632 -1.618 . . . . 1.24 106.632 154.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 32' ' ' ILE . 4.6 mp -126.29 122.04 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.172 -1.788 . . . . 1.05 106.172 173.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -94.36 82.43 4.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.356 1.863 . . . . 3.68 106.591 169.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -118.76 164.32 15.56 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.967 2.107 . . . . 2.0 109.775 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -86.89 117.76 69.11 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 107.856 -1.164 . . . . 3.26 107.856 167.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.2 -29.73 38.78 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.162 1.908 . . . . 1.31 112.918 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -86.66 29.23 0.8 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.664 1.12 . . . . 3.55 111.285 -166.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.7 pt -144.47 -50.48 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 123.95 0.9 . . . . 1.28 112.236 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.619 HG23 ' H ' ' A' ' 54' ' ' GLY 0.254 17.6 tt -95.56 -85.26 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.572 -0.899 . . . . 1.31 108.572 174.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.619 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 131.28 166.52 11.71 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.811 0.719 . . . . 0.75 112.955 173.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.59 -47.43 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.356 3.37 . . . . 0.74 111.305 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.455 ' HE ' ' CG ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -46.43 -48.25 18.88 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.118 0.967 . . . . 8.61 111.392 176.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.455 ' CG ' ' HE ' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -53.48 -56.91 13.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.876 1.271 . . . . 4.62 108.884 179.49 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.7 mt -57.56 -56.07 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.845 0.858 . . . . 0.85 109.965 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.6 mt -50.56 -51.54 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.426 -0.583 . . . . 1.4 109.426 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -36.65 84.47 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.48 0.712 . . . . 4.42 111.056 -178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.9 m -64.58 -53.66 44.26 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.34 -0.85 . . . . 0.74 109.35 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.403 HG21 HG11 ' A' ' 10' ' ' VAL . 13.1 mm -68.78 -33.14 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 121.335 -0.853 . . . . 1.59 111.158 -173.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -49.63 -62.07 1.76 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.12 0.968 . . . . 3.33 109.162 162.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -54.88 -38.7 67.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.763 0.825 . . . . 1.03 112.865 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.24 -14.71 27.92 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.954 -1.091 . . . . 2.22 112.88 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.02 47.01 2.31 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.317 0.961 . . . . 0.59 111.051 175.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -136.02 172.05 13.58 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.194 0.997 . . . . 2.07 108.387 171.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -111.89 84.8 5.8 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 113.098 0.777 . . . . 4.27 113.098 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.411 ' HB2' HD12 ' A' ' 8' ' ' LEU . 34.2 Cg_endo -68.03 80.42 0.52 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.633 2.889 . . . . 1.05 114.013 -175.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.9 p -77.13 119.68 21.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.553 -0.749 . . . . 2.54 109.654 169.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 108.687 -0.857 . . . . 2.86 108.687 178.412 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 107.691 -1.225 . . . . 2.08 107.691 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.32 111.68 4.96 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.818 -1.549 . . . . 2.14 106.818 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -92.29 141.38 28.62 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 123.28 0.632 . . . . 2.81 110.047 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.9 137.0 23.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.209 -0.663 . . . . 1.62 109.209 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.02 121.89 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 105.751 -1.944 . . . . 1.08 105.751 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -116.02 100.57 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.722 -1.214 . . . . 1.52 107.722 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -73.45 166.2 23.66 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.233 -1.025 . . . . 5.72 108.233 175.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.78 -10.76 57.5 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.511 -0.605 . . . . 1.02 112.618 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 75.8 mtm -68.05 73.02 0.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.555 1.177 . . . . 1.81 111.686 174.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -71.71 -30.12 65.31 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.533 1.133 . . . . 2.58 112.604 -171.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 82.5 m -143.46 158.92 43.26 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.225 -0.657 . . . . 3.53 109.225 -176.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.23 -45.15 8.34 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.97 1.308 . . . . 1.81 112.205 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 m -43.35 -42.46 4.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.431 1.092 . . . . 1.6 112.163 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.2 m -54.66 -40.05 68.65 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.683 -0.635 . . . . 0.72 111.608 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 t -58.34 -57.9 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.436 -0.95 . . . . 0.68 108.436 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -31.07 72.13 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.48 -0.563 . . . . 1.04 109.48 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -60.16 -51.31 70.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.946 -1.131 . . . . 3.78 107.946 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.7 mt -62.86 -54.83 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.855 -1.165 . . . . 0.73 107.855 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -51.99 -56.83 11.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 123.714 0.634 . . . . 3.09 109.53 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.7 t -59.8 -46.25 89.8 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.244 0.618 . . . . 1.52 110.079 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.3 t -65.13 -29.61 70.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.363 0.665 . . . . 0.75 111.422 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mt -79.87 -45.49 18.55 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.535 -0.745 . . . . 2.38 111.098 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.426 HG23 ' SG ' ' A' ' 35' ' ' CYS . 47.0 p -65.42 75.84 0.06 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.751 0.82 . . . . 1.98 110.747 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.94 -32.66 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 129.197 2.999 . . . . 3.45 110.301 -175.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -59.68 -23.45 63.11 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.914 0.779 . . . . 2.21 111.527 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 78.57 -42.26 0.32 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.424 1.49 . . . . 7.55 113.383 162.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.15 -20.5 58.29 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 111.735 -0.546 . . . . 1.21 111.735 168.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.72 130.86 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.584 0.753 . . . . 3.11 110.746 176.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.9 mt -74.66 -42.26 58.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.217 1.007 . . . . 2.87 108.748 169.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -161.58 165.28 28.66 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.952 -0.388 . . . . 2.86 109.952 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.426 ' SG ' HG23 ' A' ' 27' ' ' THR . 1.7 p -141.25 59.29 1.52 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 126.481 1.912 . . . . 3.11 110.894 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.32 95.72 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.827 -0.546 . . . . 1.31 111.682 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.32 149.11 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 126.265 1.826 . . . . 2.11 112.83 173.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.98 131.08 10.23 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.06 1.344 . . . . 1.02 112.086 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -65.89 -53.05 44.53 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 115.285 -0.87 . . . . 1.76 111.45 -170.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.0 -45.63 88.14 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.563 0.697 . . . . 1.67 109.435 -168.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.4 t -80.6 1.64 28.95 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.86 -0.59 . . . . 2.59 111.3 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 57.24 31.44 20.08 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.451 1.1 . . . . 2.64 109.828 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -107.1 138.79 42.61 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.453 -0.943 . . . . 1.75 108.453 -167.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.12 141.23 48.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.868 -1.901 . . . . 0.92 105.868 141.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -117.84 158.38 24.92 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 118.211 -1.395 . . . . 1.61 108.04 149.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 mp -119.46 128.93 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 106.32 -1.733 . . . . 0.94 106.32 168.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -95.34 132.32 40.49 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.396 -2.076 . . . . 2.51 105.396 163.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -165.07 167.77 17.97 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.044 0.838 . . . . 2.44 111.514 -168.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -87.71 119.09 70.49 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 107.015 -1.476 . . . . 3.49 107.015 156.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.15 -39.31 18.67 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.043 1.829 . . . . 1.34 111.065 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -89.14 39.17 0.92 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.206 1.002 . . . . 3.94 110.528 -160.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.7 pt -142.24 -49.9 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 126.052 1.741 . . . . 1.14 109.898 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 tt -95.68 -43.13 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.676 1.19 . . . . 1.3 111.373 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.36 150.64 4.93 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 123.911 0.767 . . . . 0.82 111.493 -174.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.66 -29.35 60.37 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.109 2.539 . . . . 0.87 111.775 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -55.92 -52.49 63.94 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.44 0.696 . . . . 5.95 111.458 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -50.28 -54.8 18.72 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 122.226 1.012 . . . . 2.52 109.869 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mt -54.26 -61.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.843 1.257 . . . . 0.72 110.144 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.5 mt -53.59 -47.43 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.42 0.555 . . . . 1.38 110.791 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -62.65 -42.89 99.86 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.298 0.639 . . . . 2.55 109.72 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.9 m -60.83 -54.0 50.46 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.209 -0.663 . . . . 0.61 109.209 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.2 mm -62.74 -37.58 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 119.215 -0.422 . . . . 1.67 111.037 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -52.99 -64.92 0.66 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.206 -0.664 . . . . 3.61 109.206 169.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.6 t -59.86 -24.79 64.51 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.438 0.695 . . . . 1.2 112.791 -176.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.1 tp -72.72 -5.15 35.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.078 1.351 . . . . 2.3 111.548 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.68 47.59 1.62 Allowed Glycine 0 C--N 1.337 0.628 0 C-N-CA 125.229 1.395 . . . . 0.76 110.825 168.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -144.16 172.34 13.04 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 123.949 0.9 . . . . 1.76 109.53 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -114.94 77.92 5.13 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.664 -0.684 . . . . 4.3 111.311 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.36 93.66 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.598 2.198 . . . . 1.06 112.41 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.3 t -97.04 139.65 32.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.895 0.855 . . . . 2.17 109.896 171.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 107.562 -1.273 . . . . 3.63 107.562 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 108.989 -0.745 . . . . 2.01 108.989 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.1 tp -133.65 141.74 47.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.507 -2.035 . . . . 2.8 105.507 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -129.83 139.47 51.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.278 -1.378 . . . . 2.48 107.278 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.404 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -143.84 148.5 35.59 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.073 -1.084 . . . . 3.12 108.073 176.169 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.39 133.25 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.893 -1.521 . . . . 0.99 106.893 175.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.09 87.97 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.75 0.82 . . . . 1.57 109.224 -168.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 77.0 mmt-85 -62.77 150.87 40.28 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.544 -0.909 . . . . 5.14 108.544 171.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.26 -4.5 48.26 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.862 -0.966 . . . . 0.98 113.954 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.8 mtp -75.1 49.61 0.45 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.871 1.835 . . . . 1.95 112.249 -176.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 t -82.79 37.22 0.52 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.695 -1.253 . . . . 3.02 113.407 -164.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.3 t -173.41 142.4 0.98 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.615 0.766 . . . . 3.1 108.959 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.38 -50.26 3.81 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.468 1.107 . . . . 2.01 112.456 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 m -46.36 -34.34 4.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.93 1.292 . . . . 1.54 112.866 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.0 m -48.23 -34.98 11.09 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 123.571 0.748 . . . . 1.02 111.029 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.439 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 93.9 t -49.07 -72.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 118.18 0.446 . . . . 0.88 110.115 173.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -27.9 68.47 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.693 -0.629 . . . . 1.29 111.178 -175.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -49.56 -42.84 45.3 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.213 0.605 . . . . 3.43 110.088 173.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.3 mt -83.06 -61.71 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.099 -1.075 . . . . 0.75 108.099 175.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -51.88 -61.31 2.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.39 1.476 . . . . 3.35 111.231 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 t -62.05 -45.49 93.33 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.855 0.862 . . . . 1.45 109.181 -173.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -59.95 -37.16 78.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.777 -0.647 . . . . 0.9 111.302 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mt -75.34 -37.41 60.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.235 -0.888 . . . . 2.34 112.521 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.5 p -64.35 77.6 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.749 0.704 . . . . 1.68 111.218 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HZ1' ' CD2' ' A' ' 29' ' ' HIS . 0.9 OUTLIER 168.32 -31.35 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.762 2.825 . . . . 3.3 111.152 -174.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.403 ' CD2' ' HZ1' ' A' ' 28' ' ' LYS . 24.7 m-70 -52.72 120.75 6.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.881 0.764 . . . . 1.96 110.108 177.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -70.97 80.26 0.65 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.836 0.855 . . . . 4.93 111.307 -166.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.86 -16.87 1.07 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.933 1.254 . . . . 1.2 110.743 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.496 HD11 ' SG ' ' A' ' 35' ' ' CYS . 0.3 OUTLIER -60.5 148.95 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 107.659 -1.238 . . . . 1.82 107.659 163.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 pp -122.11 -29.94 4.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.841 0.856 . . . . 2.66 112.346 167.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -159.64 154.7 24.94 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 119.547 1.067 . . . . 2.25 109.143 174.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.496 ' SG ' HD11 ' A' ' 32' ' ' ILE . 1.3 m -132.94 157.91 43.96 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.314 -0.995 . . . . 1.9 108.314 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.6 t -159.67 128.58 5.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.477 -0.934 . . . . 1.68 108.477 159.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 19' ' ' VAL . 1.1 m -121.12 159.93 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 123.203 0.601 . . . . 1.65 110.249 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.22 134.32 17.03 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.83 110.458 174.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.92 -33.92 68.67 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.152 -0.931 . . . . 1.38 110.462 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.98 80.44 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.547 0.739 . . . . 1.1 111.659 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.6 m -96.56 2.38 52.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.72 0.808 . . . . 2.14 109.974 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 46.67 44.71 14.01 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.453 2.301 . . . . 2.88 112.113 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -133.66 157.79 44.88 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 112.01 0.374 . . . . 1.73 112.01 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.66 135.94 53.37 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.422 -1.325 . . . . 0.69 107.422 162.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.59 149.77 27.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 123.832 0.707 . . . . 1.1 109.783 159.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.65 139.31 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 C-N-CA 127.481 2.312 . . . . 0.92 106.172 175.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' O ' HD13 ' A' ' 32' ' ' ILE . 76.4 mttt -113.45 135.14 54.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.62 -1.993 . . . . 2.3 105.62 161.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -170.97 175.08 4.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.228 1.011 . . . . 2.11 110.569 -164.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -98.09 96.26 3.38 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 125.457 1.503 . . . . 3.3 108.063 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -60.35 -29.75 89.51 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.128 1.885 . . . . 1.11 112.12 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -54.79 -43.93 73.28 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.872 0.869 . . . . 3.96 111.792 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.4 pt -94.77 -86.79 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.877 0.471 . . . . 1.8 112.027 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.7 tt -59.24 -45.83 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.971 0.908 . . . . 1.39 111.381 -171.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.95 161.8 31.26 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 115.329 -0.851 . . . . 0.66 112.342 172.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.27 -35.65 23.61 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.644 2.896 . . . . 0.66 111.865 -174.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -55.23 -49.35 72.22 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.918 0.487 . . . . 5.21 111.742 -174.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.28 -53.75 20.3 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.742 0.782 . . . . 2.78 109.75 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.55 -50.11 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.627 1.171 . . . . 1.04 110.555 -174.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.2 mt -55.18 -52.31 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 109.767 -0.457 . . . . 1.29 109.767 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -62.27 -36.35 81.81 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.376 -0.828 . . . . 2.36 112.22 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 66.6 m -57.21 -50.44 72.85 Favored 'General case' 0 C--O 1.225 -0.21 0 O-C-N 121.262 -0.899 . . . . 0.78 108.937 174.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.5 mt -65.73 -42.85 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.693 -0.63 . . . . 2.11 111.315 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -48.31 -46.1 35.81 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.424 1.09 . . . . 2.7 109.104 171.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.0 t -69.83 -44.07 70.68 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.741 0.817 . . . . 1.39 111.695 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.9 mt -59.38 -28.33 66.79 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.467 -0.77 . . . . 2.04 110.653 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.21 47.65 0.69 Allowed Glycine 0 C--O 1.228 -0.219 0 N-CA-C 110.117 -1.193 . . . . 0.8 110.117 157.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -134.62 171.55 14.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.529 -1.656 . . . . 1.87 106.529 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -108.93 82.01 1.69 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.06 -0.971 . . . . 4.22 111.313 -170.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.74 75.55 1.61 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.515 2.81 . . . . 1.12 112.823 -174.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m -73.51 116.92 14.66 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.959 -0.756 . . . . 2.35 108.959 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.2 tp . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.557 -1.275 . . . . 3.35 107.557 176.179 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 109.535 -0.543 . . . . 2.19 109.535 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 7' ' ' GLU . 3.1 tt -152.05 136.0 16.44 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.681 -1.97 . . . . 2.72 105.681 173.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.4 ' N ' HD23 ' A' ' 6' ' ' LEU . 63.6 mt-10 -114.13 130.01 56.6 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.251 1.021 . . . . 2.56 108.452 175.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.9 131.76 56.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.11 -1.441 . . . . 1.61 107.11 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 t -73.87 103.99 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 105.233 -2.136 . . . . 1.23 105.233 167.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 p -99.57 124.47 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 109.42 -0.585 . . . . 2.61 109.42 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -82.5 104.85 13.09 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.369 -1.715 . . . . 5.45 106.369 164.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.29 -54.32 0.03 OUTLIER Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.76 -0.257 . . . . 2.47 112.93 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -76.68 73.4 3.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.863 -0.787 . . . . 2.15 110.396 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 t -56.51 -39.06 72.66 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.907 0.483 . . . . 2.8 110.222 171.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 65.2 m -143.31 -168.01 2.7 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.743 1.617 . . . . 3.81 107.202 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.39 -168.15 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.537 0.735 . . . . 2.72 111.115 170.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.8 m 69.57 -66.86 0.25 Allowed 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.74 1.216 . . . . 1.61 109.693 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.5 m -40.85 -48.89 3.16 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.887 1.275 . . . . 0.89 110.671 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.0 t -43.26 -67.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.931 1.292 . . . . 0.71 110.968 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -24.54 67.74 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.836 -0.62 . . . . 1.13 109.643 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -65.27 -51.31 61.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.431 -0.951 . . . . 3.71 108.431 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.4 mt -65.12 -53.76 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 107.667 -1.235 . . . . 0.67 107.667 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -45.28 -51.71 10.55 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.455 0.702 . . . . 3.55 112.569 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 53.2 m -63.43 -52.88 59.66 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.684 -0.635 . . . . 1.55 110.167 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.0 t -54.45 -37.32 65.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.388 1.075 . . . . 1.22 111.506 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.07 -44.89 15.98 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.404 1.082 . . . . 1.85 110.954 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.7 p -58.24 -37.67 75.37 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.72 1.146 . . . . 1.96 110.834 176.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -51.25 -29.75 15.47 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.24 1.416 . . . . 4.8 113.057 169.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -78.8 99.45 6.7 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.76 -1.213 . . . . 2.15 110.3 175.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.71 107.83 0.17 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.864 -1.162 . . . . 6.72 107.864 157.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.75 -36.07 1.87 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.672 -1.371 . . . . 1.25 109.672 -170.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -70.68 142.49 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.697 -1.223 . . . . 2.11 107.697 168.016 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.0 tp -98.58 -47.4 5.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.639 1.576 . . . . 3.22 108.721 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -154.98 128.69 8.62 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.249 0.62 . . . . 3.2 109.913 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.0 t -108.05 150.44 27.16 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 108.347 -0.983 . . . . 2.12 108.347 171.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.9 t -156.55 129.52 7.88 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.148 -1.426 . . . . 1.81 107.148 162.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.0 m -122.85 144.71 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.89 0.768 . . . . 1.64 110.759 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.26 132.25 35.53 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.727 0.811 . . . . 0.81 111.28 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 pp -68.62 -51.71 39.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.661 1.185 . . . . 1.51 110.994 -174.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.32 -51.32 65.06 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.404 0.621 . . . . 1.17 110.178 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.04 -14.71 61.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.672 1.189 . . . . 2.03 111.738 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 55.52 33.79 21.78 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.198 1.399 . . . . 2.84 108.367 -172.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -126.48 140.72 52.25 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 118.801 0.728 . . . . 1.38 111.264 -162.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.32 120.25 39.0 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.127 -1.064 . . . . 0.74 108.127 161.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -95.27 132.0 40.73 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 126.684 1.994 . . . . 3.01 106.466 173.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.543 HG22 ' CD1' ' A' ' 48' ' ' TYR . 97.5 mt -130.47 130.32 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.799 -1.186 . . . . 1.44 107.799 173.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.486 ' O ' HD13 ' A' ' 32' ' ' ILE . 41.6 mttp -104.66 131.99 51.44 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 105.967 -1.864 . . . . 2.95 105.967 159.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.543 ' CD1' HG22 ' A' ' 46' ' ' ILE . 18.3 p90 -162.78 160.8 25.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.601 1.16 . . . . 2.19 109.283 -169.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -82.2 104.5 3.36 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 107.432 -1.321 . . . . 3.65 107.432 172.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -61.78 -45.02 18.43 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.447 2.098 . . . . 1.45 111.923 -166.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -53.32 -40.9 65.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.308 1.443 . . . . 4.41 112.938 -174.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 pt -88.56 -47.51 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 113.838 1.051 . . . . 1.48 113.838 -168.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.2 tt -83.99 -56.71 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 118.142 0.428 . . . . 1.67 111.191 -178.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.41 135.01 8.3 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.002 0.811 . . . . 1.06 112.444 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.65 -45.18 14.66 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.703 2.935 . . . . 0.9 111.059 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -53.55 -52.4 59.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.51 -0.552 . . . . 7.08 109.51 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.94 -46.39 85.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.916 1.686 . . . . 5.32 109.928 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 mt -52.31 -58.86 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 122.696 0.399 . . . . 0.96 110.732 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 mt -50.49 -43.87 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 118.091 0.405 . . . . 1.55 111.184 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -63.4 -36.35 83.43 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.495 -0.753 . . . . 2.36 111.483 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.6 m -62.25 -50.33 72.16 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.282 -0.886 . . . . 0.91 109.273 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.9 mm -59.71 -45.01 94.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.881 -0.512 . . . . 1.32 111.321 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -52.11 -53.74 38.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.115 1.366 . . . . 2.71 109.528 172.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -56.56 -39.42 73.43 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.357 1.063 . . . . 1.5 112.124 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.76 -17.27 34.06 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.573 0.583 . . . . 2.38 112.573 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.45 29.26 11.29 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.344 0.973 . . . . 1.46 110.724 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -120.31 158.68 26.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.645 1.178 . . . . 1.91 108.684 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -105.65 104.11 46.87 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-O 118.029 -0.986 . . . . 4.69 110.271 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -84.54 83.74 1.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.934 3.089 . . . . 1.06 111.552 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 m -72.54 103.67 3.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.877 -0.786 . . . . 2.51 108.877 173.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--N 1.327 -0.402 0 N-CA-C 108.237 -1.023 . . . . 3.74 108.237 174.084 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 CA--C 1.531 0.244 0 N-CA-C 109.211 -0.663 . . . . 2.18 109.211 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -74.91 111.57 10.25 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.029 -1.1 . . . . 2.43 108.029 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -92.56 122.79 35.33 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.272 -1.381 . . . . 2.94 107.272 169.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -118.66 151.0 38.77 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 108.099 -1.074 . . . . 1.54 108.099 170.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 t -103.78 119.0 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.34 -0.985 . . . . 1.11 108.34 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.56 119.98 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 126.937 2.095 . . . . 1.39 109.406 174.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -82.38 161.63 22.45 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.674 -1.232 . . . . 5.78 107.674 154.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.91 -28.17 5.47 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.185 0.898 . . . . 0.89 112.569 172.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -65.53 113.62 4.3 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.438 1.119 . . . . 2.09 109.845 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 t -67.31 -54.8 17.52 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.567 -0.531 . . . . 2.9 109.567 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 t -177.34 -90.03 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.658 1.183 . . . . 5.46 109.914 170.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.02 160.23 32.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.651 0.38 . . . . 3.23 109.989 -176.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.5 m 68.02 -60.66 0.4 Allowed 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.424 1.49 . . . . 1.56 110.983 -173.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.6 m -39.64 -41.91 1.12 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 126.438 1.895 . . . . 0.79 113.04 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.7 t -51.16 -69.57 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.709 0.29 . . . . 0.59 110.337 173.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.19 -30.73 71.66 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.302 -0.874 . . . . 1.65 110.872 -175.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.28 -40.83 17.62 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.771 1.228 . . . . 3.59 109.49 174.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.9 mt -85.32 -60.44 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 107.352 -1.351 . . . . 0.54 107.352 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -51.36 -62.28 1.72 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.242 1.417 . . . . 3.47 111.52 -170.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -61.93 -43.11 99.53 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.809 0.844 . . . . 2.76 110.144 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.9 t -62.28 -35.2 78.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.079 -0.509 . . . . 0.9 110.858 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.9 mt -70.43 -46.99 62.81 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.32 -0.847 . . . . 2.03 111.041 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.5 p -63.89 77.45 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.257 0.481 . . . . 1.78 110.779 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? 170.72 -24.58 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.654 3.182 . . . . 3.42 111.437 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -70.91 59.24 0.22 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.94 1.245 . . . . 2.19 111.683 172.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 41.04 -73.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 129.454 3.101 . . . . 5.77 115.766 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.43 97.14 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.918 0.771 . . . . 1.94 111.526 -175.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.666 HD13 HG23 ' A' ' 46' ' ' ILE . 1.3 tp -66.65 97.66 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 117.635 0.717 . . . . 2.23 110.877 -175.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 pp -86.5 -32.77 20.58 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.605 1.162 . . . . 3.01 111.721 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -147.72 136.8 22.21 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.278 0.631 . . . . 2.27 111.02 176.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -117.75 166.45 12.42 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.223 -1.028 . . . . 1.99 108.223 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 m -151.09 117.69 5.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.421 -1.326 . . . . 1.56 107.421 151.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.71 125.15 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 120.411 1.46 . . . . 2.37 109.894 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.44 129.55 55.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.181 0.593 . . . . 1.16 109.475 172.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.0 -48.17 54.68 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.849 -1.069 . . . . 1.77 111.015 -172.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.03 -51.44 69.68 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.37 0.605 . . . . 1.71 110.534 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.81 -12.82 52.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.482 1.113 . . . . 2.11 111.342 176.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 54.26 28.35 9.1 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 125.157 1.383 . . . . 2.73 109.627 -172.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -121.03 129.41 53.36 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 118.944 0.793 . . . . 1.44 110.846 -160.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.02 120.44 39.84 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.685 1.194 . . . . 0.8 108.715 164.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 127.31 36.09 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 127.002 2.121 . . . . 1.62 105.33 166.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.666 HG23 HD13 ' A' ' 32' ' ' ILE . 4.6 mp -120.9 130.2 74.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.029 1.332 . . . . 1.2 108.713 174.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -104.0 90.25 3.55 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.006 1.723 . . . . 2.58 108.278 167.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.14 179.35 7.27 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.98 1.312 . . . . 2.2 109.535 -175.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.2 124.53 41.04 Favored Pre-proline 0 N--CA 1.445 -0.719 0 O-C-N 123.34 0.4 . . . . 4.18 110.759 174.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.51 -8.79 10.4 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.406 2.738 . . . . 1.7 112.801 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -90.83 -55.1 3.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 119.154 0.888 . . . . 3.49 108.784 -175.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 pt -68.24 -78.68 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.849 0.357 . . . . 1.46 111.871 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.7 tt -69.06 -56.62 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 O-C-N 121.229 -0.92 . . . . 1.34 109.186 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.03 159.07 33.25 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 122.92 0.295 . . . . 0.64 113.1 171.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.66 -38.61 80.47 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.661 2.907 . . . . 0.83 110.979 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -32.16 -64.14 0.18 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.73 2.012 . . . . 9.91 113.487 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -53.98 -58.25 7.99 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.624 1.169 . . . . 2.91 109.906 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 mt -57.2 -59.94 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.271 -0.877 . . . . 1.22 109.899 -176.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.4 mt -49.99 -51.33 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 123.311 0.644 . . . . 1.25 110.273 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -69.31 -32.71 72.01 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.537 0.608 . . . . 2.51 111.689 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.3 m -60.6 -58.66 7.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.942 -0.762 . . . . 0.69 108.942 171.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 mm -59.98 -38.17 75.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.297 1.039 . . . . 1.83 111.474 -174.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -51.72 -65.35 0.57 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.84 1.256 . . . . 2.73 108.809 167.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.8 t -56.96 -27.58 61.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.317 0.647 . . . . 1.15 112.696 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.5 tp -76.17 -5.4 46.58 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.419 1.488 . . . . 2.28 111.57 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.1 45.36 2.85 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 124.345 0.974 . . . . 0.64 111.572 169.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -143.23 172.16 13.11 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.443 1.097 . . . . 2.15 108.11 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -115.76 78.76 7.24 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 123.106 0.562 . . . . 4.68 111.916 -175.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.13 72.78 5.75 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.786 2.991 . . . . 1.55 112.829 -168.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.8 p -69.84 138.98 53.05 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.969 -0.457 . . . . 2.08 110.488 171.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.9 tp . . . . . 0 N--CA 1.451 -0.392 0 N-CA-C 106.742 -1.577 . . . . 3.2 106.742 167.065 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 108.078 -1.082 . . . . 2.46 108.078 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.79 90.34 2.89 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.982 -1.488 . . . . 2.48 106.982 171.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -73.65 119.95 18.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.26 -1.015 . . . . 2.11 108.26 159.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -127.7 150.61 49.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.211 -1.033 . . . . 1.84 108.211 166.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.0 t -96.71 135.71 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.429 -1.693 . . . . 0.91 106.429 171.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.81 176.73 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.483 -0.932 . . . . 2.55 108.483 172.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -134.55 167.07 21.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.942 -2.244 . . . . 6.17 104.942 152.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.93 -3.9 55.89 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.295 -0.725 . . . . 1.09 114.139 176.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.9 mtm -75.7 53.93 0.76 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.72 1.76 . . . . 2.06 111.977 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -80.68 36.27 0.38 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.897 -1.127 . . . . 3.13 113.203 -166.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.7 t -171.04 140.54 1.55 Allowed 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 118.913 0.779 . . . . 3.43 109.424 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.86 -48.82 11.12 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.797 0.839 . . . . 1.94 111.162 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 m -44.84 -38.6 4.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.485 1.114 . . . . 1.56 112.234 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.0 m -54.62 -38.12 66.42 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.372 0.533 . . . . 0.8 110.908 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 86.1 t -52.46 -63.8 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 123.407 0.683 . . . . 0.75 109.487 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -29.28 69.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.908 -0.587 . . . . 1.35 109.715 -175.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -62.66 -55.55 25.87 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.184 -1.413 . . . . 4.56 107.184 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.456 HG22 HD23 ' A' ' 26' ' ' LEU . 65.4 mt -60.09 -53.45 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 107.066 -1.457 . . . . 0.69 107.066 -172.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -41.34 -64.6 0.54 Allowed 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 124.607 1.192 . . . . 4.29 109.768 174.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.2 t -58.19 -43.85 87.74 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.632 0.773 . . . . 1.41 110.259 -173.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.63 -20.84 62.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.313 1.045 . . . . 1.01 111.117 -176.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.456 HD23 HG22 ' A' ' 22' ' ' ILE . 2.4 mm? -82.72 -57.85 3.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.703 -0.665 . . . . 2.04 110.55 168.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.58 -31.27 64.06 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.231 0.923 . . . . 1.61 111.572 -177.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -37.11 -52.04 0.99 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.494 1.517 . . . . 4.62 112.798 162.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -96.64 140.84 30.66 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 118.899 0.772 . . . . 3.37 111.294 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -67.11 177.09 1.88 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.696 -0.483 . . . . 6.54 109.696 173.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.19 -48.42 3.92 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.935 -1.266 . . . . 1.39 109.935 -174.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.856 HD11 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -57.88 141.99 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.641 -0.874 . . . . 1.83 108.641 158.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.3 mt -108.97 -45.37 3.8 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.417 1.487 . . . . 3.41 108.593 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -154.98 155.96 35.14 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.013 0.925 . . . . 2.16 109.756 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.9 t -136.96 146.28 45.2 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.464 -0.939 . . . . 1.99 108.464 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.9 m -150.74 119.34 6.5 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.813 -0.81 . . . . 1.75 108.813 161.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 22' ' ' ILE . 11.3 m -101.21 155.67 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.699 0.8 . . . . 1.68 109.964 170.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.48 134.08 22.12 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.252 0.621 . . . . 1.01 110.971 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.66 -47.61 69.01 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.444 1.097 . . . . 2.35 110.133 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.79 -43.49 80.97 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 123.377 0.671 . . . . 1.69 111.384 -170.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.1 m -94.37 -0.84 54.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.167 0.587 . . . . 2.57 110.593 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.78 34.06 18.29 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.073 1.749 . . . . 2.99 111.528 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -112.14 152.11 28.69 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.567 0.747 . . . . 1.49 110.359 -165.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.417 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -116.39 121.91 43.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.428 1.091 . . . . 0.68 108.224 156.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.97 131.69 42.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.902 -1.518 . . . . 1.13 106.902 160.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.856 HG23 HD11 ' A' ' 32' ' ' ILE . 4.8 mp -118.08 119.23 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.029 -1.471 . . . . 1.11 107.029 172.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -95.88 95.7 8.43 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 126.59 1.956 . . . . 3.29 106.252 172.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -126.8 165.85 18.53 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.024 1.33 . . . . 2.33 109.474 -174.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -86.94 112.47 47.6 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.649 -0.871 . . . . 3.25 108.649 170.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.05 -19.25 45.72 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.612 2.208 . . . . 1.4 113.089 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -69.01 -36.47 77.83 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.021 0.828 . . . . 4.16 110.705 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.6 pt -99.23 -62.55 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 N-CA-C 113.599 0.963 . . . . 1.29 113.599 -165.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 tt -88.42 -47.56 15.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.576 0.703 . . . . 1.44 110.721 -165.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.5 151.6 27.13 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.045 0.831 . . . . 0.72 111.589 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.66 -30.51 34.62 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.828 3.019 . . . . 0.65 112.55 -174.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.426 HH21 ' CE1' ' A' ' 60' ' ' HIS . 2.3 mmp_? -50.97 -50.42 58.2 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.983 0.513 . . . . 6.38 111.068 176.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.24 -54.22 27.86 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.814 0.845 . . . . 2.78 110.285 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.0 mt -57.01 -54.26 32.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 124.69 1.196 . . . . 0.96 111.065 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.6 mt -54.42 -53.15 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.378 -0.601 . . . . 1.27 109.378 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.426 ' CE1' HH21 ' A' ' 56' ' ' ARG . 74.4 m-70 -61.75 -35.42 78.07 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.793 -0.567 . . . . 2.37 112.318 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.0 m -59.81 -48.93 79.7 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 121.045 -1.034 . . . . 0.87 109.508 176.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.6 mt -68.86 -42.64 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.883 -0.511 . . . . 2.12 111.511 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -49.54 -47.16 49.22 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.875 1.27 . . . . 2.78 109.08 171.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.2 t -70.66 -42.33 70.94 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.126 0.971 . . . . 1.29 110.555 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.56 -48.87 57.34 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 124.663 1.185 . . . . 3.1 109.009 174.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.26 45.96 0.28 Allowed Glycine 0 C--N 1.334 0.438 0 N-CA-C 110.179 -1.168 . . . . 0.76 110.179 168.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -127.45 172.71 10.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.561 -1.644 . . . . 1.67 106.561 169.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -110.44 71.77 0.68 Allowed Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 118.689 -0.672 . . . . 4.66 111.876 -165.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.82 136.12 34.67 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.404 2.069 . . . . 1.48 112.337 -169.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.6 p -145.56 129.19 17.1 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.728 1.211 . . . . 1.92 108.258 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 O-C-N 121.219 -0.925 . . . . 3.36 112.685 -173.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 107.207 -1.405 . . . . 2.43 107.207 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 tp -148.23 111.4 4.9 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.275 -1.379 . . . . 2.67 107.275 -172.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -100.37 46.14 0.96 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.657 1.983 . . . . 5.05 109.355 -169.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.02 156.36 39.25 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.964 -0.46 . . . . 1.75 110.031 -165.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.56 129.14 48.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 N-CA-C 107.793 -1.188 . . . . 1.0 107.793 175.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.58 125.4 68.62 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.029 0 N-CA-C 106.528 -1.656 . . . . 1.63 106.528 172.06 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -104.91 167.97 9.36 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.273 -1.01 . . . . 4.48 108.273 157.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.88 -10.51 29.71 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.783 1.183 . . . . 0.96 111.891 -173.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.0 mtm -68.11 76.14 0.23 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.114 0.957 . . . . 1.85 110.179 172.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.8 p -82.19 -75.07 0.32 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.272 1.029 . . . . 3.35 109.436 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 67.2 m -72.9 128.81 36.6 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.572 -0.899 . . . . 4.54 108.572 -179.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -34.89 -51.79 0.52 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.775 1.63 . . . . 1.76 113.394 -176.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.8 t -40.1 -42.51 1.45 Allowed 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 124.817 1.247 . . . . 3.16 111.385 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.0 m -38.38 -46.3 1.11 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.272 1.029 . . . . 0.8 112.097 177.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.0 t -50.83 -67.28 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 124.172 0.989 . . . . 0.6 110.244 175.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.43 -21.42 66.29 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.443 -0.344 . . . . 2.56 111.847 -179.003 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -68.42 -50.11 55.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.925 -1.509 . . . . 3.45 106.925 -178.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.477 HG21 HG11 ' A' ' 37' ' ' VAL . 63.5 mt -62.05 -57.84 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.374 -1.343 . . . . 0.58 107.374 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -48.19 -57.78 5.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.794 0.838 . . . . 3.32 111.16 179.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.1 t -59.7 -44.25 93.76 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.624 0.726 . . . . 1.56 110.135 -178.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.5 t -60.48 -29.01 68.79 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 118.506 -0.759 . . . . 1.09 111.446 177.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.44 HD12 HG22 ' A' ' 22' ' ' ILE . 11.8 mt -82.63 -47.98 11.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 119.161 0.892 . . . . 2.36 111.772 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.8 p -72.75 62.04 0.56 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.37 1.468 . . . . 1.73 110.938 -175.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -168.7 -30.88 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.673 1.989 . . . . 3.68 111.84 -171.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -65.59 19.76 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.247 1.573 . . . . 2.42 115.247 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 61.85 -71.83 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.504 1.521 . . . . 4.95 110.816 -169.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.68 49.47 3.66 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.309 0.956 . . . . 1.78 112.773 -172.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.65 135.16 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 104.789 -2.3 . . . . 2.69 104.789 159.421 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.7 mt -95.4 -37.55 10.89 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.147 0.979 . . . . 3.63 108.925 173.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -168.61 158.9 9.67 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.596 1.158 . . . . 2.04 108.071 177.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.8 m -145.48 155.19 42.95 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 123.669 0.788 . . . . 2.2 109.943 172.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.1 t -162.37 116.99 1.83 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.803 1.241 . . . . 1.83 107.873 167.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.477 HG11 HG21 ' A' ' 22' ' ' ILE . 2.7 m -104.05 159.95 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.429 1.013 . . . . 1.67 111.936 170.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.9 135.96 21.22 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.574 0.75 . . . . 0.79 109.981 176.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.23 -43.15 19.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.625 0.77 . . . . 1.61 111.78 -171.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.25 -39.25 89.63 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.886 0.474 . . . . 1.36 110.186 -174.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.3 t -98.19 3.67 48.97 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.599 0.76 . . . . 2.22 111.274 176.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.22 48.45 13.09 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 126.252 1.821 . . . . 3.26 110.673 173.141 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -119.55 143.29 47.69 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 125.252 1.421 . . . . 2.09 108.338 -169.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.6 109.57 14.94 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.879 -1.156 . . . . 0.9 107.879 158.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -83.65 110.51 18.33 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 104.557 -2.386 . . . . 1.54 104.557 166.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.8 mt -110.31 143.44 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.292 1.037 . . . . 0.97 108.29 171.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -120.79 133.0 55.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.455 -1.683 . . . . 2.17 106.455 163.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -164.45 167.94 19.01 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.478 0.581 . . . . 2.03 110.911 -163.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -104.02 104.87 45.85 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 108.65 -0.87 . . . . 4.22 108.65 -178.01 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.64 26.18 0.48 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.89 2.393 . . . . 1.45 113.942 -167.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -127.52 -62.89 1.06 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.424 1.09 . . . . 3.78 108.94 -172.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 pt -57.8 -39.76 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.242 0.617 . . . . 2.65 111.748 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.425 HG23 ' H ' ' A' ' 54' ' ' GLY . 6.3 tt -107.01 -81.74 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.796 0.839 . . . . 1.54 109.244 171.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.425 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 123.15 155.33 9.26 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.144 0.878 . . . . 1.09 111.242 -177.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.35 -41.42 41.71 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.123 2.549 . . . . 1.1 110.52 175.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.5 ttm105 -32.96 -71.1 0.06 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 127.01 2.124 . . . . 7.67 110.768 171.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.8 -45.64 89.43 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.275 1.83 . . . . 4.04 109.949 -171.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.0 mt -58.56 -60.86 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 109.426 -0.583 . . . . 0.91 109.426 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.4 mt -51.08 -48.43 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.958 0.503 . . . . 1.56 109.822 178.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -61.86 -38.38 88.04 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.686 1.194 . . . . 4.02 111.698 -178.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.7 m -65.03 -52.31 56.69 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.117 -0.99 . . . . 0.61 108.633 175.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 mm -63.64 -36.94 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 O-C-N 122.205 -0.31 . . . . 1.53 110.991 -175.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -52.35 -64.06 0.94 Allowed 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.028 1.331 . . . . 2.7 109.036 166.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 t -52.65 -38.15 59.88 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.345 1.058 . . . . 1.1 112.786 -175.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.9 mt -58.25 -25.78 62.14 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.512 -0.742 . . . . 1.93 112.86 176.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.13 49.94 0.8 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.229 0.918 . . . . 0.9 111.131 178.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -137.97 167.51 21.63 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 106.577 -1.638 . . . . 1.77 106.577 172.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -107.49 89.18 4.73 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 119.351 0.978 . . . . 4.21 112.539 172.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.09 70.92 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.967 2.445 . . . . 1.61 111.629 177.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.4 m -79.14 117.61 20.33 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.242 1.417 . . . . 2.04 108.515 177.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.9 tp . . . . . 0 N--CA 1.441 -0.924 0 N-CA-C 107.936 -1.135 . . . . 3.74 107.936 -179.325 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 121.068 0.461 . . . . 2.66 110.319 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.1 tp -74.93 130.95 40.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.897 -0.779 . . . . 2.23 108.897 179.483 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -103.65 149.59 24.8 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.092 -1.077 . . . . 2.04 108.092 164.327 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.68 123.88 13.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.03 -1.47 . . . . 1.64 107.03 172.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.35 135.42 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 107.497 -1.297 . . . . 1.12 107.497 166.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.0 156.82 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 124.929 1.292 . . . . 2.08 107.63 173.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.4 mtm105 -138.37 177.37 7.93 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.187 -1.783 . . . . 4.43 106.187 168.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.39 -9.23 71.95 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.53 0.586 . . . . 1.36 112.61 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -69.4 157.99 36.0 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.198 0.999 . . . . 2.89 110.206 176.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 t -149.31 140.34 22.94 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.523 -1.288 . . . . 3.87 107.523 167.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 69.2 m 68.67 153.39 0.1 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.842 1.657 . . . . 2.73 112.563 174.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.32 -36.99 22.71 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.744 0.818 . . . . 2.44 110.619 174.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -35.07 -52.16 0.56 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.931 1.692 . . . . 1.95 112.5 170.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.3 m -63.88 -35.56 81.06 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.482 -0.761 . . . . 0.98 111.627 -175.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.2 t -56.68 -59.52 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 178.567 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -31.77 73.17 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.773 -0.649 . . . . 1.64 109.792 -177.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -58.22 -58.91 6.39 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 106.957 -1.498 . . . . 4.03 106.957 176.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.537 HG21 HG11 ' A' ' 37' ' ' VAL . 60.6 mt -59.61 -53.21 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.54 -1.282 . . . . 0.66 107.54 -171.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -46.02 -57.75 4.16 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 124.127 0.892 . . . . 4.23 110.112 177.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -60.88 -46.79 89.2 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.696 0.76 . . . . 1.41 109.804 -175.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 t -60.23 -36.65 78.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.374 1.47 . . . . 0.94 109.079 -175.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.472 HD23 HG22 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -70.53 -53.08 17.6 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.344 0.658 . . . . 2.16 112.006 174.066 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.9 p -52.48 -29.17 23.5 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.377 0.535 . . . . 1.83 111.991 -173.148 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 10.23 7.23 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.802 1.408 . . . . 3.26 114.802 178.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -89.48 178.43 6.3 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.121 1.328 . . . . 2.41 109.519 165.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -81.09 159.42 24.73 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.553 -0.906 . . . . 6.63 108.553 166.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.88 -55.88 3.88 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.499 0.571 . . . . 1.97 113.162 170.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.583 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -63.03 107.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 117.713 0.756 . . . . 2.51 110.293 -178.139 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 32' ' ' ILE . 2.4 pp -99.52 -25.53 14.4 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.72 1.208 . . . . 2.82 111.732 -174.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -146.96 122.18 10.2 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.297 -1.001 . . . . 2.53 108.297 176.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.2 t -102.0 161.65 13.51 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 107.725 -1.213 . . . . 1.94 107.725 171.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 m -160.36 116.84 2.4 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.208 -1.034 . . . . 1.64 108.208 163.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 22' ' ' ILE . 2.2 m -116.01 165.57 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 122.777 0.431 . . . . 1.85 110.073 169.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.25 135.0 14.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.858 0.863 . . . . 0.71 109.195 170.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.18 -43.91 69.84 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.029 -0.987 . . . . 1.59 110.25 -177.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.34 -49.94 72.92 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.365 0.602 . . . . 1.15 110.512 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -67.74 -11.81 59.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.587 0.755 . . . . 2.1 111.132 178.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 53.8 38.36 28.39 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.799 1.24 . . . . 3.28 108.542 -173.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -133.51 142.58 48.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 O-C-N 122.143 -0.348 . . . . 1.38 111.078 -167.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.3 142.09 47.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.812 1.245 . . . . 0.71 107.928 160.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.03 154.23 48.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.549 0.613 . . . . 1.24 110.316 163.047 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.514 HG23 HD13 ' A' ' 32' ' ' ILE . 4.8 mp -127.75 138.62 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.883 -1.154 . . . . 1.18 107.883 178.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -104.12 110.82 23.15 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.035 0.934 . . . . 2.64 108.643 164.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -155.17 158.24 38.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.133 1.373 . . . . 2.55 110.178 -174.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.02 126.01 88.65 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 109.087 -0.709 . . . . 3.62 109.087 165.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.26 -7.98 14.0 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.227 2.618 . . . . 1.04 113.887 -173.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -84.09 -52.68 6.09 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 119.591 1.087 . . . . 4.98 108.439 -179.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.1 pt -62.46 -52.7 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 113.593 0.96 . . . . 1.38 113.593 -168.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.526 HG23 ' H ' ' A' ' 54' ' ' GLY . 13.1 tt -97.2 -68.79 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 124.096 0.959 . . . . 1.09 109.658 -178.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.526 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 109.49 162.14 19.49 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.735 0.683 . . . . 0.72 113.697 172.109 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.85 -42.82 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.092 3.195 . . . . 0.81 111.903 -173.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -52.26 -50.09 62.78 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.705 1.241 . . . . 8.17 108.732 -173.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.55 -54.13 41.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.005 2.922 . . . . 5.0 108.536 -176.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.1 mt -61.48 -54.85 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 123.841 0.856 . . . . 0.8 110.284 179.161 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.7 mm -48.56 -53.27 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 118.5 0.591 . . . . 2.2 109.423 178.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -63.5 -33.15 74.95 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.413 0.523 . . . . 2.93 112.413 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.8 m -59.8 -58.1 10.01 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.221 -0.924 . . . . 0.79 109.78 171.203 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.2 mm -63.89 -32.8 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.6 -0.688 . . . . 1.49 110.921 -174.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.08 -58.49 7.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.696 1.198 . . . . 3.03 108.904 167.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.7 t -55.12 -37.27 66.69 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.501 1.12 . . . . 1.0 112.378 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.0 mt -60.17 -16.45 32.97 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.905 0.706 . . . . 2.04 112.905 175.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.35 38.19 5.13 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.951 -0.86 . . . . 0.83 110.951 177.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -127.53 171.58 11.48 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 107.501 -1.296 . . . . 1.71 107.501 172.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -112.15 70.66 1.02 Allowed Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 114.446 1.276 . . . . 4.02 114.446 -168.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.7 110.73 2.82 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.963 2.442 . . . . 1.09 112.864 -175.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.7 t -71.32 177.76 3.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.694 1.198 . . . . 3.41 109.339 160.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.43 HD23 ' H ' ' A' ' 71' ' ' LEU . 0.6 OUTLIER . . . . . 0 CA--C 1.539 0.528 0 N-CA-C 108.485 -0.931 . . . . 3.93 108.485 158.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 105.994 -1.854 . . . . 2.14 105.994 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.4 tp -137.27 134.21 35.9 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 107.951 -1.129 . . . . 1.91 107.951 159.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -101.87 123.72 46.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.023 -1.103 . . . . 2.16 108.023 168.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.71 131.17 44.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 110.121 -0.326 . . . . 1.53 110.121 175.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.99 142.52 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.484 -1.672 . . . . 1.3 106.484 168.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.3 107.75 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.879 -1.526 . . . . 1.26 106.879 173.073 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -76.98 166.04 23.85 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.934 -0.765 . . . . 5.68 108.934 174.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.84 -45.77 3.36 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.778 -0.929 . . . . 1.06 110.778 -177.334 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -57.01 120.16 7.51 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.837 -0.801 . . . . 2.4 108.837 174.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 t -156.92 19.44 0.31 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.39 0.515 . . . . 3.64 112.39 -166.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.6 t -157.45 148.21 21.27 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 120.781 -1.199 . . . . 2.98 109.141 -179.089 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.76 -41.02 10.27 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.069 0.948 . . . . 2.38 111.535 173.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.8 m -51.29 -55.9 15.83 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.206 0.602 . . . . 1.72 110.513 172.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.9 m -55.97 -51.97 65.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 123.804 0.842 . . . . 0.77 109.464 178.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.9 t -46.8 -61.85 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.001 0.52 . . . . 0.98 109.734 178.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.283 0.0 OUTLIER -64.78 -21.97 66.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.936 -0.575 . . . . 1.84 110.923 -176.175 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -66.73 -47.3 72.72 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.871 -0.789 . . . . 4.06 108.871 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.429 ' HB ' HG21 ' A' ' 37' ' ' VAL . 15.2 mt -66.73 -52.21 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.769 -1.197 . . . . 0.72 107.769 -178.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -41.83 -66.57 0.33 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.486 0.714 . . . . 3.37 110.328 171.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.6 t -55.88 -49.43 73.41 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.473 1.109 . . . . 1.49 109.815 -172.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.0 t -64.31 -37.4 87.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 118.802 -0.618 . . . . 0.71 111.414 -178.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.71 -41.14 72.3 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.237 0.926 . . . . 1.88 110.33 178.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.1 p -65.18 74.65 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.964 0.906 . . . . 1.78 111.022 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.5 pttm 179.15 -36.23 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 129.521 3.129 . . . . 3.73 109.707 -178.226 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -53.53 118.59 4.0 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.193 0.597 . . . . 1.93 110.657 -178.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -67.24 82.19 0.14 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.541 1.137 . . . . 5.06 110.252 -171.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.26 -29.24 0.52 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.162 0.887 . . . . 1.23 110.927 -174.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.21 140.06 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.65 1.18 . . . . 1.86 109.239 175.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.3 mt -114.2 -47.6 2.93 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.341 1.456 . . . . 3.0 109.703 168.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -143.3 138.38 29.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.334 0.515 . . . . 2.56 110.94 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -105.49 156.71 17.95 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.656 -1.238 . . . . 2.13 107.656 173.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.1 92.64 1.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.878 -0.786 . . . . 1.35 108.878 162.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 22' ' ' ILE . 46.4 t -92.3 144.96 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 125.707 1.603 . . . . 2.39 109.59 176.387 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.83 134.56 11.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.895 -0.503 . . . . 0.8 111.577 172.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.15 -30.48 62.29 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 123.828 0.851 . . . . 1.44 111.353 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.47 -29.66 69.2 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.396 0.543 . . . . 1.28 110.722 -177.238 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.428 HG23 ' HG2' ' A' ' 43' ' ' LYS . 5.0 t -115.38 5.88 14.69 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.795 1.238 . . . . 2.26 110.836 176.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 45.45 45.49 10.31 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 127.541 2.337 . . . . 3.14 112.45 175.003 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.428 ' HG2' HG23 ' A' ' 41' ' ' THR . 16.8 ptpt -139.03 161.52 37.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.334 0.494 . . . . 1.54 112.334 -178.128 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.71 124.81 52.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.769 1.627 . . . . 0.74 106.853 160.04 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 139.22 30.84 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.069 -1.086 . . . . 1.08 108.069 153.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.96 125.95 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.955 -1.498 . . . . 1.01 106.955 174.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -101.95 87.83 3.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.027 1.331 . . . . 2.25 107.952 167.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -125.49 157.12 37.77 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.131 2.173 . . . . 2.22 109.48 178.053 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.435 ' HB2' HD11 ' A' ' 52' ' ' ILE . 2.6 m-20 -72.28 120.37 80.04 Favored Pre-proline 0 C--N 1.34 0.179 0 N-CA-C 105.987 -1.857 . . . . 3.18 105.987 167.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.8 -67.68 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.48 1.454 . . . . 1.79 113.065 -169.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -52.89 -41.16 64.1 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.349 1.06 . . . . 5.3 112.595 -159.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 49' ' ' ASP . 10.7 pt -51.9 -41.23 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.025 0.93 . . . . 1.5 113.135 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.0 tt -119.9 -48.49 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.422 1.089 . . . . 1.39 111.305 -167.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.38 160.24 35.07 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.1 1.333 . . . . 1.1 112.201 172.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -66.99 -26.52 43.47 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.198 2.599 . . . . 1.51 111.941 179.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.8 ttm105 -51.06 -55.57 16.94 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.741 0.817 . . . . 5.09 110.741 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -47.67 -53.64 14.37 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.552 1.141 . . . . 2.97 110.689 176.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.66 -57.41 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.717 0.807 . . . . 1.11 110.568 -178.397 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.62 -37.03 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 O-C-N 121.661 -0.649 . . . . 4.45 111.795 -175.063 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -55.4 -49.85 71.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.826 0.739 . . . . 3.07 109.873 169.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.6 m -56.24 -50.93 69.91 Favored 'General case' 0 C--O 1.224 -0.24 0 O-C-N 121.731 -0.606 . . . . 0.89 110.838 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.54 -41.75 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 121.539 -0.725 . . . . 1.94 111.865 -175.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -52.15 -48.21 65.03 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.006 -0.739 . . . . 4.13 109.006 169.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.0 t -64.9 -42.33 94.86 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.819 -0.628 . . . . 1.64 111.321 -177.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.43 -46.29 86.79 Favored 'General case' 0 C--N 1.34 0.172 0 O-C-N 121.485 -0.76 . . . . 1.8 109.994 173.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.34 43.84 0.34 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.132 -0.787 . . . . 0.85 111.132 170.138 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -129.7 155.83 45.26 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.039 -1.837 . . . . 1.9 106.039 170.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -107.82 102.66 46.38 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 118.579 -0.724 . . . . 3.39 110.319 -168.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -85.15 154.33 11.02 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.976 2.451 . . . . 1.72 113.124 -171.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.0 m -162.03 135.67 6.4 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 125.97 1.708 . . . . 2.5 107.953 166.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 109.565 -0.531 . . . . 3.02 109.565 173.26 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 C--O 1.234 0.289 0 N-CA-C 107.628 -1.249 . . . . 2.76 107.628 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.51 89.29 6.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.111 -1.441 . . . . 3.0 107.111 164.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -67.83 133.72 49.69 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.628 -0.879 . . . . 2.47 108.628 156.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 pp -146.13 137.41 24.64 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.51 -1.293 . . . . 1.44 107.51 167.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.71 145.82 13.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 107.966 -1.124 . . . . 1.32 107.966 173.474 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.93 105.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 127.807 2.443 . . . . 1.34 104.489 173.092 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -86.54 163.91 17.21 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.284 -1.006 . . . . 7.24 108.284 166.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.76 -13.58 29.67 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.89 0.757 . . . . 1.02 112.166 -177.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.1 mtm -65.89 88.25 0.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.233 1.016 . . . . 1.9 110.024 172.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 p -68.83 -37.21 79.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.078 0.551 . . . . 3.33 111.599 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.5 t -158.28 169.85 23.57 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.176 0.444 . . . . 3.44 110.247 -169.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.37 -28.06 7.39 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.237 1.815 . . . . 2.47 113.377 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 p -49.81 -63.18 1.19 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.309 -0.626 . . . . 2.56 109.309 169.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.2 m -51.22 -47.83 62.22 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.675 0.79 . . . . 0.73 110.697 179.614 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.4 t -49.0 -62.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 123.773 0.829 . . . . 0.75 109.927 178.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -26.47 67.69 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 120.835 -0.346 . . . . 1.35 110.468 -177.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -63.32 -50.11 71.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.79 -0.819 . . . . 4.34 108.79 179.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.9 mt -64.88 -53.24 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.815 -1.179 . . . . 0.54 107.815 -178.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -49.36 -58.83 4.41 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.784 0.834 . . . . 3.9 109.625 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.9 t -62.47 -48.19 80.71 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.458 -0.792 . . . . 1.32 109.793 -174.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.6 t -57.7 -36.2 71.66 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.72 110.69 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.2 mt -72.43 -47.62 47.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.984 -1.008 . . . . 1.96 111.973 177.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.1 p -62.11 77.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.913 0.885 . . . . 1.77 111.694 -176.058 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? 169.54 -37.32 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.935 2.494 . . . . 3.37 110.468 -171.705 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -58.19 126.8 29.07 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.246 -1.02 . . . . 2.27 108.246 171.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -72.42 74.7 1.03 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.873 0.869 . . . . 4.75 111.658 -163.086 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.91 -41.09 0.19 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.404 -1.079 . . . . 1.57 110.404 178.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.684 HD13 HG23 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -69.67 100.46 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 117.724 0.762 . . . . 2.29 110.186 -176.972 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.14 -35.49 23.59 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.596 1.158 . . . . 2.36 111.494 -176.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -143.6 116.49 8.8 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.903 0.881 . . . . 2.03 109.275 176.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.2 t -97.48 155.4 16.95 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 107.905 -1.146 . . . . 2.16 107.905 169.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 t -158.24 102.85 1.79 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.887 -1.523 . . . . 1.48 106.887 169.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.54 159.31 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 120.505 0.193 . . . . 1.71 110.708 173.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.48 134.39 21.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.404 1.082 . . . . 0.86 110.061 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.54 -41.97 62.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.527 -1.215 . . . . 1.63 110.942 -173.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.3 -47.26 80.16 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.551 0.691 . . . . 1.4 109.674 -172.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -80.78 -2.55 47.56 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.514 -0.755 . . . . 2.72 110.763 177.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 51.39 49.8 20.23 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.651 1.18 . . . . 2.62 108.769 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -139.53 142.48 37.24 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.09 0.404 . . . . 1.61 111.744 -169.06 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.98 125.03 50.5 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.262 1.425 . . . . 0.66 108.485 163.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.08 119.63 38.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.504 -2.036 . . . . 1.02 105.504 164.426 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.684 HG23 HD13 ' A' ' 32' ' ' ILE . 5.2 mp -112.12 120.55 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.04 1.336 . . . . 1.0 108.24 175.518 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -92.57 97.26 10.7 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.775 -0.824 . . . . 3.12 108.775 163.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.72 143.58 43.4 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.577 -0.897 . . . . 2.73 108.577 174.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.85 127.56 88.13 Favored Pre-proline 0 N--CA 1.452 -0.352 0 N-CA-C 106.196 -1.779 . . . . 3.73 106.196 169.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.63 -59.21 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.663 1.576 . . . . 1.85 112.507 -169.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -50.12 -43.28 51.67 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.06 1.744 . . . . 3.42 112.396 -162.657 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 pt -55.34 -40.16 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.754 0.822 . . . . 1.78 113.128 -177.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.7 tt -123.68 -48.24 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.805 0.842 . . . . 1.67 112.676 -165.058 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.45 147.56 22.69 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.129 1.347 . . . . 1.01 111.443 178.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.86 -34.42 23.98 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.106 2.538 . . . . 0.93 111.469 -177.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -55.5 -41.73 73.48 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 118.841 -0.599 . . . . 6.51 112.441 -174.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -48.71 -62.18 1.64 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.516 1.151 . . . . 2.72 110.025 174.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 mt -56.65 -56.36 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.209 1.404 . . . . 1.38 110.431 -179.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.31 -47.66 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 122.024 -0.422 . . . . 1.31 110.42 -178.334 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.7 m170 -60.8 -42.67 98.07 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.832 0.742 . . . . 2.84 110.817 178.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.3 m -57.33 -52.33 65.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.238 -0.653 . . . . 0.76 109.238 177.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.4 mm -68.36 -34.59 66.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 O-C-N 122.09 -0.381 . . . . 2.01 111.777 -175.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -56.41 -59.26 5.22 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.517 1.127 . . . . 2.82 108.026 171.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -52.99 -40.35 63.73 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.349 1.06 . . . . 1.12 111.506 176.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.1 tp -66.4 -10.5 44.28 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.121 0.968 . . . . 2.47 112.446 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.2 45.76 2.33 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 118.68 0.673 . . . . 0.68 112.055 168.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -139.32 177.81 7.65 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 107.794 -1.188 . . . . 2.14 107.794 172.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -112.6 72.49 1.33 Allowed Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 113.198 0.814 . . . . 3.42 113.198 -177.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -63.58 104.45 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.983 3.122 . . . . 1.37 111.814 -177.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.4 p -129.15 124.71 35.35 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.798 1.639 . . . . 2.11 108.735 -172.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tt . . . . . 0 CA--C 1.535 0.381 0 O-C-N 121.261 -0.899 . . . . 3.71 111.092 -171.575 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 t . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 109.739 -0.467 . . . . 2.58 109.739 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.4 tp -70.11 154.47 41.89 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.105 -0.702 . . . . 2.32 109.105 175.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -129.07 148.49 51.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.967 0.907 . . . . 2.54 110.035 170.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.52 133.78 44.19 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 107.247 -1.39 . . . . 1.79 107.247 168.283 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.6 109.39 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 105.729 -1.952 . . . . 1.06 105.729 171.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -104.41 109.08 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.944 -0.762 . . . . 1.79 108.944 -174.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.58 155.24 40.76 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.392 -1.336 . . . . 4.0 107.392 170.196 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.66 -19.85 7.88 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.405 0.526 . . . . 1.09 113.512 168.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.4 mtm -58.96 104.48 0.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.568 1.184 . . . . 2.19 110.725 171.541 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.5 p -91.36 -83.36 0.28 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.058 0.943 . . . . 3.67 110.4 177.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 84.4 m -79.17 -68.29 0.67 Allowed 'General case' 0 CA--C 1.527 0.061 0 C-N-CA 123.245 0.618 . . . . 3.91 111.279 -160.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -174.58 -61.78 0.01 OUTLIER 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 124.401 1.08 . . . . 1.77 108.865 -176.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.2 t -41.07 -46.75 3.01 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.315 1.446 . . . . 2.91 111.161 -176.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.3 m -23.62 -52.0 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.133 2.173 . . . . 0.85 113.511 168.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.4 t -49.52 -61.46 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.346 0.659 . . . . 0.6 110.589 176.115 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -28.68 66.03 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.323 0.649 . . . . 1.08 110.208 -177.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.57 -52.55 59.38 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 107.489 -1.3 . . . . 3.03 107.489 175.055 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.49 HD12 HG11 ' A' ' 37' ' ' VAL . 93.6 mt -65.84 -60.39 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 107.344 -1.354 . . . . 0.56 107.344 178.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.04 -51.81 16.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.572 0.701 . . . . 2.85 110.583 -171.379 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.1 t -67.38 -56.53 9.31 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.988 0.915 . . . . 1.6 109.739 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.1 t -64.98 -18.09 64.98 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.693 -0.67 . . . . 1.16 112.446 -173.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.44 -47.4 7.47 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 117.672 -1.156 . . . . 2.72 111.548 173.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 p -53.87 -35.13 61.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.606 1.548 . . . . 2.25 111.615 178.347 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -32.05 -48.84 0.17 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.097 1.359 . . . . 4.92 113.23 163.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -75.13 63.45 1.3 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.288 1.035 . . . . 2.21 110.798 178.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 3.76 -64.0 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 129.5 3.12 . . . . 4.58 117.247 178.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -46.02 -45.99 14.72 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.43 1.014 . . . . 1.35 112.557 178.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.609 HD13 HG23 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -73.3 84.99 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.022 -1.103 . . . . 2.87 108.022 168.515 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.5 pp -65.67 -33.79 76.71 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.988 -0.551 . . . . 3.32 111.299 -175.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -146.64 104.68 3.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.912 0.485 . . . . 3.1 111.566 173.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.3 t -80.19 142.28 34.84 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 106.89 -1.522 . . . . 2.61 106.89 162.067 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -132.73 101.77 5.41 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.719 -1.215 . . . . 1.3 107.719 -178.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.49 HG11 HD12 ' A' ' 22' ' ' ILE . 6.2 t -107.6 142.71 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 124.64 1.176 . . . . 2.59 110.193 -167.307 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.45 137.31 17.12 Favored 'General case' 0 C--N 1.339 0.109 0 O-C-N 121.481 -0.762 . . . . 0.92 111.353 177.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -81.71 -35.21 30.05 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 124.463 1.105 . . . . 1.35 112.013 -172.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.26 91.52 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 109.572 -0.529 . . . . 1.14 109.572 -177.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -93.26 -5.19 50.41 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.454 -0.794 . . . . 2.13 111.454 173.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 41.19 55.02 3.34 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 126.744 2.018 . . . . 2.79 109.456 -176.387 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -133.76 152.02 51.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.889 -1.05 . . . . 2.0 109.502 -171.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.29 129.1 56.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.646 -1.613 . . . . 0.87 106.646 157.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.72 145.51 25.24 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 107.366 -1.346 . . . . 1.13 107.366 157.543 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.609 HG23 HD13 ' A' ' 32' ' ' ILE . 5.3 mp -127.22 115.37 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.252 -0.647 . . . . 2.08 109.252 -169.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -86.48 81.03 8.45 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.196 -1.038 . . . . 2.53 108.196 165.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.33 167.95 14.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.378 1.071 . . . . 2.1 110.194 176.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -108.72 126.18 30.05 Favored Pre-proline 0 N--CA 1.447 -0.616 0 O-C-N 124.317 1.011 . . . . 3.43 109.084 171.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.5 -20.76 20.31 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.126 2.55 . . . . 1.2 112.72 -177.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -96.48 14.46 24.49 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.986 0.914 . . . . 3.92 111.434 -170.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 pt -126.96 -87.55 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.282 1.033 . . . . 1.23 109.408 163.032 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.9 tt -59.44 -49.4 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.621 1.168 . . . . 1.09 112.008 -176.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.73 159.5 30.61 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.718 -0.553 . . . . 0.82 111.718 -178.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.88 -30.84 8.83 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.052 2.501 . . . . 0.86 111.541 -175.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -54.81 -52.51 62.45 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.657 0.783 . . . . 5.01 110.849 -174.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -49.46 -55.07 14.47 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.51 1.124 . . . . 2.6 109.653 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.38 -59.79 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.877 1.271 . . . . 0.92 110.373 178.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.6 mt -52.63 -41.73 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 119.234 0.924 . . . . 1.49 111.416 -178.465 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -67.08 -45.52 77.05 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.856 -0.527 . . . . 2.4 109.911 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.3 m -57.94 -50.29 73.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.594 -0.891 . . . . 0.58 108.594 179.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.1 mm -53.54 -52.18 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.547 1.139 . . . . 1.55 109.915 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -47.68 -64.84 0.68 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.258 0.552 . . . . 3.78 109.807 173.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 m -67.57 -26.38 66.26 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.927 -0.578 . . . . 2.7 112.267 -167.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.1 tp -67.0 -12.5 60.02 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.192 1.397 . . . . 2.32 111.663 175.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.48 47.28 0.7 Allowed Glycine 0 C--N 1.339 0.716 0 C-N-CA 124.948 1.261 . . . . 1.03 110.703 168.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -143.41 178.03 8.03 Favored 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 108.853 -0.795 . . . . 1.91 108.853 -178.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.07 101.77 14.92 Favored Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 108.685 -0.857 . . . . 4.54 108.685 173.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -83.48 92.0 0.87 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.362 2.708 . . . . 1.23 112.896 -175.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.8 m -79.17 113.15 17.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.733 0.778 . . . . 2.09 109.614 170.011 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 C--N 1.328 -0.367 0 C-N-CA 123.8 0.84 . . . . 3.2 108.966 171.509 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.398 -0.593 . . . . 2.4 109.398 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.29 114.59 28.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.797 -1.927 . . . . 2.47 105.797 168.498 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -92.74 120.93 33.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.125 -1.065 . . . . 2.59 108.125 164.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -122.01 154.55 37.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.286 -1.376 . . . . 1.65 107.286 169.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.25 146.78 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.311 -1.737 . . . . 0.85 106.311 171.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.86 163.89 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.933 2.093 . . . . 1.6 105.426 -179.32 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -143.05 165.05 28.43 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.529 1.059 . . . . 4.21 108.412 173.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.07 -86.06 0.4 Allowed Glycine 0 C--N 1.337 0.587 0 N-CA-C 108.744 -1.742 . . . . 2.42 108.744 177.044 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.3 mpt? 52.12 -158.16 0.13 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.529 1.131 . . . . 4.78 112.26 -173.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.445 HG22 ' SG ' ' A' ' 18' ' ' CYS . 10.2 t -161.23 55.56 0.29 Allowed 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.17 0.988 . . . . 5.65 108.752 179.35 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.8 t 74.69 -45.46 0.58 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.442 1.497 . . . . 4.14 113.486 175.525 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.2 -71.5 0.23 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.319 0.509 . . . . 1.74 111.043 -179.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -42.88 -44.12 4.39 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.763 1.625 . . . . 1.65 114.48 -162.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.445 ' SG ' HG22 ' A' ' 14' ' ' THR . 1.6 m -47.19 -37.19 9.77 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.204 0.602 . . . . 1.78 112.454 179.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -49.7 -61.63 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 123.539 0.735 . . . . 0.69 110.558 174.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -30.35 69.65 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.932 -0.766 . . . . 1.33 108.932 -176.48 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -58.83 -53.43 58.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.299 -1.0 . . . . 4.52 108.299 177.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.4 HG21 HG11 ' A' ' 37' ' ' VAL . 61.2 mt -62.66 -50.03 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.991 -1.115 . . . . 0.7 107.991 -173.572 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -47.73 -60.93 2.21 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.927 0.767 . . . . 4.12 109.455 176.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.5 t -57.65 -47.32 82.57 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 122.224 1.012 . . . . 1.48 110.42 -173.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -70.9 -23.86 62.36 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.402 1.481 . . . . 0.85 110.899 -174.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mt -80.39 -43.71 20.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.656 0.662 . . . . 2.47 111.061 171.279 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.2 p -67.95 73.28 0.18 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.029 0.931 . . . . 1.6 110.835 179.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.92 -34.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.515 2.726 . . . . 4.22 111.289 -176.832 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -35.02 -69.49 0.1 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 126.174 1.789 . . . . 3.54 115.148 -170.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -165.17 -51.93 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 108.697 -0.853 . . . . 7.95 108.697 174.065 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -151.02 63.08 0.4 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.38 -1.488 . . . . 1.54 109.38 175.432 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.823 HD11 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -73.14 126.28 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 105.709 -1.96 . . . . 2.54 105.709 158.552 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.31 -51.68 9.75 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.139 -1.43 . . . . 2.46 107.139 165.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -155.81 139.51 16.08 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.045 -0.525 . . . . 2.45 110.955 -178.312 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.6 t -109.05 150.29 28.01 Favored 'General case' 0 C--O 1.227 -0.092 0 N-CA-C 107.622 -1.251 . . . . 2.26 107.622 167.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.66 109.7 3.29 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.357 -0.839 . . . . 1.3 109.378 175.235 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' A' ' 44' ' ' ALA . 3.2 m -113.59 155.87 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.466 0.706 . . . . 1.67 111.295 176.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.85 133.74 19.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.353 0.661 . . . . 0.97 109.694 171.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -76.09 -42.58 46.79 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.445 0.698 . . . . 1.6 111.293 -171.014 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.73 -46.32 87.63 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.081 0.552 . . . . 1.62 110.466 179.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.47 -15.69 60.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.61 1.164 . . . . 2.44 111.471 175.079 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 52.6 34.81 16.54 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.172 1.789 . . . . 2.8 110.006 -172.521 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -102.82 144.64 30.9 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.659 1.183 . . . . 1.67 108.027 -172.303 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.447 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -137.46 110.35 7.68 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.39 -0.967 . . . . 1.05 108.39 161.221 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.78 144.43 25.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.616 -0.513 . . . . 1.16 109.616 168.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.823 HG23 HD11 ' A' ' 32' ' ' ILE . 4.9 mp -124.43 120.03 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 106.377 -1.712 . . . . 1.18 106.377 175.073 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.58 ' O ' HD13 ' A' ' 32' ' ' ILE . 60.3 mttt -96.24 96.17 8.61 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.151 -1.426 . . . . 2.2 107.151 166.553 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -134.61 153.75 51.82 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.501 1.521 . . . . 2.18 107.205 -177.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -82.06 130.66 59.32 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 119.484 -0.886 . . . . 3.35 109.315 168.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.5 -40.9 9.62 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.682 2.254 . . . . 1.52 113.087 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -88.52 43.35 1.13 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.572 1.078 . . . . 3.56 110.824 -164.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 pt -142.91 -41.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 126.238 1.815 . . . . 1.66 111.342 172.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.9 tt -121.14 -61.26 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.353 1.061 . . . . 1.2 111.844 -175.319 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.41 157.0 25.84 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.734 1.159 . . . . 0.7 111.537 178.778 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.32 -32.63 12.38 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.486 2.791 . . . . 0.69 112.556 -172.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -51.93 -52.92 46.71 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.345 0.658 . . . . 5.95 111.549 -178.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -48.31 -57.42 6.02 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.487 1.115 . . . . 2.63 110.35 177.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.2 mt -53.51 -63.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.477 1.111 . . . . 0.91 109.436 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.2 mt -49.47 -52.11 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.264 0.625 . . . . 1.31 110.162 -176.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -69.81 -30.49 68.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.764 -0.585 . . . . 3.12 111.999 -175.71 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 92.1 m -66.71 -51.34 57.12 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.289 -0.882 . . . . 0.83 109.563 173.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mm -55.97 -41.92 69.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 122.809 0.444 . . . . 1.53 110.132 177.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.95 -58.45 7.82 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.023 0.929 . . . . 3.05 109.076 174.247 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.5 m -54.13 -37.47 64.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.149 0.98 . . . . 2.42 112.674 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.8 mt -67.24 -6.21 17.25 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.957 0.725 . . . . 1.83 112.957 177.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.08 48.94 2.15 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.827 -0.909 . . . . 0.63 110.827 173.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -134.61 -179.76 5.79 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.39 1.076 . . . . 2.01 109.621 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -121.8 57.87 8.34 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.069 0.947 . . . . 3.51 112.23 -173.312 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.95 85.25 0.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 124.282 3.322 . . . . 1.15 113.042 -167.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.2 m -97.56 126.24 42.74 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.719 1.608 . . . . 2.04 108.476 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 CA--C 1.532 0.256 0 CA-C-N 118.705 0.684 . . . . 3.29 109.348 170.873 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.449 -0.508 0 N-CA-C 107.26 -1.385 . . . . 2.0 107.26 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.0 tp -150.87 147.9 27.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.96 -1.496 . . . . 2.09 106.96 166.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -116.38 128.96 55.98 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.251 -1.388 . . . . 2.56 107.251 174.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.87 125.35 44.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.72 -1.585 . . . . 1.51 106.72 177.829 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.1 t -65.03 144.08 15.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 N-CA-C 106.866 -1.531 . . . . 0.99 106.866 168.159 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 m -141.75 86.17 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 119.102 0.865 . . . . 1.52 110.512 -174.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 56.7 mmt-85 -55.69 141.2 38.92 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.309 -1.367 . . . . 5.19 107.309 168.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.86 -26.45 8.87 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.845 0.736 . . . . 1.08 111.504 -175.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.402 ' SD ' HD12 ' A' ' 22' ' ' ILE . 26.8 mtm -69.73 77.27 0.44 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.936 1.368 . . . . 1.93 111.744 176.188 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -77.09 -33.8 56.94 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.898 0.879 . . . . 2.44 111.943 178.067 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -149.67 158.03 43.79 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.385 0.539 . . . . 2.98 110.766 -163.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.68 -33.1 0.67 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.156 1.782 . . . . 2.35 113.605 173.13 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.1 p -53.27 -53.29 53.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.659 -0.651 . . . . 2.69 110.269 172.21 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.3 m -58.55 -49.09 78.7 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.173 0.589 . . . . 0.88 109.99 178.153 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.1 t -45.27 -63.95 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.351 0.66 . . . . 0.64 109.66 177.059 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.282 0.0 OUTLIER -63.95 -24.64 67.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.754 -0.657 . . . . 1.41 110.984 -177.233 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -61.41 -53.58 54.74 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 108.263 -1.014 . . . . 3.38 108.263 177.038 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.402 HD12 ' SD ' ' A' ' 13' ' ' MET . 11.3 mt -67.07 -56.24 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.434 -1.321 . . . . 0.82 107.434 -175.72 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -46.39 -58.15 4.0 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.968 0.907 . . . . 3.54 112.362 177.498 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.8 t -66.45 -31.1 71.64 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.19 0.596 . . . . 1.32 110.438 -176.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 t -66.26 -53.07 41.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.571 -0.705 . . . . 1.34 109.379 175.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 26' ' ' LEU . 1.9 mm? -52.86 -45.04 67.22 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.805 0.729 . . . . 2.22 112.183 -175.025 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.6 p -62.53 -9.39 8.52 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.705 0.631 . . . . 1.65 112.705 -176.344 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -71.53 -37.15 71.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.752 0.821 . . . . 5.02 111.138 171.081 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -74.71 121.02 21.05 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.306 -0.627 . . . . 1.84 109.306 -167.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -77.84 62.6 2.71 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.164 0.586 . . . . 5.48 111.669 -176.134 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.47 42.8 0.06 OUTLIER Glycine 0 CA--C 1.526 0.719 0 N-CA-C 109.116 -1.593 . . . . 1.75 109.116 174.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.92 142.66 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 104.315 -2.476 . . . . 1.99 104.315 -178.757 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.3 tp -100.63 -45.42 5.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.67 1.188 . . . . 3.46 110.132 -179.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -162.05 151.25 15.74 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.719 -0.845 . . . . 1.87 108.719 -179.092 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.9 p -131.73 157.07 44.76 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 123.887 0.875 . . . . 2.98 108.937 173.227 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.1 t -170.8 121.43 0.57 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.817 -1.549 . . . . 1.75 106.817 176.172 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 44' ' ' ALA . 3.2 m -121.19 130.56 74.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.76 0.709 . . . . 1.66 110.178 178.311 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.3 133.83 53.33 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.349 1.06 . . . . 1.04 111.566 -173.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.18 -56.14 11.19 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 125.274 1.43 . . . . 2.55 110.665 -176.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.78 -47.61 76.78 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.186 0.594 . . . . 1.33 110.842 -174.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.72 -15.69 62.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.017 1.327 . . . . 1.97 111.29 177.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 48.53 42.34 18.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.134 1.774 . . . . 2.96 110.435 -170.691 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -123.84 132.94 53.86 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 124.092 0.957 . . . . 1.4 109.656 -165.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -102.4 117.3 34.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.284 1.033 . . . . 0.85 108.567 166.183 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.61 124.01 45.6 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.992 -1.855 . . . . 1.19 105.992 174.067 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 46' ' ' ILE . 3.2 mp -121.86 133.73 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.979 -1.119 . . . . 1.22 107.979 171.124 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -103.17 135.82 44.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.21 1.804 . . . . 2.17 106.707 161.205 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -168.66 178.95 4.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.976 1.31 . . . . 2.53 112.199 -165.777 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -110.34 74.7 0.87 Allowed Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.612 1.165 . . . . 4.17 108.985 -174.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -45.76 -48.17 12.71 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 124.452 3.435 . . . . 1.45 113.467 -165.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.71 -34.31 38.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.024 1.33 . . . . 4.76 112.236 -176.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.7 pt -95.22 -53.77 7.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 N-CA-C 112.228 0.455 . . . . 1.17 112.228 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.5 tt -72.35 -44.97 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 120.917 0.389 . . . . 1.78 111.195 -173.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.24 124.6 1.16 Allowed Glycine 0 CA--C 1.537 1.423 0 N-CA-C 110.846 -0.901 . . . . 0.94 110.846 -176.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -53.76 -33.19 69.37 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.034 2.489 . . . . 0.65 111.614 176.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -51.4 -46.0 62.7 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.809 0.843 . . . . 6.62 112.031 175.024 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -59.48 -56.37 22.81 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.603 0.716 . . . . 2.6 109.449 -176.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 89.1 mt -48.21 -62.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 124.187 0.995 . . . . 0.82 109.337 174.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.8 mt -54.22 -53.59 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 119.286 -0.388 . . . . 1.27 110.513 -173.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -65.12 -33.75 76.76 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.945 0.793 . . . . 2.6 112.365 -178.194 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 92.2 m -65.16 -50.8 64.57 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.362 -0.836 . . . . 0.7 109.473 176.159 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mm -64.08 -42.63 96.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.651 -0.656 . . . . 1.83 110.647 -177.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -48.3 -62.28 1.57 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.445 1.498 . . . . 3.2 109.316 169.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.9 t -52.52 -40.82 62.89 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.596 1.158 . . . . 1.01 112.123 -179.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.46 -3.95 5.07 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.979 1.103 . . . . 2.01 113.979 178.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.76 50.63 1.93 Allowed Glycine 0 C--N 1.335 0.494 0 N-CA-C 110.12 -1.192 . . . . 0.63 110.12 171.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -138.82 169.31 18.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.886 0.875 . . . . 1.85 109.567 178.058 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -112.51 76.98 2.17 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 118.03 -0.986 . . . . 4.42 112.408 177.193 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.01 74.56 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 124.082 3.188 . . . . 1.2 113.151 -175.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.46 115.88 13.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.925 0.89 . . . . 2.36 109.493 173.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 tt . . . . . 0 N--CA 1.451 -0.418 0 C-N-CA 124.587 1.155 . . . . 3.18 108.666 170.564 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 106.063 -1.829 . . . . 2.47 106.063 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.1 tp -91.0 122.44 33.66 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.898 -1.149 . . . . 1.93 107.898 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -88.29 136.46 32.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.218 -1.03 . . . . 2.07 108.218 163.202 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.464 HD21 HD13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -126.79 133.97 50.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.087 -1.079 . . . . 1.89 108.087 157.118 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.36 143.12 14.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.564 -1.273 . . . . 1.16 107.564 163.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.7 m -135.79 85.16 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.327 1.051 . . . . 1.7 110.89 -170.196 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -62.29 139.72 58.51 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.007 -1.058 . . . . 5.94 109.864 -174.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.31 -24.67 6.51 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.733 -0.481 . . . . 1.63 112.765 175.831 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.457 ' SD ' HD12 ' A' ' 22' ' ' ILE . 64.5 mtm -59.97 152.63 23.23 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.262 1.031 . . . . 2.47 110.738 175.165 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -161.72 -59.39 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.1 0.56 . . . . 3.09 110.145 177.44 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.8 p -81.15 153.54 27.2 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.9 -0.5 . . . . 4.23 111.116 -176.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.84 -50.32 7.94 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 124.679 1.192 . . . . 1.96 111.656 -178.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 m -43.99 -40.85 5.0 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.072 1.349 . . . . 1.61 112.399 -178.217 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.3 m -47.78 -43.14 27.22 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.762 0.825 . . . . 1.46 110.939 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.4 t -50.89 -68.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 123.632 0.773 . . . . 0.76 108.99 179.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -27.39 69.18 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.76 -0.459 . . . . 1.1 109.76 -175.75 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -59.1 -54.62 45.0 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.808 -0.812 . . . . 3.19 108.808 179.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.52 ' HB ' HG11 ' A' ' 37' ' ' VAL . 19.8 mt -70.83 -52.68 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.463 -0.94 . . . . 0.97 108.463 -176.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.25 -52.11 29.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.347 0.659 . . . . 3.34 110.744 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -67.44 -47.51 69.96 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.246 0.619 . . . . 1.37 110.407 179.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.0 t -57.46 -25.36 59.58 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.847 -0.533 . . . . 1.29 111.98 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.54 -55.22 4.25 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.7 0.8 . . . . 2.98 112.088 171.401 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.5 p -71.64 66.38 0.51 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.274 1.029 . . . . 2.33 111.039 179.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.21 -43.45 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.279 1.832 . . . . 3.37 110.111 -176.329 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -76.98 142.66 39.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.415 -0.957 . . . . 4.52 108.415 173.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -60.55 165.71 3.61 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.093 -0.706 . . . . 6.35 109.093 173.124 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.41 -35.6 3.79 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-O 118.804 -0.998 . . . . 1.08 111.462 175.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.79 133.44 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 119.039 1.42 . . . . 2.28 107.894 163.417 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.26 -55.15 3.53 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.357 -1.349 . . . . 2.96 107.357 161.211 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -149.84 145.87 26.81 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.129 0.572 . . . . 2.18 110.366 -171.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.3 t -128.64 150.27 50.3 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.434 1.094 . . . . 1.96 108.237 177.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -148.18 132.33 17.34 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.49 -0.93 . . . . 1.75 108.49 153.286 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 44' ' ' ALA . 18.0 m -107.12 165.35 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 122.814 0.445 . . . . 1.76 110.623 171.059 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.42 136.69 19.94 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.581 0.752 . . . . 1.12 110.622 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.65 -56.1 6.47 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 123.922 0.889 . . . . 2.66 110.523 -176.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.54 -52.15 60.61 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 123.161 0.584 . . . . 1.55 110.127 -176.388 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 m -77.43 -3.19 39.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.889 0.876 . . . . 2.21 111.336 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 45.75 42.95 9.26 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.197 1.399 . . . . 3.29 110.225 -179.457 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -117.09 145.54 43.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.664 -0.698 . . . . 1.47 109.757 -164.114 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -116.92 118.77 33.36 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.545 -1.65 . . . . 0.75 106.545 156.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.89 134.57 40.84 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.774 -1.195 . . . . 0.96 107.774 163.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.464 HD13 HD21 ' A' ' 8' ' ' LEU . 4.6 mp -122.81 119.94 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 106.942 -1.503 . . . . 1.26 106.942 178.086 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -96.52 98.78 10.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.081 -1.451 . . . . 2.29 107.081 162.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -138.33 178.62 6.99 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.028 0.931 . . . . 2.31 110.935 -177.714 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -107.0 83.94 1.45 Allowed Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 125.01 1.324 . . . . 3.53 109.831 176.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -52.05 -23.51 17.27 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.187 2.591 . . . . 1.47 113.793 174.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -49.67 -41.14 42.23 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.473 0.579 . . . . 4.44 112.31 172.114 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 pt -107.3 -47.32 8.12 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 N-CA-C 113.701 1.0 . . . . 1.62 113.701 -166.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.2 tt -90.0 -123.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 106.372 -1.714 . . . . 2.02 106.372 172.339 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 177.73 160.18 23.88 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 120.406 1.457 . . . . 1.25 111.681 171.779 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.88 -42.1 26.33 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.084 3.189 . . . . 1.15 111.114 173.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -51.34 -54.22 28.41 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.018 0.527 . . . . 5.73 110.06 177.216 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.94 -54.84 7.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.093 1.757 . . . . 4.11 109.657 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.1 mt -57.97 -60.68 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.856 0.862 . . . . 0.87 109.972 178.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mp -48.29 -47.21 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.128 0.422 . . . . 1.74 110.39 -178.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -70.59 -33.28 70.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.366 0.666 . . . . 2.33 111.777 -178.174 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.2 m -59.64 -54.89 41.15 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.372 -0.83 . . . . 0.8 108.801 170.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.1 mm -58.09 -44.49 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.625 0.77 . . . . 1.34 111.421 -178.254 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -49.99 -56.63 9.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.001 1.32 . . . . 2.9 109.123 170.265 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.3 m -58.03 -36.03 72.15 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.793 0.664 . . . . 1.91 112.793 178.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.87 -17.47 64.32 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.543 -0.723 . . . . 2.35 112.209 174.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.17 37.49 9.07 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.665 -0.974 . . . . 1.2 110.665 -178.335 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CD2' HD11 ' A' ' 22' ' ' ILE . 27.0 m-85 -125.02 151.26 45.82 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.049 -1.463 . . . . 1.97 107.049 165.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -104.76 101.09 26.8 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 124.835 1.254 . . . . 5.54 110.049 -169.092 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -76.22 158.56 37.35 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.391 1.394 . . . . 1.67 113.147 -171.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.0 m -155.27 133.42 11.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.758 -1.571 . . . . 1.9 106.758 164.047 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 CA--C 1.535 0.384 0 CA-C-N 118.819 0.736 . . . . 3.32 111.221 174.401 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 113.517 0.932 . . . . 2.11 113.517 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.29 104.09 15.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.339 -1.356 . . . . 2.31 107.339 179.061 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -84.15 116.22 22.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.828 -1.175 . . . . 2.13 107.828 162.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.7 pp -115.96 161.51 18.74 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.89 -1.152 . . . . 1.86 107.89 164.23 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -112.3 145.95 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 107.064 -1.458 . . . . 0.94 107.064 171.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -176.41 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.679 1.192 . . . . 2.57 108.517 -176.53 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -135.23 164.81 26.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.197 -2.149 . . . . 4.98 105.197 167.225 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.7 -0.36 89.57 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.575 -0.57 . . . . 1.05 113.731 171.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.4 mtp -73.77 74.33 1.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.817 1.308 . . . . 2.02 108.78 172.543 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 t -88.53 0.27 56.5 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.802 1.038 . . . . 2.26 113.802 -167.208 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.6 t -165.79 159.08 15.76 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 120.004 1.274 . . . . 2.97 110.195 -173.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.32 -38.97 13.77 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.874 1.27 . . . . 2.35 111.092 170.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -44.64 -50.15 9.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.997 0.919 . . . . 1.71 111.023 171.512 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.3 m -61.31 -45.43 94.49 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.713 -0.617 . . . . 0.84 109.991 -177.528 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.9 t -48.88 -60.08 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 C-N-CA 123.683 0.793 . . . . 0.68 108.897 176.335 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -33.44 75.74 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.579 -0.282 . . . . 1.28 110.359 -176.336 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -60.24 -45.54 92.88 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.64 -0.874 . . . . 2.82 108.64 -178.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.545 HG22 HD23 ' A' ' 26' ' ' LEU . 78.2 mt -70.66 -61.47 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 106.18 -1.785 . . . . 0.58 106.18 -178.441 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -37.19 -64.61 0.36 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.541 1.536 . . . . 4.72 110.701 -179.123 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.9 p -58.42 -41.16 84.38 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.612 -0.722 . . . . 2.39 109.941 -173.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.1 t -71.23 -20.12 62.29 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.914 0.886 . . . . 0.8 112.553 -178.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.545 HD23 HG22 ' A' ' 22' ' ' ILE . 3.7 mm? -81.32 -57.75 3.35 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 118.634 0.652 . . . . 2.26 110.56 167.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 p -56.5 -32.39 64.99 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.162 0.437 . . . . 1.6 111.103 -176.265 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.5 tptt -37.03 -54.13 0.97 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.911 1.684 . . . . 4.59 113.895 161.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -90.36 149.89 22.11 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.069 0.85 . . . . 4.23 112.621 -165.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -59.02 154.82 14.74 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.803 -0.635 . . . . 7.69 110.535 175.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.11 24.25 66.91 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.5 -0.611 . . . . 1.63 113.339 170.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.4 HD11 HG23 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -98.43 138.44 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 104.399 -2.445 . . . . 1.93 104.399 156.002 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.3 mt -97.77 -45.86 6.18 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.441 1.096 . . . . 3.45 109.026 178.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -160.36 133.51 6.69 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.286 -0.635 . . . . 1.82 109.286 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.0 t -109.21 143.08 39.12 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.644 -0.873 . . . . 1.95 108.644 176.182 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.1 t -154.64 109.52 3.05 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.033 -0.729 . . . . 1.47 109.033 168.594 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.543 HG11 HG21 ' A' ' 22' ' ' ILE . 3.1 m -104.89 145.81 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 123.19 0.596 . . . . 1.83 110.239 172.248 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.36 134.48 46.34 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 124.634 1.174 . . . . 1.17 110.846 -174.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.5 mt -72.23 -49.41 35.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.816 1.247 . . . . 2.83 111.073 -175.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.5 -32.09 68.48 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.037 0.535 . . . . 1.38 111.375 -170.045 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 t -108.32 2.5 22.63 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.313 1.045 . . . . 2.87 111.431 179.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 41.12 41.78 1.43 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.653 1.981 . . . . 3.93 111.067 -172.513 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -99.08 149.8 22.66 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.606 -0.887 . . . . 1.41 108.606 -174.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.48 114.58 21.46 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.69 -1.226 . . . . 0.71 107.69 159.359 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.84 133.36 38.65 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.873 -1.158 . . . . 0.95 107.873 163.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.4 HG23 HD11 ' A' ' 32' ' ' ILE . 3.6 mp -121.59 122.75 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 106.851 -1.537 . . . . 1.06 106.851 172.207 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -92.2 127.52 37.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.773 -1.936 . . . . 3.11 105.773 157.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -166.82 161.37 15.32 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 126.289 1.836 . . . . 2.0 107.967 -167.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -98.21 95.34 2.78 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.448 0.699 . . . . 4.15 109.833 -174.329 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -58.55 -32.14 95.93 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.637 2.225 . . . . 1.56 111.709 -176.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -61.19 -15.8 38.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.033 1.333 . . . . 3.69 112.955 -178.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 pt -123.49 -49.06 2.3 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 N-CA-C 114.019 1.118 . . . . 1.37 114.019 -178.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.426 HG23 ' H ' ' A' ' 54' ' ' GLY . 17.9 tt -90.19 -70.11 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 118.462 0.574 . . . . 1.18 109.97 178.509 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.426 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 117.72 149.09 8.81 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 123.605 0.622 . . . . 0.7 112.12 178.487 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.41 -39.57 9.49 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.72 2.947 . . . . 1.1 111.733 179.509 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -51.27 -56.25 13.93 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 122.595 0.358 . . . . 5.67 110.504 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -49.25 -47.45 46.52 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.014 1.725 . . . . 4.93 110.842 179.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.0 mt -58.32 -54.16 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 118.992 -0.528 . . . . 0.83 110.424 174.003 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.7 mt -52.41 -45.36 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 119.203 0.91 . . . . 1.43 110.703 177.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -58.33 -44.83 88.84 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.288 0.635 . . . . 3.89 110.262 176.249 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 56.7 m -60.17 -54.4 46.25 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.776 -0.577 . . . . 1.01 109.635 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.9 mm -58.8 -42.01 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 121.867 -0.521 . . . . 1.33 110.829 -178.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -53.02 -65.33 0.58 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.683 0.793 . . . . 3.17 109.415 171.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.4 t -54.77 -36.55 64.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.148 1.379 . . . . 1.1 112.457 -174.564 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.76 -12.6 25.16 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.244 0.831 . . . . 2.25 113.244 176.79 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.26 44.72 1.23 Allowed Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.604 1.097 . . . . 0.68 111.18 169.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -141.62 174.04 10.94 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.554 0.741 . . . . 2.14 109.108 178.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -113.75 76.71 3.19 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 123.706 0.802 . . . . 4.1 112.177 -177.252 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.04 133.37 26.7 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.765 1.643 . . . . 1.4 111.929 -177.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.6 t -139.08 151.91 47.11 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.524 1.129 . . . . 2.83 108.208 167.425 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.5 mt . . . . . 0 N--CA 1.452 -0.375 0 N-CA-C 107.765 -1.198 . . . . 3.26 107.765 161.482 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.634 0.254 . . . . 2.66 111.613 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.9 tp -150.79 156.43 41.25 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.564 1.946 . . . . 2.15 106.34 174.171 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -124.04 155.09 38.92 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.761 0.824 . . . . 2.48 109.577 176.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.422 HD13 ' N ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -150.74 141.98 23.22 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.804 0.842 . . . . 2.72 109.126 175.192 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.6 t -90.97 131.32 38.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 C-N-CA 125.685 1.594 . . . . 0.85 107.142 177.123 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.619 HG12 ' HB3' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -126.35 78.43 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 122.454 1.121 . . . . 1.45 110.487 -166.539 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.9 mtm105 -58.34 133.34 55.63 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.041 -1.096 . . . . 5.57 108.041 170.254 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.32 -32.96 3.43 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.578 1.085 . . . . 0.96 110.391 -171.108 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 55.8 mtm -60.85 144.62 52.39 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.327 -1.102 . . . . 2.33 108.489 163.51 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 t -164.42 -65.56 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.777 0.431 . . . . 3.05 110.407 -177.273 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -79.46 -75.69 0.24 Allowed 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.131 -0.356 . . . . 3.75 111.78 -168.809 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -167.67 -66.1 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.322 0.649 . . . . 1.95 109.494 -175.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.6 t -49.53 -38.4 30.59 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.513 0.725 . . . . 2.25 111.52 -171.185 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.4 m -39.25 -37.97 0.47 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.999 1.32 . . . . 0.94 112.68 174.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.0 t -51.74 -71.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.401 0.68 . . . . 0.93 110.251 173.096 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -27.68 69.31 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.12 -0.988 . . . . 1.48 110.626 -176.611 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -54.25 -41.89 69.29 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 124.224 1.009 . . . . 3.04 109.425 174.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.6 mt -78.33 -64.23 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.499 -1.297 . . . . 0.82 107.499 176.071 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -48.86 -57.71 5.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.79 1.236 . . . . 3.19 111.07 -169.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 t -75.25 0.19 17.39 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.863 0.865 . . . . 1.84 112.27 -176.258 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.6 t -98.72 -37.36 9.51 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.662 1.185 . . . . 0.83 109.996 173.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.75 -45.29 90.52 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.844 0.747 . . . . 2.51 111.052 173.323 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.3 p -64.84 80.45 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.194 0.598 . . . . 2.04 110.817 -172.246 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt 164.95 -33.88 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.853 2.861 . . . . 5.06 110.766 -176.055 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -50.6 118.82 3.31 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.323 0.51 . . . . 1.92 110.036 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -71.09 77.56 0.68 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.009 0.923 . . . . 5.4 110.547 -168.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.53 -16.83 0.98 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.658 1.123 . . . . 1.17 111.27 -175.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.84 145.41 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 107.136 -1.431 . . . . 1.92 107.136 162.457 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.5 mt -108.2 -43.83 4.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.496 1.518 . . . . 2.89 108.761 170.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -164.5 159.77 19.71 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 108.578 -0.897 . . . . 2.73 108.578 -178.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.4 p -133.85 160.93 36.16 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.751 1.22 . . . . 2.84 107.919 173.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 m -153.42 117.44 4.81 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.509 -1.293 . . . . 1.96 107.509 161.26 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 p -106.2 153.16 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 118.712 0.687 . . . . 2.34 111.364 174.222 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.83 135.55 22.16 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.683 -0.635 . . . . 0.91 110.404 170.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.35 -37.6 63.47 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 115.45 -0.796 . . . . 1.37 110.493 -178.673 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.0 84.12 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.13 0.572 . . . . 1.15 110.604 179.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.84 -11.1 59.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.217 1.007 . . . . 2.38 111.107 175.643 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 46.44 40.33 7.85 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.737 2.015 . . . . 2.95 111.696 -167.604 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -132.25 144.17 50.43 Favored 'General case' 0 C--O 1.228 -0.034 0 CA-C-O 119.375 -0.345 . . . . 1.63 111.126 -167.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.0 136.63 44.11 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.331 -0.989 . . . . 0.86 108.331 155.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.31 145.17 25.83 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.41 -1.329 . . . . 1.46 107.41 148.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.5 mt -125.68 132.71 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.086 -1.449 . . . . 2.02 107.086 167.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -96.87 128.95 44.32 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.382 -2.081 . . . . 2.63 105.382 160.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -166.66 161.36 15.72 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.684 1.594 . . . . 2.43 108.757 -176.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -97.01 109.5 49.46 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 123.419 0.687 . . . . 3.36 109.433 176.574 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.52 29.07 0.43 Allowed 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.605 2.204 . . . . 1.61 113.254 -176.361 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -123.12 1.36 9.17 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.619 1.168 . . . . 3.48 111.017 -176.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -129.64 -67.88 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.229 0 C-N-CA 123.514 0.726 . . . . 1.47 110.488 178.443 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 tt -80.0 -49.12 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.515 0.674 . . . . 1.72 110.424 -175.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.26 161.35 34.21 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.109 0.862 . . . . 0.97 111.953 174.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.8 -34.94 47.76 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.482 2.788 . . . . 1.05 111.715 -177.4 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -53.44 -58.96 5.28 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.702 0.801 . . . . 5.65 111.284 -175.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -44.96 -57.31 3.89 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.226 1.01 . . . . 2.81 110.752 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 76.9 mt -56.09 -61.63 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 114.588 -1.187 . . . . 1.04 109.835 -177.358 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.0 mt -58.09 -42.66 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 121.937 -0.477 . . . . 1.41 111.098 -176.097 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 57.7 m170 -58.46 -46.58 86.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.778 0.717 . . . . 3.51 109.959 176.116 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 m -58.45 -57.48 12.74 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.414 -0.587 . . . . 0.77 109.414 177.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.5 mm -61.45 -35.23 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.817 0.735 . . . . 1.83 111.662 -174.292 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -53.11 -68.8 0.14 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.293 -0.632 . . . . 3.44 109.293 168.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.6 t -62.38 -21.16 65.13 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.897 0.702 . . . . 1.43 112.897 -174.087 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.4 tp -65.65 -18.44 65.33 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.264 1.425 . . . . 2.47 111.097 174.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.17 43.56 0.6 Allowed Glycine 0 C--N 1.337 0.591 0 C-N-CA 125.285 1.421 . . . . 0.69 110.851 168.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.619 ' HB3' HG12 ' A' ' 10' ' ' VAL . 64.1 m-85 -146.54 178.83 7.98 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 117.394 0.597 . . . . 1.77 110.028 -177.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.99 87.5 47.23 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 123.848 0.859 . . . . 5.44 109.851 172.385 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.16 75.86 4.06 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 124.303 3.335 . . . . 1.86 111.015 -175.379 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.3 t -71.82 150.81 43.98 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.161 -0.681 . . . . 2.38 109.161 175.111 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.2 tp . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 106.919 -1.511 . . . . 3.46 106.919 164.156 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 105.545 -2.02 . . . . 8.15 105.545 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.54 177.29 10.34 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 109.025 -1.63 . . . . 3.36 109.025 -138.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.0 t0 63.4 159.75 0.09 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.05 2.14 . . . . 4.18 112.157 -174.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.55 -179.43 36.95 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.142 -1.183 . . . . 2.54 110.142 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 m -142.46 161.39 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.128 -0.693 . . . . 2.33 109.128 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 tp -144.69 142.32 29.98 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.156 -1.054 . . . . 2.47 108.156 168.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -101.14 132.88 46.39 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.975 0.91 . . . . 2.47 109.487 166.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -132.6 162.18 31.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.934 1.294 . . . . 1.88 107.644 166.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 t -117.7 133.09 65.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 126.166 1.786 . . . . 1.26 107.108 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.48 99.36 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 C-N-CA 124.086 0.954 . . . . 1.34 110.891 -168.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.4 mtt85 -68.84 150.64 47.58 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 107.924 -1.139 . . . . 5.02 107.924 171.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.72 -5.14 39.95 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.215 0.912 . . . . 0.97 113.67 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 69.7 mtm -74.17 69.2 1.51 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.831 1.315 . . . . 2.1 112.543 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 t -65.82 126.35 28.2 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.214 0.531 . . . . 3.55 111.817 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 t 52.02 82.42 0.07 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.811 2.044 . . . . 3.15 114.391 156.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 50.77 -101.83 0.1 Allowed 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 124.614 1.166 . . . . 2.04 110.229 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 9.85 -71.65 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 129.99 3.316 . . . . 1.83 115.781 172.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.7 m -36.78 -46.49 0.61 Allowed 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 125.589 1.555 . . . . 0.99 112.516 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.1 t -36.42 -68.12 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.027 1.331 . . . . 0.89 111.579 168.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -29.0 65.78 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.896 -0.503 . . . . 1.19 110.072 -175.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -38.29 77.37 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.531 0.733 . . . . 3.37 109.59 177.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.477 HD12 HG11 ' A' ' 37' ' ' VAL . 95.7 mt -74.41 -68.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 106.422 -1.696 . . . . 0.89 106.422 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -48.0 -56.34 7.9 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.311 1.444 . . . . 3.08 111.369 -166.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 t -60.99 -42.3 98.15 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.586 0.708 . . . . 1.39 109.992 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.3 t -65.95 -49.45 67.88 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 109.224 -0.658 . . . . 0.99 109.224 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.41 -39.44 83.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.023 -1.048 . . . . 2.4 111.301 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.2 p -58.34 -11.24 2.59 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.934 1.087 . . . . 1.67 113.934 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.6 mtmt -68.7 -34.95 76.52 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.505 1.048 . . . . 3.79 111.592 170.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -62.71 122.06 14.94 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.784 0.434 . . . . 1.87 110.509 -167.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -76.56 65.9 2.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.209 1.004 . . . . 6.12 110.824 -172.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.78 9.31 0.02 OUTLIER Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.953 1.739 . . . . 1.13 112.504 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -103.19 132.98 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.778 1.631 . . . . 1.77 106.765 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -90.17 -56.87 3.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.51 1.124 . . . . 2.79 108.777 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -148.64 136.58 20.82 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.101 0.56 . . . . 2.67 111.549 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.0 m -106.51 161.78 14.3 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.933 0.893 . . . . 1.76 109.035 172.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.1 m -150.84 96.95 2.41 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.089 0.555 . . . . 1.67 109.675 162.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.477 HG11 HD12 ' A' ' 22' ' ' ILE . 38.9 t -90.58 86.2 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 C-N-CA 126.147 1.779 . . . . 2.33 109.341 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.86 129.41 34.84 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 121.323 -0.861 . . . . 1.02 110.946 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -77.83 -45.63 23.82 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.516 -0.766 . . . . 2.04 111.063 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.58 -45.88 90.56 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 121.299 0.571 . . . . 1.42 110.352 -177.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.24 -10.5 59.66 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.463 1.105 . . . . 2.58 111.513 176.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 51.72 31.04 7.46 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.203 1.801 . . . . 2.69 111.802 -171.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -117.21 133.83 55.51 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.641 0.777 . . . . 1.89 109.632 -165.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -106.94 114.39 28.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.648 -1.242 . . . . 0.7 107.648 161.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.3 142.3 27.86 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.94 -1.133 . . . . 1.04 107.94 159.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 mp -127.93 127.64 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 106.581 -1.637 . . . . 1.05 106.581 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -98.51 80.85 2.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.364 1.466 . . . . 3.26 108.376 169.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -116.95 165.46 13.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.591 1.556 . . . . 2.31 110.883 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -81.13 115.77 58.3 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 122.589 0.356 . . . . 3.44 110.511 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.88 -13.06 21.79 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.79 2.327 . . . . 1.68 113.92 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -81.93 -45.97 14.69 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 119.316 0.962 . . . . 4.39 108.956 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pt -81.92 -89.94 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.08 0.4 . . . . 2.05 112.08 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 tt -57.38 -47.02 85.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.806 1.242 . . . . 1.2 111.09 -173.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.42 164.29 28.02 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 121.512 0.507 . . . . 1.19 112.681 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.22 -37.57 31.16 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.058 3.172 . . . . 1.1 112.215 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.418 ' HE ' ' CD2' ' A' ' 60' ' ' HIS . 1.8 tpm_? -60.08 -50.17 74.78 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.442 0.697 . . . . 7.35 110.902 -168.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -50.21 -56.3 11.65 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.978 0.911 . . . . 2.43 110.037 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.9 mt -53.6 -60.6 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.496 1.118 . . . . 0.74 109.745 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.4 mt -50.69 -43.54 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 118.641 0.655 . . . . 1.68 111.208 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.418 ' CD2' ' HE ' ' A' ' 56' ' ' ARG . 61.5 m-70 -76.37 -30.94 57.77 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.363 -0.836 . . . . 3.18 112.272 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.6 m -61.67 -49.76 75.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.401 -0.962 . . . . 0.82 108.401 171.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -59.58 -49.03 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.716 1.206 . . . . 1.51 109.814 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -48.84 -61.16 2.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.307 1.443 . . . . 3.53 109.252 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.0 t -59.5 -31.76 69.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.202 1.001 . . . . 1.2 112.646 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.2 mt -67.06 -14.34 62.8 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 118.63 -0.7 . . . . 1.99 111.526 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.23 49.4 1.14 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.451 -1.06 . . . . 0.74 110.451 168.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -141.37 169.25 17.96 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.355 1.062 . . . . 2.0 108.519 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -108.03 85.56 2.67 Favored Pre-proline 0 CA--C 1.529 0.139 0 CA-C-O 117.361 -1.304 . . . . 3.76 112.943 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 75.52 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.847 2.365 . . . . 1.46 112.133 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.1 m -66.91 143.16 57.0 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.646 -0.872 . . . . 2.04 108.646 166.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.92 153.89 32.16 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.867 0.841 . . . . 3.13 109.266 171.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.4 t -87.17 -46.71 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.826 0.85 . . . . 4.12 110.295 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -64.04 -48.35 76.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.044 0.938 . . . . 7.54 110.597 -171.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -147.51 -173.94 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 127.696 2.398 . . . . 8.38 105.413 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 C--O 1.249 1.04 0 N-CA-C 103.462 -2.792 . . . . 13.52 103.462 158.773 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 119.462 -0.304 . . . . 7.02 111.352 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.11 -177.15 41.85 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 108.733 -1.747 . . . . 3.46 108.733 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -36.48 80.43 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.746 2.818 . . . . 4.69 115.856 -173.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.53 86.06 0.73 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 106.636 -2.585 . . . . 2.69 106.636 157.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.5 t -70.72 67.38 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.595 -0.891 . . . . 2.33 108.595 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -90.18 99.07 12.16 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.905 -1.517 . . . . 3.27 106.905 -172.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -71.2 142.63 50.63 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 110.026 -0.361 . . . . 2.58 110.026 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 131.83 55.76 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.133 -1.432 . . . . 1.59 107.133 166.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.1 t -70.02 133.76 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 105.343 -2.095 . . . . 1.29 105.343 165.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.94 114.69 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.413 1.085 . . . . 1.24 108.093 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 ttm-85 -74.05 155.27 38.7 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.429 -0.952 . . . . 5.4 108.429 171.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.6 -20.86 10.86 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.191 -0.783 . . . . 0.99 114.115 164.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -73.63 73.5 1.49 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.537 1.669 . . . . 1.93 109.921 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 t -59.58 -34.72 73.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.869 0.868 . . . . 2.97 111.805 -177.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.1 m -144.83 -167.01 2.55 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.284 -1.006 . . . . 3.99 108.284 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.36 -174.05 0.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.622 0.769 . . . . 2.78 111.057 173.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m 72.52 -58.53 0.59 Allowed 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 125.108 1.363 . . . . 1.95 110.5 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.6 m -40.4 -46.71 2.44 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.714 1.206 . . . . 0.86 110.491 168.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.4 t -38.11 -69.61 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.272 1.029 . . . . 0.8 111.3 169.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -26.51 62.46 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.58 -0.7 . . . . 1.28 111.236 -175.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -50.81 -40.44 55.47 Favored 'General case' 0 N--CA 1.461 0.093 0 N-CA-C 108.881 -0.785 . . . . 3.13 108.881 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.6 mt -81.25 -69.14 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 108.065 -1.087 . . . . 0.81 108.065 172.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -46.52 -55.94 6.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.661 1.584 . . . . 3.27 111.928 -169.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.0 t -62.02 -38.62 89.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.711 0.804 . . . . 1.44 109.973 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.5 t -72.97 -27.55 61.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.992 0.517 . . . . 1.01 110.878 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.89 -44.51 55.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.709 0.804 . . . . 1.96 110.218 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.6 p -65.17 80.55 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.242 0.617 . . . . 1.78 110.373 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 165.91 -26.18 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.773 2.829 . . . . 3.69 111.415 -174.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -66.44 76.25 0.1 Allowed 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.484 1.038 . . . . 2.22 110.378 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -42.17 97.74 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.417 1.887 . . . . 5.73 110.948 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.39 -40.93 0.91 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.386 -1.486 . . . . 1.48 109.386 -165.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.47 154.93 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.941 -0.762 . . . . 3.22 108.941 156.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.05 -23.89 10.66 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.906 0.883 . . . . 2.52 110.812 165.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -159.44 155.02 25.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.696 0.68 . . . . 2.04 109.3 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.3 t -136.48 147.84 47.36 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.197 1.399 . . . . 2.05 108.014 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.5 m -146.05 131.55 18.74 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.62 -0.881 . . . . 1.78 108.62 151.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.3 m -111.69 163.73 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 123.234 0.614 . . . . 1.69 109.994 173.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.13 137.15 11.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.774 -0.579 . . . . 0.89 111.297 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 pp -72.98 -41.25 64.55 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.948 1.299 . . . . 1.42 111.262 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.45 -27.56 69.2 Favored 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 123.105 0.562 . . . . 1.09 111.376 -171.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.445 HG23 ' HG2' ' A' ' 43' ' ' LYS . 4.4 t -114.97 6.64 15.36 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.925 1.29 . . . . 2.15 110.579 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.3 m120 51.2 45.53 27.74 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.741 1.616 . . . . 2.86 111.609 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HG2' HG23 ' A' ' 41' ' ' THR . 15.6 ptpt -141.74 162.13 36.23 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 113.504 0.927 . . . . 1.77 113.504 -174.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.45 120.72 34.75 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 126.491 1.916 . . . . 0.8 106.889 167.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.21 135.38 39.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.587 -1.264 . . . . 1.26 107.587 161.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -119.27 135.84 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 104.236 -2.505 . . . . 1.04 104.236 168.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -97.46 112.13 24.1 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.141 -1.8 . . . . 3.48 106.141 165.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -150.48 160.79 43.52 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 122.989 0.516 . . . . 2.36 110.029 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -87.61 112.6 49.65 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 108.455 -0.943 . . . . 4.42 108.455 169.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.86 -18.45 36.53 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.078 1.852 . . . . 1.48 112.595 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -69.82 -38.93 76.73 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.683 1.129 . . . . 3.88 110.913 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.3 pt -83.2 -56.16 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 112.381 0.512 . . . . 1.72 112.381 -172.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.2 tt -98.13 -51.16 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.268 0.627 . . . . 1.31 110.694 -172.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.73 163.7 37.04 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 115.846 -0.615 . . . . 0.87 113.153 171.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.84 -37.23 28.21 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 124.161 3.24 . . . . 1.01 112.527 -175.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -52.73 -49.17 65.95 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.902 0.481 . . . . 5.22 112.019 -174.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -48.73 -60.5 2.68 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.925 0.89 . . . . 3.03 110.082 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.4 mt -56.19 -54.31 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 125.01 1.324 . . . . 0.78 110.35 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.7 mt -54.44 -58.29 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.609 0.764 . . . . 1.33 110.173 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -62.77 -34.73 77.85 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.384 0.611 . . . . 5.06 110.636 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 83.5 m -62.36 -51.71 66.51 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.349 -0.844 . . . . 0.67 109.717 173.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 76.2 mt -65.8 -37.77 80.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 121.299 -0.876 . . . . 1.75 111.649 -175.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -47.79 -50.97 24.23 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.866 0.866 . . . . 2.56 108.767 167.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.8 t -65.26 -45.58 83.99 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.287 0.477 . . . . 1.46 112.287 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.47 -32.03 69.87 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.37 -0.831 . . . . 1.9 110.769 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.23 45.9 0.56 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 111.196 -0.762 . . . . 0.91 111.196 161.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -136.16 161.14 36.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.035 -1.469 . . . . 2.21 107.035 174.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -106.38 85.66 1.82 Allowed Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 118.045 -0.979 . . . . 4.32 113.139 -165.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.61 134.12 31.88 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.533 2.155 . . . . 1.67 112.889 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.8 t -143.46 172.68 12.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.787 1.635 . . . . 2.52 106.897 162.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.51 175.2 4.98 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.953 0.501 . . . . 4.92 111.416 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.0 -86.89 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 105.972 -1.862 . . . . 3.98 105.972 171.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.4 ' NZ ' ' O ' ' A' ' 75' ' ' GLU . 8.9 mtmp? -158.08 151.85 23.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.723 1.609 . . . . 7.6 107.032 169.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 51.7 mt -80.71 77.14 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 105.719 -1.956 . . . . 9.42 105.719 166.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.4 ' O ' ' NZ ' ' A' ' 73' ' ' LYS . 27.6 tt0 . . . . . 0 C--O 1.252 1.202 0 C-N-CA 127.29 2.236 . . . . 12.2 107.474 -165.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 mtt . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 107.791 -1.188 . . . . 9.45 107.791 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.08 -150.75 52.12 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.317 0.484 . . . . 3.7 112.746 170.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -125.86 140.94 52.24 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.002 -1.481 . . . . 4.63 107.002 173.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.1 -22.25 20.62 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.254 1.407 . . . . 3.68 112.241 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t 44.93 70.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 118.655 1.227 . . . . 2.33 110.888 -171.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.98 146.56 51.01 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.466 -1.309 . . . . 2.86 107.466 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -125.85 150.17 48.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.459 -0.941 . . . . 2.21 108.459 159.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.427 ' CD1' ' HB3' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -135.91 118.2 15.62 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.189 -1.412 . . . . 1.61 107.189 172.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.26 122.57 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 106.528 -1.656 . . . . 1.41 106.528 165.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.35 137.43 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.903 0.881 . . . . 2.45 109.576 -172.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -120.7 168.51 11.33 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.684 0.794 . . . . 6.51 110.688 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.56 -19.47 11.46 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 125.101 1.334 . . . . 0.87 112.396 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.3 mtm -60.41 113.35 2.36 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.838 0.819 . . . . 1.6 111.272 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.9 p -77.14 -42.34 38.28 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.771 0.828 . . . . 4.12 111.414 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.4 t -162.64 171.76 16.4 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.579 0.752 . . . . 3.34 109.103 -165.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.07 -35.7 2.24 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.916 1.686 . . . . 2.34 112.661 174.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -47.98 -53.37 16.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.172 0.589 . . . . 1.93 110.882 171.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 58.7 m -62.47 -43.99 97.48 Favored 'General case' 0 CA--C 1.522 -0.104 0 O-C-N 121.627 -0.67 . . . . 0.83 110.118 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 68.6 t -49.2 -59.83 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 109.256 -0.646 . . . . 0.85 109.256 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -26.62 66.33 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.702 -0.399 . . . . 1.51 111.341 -177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -60.26 -51.58 68.95 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.587 -0.894 . . . . 2.79 108.587 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.5 mt -62.86 -57.15 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.753 -1.573 . . . . 0.61 106.753 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -52.79 -53.63 45.53 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 123.993 0.808 . . . . 3.27 110.073 -173.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.6 t -58.94 -53.2 61.03 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.498 -0.556 . . . . 1.36 109.498 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.9 t -63.98 -20.01 65.58 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 118.571 -0.728 . . . . 0.9 112.609 -176.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.41 -47.74 10.36 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 118.29 -0.862 . . . . 2.14 111.251 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.3 p -50.88 -26.85 6.35 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.158 0.89 . . . . 1.8 113.025 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -25.11 66.44 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.752 1.39 . . . . 3.23 114.752 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -67.77 129.14 39.0 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 120.199 1.363 . . . . 1.92 110.594 -174.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.73 71.63 1.45 Allowed 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.555 -0.715 . . . . 7.12 109.595 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.42 -40.13 0.07 OUTLIER Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.612 -0.549 . . . . 1.18 113.254 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.93 158.01 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 118.078 0.939 . . . . 3.33 109.594 170.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 pp -107.94 -25.74 11.04 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.708 0.803 . . . . 2.99 110.206 164.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -158.44 149.21 20.41 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 118.773 0.715 . . . . 2.84 109.289 171.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.7 t -117.97 137.6 52.74 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 105.315 -2.106 . . . . 2.51 105.315 163.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.97 103.8 6.5 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.186 -1.413 . . . . 1.25 107.186 173.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 44' ' ' ALA . 1.1 p -103.68 151.11 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 118.436 0.562 . . . . 2.26 112.13 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.92 136.24 16.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.11 0.481 . . . . 0.78 110.73 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.05 -31.92 56.52 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.107 0.963 . . . . 1.87 111.335 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.94 -52.86 62.64 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.211 0.604 . . . . 1.14 109.915 175.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.98 -30.41 68.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.845 0.858 . . . . 1.94 109.446 173.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.256 0.0 OUTLIER 52.72 56.29 7.82 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.023 -1.473 . . . . 3.08 107.023 -164.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -140.85 143.61 34.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.613 -1.176 . . . . 1.39 109.086 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.464 ' HB2' HG23 ' A' ' 37' ' ' VAL . . . -109.73 129.16 55.64 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.421 -1.326 . . . . 0.7 107.421 155.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -90.67 145.81 24.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.616 -1.253 . . . . 0.96 107.616 154.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.7 mp -129.21 117.88 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 106.61 -1.626 . . . . 0.89 106.61 170.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -88.21 125.99 34.92 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.575 -1.639 . . . . 2.1 106.575 167.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -170.45 151.97 3.85 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.396 0.678 . . . . 2.17 110.331 -167.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -77.64 118.78 74.27 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.499 -1.297 . . . . 3.56 107.499 168.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.11 -18.61 23.68 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.441 2.094 . . . . 1.09 112.37 -176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -74.62 -51.27 14.94 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.6 0.636 . . . . 4.28 109.364 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 pt -69.72 -54.96 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 112.566 0.58 . . . . 1.21 112.566 -168.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 tt -98.96 -48.83 11.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 123.662 0.785 . . . . 1.33 110.913 -169.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.33 157.77 26.87 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.226 0.917 . . . . 0.71 111.85 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.02 -25.23 32.22 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 124.026 3.15 . . . . 0.66 113.34 -172.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -55.15 -51.62 65.89 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.316 0.507 . . . . 5.61 111.226 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -42.6 -61.92 1.11 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.192 1.397 . . . . 3.36 109.9 176.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mt -51.44 -63.46 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 124.785 1.234 . . . . 0.81 110.685 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.5 mt -49.93 -43.76 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 118.573 0.624 . . . . 1.32 111.228 -175.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -75.92 -31.53 59.18 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.064 0.546 . . . . 2.43 111.391 -176.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.7 m -62.6 -53.23 57.68 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.808 -0.812 . . . . 1.16 108.808 169.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.7 mm -55.93 -47.9 79.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 123.135 0.574 . . . . 1.55 110.2 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -49.13 -66.56 0.38 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.102 1.361 . . . . 2.65 109.753 170.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 t -51.95 -42.88 63.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.445 1.498 . . . . 1.19 112.598 -174.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.03 -14.58 55.34 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.782 -0.627 . . . . 1.79 112.658 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.01 47.4 1.35 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.75 -0.94 . . . . 0.62 110.75 172.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -135.74 168.63 18.94 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.049 0.939 . . . . 2.02 108.805 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -117.38 88.75 29.39 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-O 117.962 -1.018 . . . . 4.4 110.38 -173.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.04 108.93 0.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.181 2.588 . . . . 1.12 111.853 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.1 t -72.41 -165.85 0.22 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.8 0.81 . . . . 2.68 109.128 156.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.89 -159.24 0.71 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.422 1.089 . . . . 4.33 110.71 -174.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.43 73.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.943 1.297 . . . . 7.0 109.08 165.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -55.93 148.77 16.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.195 0.998 . . . . 11.75 110.602 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.6 tt -60.91 134.57 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.335 -0.617 . . . . 7.46 109.335 169.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 . . . . . 0 C--O 1.255 1.359 0 N-CA-C 104.508 -2.404 . . . . 9.93 104.508 178.372 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.4 mtp . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 105.632 -1.988 . . . . 7.93 105.632 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.29 -150.89 20.61 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 106.569 -2.612 . . . . 2.92 106.569 -167.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.48 97.66 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.146 1.778 . . . . 4.66 111.196 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.03 51.34 4.4 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 109.638 -1.385 . . . . 3.41 109.638 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 m -56.06 143.26 9.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 O-C-N 123.702 0.295 . . . . 2.46 111.666 -157.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.5 tp -138.9 141.68 38.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.36 -0.978 . . . . 2.09 108.36 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.406 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 32.9 mt-10 -108.02 123.31 48.48 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.052 -1.462 . . . . 2.38 107.052 174.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.5 mt -106.87 122.17 45.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.108 -1.812 . . . . 2.26 106.108 172.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.87 118.56 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 N-CA-C 106.082 -1.821 . . . . 0.92 106.082 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.9 m -117.4 115.14 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 123.573 0.749 . . . . 1.25 109.097 -169.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -83.88 175.0 9.92 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.561 -0.903 . . . . 6.36 108.561 168.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.6 -32.52 7.44 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.452 0.548 . . . . 1.14 112.737 172.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -61.4 138.74 58.27 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.684 1.242 . . . . 2.18 110.336 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -155.49 28.89 0.39 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.001 0.52 . . . . 3.09 111.066 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.2 t -167.87 141.58 3.4 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 107.79 -1.189 . . . . 3.47 107.79 175.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -38.38 -48.91 1.4 Allowed 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.001 1.32 . . . . 1.93 112.069 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.6 m -42.68 -40.97 2.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.601 1.16 . . . . 1.57 111.827 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.2 m -47.6 -39.61 17.23 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.739 0.816 . . . . 0.83 111.364 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.6 t -53.17 -61.9 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 123.295 0.638 . . . . 0.94 109.943 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -28.83 69.07 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.494 -0.558 . . . . 1.27 109.494 -177.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -59.51 -52.79 64.05 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.958 -1.127 . . . . 2.92 107.958 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.94 -51.23 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.115 -1.068 . . . . 0.64 108.115 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -47.82 -61.97 1.69 Allowed 'General case' 0 C--N 1.341 0.229 0 O-C-N 123.901 0.75 . . . . 4.72 109.16 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -62.76 -43.32 99.1 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.974 0.91 . . . . 1.79 109.97 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.6 t -58.49 -30.02 66.68 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 118.798 -0.62 . . . . 1.12 111.489 176.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.446 HD21 HG23 ' A' ' 58' ' ' ILE . 6.1 mt -85.46 -48.48 8.94 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 113.253 0.835 . . . . 2.42 113.253 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.4 p -71.6 66.31 0.5 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.541 1.536 . . . . 1.86 110.742 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.99 -33.91 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.618 2.367 . . . . 3.82 110.832 -171.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -53.87 -29.69 42.6 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.733 1.012 . . . . 3.06 113.733 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? 60.4 67.75 0.82 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.739 -1.208 . . . . 6.33 107.739 -173.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.54 -51.22 0.07 OUTLIER Glycine 0 CA--C 1.52 0.373 0 N-CA-C 107.171 -2.372 . . . . 1.18 107.171 -171.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.556 HD11 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -42.04 132.01 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 123.486 0.715 . . . . 2.0 109.158 147.332 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.8 tp -95.4 -46.15 6.82 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.8 2.04 . . . . 2.58 107.9 160.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -154.79 138.16 15.83 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 122.908 0.483 . . . . 2.32 110.306 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -111.15 147.64 34.46 Favored 'General case' 0 CA--C 1.523 -0.084 0 N-CA-C 108.005 -1.109 . . . . 2.02 108.005 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.74 104.43 2.87 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.589 -0.893 . . . . 1.36 108.589 171.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.05 157.43 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 122.873 0.469 . . . . 1.81 111.477 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.62 136.66 17.37 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.611 0.765 . . . . 0.9 109.53 170.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.72 -38.17 64.89 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.622 -0.717 . . . . 1.53 110.722 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.05 -46.5 82.39 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.27 0.628 . . . . 1.24 110.89 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -74.74 -11.42 60.16 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.283 1.033 . . . . 2.52 110.871 176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 49.78 41.91 22.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.394 1.878 . . . . 2.45 110.84 -172.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -137.61 147.68 45.19 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.291 -0.413 . . . . 1.2 111.26 -164.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.92 112.26 18.55 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.098 1.759 . . . . 0.69 107.422 164.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.78 143.05 27.16 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 166.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.653 HG21 HD13 ' A' ' 58' ' ' ILE . 4.5 mp -127.03 124.08 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 107.259 -1.386 . . . . 1.05 107.259 174.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -97.15 120.65 37.9 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.477 -1.675 . . . . 2.25 106.477 158.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.45 ' CD1' HG22 ' A' ' 46' ' ' ILE . 12.4 p90 -153.48 157.15 39.43 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.89 1.276 . . . . 2.07 107.773 -174.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -85.51 118.44 70.69 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 107.55 -1.278 . . . . 3.19 107.55 170.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.69 -31.41 40.19 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.714 1.609 . . . . 1.47 111.611 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -86.65 29.11 0.81 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.321 0.964 . . . . 3.64 111.378 -166.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 pt -142.77 -53.86 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 124.846 1.258 . . . . 1.26 110.384 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.4 tt -98.85 -45.55 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.764 0.826 . . . . 1.08 111.015 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.36 158.98 7.38 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.039 0.828 . . . . 0.76 111.251 -172.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.86 -23.78 40.93 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.804 2.336 . . . . 1.04 111.5 177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -56.74 -55.13 38.13 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.571 1.148 . . . . 6.08 111.338 -175.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -52.59 -52.13 56.66 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 122.472 1.129 . . . . 2.62 109.824 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.653 HD13 HG21 ' A' ' 46' ' ' ILE . 51.7 mt -56.99 -57.87 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 125.049 1.339 . . . . 0.94 110.259 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.9 mt -51.12 -51.54 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 109.964 -0.384 . . . . 1.42 109.964 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -63.17 -34.73 78.26 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 118.73 0.696 . . . . 2.53 112.393 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 85.9 m -59.92 -56.83 16.92 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.608 -0.886 . . . . 0.64 108.608 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mm -62.11 -46.34 96.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 119.667 -0.206 . . . . 1.63 110.962 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -42.02 -57.76 2.33 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.461 1.504 . . . . 3.44 109.574 166.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 t -65.41 -9.03 21.76 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.353 1.242 . . . . 1.02 114.353 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.1 mt -83.44 -10.01 58.65 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 120.553 1.524 . . . . 2.02 111.128 170.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.34 40.56 28.16 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.056 -1.218 . . . . 0.96 110.056 -170.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -126.67 151.29 48.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.262 -1.755 . . . . 1.76 106.262 161.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -110.64 84.86 4.35 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 113.59 0.959 . . . . 5.54 113.59 -158.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.61 85.67 0.59 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.402 2.735 . . . . 1.2 113.756 -173.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.1 t -70.52 156.54 39.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.624 0.77 . . . . 2.53 109.878 161.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.84 179.49 2.21 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.549 -0.537 . . . . 4.64 109.549 161.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 p -152.45 -48.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.183 0.593 . . . . 4.07 111.703 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.406 ' NZ ' ' OE2' ' A' ' 7' ' ' GLU . 9.9 mptt -63.72 147.75 50.87 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.059 -0.719 . . . . 8.52 109.059 169.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.5 mm 72.82 116.88 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 126.702 2.001 . . . . 7.43 109.176 -167.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 C--O 1.25 1.111 0 N-CA-C 104.627 -2.36 . . . . 9.14 104.627 -177.4 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 mtt . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 108.844 -0.799 . . . . 7.28 108.844 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 51.95 31.91 33.24 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.996 -0.891 . . . . 4.52 111.434 -163.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.3 t0 168.37 156.2 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.622 1.969 . . . . 3.61 109.085 -173.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.04 173.6 36.16 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 128.045 2.736 . . . . 1.94 107.817 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.7 t -133.67 145.97 32.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 N-CA-C 108.122 -1.066 . . . . 2.05 108.122 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.2 tt -140.71 137.15 33.26 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.561 -0.903 . . . . 2.23 108.561 166.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -103.54 132.04 50.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.059 1.344 . . . . 2.26 109.416 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -132.08 131.81 42.75 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 123.67 0.788 . . . . 1.78 109.435 173.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.41 132.97 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.183 -2.155 . . . . 1.06 105.183 165.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 m -130.34 129.15 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.298 -1.001 . . . . 1.66 108.298 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -101.38 -176.85 3.27 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 109.213 -0.662 . . . . 4.25 109.213 170.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.98 -29.01 11.33 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.636 1.112 . . . . 1.26 110.698 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 73.2 mtm -57.71 120.71 8.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.964 -0.754 . . . . 2.0 108.964 170.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 t -155.84 43.92 0.43 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.831 0.824 . . . . 3.51 110.393 -170.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -164.08 -89.02 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.37 -0.831 . . . . 3.27 110.064 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -175.57 -62.3 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 125.428 1.491 . . . . 1.93 107.299 -175.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 t -41.46 -46.16 3.37 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 124.706 1.202 . . . . 2.86 110.304 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.4 m -25.46 -48.4 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.63 1.972 . . . . 0.69 114.099 169.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.6 t -51.44 -64.2 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.26 0.624 . . . . 0.69 110.347 174.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -27.83 66.43 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.101 -0.999 . . . . 1.2 110.706 -177.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.93 -44.01 70.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.126 1.37 . . . . 3.25 108.373 176.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.1 mt -72.69 -67.49 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 106.288 -1.745 . . . . 0.57 106.288 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -48.91 -56.17 9.6 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.612 1.165 . . . . 3.55 111.563 -166.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 m -68.95 -20.17 64.19 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.753 1.221 . . . . 2.83 111.792 -174.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.5 t -87.08 -48.89 7.7 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.027 -1.101 . . . . 1.18 108.027 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.27 -35.7 76.14 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.035 -1.041 . . . . 2.28 111.718 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 p -57.69 -18.94 23.63 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.483 0.92 . . . . 1.94 113.483 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.9 mtmt -63.02 -34.21 77.08 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.571 1.078 . . . . 3.84 110.28 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.44 ' HB3' HD12 ' A' ' 53' ' ' ILE . 16.8 m-70 -72.41 107.75 5.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.895 -1.15 . . . . 2.14 107.895 179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -52.52 -26.12 12.22 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.006 1.113 . . . . 4.81 114.006 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.09 -21.23 69.71 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 118.198 0.454 . . . . 1.18 113.05 177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.2 mp -60.76 124.31 14.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 118.965 1.382 . . . . 2.97 108.689 171.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.5 tp -84.45 -45.31 12.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.732 -1.21 . . . . 3.26 107.732 162.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -163.62 114.44 1.36 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 119.152 -0.451 . . . . 3.07 111.042 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.7 m -77.92 161.9 27.21 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.713 -0.847 . . . . 2.13 108.713 166.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -166.18 94.5 0.55 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.399 -0.963 . . . . 2.33 108.399 170.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.5 p -104.87 147.99 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 123.428 0.691 . . . . 2.11 112.075 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.9 135.02 30.87 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.635 0.774 . . . . 0.69 109.904 174.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.93 -39.87 63.5 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.31 -0.859 . . . . 1.41 110.728 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.36 -46.33 80.07 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.134 0.574 . . . . 0.96 110.349 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.19 -15.49 60.56 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.131 0.972 . . . . 1.95 111.086 178.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.39 36.32 26.85 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.676 0.79 . . . . 2.69 109.155 -172.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -135.69 135.6 40.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 122.411 0.284 . . . . 1.5 110.575 -168.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.06 124.69 49.96 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.594 -1.262 . . . . 0.77 107.594 160.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.79 147.51 25.99 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 107.674 -1.232 . . . . 1.43 107.674 155.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.4 mp -130.17 139.15 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 107.139 -1.43 . . . . 1.05 107.139 166.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -97.18 123.73 41.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.79 -1.559 . . . . 2.91 106.79 161.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -168.58 171.43 8.86 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.835 -1.172 . . . . 2.51 107.835 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.74 110.16 30.05 Favored Pre-proline 0 C--O 1.237 0.41 0 CA-C-N 119.015 0.825 . . . . 3.89 109.364 175.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.28 51.32 3.16 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.694 2.263 . . . . 2.58 110.365 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -145.44 -60.5 0.34 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.922 1.689 . . . . 4.39 107.598 -159.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.1 pt -94.57 -60.37 2.6 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 C-N-CA 123.893 0.877 . . . . 1.49 111.469 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.44 HD12 ' HB3' ' A' ' 29' ' ' HIS . 10.7 tt -72.28 -52.71 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.246 -1.02 . . . . 1.9 108.246 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.8 160.69 24.28 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.287 -0.869 . . . . 0.82 112.02 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -57.37 -39.69 87.53 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.755 2.97 . . . . 0.78 110.909 173.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -59.44 -53.9 52.8 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.251 0.463 . . . . 6.77 112.251 -171.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -52.67 -46.74 67.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.897 0.856 . . . . 2.55 109.75 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.96 -66.45 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.827 -1.079 . . . . 1.0 110.025 172.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.353 2.7 pp -61.62 -28.88 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 121.075 1.762 . . . . 3.82 114.366 -174.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.49 -51.77 66.13 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 118.819 0.736 . . . . 3.23 109.139 173.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.0 m -57.39 -52.34 65.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.567 -0.531 . . . . 0.63 109.567 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mm -56.35 -49.6 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.516 1.126 . . . . 1.4 110.181 -175.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -48.4 -62.84 1.29 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.39 1.076 . . . . 3.91 109.675 170.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -62.47 -23.89 67.16 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.79 -0.641 . . . . 1.18 112.286 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 16.5 tp -82.7 -5.16 58.73 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.951 1.7 . . . . 2.32 110.966 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.38 48.36 1.56 Allowed Glycine 0 CA--C 1.525 0.696 0 C-N-CA 125.103 1.335 . . . . 0.94 111.803 167.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -141.61 162.54 35.23 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.794 0.838 . . . . 2.03 109.902 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -109.66 93.2 13.68 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-O 117.95 -1.024 . . . . 4.41 109.578 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.78 136.78 6.28 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 121.553 1.502 . . . . 1.49 112.826 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.3 m -135.79 117.5 15.01 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 126.02 1.728 . . . . 1.92 107.751 170.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -58.02 135.36 56.95 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.438 0.295 . . . . 3.18 110.482 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.2 m -119.79 -41.34 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 123.273 0.629 . . . . 3.62 110.777 174.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt 70.73 -56.57 0.61 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.858 1.663 . . . . 7.64 111.56 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.7 pt -93.16 -173.73 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.098 1.359 . . . . 5.56 109.109 168.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 . . . . . 0 C--O 1.256 1.399 0 N-CA-C 103.319 -2.845 . . . . 11.75 103.319 164.886 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 106.368 -1.715 . . . . 8.61 106.368 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 62.27 58.94 10.4 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 108.72 -1.752 . . . . 3.55 108.72 -165.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -170.15 171.57 6.81 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 107.547 -1.279 . . . . 4.25 107.547 -137.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 130.55 -176.38 18.9 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.642 1.591 . . . . 2.12 110.259 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.0 156.12 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.191 -1.411 . . . . 1.96 107.191 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.409 HD12 HD23 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -127.22 127.27 44.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.678 -1.601 . . . . 2.55 106.678 174.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.37 117.69 35.08 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.72 -1.215 . . . . 2.18 107.72 170.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.409 HD23 HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -110.12 141.82 42.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.298 -1.371 . . . . 1.88 107.298 172.009 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.85 135.79 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 106.357 -1.72 . . . . 0.85 106.357 167.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.26 108.74 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 C-N-CA 125.853 1.661 . . . . 1.26 108.869 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? -67.48 158.48 31.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.688 -0.856 . . . . 5.67 108.688 160.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.02 -23.58 7.69 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.03 0.824 . . . . 1.14 113.111 163.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -70.44 85.59 0.61 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.819 1.309 . . . . 2.16 112.6 -175.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.3 t -76.79 100.41 5.47 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.02 0.914 . . . . 3.09 110.845 175.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.4 t 68.62 -76.33 0.06 Allowed 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 115.21 1.559 . . . . 3.99 115.21 164.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.41 170.34 15.99 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 123.864 0.865 . . . . 3.33 108.709 -171.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.9 m 69.7 -58.48 0.52 Allowed 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 124.978 1.311 . . . . 1.84 111.034 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 97.8 m -44.21 -47.16 9.21 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 124.924 1.289 . . . . 0.85 111.512 -177.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.6 t -42.99 -64.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.45 0.7 . . . . 0.88 110.197 174.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -25.9 61.11 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.861 -0.524 . . . . 1.44 111.395 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -51.53 -41.61 61.16 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.767 0.827 . . . . 3.24 108.824 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.6 mt -80.23 -65.91 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.682 -1.229 . . . . 0.64 107.682 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.0 -56.62 7.23 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.013 1.325 . . . . 3.29 111.311 -169.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 t -65.23 -45.12 85.9 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.897 0.879 . . . . 1.36 110.12 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 t -62.16 -29.6 70.47 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 119.161 -0.447 . . . . 0.89 111.388 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.39 -55.22 5.04 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.957 -0.544 . . . . 2.61 111.311 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.9 p -68.83 66.08 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.962 1.305 . . . . 2.06 111.956 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.87 -42.33 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.77 1.628 . . . . 4.27 110.779 -170.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -72.99 150.32 42.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.04 -0.726 . . . . 3.63 109.04 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -60.69 160.07 9.86 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.919 -0.401 . . . . 5.4 109.919 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.2 -5.09 81.66 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.028 -0.873 . . . . 1.8 113.111 174.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.553 HD11 ' SG ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -99.18 146.43 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 106.712 -1.588 . . . . 1.93 106.712 176.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.9 tp -104.53 -48.74 3.73 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.681 1.192 . . . . 2.77 110.603 172.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -164.95 162.4 20.58 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.007 0.923 . . . . 2.5 108.761 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' HD11 ' A' ' 32' ' ' ILE . 56.0 m -138.15 161.34 37.06 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 119.332 0.969 . . . . 1.85 108.538 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.6 t -155.0 133.62 12.01 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.774 -0.824 . . . . 2.35 108.774 150.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 m -115.94 155.81 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.369 0.668 . . . . 1.73 111.036 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.39 137.69 16.6 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.101 0.561 . . . . 1.01 110.88 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -79.24 -34.83 42.36 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 124.559 1.144 . . . . 1.72 112.521 -174.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.82 -41.34 91.05 Favored 'General case' 0 C--O 1.227 -0.109 0 N-CA-C 109.596 -0.52 . . . . 1.11 109.596 -177.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.3 t -92.9 -6.36 48.8 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 118.533 -0.746 . . . . 2.07 111.297 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.269 0.0 OUTLIER 39.32 60.69 1.48 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 126.576 1.951 . . . . 2.83 109.791 -172.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -131.38 147.13 52.54 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.201 1.4 . . . . 2.05 108.866 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.93 120.71 38.09 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.938 -1.504 . . . . 0.63 106.938 159.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.01 138.18 31.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.043 -1.466 . . . . 1.58 107.043 161.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.63 130.3 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 107.619 -1.252 . . . . 1.05 107.619 169.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.5 mttt -101.06 139.26 37.0 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.085 -1.82 . . . . 2.4 106.085 161.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -175.18 177.38 1.91 Allowed 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 125.371 1.468 . . . . 2.49 108.777 -160.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -112.85 81.33 4.4 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 125.241 1.416 . . . . 4.09 107.544 -170.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.74 -43.53 55.05 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.421 2.747 . . . . 1.23 113.902 -167.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.33 -23.72 65.94 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.239 0.829 . . . . 3.72 113.239 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.8 pt -100.75 -58.17 4.05 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 CA-C-N 118.888 0.767 . . . . 1.52 112.629 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.7 tt -89.32 -45.35 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-O 121.356 0.598 . . . . 1.2 110.425 -171.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.68 151.47 13.87 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.859 0.742 . . . . 1.02 111.815 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -66.42 -31.42 42.63 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.389 2.726 . . . . 1.48 111.866 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -56.55 -43.17 79.65 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.91 -0.494 . . . . 6.16 111.452 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -53.99 -53.01 58.81 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-O 121.225 0.536 . . . . 2.71 109.732 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.3 mt -57.58 -49.15 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 124.276 1.03 . . . . 0.82 110.25 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.4 mt -54.85 -56.74 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 110.151 -0.314 . . . . 1.44 110.151 177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -60.88 -36.96 80.53 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.742 0.701 . . . . 2.63 112.027 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.7 m -59.21 -51.16 71.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 121.479 -0.763 . . . . 0.91 109.095 176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.7 mt -65.25 -43.03 95.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 121.508 -0.745 . . . . 2.22 111.753 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -49.48 -49.76 44.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.425 1.09 . . . . 3.05 108.356 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 t -64.96 -44.31 89.8 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.57 0.748 . . . . 1.04 111.419 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.6 mt -63.47 -30.41 71.54 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 121.5 -0.75 . . . . 2.16 110.651 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.07 53.45 0.2 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.44 -0.664 . . . . 0.95 111.44 156.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -137.47 175.28 9.74 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.709 -0.849 . . . . 1.98 108.709 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -106.65 77.15 0.46 Allowed Pre-proline 0 N--CA 1.47 0.547 0 CA-C-O 117.734 -1.127 . . . . 4.35 111.76 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.68 71.79 1.45 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.662 2.908 . . . . 1.27 112.37 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.7 m -74.38 117.84 16.65 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.357 1.063 . . . . 2.08 108.49 173.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tt -76.74 69.64 3.13 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.086 0.954 . . . . 3.09 109.466 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.9 t -82.19 -36.86 14.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 123.378 0.671 . . . . 4.34 111.59 -173.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.461 ' NZ ' ' OE2' ' A' ' 75' ' ' GLU . 1.1 tmtm? -66.14 -46.68 76.62 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 119.577 -0.849 . . . . 6.61 111.196 -168.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 35.6 mm -71.55 144.27 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.346 -0.983 . . . . 8.42 108.346 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.461 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 14.2 pt-20 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 105.122 -2.177 . . . . 9.42 105.122 -157.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.2 mtm . . . . . 0 N--CA 1.467 0.396 0 N-CA-C 107.382 -1.34 . . . . 9.94 107.382 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.68 145.75 19.12 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 108.765 -1.734 . . . . 4.06 108.765 -167.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -87.47 -167.4 1.87 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.178 0.591 . . . . 4.99 111.202 -176.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.51 47.92 0.5 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.572 -1.011 . . . . 3.96 110.572 170.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.347 1.2 m 20.84 80.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 128.256 2.622 . . . . 3.04 113.161 -177.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -74.07 99.28 3.3 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.557 -1.275 . . . . 2.57 107.557 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -78.22 117.94 19.97 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 120.848 0.356 . . . . 2.59 110.046 169.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 pp -108.21 133.99 51.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.544 -1.28 . . . . 1.87 107.544 160.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.1 t -85.63 136.67 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 105.563 -2.014 . . . . 1.38 105.563 169.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.3 p -156.38 112.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 108.499 -0.926 . . . . 2.33 108.499 -163.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -96.89 178.71 5.2 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.326 -0.99 . . . . 4.56 108.326 174.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.08 -36.99 4.04 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.375 -1.09 . . . . 0.95 110.375 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.6 ptp -57.08 123.11 14.08 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.811 -0.811 . . . . 2.06 108.811 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.0 t -149.07 21.54 0.97 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.368 0.507 . . . . 2.87 112.368 -167.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.5 t -162.98 142.74 9.0 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 106.097 -1.816 . . . . 3.75 106.097 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.58 -49.27 5.46 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.755 1.222 . . . . 2.02 111.817 -173.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -37.2 -47.45 0.79 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.082 1.753 . . . . 1.65 112.45 174.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.7 m -52.62 -43.62 65.5 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 124.102 0.961 . . . . 0.96 110.864 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.9 t -54.62 -61.49 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.479 -0.934 . . . . 0.75 108.479 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -24.66 67.02 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.241 -0.89 . . . . 1.47 109.792 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -65.25 -52.73 52.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.977 0.808 . . . . 4.57 108.96 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.7 mt -58.79 -54.49 32.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.834 -1.173 . . . . 0.63 107.834 -172.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -38.35 -69.34 0.12 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.369 1.468 . . . . 3.16 111.588 165.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -53.21 -50.35 64.89 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.642 1.177 . . . . 1.73 110.71 -171.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -33.13 73.56 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.154 1.382 . . . . 0.99 110.469 -177.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.8 mt -77.25 -47.54 19.86 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.828 0.451 . . . . 2.21 111.155 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.4 p -66.99 74.57 0.11 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.578 1.151 . . . . 1.75 110.079 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 163.13 -9.63 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.501 2.72 . . . . 3.63 113.284 -171.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -69.67 -101.45 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 121.76 2.073 . . . . 3.07 110.01 170.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -167.8 158.85 11.19 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 105.059 -2.2 . . . . 6.2 105.059 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.11 -58.44 2.3 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.688 -0.565 . . . . 1.88 111.688 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -38.74 99.92 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 126.905 2.082 . . . . 2.08 111.258 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.4 mt -82.46 -44.64 15.76 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.497 1.919 . . . . 2.94 108.694 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -145.36 150.12 36.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.218 1.007 . . . . 2.28 109.926 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -131.24 154.48 48.41 Favored 'General case' 0 C--O 1.231 0.082 0 N-CA-C 107.01 -1.478 . . . . 1.97 107.01 169.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 73.7 m -152.41 141.93 21.72 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.044 -0.725 . . . . 2.05 109.044 150.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.43 HG12 ' CB ' ' A' ' 44' ' ' ALA . 1.5 m -119.59 168.19 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 123.365 0.666 . . . . 1.73 111.355 170.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -158.01 139.66 13.78 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.631 0.772 . . . . 0.88 109.853 176.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.32 -36.05 22.84 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.994 0.918 . . . . 1.63 112.236 -172.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.29 -39.04 81.7 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.67 -0.493 . . . . 1.12 109.67 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 t -97.17 -4.63 38.79 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.151 -0.928 . . . . 2.14 111.394 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 42.38 61.3 2.06 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 126.221 1.808 . . . . 2.81 109.13 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -135.27 145.36 47.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.736 -1.12 . . . . 1.45 108.614 -171.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.43 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -127.84 123.44 35.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.14 -1.43 . . . . 0.66 107.14 164.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -103.92 130.69 51.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.098 -1.075 . . . . 1.39 108.098 169.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.85 124.35 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.746 -0.835 . . . . 0.91 108.746 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -97.48 82.16 3.07 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.743 0.817 . . . . 2.19 108.869 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -122.77 151.18 41.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.749 1.22 . . . . 2.22 109.956 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.77 114.06 22.01 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 109.511 -0.552 . . . . 3.25 109.511 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.95 -25.85 59.32 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.046 1.831 . . . . 1.19 113.225 -176.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -54.5 -30.36 53.1 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.839 1.256 . . . . 4.11 113.453 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 pt -105.57 -92.74 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.366 0.666 . . . . 2.15 111.854 -172.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 tt -49.7 -52.37 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.982 1.313 . . . . 1.37 112.291 -174.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.44 162.1 35.5 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.992 0.806 . . . . 0.78 111.831 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.2 -36.78 27.31 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.795 2.997 . . . . 0.85 112.776 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -56.64 -45.69 81.44 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.689 0.625 . . . . 6.16 112.689 -173.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -54.42 -57.48 11.14 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 122.15 0.976 . . . . 3.01 109.538 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.4 mt -49.7 -62.46 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.329 1.452 . . . . 0.79 109.725 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.6 mt -52.81 -52.77 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 122.755 0.422 . . . . 1.33 110.201 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 -68.7 -30.66 69.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.119 0.418 . . . . 3.17 111.746 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.9 m -65.69 -52.18 53.51 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.567 -0.708 . . . . 0.98 109.313 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.9 mm -65.31 -33.64 65.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 121.742 -0.599 . . . . 1.89 111.174 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -54.32 -58.64 6.63 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.787 1.235 . . . . 3.0 108.712 166.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.8 t -60.04 -26.5 66.17 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.083 0.953 . . . . 1.32 113.57 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.81 -20.47 61.63 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.382 0.992 . . . . 2.75 111.9 172.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.87 38.75 5.4 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.222 -1.151 . . . . 1.09 110.222 -175.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -126.32 163.2 23.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.082 -1.821 . . . . 2.27 106.082 171.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.14 83.58 8.21 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 119.375 0.989 . . . . 3.9 112.96 -172.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.89 147.51 24.3 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.374 2.049 . . . . 1.56 112.224 -175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.3 m -154.37 144.29 21.79 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.157 1.383 . . . . 2.01 108.311 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.2 mt -61.84 143.94 55.59 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 122.862 0.465 . . . . 3.74 111.052 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.3 t -67.31 -46.98 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 109.744 -0.465 . . . . 4.4 109.744 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -62.46 135.0 57.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.769 -0.456 . . . . 7.28 109.769 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 72.8 mt -116.06 126.75 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 105.113 -2.18 . . . . 8.08 105.113 169.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 . . . . . 0 C--O 1.252 1.23 0 C-N-CA 124.518 1.127 . . . . 14.49 109.303 -173.641 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptm . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 110.361 -0.237 . . . . 6.99 110.361 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.65 -161.78 38.95 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.843 -0.903 . . . . 3.84 110.843 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -83.66 -40.69 18.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.476 1.11 . . . . 4.79 109.468 168.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.78 74.6 1.19 Allowed Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 109.767 -1.333 . . . . 2.08 109.767 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 t -79.22 130.73 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.84 -0.8 . . . . 2.19 108.84 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.8 tp -129.86 138.31 50.9 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.407 -1.331 . . . . 1.95 107.407 164.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -110.9 137.69 48.22 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.784 1.234 . . . . 2.46 109.535 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.04 128.15 20.79 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.848 -0.797 . . . . 1.49 108.848 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.0 t -65.35 145.15 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 107.619 -1.252 . . . . 1.09 107.619 167.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.42 98.16 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 125.767 1.627 . . . . 1.36 107.68 -178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -63.57 162.94 12.0 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.972 -0.751 . . . . 4.16 108.972 160.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.47 -0.32 46.46 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.866 1.222 . . . . 1.42 113.014 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.2 mtm -73.64 75.76 1.52 Allowed 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.336 -1.096 . . . . 2.22 112.097 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.9 p -67.54 81.58 0.17 Allowed 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 121.686 -0.634 . . . . 4.79 109.892 168.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 t 72.75 176.28 0.27 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.04 1.736 . . . . 3.51 112.253 165.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.7 -36.11 4.71 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 126.363 1.865 . . . . 2.27 112.667 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -41.22 -60.63 1.19 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.673 1.189 . . . . 2.37 110.845 168.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.4 m -68.19 -31.54 71.14 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.532 -0.73 . . . . 1.43 111.675 -176.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.0 t -57.04 -56.26 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.887 -0.783 . . . . 0.9 108.887 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -30.49 71.07 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.709 -0.619 . . . . 1.27 110.626 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -50.58 72.42 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.333 -0.988 . . . . 3.7 108.333 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 52.5 mt -62.52 -65.18 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 107.207 -1.405 . . . . 1.03 107.207 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -46.53 -57.12 5.03 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.855 0.862 . . . . 3.64 110.151 -174.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -56.79 -49.56 74.96 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.354 -0.839 . . . . 1.44 109.283 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.7 t -65.67 -29.38 69.92 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 118.993 -0.527 . . . . 0.88 111.811 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 26' ' ' LEU . 2.8 mm? -70.63 -44.25 67.58 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.76 0.709 . . . . 2.64 111.648 174.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.8 p -54.56 -21.54 10.55 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.649 0.981 . . . . 2.13 113.649 -172.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.12 -4.49 58.83 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 115.064 1.505 . . . . 4.54 115.064 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -67.11 122.94 18.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.869 1.213 . . . . 2.11 110.162 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -71.0 73.43 0.61 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.679 1.192 . . . . 7.34 111.176 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.39 -2.42 0.8 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.887 1.232 . . . . 1.23 112.62 -177.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.94 150.14 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 125.075 1.35 . . . . 1.97 108.282 170.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.1 tp -111.4 -48.12 3.12 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.278 1.831 . . . . 3.1 110.055 172.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -157.34 155.14 30.12 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.357 1.063 . . . . 2.71 108.32 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.43 163.95 28.54 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.169 -1.048 . . . . 2.34 108.169 172.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -162.56 103.14 1.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.82 -1.178 . . . . 1.66 107.82 170.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.7 147.21 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 C-N-CA 124.997 1.319 . . . . 1.95 110.641 171.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.97 137.14 16.46 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.764 0.792 . . . . 1.06 111.601 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.1 pp -77.7 -23.22 49.56 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 115.29 -0.868 . . . . 1.5 111.967 -176.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.14 -41.15 97.98 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 109.245 -0.65 . . . . 1.27 109.245 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -86.34 -31.21 21.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.565 -0.743 . . . . 2.17 109.909 172.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 77.68 44.3 0.09 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.63 1.972 . . . . 3.08 107.75 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt -140.17 146.76 39.18 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.944 -0.391 . . . . 1.64 109.944 -167.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.98 127.1 55.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.136 1.375 . . . . 0.65 107.359 162.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.19 141.74 32.62 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.914 -1.143 . . . . 1.01 107.914 155.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.73 136.47 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 107.572 -1.27 . . . . 1.25 107.572 170.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 mttt -100.61 125.37 47.0 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.421 -1.696 . . . . 2.35 106.421 160.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -166.57 142.04 4.47 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 128.126 2.571 . . . . 1.85 107.267 -174.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -71.61 125.54 91.71 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 118.833 -1.147 . . . . 3.83 108.93 174.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -82.67 -9.78 10.96 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.745 2.296 . . . . 1.3 113.275 -173.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.92 -44.08 11.31 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.255 0.934 . . . . 4.18 109.191 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 pt -67.41 -54.66 21.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 112.716 0.635 . . . . 1.46 112.716 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.5 tt -105.14 -58.08 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.84 0.856 . . . . 1.65 111.653 -173.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.04 161.6 27.55 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 123.579 0.609 . . . . 0.62 113.905 169.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.78 -36.48 6.24 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 124.048 3.165 . . . . 0.7 112.983 -171.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.5 ttm105 -55.39 -47.11 76.35 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.768 0.427 . . . . 4.89 111.186 -173.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -47.36 -61.4 1.93 Allowed 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.477 1.511 . . . . 2.79 110.312 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.5 mt -51.09 -63.34 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 124.127 0.971 . . . . 0.69 109.791 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.7 mt -51.86 -52.66 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.235 0.471 . . . . 1.28 110.689 -173.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -64.18 -34.38 77.95 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.99 0.814 . . . . 2.71 112.272 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.4 m -61.01 -53.13 61.01 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.355 -0.841 . . . . 0.7 109.888 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.2 mm -61.56 -38.44 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 O-C-N 121.667 -0.645 . . . . 1.63 110.693 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -55.76 -59.7 4.49 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.954 1.301 . . . . 2.77 108.803 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.5 t -52.37 -40.49 62.08 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.587 1.155 . . . . 1.03 111.739 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.7 mt -70.32 5.38 1.76 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.466 0.913 . . . . 1.96 113.466 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.19 45.98 5.45 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 119.069 0.849 . . . . 0.65 111.249 169.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -135.74 174.69 10.33 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.046 0.938 . . . . 1.92 109.782 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -113.59 68.34 1.4 Allowed Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 112.892 0.701 . . . . 3.61 112.892 -177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.76 85.09 0.23 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.194 3.263 . . . . 1.1 112.503 -174.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.2 m -101.3 125.54 47.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.726 1.611 . . . . 2.28 108.177 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -56.06 134.86 52.89 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.154 -0.684 . . . . 3.58 109.154 175.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.7 p -74.35 -50.58 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 110.399 -0.222 . . . . 3.87 110.399 -173.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -177.81 177.22 1.11 Allowed 'General case' 0 C--O 1.233 0.216 0 C-N-CA 127.821 2.448 . . . . 7.34 105.693 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.15 155.72 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 106.932 -1.506 . . . . 8.03 106.932 166.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 . . . . . 0 C--O 1.25 1.102 0 N-CA-C 104.448 -2.427 . . . . 11.38 104.448 172.439 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 105.306 -2.109 . . . . 9.07 105.306 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -173.96 50.05 0.15 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 107.68 -2.168 . . . . 3.67 107.68 -177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -165.93 167.7 16.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.548 1.539 . . . . 4.73 108.571 -154.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.97 -130.42 2.2 Favored Glycine 0 C--N 1.334 0.463 0 N-CA-C 109.539 -1.424 . . . . 2.62 109.539 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 m -136.06 162.73 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.059 -1.459 . . . . 2.29 107.059 157.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 tt -153.08 82.3 1.2 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 103.618 -2.734 . . . . 3.02 103.618 174.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.0 152.81 42.19 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.882 -0.727 . . . . 3.4 110.438 -169.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.39 133.92 50.33 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.125 -1.435 . . . . 1.73 107.125 168.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.61 136.14 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.441 -2.059 . . . . 0.89 105.441 153.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 m -134.92 134.97 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.573 -1.269 . . . . 1.34 107.573 175.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -117.2 173.73 6.51 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.737 -0.838 . . . . 5.68 108.737 170.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.24 -22.93 37.21 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 110.916 -0.874 . . . . 1.23 110.916 -172.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.2 mtm -60.1 151.81 25.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.554 0.677 . . . . 2.21 109.583 170.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -158.45 -58.27 0.07 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.472 -0.566 . . . . 2.4 109.472 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.3 t -73.38 140.45 46.63 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.206 -0.664 . . . . 3.49 109.206 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.35 -43.94 5.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.022 0.929 . . . . 1.9 111.728 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 m -41.21 -47.32 3.31 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.422 1.089 . . . . 1.51 111.811 174.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.7 m -45.44 -49.1 13.63 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 118.992 0.815 . . . . 0.74 110.671 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.8 t -52.32 -59.49 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.646 0.778 . . . . 1.25 109.694 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.21 -36.57 71.03 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.418 1.087 . . . . 1.7 109.37 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -61.47 -49.78 75.4 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.375 -0.602 . . . . 4.35 109.375 -174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.9 mt -63.33 -53.27 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 108.167 -1.049 . . . . 0.73 108.167 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -48.04 -59.98 2.96 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.089 0.956 . . . . 3.15 110.016 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.1 m -66.31 -43.25 86.78 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.027 0.931 . . . . 2.3 109.99 -173.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.5 t -57.23 -38.31 73.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.862 -0.59 . . . . 0.88 110.222 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 mt -75.53 -51.09 13.75 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 118.385 -0.817 . . . . 2.62 112.48 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.9 p -68.18 73.28 0.2 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.466 0.706 . . . . 1.61 110.277 -172.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? 177.84 -33.93 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.633 2.773 . . . . 3.47 111.638 -171.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -44.41 -76.95 0.02 OUTLIER 'General case' 0 C--N 1.348 0.515 0 N-CA-C 113.904 1.076 . . . . 3.59 113.904 -171.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 ptt85 171.01 134.05 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 104.924 -2.25 . . . . 11.14 104.924 -172.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.76 -59.66 2.98 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-N 118.774 0.716 . . . . 2.57 113.216 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -33.89 116.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 127.432 2.293 . . . . 1.92 111.605 177.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 72.2 mt -89.03 -46.32 8.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.357 1.063 . . . . 3.17 110.52 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -154.45 152.13 29.78 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.947 0.899 . . . . 2.56 108.946 -173.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.1 m -125.7 160.75 28.93 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 107.761 -1.2 . . . . 1.88 107.761 168.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.1 t -146.64 120.42 9.25 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.108 -1.071 . . . . 1.82 108.108 155.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.1 t -102.69 150.87 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 124.519 1.127 . . . . 2.31 108.584 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.16 135.11 20.15 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.598 -0.689 . . . . 0.72 110.465 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -73.35 -49.85 25.13 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.29 -0.868 . . . . 1.56 111.148 -172.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.98 -48.42 80.03 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.586 0.707 . . . . 1.15 110.376 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.64 -16.54 62.93 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.35 1.06 . . . . 2.24 111.1 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 50.76 42.07 27.09 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.886 1.274 . . . . 2.77 108.117 -171.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -129.32 144.8 51.37 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 122.565 0.346 . . . . 1.41 110.957 -166.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.72 110.49 17.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.094 1.758 . . . . 0.87 107.393 161.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.92 142.7 27.42 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 107.471 -1.307 . . . . 1.36 107.471 166.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.58 128.56 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 108.169 -1.048 . . . . 1.1 108.169 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 60.7 mmtt -93.85 74.72 4.22 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 126.43 1.892 . . . . 2.24 108.926 171.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -119.32 179.43 4.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.437 1.495 . . . . 2.45 113.434 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.18 88.3 31.94 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 130.774 3.63 . . . . 4.07 108.097 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -61.16 -22.23 74.04 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.963 2.442 . . . . 1.35 112.892 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -57.52 -30.74 65.4 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 118.911 -0.566 . . . . 3.03 112.051 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.9 pt -114.15 -54.43 4.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 N-CA-C 113.976 1.102 . . . . 1.37 113.976 -173.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.6 tt -74.02 -63.35 1.03 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.496 -0.927 . . . . 1.8 108.496 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.2 147.91 23.38 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.128 -0.942 . . . . 0.96 111.553 173.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -54.11 -43.74 55.65 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.985 3.124 . . . . 0.81 111.753 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -56.61 -51.85 67.08 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.048 0.539 . . . . 5.58 112.35 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -47.32 -55.38 8.9 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.087 1.355 . . . . 2.61 109.391 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.1 mt -56.42 -65.11 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 114.687 -1.142 . . . . 0.96 110.406 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.2 mt -48.37 -52.86 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.259 1.024 . . . . 1.25 109.81 -173.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -68.92 -30.41 68.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 111.839 0.311 . . . . 2.92 111.839 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.8 m -67.32 -51.42 52.73 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.613 -0.835 . . . . 0.95 109.905 173.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.2 mm -64.17 -33.67 63.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.748 -0.595 . . . . 2.09 111.092 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -55.11 -60.32 3.54 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.918 1.287 . . . . 2.81 108.607 167.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -52.66 -38.54 60.62 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.862 1.265 . . . . 1.05 112.759 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -55.22 -22.84 19.44 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.925 0.713 . . . . 2.86 112.925 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.39 46.66 1.4 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.121 -1.192 . . . . 0.92 110.121 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -132.63 168.49 18.17 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.333 -1.358 . . . . 1.74 107.333 172.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -112.47 88.14 10.57 Favored Pre-proline 0 N--CA 1.454 -0.231 0 CA-C-O 118.515 -0.755 . . . . 3.88 109.324 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.45 151.65 22.85 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.578 2.185 . . . . 1.58 111.944 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.5 m -157.75 145.97 19.0 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.662 1.585 . . . . 2.48 107.386 170.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mp -55.25 133.93 49.57 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.038 -0.727 . . . . 3.6 109.038 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.46 -49.26 84.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 118.852 0.751 . . . . 4.63 111.161 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.6 tttp 65.77 172.7 0.23 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.234 1.014 . . . . 8.03 110.454 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.4 mt -131.41 -67.06 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.284 -1.376 . . . . 6.66 107.284 170.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--O 1.253 1.251 0 CA-C-O 115.818 -2.039 . . . . 11.17 109.154 -171.423 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mtp . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 118.771 -0.633 . . . . 6.8 110.031 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -82.64 -74.2 1.2 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.249 -1.54 . . . . 4.3 109.249 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -157.85 175.59 13.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.162 -1.422 . . . . 3.93 107.162 166.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.59 172.7 22.4 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 106.852 -2.499 . . . . 1.86 106.852 161.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.15 146.73 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 108.533 -0.914 . . . . 2.55 108.533 175.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.6 tt -134.59 115.5 13.93 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.453 -1.314 . . . . 2.41 107.453 169.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -89.74 84.85 6.31 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.071 1.348 . . . . 2.67 108.89 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.61 132.04 34.24 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.961 -1.126 . . . . 1.65 107.961 174.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -74.17 149.57 7.67 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 N-CA-C 106.038 -1.838 . . . . 1.17 106.038 164.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -152.69 54.58 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 127.082 2.153 . . . . 1.65 107.696 -169.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -56.84 157.33 5.67 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.779 -0.646 . . . . 5.79 109.338 171.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.48 -37.99 3.55 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 107.851 -2.099 . . . . 1.24 107.851 -162.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 40.5 mtp -53.03 143.63 16.96 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.331 -0.988 . . . . 2.59 108.331 157.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.9 t -168.08 -56.24 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.422 -0.955 . . . . 3.93 108.422 -174.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.8 t -86.9 171.39 10.85 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.466 -0.938 . . . . 2.8 108.466 172.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.81 -166.07 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.467 -0.568 . . . . 2.81 109.467 160.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.5 m 71.79 -60.23 0.53 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.433 1.093 . . . . 1.8 109.728 -171.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 77.7 m -36.98 -53.04 0.97 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 126.123 1.769 . . . . 1.21 109.875 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.6 t -36.08 -66.34 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.899 1.28 . . . . 0.67 111.336 173.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -26.02 56.26 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 122.124 -0.36 . . . . 1.04 111.073 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -51.78 -41.64 61.8 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 124.157 0.983 . . . . 3.16 108.786 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.465 ' HB ' HG21 ' A' ' 37' ' ' VAL . 11.2 mt -77.7 -70.3 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 107.234 -1.395 . . . . 0.74 107.234 172.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -47.17 -55.92 7.6 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.746 1.218 . . . . 3.29 112.165 -166.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.8 t -58.15 -49.22 77.76 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.097 -0.705 . . . . 1.3 109.097 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.8 t -62.62 -50.16 72.33 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 122.029 -0.42 . . . . 1.07 110.11 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.02 -36.79 80.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.575 -1.328 . . . . 2.52 111.547 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.1 p -57.67 -17.21 13.59 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.55 0.945 . . . . 1.87 113.55 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -62.25 -33.89 75.47 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.267 0.939 . . . . 3.76 111.641 171.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -73.34 76.09 1.37 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.127 0.571 . . . . 2.03 110.868 -173.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.3 mtm105 -42.39 99.87 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.062 1.345 . . . . 5.64 110.668 169.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.39 -44.66 0.86 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.413 -1.875 . . . . 1.34 108.413 -168.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.93 144.83 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 106.303 -1.74 . . . . 1.68 106.303 142.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -105.02 -57.88 1.97 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.969 1.308 . . . . 3.31 107.526 163.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -136.77 144.8 43.95 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.81 0.844 . . . . 1.87 110.886 -172.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.8 m -114.82 158.12 22.34 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 124.488 1.115 . . . . 1.97 108.013 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.0 t -150.97 76.23 1.23 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.697 -0.853 . . . . 2.41 108.697 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.465 HG21 ' HB ' ' A' ' 22' ' ' ILE . 22.1 t -81.35 136.19 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 125.292 1.437 . . . . 2.4 109.742 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.14 130.23 22.03 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.747 0.819 . . . . 0.82 111.357 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.53 -51.39 36.06 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 124.197 0.999 . . . . 1.56 111.308 -171.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.65 -44.86 90.23 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.537 0.684 . . . . 1.19 110.344 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -13.53 62.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.577 0.751 . . . . 1.99 110.922 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 52.95 33.45 14.65 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.762 1.225 . . . . 2.68 109.561 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -128.83 150.71 50.21 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.673 -0.491 . . . . 1.56 109.673 -164.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.84 123.24 36.86 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.372 -0.973 . . . . 0.9 108.372 153.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 129.65 34.65 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 104.459 -2.423 . . . . 1.34 104.459 159.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.8 mt -114.15 133.97 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 N-CA-C 107.425 -1.324 . . . . 2.05 107.425 168.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -118.64 99.13 6.6 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.677 2.791 . . . . 4.26 105.297 -170.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -151.71 157.23 41.77 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 126.633 1.973 . . . . 2.1 109.425 -157.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -82.29 123.09 79.54 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 119.365 0.984 . . . . 3.85 108.553 171.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.08 -2.96 12.42 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.625 2.216 . . . . 1.44 113.61 -173.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -100.23 -51.01 3.77 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 119.174 0.897 . . . . 3.11 109.196 -176.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 pt -69.19 -54.52 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-O 120.777 0.323 . . . . 1.18 111.701 -172.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.5 tt -91.06 -49.81 13.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 124.199 1.0 . . . . 1.1 109.739 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.65 154.58 5.75 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 111.667 -0.573 . . . . 0.76 111.667 -177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.76 -25.35 28.68 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.655 2.237 . . . . 0.76 112.862 -172.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -55.19 -48.91 73.15 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.395 0.543 . . . . 5.96 111.121 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -54.48 -58.53 7.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 122.475 1.131 . . . . 2.78 109.709 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.2 mt -48.82 -56.57 2.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 125.855 1.662 . . . . 0.91 111.711 175.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.7 -50.86 64.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 109.863 -0.421 . . . . 1.35 109.863 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.08 -39.83 83.38 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.145 0.578 . . . . 5.43 110.921 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 36.5 m -58.52 -56.82 17.21 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.542 -0.724 . . . . 1.02 109.57 173.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.9 mt -63.64 -41.12 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 119.031 0.832 . . . . 2.29 111.413 -172.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -45.73 -58.35 3.54 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.256 1.023 . . . . 3.51 108.858 168.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t -61.54 -30.19 70.48 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.87 0.692 . . . . 1.29 112.87 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.3 mt -71.92 -34.67 69.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.369 0.986 . . . . 1.89 110.717 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.37 51.34 0.29 Allowed Glycine 0 C--N 1.334 0.445 0 O-C-N 123.863 0.727 . . . . 0.82 112.068 160.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -140.67 170.66 15.36 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 106.345 -1.724 . . . . 2.03 106.345 174.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.67 86.19 0.42 Allowed Pre-proline 0 N--CA 1.466 0.367 0 CA-C-O 117.167 -1.397 . . . . 4.48 114.248 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.69 76.4 0.2 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.504 2.803 . . . . 1.57 112.244 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 p -90.62 128.43 36.61 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.288 1.435 . . . . 2.13 108.669 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 121.4 15.86 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.87 -1.159 . . . . 3.61 107.87 169.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.1 t -142.74 -60.21 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 124.293 1.037 . . . . 4.16 108.61 -174.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt 64.54 -72.17 0.07 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.731 1.213 . . . . 7.56 111.534 -173.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.5 mm -82.27 115.08 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.016 -1.105 . . . . 6.06 108.016 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 . . . . . 0 C--O 1.25 1.098 0 N-CA-C 103.327 -2.842 . . . . 12.65 103.327 174.534 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 mtt . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 108.802 -0.814 . . . . 9.74 108.802 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.71 -105.02 0.96 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 107.96 -2.056 . . . . 5.23 107.96 -174.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -164.01 158.54 19.66 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.168 1.387 . . . . 4.67 107.426 164.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.93 144.7 18.3 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 107.601 -2.2 . . . . 1.85 107.601 167.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.6 t -127.65 117.76 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 107.118 -1.438 . . . . 2.44 107.118 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.1 tt -138.03 97.29 3.37 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.06 -1.83 . . . . 2.78 106.06 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -83.2 135.5 34.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.487 -0.324 . . . . 2.41 110.354 -174.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.46 139.04 54.26 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.532 -0.914 . . . . 2.11 108.532 175.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.16 116.4 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 106.461 -1.681 . . . . 1.09 106.461 170.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 m -104.38 83.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 106.395 -1.705 . . . . 1.69 106.395 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -65.3 136.52 56.67 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.999 -0.741 . . . . 5.52 108.999 -169.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.76 -2.09 10.09 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 119.463 -0.632 . . . . 1.2 113.701 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.561 ' SD ' HD12 ' A' ' 22' ' ' ILE . 73.9 mtm -68.64 79.25 0.28 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.981 1.391 . . . . 2.21 111.038 174.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 t -50.39 -52.9 33.42 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.532 1.133 . . . . 3.24 112.661 -172.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -170.04 -103.16 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.346 0.658 . . . . 5.95 109.557 176.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.67 168.98 18.75 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.595 0.634 . . . . 2.79 110.625 -174.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.0 m 69.53 -62.63 0.41 Allowed 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 126.067 1.747 . . . . 1.51 110.004 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.9 m -37.36 -51.42 1.09 Allowed 'General case' 0 N--CA 1.458 -0.044 0 C-N-CA 127.068 2.147 . . . . 0.99 111.492 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.9 t -45.56 -70.77 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.232 1.013 . . . . 0.76 110.156 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -23.76 67.29 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.873 -0.517 . . . . 1.03 111.171 -175.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -59.03 -52.19 66.82 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.718 -1.216 . . . . 3.12 107.718 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.561 HD12 ' SD ' ' A' ' 13' ' ' MET . 30.3 mt -75.34 -56.42 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 108.583 -0.895 . . . . 0.94 108.583 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -38.0 -65.87 0.3 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.186 1.394 . . . . 3.49 112.02 170.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.2 t -62.72 -38.58 91.02 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.928 0.491 . . . . 1.46 110.373 -174.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.6 t -65.62 -24.94 67.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 118.973 -0.537 . . . . 0.87 111.702 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.8 mt -86.75 -44.87 11.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.05 0.94 . . . . 2.39 112.277 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.4 p -72.01 61.63 0.43 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.179 0.992 . . . . 1.53 111.183 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.34 -26.67 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.714 1.606 . . . . 3.68 113.132 -165.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -67.99 -128.72 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 119.621 1.1 . . . . 2.6 110.169 172.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -144.97 163.17 34.99 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 129.503 3.121 . . . . 5.61 104.757 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 75.41 -61.39 2.75 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.192 -0.763 . . . . 1.58 111.192 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.537 ' C ' HD13 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -51.52 111.59 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 117.842 0.821 . . . . 2.27 109.102 172.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 pp -107.71 -23.54 12.06 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.602 1.561 . . . . 2.41 110.962 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -145.32 158.97 43.71 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.842 -0.799 . . . . 2.4 108.842 167.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.7 t -153.48 145.97 24.08 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.003 -1.11 . . . . 1.85 108.003 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 p -150.51 132.52 15.22 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.387 -0.968 . . . . 2.15 108.387 169.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.38 125.13 67.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.247 0.619 . . . . 1.97 111.395 170.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.97 128.04 44.29 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.279 0.632 . . . . 1.28 110.397 172.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -72.95 -52.55 14.13 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.91 -1.041 . . . . 2.01 111.436 -165.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.14 -46.44 87.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-O 121.614 0.721 . . . . 2.29 109.72 -172.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -77.17 -6.36 52.66 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.71 -0.677 . . . . 3.01 110.573 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 56.55 31.53 19.22 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 125.235 1.414 . . . . 3.03 110.146 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -108.66 125.64 52.1 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 121.841 -0.537 . . . . 2.25 109.919 -164.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.5 121.98 37.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.454 1.102 . . . . 0.88 108.558 167.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.72 114.21 28.23 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 103.615 -2.735 . . . . 1.42 103.615 168.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.8 mp -111.37 132.5 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 106.392 -1.707 . . . . 0.97 106.392 173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -101.23 98.76 9.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.44 -1.689 . . . . 3.19 106.44 169.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -140.53 155.27 46.68 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.816 0.846 . . . . 2.31 112.006 -174.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.73 111.01 19.62 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 108.429 -0.952 . . . . 3.09 108.429 166.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.97 -21.8 36.66 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.944 2.429 . . . . 1.31 112.72 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -46.61 -54.62 9.11 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.132 1.373 . . . . 3.49 109.773 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pt -90.36 -71.13 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 124.92 1.288 . . . . 1.73 112.38 -166.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.401 HG23 ' H ' ' A' ' 54' ' ' GLY . 14.2 tt -67.01 -62.93 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.912 -0.773 . . . . 2.02 108.912 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.401 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 81.47 159.44 23.5 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-N 115.701 -0.681 . . . . 1.04 112.205 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -54.83 -40.16 86.44 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 124.08 3.187 . . . . 1.1 111.337 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptt180 -35.51 -65.04 0.26 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.582 1.953 . . . . 9.77 113.516 175.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -60.47 -54.01 50.61 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.024 0.93 . . . . 3.03 108.546 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 88.7 mt -49.33 -57.62 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.282 0.633 . . . . 1.23 109.542 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.5 mt -54.81 -52.87 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.76 -0.587 . . . . 1.51 110.835 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 18.3 m170 -58.72 -45.01 90.54 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.095 0.95 . . . . 2.86 110.55 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 54.2 m -69.31 -50.59 45.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.956 -0.757 . . . . 1.03 108.956 -174.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.61 -33.7 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-O 118.798 -0.62 . . . . 1.98 110.919 -177.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -53.01 -58.12 8.07 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.886 -0.783 . . . . 4.09 108.886 165.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.4 t -58.84 -27.5 65.18 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.247 0.832 . . . . 1.33 113.247 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 25.0 mt -69.35 -10.1 56.41 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.511 1.05 . . . . 1.76 112.808 174.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.45 50.43 2.19 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 124.466 1.031 . . . . 0.9 111.256 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.495 ' CD2' HD11 ' A' ' 22' ' ' ILE . 69.3 m-85 -142.07 171.71 13.68 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 124.739 1.216 . . . . 2.12 107.877 172.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -110.74 84.55 4.23 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.68 -0.676 . . . . 4.48 110.992 -175.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.3 128.08 15.91 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.047 2.498 . . . . 1.9 112.52 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.2 p -138.54 129.63 26.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.627 1.571 . . . . 1.99 107.736 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -64.97 141.81 58.65 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.245 -0.65 . . . . 3.36 109.245 177.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.4 t -140.65 -47.33 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 C-N-CA 122.385 0.274 . . . . 3.47 111.191 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp 59.13 -131.71 1.06 Allowed 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 107.062 -1.458 . . . . 6.16 107.062 -163.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.8 mp -131.57 -71.23 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 121.432 1.924 . . . . 8.31 107.206 171.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 . . . . . 0 C--O 1.25 1.13 0 N-CA-C 102.044 -3.317 . . . . 10.2 102.044 138.583 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.7 ttm . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 108.963 -0.754 . . . . 11.35 108.963 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.85 -152.43 5.84 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 107.135 -2.386 . . . . 3.57 107.135 168.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -161.49 169.09 22.48 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.082 -2.192 . . . . 4.47 105.082 169.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.34 80.42 0.15 Allowed Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 106.328 -2.709 . . . . 2.77 106.328 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.1 t -67.14 73.44 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 124.966 1.306 . . . . 2.04 108.956 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.5 tp -87.82 111.97 21.96 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.73 -1.211 . . . . 2.08 107.73 -170.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -85.21 123.48 30.76 Favored 'General case' 0 N--CA 1.447 -0.609 0 O-C-N 123.622 0.576 . . . . 2.42 109.612 169.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.21 124.91 44.07 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.584 -2.006 . . . . 1.76 105.584 167.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -82.93 111.32 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 105.698 -1.964 . . . . 1.42 105.698 171.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.472 HG23 ' SD ' ' A' ' 13' ' ' MET . 2.5 m -96.9 77.38 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 125.062 1.345 . . . . 1.53 109.079 -163.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -67.14 107.21 2.24 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.284 1.034 . . . . 6.78 108.892 -166.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.1 -40.76 0.27 Allowed Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.151 -0.805 . . . . 1.59 113.543 -175.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.472 ' SD ' HG23 ' A' ' 10' ' ' VAL . 2.2 mpp? -62.77 162.88 10.17 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 119.182 1.491 . . . . 2.19 111.169 -178.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.9 t -163.98 -56.86 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.245 -1.02 . . . . 3.07 108.245 -175.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 73.5 m -81.82 172.74 12.99 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.389 0.676 . . . . 3.99 109.818 176.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.88 -172.27 0.17 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.059 -0.519 . . . . 3.14 109.76 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.8 m 71.55 -61.89 0.47 Allowed 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 124.68 1.192 . . . . 1.73 110.286 -177.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.2 m -34.62 -51.74 0.49 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.903 1.681 . . . . 0.85 112.081 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.0 t -48.42 -59.66 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.817 0.847 . . . . 0.88 111.197 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -32.03 73.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.718 -0.613 . . . . 1.49 109.41 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -60.46 -45.75 92.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.553 -0.906 . . . . 3.71 108.553 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.63 ' HB ' HG11 ' A' ' 37' ' ' VAL . 96.6 mt -65.95 -62.16 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.817 -1.549 . . . . 0.55 106.817 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -47.59 -62.09 1.61 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 122.375 1.083 . . . . 3.96 110.812 -175.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.6 m -63.8 -44.43 93.34 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.835 -1.075 . . . . 2.36 109.34 -168.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.7 t -59.31 -51.63 69.12 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.234 -0.654 . . . . 1.06 109.234 175.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -59.99 -36.61 77.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.043 -1.036 . . . . 2.4 112.277 -175.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 78.1 p -55.51 -19.56 10.14 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.509 1.05 . . . . 1.98 113.755 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -61.16 -30.94 70.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.573 1.079 . . . . 3.7 111.491 175.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -77.9 63.33 2.9 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 124.495 1.118 . . . . 2.04 110.932 -164.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -28.45 -25.85 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 120.261 3.43 . . . . 6.95 120.261 -164.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -68.09 -16.3 68.51 Favored Glycine 0 CA--C 1.538 1.482 0 CA-C-N 120.64 1.563 . . . . 1.22 111.823 169.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.04 125.87 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 127.435 2.294 . . . . 1.84 108.467 171.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.4 mt -91.45 -48.06 7.09 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.699 1.199 . . . . 2.87 109.274 174.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -154.04 138.45 16.74 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 118.495 -0.764 . . . . 2.1 110.137 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.95 164.56 15.9 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 119.444 1.02 . . . . 2.23 108.664 167.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.0 m -157.44 112.86 2.8 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.432 -1.321 . . . . 1.77 107.432 162.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.63 HG11 ' HB ' ' A' ' 22' ' ' ILE . 7.9 p -102.61 154.09 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 O-C-N 123.518 0.511 . . . . 1.96 110.697 166.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.81 137.3 19.93 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 124.008 0.923 . . . . 1.08 110.629 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -74.72 -41.92 59.29 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 122.943 0.497 . . . . 1.42 111.762 -172.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.54 -34.7 74.51 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 122.744 0.418 . . . . 1.39 110.99 -173.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 t -100.86 -7.28 23.7 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.063 0.945 . . . . 2.44 110.791 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 53.19 22.9 2.83 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.282 1.833 . . . . 3.31 112.475 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -94.04 133.97 36.94 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.09 -1.448 . . . . 1.59 107.09 -172.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.17 112.99 23.36 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.777 -1.564 . . . . 0.61 106.777 160.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.29 138.46 36.35 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.322 -1.362 . . . . 0.99 107.322 165.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.62 131.14 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 109.132 -0.692 . . . . 0.92 109.132 170.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -103.81 88.51 3.07 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 127.365 2.266 . . . . 3.27 108.061 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -115.79 162.25 17.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.486 1.514 . . . . 2.33 110.282 171.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.04 106.89 4.49 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.187 0.595 . . . . 3.18 109.575 171.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -64.97 -22.53 62.57 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.046 1.831 . . . . 1.47 111.981 175.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -41.1 -44.49 2.49 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.376 1.87 . . . . 5.6 111.6 170.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.6 pt -113.94 -62.85 2.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 113.34 0.867 . . . . 1.15 113.34 -165.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 tt -88.73 -48.03 14.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.482 0.658 . . . . 1.72 110.4 -165.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.3 159.94 35.04 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-N 115.474 -0.785 . . . . 0.74 112.676 169.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.02 -42.14 25.18 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.477 3.452 . . . . 0.79 112.263 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -53.0 -51.23 62.3 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 123.41 0.684 . . . . 5.63 111.48 -172.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -47.97 -57.22 6.03 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.722 0.773 . . . . 2.79 110.435 178.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.4 mt -61.67 -48.62 87.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 124.821 1.248 . . . . 0.99 111.043 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.2 mt -52.85 -58.56 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.541 -0.541 . . . . 1.36 109.541 174.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -61.55 -31.74 71.78 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.077 0.551 . . . . 2.71 111.966 -176.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.2 m -58.99 -53.14 61.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.457 -0.777 . . . . 0.81 109.518 173.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.6 mt -73.38 -36.02 47.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 O-C-N 121.617 -0.677 . . . . 1.93 110.647 -173.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -48.39 -50.4 30.91 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.337 1.055 . . . . 3.31 108.924 166.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.4 t -66.27 -42.55 88.28 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.336 0.654 . . . . 1.03 112.001 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -59.37 -40.5 86.68 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 118.606 0.639 . . . . 1.79 109.897 176.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.46 46.96 0.47 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.346 -0.702 . . . . 0.86 111.346 164.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -140.91 141.31 34.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.805 -1.924 . . . . 2.53 105.805 168.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -94.27 106.23 21.97 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 118.186 -0.911 . . . . 5.59 112.25 -158.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -71.75 80.68 1.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.277 2.651 . . . . 1.45 110.838 -174.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.1 m -67.15 111.42 3.9 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.859 -1.163 . . . . 2.08 107.859 168.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 mt -60.42 139.52 57.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.921 -1.14 . . . . 3.47 107.921 166.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 50.5 t -114.5 -94.13 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 O-C-N 123.974 0.796 . . . . 3.19 109.069 -175.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt 71.0 -54.43 0.66 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.163 0.985 . . . . 7.41 109.695 -164.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -133.37 164.29 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.345 1.458 . . . . 6.38 107.413 159.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 . . . . . 0 C--O 1.249 1.075 0 N-CA-C 104.34 -2.467 . . . . 10.81 104.34 163.497 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtt . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 109.266 -0.642 . . . . 10.58 109.266 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.28 -163.9 54.87 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.209 -0.756 . . . . 3.45 111.209 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -25.02 88.0 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 129.239 3.015 . . . . 4.63 114.885 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.9 126.74 8.32 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 108.601 -1.799 . . . . 1.98 108.601 172.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.4 t -91.87 78.22 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 106.396 -1.705 . . . . 2.55 106.396 168.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.1 tt -84.33 115.21 22.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.672 -0.862 . . . . 2.42 108.672 -172.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -90.18 133.37 34.94 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.292 0.496 . . . . 2.69 111.227 172.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 pp -129.07 130.57 46.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.109 -1.441 . . . . 1.81 107.109 166.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.15 134.48 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.426 -2.065 . . . . 1.4 105.426 170.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.24 82.04 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.668 -1.604 . . . . 1.78 106.668 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -72.37 146.36 47.11 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.002 -1.481 . . . . 6.35 107.002 175.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.14 -36.44 4.4 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.87 -0.892 . . . . 1.1 110.87 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 11.6 ttp -57.72 133.34 55.27 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.286 -1.005 . . . . 2.33 108.286 167.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -153.48 -57.62 0.12 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.536 1.134 . . . . 2.87 110.264 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.2 t -67.46 140.13 57.08 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.314 -0.866 . . . . 3.56 110.342 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -39.69 -50.3 2.3 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.215 1.006 . . . . 1.84 112.155 175.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.8 m -43.72 -43.45 5.99 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.448 1.099 . . . . 1.6 111.768 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.2 m -46.48 -41.6 14.25 Favored 'General case' 0 C--N 1.338 0.104 0 C-N-CA 124.566 1.147 . . . . 0.75 111.116 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.5 t -54.16 -62.31 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.157 -0.683 . . . . 0.9 109.157 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -30.31 68.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.507 -0.746 . . . . 1.46 110.061 -176.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.61 -51.41 67.23 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 107.435 -1.32 . . . . 3.06 107.435 177.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -68.84 -54.18 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 124.712 1.205 . . . . 0.73 108.584 -176.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -50.79 -61.11 2.41 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 108.724 -0.843 . . . . 4.58 108.724 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m -60.17 -47.96 83.76 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.808 0.813 . . . . 1.46 109.715 -171.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.4 t -66.96 -22.51 65.92 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 118.415 -0.802 . . . . 1.46 112.087 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.8 mt -82.3 -63.32 1.4 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 118.274 -0.87 . . . . 2.35 111.107 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.2 p -54.11 -28.37 39.15 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.286 0.948 . . . . 2.63 113.109 -169.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.62 -30.72 65.57 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.369 0.878 . . . . 3.98 113.369 173.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -70.9 72.49 0.56 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.694 -0.854 . . . . 2.21 108.694 164.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -13.23 -50.66 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 129.193 2.997 . . . . 5.82 116.713 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -43.22 -50.62 6.42 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.975 -0.903 . . . . 1.37 113.251 174.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.635 HD13 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -71.53 100.94 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.327 -1.36 . . . . 2.8 107.327 170.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.99 -34.65 32.86 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.699 0.4 . . . . 2.56 111.526 -176.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -148.17 120.35 8.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.628 1.171 . . . . 2.15 109.072 -175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 t -99.47 168.43 9.98 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.239 0.927 . . . . 2.53 108.807 170.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.3 m -145.97 66.2 1.21 Allowed 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 120.892 -1.13 . . . . 1.61 108.846 160.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.7 p -58.06 138.47 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 115.312 -0.858 . . . . 2.21 111.624 161.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.71 137.69 16.33 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.697 1.199 . . . . 1.37 110.31 175.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.12 -34.33 61.67 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 123.479 0.712 . . . . 1.8 111.365 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.58 -31.35 71.4 Favored 'General case' 0 C--O 1.226 -0.155 0 O-C-N 121.838 -0.539 . . . . 2.3 110.77 -173.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -111.69 5.73 19.41 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.512 1.125 . . . . 2.63 110.998 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.23 44.29 6.44 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 127.889 2.475 . . . . 3.51 112.068 176.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -142.06 169.6 17.29 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 122.23 -0.294 . . . . 2.18 110.808 -175.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.4 132.45 39.4 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 124.416 1.073 . . . . 1.38 108.988 160.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.43 135.46 34.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.538 -1.282 . . . . 1.22 107.538 158.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.635 HG23 HD13 ' A' ' 32' ' ' ILE . 1.7 mp -112.68 120.6 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 105.516 -2.031 . . . . 1.43 105.516 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -90.83 99.9 12.85 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.513 -0.921 . . . . 3.28 108.513 166.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.8 159.26 42.49 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 123.202 0.601 . . . . 1.88 112.284 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -81.98 120.14 76.76 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 106.08 -1.822 . . . . 3.51 106.08 162.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -63.56 -40.43 30.49 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.525 1.484 . . . . 1.29 111.381 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -85.63 30.96 0.61 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.693 1.197 . . . . 3.72 112.067 -160.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.3 pt -134.98 -50.23 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 124.762 1.225 . . . . 1.21 109.96 172.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.4 tt -96.79 -41.68 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.921 1.288 . . . . 1.17 111.494 -174.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.68 148.26 5.56 Favored Glycine 0 CA--C 1.535 1.29 0 N-CA-C 111.33 -0.708 . . . . 0.83 111.33 -175.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.11 -36.46 58.4 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.208 2.606 . . . . 0.73 111.554 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -50.65 -50.38 54.64 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.829 0.852 . . . . 6.2 112.256 -177.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -52.28 -56.06 17.25 Favored 'General case' 0 C--N 1.339 0.114 0 CA-C-O 121.765 0.793 . . . . 2.62 109.537 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.0 mt -57.41 -53.54 42.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.463 1.105 . . . . 1.01 111.56 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 66.7 mt -57.53 -54.29 33.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 122.02 -0.425 . . . . 1.4 109.98 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -64.93 -33.04 75.07 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.535 -0.728 . . . . 3.13 111.769 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.3 m -56.81 -52.04 66.59 Favored 'General case' 0 C--O 1.223 -0.336 0 O-C-N 121.565 -0.71 . . . . 0.68 109.091 171.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.7 mt -64.32 -42.08 94.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 119.608 1.094 . . . . 2.37 111.079 -178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -49.56 -51.73 34.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.159 0.984 . . . . 3.4 109.039 174.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.2 t -64.51 -43.86 92.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.609 0.764 . . . . 1.0 111.387 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.7 tp -59.19 -34.6 72.33 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.891 1.676 . . . . 2.43 111.262 -175.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 132.36 39.46 0.23 Allowed Glycine 0 C--N 1.333 0.416 0 O-C-N 124.685 1.241 . . . . 0.75 111.857 152.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -142.74 174.62 10.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.78 -0.822 . . . . 1.85 108.78 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -108.93 92.07 10.1 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.955 1.302 . . . . 3.96 109.848 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.99 65.85 7.74 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.685 2.924 . . . . 1.78 111.124 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.7 m -74.98 119.9 19.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.575 0.702 . . . . 2.14 110.256 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -70.23 130.24 41.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.177 -0.675 . . . . 4.32 109.177 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.77 -42.21 40.35 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.115 0 C-N-CA 122.931 0.492 . . . . 3.66 109.901 176.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -56.14 -66.65 0.39 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.726 0.81 . . . . 6.29 110.464 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.1 mt 65.69 -71.76 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.581 1.153 . . . . 9.61 111.502 -172.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 C--O 1.253 1.273 0 N-CA-C 106.745 -1.576 . . . . 13.99 106.745 179.416 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 105.652 -1.981 . . . . 7.97 105.652 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.26 35.91 92.7 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 109.554 -1.418 . . . . 4.57 109.554 -161.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -173.74 164.47 4.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.118 2.167 . . . . 5.5 106.798 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.87 171.42 33.8 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 109.532 -1.427 . . . . 2.53 109.532 171.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 m -138.95 154.72 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 106.835 -1.543 . . . . 2.46 106.835 161.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 tt -150.47 147.29 27.34 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.772 -1.196 . . . . 2.19 107.772 170.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -103.3 150.45 23.74 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.981 1.312 . . . . 2.74 109.431 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.95 138.15 25.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.601 -0.888 . . . . 2.49 108.601 164.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -77.79 143.29 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 107.256 -1.387 . . . . 0.97 107.256 170.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.28 103.74 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 125.529 1.532 . . . . 1.41 107.618 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.6 mtm180 -73.89 166.49 23.25 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.251 -1.018 . . . . 5.52 108.251 165.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.6 -11.34 59.51 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 123.663 0.649 . . . . 0.9 112.612 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.7 mtm -73.83 65.5 1.05 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.523 1.161 . . . . 1.69 110.423 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 t -91.18 12.72 19.18 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.352 1.061 . . . . 3.11 112.849 -166.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.4 t -165.52 173.86 10.53 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.428 -0.953 . . . . 3.03 108.428 -173.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.21 -176.01 0.06 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.398 0.545 . . . . 3.17 110.435 164.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.0 p 68.77 -54.37 0.55 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 126.804 2.042 . . . . 2.55 111.388 -171.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.4 m -24.98 -54.11 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.492 2.717 . . . . 1.24 113.105 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 76.1 t -43.18 -70.85 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.444 1.098 . . . . 0.92 110.614 172.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -26.74 64.86 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.315 -0.866 . . . . 1.17 111.069 -176.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -51.51 -41.62 61.12 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 124.158 0.983 . . . . 3.47 109.195 173.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.485 ' HB ' HG11 ' A' ' 37' ' ' VAL . 83.5 mt -80.9 -65.0 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.454 -1.313 . . . . 0.75 107.454 175.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -47.85 -56.0 8.48 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.026 1.33 . . . . 3.37 111.645 -169.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 t -62.39 -50.6 70.91 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.676 0.75 . . . . 1.39 109.22 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.6 t -60.79 -24.43 65.79 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 118.686 -0.673 . . . . 0.71 111.923 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.96 -46.57 14.92 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 117.947 -1.025 . . . . 2.06 111.494 172.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.9 p -51.58 -32.02 26.98 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.612 1.096 . . . . 1.93 112.336 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -47.44 -45.26 25.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.014 1.325 . . . . 5.09 113.475 170.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.424 ' HB3' HD12 ' A' ' 53' ' ' ILE . 17.6 m-70 -67.69 136.26 54.04 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 119.412 1.005 . . . . 2.09 108.402 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -63.66 -53.06 57.25 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.75 -0.593 . . . . 7.77 112.513 -168.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -80.05 47.07 3.28 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-N 117.881 0.309 . . . . 1.32 113.261 -169.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -123.83 112.85 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.49 -1.3 . . . . 1.82 107.49 177.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 tp -73.53 -48.73 30.88 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.882 0.873 . . . . 3.31 109.025 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -156.94 120.25 4.14 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 121.843 -0.536 . . . . 2.61 110.825 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.37 157.86 15.83 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.542 -1.281 . . . . 2.58 107.542 168.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.9 t -163.35 113.35 1.34 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.859 -0.793 . . . . 1.31 108.859 168.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.485 HG11 ' HB ' ' A' ' 22' ' ' ILE . 7.5 p -114.93 145.48 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 112.544 0.572 . . . . 2.18 112.544 175.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.57 133.1 44.66 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.869 0.868 . . . . 0.77 110.3 174.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.61 -43.83 65.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.067 -0.97 . . . . 1.44 110.555 -174.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.93 -50.81 71.44 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.316 0.579 . . . . 1.18 110.547 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -65.54 -14.09 60.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.745 0.818 . . . . 1.92 110.967 177.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 55.02 30.36 14.06 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.264 1.426 . . . . 2.78 109.15 -171.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -132.45 131.12 41.4 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.319 0.509 . . . . 1.6 111.365 -164.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.52 132.63 44.72 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.996 -1.112 . . . . 0.69 107.996 160.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.21 144.88 32.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.535 -1.283 . . . . 1.03 107.535 156.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 32' ' ' ILE . 55.5 mt -135.72 126.31 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 107.929 -1.137 . . . . 1.75 107.929 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -93.86 72.96 4.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.366 1.466 . . . . 2.18 108.418 172.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -101.58 170.74 7.99 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.702 0.801 . . . . 2.23 113.147 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -95.33 97.48 2.76 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.365 1.466 . . . . 3.97 108.861 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.86 -33.04 85.45 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.931 2.421 . . . . 1.06 113.636 -166.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.1 mp0 -63.74 -30.21 71.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.244 0.617 . . . . 4.01 112.05 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.0 pt -107.09 -56.14 5.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 112.864 0.691 . . . . 1.31 112.864 -168.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.424 HD12 ' HB3' ' A' ' 29' ' ' HIS . 6.1 tt -87.07 -52.03 12.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 108.46 -0.941 . . . . 1.67 108.46 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.42 167.51 28.8 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 115.482 -0.781 . . . . 0.83 113.099 173.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.72 -38.53 70.6 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.273 3.316 . . . . 0.77 111.838 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -58.76 -60.15 4.29 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.973 0.509 . . . . 5.66 112.061 -172.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -49.85 -52.47 32.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 122.44 1.114 . . . . 2.75 110.173 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 95.0 mt -48.63 -69.72 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 114.08 -1.418 . . . . 0.73 109.894 171.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.8 mt -51.34 -40.92 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.714 0.688 . . . . 1.24 111.535 -173.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 52.8 m170 -63.15 -47.47 82.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.547 0.689 . . . . 3.55 109.456 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.2 m -66.27 -44.73 82.76 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.606 -0.516 . . . . 0.7 109.606 -177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.4 mm -57.01 -47.59 83.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.994 0.918 . . . . 1.42 110.081 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -53.09 -58.85 5.6 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.181 -0.674 . . . . 3.62 109.181 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -55.38 -38.68 69.17 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.057 0.943 . . . . 1.1 112.279 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.8 mt -63.62 -14.49 52.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.611 0.764 . . . . 1.98 112.584 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.66 48.24 1.12 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.482 1.039 . . . . 0.67 110.964 168.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -141.74 171.2 14.39 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.399 1.08 . . . . 2.05 108.809 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -109.96 79.89 1.62 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-O 118.534 -0.746 . . . . 3.89 112.923 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.76 123.73 11.41 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.141 1.894 . . . . 1.25 111.511 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.9 t -148.68 152.69 37.11 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.726 0.81 . . . . 2.71 109.235 172.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.9 mt -86.41 40.36 0.88 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 121.346 -0.846 . . . . 3.28 111.601 -165.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.4 t -80.44 68.35 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.408 -0.96 . . . . 4.87 108.408 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -55.77 -37.91 69.17 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.718 0.807 . . . . 5.89 111.778 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 pp -136.31 162.05 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.301 -1.74 . . . . 6.42 106.301 170.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 C--O 1.249 1.073 0 N-CA-C 103.557 -2.757 . . . . 12.7 103.557 176.835 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 tpt . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 108.722 -0.844 . . . . 8.44 108.722 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.91 -46.91 58.05 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 108.268 -1.933 . . . . 4.08 108.268 162.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -67.11 165.8 15.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.82 0.848 . . . . 3.98 109.752 166.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.24 -163.32 15.67 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 106.912 -2.475 . . . . 1.93 106.912 170.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m -136.12 149.44 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.802 -1.184 . . . . 2.77 107.802 163.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.63 89.8 3.19 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.43 -2.433 . . . . 2.54 104.43 166.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -70.06 145.94 51.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.506 -0.553 . . . . 2.24 109.506 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 69' ' ' PRO . 0.3 OUTLIER -149.78 139.31 21.56 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.807 -0.812 . . . . 2.17 108.807 178.16 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.7 t -94.44 129.64 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 107.645 -1.243 . . . . 1.1 107.645 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.406 HG23 ' SD ' ' A' ' 13' ' ' MET . 1.6 m -132.26 74.7 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 C-N-CA 125.215 1.406 . . . . 1.86 109.953 -160.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -66.83 153.3 43.75 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.777 -0.823 . . . . 5.04 108.777 175.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.14 -29.56 7.61 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 109.632 -1.387 . . . . 0.98 109.632 -163.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.406 ' SD ' HG23 ' A' ' 10' ' ' VAL . 56.4 mtp -56.26 144.66 29.31 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.831 -0.805 . . . . 1.97 109.375 166.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 t -166.09 -58.92 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.005 0.522 . . . . 2.37 109.719 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.8 t -77.2 147.23 36.54 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.977 -0.749 . . . . 3.49 108.977 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.29 -43.34 10.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.409 0.684 . . . . 1.89 111.796 174.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.7 p -48.34 -41.27 28.01 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.374 0.67 . . . . 2.08 111.561 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 99.3 m -50.24 -29.04 8.65 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.774 0.83 . . . . 0.85 112.544 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t -55.85 -69.5 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.56 0.618 . . . . 0.76 109.421 169.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -27.98 67.59 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.895 -1.128 . . . . 1.75 111.436 -172.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.63 -33.64 16.01 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.924 1.29 . . . . 3.88 110.375 172.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 98.8 mt -91.07 -60.2 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.123 -1.436 . . . . 0.59 107.123 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -54.44 -64.17 0.92 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.618 1.167 . . . . 3.26 111.267 -170.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.6 m -59.55 -35.27 73.9 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.303 0.641 . . . . 2.35 111.504 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -62.62 -40.49 97.12 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.305 -0.247 . . . . 0.76 110.383 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.4 mt -72.02 -62.33 1.47 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 119.306 -0.378 . . . . 2.11 111.092 176.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.2 p -66.91 69.83 0.08 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.495 1.918 . . . . 2.33 111.03 -168.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.64 -40.84 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.071 2.148 . . . . 3.85 110.561 -172.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -74.26 150.73 40.1 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.119 0.872 . . . . 3.87 110.371 -177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -54.14 148.8 10.47 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.045 0.45 . . . . 6.62 110.215 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.22 -31.51 5.37 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 119.491 -0.616 . . . . 1.16 112.473 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.411 HD11 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -70.19 148.58 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 118.005 0.903 . . . . 1.96 108.679 171.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 36.0 mt -114.5 -51.29 2.76 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.821 1.249 . . . . 3.15 109.604 167.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -150.35 161.36 42.62 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.895 0.878 . . . . 2.32 109.881 -175.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.8 m -143.29 168.35 19.99 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.16 -1.052 . . . . 2.02 108.16 170.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.0 m -148.01 132.21 17.39 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.487 -1.301 . . . . 1.54 107.487 148.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.0 p -104.57 142.25 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 118.433 0.561 . . . . 2.15 110.048 164.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.62 132.26 48.14 Favored 'General case' 0 C--N 1.339 0.15 0 O-C-N 121.864 -0.522 . . . . 0.93 111.407 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.39 -58.96 6.28 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.236 1.014 . . . . 2.67 110.501 -177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.28 -39.41 69.81 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.59 0.756 . . . . 1.25 112.664 -169.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.6 m -95.63 -8.39 34.99 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.338 0.655 . . . . 2.3 110.499 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 54.65 23.16 4.5 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.562 1.945 . . . . 3.34 112.577 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -98.96 145.12 27.37 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 119.035 -0.507 . . . . 1.67 110.494 -178.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.16 138.69 40.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.121 -1.437 . . . . 0.57 107.121 154.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -107.82 150.82 26.54 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 106.632 -1.618 . . . . 1.24 106.632 154.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.411 HG23 HD11 ' A' ' 32' ' ' ILE . 4.6 mp -126.29 122.04 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.172 -1.788 . . . . 1.05 106.172 173.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -94.36 82.43 4.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.356 1.863 . . . . 3.68 106.591 169.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -118.76 164.32 15.56 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 126.967 2.107 . . . . 2.0 109.775 176.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -86.89 117.76 69.11 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 107.856 -1.164 . . . . 3.26 107.856 167.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.2 -29.73 38.78 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.162 1.908 . . . . 1.31 112.918 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -86.66 29.23 0.8 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.664 1.12 . . . . 3.55 111.285 -166.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.7 pt -144.47 -50.48 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.096 0 C-N-CA 123.95 0.9 . . . . 1.28 112.236 176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.619 HG23 ' H ' ' A' ' 54' ' ' GLY 0.254 17.6 tt -95.56 -85.26 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 108.572 -0.899 . . . . 1.31 108.572 174.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.619 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 131.28 166.52 11.71 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.811 0.719 . . . . 0.75 112.955 173.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.59 -47.43 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.356 3.37 . . . . 0.74 111.305 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.455 ' HE ' ' CG ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -46.43 -48.25 18.88 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.118 0.967 . . . . 8.61 111.392 176.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.455 ' CG ' ' HE ' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -53.48 -56.91 13.0 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.876 1.271 . . . . 4.62 108.884 179.49 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.7 mt -57.56 -56.07 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.845 0.858 . . . . 0.85 109.965 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.6 mt -50.56 -51.54 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.426 -0.583 . . . . 1.4 109.426 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.49 -36.65 84.47 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.48 0.712 . . . . 4.42 111.056 -178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.9 m -64.58 -53.66 44.26 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.34 -0.85 . . . . 0.74 109.35 176.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.403 HG21 HG11 ' A' ' 10' ' ' VAL . 13.1 mm -68.78 -33.14 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 121.335 -0.853 . . . . 1.59 111.158 -173.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -49.63 -62.07 1.76 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.12 0.968 . . . . 3.33 109.162 162.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -54.88 -38.7 67.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.763 0.825 . . . . 1.03 112.865 -177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.24 -14.71 27.92 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.954 -1.091 . . . . 2.22 112.88 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.02 47.01 2.31 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.317 0.961 . . . . 0.59 111.051 175.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -136.02 172.05 13.58 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.194 0.997 . . . . 2.07 108.387 171.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -111.89 84.8 5.8 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 113.098 0.777 . . . . 4.27 113.098 -174.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.411 ' HB2' HD12 ' A' ' 8' ' ' LEU . 34.2 Cg_endo -68.03 80.42 0.52 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.633 2.889 . . . . 1.05 114.013 -175.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.9 p -77.13 119.68 21.16 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.553 -0.749 . . . . 2.54 109.654 169.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tt -65.24 103.25 0.75 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.687 -0.857 . . . . 2.86 108.687 178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.1 p -77.59 -44.56 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 122.192 -0.318 . . . . 3.65 111.558 -168.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HZ2' ' C ' ' A' ' 75' ' ' GLU . 54.3 tttm 68.99 -55.2 0.55 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.02 1.728 . . . . 6.5 112.374 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.287 0.4 OUTLIER 47.92 44.34 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 126.815 2.046 . . . . 7.21 111.77 179.333 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.423 ' C ' ' HZ2' ' A' ' 73' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.256 1.431 0 N-CA-C 102.515 -3.143 . . . . 11.02 102.515 -172.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mmt . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 107.877 -1.157 . . . . 9.3 107.877 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.42 161.43 2.79 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 109.584 -1.406 . . . . 3.93 109.584 -136.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.5 t0 58.48 158.96 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.958 2.503 . . . . 3.95 114.529 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.73 179.86 30.28 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.287 0.946 . . . . 2.12 113.15 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.04 166.5 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.691 -1.225 . . . . 2.08 107.691 168.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.32 111.68 4.96 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.818 -1.549 . . . . 2.14 106.818 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -92.29 141.38 28.62 Favored 'General case' 0 C--N 1.338 0.106 0 C-N-CA 123.28 0.632 . . . . 2.81 110.047 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.9 137.0 23.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.209 -0.663 . . . . 1.62 109.209 176.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.02 121.89 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 105.751 -1.944 . . . . 1.08 105.751 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 m -116.02 100.57 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.722 -1.214 . . . . 1.52 107.722 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -73.45 166.2 23.66 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.233 -1.025 . . . . 5.72 108.233 175.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.78 -10.76 57.5 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.511 -0.605 . . . . 1.02 112.618 176.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 75.8 mtm -68.05 73.02 0.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.555 1.177 . . . . 1.81 111.686 174.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -71.71 -30.12 65.31 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.533 1.133 . . . . 2.58 112.604 -171.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 82.5 m -143.46 158.92 43.26 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.225 -0.657 . . . . 3.53 109.225 -176.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.23 -45.15 8.34 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.97 1.308 . . . . 1.81 112.205 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 m -43.35 -42.46 4.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.431 1.092 . . . . 1.6 112.163 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.2 m -54.66 -40.05 68.65 Favored 'General case' 0 C--N 1.334 -0.101 0 O-C-N 121.683 -0.635 . . . . 0.72 111.608 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 t -58.34 -57.9 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.436 -0.95 . . . . 0.68 108.436 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -31.07 72.13 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.48 -0.563 . . . . 1.04 109.48 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -60.16 -51.31 70.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.946 -1.131 . . . . 3.78 107.946 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.7 mt -62.86 -54.83 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.855 -1.165 . . . . 0.73 107.855 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -51.99 -56.83 11.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 123.714 0.634 . . . . 3.09 109.53 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.7 t -59.8 -46.25 89.8 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.244 0.618 . . . . 1.52 110.079 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.3 t -65.13 -29.61 70.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.363 0.665 . . . . 0.75 111.422 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mt -79.87 -45.49 18.55 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.535 -0.745 . . . . 2.38 111.098 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.426 HG23 ' SG ' ' A' ' 35' ' ' CYS . 47.0 p -65.42 75.84 0.06 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.751 0.82 . . . . 1.98 110.747 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.94 -32.66 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 129.197 2.999 . . . . 3.45 110.301 -175.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -59.68 -23.45 63.11 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.914 0.779 . . . . 2.21 111.527 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 78.57 -42.26 0.32 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.424 1.49 . . . . 7.55 113.383 162.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.15 -20.5 58.29 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 111.735 -0.546 . . . . 1.21 111.735 168.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.72 130.86 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 123.584 0.753 . . . . 3.11 110.746 176.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.9 mt -74.66 -42.26 58.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.217 1.007 . . . . 2.87 108.748 169.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -161.58 165.28 28.66 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.952 -0.388 . . . . 2.86 109.952 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.426 ' SG ' HG23 ' A' ' 27' ' ' THR . 1.7 p -141.25 59.29 1.52 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 126.481 1.912 . . . . 3.11 110.894 -176.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.32 95.72 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.827 -0.546 . . . . 1.31 111.682 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -103.32 149.11 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 126.265 1.826 . . . . 2.11 112.83 173.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.98 131.08 10.23 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 125.06 1.344 . . . . 1.02 112.086 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -65.89 -53.05 44.53 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 115.285 -0.87 . . . . 1.76 111.45 -170.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.0 -45.63 88.14 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 121.563 0.697 . . . . 1.67 109.435 -168.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.4 t -80.6 1.64 28.95 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.86 -0.59 . . . . 2.59 111.3 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 57.24 31.44 20.08 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 124.451 1.1 . . . . 2.64 109.828 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -107.1 138.79 42.61 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.453 -0.943 . . . . 1.75 108.453 -167.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.12 141.23 48.52 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.868 -1.901 . . . . 0.92 105.868 141.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -117.84 158.38 24.92 Favored 'General case' 0 CA--C 1.496 -1.116 0 C-N-CA 118.211 -1.395 . . . . 1.61 108.04 149.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 mp -119.46 128.93 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 106.32 -1.733 . . . . 0.94 106.32 168.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -95.34 132.32 40.49 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.396 -2.076 . . . . 2.51 105.396 163.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -165.07 167.77 17.97 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.044 0.838 . . . . 2.44 111.514 -168.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -87.71 119.09 70.49 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 107.015 -1.476 . . . . 3.49 107.015 156.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.15 -39.31 18.67 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.043 1.829 . . . . 1.34 111.065 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -89.14 39.17 0.92 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.206 1.002 . . . . 3.94 110.528 -160.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.7 pt -142.24 -49.9 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 126.052 1.741 . . . . 1.14 109.898 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 tt -95.68 -43.13 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.676 1.19 . . . . 1.3 111.373 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.36 150.64 4.93 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 123.911 0.767 . . . . 0.82 111.493 -174.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -64.66 -29.35 60.37 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.109 2.539 . . . . 0.87 111.775 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -55.92 -52.49 63.94 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.44 0.696 . . . . 5.95 111.458 -176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -50.28 -54.8 18.72 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 122.226 1.012 . . . . 2.52 109.869 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mt -54.26 -61.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 124.843 1.257 . . . . 0.72 110.144 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.5 mt -53.59 -47.43 60.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 118.42 0.555 . . . . 1.38 110.791 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -62.65 -42.89 99.86 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.298 0.639 . . . . 2.55 109.72 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.9 m -60.83 -54.0 50.46 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.209 -0.663 . . . . 0.61 109.209 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.2 mm -62.74 -37.58 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 119.215 -0.422 . . . . 1.67 111.037 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -52.99 -64.92 0.66 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.206 -0.664 . . . . 3.61 109.206 169.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.6 t -59.86 -24.79 64.51 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.438 0.695 . . . . 1.2 112.791 -176.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.1 tp -72.72 -5.15 35.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.078 1.351 . . . . 2.3 111.548 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.68 47.59 1.62 Allowed Glycine 0 C--N 1.337 0.628 0 C-N-CA 125.229 1.395 . . . . 0.76 110.825 168.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -144.16 172.34 13.04 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 123.949 0.9 . . . . 1.76 109.53 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -114.94 77.92 5.13 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.664 -0.684 . . . . 4.3 111.311 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.36 93.66 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.598 2.198 . . . . 1.06 112.41 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.3 t -97.04 139.65 32.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.895 0.855 . . . . 2.17 109.896 171.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.9 104.36 16.17 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.562 -1.273 . . . . 3.63 107.562 174.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -66.54 -43.5 90.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 111.802 0.297 . . . . 3.84 111.802 -174.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -170.37 153.84 4.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.129 -1.804 . . . . 6.93 106.129 -172.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.2 pt -101.35 -53.13 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 118.286 -0.864 . . . . 9.53 110.789 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 C--O 1.248 0.99 0 CA-C-N 119.287 0.949 . . . . 11.77 109.102 171.53 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.6 mtp . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 106.686 -1.598 . . . . 8.61 106.686 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.12 32.09 0.09 OUTLIER Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.793 1.663 . . . . 3.78 109.267 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -127.25 153.42 46.15 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 128.026 2.53 . . . . 5.23 108.455 -156.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.3 -170.43 33.84 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.561 -1.016 . . . . 2.08 110.561 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -130.76 156.45 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 123.584 0.754 . . . . 2.01 108.989 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.1 tp -133.65 141.74 47.75 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.507 -2.035 . . . . 2.8 105.507 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -129.83 139.47 51.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.278 -1.378 . . . . 2.48 107.278 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.404 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -143.84 148.5 35.59 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.073 -1.084 . . . . 3.12 108.073 176.169 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.39 133.25 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 106.893 -1.521 . . . . 0.99 106.893 175.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.09 87.97 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.75 0.82 . . . . 1.57 109.224 -168.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 77.0 mmt-85 -62.77 150.87 40.28 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.544 -0.909 . . . . 5.14 108.544 171.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.26 -4.5 48.26 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.862 -0.966 . . . . 0.98 113.954 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.8 mtp -75.1 49.61 0.45 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.871 1.835 . . . . 1.95 112.249 -176.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 t -82.79 37.22 0.52 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.695 -1.253 . . . . 3.02 113.407 -164.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.3 t -173.41 142.4 0.98 Allowed 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.615 0.766 . . . . 3.1 108.959 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.38 -50.26 3.81 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.468 1.107 . . . . 2.01 112.456 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 m -46.36 -34.34 4.52 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.93 1.292 . . . . 1.54 112.866 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.0 m -48.23 -34.98 11.09 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 123.571 0.748 . . . . 1.02 111.029 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.439 ' HA ' ' CG2' ' A' ' 37' ' ' VAL . 93.9 t -49.07 -72.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 118.18 0.446 . . . . 0.88 110.115 173.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -27.9 68.47 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.693 -0.629 . . . . 1.29 111.178 -175.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -49.56 -42.84 45.3 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.213 0.605 . . . . 3.43 110.088 173.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.3 mt -83.06 -61.71 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.099 -1.075 . . . . 0.75 108.099 175.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -51.88 -61.31 2.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.39 1.476 . . . . 3.35 111.231 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 t -62.05 -45.49 93.33 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.855 0.862 . . . . 1.45 109.181 -173.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -59.95 -37.16 78.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.777 -0.647 . . . . 0.9 111.302 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.7 mt -75.34 -37.41 60.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.235 -0.888 . . . . 2.34 112.521 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.5 p -64.35 77.6 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.749 0.704 . . . . 1.68 111.218 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HZ1' ' CD2' ' A' ' 29' ' ' HIS . 0.9 OUTLIER 168.32 -31.35 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.762 2.825 . . . . 3.3 111.152 -174.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.403 ' CD2' ' HZ1' ' A' ' 28' ' ' LYS . 24.7 m-70 -52.72 120.75 6.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.881 0.764 . . . . 1.96 110.108 177.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -70.97 80.26 0.65 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.836 0.855 . . . . 4.93 111.307 -166.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.86 -16.87 1.07 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.933 1.254 . . . . 1.2 110.743 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.496 HD11 ' SG ' ' A' ' 35' ' ' CYS . 0.3 OUTLIER -60.5 148.95 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 107.659 -1.238 . . . . 1.82 107.659 163.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 pp -122.11 -29.94 4.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.841 0.856 . . . . 2.66 112.346 167.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -159.64 154.7 24.94 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 119.547 1.067 . . . . 2.25 109.143 174.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.496 ' SG ' HD11 ' A' ' 32' ' ' ILE . 1.3 m -132.94 157.91 43.96 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.314 -0.995 . . . . 1.9 108.314 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.6 t -159.67 128.58 5.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.477 -0.934 . . . . 1.68 108.477 159.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 19' ' ' VAL . 1.1 m -121.12 159.93 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 123.203 0.601 . . . . 1.65 110.249 177.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.22 134.32 17.03 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.83 110.458 174.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.92 -33.92 68.67 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.152 -0.931 . . . . 1.38 110.462 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.55 -43.98 80.44 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.547 0.739 . . . . 1.1 111.659 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.6 m -96.56 2.38 52.28 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.72 0.808 . . . . 2.14 109.974 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 46.67 44.71 14.01 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.453 2.301 . . . . 2.88 112.113 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -133.66 157.79 44.88 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 112.01 0.374 . . . . 1.73 112.01 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.66 135.94 53.37 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.422 -1.325 . . . . 0.69 107.422 162.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.59 149.77 27.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 123.832 0.707 . . . . 1.1 109.783 159.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.65 139.31 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 C-N-CA 127.481 2.312 . . . . 0.92 106.172 175.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' O ' HD13 ' A' ' 32' ' ' ILE . 76.4 mttt -113.45 135.14 54.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.62 -1.993 . . . . 2.3 105.62 161.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -170.97 175.08 4.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.228 1.011 . . . . 2.11 110.569 -164.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -98.09 96.26 3.38 Favored Pre-proline 0 N--CA 1.449 -0.505 0 C-N-CA 125.457 1.503 . . . . 3.3 108.063 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -60.35 -29.75 89.51 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.128 1.885 . . . . 1.11 112.12 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -54.79 -43.93 73.28 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.872 0.869 . . . . 3.96 111.792 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.4 pt -94.77 -86.79 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.877 0.471 . . . . 1.8 112.027 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.7 tt -59.24 -45.83 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.971 0.908 . . . . 1.39 111.381 -171.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.95 161.8 31.26 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 115.329 -0.851 . . . . 0.66 112.342 172.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.27 -35.65 23.61 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.644 2.896 . . . . 0.66 111.865 -174.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -55.23 -49.35 72.22 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.918 0.487 . . . . 5.21 111.742 -174.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -49.28 -53.75 20.3 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.742 0.782 . . . . 2.78 109.75 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.2 mt -64.55 -50.11 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 124.627 1.171 . . . . 1.04 110.555 -174.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.2 mt -55.18 -52.31 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 109.767 -0.457 . . . . 1.29 109.767 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -62.27 -36.35 81.81 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.376 -0.828 . . . . 2.36 112.22 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 66.6 m -57.21 -50.44 72.85 Favored 'General case' 0 C--O 1.225 -0.21 0 O-C-N 121.262 -0.899 . . . . 0.78 108.937 174.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.5 mt -65.73 -42.85 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.693 -0.63 . . . . 2.11 111.315 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -48.31 -46.1 35.81 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.424 1.09 . . . . 2.7 109.104 171.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.0 t -69.83 -44.07 70.68 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.741 0.817 . . . . 1.39 111.695 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.9 mt -59.38 -28.33 66.79 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 121.467 -0.77 . . . . 2.04 110.653 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.21 47.65 0.69 Allowed Glycine 0 C--O 1.228 -0.219 0 N-CA-C 110.117 -1.193 . . . . 0.8 110.117 157.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -134.62 171.55 14.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.529 -1.656 . . . . 1.87 106.529 173.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -108.93 82.01 1.69 Allowed Pre-proline 0 CA--C 1.535 0.375 0 CA-C-O 118.06 -0.971 . . . . 4.22 111.313 -170.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.74 75.55 1.61 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.515 2.81 . . . . 1.12 112.823 -174.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m -73.51 116.92 14.66 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.959 -0.756 . . . . 2.35 108.959 171.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.2 tp -76.22 75.75 3.03 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.557 -1.275 . . . . 3.35 107.557 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.7 t -73.82 -62.95 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.778 -0.823 . . . . 4.62 108.778 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt 61.74 169.85 0.11 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.589 1.156 . . . . 7.7 111.944 -175.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.7 mp -135.43 -70.98 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 105.446 -2.057 . . . . 7.31 105.446 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 C--O 1.259 1.559 0 N-CA-C 102.507 -3.145 . . . . 10.9 102.507 152.933 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 109.785 -0.45 . . . . 10.39 109.785 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.11 143.95 4.43 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 106.818 -2.513 . . . . 3.46 106.818 174.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -86.66 -124.8 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.102 -0.703 . . . . 3.62 109.102 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.89 157.56 7.27 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 107.523 -2.231 . . . . 1.87 107.523 -171.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 m -136.63 156.89 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 117.514 0.657 . . . . 2.19 109.535 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 7' ' ' GLU . 3.1 tt -152.05 136.0 16.44 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.681 -1.97 . . . . 2.72 105.681 173.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.4 ' N ' HD23 ' A' ' 6' ' ' LEU . 63.6 mt-10 -114.13 130.01 56.6 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.251 1.021 . . . . 2.56 108.452 175.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.9 131.76 56.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.11 -1.441 . . . . 1.61 107.11 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 t -73.87 103.99 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 105.233 -2.136 . . . . 1.23 105.233 167.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 p -99.57 124.47 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 109.42 -0.585 . . . . 2.61 109.42 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -82.5 104.85 13.09 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.369 -1.715 . . . . 5.45 106.369 164.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.29 -54.32 0.03 OUTLIER Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.76 -0.257 . . . . 2.47 112.93 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -76.68 73.4 3.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.863 -0.787 . . . . 2.15 110.396 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 t -56.51 -39.06 72.66 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.907 0.483 . . . . 2.8 110.222 171.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 65.2 m -143.31 -168.01 2.7 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.743 1.617 . . . . 3.81 107.202 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.39 -168.15 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.537 0.735 . . . . 2.72 111.115 170.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.8 m 69.57 -66.86 0.25 Allowed 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.74 1.216 . . . . 1.61 109.693 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.5 m -40.85 -48.89 3.16 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.887 1.275 . . . . 0.89 110.671 172.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.0 t -43.26 -67.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.931 1.292 . . . . 0.71 110.968 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -24.54 67.74 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.836 -0.62 . . . . 1.13 109.643 -177.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -65.27 -51.31 61.59 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.431 -0.951 . . . . 3.71 108.431 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.4 mt -65.12 -53.76 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 107.667 -1.235 . . . . 0.67 107.667 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -45.28 -51.71 10.55 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.455 0.702 . . . . 3.55 112.569 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 53.2 m -63.43 -52.88 59.66 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.684 -0.635 . . . . 1.55 110.167 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.0 t -54.45 -37.32 65.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.388 1.075 . . . . 1.22 111.506 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -82.07 -44.89 15.98 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.404 1.082 . . . . 1.85 110.954 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.7 p -58.24 -37.67 75.37 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.72 1.146 . . . . 1.96 110.834 176.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -51.25 -29.75 15.47 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.24 1.416 . . . . 4.8 113.057 169.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -78.8 99.45 6.7 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 120.76 -1.213 . . . . 2.15 110.3 175.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.71 107.83 0.17 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.864 -1.162 . . . . 6.72 107.864 157.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 139.75 -36.07 1.87 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.672 -1.371 . . . . 1.25 109.672 -170.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -70.68 142.49 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.697 -1.223 . . . . 2.11 107.697 168.016 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.0 tp -98.58 -47.4 5.38 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.639 1.576 . . . . 3.22 108.721 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -154.98 128.69 8.62 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.249 0.62 . . . . 3.2 109.913 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.0 t -108.05 150.44 27.16 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 108.347 -0.983 . . . . 2.12 108.347 171.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.9 t -156.55 129.52 7.88 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.148 -1.426 . . . . 1.81 107.148 162.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.0 m -122.85 144.71 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 118.89 0.768 . . . . 1.64 110.759 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.26 132.25 35.53 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.727 0.811 . . . . 0.81 111.28 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 pp -68.62 -51.71 39.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.661 1.185 . . . . 1.51 110.994 -174.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.32 -51.32 65.06 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.404 0.621 . . . . 1.17 110.178 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.04 -14.71 61.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.672 1.189 . . . . 2.03 111.738 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 55.52 33.79 21.78 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 125.198 1.399 . . . . 2.84 108.367 -172.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -126.48 140.72 52.25 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 118.801 0.728 . . . . 1.38 111.264 -162.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.32 120.25 39.0 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.127 -1.064 . . . . 0.74 108.127 161.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -95.27 132.0 40.73 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 126.684 1.994 . . . . 3.01 106.466 173.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.543 HG22 ' CD1' ' A' ' 48' ' ' TYR . 97.5 mt -130.47 130.32 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 107.799 -1.186 . . . . 1.44 107.799 173.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.486 ' O ' HD13 ' A' ' 32' ' ' ILE . 41.6 mttp -104.66 131.99 51.44 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 105.967 -1.864 . . . . 2.95 105.967 159.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.543 ' CD1' HG22 ' A' ' 46' ' ' ILE . 18.3 p90 -162.78 160.8 25.71 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.601 1.16 . . . . 2.19 109.283 -169.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -82.2 104.5 3.36 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 107.432 -1.321 . . . . 3.65 107.432 172.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -61.78 -45.02 18.43 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.447 2.098 . . . . 1.45 111.923 -166.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -53.32 -40.9 65.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.308 1.443 . . . . 4.41 112.938 -174.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.0 pt -88.56 -47.51 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 113.838 1.051 . . . . 1.48 113.838 -168.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.2 tt -83.99 -56.71 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 118.142 0.428 . . . . 1.67 111.191 -178.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.41 135.01 8.3 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.002 0.811 . . . . 1.06 112.444 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.65 -45.18 14.66 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.703 2.935 . . . . 0.9 111.059 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -53.55 -52.4 59.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.51 -0.552 . . . . 7.08 109.51 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.94 -46.39 85.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.916 1.686 . . . . 5.32 109.928 -174.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 mt -52.31 -58.86 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 122.696 0.399 . . . . 0.96 110.732 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 mt -50.49 -43.87 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 118.091 0.405 . . . . 1.55 111.184 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -63.4 -36.35 83.43 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.495 -0.753 . . . . 2.36 111.483 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.6 m -62.25 -50.33 72.16 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.282 -0.886 . . . . 0.91 109.273 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.9 mm -59.71 -45.01 94.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.881 -0.512 . . . . 1.32 111.321 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -52.11 -53.74 38.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.115 1.366 . . . . 2.71 109.528 172.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -56.56 -39.42 73.43 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.357 1.063 . . . . 1.5 112.124 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.76 -17.27 34.06 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.573 0.583 . . . . 2.38 112.573 173.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.45 29.26 11.29 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.344 0.973 . . . . 1.46 110.724 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -120.31 158.68 26.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.645 1.178 . . . . 1.91 108.684 177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -105.65 104.11 46.87 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-O 118.029 -0.986 . . . . 4.69 110.271 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -84.54 83.74 1.58 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.934 3.089 . . . . 1.06 111.552 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 m -72.54 103.67 3.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.877 -0.786 . . . . 2.51 108.877 173.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -66.3 136.49 55.9 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.237 -1.023 . . . . 3.74 108.237 174.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.6 m -113.4 -56.6 4.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 C-N-CA 123.144 0.578 . . . . 3.65 110.797 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt 64.93 173.07 0.2 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.721 0.808 . . . . 7.9 109.054 -159.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.2 mp 53.33 62.4 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.74 0.816 . . . . 5.73 109.871 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 C--O 1.254 1.311 0 C-N-CA 125.146 1.379 . . . . 10.73 112.081 171.337 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 ttt . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 118.988 -0.529 . . . . 6.98 111.294 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.24 171.87 26.07 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 123.162 0.41 . . . . 3.8 113.581 169.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.7 t0 62.34 160.47 0.07 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.233 2.213 . . . . 3.66 111.681 -167.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.55 107.21 0.2 Allowed Glycine 0 CA--C 1.525 0.677 0 O-C-N 121.156 -0.965 . . . . 2.13 111.157 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -73.18 75.08 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 O-C-N 121.988 -0.713 . . . . 2.18 109.211 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -74.91 111.57 10.25 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.029 -1.1 . . . . 2.43 108.029 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -92.56 122.79 35.33 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.272 -1.381 . . . . 2.94 107.272 169.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -118.66 151.0 38.77 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 108.099 -1.074 . . . . 1.54 108.099 170.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 t -103.78 119.0 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.34 -0.985 . . . . 1.11 108.34 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.56 119.98 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 126.937 2.095 . . . . 1.39 109.406 174.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -82.38 161.63 22.45 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.674 -1.232 . . . . 5.78 107.674 154.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.91 -28.17 5.47 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.185 0.898 . . . . 0.89 112.569 172.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -65.53 113.62 4.3 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.438 1.119 . . . . 2.09 109.845 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 t -67.31 -54.8 17.52 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.567 -0.531 . . . . 2.9 109.567 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 t -177.34 -90.03 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.658 1.183 . . . . 5.46 109.914 170.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.02 160.23 32.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.651 0.38 . . . . 3.23 109.989 -176.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.5 m 68.02 -60.66 0.4 Allowed 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.424 1.49 . . . . 1.56 110.983 -173.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.6 m -39.64 -41.91 1.12 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 126.438 1.895 . . . . 0.79 113.04 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.7 t -51.16 -69.57 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.709 0.29 . . . . 0.59 110.337 173.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.19 -30.73 71.66 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.302 -0.874 . . . . 1.65 110.872 -175.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.28 -40.83 17.62 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.771 1.228 . . . . 3.59 109.49 174.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.9 mt -85.32 -60.44 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 107.352 -1.351 . . . . 0.54 107.352 177.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -51.36 -62.28 1.72 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.242 1.417 . . . . 3.47 111.52 -170.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -61.93 -43.11 99.53 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.809 0.844 . . . . 2.76 110.144 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.9 t -62.28 -35.2 78.25 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.079 -0.509 . . . . 0.9 110.858 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.9 mt -70.43 -46.99 62.81 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.32 -0.847 . . . . 2.03 111.041 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.5 p -63.89 77.45 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.257 0.481 . . . . 1.78 110.779 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? 170.72 -24.58 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.654 3.182 . . . . 3.42 111.437 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -70.91 59.24 0.22 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 119.94 1.245 . . . . 2.19 111.683 172.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 41.04 -73.47 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 129.454 3.101 . . . . 5.77 115.766 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.08 -41.43 97.14 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 123.918 0.771 . . . . 1.94 111.526 -175.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.666 HD13 HG23 ' A' ' 46' ' ' ILE . 1.3 tp -66.65 97.66 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 117.635 0.717 . . . . 2.23 110.877 -175.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 pp -86.5 -32.77 20.58 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.605 1.162 . . . . 3.01 111.721 -174.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -147.72 136.8 22.21 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.278 0.631 . . . . 2.27 111.02 176.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.6 m -117.75 166.45 12.42 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.223 -1.028 . . . . 1.99 108.223 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 m -151.09 117.69 5.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.421 -1.326 . . . . 1.56 107.421 151.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.71 125.15 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 120.411 1.46 . . . . 2.37 109.894 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.44 129.55 55.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.181 0.593 . . . . 1.16 109.475 172.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.0 -48.17 54.68 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.849 -1.069 . . . . 1.77 111.015 -172.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.03 -51.44 69.68 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.37 0.605 . . . . 1.71 110.534 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.81 -12.82 52.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.482 1.113 . . . . 2.11 111.342 176.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 54.26 28.35 9.1 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 125.157 1.383 . . . . 2.73 109.627 -172.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -121.03 129.41 53.36 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 118.944 0.793 . . . . 1.44 110.846 -160.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.02 120.44 39.84 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.685 1.194 . . . . 0.8 108.715 164.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 127.31 36.09 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 127.002 2.121 . . . . 1.62 105.33 166.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.666 HG23 HD13 ' A' ' 32' ' ' ILE . 4.6 mp -120.9 130.2 74.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.029 1.332 . . . . 1.2 108.713 174.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -104.0 90.25 3.55 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.006 1.723 . . . . 2.58 108.278 167.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.14 179.35 7.27 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.98 1.312 . . . . 2.2 109.535 -175.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.2 124.53 41.04 Favored Pre-proline 0 N--CA 1.445 -0.719 0 O-C-N 123.34 0.4 . . . . 4.18 110.759 174.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -83.51 -8.79 10.4 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.406 2.738 . . . . 1.7 112.801 -177.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -90.83 -55.1 3.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 119.154 0.888 . . . . 3.49 108.784 -175.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 pt -68.24 -78.68 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.849 0.357 . . . . 1.46 111.871 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.7 tt -69.06 -56.62 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 O-C-N 121.229 -0.92 . . . . 1.34 109.186 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.03 159.07 33.25 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 122.92 0.295 . . . . 0.64 113.1 171.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.66 -38.61 80.47 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.661 2.907 . . . . 0.83 110.979 -173.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -32.16 -64.14 0.18 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.73 2.012 . . . . 9.91 113.487 174.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -53.98 -58.25 7.99 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.624 1.169 . . . . 2.91 109.906 -177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 mt -57.2 -59.94 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.271 -0.877 . . . . 1.22 109.899 -176.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.4 mt -49.99 -51.33 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 123.311 0.644 . . . . 1.25 110.273 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -69.31 -32.71 72.01 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.537 0.608 . . . . 2.51 111.689 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.3 m -60.6 -58.66 7.53 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.942 -0.762 . . . . 0.69 108.942 171.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 mm -59.98 -38.17 75.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.297 1.039 . . . . 1.83 111.474 -174.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -51.72 -65.35 0.57 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.84 1.256 . . . . 2.73 108.809 167.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.8 t -56.96 -27.58 61.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.317 0.647 . . . . 1.15 112.696 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.5 tp -76.17 -5.4 46.58 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.419 1.488 . . . . 2.28 111.57 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.1 45.36 2.85 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 124.345 0.974 . . . . 0.64 111.572 169.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -143.23 172.16 13.11 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.443 1.097 . . . . 2.15 108.11 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -115.76 78.76 7.24 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 123.106 0.562 . . . . 4.68 111.916 -175.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.13 72.78 5.75 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.786 2.991 . . . . 1.55 112.829 -168.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.8 p -69.84 138.98 53.05 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.969 -0.457 . . . . 2.08 110.488 171.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.9 tp -78.82 116.09 18.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.742 -1.577 . . . . 3.2 106.742 167.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.9 t -132.6 -49.01 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.185 0.994 . . . . 4.01 109.546 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.1 tttm 71.02 -60.08 0.52 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.768 1.627 . . . . 7.91 111.55 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.9 pt -62.85 166.96 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 122.509 0.324 . . . . 6.48 110.674 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.312 -1.327 . . . . 10.97 109.568 -173.13 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 ttp . . . . . 0 N--CA 1.468 0.435 0 N-CA-C 109.279 -0.638 . . . . 8.35 109.279 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.71 155.65 3.74 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 109.511 -1.435 . . . . 3.33 109.511 -166.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -87.77 155.28 19.98 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 117.722 0.761 . . . . 3.9 109.477 173.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.61 136.72 9.4 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 106.131 -2.788 . . . . 2.08 106.131 168.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.2 t -101.64 87.42 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.078 -1.082 . . . . 2.46 108.078 -176.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.79 90.34 2.89 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.982 -1.488 . . . . 2.48 106.982 171.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -73.65 119.95 18.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.26 -1.015 . . . . 2.11 108.26 159.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -127.7 150.61 49.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.211 -1.033 . . . . 1.84 108.211 166.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.0 t -96.71 135.71 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.429 -1.693 . . . . 0.91 106.429 171.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.81 176.73 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 108.483 -0.932 . . . . 2.55 108.483 172.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -134.55 167.07 21.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.942 -2.244 . . . . 6.17 104.942 152.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.93 -3.9 55.89 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 119.295 -0.725 . . . . 1.09 114.139 176.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.9 mtm -75.7 53.93 0.76 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.72 1.76 . . . . 2.06 111.977 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -80.68 36.27 0.38 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.897 -1.127 . . . . 3.13 113.203 -166.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.7 t -171.04 140.54 1.55 Allowed 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 118.913 0.779 . . . . 3.43 109.424 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.86 -48.82 11.12 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 123.797 0.839 . . . . 1.94 111.162 175.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 m -44.84 -38.6 4.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.485 1.114 . . . . 1.56 112.234 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.0 m -54.62 -38.12 66.42 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.372 0.533 . . . . 0.8 110.908 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 86.1 t -52.46 -63.8 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 123.407 0.683 . . . . 0.75 109.487 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -29.28 69.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.908 -0.587 . . . . 1.35 109.715 -175.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -62.66 -55.55 25.87 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.184 -1.413 . . . . 4.56 107.184 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.456 HG22 HD23 ' A' ' 26' ' ' LEU . 65.4 mt -60.09 -53.45 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 107.066 -1.457 . . . . 0.69 107.066 -172.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -41.34 -64.6 0.54 Allowed 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 124.607 1.192 . . . . 4.29 109.768 174.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.2 t -58.19 -43.85 87.74 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.632 0.773 . . . . 1.41 110.259 -173.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.63 -20.84 62.7 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.313 1.045 . . . . 1.01 111.117 -176.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.456 HD23 HG22 ' A' ' 22' ' ' ILE . 2.4 mm? -82.72 -57.85 3.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.703 -0.665 . . . . 2.04 110.55 168.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.58 -31.27 64.06 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.231 0.923 . . . . 1.61 111.572 -177.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -37.11 -52.04 0.99 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.494 1.517 . . . . 4.62 112.798 162.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -96.64 140.84 30.66 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 118.899 0.772 . . . . 3.37 111.294 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -67.11 177.09 1.88 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.696 -0.483 . . . . 6.54 109.696 173.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.19 -48.42 3.92 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.935 -1.266 . . . . 1.39 109.935 -174.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.856 HD11 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -57.88 141.99 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.641 -0.874 . . . . 1.83 108.641 158.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.3 mt -108.97 -45.37 3.8 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.417 1.487 . . . . 3.41 108.593 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -154.98 155.96 35.14 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.013 0.925 . . . . 2.16 109.756 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.9 t -136.96 146.28 45.2 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.464 -0.939 . . . . 1.99 108.464 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.9 m -150.74 119.34 6.5 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.813 -0.81 . . . . 1.75 108.813 161.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.418 HG11 HG21 ' A' ' 22' ' ' ILE . 11.3 m -101.21 155.67 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.699 0.8 . . . . 1.68 109.964 170.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.48 134.08 22.12 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.252 0.621 . . . . 1.01 110.971 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.66 -47.61 69.01 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.444 1.097 . . . . 2.35 110.133 -178.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.79 -43.49 80.97 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 123.377 0.671 . . . . 1.69 111.384 -170.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.1 m -94.37 -0.84 54.59 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.167 0.587 . . . . 2.57 110.593 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.78 34.06 18.29 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.073 1.749 . . . . 2.99 111.528 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -112.14 152.11 28.69 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.567 0.747 . . . . 1.49 110.359 -165.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.417 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -116.39 121.91 43.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.428 1.091 . . . . 0.68 108.224 156.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.97 131.69 42.07 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.902 -1.518 . . . . 1.13 106.902 160.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.856 HG23 HD11 ' A' ' 32' ' ' ILE . 4.8 mp -118.08 119.23 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.029 -1.471 . . . . 1.11 107.029 172.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -95.88 95.7 8.43 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 126.59 1.956 . . . . 3.29 106.252 172.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -126.8 165.85 18.53 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.024 1.33 . . . . 2.33 109.474 -174.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -86.94 112.47 47.6 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.649 -0.871 . . . . 3.25 108.649 170.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.05 -19.25 45.72 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.612 2.208 . . . . 1.4 113.089 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -69.01 -36.47 77.83 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.021 0.828 . . . . 4.16 110.705 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.6 pt -99.23 -62.55 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 N-CA-C 113.599 0.963 . . . . 1.29 113.599 -165.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 tt -88.42 -47.56 15.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.576 0.703 . . . . 1.44 110.721 -165.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.5 151.6 27.13 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.045 0.831 . . . . 0.72 111.589 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.66 -30.51 34.62 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.828 3.019 . . . . 0.65 112.55 -174.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.426 HH21 ' CE1' ' A' ' 60' ' ' HIS . 2.3 mmp_? -50.97 -50.42 58.2 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.983 0.513 . . . . 6.38 111.068 176.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.24 -54.22 27.86 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.814 0.845 . . . . 2.78 110.285 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.0 mt -57.01 -54.26 32.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 124.69 1.196 . . . . 0.96 111.065 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 65.6 mt -54.42 -53.15 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 109.378 -0.601 . . . . 1.27 109.378 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.426 ' CE1' HH21 ' A' ' 56' ' ' ARG . 74.4 m-70 -61.75 -35.42 78.07 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.793 -0.567 . . . . 2.37 112.318 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.0 m -59.81 -48.93 79.7 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 121.045 -1.034 . . . . 0.87 109.508 176.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.6 mt -68.86 -42.64 82.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.883 -0.511 . . . . 2.12 111.511 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -49.54 -47.16 49.22 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.875 1.27 . . . . 2.78 109.08 171.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.2 t -70.66 -42.33 70.94 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.126 0.971 . . . . 1.29 110.555 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.56 -48.87 57.34 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 124.663 1.185 . . . . 3.1 109.009 174.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.26 45.96 0.28 Allowed Glycine 0 C--N 1.334 0.438 0 N-CA-C 110.179 -1.168 . . . . 0.76 110.179 168.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -127.45 172.71 10.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.561 -1.644 . . . . 1.67 106.561 169.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -110.44 71.77 0.68 Allowed Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 118.689 -0.672 . . . . 4.66 111.876 -165.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.82 136.12 34.67 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.404 2.069 . . . . 1.48 112.337 -169.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.6 p -145.56 129.19 17.1 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.728 1.211 . . . . 1.92 108.258 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.78 35.16 0.19 Allowed 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.219 -0.925 . . . . 3.36 112.685 -173.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.1 m -82.21 65.92 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 O-C-N 121.278 -0.889 . . . . 5.87 109.294 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -51.44 150.19 3.77 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.469 -0.787 . . . . 5.92 110.562 170.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.0 tp -60.38 143.17 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 108.09 -1.078 . . . . 8.06 108.09 166.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 . . . . . 0 C--O 1.248 0.984 0 N-CA-C 104.342 -2.466 . . . . 9.2 104.342 -179.544 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 mtt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 109.664 -0.495 . . . . 9.99 109.664 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 137.12 -70.94 0.48 Allowed Glycine 0 CA--C 1.52 0.345 0 N-CA-C 105.196 -3.162 . . . . 4.06 105.196 -172.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 60.03 -154.31 0.37 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.216 1.006 . . . . 5.28 110.012 158.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.53 140.99 4.34 Favored Glycine 0 CA--C 1.523 0.581 0 O-C-N 121.403 -0.81 . . . . 2.16 111.763 176.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 m -129.81 156.93 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 107.207 -1.405 . . . . 2.43 107.207 160.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 tp -148.23 111.4 4.9 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.275 -1.379 . . . . 2.67 107.275 -172.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -100.37 46.14 0.96 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.657 1.983 . . . . 5.05 109.355 -169.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -70.02 156.36 39.25 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.964 -0.46 . . . . 1.75 110.031 -165.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.56 129.14 48.12 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 N-CA-C 107.793 -1.188 . . . . 1.0 107.793 175.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.58 125.4 68.62 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.029 0 N-CA-C 106.528 -1.656 . . . . 1.63 106.528 172.06 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -104.91 167.97 9.36 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.273 -1.01 . . . . 4.48 108.273 157.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.88 -10.51 29.71 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.783 1.183 . . . . 0.96 111.891 -173.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.0 mtm -68.11 76.14 0.23 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.114 0.957 . . . . 1.85 110.179 172.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.8 p -82.19 -75.07 0.32 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.272 1.029 . . . . 3.35 109.436 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 67.2 m -72.9 128.81 36.6 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.572 -0.899 . . . . 4.54 108.572 -179.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -34.89 -51.79 0.52 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.775 1.63 . . . . 1.76 113.394 -176.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.8 t -40.1 -42.51 1.45 Allowed 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 124.817 1.247 . . . . 3.16 111.385 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 90.0 m -38.38 -46.3 1.11 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.272 1.029 . . . . 0.8 112.097 177.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.0 t -50.83 -67.28 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 124.172 0.989 . . . . 0.6 110.244 175.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.43 -21.42 66.29 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.443 -0.344 . . . . 2.56 111.847 -179.003 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -68.42 -50.11 55.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.925 -1.509 . . . . 3.45 106.925 -178.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.477 HG21 HG11 ' A' ' 37' ' ' VAL . 63.5 mt -62.05 -57.84 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.374 -1.343 . . . . 0.58 107.374 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -48.19 -57.78 5.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.794 0.838 . . . . 3.32 111.16 179.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.1 t -59.7 -44.25 93.76 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 121.624 0.726 . . . . 1.56 110.135 -178.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.5 t -60.48 -29.01 68.79 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 118.506 -0.759 . . . . 1.09 111.446 177.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.44 HD12 HG22 ' A' ' 22' ' ' ILE . 11.8 mt -82.63 -47.98 11.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 119.161 0.892 . . . . 2.36 111.772 178.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.8 p -72.75 62.04 0.56 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.37 1.468 . . . . 1.73 110.938 -175.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -168.7 -30.88 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.673 1.989 . . . . 3.68 111.84 -171.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -65.59 19.76 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.247 1.573 . . . . 2.42 115.247 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 61.85 -71.83 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.504 1.521 . . . . 4.95 110.816 -169.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -79.68 49.47 3.66 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 124.309 0.956 . . . . 1.78 112.773 -172.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.65 135.16 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 104.789 -2.3 . . . . 2.69 104.789 159.421 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.7 mt -95.4 -37.55 10.89 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.147 0.979 . . . . 3.63 108.925 173.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -168.61 158.9 9.67 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.596 1.158 . . . . 2.04 108.071 177.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.8 m -145.48 155.19 42.95 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 123.669 0.788 . . . . 2.2 109.943 172.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.1 t -162.37 116.99 1.83 Allowed 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.803 1.241 . . . . 1.83 107.873 167.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.477 HG11 HG21 ' A' ' 22' ' ' ILE . 2.7 m -104.05 159.95 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 119.429 1.013 . . . . 1.67 111.936 170.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.9 135.96 21.22 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.574 0.75 . . . . 0.79 109.981 176.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.23 -43.15 19.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.625 0.77 . . . . 1.61 111.78 -171.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.25 -39.25 89.63 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.886 0.474 . . . . 1.36 110.186 -174.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.3 t -98.19 3.67 48.97 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.599 0.76 . . . . 2.22 111.274 176.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.22 48.45 13.09 Favored 'General case' 0 C--N 1.342 0.269 0 C-N-CA 126.252 1.821 . . . . 3.26 110.673 173.141 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -119.55 143.29 47.69 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 125.252 1.421 . . . . 2.09 108.338 -169.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.6 109.57 14.94 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.879 -1.156 . . . . 0.9 107.879 158.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -83.65 110.51 18.33 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 104.557 -2.386 . . . . 1.54 104.557 166.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.8 mt -110.31 143.44 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.292 1.037 . . . . 0.97 108.29 171.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -120.79 133.0 55.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.455 -1.683 . . . . 2.17 106.455 163.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -164.45 167.94 19.01 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.478 0.581 . . . . 2.03 110.911 -163.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -104.02 104.87 45.85 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 108.65 -0.87 . . . . 4.22 108.65 -178.01 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.64 26.18 0.48 Allowed 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 122.89 2.393 . . . . 1.45 113.942 -167.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -127.52 -62.89 1.06 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 124.424 1.09 . . . . 3.78 108.94 -172.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 pt -57.8 -39.76 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.242 0.617 . . . . 2.65 111.748 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.425 HG23 ' H ' ' A' ' 54' ' ' GLY . 6.3 tt -107.01 -81.74 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.796 0.839 . . . . 1.54 109.244 171.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.425 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 123.15 155.33 9.26 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.144 0.878 . . . . 1.09 111.242 -177.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.35 -41.42 41.71 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.123 2.549 . . . . 1.1 110.52 175.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.5 ttm105 -32.96 -71.1 0.06 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 127.01 2.124 . . . . 7.67 110.768 171.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.8 -45.64 89.43 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.275 1.83 . . . . 4.04 109.949 -171.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.0 mt -58.56 -60.86 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 109.426 -0.583 . . . . 0.91 109.426 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.4 mt -51.08 -48.43 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.958 0.503 . . . . 1.56 109.822 178.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -61.86 -38.38 88.04 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.686 1.194 . . . . 4.02 111.698 -178.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 95.7 m -65.03 -52.31 56.69 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.117 -0.99 . . . . 0.61 108.633 175.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.3 mm -63.64 -36.94 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 O-C-N 122.205 -0.31 . . . . 1.53 110.991 -175.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -52.35 -64.06 0.94 Allowed 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.028 1.331 . . . . 2.7 109.036 166.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 t -52.65 -38.15 59.88 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.345 1.058 . . . . 1.1 112.786 -175.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.9 mt -58.25 -25.78 62.14 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.512 -0.742 . . . . 1.93 112.86 176.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.13 49.94 0.8 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.229 0.918 . . . . 0.9 111.131 178.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -137.97 167.51 21.63 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 106.577 -1.638 . . . . 1.77 106.577 172.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -107.49 89.18 4.73 Favored Pre-proline 0 N--CA 1.463 0.216 0 CA-C-N 119.351 0.978 . . . . 4.21 112.539 172.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.09 70.92 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.967 2.445 . . . . 1.61 111.629 177.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.4 m -79.14 117.61 20.33 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.242 1.417 . . . . 2.04 108.515 177.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.9 tp -84.69 68.59 10.45 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.936 -1.135 . . . . 3.74 107.936 -179.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.3 p -79.71 -25.9 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 115.393 -0.821 . . . . 4.98 108.875 165.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.1 tttt 72.85 -70.94 0.15 Allowed 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.9 1.68 . . . . 7.0 110.687 176.046 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.7 mm -89.09 -76.29 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 108.99 -0.744 . . . . 6.62 108.99 -173.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--O 1.25 1.119 0 N-CA-C 105.307 -2.108 . . . . 10.25 105.307 -176.814 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.5 mtt . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 107.199 -1.408 . . . . 8.11 107.199 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.95 163.72 14.71 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 108.065 -2.014 . . . . 3.58 108.065 144.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -78.24 134.1 37.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.773 0.829 . . . . 5.11 110.36 -174.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.04 78.85 1.96 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 108.412 -1.875 . . . . 2.51 108.412 174.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.34 76.0 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 117.347 0.573 . . . . 2.66 110.319 -177.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.1 tp -74.93 130.95 40.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.897 -0.779 . . . . 2.23 108.897 179.483 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -103.65 149.59 24.8 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.092 -1.077 . . . . 2.04 108.092 164.327 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.68 123.88 13.74 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.03 -1.47 . . . . 1.64 107.03 172.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.35 135.42 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 107.497 -1.297 . . . . 1.12 107.497 166.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.0 156.82 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 124.929 1.292 . . . . 2.08 107.63 173.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.4 mtm105 -138.37 177.37 7.93 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.187 -1.783 . . . . 4.43 106.187 168.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.39 -9.23 71.95 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 123.53 0.586 . . . . 1.36 112.61 179.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -69.4 157.99 36.0 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 118.198 0.999 . . . . 2.89 110.206 176.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 t -149.31 140.34 22.94 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.523 -1.288 . . . . 3.87 107.523 167.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 69.2 m 68.67 153.39 0.1 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.842 1.657 . . . . 2.73 112.563 174.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.32 -36.99 22.71 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.744 0.818 . . . . 2.44 110.619 174.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -35.07 -52.16 0.56 Allowed 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.931 1.692 . . . . 1.95 112.5 170.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.3 m -63.88 -35.56 81.06 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.482 -0.761 . . . . 0.98 111.627 -175.582 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.2 t -56.68 -59.52 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 178.567 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -31.77 73.17 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.773 -0.649 . . . . 1.64 109.792 -177.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -58.22 -58.91 6.39 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 106.957 -1.498 . . . . 4.03 106.957 176.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.537 HG21 HG11 ' A' ' 37' ' ' VAL . 60.6 mt -59.61 -53.21 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.54 -1.282 . . . . 0.66 107.54 -171.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -46.02 -57.75 4.16 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 124.127 0.892 . . . . 4.23 110.112 177.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 t -60.88 -46.79 89.2 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.696 0.76 . . . . 1.41 109.804 -175.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 t -60.23 -36.65 78.22 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.374 1.47 . . . . 0.94 109.079 -175.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.472 HD23 HG22 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -70.53 -53.08 17.6 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.344 0.658 . . . . 2.16 112.006 174.066 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.9 p -52.48 -29.17 23.5 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.377 0.535 . . . . 1.83 111.991 -173.148 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 10.23 7.23 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.802 1.408 . . . . 3.26 114.802 178.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -89.48 178.43 6.3 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.121 1.328 . . . . 2.41 109.519 165.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -81.09 159.42 24.73 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.553 -0.906 . . . . 6.63 108.553 166.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.88 -55.88 3.88 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.499 0.571 . . . . 1.97 113.162 170.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.583 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -63.03 107.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 117.713 0.756 . . . . 2.51 110.293 -178.139 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 32' ' ' ILE . 2.4 pp -99.52 -25.53 14.4 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.72 1.208 . . . . 2.82 111.732 -174.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -146.96 122.18 10.2 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.297 -1.001 . . . . 2.53 108.297 176.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.2 t -102.0 161.65 13.51 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 107.725 -1.213 . . . . 1.94 107.725 171.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 m -160.36 116.84 2.4 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.208 -1.034 . . . . 1.64 108.208 163.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 22' ' ' ILE . 2.2 m -116.01 165.57 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 122.777 0.431 . . . . 1.85 110.073 169.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.25 135.0 14.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.858 0.863 . . . . 0.71 109.195 170.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.18 -43.91 69.84 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.029 -0.987 . . . . 1.59 110.25 -177.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.34 -49.94 72.92 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.365 0.602 . . . . 1.15 110.512 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 m -67.74 -11.81 59.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.587 0.755 . . . . 2.1 111.132 178.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 53.8 38.36 28.39 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.799 1.24 . . . . 3.28 108.542 -173.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -133.51 142.58 48.29 Favored 'General case' 0 CA--C 1.519 -0.24 0 O-C-N 122.143 -0.348 . . . . 1.38 111.078 -167.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -117.3 142.09 47.5 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.812 1.245 . . . . 0.71 107.928 160.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.03 154.23 48.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.549 0.613 . . . . 1.24 110.316 163.047 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.514 HG23 HD13 ' A' ' 32' ' ' ILE . 4.8 mp -127.75 138.62 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 107.883 -1.154 . . . . 1.18 107.883 178.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -104.12 110.82 23.15 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.035 0.934 . . . . 2.64 108.643 164.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -155.17 158.24 38.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.133 1.373 . . . . 2.55 110.178 -174.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.02 126.01 88.65 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 109.087 -0.709 . . . . 3.62 109.087 165.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.26 -7.98 14.0 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.227 2.618 . . . . 1.04 113.887 -173.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -84.09 -52.68 6.09 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 119.591 1.087 . . . . 4.98 108.439 -179.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.1 pt -62.46 -52.7 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 113.593 0.96 . . . . 1.38 113.593 -168.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.526 HG23 ' H ' ' A' ' 54' ' ' GLY . 13.1 tt -97.2 -68.79 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 124.096 0.959 . . . . 1.09 109.658 -178.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.526 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 109.49 162.14 19.49 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.735 0.683 . . . . 0.72 113.697 172.109 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.85 -42.82 0.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.092 3.195 . . . . 0.81 111.903 -173.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -52.26 -50.09 62.78 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.705 1.241 . . . . 8.17 108.732 -173.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.55 -54.13 41.74 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.005 2.922 . . . . 5.0 108.536 -176.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.1 mt -61.48 -54.85 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 123.841 0.856 . . . . 0.8 110.284 179.161 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.7 mm -48.56 -53.27 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 118.5 0.591 . . . . 2.2 109.423 178.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -63.5 -33.15 74.95 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.413 0.523 . . . . 2.93 112.413 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.8 m -59.8 -58.1 10.01 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.221 -0.924 . . . . 0.79 109.78 171.203 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.2 mm -63.89 -32.8 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 121.6 -0.688 . . . . 1.49 110.921 -174.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.08 -58.49 7.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.696 1.198 . . . . 3.03 108.904 167.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.7 t -55.12 -37.27 66.69 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.501 1.12 . . . . 1.0 112.378 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.0 mt -60.17 -16.45 32.97 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.905 0.706 . . . . 2.04 112.905 175.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.35 38.19 5.13 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.951 -0.86 . . . . 0.83 110.951 177.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -127.53 171.58 11.48 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 107.501 -1.296 . . . . 1.71 107.501 172.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -112.15 70.66 1.02 Allowed Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 114.446 1.276 . . . . 4.02 114.446 -168.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.7 110.73 2.82 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.963 2.442 . . . . 1.09 112.864 -175.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.7 t -71.32 177.76 3.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.694 1.198 . . . . 3.41 109.339 160.282 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.43 HD23 ' H ' ' A' ' 71' ' ' LEU . 0.6 OUTLIER -78.25 -163.48 0.44 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.485 -0.931 . . . . 3.93 108.485 158.345 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.9 m -61.74 74.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.752 1.621 . . . . 7.05 111.661 175.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -60.68 137.5 58.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.528 1.131 . . . . 11.75 110.128 178.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.4 mt -93.28 121.98 44.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 104.776 -2.305 . . . . 6.47 104.776 163.22 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.274 0 C-N-CA 127.276 2.23 . . . . 9.68 112.178 -177.209 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ttt . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 111.971 0.36 . . . . 10.87 111.971 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.12 -75.49 0.18 Allowed Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.349 -1.101 . . . . 5.87 110.349 -168.524 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.7 t0 24.62 55.08 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 128.661 2.784 . . . . 6.51 113.271 -175.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.99 161.31 10.46 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 107.074 -2.41 . . . . 2.36 107.074 -169.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 m -148.55 172.89 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 105.994 -1.854 . . . . 2.14 105.994 174.334 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.4 tp -137.27 134.21 35.9 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 107.951 -1.129 . . . . 1.91 107.951 159.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -101.87 123.72 46.27 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.023 -1.103 . . . . 2.16 108.023 168.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 pp -130.71 131.17 44.64 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 110.121 -0.326 . . . . 1.53 110.121 175.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.99 142.52 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.484 -1.672 . . . . 1.3 106.484 168.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.3 107.75 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.879 -1.526 . . . . 1.26 106.879 173.073 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -76.98 166.04 23.85 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.934 -0.765 . . . . 5.68 108.934 174.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.84 -45.77 3.36 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.778 -0.929 . . . . 1.06 110.778 -177.334 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -57.01 120.16 7.51 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.837 -0.801 . . . . 2.4 108.837 174.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 t -156.92 19.44 0.31 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.39 0.515 . . . . 3.64 112.39 -166.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.6 t -157.45 148.21 21.27 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 120.781 -1.199 . . . . 2.98 109.141 -179.089 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.76 -41.02 10.27 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.069 0.948 . . . . 2.38 111.535 173.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.8 m -51.29 -55.9 15.83 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.206 0.602 . . . . 1.72 110.513 172.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.9 m -55.97 -51.97 65.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 123.804 0.842 . . . . 0.77 109.464 178.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.9 t -46.8 -61.85 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.001 0.52 . . . . 0.98 109.734 178.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.283 0.0 OUTLIER -64.78 -21.97 66.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.936 -0.575 . . . . 1.84 110.923 -176.175 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -66.73 -47.3 72.72 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.871 -0.789 . . . . 4.06 108.871 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.429 ' HB ' HG21 ' A' ' 37' ' ' VAL . 15.2 mt -66.73 -52.21 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.769 -1.197 . . . . 0.72 107.769 -178.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -41.83 -66.57 0.33 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.486 0.714 . . . . 3.37 110.328 171.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.6 t -55.88 -49.43 73.41 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.473 1.109 . . . . 1.49 109.815 -172.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.0 t -64.31 -37.4 87.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 118.802 -0.618 . . . . 0.71 111.414 -178.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.71 -41.14 72.3 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.237 0.926 . . . . 1.88 110.33 178.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.1 p -65.18 74.65 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.964 0.906 . . . . 1.78 111.022 179.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.5 pttm 179.15 -36.23 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 129.521 3.129 . . . . 3.73 109.707 -178.226 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -53.53 118.59 4.0 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.193 0.597 . . . . 1.93 110.657 -178.292 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.9 ttm-85 -67.24 82.19 0.14 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.541 1.137 . . . . 5.06 110.252 -171.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.26 -29.24 0.52 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.162 0.887 . . . . 1.23 110.927 -174.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.21 140.06 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.65 1.18 . . . . 1.86 109.239 175.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.3 mt -114.2 -47.6 2.93 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.341 1.456 . . . . 3.0 109.703 168.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -143.3 138.38 29.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 118.334 0.515 . . . . 2.56 110.94 -177.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -105.49 156.71 17.95 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.656 -1.238 . . . . 2.13 107.656 173.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.1 92.64 1.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.878 -0.786 . . . . 1.35 108.878 162.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.429 HG21 ' HB ' ' A' ' 22' ' ' ILE . 46.4 t -92.3 144.96 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 125.707 1.603 . . . . 2.39 109.59 176.387 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.83 134.56 11.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.895 -0.503 . . . . 0.8 111.577 172.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.15 -30.48 62.29 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 123.828 0.851 . . . . 1.44 111.353 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.47 -29.66 69.2 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.396 0.543 . . . . 1.28 110.722 -177.238 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.428 HG23 ' HG2' ' A' ' 43' ' ' LYS . 5.0 t -115.38 5.88 14.69 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.795 1.238 . . . . 2.26 110.836 176.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 45.45 45.49 10.31 Favored 'General case' 0 C--N 1.339 0.143 0 C-N-CA 127.541 2.337 . . . . 3.14 112.45 175.003 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.428 ' HG2' HG23 ' A' ' 41' ' ' THR . 16.8 ptpt -139.03 161.52 37.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.334 0.494 . . . . 1.54 112.334 -178.128 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.71 124.81 52.67 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.769 1.627 . . . . 0.74 106.853 160.04 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 139.22 30.84 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.069 -1.086 . . . . 1.08 108.069 153.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.96 125.95 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.955 -1.498 . . . . 1.01 106.955 174.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -101.95 87.83 3.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.027 1.331 . . . . 2.25 107.952 167.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -125.49 157.12 37.77 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.131 2.173 . . . . 2.22 109.48 178.053 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.435 ' HB2' HD11 ' A' ' 52' ' ' ILE . 2.6 m-20 -72.28 120.37 80.04 Favored Pre-proline 0 C--N 1.34 0.179 0 N-CA-C 105.987 -1.857 . . . . 3.18 105.987 167.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.8 -67.68 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.48 1.454 . . . . 1.79 113.065 -169.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -52.89 -41.16 64.1 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.349 1.06 . . . . 5.3 112.595 -159.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 49' ' ' ASP . 10.7 pt -51.9 -41.23 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.025 0.93 . . . . 1.5 113.135 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.0 tt -119.9 -48.49 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 124.422 1.089 . . . . 1.39 111.305 -167.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.38 160.24 35.07 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.1 1.333 . . . . 1.1 112.201 172.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -66.99 -26.52 43.47 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.198 2.599 . . . . 1.51 111.941 179.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 36.8 ttm105 -51.06 -55.57 16.94 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.741 0.817 . . . . 5.09 110.741 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -47.67 -53.64 14.37 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.552 1.141 . . . . 2.97 110.689 176.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.66 -57.41 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.717 0.807 . . . . 1.11 110.568 -178.397 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.62 -37.03 79.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 O-C-N 121.661 -0.649 . . . . 4.45 111.795 -175.063 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -55.4 -49.85 71.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.826 0.739 . . . . 3.07 109.873 169.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.6 m -56.24 -50.93 69.91 Favored 'General case' 0 C--O 1.224 -0.24 0 O-C-N 121.731 -0.606 . . . . 0.89 110.838 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.54 -41.75 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 121.539 -0.725 . . . . 1.94 111.865 -175.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -52.15 -48.21 65.03 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.006 -0.739 . . . . 4.13 109.006 169.67 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.0 t -64.9 -42.33 94.86 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.819 -0.628 . . . . 1.64 111.321 -177.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.43 -46.29 86.79 Favored 'General case' 0 C--N 1.34 0.172 0 O-C-N 121.485 -0.76 . . . . 1.8 109.994 173.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.34 43.84 0.34 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.132 -0.787 . . . . 0.85 111.132 170.138 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -129.7 155.83 45.26 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.039 -1.837 . . . . 1.9 106.039 170.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -107.82 102.66 46.38 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 118.579 -0.724 . . . . 3.39 110.319 -168.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -85.15 154.33 11.02 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.976 2.451 . . . . 1.72 113.124 -171.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.0 m -162.03 135.67 6.4 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 125.97 1.708 . . . . 2.5 107.953 166.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -54.27 138.86 37.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.565 -0.531 . . . . 3.02 109.565 173.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.4 p -90.19 -49.04 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.752 -0.462 . . . . 3.87 109.752 -175.122 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.3 tttm 67.32 159.38 0.15 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.338 1.455 . . . . 6.54 110.864 -173.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.18 146.11 34.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 104.041 -2.577 . . . . 7.4 104.041 152.741 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 C--O 1.255 1.382 0 CA-C-O 116.29 -1.814 . . . . 9.01 112.17 -164.946 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 106.019 -1.845 . . . . 8.83 106.019 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 149.03 -156.68 26.93 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 107.105 -2.398 . . . . 5.55 107.105 -175.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -130.35 171.14 13.26 Favored 'General case' 0 C--N 1.334 -0.106 0 N-CA-C 106.677 -1.601 . . . . 7.21 106.677 163.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.53 41.58 0.62 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-O 118.033 -1.426 . . . . 3.28 111.47 158.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -150.78 80.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 118.855 1.327 . . . . 2.76 107.628 172.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.51 89.29 6.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.111 -1.441 . . . . 3.0 107.111 164.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -67.83 133.72 49.69 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.628 -0.879 . . . . 2.47 108.628 156.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 pp -146.13 137.41 24.64 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.51 -1.293 . . . . 1.44 107.51 167.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.71 145.82 13.19 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 107.966 -1.124 . . . . 1.32 107.966 173.474 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.93 105.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 127.807 2.443 . . . . 1.34 104.489 173.092 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -86.54 163.91 17.21 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.284 -1.006 . . . . 7.24 108.284 166.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.76 -13.58 29.67 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.89 0.757 . . . . 1.02 112.166 -177.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.1 mtm -65.89 88.25 0.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.233 1.016 . . . . 1.9 110.024 172.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 p -68.83 -37.21 79.01 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.078 0.551 . . . . 3.33 111.599 179.281 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.5 t -158.28 169.85 23.57 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.176 0.444 . . . . 3.44 110.247 -169.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.37 -28.06 7.39 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.237 1.815 . . . . 2.47 113.377 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 p -49.81 -63.18 1.19 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.309 -0.626 . . . . 2.56 109.309 169.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.2 m -51.22 -47.83 62.22 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 123.675 0.79 . . . . 0.73 110.697 179.614 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.4 t -49.0 -62.49 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 123.773 0.829 . . . . 0.75 109.927 178.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -26.47 67.69 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 120.835 -0.346 . . . . 1.35 110.468 -177.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -63.32 -50.11 71.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.79 -0.819 . . . . 4.34 108.79 179.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.9 mt -64.88 -53.24 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 107.815 -1.179 . . . . 0.54 107.815 -178.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -49.36 -58.83 4.41 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.784 0.834 . . . . 3.9 109.625 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.9 t -62.47 -48.19 80.71 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.458 -0.792 . . . . 1.32 109.793 -174.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.6 t -57.7 -36.2 71.66 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.72 110.69 178.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.2 mt -72.43 -47.62 47.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.984 -1.008 . . . . 1.96 111.973 177.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 17.1 p -62.11 77.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.913 0.885 . . . . 1.77 111.694 -176.058 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? 169.54 -37.32 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.935 2.494 . . . . 3.37 110.468 -171.705 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -58.19 126.8 29.07 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.246 -1.02 . . . . 2.27 108.246 171.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -72.42 74.7 1.03 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.873 0.869 . . . . 4.75 111.658 -163.086 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 170.91 -41.09 0.19 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.404 -1.079 . . . . 1.57 110.404 178.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.684 HD13 HG23 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -69.67 100.46 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 117.724 0.762 . . . . 2.29 110.186 -176.972 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.14 -35.49 23.59 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.596 1.158 . . . . 2.36 111.494 -176.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -143.6 116.49 8.8 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.903 0.881 . . . . 2.03 109.275 176.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 36.2 t -97.48 155.4 16.95 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 107.905 -1.146 . . . . 2.16 107.905 169.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 t -158.24 102.85 1.79 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.887 -1.523 . . . . 1.48 106.887 169.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.54 159.31 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 120.505 0.193 . . . . 1.71 110.708 173.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.48 134.39 21.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.404 1.082 . . . . 0.86 110.061 178.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.54 -41.97 62.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.527 -1.215 . . . . 1.63 110.942 -173.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.3 -47.26 80.16 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.551 0.691 . . . . 1.4 109.674 -172.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 t -80.78 -2.55 47.56 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 118.514 -0.755 . . . . 2.72 110.763 177.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 51.39 49.8 20.23 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.651 1.18 . . . . 2.62 108.769 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -139.53 142.48 37.24 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 118.09 0.404 . . . . 1.61 111.744 -169.06 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.98 125.03 50.5 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.262 1.425 . . . . 0.66 108.485 163.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.08 119.63 38.15 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.504 -2.036 . . . . 1.02 105.504 164.426 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.684 HG23 HD13 ' A' ' 32' ' ' ILE . 5.2 mp -112.12 120.55 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.04 1.336 . . . . 1.0 108.24 175.518 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -92.57 97.26 10.7 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.775 -0.824 . . . . 3.12 108.775 163.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.72 143.58 43.4 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.577 -0.897 . . . . 2.73 108.577 174.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -73.85 127.56 88.13 Favored Pre-proline 0 N--CA 1.452 -0.352 0 N-CA-C 106.196 -1.779 . . . . 3.73 106.196 169.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -69.63 -59.21 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.663 1.576 . . . . 1.85 112.507 -169.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -50.12 -43.28 51.67 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.06 1.744 . . . . 3.42 112.396 -162.657 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 pt -55.34 -40.16 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.754 0.822 . . . . 1.78 113.128 -177.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.7 tt -123.68 -48.24 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.805 0.842 . . . . 1.67 112.676 -165.058 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.45 147.56 22.69 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.129 1.347 . . . . 1.01 111.443 178.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.86 -34.42 23.98 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.106 2.538 . . . . 0.93 111.469 -177.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -55.5 -41.73 73.48 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 118.841 -0.599 . . . . 6.51 112.441 -174.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -48.71 -62.18 1.64 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.516 1.151 . . . . 2.72 110.025 174.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.3 mt -56.65 -56.36 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.209 1.404 . . . . 1.38 110.431 -179.077 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.31 -47.66 77.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 122.024 -0.422 . . . . 1.31 110.42 -178.334 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.7 m170 -60.8 -42.67 98.07 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 118.832 0.742 . . . . 2.84 110.817 178.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.3 m -57.33 -52.33 65.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.238 -0.653 . . . . 0.76 109.238 177.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.4 mm -68.36 -34.59 66.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 O-C-N 122.09 -0.381 . . . . 2.01 111.777 -175.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -56.41 -59.26 5.22 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.517 1.127 . . . . 2.82 108.026 171.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.0 t -52.99 -40.35 63.73 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.349 1.06 . . . . 1.12 111.506 176.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.1 tp -66.4 -10.5 44.28 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.121 0.968 . . . . 2.47 112.446 -179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.2 45.76 2.33 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 118.68 0.673 . . . . 0.68 112.055 168.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -139.32 177.81 7.65 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 107.794 -1.188 . . . . 2.14 107.794 172.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -112.6 72.49 1.33 Allowed Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 113.198 0.814 . . . . 3.42 113.198 -177.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -63.58 104.45 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.983 3.122 . . . . 1.37 111.814 -177.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.4 p -129.15 124.71 35.35 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.798 1.639 . . . . 2.11 108.735 -172.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tt -76.33 73.52 3.11 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.261 -0.899 . . . . 3.71 111.092 -171.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.9 t -86.47 -37.88 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.408 1.083 . . . . 3.99 111.593 -177.231 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.1 mttt 52.14 -114.31 0.81 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.654 0.782 . . . . 8.6 111.03 -168.084 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.5 mm -132.46 -64.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 105.519 -2.03 . . . . 8.34 105.519 163.523 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 C--O 1.26 1.637 0 N-CA-C 101.993 -3.336 . . . . 9.7 101.993 136.507 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttm . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 119.29 -0.386 . . . . 8.33 111.136 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.78 159.33 30.43 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 123.214 0.435 . . . . 3.38 112.061 -178.541 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 t70 51.38 -172.32 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.203 1.801 . . . . 3.83 111.149 -165.059 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.95 96.9 0.2 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.52 -1.432 . . . . 2.01 109.52 -176.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 t -75.19 70.16 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 117.64 0.72 . . . . 2.58 109.739 178.174 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.4 tp -70.11 154.47 41.89 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.105 -0.702 . . . . 2.32 109.105 175.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -129.07 148.49 51.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.967 0.907 . . . . 2.54 110.035 170.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.52 133.78 44.19 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 107.247 -1.39 . . . . 1.79 107.247 168.283 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.6 109.39 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 105.729 -1.952 . . . . 1.06 105.729 171.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -104.41 109.08 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.944 -0.762 . . . . 1.79 108.944 -174.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.58 155.24 40.76 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.392 -1.336 . . . . 4.0 107.392 170.196 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.66 -19.85 7.88 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 123.405 0.526 . . . . 1.09 113.512 168.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.4 mtm -58.96 104.48 0.24 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.568 1.184 . . . . 2.19 110.725 171.541 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.5 p -91.36 -83.36 0.28 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.058 0.943 . . . . 3.67 110.4 177.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 84.4 m -79.17 -68.29 0.67 Allowed 'General case' 0 CA--C 1.527 0.061 0 C-N-CA 123.245 0.618 . . . . 3.91 111.279 -160.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -174.58 -61.78 0.01 OUTLIER 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 124.401 1.08 . . . . 1.77 108.865 -176.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.2 t -41.07 -46.75 3.01 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.315 1.446 . . . . 2.91 111.161 -176.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.3 m -23.62 -52.0 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.133 2.173 . . . . 0.85 113.511 168.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.4 t -49.52 -61.46 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.346 0.659 . . . . 0.6 110.589 176.115 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.71 -28.68 66.03 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.323 0.649 . . . . 1.08 110.208 -177.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.57 -52.55 59.38 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 107.489 -1.3 . . . . 3.03 107.489 175.055 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.49 HD12 HG11 ' A' ' 37' ' ' VAL . 93.6 mt -65.84 -60.39 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 107.344 -1.354 . . . . 0.56 107.344 178.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.04 -51.81 16.48 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.572 0.701 . . . . 2.85 110.583 -171.379 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.1 t -67.38 -56.53 9.31 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.988 0.915 . . . . 1.6 109.739 -178.402 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.1 t -64.98 -18.09 64.98 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 118.693 -0.67 . . . . 1.16 112.446 -173.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -91.44 -47.4 7.47 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 117.672 -1.156 . . . . 2.72 111.548 173.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 p -53.87 -35.13 61.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.606 1.548 . . . . 2.25 111.615 178.347 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -32.05 -48.84 0.17 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.097 1.359 . . . . 4.92 113.23 163.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -75.13 63.45 1.3 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.288 1.035 . . . . 2.21 110.798 178.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 3.76 -64.0 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 129.5 3.12 . . . . 4.58 117.247 178.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -46.02 -45.99 14.72 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.43 1.014 . . . . 1.35 112.557 178.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.609 HD13 HG23 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -73.3 84.99 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 108.022 -1.103 . . . . 2.87 108.022 168.515 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.5 pp -65.67 -33.79 76.71 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.988 -0.551 . . . . 3.32 111.299 -175.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -146.64 104.68 3.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.912 0.485 . . . . 3.1 111.566 173.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.3 t -80.19 142.28 34.84 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 106.89 -1.522 . . . . 2.61 106.89 162.067 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.9 t -132.73 101.77 5.41 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.719 -1.215 . . . . 1.3 107.719 -178.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.49 HG11 HD12 ' A' ' 22' ' ' ILE . 6.2 t -107.6 142.71 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 124.64 1.176 . . . . 2.59 110.193 -167.307 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.45 137.31 17.12 Favored 'General case' 0 C--N 1.339 0.109 0 O-C-N 121.481 -0.762 . . . . 0.92 111.353 177.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -81.71 -35.21 30.05 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 124.463 1.105 . . . . 1.35 112.013 -172.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.26 91.52 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 109.572 -0.529 . . . . 1.14 109.572 -177.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 t -93.26 -5.19 50.41 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.454 -0.794 . . . . 2.13 111.454 173.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 41.19 55.02 3.34 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 126.744 2.018 . . . . 2.79 109.456 -176.387 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -133.76 152.02 51.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.889 -1.05 . . . . 2.0 109.502 -171.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.29 129.1 56.1 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.646 -1.613 . . . . 0.87 106.646 157.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.72 145.51 25.24 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 107.366 -1.346 . . . . 1.13 107.366 157.543 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.609 HG23 HD13 ' A' ' 32' ' ' ILE . 5.3 mp -127.22 115.37 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.252 -0.647 . . . . 2.08 109.252 -169.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -86.48 81.03 8.45 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.196 -1.038 . . . . 2.53 108.196 165.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.33 167.95 14.81 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.378 1.071 . . . . 2.1 110.194 176.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -108.72 126.18 30.05 Favored Pre-proline 0 N--CA 1.447 -0.616 0 O-C-N 124.317 1.011 . . . . 3.43 109.084 171.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.5 -20.76 20.31 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.126 2.55 . . . . 1.2 112.72 -177.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -96.48 14.46 24.49 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.986 0.914 . . . . 3.92 111.434 -170.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 pt -126.96 -87.55 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.282 1.033 . . . . 1.23 109.408 163.032 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.9 tt -59.44 -49.4 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.621 1.168 . . . . 1.09 112.008 -176.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.73 159.5 30.61 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.718 -0.553 . . . . 0.82 111.718 -178.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.88 -30.84 8.83 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.052 2.501 . . . . 0.86 111.541 -175.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -54.81 -52.51 62.45 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.657 0.783 . . . . 5.01 110.849 -174.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -49.46 -55.07 14.47 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.51 1.124 . . . . 2.6 109.653 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.38 -59.79 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.877 1.271 . . . . 0.92 110.373 178.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.6 mt -52.63 -41.73 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 119.234 0.924 . . . . 1.49 111.416 -178.465 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -67.08 -45.52 77.05 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 121.856 -0.527 . . . . 2.4 109.911 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.3 m -57.94 -50.29 73.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.594 -0.891 . . . . 0.58 108.594 179.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.1 mm -53.54 -52.18 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.547 1.139 . . . . 1.55 109.915 -179.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -47.68 -64.84 0.68 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.258 0.552 . . . . 3.78 109.807 173.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 m -67.57 -26.38 66.26 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.927 -0.578 . . . . 2.7 112.267 -167.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.1 tp -67.0 -12.5 60.02 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.192 1.397 . . . . 2.32 111.663 175.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.48 47.28 0.7 Allowed Glycine 0 C--N 1.339 0.716 0 C-N-CA 124.948 1.261 . . . . 1.03 110.703 168.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -143.41 178.03 8.03 Favored 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 108.853 -0.795 . . . . 1.91 108.853 -178.209 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.07 101.77 14.92 Favored Pre-proline 0 CA--C 1.533 0.312 0 N-CA-C 108.685 -0.857 . . . . 4.54 108.685 173.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -83.48 92.0 0.87 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.362 2.708 . . . . 1.23 112.896 -175.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.8 m -79.17 113.15 17.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.733 0.778 . . . . 2.09 109.614 170.011 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tt -76.76 71.69 3.34 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.8 0.84 . . . . 3.2 108.966 171.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.7 t -64.52 -43.41 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 122.99 0.516 . . . . 4.18 111.333 -173.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 75' ' ' GLU 0.295 0.0 OUTLIER 42.65 -154.46 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.829 1.651 . . . . 7.36 112.566 -169.395 . . . . . . . . 4 4 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 tp -70.28 143.56 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 O-C-N 121.588 -0.695 . . . . 6.54 109.352 168.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 21.5 mm-40 . . . . . 0 C--O 1.256 1.442 0 N-CA-C 103.343 -2.836 . . . . 10.5 103.343 164.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 108.259 -1.015 . . . . 9.49 108.259 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.32 156.32 15.79 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 107.702 -2.159 . . . . 3.43 107.702 168.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.1 t70 46.79 -131.57 1.27 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.51 1.124 . . . . 3.99 109.983 -175.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.24 174.3 49.66 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.776 -1.33 . . . . 1.89 109.776 -170.085 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.69 146.16 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 O-C-N 122.074 -0.662 . . . . 2.4 109.398 -176.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.29 114.59 28.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.797 -1.927 . . . . 2.47 105.797 168.498 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -92.74 120.93 33.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.125 -1.065 . . . . 2.59 108.125 164.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pp -122.01 154.55 37.1 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.286 -1.376 . . . . 1.65 107.286 169.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.25 146.78 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 106.311 -1.737 . . . . 0.85 106.311 171.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 m -137.86 163.89 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.933 2.093 . . . . 1.6 105.426 -179.32 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -143.05 165.05 28.43 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.529 1.059 . . . . 4.21 108.412 173.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 116.07 -86.06 0.4 Allowed Glycine 0 C--N 1.337 0.587 0 N-CA-C 108.744 -1.742 . . . . 2.42 108.744 177.044 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.3 mpt? 52.12 -158.16 0.13 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.529 1.131 . . . . 4.78 112.26 -173.826 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.445 HG22 ' SG ' ' A' ' 18' ' ' CYS . 10.2 t -161.23 55.56 0.29 Allowed 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.17 0.988 . . . . 5.65 108.752 179.35 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.8 t 74.69 -45.46 0.58 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.442 1.497 . . . . 4.14 113.486 175.525 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.2 -71.5 0.23 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.319 0.509 . . . . 1.74 111.043 -179.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -42.88 -44.12 4.39 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.763 1.625 . . . . 1.65 114.48 -162.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.445 ' SG ' HG22 ' A' ' 14' ' ' THR . 1.6 m -47.19 -37.19 9.77 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.204 0.602 . . . . 1.78 112.454 179.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -49.7 -61.63 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 123.539 0.735 . . . . 0.69 110.558 174.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -30.35 69.65 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.932 -0.766 . . . . 1.33 108.932 -176.48 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -58.83 -53.43 58.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.299 -1.0 . . . . 4.52 108.299 177.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.4 HG21 HG11 ' A' ' 37' ' ' VAL . 61.2 mt -62.66 -50.03 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 107.991 -1.115 . . . . 0.7 107.991 -173.572 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -47.73 -60.93 2.21 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.927 0.767 . . . . 4.12 109.455 176.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.5 t -57.65 -47.32 82.57 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 122.224 1.012 . . . . 1.48 110.42 -173.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -70.9 -23.86 62.36 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.402 1.481 . . . . 0.85 110.899 -174.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mt -80.39 -43.71 20.6 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 118.656 0.662 . . . . 2.47 111.061 171.279 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.2 p -67.95 73.28 0.18 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.029 0.931 . . . . 1.6 110.835 179.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.92 -34.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.515 2.726 . . . . 4.22 111.289 -176.832 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -35.02 -69.49 0.1 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 126.174 1.789 . . . . 3.54 115.148 -170.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -165.17 -51.93 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 108.697 -0.853 . . . . 7.95 108.697 174.065 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -151.02 63.08 0.4 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.38 -1.488 . . . . 1.54 109.38 175.432 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.823 HD11 HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -73.14 126.28 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 105.709 -1.96 . . . . 2.54 105.709 158.552 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.31 -51.68 9.75 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.139 -1.43 . . . . 2.46 107.139 165.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -155.81 139.51 16.08 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.045 -0.525 . . . . 2.45 110.955 -178.312 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.6 t -109.05 150.29 28.01 Favored 'General case' 0 C--O 1.227 -0.092 0 N-CA-C 107.622 -1.251 . . . . 2.26 107.622 167.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.66 109.7 3.29 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.357 -0.839 . . . . 1.3 109.378 175.235 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.447 HG12 ' CB ' ' A' ' 44' ' ' ALA . 3.2 m -113.59 155.87 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.466 0.706 . . . . 1.67 111.295 176.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.85 133.74 19.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.353 0.661 . . . . 0.97 109.694 171.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -76.09 -42.58 46.79 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.445 0.698 . . . . 1.6 111.293 -171.014 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.73 -46.32 87.63 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.081 0.552 . . . . 1.62 110.466 179.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.47 -15.69 60.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.61 1.164 . . . . 2.44 111.471 175.079 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 52.6 34.81 16.54 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.172 1.789 . . . . 2.8 110.006 -172.521 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -102.82 144.64 30.9 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.659 1.183 . . . . 1.67 108.027 -172.303 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.447 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -137.46 110.35 7.68 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.39 -0.967 . . . . 1.05 108.39 161.221 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.78 144.43 25.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.616 -0.513 . . . . 1.16 109.616 168.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.823 HG23 HD11 ' A' ' 32' ' ' ILE . 4.9 mp -124.43 120.03 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 106.377 -1.712 . . . . 1.18 106.377 175.073 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.58 ' O ' HD13 ' A' ' 32' ' ' ILE . 60.3 mttt -96.24 96.17 8.61 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.151 -1.426 . . . . 2.2 107.151 166.553 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -134.61 153.75 51.82 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.501 1.521 . . . . 2.18 107.205 -177.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -82.06 130.66 59.32 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 119.484 -0.886 . . . . 3.35 109.315 168.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.5 -40.9 9.62 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.682 2.254 . . . . 1.52 113.087 179.289 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -88.52 43.35 1.13 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.572 1.078 . . . . 3.56 110.824 -164.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.1 pt -142.91 -41.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 126.238 1.815 . . . . 1.66 111.342 172.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 20.9 tt -121.14 -61.26 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.353 1.061 . . . . 1.2 111.844 -175.319 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.41 157.0 25.84 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.734 1.159 . . . . 0.7 111.537 178.778 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -71.32 -32.63 12.38 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.486 2.791 . . . . 0.69 112.556 -172.592 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -51.93 -52.92 46.71 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.345 0.658 . . . . 5.95 111.549 -178.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -48.31 -57.42 6.02 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.487 1.115 . . . . 2.63 110.35 177.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.2 mt -53.51 -63.46 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.477 1.111 . . . . 0.91 109.436 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.2 mt -49.47 -52.11 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.264 0.625 . . . . 1.31 110.162 -176.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -69.81 -30.49 68.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.764 -0.585 . . . . 3.12 111.999 -175.71 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 92.1 m -66.71 -51.34 57.12 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.289 -0.882 . . . . 0.83 109.563 173.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mm -55.97 -41.92 69.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 122.809 0.444 . . . . 1.53 110.132 177.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.95 -58.45 7.82 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.023 0.929 . . . . 3.05 109.076 174.247 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.5 m -54.13 -37.47 64.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.149 0.98 . . . . 2.42 112.674 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.8 mt -67.24 -6.21 17.25 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.957 0.725 . . . . 1.83 112.957 177.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.08 48.94 2.15 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.827 -0.909 . . . . 0.63 110.827 173.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -134.61 -179.76 5.79 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.39 1.076 . . . . 2.01 109.621 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -121.8 57.87 8.34 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.069 0.947 . . . . 3.51 112.23 -173.312 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.95 85.25 0.24 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 124.282 3.322 . . . . 1.15 113.042 -167.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.2 m -97.56 126.24 42.74 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.719 1.608 . . . . 2.04 108.476 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 pp -62.06 151.32 35.79 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.705 0.684 . . . . 3.29 109.348 170.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.0 t -136.07 -54.19 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 122.753 0.421 . . . . 3.32 111.689 -179.262 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.24 150.98 28.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 121.188 -0.205 . . . . 7.64 111.347 -171.263 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 75.4 mt -122.28 -66.37 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 104.746 -2.316 . . . . 7.63 104.746 173.055 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--O 1.25 1.109 0 N-CA-C 104.882 -2.266 . . . . 11.76 104.882 137.271 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 106.638 -1.615 . . . . 11.09 106.638 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.97 -64.76 0.45 Allowed Glycine 0 CA--C 1.52 0.399 0 N-CA-C 105.285 -3.126 . . . . 4.01 105.285 -173.026 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 56.75 -148.02 0.51 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.52 1.128 . . . . 4.91 109.395 162.23 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.65 155.26 8.32 Favored Glycine 0 CA--C 1.522 0.481 0 O-C-N 121.765 -0.584 . . . . 2.11 112.052 171.752 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m -139.84 161.95 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.26 -1.385 . . . . 2.0 107.26 167.008 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.0 tp -150.87 147.9 27.79 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.96 -1.496 . . . . 2.09 106.96 166.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -116.38 128.96 55.98 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.251 -1.388 . . . . 2.56 107.251 174.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.87 125.35 44.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.72 -1.585 . . . . 1.51 106.72 177.829 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.1 t -65.03 144.08 15.16 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 N-CA-C 106.866 -1.531 . . . . 0.99 106.866 168.159 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 m -141.75 86.17 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 119.102 0.865 . . . . 1.52 110.512 -174.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 56.7 mmt-85 -55.69 141.2 38.92 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.309 -1.367 . . . . 5.19 107.309 168.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.86 -26.45 8.87 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.845 0.736 . . . . 1.08 111.504 -175.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.402 ' SD ' HD12 ' A' ' 22' ' ' ILE . 26.8 mtm -69.73 77.27 0.44 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.936 1.368 . . . . 1.93 111.744 176.188 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -77.09 -33.8 56.94 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.898 0.879 . . . . 2.44 111.943 178.067 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -149.67 158.03 43.79 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.385 0.539 . . . . 2.98 110.766 -163.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.68 -33.1 0.67 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.156 1.782 . . . . 2.35 113.605 173.13 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.1 p -53.27 -53.29 53.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.659 -0.651 . . . . 2.69 110.269 172.21 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.3 m -58.55 -49.09 78.7 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.173 0.589 . . . . 0.88 109.99 178.153 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.1 t -45.27 -63.95 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 123.351 0.66 . . . . 0.64 109.66 177.059 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.282 0.0 OUTLIER -63.95 -24.64 67.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.754 -0.657 . . . . 1.41 110.984 -177.233 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -61.41 -53.58 54.74 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 108.263 -1.014 . . . . 3.38 108.263 177.038 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.402 HD12 ' SD ' ' A' ' 13' ' ' MET . 11.3 mt -67.07 -56.24 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 107.434 -1.321 . . . . 0.82 107.434 -175.72 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -46.39 -58.15 4.0 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.968 0.907 . . . . 3.54 112.362 177.498 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.8 t -66.45 -31.1 71.64 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.19 0.596 . . . . 1.32 110.438 -176.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.5 t -66.26 -53.07 41.16 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.571 -0.705 . . . . 1.34 109.379 175.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 26' ' ' LEU . 1.9 mm? -52.86 -45.04 67.22 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.805 0.729 . . . . 2.22 112.183 -175.025 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.6 p -62.53 -9.39 8.52 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.705 0.631 . . . . 1.65 112.705 -176.344 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt -71.53 -37.15 71.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.752 0.821 . . . . 5.02 111.138 171.081 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -74.71 121.02 21.05 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.306 -0.627 . . . . 1.84 109.306 -167.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -77.84 62.6 2.71 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.164 0.586 . . . . 5.48 111.669 -176.134 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.47 42.8 0.06 OUTLIER Glycine 0 CA--C 1.526 0.719 0 N-CA-C 109.116 -1.593 . . . . 1.75 109.116 174.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.92 142.66 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 104.315 -2.476 . . . . 1.99 104.315 -178.757 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.3 tp -100.63 -45.42 5.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.67 1.188 . . . . 3.46 110.132 -179.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -162.05 151.25 15.74 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.719 -0.845 . . . . 1.87 108.719 -179.092 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.9 p -131.73 157.07 44.76 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 123.887 0.875 . . . . 2.98 108.937 173.227 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.1 t -170.8 121.43 0.57 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.817 -1.549 . . . . 1.75 106.817 176.172 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 44' ' ' ALA . 3.2 m -121.19 130.56 74.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.76 0.709 . . . . 1.66 110.178 178.311 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.3 133.83 53.33 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.349 1.06 . . . . 1.04 111.566 -173.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.18 -56.14 11.19 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 125.274 1.43 . . . . 2.55 110.665 -176.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.78 -47.61 76.78 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.186 0.594 . . . . 1.33 110.842 -174.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.72 -15.69 62.2 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.017 1.327 . . . . 1.97 111.29 177.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 48.53 42.34 18.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.134 1.774 . . . . 2.96 110.435 -170.691 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -123.84 132.94 53.86 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 124.092 0.957 . . . . 1.4 109.656 -165.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -102.4 117.3 34.42 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.284 1.033 . . . . 0.85 108.567 166.183 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.61 124.01 45.6 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.992 -1.855 . . . . 1.19 105.992 174.067 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 46' ' ' ILE . 3.2 mp -121.86 133.73 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.979 -1.119 . . . . 1.22 107.979 171.124 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -103.17 135.82 44.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.21 1.804 . . . . 2.17 106.707 161.205 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -168.66 178.95 4.47 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.976 1.31 . . . . 2.53 112.199 -165.777 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -110.34 74.7 0.87 Allowed Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.612 1.165 . . . . 4.17 108.985 -174.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -45.76 -48.17 12.71 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 124.452 3.435 . . . . 1.45 113.467 -165.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -51.71 -34.31 38.21 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.024 1.33 . . . . 4.76 112.236 -176.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.7 pt -95.22 -53.77 7.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 N-CA-C 112.228 0.455 . . . . 1.17 112.228 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.5 tt -72.35 -44.97 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-O 120.917 0.389 . . . . 1.78 111.195 -173.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.24 124.6 1.16 Allowed Glycine 0 CA--C 1.537 1.423 0 N-CA-C 110.846 -0.901 . . . . 0.94 110.846 -176.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -53.76 -33.19 69.37 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.034 2.489 . . . . 0.65 111.614 176.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -51.4 -46.0 62.7 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.809 0.843 . . . . 6.62 112.031 175.024 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -59.48 -56.37 22.81 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.603 0.716 . . . . 2.6 109.449 -176.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 89.1 mt -48.21 -62.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 124.187 0.995 . . . . 0.82 109.337 174.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.8 mt -54.22 -53.59 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 119.286 -0.388 . . . . 1.27 110.513 -173.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -65.12 -33.75 76.76 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.945 0.793 . . . . 2.6 112.365 -178.194 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 92.2 m -65.16 -50.8 64.57 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.362 -0.836 . . . . 0.7 109.473 176.159 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.4 mm -64.08 -42.63 96.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 O-C-N 121.651 -0.656 . . . . 1.83 110.647 -177.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -48.3 -62.28 1.57 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.445 1.498 . . . . 3.2 109.316 169.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.9 t -52.52 -40.82 62.89 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.596 1.158 . . . . 1.01 112.123 -179.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.46 -3.95 5.07 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 113.979 1.103 . . . . 2.01 113.979 178.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.76 50.63 1.93 Allowed Glycine 0 C--N 1.335 0.494 0 N-CA-C 110.12 -1.192 . . . . 0.63 110.12 171.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -138.82 169.31 18.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.886 0.875 . . . . 1.85 109.567 178.058 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -112.51 76.98 2.17 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 118.03 -0.986 . . . . 4.42 112.408 177.193 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.01 74.56 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 124.082 3.188 . . . . 1.2 113.151 -175.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.46 115.88 13.36 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.925 0.89 . . . . 2.36 109.493 173.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 tt -67.99 76.52 0.22 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.587 1.155 . . . . 3.18 108.666 170.564 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -44.07 -67.61 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 126.529 1.932 . . . . 3.47 112.048 -174.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.4 tttm 80.31 140.68 0.07 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.544 1.537 . . . . 7.25 109.839 176.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.6 mm 61.57 67.2 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 106.476 -1.675 . . . . 6.1 106.476 -160.46 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 C--O 1.252 1.223 0 C-N-CA 125.718 1.607 . . . . 10.53 109.952 -157.961 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 109.648 -0.501 . . . . 10.29 109.648 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.58 -42.12 55.86 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 108.744 -1.743 . . . . 4.62 108.744 167.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -67.4 158.19 32.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 129.248 3.019 . . . . 5.92 110.453 160.05 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.99 115.59 0.67 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.832 -0.507 . . . . 2.03 111.832 173.008 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.1 t -84.84 81.92 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.242 0 N-CA-C 106.063 -1.829 . . . . 2.47 106.063 156.097 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.1 tp -91.0 122.44 33.66 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.898 -1.149 . . . . 1.93 107.898 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -88.29 136.46 32.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.218 -1.03 . . . . 2.07 108.218 163.202 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.464 HD21 HD13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -126.79 133.97 50.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.087 -1.079 . . . . 1.89 108.087 157.118 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.36 143.12 14.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.564 -1.273 . . . . 1.16 107.564 163.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.7 m -135.79 85.16 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.327 1.051 . . . . 1.7 110.89 -170.196 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -62.29 139.72 58.51 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.007 -1.058 . . . . 5.94 109.864 -174.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 123.31 -24.67 6.51 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.733 -0.481 . . . . 1.63 112.765 175.831 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.457 ' SD ' HD12 ' A' ' 22' ' ' ILE . 64.5 mtm -59.97 152.63 23.23 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.262 1.031 . . . . 2.47 110.738 175.165 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.3 t -161.72 -59.39 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.1 0.56 . . . . 3.09 110.145 177.44 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.8 p -81.15 153.54 27.2 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.9 -0.5 . . . . 4.23 111.116 -176.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.84 -50.32 7.94 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 124.679 1.192 . . . . 1.96 111.656 -178.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 m -43.99 -40.85 5.0 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.072 1.349 . . . . 1.61 112.399 -178.217 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.3 m -47.78 -43.14 27.22 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.762 0.825 . . . . 1.46 110.939 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.4 t -50.89 -68.06 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 123.632 0.773 . . . . 0.76 108.99 179.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -27.39 69.18 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.76 -0.459 . . . . 1.1 109.76 -175.75 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -59.1 -54.62 45.0 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.808 -0.812 . . . . 3.19 108.808 179.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.52 ' HB ' HG11 ' A' ' 37' ' ' VAL . 19.8 mt -70.83 -52.68 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 108.463 -0.94 . . . . 0.97 108.463 -176.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.25 -52.11 29.24 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.347 0.659 . . . . 3.34 110.744 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -67.44 -47.51 69.96 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.246 0.619 . . . . 1.37 110.407 179.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.0 t -57.46 -25.36 59.58 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.847 -0.533 . . . . 1.29 111.98 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.54 -55.22 4.25 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.7 0.8 . . . . 2.98 112.088 171.401 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 41.5 p -71.64 66.38 0.51 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.274 1.029 . . . . 2.33 111.039 179.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.21 -43.45 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.279 1.832 . . . . 3.37 110.111 -176.329 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -76.98 142.66 39.87 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.415 -0.957 . . . . 4.52 108.415 173.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -60.55 165.71 3.61 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.093 -0.706 . . . . 6.35 109.093 173.124 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.41 -35.6 3.79 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-O 118.804 -0.998 . . . . 1.08 111.462 175.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.79 133.44 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 119.039 1.42 . . . . 2.28 107.894 163.417 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.26 -55.15 3.53 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.357 -1.349 . . . . 2.96 107.357 161.211 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -149.84 145.87 26.81 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.129 0.572 . . . . 2.18 110.366 -171.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.3 t -128.64 150.27 50.3 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 124.434 1.094 . . . . 1.96 108.237 177.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 51.1 m -148.18 132.33 17.34 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.49 -0.93 . . . . 1.75 108.49 153.286 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 44' ' ' ALA . 18.0 m -107.12 165.35 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 122.814 0.445 . . . . 1.76 110.623 171.059 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.42 136.69 19.94 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.581 0.752 . . . . 1.12 110.622 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.65 -56.1 6.47 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 123.922 0.889 . . . . 2.66 110.523 -176.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.54 -52.15 60.61 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 123.161 0.584 . . . . 1.55 110.127 -176.388 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 m -77.43 -3.19 39.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.889 0.876 . . . . 2.21 111.336 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 45.75 42.95 9.26 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.197 1.399 . . . . 3.29 110.225 -179.457 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -117.09 145.54 43.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.664 -0.698 . . . . 1.47 109.757 -164.114 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.621 ' HA ' HG12 ' A' ' 37' ' ' VAL . . . -116.92 118.77 33.36 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.545 -1.65 . . . . 0.75 106.545 156.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.89 134.57 40.84 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.774 -1.195 . . . . 0.96 107.774 163.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.464 HD13 HD21 ' A' ' 8' ' ' LEU . 4.6 mp -122.81 119.94 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 106.942 -1.503 . . . . 1.26 106.942 178.086 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -96.52 98.78 10.5 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.081 -1.451 . . . . 2.29 107.081 162.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -138.33 178.62 6.99 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.028 0.931 . . . . 2.31 110.935 -177.714 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -107.0 83.94 1.45 Allowed Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 125.01 1.324 . . . . 3.53 109.831 176.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -52.05 -23.51 17.27 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.187 2.591 . . . . 1.47 113.793 174.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -49.67 -41.14 42.23 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.473 0.579 . . . . 4.44 112.31 172.114 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 pt -107.3 -47.32 8.12 Favored 'Isoleucine or valine' 0 C--N 1.341 0.207 0 N-CA-C 113.701 1.0 . . . . 1.62 113.701 -166.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.2 tt -90.0 -123.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 106.372 -1.714 . . . . 2.02 106.372 172.339 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 177.73 160.18 23.88 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 120.406 1.457 . . . . 1.25 111.681 171.779 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.88 -42.1 26.33 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.084 3.189 . . . . 1.15 111.114 173.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -51.34 -54.22 28.41 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.018 0.527 . . . . 5.73 110.06 177.216 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.94 -54.84 7.61 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.093 1.757 . . . . 4.11 109.657 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.1 mt -57.97 -60.68 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.856 0.862 . . . . 0.87 109.972 178.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mp -48.29 -47.21 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.128 0.422 . . . . 1.74 110.39 -178.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -70.59 -33.28 70.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.366 0.666 . . . . 2.33 111.777 -178.174 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.2 m -59.64 -54.89 41.15 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.372 -0.83 . . . . 0.8 108.801 170.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.1 mm -58.09 -44.49 87.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.625 0.77 . . . . 1.34 111.421 -178.254 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -49.99 -56.63 9.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.001 1.32 . . . . 2.9 109.123 170.265 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.3 m -58.03 -36.03 72.15 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.793 0.664 . . . . 1.91 112.793 178.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.87 -17.47 64.32 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.543 -0.723 . . . . 2.35 112.209 174.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.17 37.49 9.07 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.665 -0.974 . . . . 1.2 110.665 -178.335 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.425 ' CD2' HD11 ' A' ' 22' ' ' ILE . 27.0 m-85 -125.02 151.26 45.82 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.049 -1.463 . . . . 1.97 107.049 165.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -104.76 101.09 26.8 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 124.835 1.254 . . . . 5.54 110.049 -169.092 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -76.22 158.56 37.35 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.391 1.394 . . . . 1.67 113.147 -171.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.0 m -155.27 133.42 11.59 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.758 -1.571 . . . . 1.9 106.758 164.047 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 pp -53.67 148.19 10.2 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.819 0.736 . . . . 3.32 111.221 174.401 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 t 20.84 90.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 129.072 2.949 . . . . 6.71 114.065 166.147 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -138.91 174.68 10.27 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.368 1.467 . . . . 11.89 108.744 176.201 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.6 pt -87.94 -170.9 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.078 1.351 . . . . 10.05 109.891 174.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 117.673 -1.156 . . . . 15.1 113.011 -169.113 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.402 ' N ' ' OE2' ' A' ' 51' ' ' GLU . 74.6 mtm . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 108.903 -0.777 . . . . 8.39 108.903 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.88 39.19 64.93 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.529 -0.595 . . . . 4.26 113.047 172.591 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -175.92 166.85 3.05 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.903 2.481 . . . . 4.8 106.468 157.356 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.3 -8.01 0.89 Allowed Glycine 0 CA--C 1.54 1.612 0 C-N-CA 126.25 1.881 . . . . 3.72 114.859 168.025 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t 31.29 70.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 120.442 2.121 . . . . 2.11 113.517 -174.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.29 104.09 15.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.339 -1.356 . . . . 2.31 107.339 179.061 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -84.15 116.22 22.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.828 -1.175 . . . . 2.13 107.828 162.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.7 pp -115.96 161.51 18.74 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.89 -1.152 . . . . 1.86 107.89 164.23 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.6 t -112.3 145.95 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 107.064 -1.458 . . . . 0.94 107.064 171.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -176.41 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.679 1.192 . . . . 2.57 108.517 -176.53 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -135.23 164.81 26.85 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.197 -2.149 . . . . 4.98 105.197 167.225 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.7 -0.36 89.57 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.575 -0.57 . . . . 1.05 113.731 171.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.4 mtp -73.77 74.33 1.57 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.817 1.308 . . . . 2.02 108.78 172.543 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 t -88.53 0.27 56.5 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.802 1.038 . . . . 2.26 113.802 -167.208 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.6 t -165.79 159.08 15.76 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 120.004 1.274 . . . . 2.97 110.195 -173.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.32 -38.97 13.77 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.874 1.27 . . . . 2.35 111.092 170.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -44.64 -50.15 9.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.997 0.919 . . . . 1.71 111.023 171.512 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.3 m -61.31 -45.43 94.49 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.713 -0.617 . . . . 0.84 109.991 -177.528 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.9 t -48.88 -60.08 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 C-N-CA 123.683 0.793 . . . . 0.68 108.897 176.335 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -33.44 75.74 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 116.579 -0.282 . . . . 1.28 110.359 -176.336 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -60.24 -45.54 92.88 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 108.64 -0.874 . . . . 2.82 108.64 -178.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.545 HG22 HD23 ' A' ' 26' ' ' LEU . 78.2 mt -70.66 -61.47 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 106.18 -1.785 . . . . 0.58 106.18 -178.441 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -37.19 -64.61 0.36 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.541 1.536 . . . . 4.72 110.701 -179.123 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.9 p -58.42 -41.16 84.38 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.612 -0.722 . . . . 2.39 109.941 -173.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.1 t -71.23 -20.12 62.29 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.914 0.886 . . . . 0.8 112.553 -178.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.545 HD23 HG22 ' A' ' 22' ' ' ILE . 3.7 mm? -81.32 -57.75 3.35 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 118.634 0.652 . . . . 2.26 110.56 167.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.6 p -56.5 -32.39 64.99 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.162 0.437 . . . . 1.6 111.103 -176.265 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.5 tptt -37.03 -54.13 0.97 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.911 1.684 . . . . 4.59 113.895 161.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -90.36 149.89 22.11 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.069 0.85 . . . . 4.23 112.621 -165.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -59.02 154.82 14.74 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.803 -0.635 . . . . 7.69 110.535 175.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.11 24.25 66.91 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.5 -0.611 . . . . 1.63 113.339 170.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.4 HD11 HG23 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -98.43 138.44 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 104.399 -2.445 . . . . 1.93 104.399 156.002 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.3 mt -97.77 -45.86 6.18 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.441 1.096 . . . . 3.45 109.026 178.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -160.36 133.51 6.69 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.286 -0.635 . . . . 1.82 109.286 179.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.0 t -109.21 143.08 39.12 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.644 -0.873 . . . . 1.95 108.644 176.182 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.1 t -154.64 109.52 3.05 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.033 -0.729 . . . . 1.47 109.033 168.594 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.543 HG11 HG21 ' A' ' 22' ' ' ILE . 3.1 m -104.89 145.81 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 123.19 0.596 . . . . 1.83 110.239 172.248 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.36 134.48 46.34 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 124.634 1.174 . . . . 1.17 110.846 -174.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.5 mt -72.23 -49.41 35.35 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.816 1.247 . . . . 2.83 111.073 -175.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.5 -32.09 68.48 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.037 0.535 . . . . 1.38 111.375 -170.045 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 t -108.32 2.5 22.63 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.313 1.045 . . . . 2.87 111.431 179.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 41.12 41.78 1.43 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.653 1.981 . . . . 3.93 111.067 -172.513 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -99.08 149.8 22.66 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.606 -0.887 . . . . 1.41 108.606 -174.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.48 114.58 21.46 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.69 -1.226 . . . . 0.71 107.69 159.359 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.84 133.36 38.65 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.873 -1.158 . . . . 0.95 107.873 163.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.4 HG23 HD11 ' A' ' 32' ' ' ILE . 3.6 mp -121.59 122.75 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 106.851 -1.537 . . . . 1.06 106.851 172.207 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -92.2 127.52 37.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 105.773 -1.936 . . . . 3.11 105.773 157.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -166.82 161.37 15.32 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 126.289 1.836 . . . . 2.0 107.967 -167.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -98.21 95.34 2.78 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.448 0.699 . . . . 4.15 109.833 -174.329 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -58.55 -32.14 95.93 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.637 2.225 . . . . 1.56 111.709 -176.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.402 ' OE2' ' N ' ' A' ' 1' ' ' MET . 33.2 mt-10 -61.19 -15.8 38.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.033 1.333 . . . . 3.69 112.955 -178.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 pt -123.49 -49.06 2.3 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 N-CA-C 114.019 1.118 . . . . 1.37 114.019 -178.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.426 HG23 ' H ' ' A' ' 54' ' ' GLY . 17.9 tt -90.19 -70.11 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 118.462 0.574 . . . . 1.18 109.97 178.509 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.426 ' H ' HG23 ' A' ' 53' ' ' ILE . . . 117.72 149.09 8.81 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 123.605 0.622 . . . . 0.7 112.12 178.487 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.41 -39.57 9.49 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.72 2.947 . . . . 1.1 111.733 179.509 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -51.27 -56.25 13.93 Favored 'General case' 0 C--O 1.226 -0.159 0 C-N-CA 122.595 0.358 . . . . 5.67 110.504 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -49.25 -47.45 46.52 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.014 1.725 . . . . 4.93 110.842 179.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.0 mt -58.32 -54.16 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 118.992 -0.528 . . . . 0.83 110.424 174.003 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.7 mt -52.41 -45.36 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 119.203 0.91 . . . . 1.43 110.703 177.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -58.33 -44.83 88.84 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.288 0.635 . . . . 3.89 110.262 176.249 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 56.7 m -60.17 -54.4 46.25 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 121.776 -0.577 . . . . 1.01 109.635 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.9 mm -58.8 -42.01 84.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 121.867 -0.521 . . . . 1.33 110.829 -178.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -53.02 -65.33 0.58 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.683 0.793 . . . . 3.17 109.415 171.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.4 t -54.77 -36.55 64.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.148 1.379 . . . . 1.1 112.457 -174.564 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.76 -12.6 25.16 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.244 0.831 . . . . 2.25 113.244 176.79 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.26 44.72 1.23 Allowed Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.604 1.097 . . . . 0.68 111.18 169.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -141.62 174.04 10.94 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.554 0.741 . . . . 2.14 109.108 178.285 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -113.75 76.71 3.19 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 123.706 0.802 . . . . 4.1 112.177 -177.252 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.04 133.37 26.7 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 121.765 1.643 . . . . 1.4 111.929 -177.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.6 t -139.08 151.91 47.11 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.524 1.129 . . . . 2.83 108.208 167.425 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.5 mt -66.68 145.1 55.92 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.765 -1.198 . . . . 3.26 107.765 161.482 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 64.2 t -145.39 -77.54 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 105.297 -2.112 . . . . 4.0 105.297 175.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt 64.39 -73.04 0.06 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.08 1.352 . . . . 6.74 111.665 -179.126 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.1 mm -111.31 65.87 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 107.378 -1.342 . . . . 6.16 107.378 -176.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 124.639 1.175 . . . . 10.95 110.8 -173.852 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 108.542 -0.91 . . . . 13.23 108.542 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.69 62.59 0.82 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 106.846 -2.502 . . . . 6.02 106.846 -169.006 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -109.57 -128.97 0.28 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.963 0.905 . . . . 8.2 109.786 -153.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.07 -38.07 1.06 Allowed Glycine 0 C--N 1.335 0.507 0 N-CA-C 109.499 -1.44 . . . . 2.86 109.499 179.534 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -137.6 159.11 34.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 C-N-CA 123.306 0.643 . . . . 2.66 111.613 -176.774 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.9 tp -150.79 156.43 41.25 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.564 1.946 . . . . 2.15 106.34 174.171 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -124.04 155.09 38.92 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.761 0.824 . . . . 2.48 109.577 176.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.422 HD13 ' N ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -150.74 141.98 23.22 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.804 0.842 . . . . 2.72 109.126 175.192 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.6 t -90.97 131.32 38.43 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 C-N-CA 125.685 1.594 . . . . 0.85 107.142 177.123 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.619 HG12 ' HB3' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -126.35 78.43 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 122.454 1.121 . . . . 1.45 110.487 -166.539 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.9 mtm105 -58.34 133.34 55.63 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.041 -1.096 . . . . 5.57 108.041 170.254 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.32 -32.96 3.43 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.578 1.085 . . . . 0.96 110.391 -171.108 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 55.8 mtm -60.85 144.62 52.39 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.327 -1.102 . . . . 2.33 108.489 163.51 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.4 t -164.42 -65.56 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.777 0.431 . . . . 3.05 110.407 -177.273 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -79.46 -75.69 0.24 Allowed 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.131 -0.356 . . . . 3.75 111.78 -168.809 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -167.67 -66.1 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.322 0.649 . . . . 1.95 109.494 -175.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.6 t -49.53 -38.4 30.59 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.513 0.725 . . . . 2.25 111.52 -171.185 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 95.4 m -39.25 -37.97 0.47 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.999 1.32 . . . . 0.94 112.68 174.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 72.0 t -51.74 -71.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 123.401 0.68 . . . . 0.93 110.251 173.096 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -27.68 69.31 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.12 -0.988 . . . . 1.48 110.626 -176.611 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -54.25 -41.89 69.29 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 124.224 1.009 . . . . 3.04 109.425 174.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.6 mt -78.33 -64.23 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.499 -1.297 . . . . 0.82 107.499 176.071 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -48.86 -57.71 5.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.79 1.236 . . . . 3.19 111.07 -169.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 t -75.25 0.19 17.39 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.863 0.865 . . . . 1.84 112.27 -176.258 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.6 t -98.72 -37.36 9.51 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.662 1.185 . . . . 0.83 109.996 173.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -63.75 -45.29 90.52 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 118.844 0.747 . . . . 2.51 111.052 173.323 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.3 p -64.84 80.45 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.194 0.598 . . . . 2.04 110.817 -172.246 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt 164.95 -33.88 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.853 2.861 . . . . 5.06 110.766 -176.055 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -50.6 118.82 3.31 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.323 0.51 . . . . 1.92 110.036 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -71.09 77.56 0.68 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.009 0.923 . . . . 5.4 110.547 -168.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.53 -16.83 0.98 Allowed Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.658 1.123 . . . . 1.17 111.27 -175.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.84 145.41 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 107.136 -1.431 . . . . 1.92 107.136 162.457 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.5 mt -108.2 -43.83 4.29 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.496 1.518 . . . . 2.89 108.761 170.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -164.5 159.77 19.71 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 108.578 -0.897 . . . . 2.73 108.578 -178.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.4 p -133.85 160.93 36.16 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.751 1.22 . . . . 2.84 107.919 173.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 m -153.42 117.44 4.81 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.509 -1.293 . . . . 1.96 107.509 161.26 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 p -106.2 153.16 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-N 118.712 0.687 . . . . 2.34 111.364 174.222 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.83 135.55 22.16 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.683 -0.635 . . . . 0.91 110.404 170.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.35 -37.6 63.47 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-N 115.45 -0.796 . . . . 1.37 110.493 -178.673 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.91 -47.0 84.12 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.13 0.572 . . . . 1.15 110.604 179.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.84 -11.1 59.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.217 1.007 . . . . 2.38 111.107 175.643 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 46.44 40.33 7.85 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.737 2.015 . . . . 2.95 111.696 -167.604 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -132.25 144.17 50.43 Favored 'General case' 0 C--O 1.228 -0.034 0 CA-C-O 119.375 -0.345 . . . . 1.63 111.126 -167.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -105.0 136.63 44.11 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.331 -0.989 . . . . 0.86 108.331 155.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -96.31 145.17 25.83 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.41 -1.329 . . . . 1.46 107.41 148.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 56.5 mt -125.68 132.71 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.086 -1.449 . . . . 2.02 107.086 167.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -96.87 128.95 44.32 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 105.382 -2.081 . . . . 2.63 105.382 160.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -166.66 161.36 15.72 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.684 1.594 . . . . 2.43 108.757 -176.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -97.01 109.5 49.46 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 123.419 0.687 . . . . 3.36 109.433 176.574 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.52 29.07 0.43 Allowed 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.605 2.204 . . . . 1.61 113.254 -176.361 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -123.12 1.36 9.17 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.619 1.168 . . . . 3.48 111.017 -176.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -129.64 -67.88 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.229 0 C-N-CA 123.514 0.726 . . . . 1.47 110.488 178.443 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.6 tt -80.0 -49.12 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.515 0.674 . . . . 1.72 110.424 -175.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.26 161.35 34.21 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.109 0.862 . . . . 0.97 111.953 174.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -64.8 -34.94 47.76 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.482 2.788 . . . . 1.05 111.715 -177.4 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -53.44 -58.96 5.28 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.702 0.801 . . . . 5.65 111.284 -175.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -44.96 -57.31 3.89 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.226 1.01 . . . . 2.81 110.752 177.23 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 76.9 mt -56.09 -61.63 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 114.588 -1.187 . . . . 1.04 109.835 -177.358 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.0 mt -58.09 -42.66 83.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 121.937 -0.477 . . . . 1.41 111.098 -176.097 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 57.7 m170 -58.46 -46.58 86.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.778 0.717 . . . . 3.51 109.959 176.116 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 m -58.45 -57.48 12.74 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.414 -0.587 . . . . 0.77 109.414 177.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.5 mm -61.45 -35.23 65.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 118.817 0.735 . . . . 1.83 111.662 -174.292 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -53.11 -68.8 0.14 Allowed 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 109.293 -0.632 . . . . 3.44 109.293 168.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.6 t -62.38 -21.16 65.13 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.897 0.702 . . . . 1.43 112.897 -174.087 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.4 tp -65.65 -18.44 65.33 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.264 1.425 . . . . 2.47 111.097 174.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.17 43.56 0.6 Allowed Glycine 0 C--N 1.337 0.591 0 C-N-CA 125.285 1.421 . . . . 0.69 110.851 168.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.619 ' HB3' HG12 ' A' ' 10' ' ' VAL . 64.1 m-85 -146.54 178.83 7.98 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 117.394 0.597 . . . . 1.77 110.028 -177.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.99 87.5 47.23 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 123.848 0.859 . . . . 5.44 109.851 172.385 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.16 75.86 4.06 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 124.303 3.335 . . . . 1.86 111.015 -175.379 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.3 t -71.82 150.81 43.98 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.161 -0.681 . . . . 2.38 109.161 175.111 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.2 tp -60.27 144.92 49.24 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.919 -1.511 . . . . 3.46 106.919 164.156 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.3 t -59.7 -57.01 13.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 N-CA-C 109.83 -0.433 . . . . 4.58 109.83 179.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.9 tptp 66.89 129.25 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.713 2.005 . . . . 8.44 110.814 -168.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 44.6 mm -73.85 118.4 19.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.262 -1.384 . . . . 5.91 107.262 171.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 . . . . . 0 C--O 1.248 1.022 0 C-N-CA 129.559 3.143 . . . . 10.41 103.932 178.894 . . . . . . . . 0 0 . 1 stop_ save_